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Governance and Major Affiliations
The Laboratory is governed by a 25-member Board of Trustees which meets three or four
times a year. Authority to act for the Board of Trustees between meetings is vested in the
Executive Committee of the Board of Trustees. The Executive Committee is composed of
the Officers of the Board plus any other members who may be elected to the Executive
Committee by the Board of Trustees. Additional standing and ad hoc committees are ap-
pointed by the Board of Trustees to provide guidance and advice in specific areas of the
Laboratory's operations.
Representation on the Board of Trustees itself is divided between community represen-
tatives and scientists from major research institutions. Ten such institutions are presently
represented on the Board of Trustees: Albert Einstein College of Medicine, Columbia Uni-
versity, Duke University, Princeton University, Massachusetts Institute of Technology, Mem-
orial Sloan-Kettering Cancer Center, New York University, The Rockefeller University, The
State University of New York at Stony Brook, and Yale University.
Institutional Trustees were brought onto the Board during the 1960s-a difficult period
when the Laboratory was undergoing reorganization as an independent entity. In addition
to supplying scientific leadership to the governing body, participating institutions also pro-
vided emergency funds to help keep the Laboratory afloat during this crucial phase of de-
velopment. Although participating institutions now give only token financial support, their
Trustees continue to help steer the course of the Laboratory's scientific and administrative
policies.
Also represented as participating institutions are the Wawepex Society and the Long
Island Biological Association (LIBA). The Wawepex Society was formed in the mid-nine-
teenth century as a philanthropic arm of the Jones family, who supported the formation of
the Laboratory. LIBA's origins began in 1890 when members of the local community be-
came involved as friends and with membership on the Board of Managers of the Biological
Station in Cold Spring Harbor, under the aegis of the Brooklyn Academy of Arts and Sci-
ences. When the Brooklyn Academy withdrew its support of the Biological Station, commu-
nity leaders, in 1924, organized their own association that actually administered the Labo-
ratory until the Laboratory's reorganization as an independent unit in 1962. Today, LIBA
remains a nonprofit organization organized under the Department of Social Welfare of the
State of New York and represents a growing constituency of "friends of the Laboratory." Its
450 member families support the Laboratory through annual contributions and participa-
tion in fund drives to raise money for major construction projects.
The Laboratory is chartered as an educational and research institution by the Board of
Regents of the Education Department of the State of New York. It is designated as a "public
charity" by the Internal Revenue Service and claims special status as a school under the
Internal Revenue Code.
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DIRECTOR'S
REPORT
Much more than it realizes, our nation now faces the choice of how to
deal with the great scientific revolutions whose consequences increasingly domi-
nate the quality of human life. Whether we use or misuse this new science will
determine whether our now old and venerable Western Civilization can be main-
tained or whether it will collapse into a form of modern feudalism marked by con-
formity to arbitrary ideals and a reluctance to question ideas and customs al-
ready in use. Past history provides no example of a civilization that did not
eventually dig its own grave and great achievements like the Taj Mahal have oc-
curred when the tide was already turning.
In particular, we must face the fact that the human brain is probably no more
effective than it was at the time of the American Revolution, or for that matter
during the reign of the Pharaohs. Yet the world's affairs move incredibly faster,
with the implications of single human acts having infinitely greater long-term con-
sequences. So we have to develop institutions that allow us to react better to the
rapid changes of the moment without stifling our capacity for self-expression and
innovation. Today, our most perplexing concerns arise from the consequences of
modern physics and the development of nuclear weapons. Their use on even a
modest scale would destroy the essence of Western Civilization, leaving what-
ever population remained so mesmerized by fear of a recurrence that it would be
likely to trade off freedom as we know it today in the West for easy assurances,
no matter how hollow, that the holocaust would never be repeated.
It is just 40 years since Hiroshima entered our vocabularies, and yet the imme-
diate horror of the apocalypse that it epitomized is now, more often than not, re-
placed with an uneasy satisfaction that the threat of mutual annihilation will keep
the peace. Initially I would have thought that the possession of just a few dozen
atomic bombs and perhaps only one or two hydrogen bombs would scare off
even the most fearless. Today, however, we find ourselves and our putative en-
emy, the Russians, with tens of thousands of nuclear weapons, all too many of
which are encased in delivery vehicles that have reduced the time between deci-
sion to strike and indescribable destruction to mere minutes. So as each year
passes, the chance of our respective military establishments knowing how to act
and react during any nuclear exchange becomes more and more remote. But
like all too many cancers, we know not how to remove the nuclear triggers from
our lives.
It is thus natural to want to believe that modern science, having first given us
nuclear weapons, would someday be able to provide the magic bullets that
would flick them off course to explode harmlessly in the desolation of outer
space. Today, in fact, we are told that given some 50-1000 billion dollars and the
active participation of our nation's brightest, we might some 15-20 years from
now throw up a shield of powerful laser beams that would knock down the major-
ity of intruders and let us retain the capacity to get back at any power so insane
as to believe that we can be defeated. Conceivably, this modern form of Maginot
Line might actually work as planned, giving us the capacity to retaliate against
any evil force that would enslave us.
But before devoting such a large fraction of our national creative talent to this
purpose, we must ask what level of contingency planning does this Star Wars
response represent. In my opinion, we are reacting to a very, very low probability
event, merely because if it were to happen, it would be so catastrophic. That the
collective Russian leadership would actually ever believe that it could win a nu-
clear exchange, no matter how one-sided, strikes me as a most improbable
event. Much more likely, though also a very improbable event, would be the fail-
ure of our nation's soundest bank, the Morgan Bank, followed by a complete col-
lapse of the world's financial institutions. Yet today I suspect that not one treas-
urer of a major world corporation is devoting any of his real resources to the
consequences of such a total banking collapse. Assuming the worst possible
outcome is not the way successful individuals, banks, or nations run their daily
lives. If they have the money, they take out just enough insurance (weapons) to
survive a finitely calculable misfortune. Most certainly I would be thought silly, if
not insane, to spend most of my funds on life insurance, leaving virtually no
money to feed, house, educate, or medically protect my family.
The counter arguments, of course, can be made that as biologists we are too
inexperienced to think in a military way and, even more important, that we are
too small a lobby ever to influence major national priorities. So, no matter how
we feel, we should sit tight, not unnecessarily make enemies in the wrong places,
and leave to others the task of controlling the arms race. This is a position I can-
not subscribe to as long as I feel that Star Wars money could be spent much
more wisely to prevent tragedies that we know will actually happen.
Now that we at last have the means to finally understand the molecular nature
of cancer, it would be at best perverse for us not to find the added monies neces-
sary to deploy this knowledge for the human good within the lifetimes of those
we love. Today, not 20 years distant, is the time to find out, say, the molecular
defects that make a breast cell cancerous. Yet at this moment, even though can-
cer research is still better funded than all other parts of biology (but not phys-
ics! ), there is not enough money for even our major laboratories to push ahead
full speed. We are now half-throttled back, often spending more time worrying
about money than our science. Instead, our recent great successes in the isola-
tion and molecular dissection of oncogenes should be followed up by a national
commitment, expressed by our President himself, to go forward with cancer re-
search even faster. By so behaving as a nation, we would be living up to our
greatest potential as humans, the capacity for accumulating the self-knowledge
that will let us live even more meaningful lives.
Until such a turnabout in national priorities occurs, I fear that an ever-increas-
ing malaise will spread through our lives as biologists. Up till now, our scientific
system has worked well because we could treat our younger scientists with the
respect they deserve. It is they who do most of the experiments that our more
senior scientists talk about. So when they succeed, they should know that they,
like their bosses at the moment, will soon be able to set up their own labs and
test out their own ideas. Today, however, even our most talented younger scien-
tists live with the fear that they will not get research grants of a size sufficient to
let them do effective science. This situation cannot go on too much longer with-
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out destroying the civility of the peer review system that up till now has worked
so well to support our country's science. Without some form of major upward fi-
nancial readjustment, it will be all too clear that one's success in getting a grant
will be at the expense of another equally talented scientist's potential for doing
science. So, hopefully, the greatly enlarged funds available to the Howard
Hughes Medical Research Institute can very soon be used to help the essential
fabric of biology and medical research temporarily survive while our nation reas-
sesses our national priorities.
Even the Howard Hughes monies, however, will not be enough to let today's
biologists do all the jobs of which they are now capable. I would guess that we
shall need at least a fifty percent increase in total funds (toward 10 billion dollars)
to generate the new facts that will let us not only handle current, immediate chal-
lenges like AIDS, but also respond to the fact that as our nation ages, we must
produce the medical advances that will allow many more of our over-65 popula-
tion to continue to work productively. What thus represents the self-interests of
today's biologists and medical research communities should serve equally well
the long-term interests of our nation as a whole.
We thus must not be alarmed that an ever-growing part of our national wealth
must go not only to biological research, but also to the other forms of science
whose futures look equally bright. Instead, we would have every reason to worry
if we thought that our national scientific effort could stay constant while the grow-
ing impact of the world's vast population increase continues to present us with
dilemmas, both practical and ethical, which at a minimum must be called daunt-
ing. In the long run, the effective limit for our scientific efforts is likely to be the
educational aspirations of our population. With the world changing so fast, we
have no reason to believe that our nation will remain a leading power if the peo-
ples of other countries have a greater desire to learn the facts necessary to take
up the new technologies of the future. There is no reason at all to believe that if
we lose the will to move ahead, then other people will drop out at the same time.
Our only sensible course is to look as far into the future as possible, make intel-
ligent guesses as to what will and will not happen, and act accordingly. Those
nations who so arrange their affairs will have the best chance to have long-term
destinies for the civilizations they promote.
HIGHLIGHTS OF THE YEAR
Using Yeast Cells to Understand Human Cancer
Over the past several years, Mike Wig ler and his research group have focused
much of their research on a group of three human ras genes, mutations in which
lead to the cancerous phenotype. Each of these ras genes codes for one of a
closely related set of small (189 amino acids) proteins that associate with the in-
ner surfaces of the outer cytoplasmic membrane of cells and that bind GTP
(GDP). These two characteristics suggested that the ras proteins might be func-
tionally related to the so-called "G proteins" that mediate the transmission of sig-
nals from cell-surface receptors to the membrane-bound enzyme adenyl cyclase
which converts ATP to cyclic AMP (cAMP), the key intracellular regulator. Be-
cause the ras proteins are present in relatively small amounts in cells, the effec-
tive purification and characterization of these proteins from cancer cells have
proved very difficult, and the working out of how they function at the molecular
level has not been straightforward.
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Wigler's group has thus recently directed much of its attention to the two RAS
proteins of yeast whose structures are very similar to those of mammalian cells
and whose functioning is required for yeast cell growth. Most importantly, the
powerful new recombinant DNA procedures for introducing genetic information
into yeast allow a genetic analysis far more subtle than would ever be possible
with mammalian cells. Through such experiments they have shown that the same
amino acid replacements that generate cancer-producing ras proteins in mam-
malian cells lead to metabolically out-of-control yeast cells that overproduce
cAMP. Further evidence favoring regulation of cAMP production by the RAS pro-
teins comes from analysis of a special class of yeast mutants that compensate for
the absence of functional RAS genes. These genes that effectively suppress the
RAS phenotype have been shown by Matsumoto in Japan to code for the regula-
tory subunit of the protein kinase normally controlled by cAMP. Thus, mutants
that lead to the absence of the regulatory subunit need not require cAMP for ki-
nase activation. Hence, they have the ability to survive in the absence of the RAS
proteins whose presence is normally required to make cAMP. These very impor-
tant experiments confirm the now almost forgotten mania of some 12 years ago
when the cAMP levels of many cancer cells were found to be abnormally high
and the essence of cancer was proclaimed to be an excess of cAMP. Though this
hypothesis clearly understates the true complexity of cancer, it is now clear that
one must think about cAMP levels if we are to have a serious understanding of
the metabolic uniqueness of many forms of cancer.
The Loss of a Superb Administrator
It was with sadness that we bid farewell to Administrative Director Bill Udry at the
end of the year. Bill came to us in late 1970, after serving as Chief Executive
Officer of the Eye Research Institute of Bethesda, Maryland. A skillful administra-
tor, he introduced professional management to our then financially uinsophisti-
cated institution. His advice at many levels, from the receipt of the first Cancer
Center grant in 1971, through the renovation of our once highly decrepit physical
plant, to initiating construction on the Grace Auditorium, was a crucial factor in
the development of this Laboratory over the past 15 years.
Bill's departure created a large gap in our administrative infrastructure, which
was exacerbated by my own slow recovery from injuries sustained in a wretched
car accident in December. It is a tribute to Bill that the senior administrative staff
selected and trained during his tenure pitched in admirably to close the breach
during this difficult period.
Changes in Our Scientific Staff
The Laboratory's great success in recent years has been built upon a steady in-
flux of young scientists, to whom we give virtually unlimited intellectual freedom
and few administrative duties. Under this system, the Laboratory has nurtured
the early careers of many molecular biologists who have since risen to promi-
nence. Although we benefit greatly from the intellectual fervor of youth, it is a sadfact that we cannot permanently absorb a large number of mature scientists.
Due to a lack of endowed research appointments, we often cannot offer the
security-and, increasingly, the salaries-offered by major universities and com-
panies. Thus, we are forced to contend with a high turnover in our staff. Though
we have come to accept this fact of life, we are always saddened to face the
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departure of long-valued staff members. This is tempered by the knowledge that
they have accepted positions at some of the foremost universities and compa-
nies in the country.
Tom Broker and Louise Chow left their Senior Scientist positions in July to es-
tablish a new electron microscopy unit at the University of Rochester. Tom and
Louise arrived in 1975, after serving post- and predoctoral periods, respectively,
in Norm Davidson's lab at Caltech. Even before coming here, they had estab-
lished themselves as leaders in the electron microscopy of nucleic acids. In
1977, their superb photos did much to first establish the phenomenon of RNA
splicing.
Jeff Strathern left his Senior Scientist position in June to head up a research
group at the Frederick Cancer Research Facility. Jeff arrived in 1977 from Ira
Herskowitz's lab to organize, with Jim Hicks, the Debi-Lick (then Davenport) Yeast
Group. In 1979, Jeff, Jim Hicks, Amar Klar, and Jim Broach firmly established
yeast as a major system for studying development when they showed at the mo-
lecular level that mating-type switches in Saccharomyces cerevisiae are achieved
through the movement of genetic cassettes.
Also leaving for the Frederick Cancer Research Facility was Steve Hughes.
After serving a postdoctoral period with the Bishop-Varmus group in San Fran-
cisco, Steve came to the Laboratory in 1979 as a Senior Staff Investigator. Our
first neurobiology appointment in 1978, Birgit Zipser left in December from her
position as a Senior Staff Investigator for a visiting professorship at the National
Institutes of Health. Senior Staff Investigator Ron McKay, a tumor virologist
turned neurobiologist, left in July to accept an associate professorship at MIT. In
1980, Ron and Birgit helped revolutionize neurobiology when they developed
cell fusion techniques to produce monoclonal antibodies against leech neural an-
tigens.
After ten years at the Laboratory, Bill Topp accepted a position as President of
Otisville Biotech, Inc., in upstate New York. Bill came to us in 1974 as a postdoc-
toral fellow in Bob Pollack's mammalian cell genetics unit and advanced in 1978
to Senior Staff Investigator working in James lab. Leaving in October for an as-
sistant professorship at Princeton was Lee Silver, who came to us as a Senior
Staff Investigator in 1981 to begin our effort in mouse embryology. After scoring
a major coup by showing that two oncogenic functions are required to transform
primary cells, Earl Ruley left his Senior Staff Investigator position for an assistant
professorship appointment at MIT.
Accepting a position at the College of Physicians & Surgeons of Columbia Uni-
versity was Staff Investigator Mitch Goldfarb, who worked with Mike Wigler over
the last four years and played a key role in isolating the ras oncogenes. Jim Lin,
a Staff Investigator in McClintock who developed many of the first monoclonal
antibodies against cytoskeletal proteins, left in February for an assistant profes-
sorship at Iowa State University. A native of Italy, Staff Investigator Mara Rossini
accepted a position with the biotechnology firm SCLAVO in Siena. Returning to
Exxon Research and Engineering Company in Clinton, New Jersey, following
joint appointments at Cold Spring Harbor, were Susan Bonitz and Dan Lundell.
Visiting scientists Pei-Mao Lin and Guang-Yun Cai returned to the People's Re-
public of China, while Jin-Zhao Li took a position at Downstate Medical Center in
Brooklyn. Kristen Frederiksen relocated to MIT with Ron McKay's research
group.
Leaving after their postdoctoral periods were Bill Huse to become an assistant
professor at Yale in Chuck Stevens' neurobiology program; Prasad Koka to the
Louise Chow and Tom Broker
Jeff Strathern
Center for Cancer Research at MIT; Nita Maihle to work with Steve Hughes at the
Frederick Cancer Research Facility; Paul Mains to the Department of Molecular,
Cellular and Developmental Biology at the University of Colorado; Kazuo Maruy-
ama to MIT with Earl Ruley; Olof Sundin to the MRC Laboratory in Cambridge;
Elizabeth (B.J.) Taparowski to continue postdoctoral work at the University of Vir-
ginia; Stuart Weisbrod to pursue a MBA degree at Columbia Business School;
and Bob Weiss to the University of Utah.
Joining the Laboratory in 1984 as Senior Staff Investigator was Clive Slaughter.
Clive came to us from the University of Texas Health Science Center at Dallas to
reestablish a major focus in protein chemistry in the new Demerec extension. Pab-
lo Scolnick, formerly a research associate at the University of Chicago, also set
up a laboratory in the Demerec extension. Pablo studies gene expression and
carotenoid biosynthesis in Rhodopseudomonas and tomatoes.
During the year, both Russell Malmberg and David Beach were promoted to
Senior Staff Investigator from Staff Investigator positions. Russell studies the role
of polyamines in tobacco flower development, and David's studies focus on cell-
cycle control in fission yeast. Receiving promotions from Postdoctoral Fellow to
Staff Investigator were Steve Dellaporta, Bob Franza, Doug Hanahan, Winship
Herr, and Bill Welch. After completing his dissertation under our joint Ph.D. pro-
gram in genetics with Stony Brook, Rich Kostriken began a postdoctoral fellow-
ship with Mark Zoller.
Jim Feramisco Appointed to Rolling Five Position
In April, the Trustees of the Laboratory approved the promotion of Jim Feramisco
to Senior Scientist in recognition of his work in focusing the efforts of McClintock
lab on the cell biochemistry of oncogenic proteins. Jim came to Cold Spring Har-
bor in 1978 as a postdoctoral fellow in our Cell Biology Group. With Guenter Al-
brecht-Buehler's departure in 1982, Jim assumed leadership of the cell biology
effort.
Our Senior Scientist rank carries with it a "rolling" five-year appointment, which
means that the position will be funded continuously for a minimum of five years
from any point in time. Our closest approximation to tenure for almost all our sen-
ior staff, the rolling five falls short of the job security offered by universities and
industry. Thus, over the next several years, we must work hard to establish sev-
eral tenured research professorships funded by hard money if we are to remain
competitive for the top echelon of mature scientists.
Joe Sambrook F.R.S.
In March of this year, the Fellows of the Royal Society, meeting in London,
elected into their Fellowship Joe Sambrook for his distinguished contributions to
the understanding of tumor viruses at the molecular level. That Joe would re-
ceive this most coveted honor for a British scientist was long expected since his
record of involvement in important discoveries about DNA tumor viruses dates
back to the late 1960s when he was at the Salk Institute. Since coming here, he
has attracted an extraordinarily talented group of co-workers who, with him, have
made this Laboratory into a major, internationally recognized site for research on
DNA tumor viruses. In doing so, they have given James lab a reputation for intel-
lectual intensity of which we are most proud.
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Joint Agreement with Monsanto to Study Mouse Genetics
In October, we signed a five-year, $2.1 million agreement with Monsanto Com-
pany to conduct a cooperative research program on the use of gene transfer in
the study of gene expression during mammalian development. Under the terms
of the agreement, Monsanto has the option for an exclusive license to develop
for commercial use inventions arising from research covered by the agreement.
Cold Spring Harbor will retain ownership of any patents and will receive royalties
on sales resulting from technology developed here. Also, up to two Monsanto
scientists will be trained for three-month periods at Cold Spring Harbor.
The program's main goal is to shed light on one of the great unanswered ques-
tions in modern biology: How does an organism develop from a single, undiffer-
entiated cell into a complex system of many different types of cells, tissues, and
organs? Current theory holds that differentiation is achieved by "tissue-specific"
expression of genes-the selective turning on and off of specific genes in spe-
cific tissues during different phases of development.
One major approach to this problem is the microinjection of a solution of for-
eign DNA directly into fertilized mouse eggs. The eggs are then reinserted into
the oviducts of pseudopregnant female mice and allowed to develop. Approxi-
mately six percent of all microinjected eggs give rise to live "transgenic" mice in
which the injected DNA has become incorporated into the host DNA. Because
the injected DNA can code for one or more novel proteins not found in normal
mice, expression of the foreign DNA in various tissues of transgenic mice can be
detected by looking for the telltale proteins.
Early in 1985, Doug Hanahan obtained a remarkable research result using this
technique. Following microinjection of a fusion gene that linked the insulin pro-
moter to the SV40 large-T antigen, he found that the T antigen is expressed only
in the insulin-producing beta cells of the pancreas. Now that he has achieved
correct tissue-specific expression, regulatory DNA sequences within the insulin
promoters which are responsible for turning the transplanted genes on and off at
the proper stages in development can be isolated.
Our current foray into the world of mouse genetics dates to the appointment of
Lee Silver in 1981, who came to study the T locus. With the completion of the
Harris building in 1982, we had a first-class facility for rearing mice, and in 1983
we introduced a course on the Molecular Embryology of the Mouse. The Labora-
tory's involvement in mouse genetics actually dates to the 1920s, when Drs. Clar-
ence Little and Carlton Mac Dowell of the Carnegie Institution of Washington staff
began to develop pure strains of inbred mice that have unusually high inci-
dences of cancer. Little went on to found the Jackson Laboratory in Bar Harbor,
Maine, now a major supplier of genetically pure strains of mice, while Mac Dowell
continued work here, developing the important high leukemic mouse strain C58
black.
New Building Projects Continue Apace
Throughout this decade we have completed an average of one or more major
construction projects per year: the Davenport restoration in 1980, DelbrOck labo-
ratory and Sammis Hall in 1981, the Harris Animal Facility in 1982, and the De-
merec protein chemistry-nucleic acid addition in 1983. This trend has continued
with the completion, in late fall, of the monoclonal antibody extension to James
lab.
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Construction costs for the extension were underwritten by grants of $425,000
from the National Cancer Institute, $400,000 from the Pew Memorial Trust, and
$30,000 from the William Randolf Hearst Foundation. An additional grant of
$30,000 from the Hearst Foundation, a $100,000 grant from the Fannie E. Rippel
Foundation, $15,000 from the Samuel Freeman Charitable Trust, and $50,000
from various Long Island businesses went toward purchasing equipment.
The 6400-square-foot addition to the north end of James contains offices and
two very spacious laboratories-one for Joe Sambrook's and Mary-Jane Ge-
thing's group and another for Ed Harlow-a cell fusion facility, and a large
kitchen. Combined with the Harris animal house, we now have state-of-the-art
facilities for the production of monoclonal antibodies needed to isolate cellular
proteins and probe their structures. Already the James extension is fulfilling its
role as a clearinghouse of monoclonal antibody technology for the entire cam-
pus; Ed Harlow provides expert technical advice, with Carol Schley available to
perform cell fusions and screening procedures.
In May, we began the long-awaited construction of the Oliver and Lorraine
Grace Auditorium. When completed in late fall 1985, this 360-seat facility will alle-
viate the long-standing problem of inadequate seating at our major meetings.
With its massive dormers, richly textured brick and stucco exterior, and airy pub-
lic spaces, the Grace Auditorium will be perhaps the finest meeting facility on
Long Island.
Now planned as a multifunction building, the upper floor of the auditorium, be-
sides containing the Lecture Hall, will house our Information Services Depart-
ment, while on the lower floor will be our Meetings Office and a new computer
center that will be the hub of an integrated network serving the entire scientific
staff.
Delays in the Construction of Our Squash Court
Two years ago we thought we would soon be starting construction on both the
Grace Auditorium and a squash court, to be located near the tennis court, which
would give us a year-round facility in which our scientific staff, steadily growing in
number, could benefit from short intervals of intense exercise. But as planning
for the Grace Auditorium proceeded, we expanded its scope greatly through the
decision to build a fully functional basement so as to give us the freedom to
move within it the headquarters of our ever-expanding computer system. With
this decision, the cost of the building rose to nearly $3.6 million, a sum far in
excess of the earlier anticipated $2 million expenditure. In making the decision to
start construction on the auditorium, we have had to commit virtually all the free
funds in our treasury, leaving no monies to cover the estimated $200,000 cost of
the squash court facility. We thus have had no choice but to postpone construc-
tion of the squash court until we find funds specifically donated for this effort.
This may not be easy to do, since our neighbors know by now how much we also
need new monies to expand our facilities for research and the holding of meet-
ings and courses. Hopefully, we can persuade one of the now growing number
of Cold Spring Harbor alumni who have helped form the biotechnology industry
to donate his name along with the necessary number of stock certificates to
bring this very much needed building into existence.
8
Revised Plans for New Facilities for Plant Molecular Biology
Initially, the most sensible way for us to expand our efforts in plant molecular biol-
ogy appeared to be the construction of a joint laboratory-field station complex at
Uplands Farm, the nearby former dairy farm that was owned by Mrs. George
Nichols and whose land and buildings now belong, through her donation, to the
Nature Conservancy. We thus entered into a contract with the Conservancy in
the fall of 1984 to purchase from them some 10 acres of this land, on which are
situated two houses and a 6000-square-foot garage/apartment building, for a
price of $705,000. As our planning for this complex grew more precise, we real-
ized that instead of saving money by using the existing garage for a new lab, the
renovations required would actually cost more money and provide less suitable
facilities than a new laboratory facility on our main Bungtown Road site. We thus
now plan to use the Uplands Farm land and buildings exclusively for a Field Sta-
tion on which we shall grow corn and erect a major new greenhouse specifically
designed for corn. At the same time, the garage will be extensively renovated to
provide areas for corn seed storage and examination, microscope facilities for
chromosome analysis, plant growth chambers, and the housing of the necessary
farm equipment. We are simultaneously making detailed plans for a 6000 -
square -foot addition to Delbruck laboratory, made possible by moving the
nearby Firehouse (which now contains three apartments) to a site 80 feet to the
north. Relocation of the Firehouse is now planned for late August 1985, with the
construction of the Delbruck north addition scheduled to start in September and
hopefully to be completed in the early summer of 1986. The projected cost of
these various efforts now totals $2.3 million. Toward this sum, we have received a
grant of some $700,000 from the National Science Foundation, $350,000 of
foundation support, and have hope of another major donation being received
before construction is to begin.
Already we have initiated work on the Uplands Farm garage, with occupancy
scheduled by the end of summer 1985. Bids will soon be asked for the new
greenhouse, with its completion date hopefully in time for a winter planting of the
corn seeds that will result from the summer 1985 crop of Steve Dellaporta and
his associates.
2-D Gel Technology Attracts Major Support
After years of hard work, Jim Garrel's computerized system for analyzing pro-
teins separated by two-dimensional gel electrophoresis is attracting the attention
it deserves. In June, the Laboratory granted an exclusive license to Protein Data-
bases, Inc. (PDI), to develop this technology for commercial use. In return for the
license, the Laboratory will receive $400,000 in research support from PDI,
which has opened a facility on Oakwood Road in Huntington Station, N.Y.
Later in the year, we received a $2 million Biotechnology Resource grant from
the National Institutes of Health to develop Cold Spring Harbor as a major center
to train scientists in the uses of 2-D gel analysis in biomedical research. The Bio-
technology Resource Center will be set up as a separate unit on the lower floor of
the Grace Auditorium and will contain three Mass Comp computer workstations
powerful enough to generate the complex graphics that are part of the analysis.
Serving on the NIH advisory committee to the Center are Matthew Scharff, Bar-
ney Clarkson, Rich Roberts, Sidney Strickland, and James Schwartz.
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Two-dimensional gel electrophoresis, first developed in 1975 by Patrick O'Far-
rell at the University of Colorado, can resolve more than 2000 different proteins
in a single trial. Because of this exquisite sensitivity, 2-D gels contain far more
information than can possibly be analyzed by visual observation alone. Jim Car-
rels, who came to the Laboratory in 1978 from the Salk Institute, was among the
first to work out a practical, computerized method for analyzing the complex spot
patterns generated by 2-D gels. One major goal of the Biotechnology Resource
Center will be to establish complete protein databases for normal vs. transformed
rat cell lines, yeast cell lines, and mouse embryo cell lines.
Our Summer Teaching Program Flourishes
Educational outreach-in the form of meetings and courses-has been a Cold
Spring Harbor hallmark since the founding of the Biological Laboratory here in
1890. At that time, the harbor, mill ponds, and Long Island Sound were used as
a natural laboratory in which to test Darwin's notions about how species evolve to
exploit various environmental niches. Although our bucolic surroundings are no
longer the object of experimentation, they do continue to inspire a serious,
though informal, approach to science.
Our specialized courses in molecular genetics and neurobiology continue to
attract three times as many applicants as there are available spaces. More than
400 applicants vied for 89 slots in six genetics courses, while 185 researchers
applied for 91 positions in six neurobiology courses. Far and away the most pop-
ular courses, Molecular Cloning and Advanced Cloning drew a record 200 and
64 applicants, respectively.
The Neurobiology Teaching Program, which has functioned exceptionally
smoothly under the direction of Sue Hockfield, was substantially boosted by the
receipt in December of a $110,000 equipment grant from the McKnight Founda-
tion. The grant will allow us to purchase centrifuges, incubators, and other equip-
ment necessary to bring recombinant DNA techniques into our Drosophila, im-
munoglobin probes, and single channel methods courses. A Banbury meeting
on Computational Neuroscience-sponsored by the Sloan Foundation-was so
well received that in 1985 we are creating a new lecture course at Banbury to
explore the topic.
A High-level Symposium on Genetic Recombination
The 49th Symposia on Quantitative Biology had as its major theme recombina-
tion at the DNA level, a topic that brought the return of many old friends to the
Laboratory as well as first-time visits by many whom we hope will also come
back many times. Serving as its major organizers were Amar Klar and Jeff Strath-
ern who brought together a most distinguished and varied collection of speak-
ers. Starting off the meeting on a high intellectual level was Bruce Alberts, who
gave his view of how proteins work during DNA replication. Equally satisfying
was Allen Campbell's final summary. Greatly assisting our standing-room-only au-
dience was the use of a very large TV screen which often provided more than life
size views of speakers faces to those watching the proceedings in the adjacent
room of Bush Lecture Hall. As usual, our more than competent Meetings Office
staff received much praise from our visitors for the kindly way in which they were
introduced to the way of life here, a feature we must always maintain if we are to
expect to keep our position as the leading meetings center for molecular biology.
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The Robertson Research Fund Provides Our Main Source of Discretionary
Research Funds
The gift from Mr. Charles S. Robertson in 1973 of an $8 million fund whose in-
come should go exclusively to the support of research changed radically the na-
ture of this Laboratory. In 1984, we used some $600,000 of this income to further
help our newly created Mouse Embryology Group, to provide major items of
equipment for the new north extension to James lab, to provide carryover funds
needed for the temporary maintenance of the late Ahmad Bukhari's research ef-
forts, to support our meeting programs, to help buy a cell sorter for James lab,
and to support the stipends of several postdoctoral fellows and visiting scientists.
The Banbury Center Now Functions with a Balanced Budget
With each year we have made increasing use of our Banbury Center located on
the site of Mr. Charles S. Robertson's former estate in Lloyd Harbor. During the
five-month-long meeting and summer courses period its facilities are now in full-
time use. Particularly important is its conference facility, which serves as the site
of our summer neurobiology lecture courses. During the rest of the year, it serves
as the perfect site for a series of small meetings arranged by Mike Shodell, the
Director of Banbury Center. While Mr. Robertson provided a generous endow-
ment fund for the upkeep of his marvelous house and the grounds of this beauti-
ful 40-acre estate, each of the meetings we hold there demands additional out-
side funding. Toward this end, applications for grants are constantly being made
to potentially interested governmental agencies and requests made to major in-
dustrial sources and private foundations for core-type support. The raising of this
money has never been easy, and so it is with much satisfaction that I can report
that all of last year's $550,000 in operating expenses were raised, leaving us, in
fact, with a minor surplus. This coming year I fear may not be so satisfactory.
Grant support for meetings is now very hard to get, even with high priority
scores, due to the proposed reductions anticipated in the number of grants
awarded. We shall thus have to work even harder to see that Banbury Center
remains an important site of incisive small meetings, many devoted specifically to
the interaction between the latest biological research and human society.
LIBA Continues to Provide Us with Critically Needed Building Funds
Our neighbors who work so effectively on our behalf under the auspices of the
Long Island Biological Association (LIBA) came again to our rescue in a moment
of great need by providing an additional $100,000 toward the costs of the Oliver
and Lorraine Grace Auditorium. This project, initiated with the enthusiastic sup-
port of LIBA, will radically upgrade our facilities for the holding of our major
meetings, allowing us to respond effectively to the enormous expansion in the
number of molecular biologists that is accompanying the recombinant DNA revo-
lution. So we remain deeply indebted to all of our LIBA members for their contin-
ued assistance which allows us to remain a major center of DNA research for the
entire world.
Over the next year the officers and directors of LIBA will be engaged in discus-
sions with our Trustees as to how we should prepare for the 100th anniversary of
our founding in 1890. The five years still to pass before this major anniversary
provide an obvious interval in which to reassess where we want to be on our
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100th birthday and hopefully to plan out a major program for achieving these
objectives.
Formation of an Ad Hoc Committee of Our Board of Trustees for
Neurobiology
While we offer the most comprehensive series of summer courses in neurobiol-
ogy in the world and are now generally recognized worldwide as a major asset
for the promotion of neurobiology, we still do not possess a laboratory in which
neurobiologists can work throughout the year. Jones laboratory, our sole facility
specifically equipped and renovated to do neurobiology, must also function each
year as the site of our summer courses. During the summer our neurobiologists
must go away or crowd together in a modernized mini-lab in the old Mouse
House, where effectively they must stop most of their research. This is clearly an
intolerable situation in the long-term. This situation recalls the similar circumstan-
ces of our Yeast Group when their booming research on mating-type switching
led us to build for them an addition to Davenport (now DelbrOck) laboratory.
There is no way, however, that a major addition can be added to the 1893-built
Jones lab without destroying the intrinsically beautiful way our complex of old
buildings appears when seen from both the Lab grounds and from across the
inner harbor.
It was thus virtually inevitable that we would witness the premature breakup of
the small Neurobiology Group that has worked in Jones lab over the past several
years. This is inherently very distressing in view of their seminal role in showing
the great potential of monoclonal antibodies not only for probing the anatomy of
the nervous system, but also for potentially revealing the identity of the key mole-
cules whose interactions lead to linking of nerve cells to their correct cellular
partners during embryonic development. First to leave us for the prospect of a
more stable long-term future was Ron McKay, who moved in the summer of 1984
to the Whittaker School of MIT. Soon afterwards, Birgit Zipser left to continue her
research on the leech at the National Institutes of Health. And earlier this year we
had to accept the fact that Sue Hockfield would be leaving in mid-1985 for the
Neuroanatomy Department of Yale Medical School.
The prospective long-term absence of any year-round efforts in neurobiology
is clearly incompatible with the running of a major summer program. We must
thus design, and then find the funds for, a new laboratory specifically designed
for neurobiology. Toward this end, a committee of our Board of Trustees has
been created whose members are Charles Stevens, Eric Kandel, John Klingen-
stein, and William Robertson. Hopefully, semiprecise plans as to how we should
proceed will be available by the end of the summer of 1985.
A Strong New Set of Additions to Our Board of Trustees
That our Board of Trustees combines science and the public sector at its best
remains one of the strongest assets of the Laboratory. I consider myself most for-
tunate that from our trustees I can call on the collective wisdom of many very
talented scientists as well as the financial and legal savvy necessary for quick,
experienced reactions to a multiplicity of problems that need answers. It is thus
with much regret that the statutory six-year terms of three very devoted trustees
expired this past November. Roderick Cushman, Mary Lindsay, and Alexander
Tomlinson have all served us with distinction. In particular, I wish to note that this
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is the second time Mary Lindsay has completed a six-year term of office. Happily,
all our departing trustees live near to us, and we are sure that their repeated help
can be relied upon. Following his move to Princeton in the fall, Tom Shenk now
becomes our trustee from Princeton University, with the Stony Brook slot now
ably filled by Sidney Strickland. Newly elected as individual trustees are Mrs.
Charles Dolan of Cove Neck, who, with her husband, has been a major imagina-
tive force in the development of cable TV in the United States; Mrs. Sinclair
Hatch of Oyster Bay, a longtime activist for a variety of medically important goals;
and Mr. Harvey Sampson of Cold Spring Harbor, a distinguished leader of busi-
ness and Chairman of the Harvey Electronic Corporation.
We Are Going Through a Major Transition in Leadership
That I have been the director for 17 years and still enjoy the many tasks that go
with my position owes much to the fact that I have for almost all this time effec-
tively shared most of my burdens with Joe Sambrook, who has headed James
lab since his arrival here in 1969 and who for the last seven years has functioned
also as our Assistant Director for Research. It was thus with both unease and
regret that last August I learned of Joe's decision to resign from his position here
in September of 1985 to join the University of Texas Medical School in Dallas as
Head of its Department of Biochemistry. Filling Joe's shoes will be no easy task,
since Joe has a forceful, innovative mind that consistently and wisely has worked
for the good of this institution. In doing so, he has played a far more major role
than generally perceived by the outside world in preserving Cold Spring Harbor
as a major site for teaching and research in molecular biology.
To help me now with many of the tasks that Joe carried out, I have asked Terri
Grodzicker to serve as Assistant Director with the particular charge of overseeing
our summer teaching and meetings programs. Still to be filled is the position akin
to that of the Scientific Director in many other research institutions, where one
individual has the major role of overseeing the recruitment and subsequent pro-
motions of the scientific staff. This is a task that Joe ably performed for many
years, since as the Laboratory grew larger, I no longer had the time to effectively
know the world of younger scientists. The recruitment of a high-level scientist
versed in all aspects of DNA research, if not of biology itself, thus stands out as
the most important goal for me to accomplish over the next year.
In this period when I have more tasks than one individual can handle, I take
relief that in the recent appointment of G. Morgan Browne, we now have a new
Administrative Director in whom we already have great confidence. A 1957 grad-
uate of Yale, he is an experienced business executive, with a strong financial
background, particularly in the high technology area. A member of LIBA for sev-
eral years, and with a keen liking for and interest in science, Morgan knows
many of the Lab's longtime supporters and needs no introduction either into the
unique roles of the Laboratory or to our community that so long has been an
indispensable asset.
The Grace Auditorium Will Transform the Way We Are Seen by Incoming
Visitors
With the completion of the Grace Auditorium, our Laboratory will be ending a 23-
year era that commenced in 1953 with the completion of Bush Auditorium and
Demerec lab. With these new buildings in hand, Cold Spring Harbor had the re-
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sources to participate in the biological revolution that took off with the discovery
of the double helix. Though we have continued to make many important new
additions to our physical plant, the Laboratory has looked much the same to un-
initiated visitors. The hill overlooking the Blackford entrance hid much of the
western afternoon sun and was never a site of beauty, remaining permanently
scarred from the removal of the sand used in the 1906 building of Blackford it-
self. Thanks to the powers of modern earth-moving equipment, Blackford Hall
now looks out onto a newly made open area created so that our auditorium
would be graced with an adjacent area into which our meeting participants can
move freely during coffee breaks and on the way to meals. Soon the now
pushed-back hill will be landscaped and on its top will be placed an ancient
eight-sided Gazebo given to us when a recently sold estate was broken up. Back
of the gazebo we shall be creating a brand new parking area for some 70 cars to
handle the increased number of visitors that shall come to the new lecture hall. In
opening up this area, we shall be losing a few more trees than we would like, but
to compensate for this, we shall plant even more to eventually allow a forestlike
feeling to return. As we rework this upper space, we will face the facts that the
26-bed Page Motel built in 1953 functions too often like a 1930s New Hampshire
motel and that guests chosen to live in our four 1930s-type cabins often remem-
ber the experience more than they wish. So we are already thinking about what
their replacements should look like and tentatively have decided to have our ar-
chitects come forth with the "Adirondack Style" revisited. And next to their poten-
tial site is an area that could be perfect for a new neurobiology building.
Hopefully, all of these dreams will be reality by our 100th birthday. If so, what a
glorious next 100 years we can share with the world of biology.
June 26, 1985 J.D. Watson
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ADMINISTRATION
The continued growth of the Laboratory over the past years has had a dramatic
impact on the Administrative staff. Since 1968, the Laboratory's expenditures
have increased from $580,000 to over $20 million, almost a 3500% increase.
The number of research grants has grown from less than 10 to over 200 (not
including subprojects within a grant), and the Laboratory staff has increased
from approximately 35 to more than 325. Meetings and course participants went
from approximately 700 in 1968 to 3300 in 1984. Although the challenges have
been considerable throughout this period, they have been met through in-
creased efficiency in virtually all areas.
From a small, in some ways "patchwork," operation, Administration has
evolved into a modern, computerized organization built around a core of experi-
enced professional managers and highly qualified clerical personnel. In stream-
lining our operations to provide greater support and assistance for the Labora-
tory's scientific endeavors, we have not, however, lost sight of the Laboratory's
small-town, spontaneous, and scientifically intensive atmosphere that has served
science so well for so long.
Installation of the Administrative Computer
Prior to the installation of the administrative computer, records and data were
spread throughout the campus in separate offices located in separate buildings.
The flow of paper from building to building and office to office precluded timely
and coordinated information exchange. Now, with direct access to our MAI Basic
Four computer, the various administrative segments can instantly and accurately
reflect and report their daily activities to related departments.
In addition to greatly assisting clerical functions, the computer has eased the
burden of processing purchase orders, maintaining personnel records, and man-
aging finances. Up-to-date financial and grant reports are now readily available
to senior management and scientific staff. It is difficult to imagine how the present
volume and variety of transactions would have been managed without the accu-
racy, simplicity, and consolidation afforded by a computer.
Formation of the Commerical Relations Committee
The advance of biotechnology at the Laboratory has drawn the interest of sev-
eral commercial organizations. To safeguard the Laboratory's basic research
mission and to avoid potential conflicts of interest, the Commercial Relations
Committee was established by the Board of Trustees to review such relationships
and to generate policies and guidelines to govern staff interactions with commer-
cial organizations. Townsend Knight, Chairman of the Committee, has contrib-
uted enormously toward reviewing the frequently complex and somewhat un-
precedented new partnerships between commerce and basic research
institutions.
Nichols Renovation
After years of neglect and overcrowding, the Nichols Administration building had
become inefficient and no longer suited to the increased administrative tasks. It
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had also become structurally unsound and could no longer support the number
of people using the facility. Renovation plans were drawn up and Jack Richards
turned the attention of his staff toward making Nichols into a more efficient and
better place to work. The results are dramatic from both an aesthetic and func-
tional point of view. Offices are now arranged on the basis of operating efficiency
and functional considerations, and the staff has a much more productive and
pleasant environment.
Tax Exempt Bond Issue
What began over 15 years ago as a critical program to restore the Laboratory's
deteriorated physical plant has evolved into a substantial program of capital im-
provements and expansion which include large additions to Demerec and James
labs, construction of the dramatic Grace Auditorium, modernization of Blackford
Hall, and the addition of a much needed new parking area. To provide the funds
necessary for these ambitious projects, we applied for and received an $8 million
Nassau County Tax Exempt Industrial Bond Issue. With Morgan Guaranty Trust
as bond purchaser, we can proceed with all of these capital projects without limit-
ing the ongoing research program. Special recognition is due William R. Udry
who, working together with our former Treasurer and Trustee, Clarence Galston,
provided long hours of effort and invaluable financial savvy, which enabled this
bond issue to succeed.
Consolidation of Core Services
Some of the most direct and important services provided in support of the scien-
tific staff are the operations referred to as core services. These include the safety
department, machine shop, electronics repair shop, equipment repair shop, Har-
ris animal care facility, photography and technical illustrating, and the scientific
computer staff. In 1984 these services were centralized under the direction of our
highly capable Safety Director, Art Brings. With Art's well-established leadership,
we expect that these vital services will prove even more useful to the Laboratory.
The Laboratory continues to be fortunate to have a high-quality administrative
staff. We welcome to the staff Fred Lukas, who has already proven to be an able
assistant to our Comptroller, Bill Keen. Roberta Salant continues to provide inva-
luable assistance to me and to the members of the Board of Trustees. Guy Cozza
and Bob Pace deserve specific mention, for without them our computer installa-
tion could never have succeeded.
John Maroney
BUILDINGS AND GROUNDS
The overall expansion of the Laboratory since 1969 has resulted in an expanding
workload for the Buildings and Grounds Department and an increase in person-
nel from 10 to 42 (including Banbury personnel). Maintenance of an ever-ex-
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panding physical plant and the attendant landscaping has become increasingly 
more sophisticated and time consuming. In sharp contrast to the one part-time 
handyman of years gone by, who'maintained five or six buildings using a ham- 
mer and screwdriver, our maintenihft! personnel todayBptide men a
knowledge of air conditioning and heating, plumbers, and electricians, 
f i e  advanced planning of future buildings, done in conjunction with architects, 
engineers, and contractors, and the supervision of ongoing construction and 
renovations also increase the demands on the department.
Jam es Lab Extension for Monoclonal Antibody 
Research Completed
Th^major highlight of 1984 was the completion; in mid-summer of th i new James 
laboratory extension by the contracting figjj of Robins and Cowan of Huntington, 
Long Island. The Buildings and Grounds staff soon after fifti|hed-the-offtces, in- 
stalled the kitchen, and coordinated the long awaited move of the scientists and 
their equipment from their previous quarters in James lab. In addition, the park- 
ing area behind James was extended, and the site around the building and lot 
was landscaped.
First Underground Conduits in Place for Utility L ines
James Lab extension
A goal ffethe Labo ra to ry  to bury all telephone, electrical', and comput:#r:Hiihes 
for all facilities by late 1986 or early 1987. Through 1984, the lines from Harris to 
the James extension, including extra computer conduits for future use, have 
been buried. This leg was quite an undertaking and only with Owen Stewart’s 
excellent planning were we able to proceed, despite the inevitable complications 
associated with dealings with major utility companies.
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Oliver and Lorraine
Grace Auditorium
Work Is Begun on Much Needed Auditorium
Construction of the new Grace Auditorium began early in 1984, and although the
job is being done by an outside contractor, A.D. Herman, much time has been
spent by members of the department in helping the contractor along. Hopes to
complete construction in time for the 50th Symposium in June 1985 faded as
labor strikes halted work during the summer. Completion is now expected in fall
1985.
Facilities Must Keep Pace as Needs Change
Interior renovations in 1984 were numerous. With a laboratory vacancy comes
the planning for renovation of the facility, and it always seems that it was only
"last year" that we were reworking the same rooms. The Slaughter and Tamanoi-
Stillman labs in Demerec were completed and the entire first floor of Demerec A
was reworked, including a new kitchen, halls, hall floors, and media room. In
McClintock, the first floor south office and laboratory were redone as a full lab.
Refurbishing of James Annex Library included the removal, refinishing, and rein-
stallation of all book shelves on foam-insulated walls. The James Annex coffee
kitchen received a facelift with refinished cabinets and a ceramic tile countertop,
while a laser printer room was constructed in lower James Annex. To correct a
water problem caused by our hills and springs, it was necessary to install along
the west wall of the James Annex a drainage grate and pipe leading to a sump
pump pit. Now that the James (North) extension is completed and occupied, a
complete remodeling of the original James (Middle) lab is planned for 1985.
Work was begun on the first floor of the Nichols administration building to mod-
ernize the facility and to correct problems that have developed over the years as
the result of rushed expansions to meet critical needs. Duplicate equipment was
installed in the wastewater treatment plant, increasing the capacity by at least
one third. None of these renovations could have been accomplished without the
advance sketching done by Charlie Schneider, as well as the talents of Diamond
Scarduzio in carpentry and overall planning and coordination.
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General Maintenance and Repairs Are Ever Present
Over and above the capital improvements and renovations, Buildings and
Grounds works closely with our scientists and their families to assist them in both
their work and personal lives. Rarely a day goes by without a maintenance or
repair request from the scientific laboratories and tenants in our housing, both on
and off grounds. With off-grounds rentals, the Banbury site, and Uplands Farm,
the workload can become quite staggering. The summer courses and meetings
increase the workload in all departments, and so too in Buildings and Grounds
which must respond to the additional strain placed on all facilities through in-
creased use.
Department Saddened by Three Losses
Our department was saddened early in the year by the deaths of Fred Pfeiffer in
March, Mary Hill in April, and Jim Stanley (who retired in 1980) in June. We hope
that in the future we will be fortunate to have people of their caliber on our team.
Jack Richards
INFORMATION SERVICES
Two Programs Aimed at Nonscientists
One major goal of the Information Services Department is to help explain the
Laboratory and its research to nonscientists. Toward this end, "The Biological
Revolution," a six-week series of public seminars, was held last spring in con-
junction with Hutton House Lectures of Long Island University. Dave Mick los,
Joe Sambrook, Mary-Jane Gething, Steve Dellaporta, Sue Hockfield, and Mike
Shodell presented talks on recombinant DNA and its applications to biomedicine,
agriculture, and industry.
Also in 1984, the Laboratory's outreach to local schools was formalized as the
Cold Spring Harbor Curriculum Study. In conjunction with Superintendent Fran-
cis Roberts from Cold Spring Harbor High School, a cooperative program was
developed to improve teacher competence and to bring state-of-the-art research
concepts into school biology classes. Building upon an initial $10,000 grant from
Citibank N.A., we were able to attract pledges of $10,000 apiece from eight
neighboring school districts who are participating for the 1984-1985 school
year: Cold Spring Harbor, East Williston, Great Neck, Herricks, Jericho, North-
port-East Northport, Oyster Bay, and Syosset. It is hoped that the Curriculum
Study will serve as a model for similar efforts throughout the United States.
Support from Foundations Increases
The department set out to match a $100,000 grant from the Fannie E. Rippel
Foundation for the purchase of equipment for the new Monoclonal Antibody Ex-
tension to James lab. The first attempt to involve local companies in the Labora-
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tory's research-the Long Island Business Cancer Campaign-yielded $50,000
in cash and donated equipment. Grants of $30,000 and $15,000 were secured
from the William Randolf Hearst Foundation and the Samuel Freeman Charitable
Trust.
The department also coordinated efforts to augment a $691,000 National Sci-
ence Foundation grant to expand the Laboratory's research on the molecular ba-
sis of plant development. A reception held at the home of Ambassador John
Humes led to grants from the William and Maude Pritchard Charitable Trust
($60,000) and the Griggs and Burke Foundation ($10,000) and numerous indi-
vidual gifts. Two other major grants were secured: $75,000 from the Charles E.
Culpeper Foundation and $50,000 from the Surdna Foundation.
Another highlight was the receipt of a $110,000 grant from the McKnight Foun-
dation to purchase equipment to teach molecular genetic techniques in our sum-
mer neurobiology courses. Also heartening was news of a four-year, $74,000
grant in support of the Undergraduate Research Program from the Alfred P
Sloan Foundation.
Inauguration of the Corporate Sponsor Program
The 1984 Corporate Sponsor Program achieved its two goals: to provide a stable
base of support for our meetings program and to increase dialog between aca-
demic and industrial researchers. Last year, 260 industrial scientists attended
Cold Spring Harbor Laboratory and Banbury Center meetings. A new series of
Banbury conferences dealing with technical aspects of genetic engineering was
especially well received. So enthusiastic was the response to the inaugural year
that 1985 membership has been expanded from 15 to 22 companies. Repre-
sented among the Laboratory's sponsors are prestigious Fortune-500 pharma-
ceutical and chemical companies and specialty biotechnology firms.
LIBRARY SERVICES
David Mick los
Reference Services Increase and Archives Expand
In 1984, patron/reference services became the focal point for the Library staff.
Following the resignation of Audrey Powers as Librarian in July 1983, we were
fortunate to have Genemary Falvey, a staff member for three years, step in as
Acting Librarian while she completed her Master's Degree in Library and Infor-
mation Science. In December 1984, Ms. Falvey graduated with honors and was
promoted to Librarian. Genemary's expertise is in reference services, with em-
phasis on computer-based literature searches tailored to the needs of individual
users. The impact of these new services on library activity is clear: Scientific
searches increased from a total of 60 in 1983 to 105 in 1984 and reference and
information questions increased by 41% (from 5000 in 1983 to 8500 in 1984).
Several major objectives were accomplished in the reference and archival
areas this year. The reference collection has been weeded and updated, and the
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foundation has been laid for upgrading the textbook collection. A DEC personal
computer was purchased so that extensive on-line searches would no longer sap
the campus-wide system. The preservation and cataloging of 32 maps related to
the history of Cold Spring Harbor Laboratory and its environs were completed.
Organization of the historical records of the Laboratory, including completion of
the registry of the Carnegie correspondence from 1930 to 1950 and the stream-
lining of the portrait files, continued. On the recommendation of Trustee Ed Pull-
ing, the library also established a Long Island Cultural Arts/Activities File for the
Laboratory community. This service provides announcements from all entertain-
ment facilities on Long Island.
Permanent Collection and Patron Services Grow Amid Staff Economies
The growth of library resources included the addition of 14 periodical titles, while
14 others were withdrawn, keeping our journal subscription count stable at 433.
The book collection grew by a net total of 1,404 bound volumes, bringing the
number of bound volumes to 27,299. Patron services increased an overall 355/o
from 1983 to 1984.
I would like to publicly acknowledge the contribution made by the entire Li-
brary staff in 1984. All individuals contributed beyond their usually high perfor-
mance, allowing a smooth operation and reducing salary expenditures by the
equivalent of one full-time staff member.
PUBLICATIONS
Susan Gensel
New Titles Published and a New Series Launched
The Publications Department continued to grow in 1984, with a total of 11 new
titles published in addition to 18 reprintings. A new series, Cancer Cells, was in-
augurated with the publication of "The Transformed Phenotype" and "Oncogenes
and Viral Genes." This series supersedes Cold Spring Harbor Conferences on
Cell Proliferation, and its journal format provides a forum for scientists from di-
verse disciplines. Two new monographs were published this year: Microbial De-
velopment, issued simultaneously in cloth and paperback, and Gene Function in
Prokaryotes, which was later released in paperback in early 1985.
The practice of paperbacking selected titles to extend readership particularly
to the student market was continued with the publication of RNA Tumor Viruses/1,
Text. This volume and RNA Tumor Viruses/2, Supplements and Appendixes
(due in 1985), with a combined total of more than 2500 pages, constitute an up-
dated and expanded edition of the RNA Tumor Viruses volume originally pub-
lished in 1982.
Experiments with Gene Fusions, a manual based on the Bacterial Genetics
courses held at Cold Spring Harbor in 1981 and 1982 was well received by re-
viewers and by our teaching and research colleagues. A Strain Kit for use with
this manual will be available in 1985.
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Other titles produced include Modern Approaches to Vaccines, which was an
outgrowth of a 1983 Cold Spring Harbor meeting. So successful was the meeting
that its organizers, Robert Chanock and Richard Lerner, were able to contract for
five more annual meetings. From these meetings will be published a five-year
series, beginning with Vaccines 85. Another timely publication was Human T-Cell
Leukemia/Lymphoma Virus, which studies the role of this virus family in malig-
nancies and in AIDS. A meeting in April 1984 gave impetus to the publication in
December of Molecular Biology of the Cytoskeleton.
In 1984, we assumed publication of a biennial series entitled Genetic Maps: A
Compilation of Linkage and Restriction Maps of Genetically Studied Organisms.
Originally published and distributed as a service in 1980 and 1982 by Steve
O'Brien of the National Cancer Institute, the growing demand for, and complexity
of, the volume required the expertise of a publisher and we were happy to add
this series to our list.
In recent years, we have strived to publish me results of our meetings as rap-
idly as possible, even though most of our books are multi-authored and inevita-
bly turn out to be at least 100 pages longer than initially planned. In spite of this,
it has been our goal to publish our annual Symposium volume in the same year
in which the meeting takes place. Although the proceedings of the 1983 Sympo-
sium on Molecular Neurobiology was at the printers in 1983, bound books were
not available until 1984. For the first time, the Symposium was published simulta-
neously in cloth and paperback editions. When the subject matter warrants the
publication of a paperback edition for the student market, this practice will be
carried out in the future. In addition to these new titles, we published abstracts of
the 11 meetings held here in 1984 and the Annual Report.
Use of In-house Computer Saves Time and Money
In-house computer typesetting was utilized in producing seven of the 1984 titles.
This technology saves time and cuts composition costs by approximately 30%.
We achieved even greater efficiency and savings by initiating the practice of
sending authors letter-quality computer printouts instead of typeset galleys. This
allows all author corrections to be inserted before the manuscript is transmitted
to the typesetter.
Move to Paperbacks Increases Volume
Although unit sales increased from approximately 35,000 units in 1983 to more
than 37,000 in 1984, net sales declined to slightly more than $1,500,000. This
decline in the wake of increasing volume is directly related to our major move
into offering lower-priced paperback editions of many titles. To continue this pro-
gram of providing paperbacks priced within reach of the economically hard-
pressed student market, every means of increasing sales volume while control-
ling costs must be explored.
Marketing Pushes for Greater Foreign Sales
With an eye toward increasing volume, the Marketing Department has been vig-
orously pursuing new channels for foreign distribution, including finalizing an
agreement with a new distributor for India, Panima Educational Book Agency,
and opening negotiations for a new Japanese distributor with the prospect of in-
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creasing sales to Japan over the next three years from $100,000 to $250,000
annually.
A consistent program of follow-up by Marketing on all books sent to journals
for review has yielded an impressive 40-43% response with a review and/or list-
ing within 18-24 months, well above the industry norm of a 25-30% response
within the same time frame.
Fulfillment Moves Toward Consolidating All
Warehousing and Shipping
Equally responsive to the need for greater volume, the Fulfillment Department
increased t, le ease of placing orders by offering customers the convenience of
an 800 'oll-free number. To speed delivery, 48% of 1984 orders were shipped
directly from the storage facility at Cold Spring Harbor. With this increase in di-
rect shipments it became imperative that sufficient warehousing space be ac-
quired locally not only to solve the on-grounds storage problem, but also to con-
solidate all warehousing and shipping under our direct control. Having
completed negotiations with the Board of Education to lease a portion of the no-
longer-needed East Side School in Cold Spring Harbor, it is expected that all in-
ventory will be transferred to this new warehouse by mid-summer of 1985.
Publications Completes First Full Year in Urey Cottage
The start of 1984 saw the Publications group happily installed in our attractive
new quarters. Specifically renovated to meet our growing needs, the function-
oriented planning has more than lived up to expectations in providing the quie-
tude and ease of communication needed for efficiently handling the myriad de-
tails involved in editing and producing high-quality scientific books. This combi-
nation of an environment conducive to productivity and a superb staff, both
knowledgeable and dedicated, should enable us to continue to increase the
number of titles published over the next few years while maintaining present staff
levels.
Nancy Ford
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RESEARCH

TUMOR VIRUSES
Thirteen years ago, the National Cancer Institute funded a major Program Proj-
ect Grant to support work on tumor viruses at Cold Spring Harbor Laboratory.
This grant is now in its third cycle and has allowed us to focus the efforts of a
multidisciplinary team toward the study of adenoviruses, SV40, and papilloma vi-
ruses. Because this work has been funded by the Program Project mechanism, it
has been characterized by extensive collaboration both within and between the
various sections whose activities are described in the following pages.
In addition to the inherent challenge of understanding how they work, these
viruses have provided exciting model systems and tools for exploring the molec-
ular biology of eukaryotic organisms in general. Thus, viral vectors have been
designed that enable the overproduction of both viral and host proteins. Studies
of viral transformation are already leading into the more general phenomena of
gene regulation and cellular growth control. The adenovirus El A region and its
gene products are the subjects of intensive research efforts. Studies of RNA
splicing and viral enhancers continue while the role of the adenovirus VA RNAs
finally seems to be unraveling. In vitro systems that replicate adenovirus and
SV40 DNAs have led to the identification of essential viral and host proteins.
Our long-time colleagues, Tom Broker and Louise Chow, have left Cold Spring
Harbor Laboratory to take up appointments at the University of Rochester. They
have played key roles in many of our past projects and will be sorely missed.
Likewise, Earl Ruley, who has moved to the Massachusetts Institute of Technol-
ogy, has been a valued and productive colleague.
MOLECULAR BIOLOGY OF TUMOR VIRUSES
Y. Gluzman T. Adams N. Beck M. McKeever
T. Grodzicker R. Gerard N. Cap lin M. Merle
E. Harlow J. Harper D. Chao J. Moomaw
W. Herr M. Manos R. Chisum S. Rook
H.E. Ruley K. Maruyama J. Clarke L. Sansome
M. Quinlan J. Cosetti C. Schley
K. Van Doren M. DeLuca L. van der Wal
P. Whyte M. Goodwin J. Wiggins
M. Yamada R. McGuirk N. Williamson
B. Ahrens
The major emphasis of our research continues to
be the analysis of DNA tumor viruses, especially
SV40 and adenoviruses. A major effort is di-
rected toward the analysis of the transforming
genes of these viruses. A wide variety of mutants
in these genes, viral vectors that overproduce
transforming proteins as well as a large set of
monoclonal antibodies directed against trans-
forming proteins, provide reagents used in a va-
riety of studies. Thus, many projects are con-
cerned with the role of viral transforming genes
in the regulation of cellular and viral gene expres-
sion, in the establishment and transformation of
primary cells, in the interaction of viral trans-
forming genes with each other and with other on-
cogenes, and with the interaction of virus-en-
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coded transforming proteins with other cellular
proteins. Experiments on the cellular localiza-
tion and modification of transforming proteins
are also being carried out. We are continuing
studies of controlling elements of viral early genes
that are involved in the regulation of transcrip-
tion, mRNA processing and translation, and the
interaction of viral and cellular proteins with
these controlling elements. Work has continued
on the construction and analysis of viral vectors
that has allowed us to produce, in mammalian
cells, large amounts of eukaryotic proteins, in-
cluding transforming proteins that can be used for
purification and biochemical studies.
Analysis of Wild-type and Mutant
Ad2 E1A cDNAs
H.E. Ruley, T. Grodzicker [in collaboration with
E. Moran, B. Zerler, and M.B. Mathews]
The adenovirus early region IA (E1A) gene is re-
quired for adenovirus-induced cell transforma-
tion and is involved in the regulation of expres-
sion of other adenovirus genes. To distinguish the
individual roles of the 13S, 12S, and 9S E1A gene
products, we have isolated the corresponding
cDNA clones and have recombined them into
both plasmids and viruses (see Protein Synthesis
in this section).
The 13S virus plaques equally well in human
293 cells, He La cells, and A549 cells, a human
lung-oat cell carcinoma line that does not con-
tain adenovirus DNA. Plaque titers of the 12S
virus are much reduced in He La and A549 cells
as compared with that in 293 cells. The 12S virus
is multiplicity-dependent leaky in both He La and
A549 cells. At low multiplicities of infection, the
yield of 12S virus in He La cells is low; however,
in A549 cells, even at low multiplicities of infec-
tion, the yield of 12S virus increases with time to
approach the maximum yield from 293 cells.
These results suggest that the A549 tumor cell
line, even though it contains no adenovirus DNA,
can partially complement the E1A defect of the
12S virus so that transcription of other early ad-
enovirus genes is activated. Immunofluorescence
studies indicate that the adenovirus DNA-bind-
ing protein is made during infection of He La cells
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with the 13S virus but is not detectable during in-
fection with the 12S virus. Primary baby rat kid-
ney (BRK) cells are immortalized by the 12S virus
at very high efficiency, whereas infection of these
cells with 13S virus, as with wild-type El A virus,
results mainly in cell death. Transfection with
12S or 13S plasmids shows that both the 12S and
13S plasmids can, like genomic El A, establish
BRK cells or cooperate with plasmids carrying the
ras gene to transform these cells. In a transient
expression assay in HeLa cells, the 13S plasmid
stimulates expression of the chloramphenicol
acetyltransferase (cat) gene from the adenovirus
E3 promoter, but the 12S plasmid does not. The
12S plasmid appears to interfere with the stimu-
lation of E3-cat expression by the 13S plasmid.
To differentiate the functions of the E1A prod-
ucts further, we have used oligonucleotide-di-
rected mutagenesis to obtain several point muta-
tions in the genomic E1A or cDNA clones. A
point mutation at position 961, which converts a
glutamic acid residue to lysine, appears to impair
the transformation function seen in the transfec-
tion assay while not interfering with the gene-reg-
ulating functions studied in the E3-cat transient
expression assay. We are presently transferring
the mutant E1A 12S and/or 13S regions into ad-
enovirus so that their lytic and transforming
properties can be assessed. Several other point
mutations at nearby sites have also been made and
are being analyzed.
Analysis of the Transforming Functions
of Adenovirus E1A
P. Whyte, K. Maruyama, T. Grodzicker, H.E. Ruley
[in collaboration with E. Moran and B. Zerler]
The polyoma virus middle T antigen, T24 Ha-ras-
1, and adenovirus E1B genes are all individually
unable to transform cultured primary BRK cells.
Adenovirus E1A expresses functions that enable
these genes to transform. We have speculated
that the oncogene cooperativity in transforma-
tion is linked to the E1A functions which pro-
mote the in vitro establishment of cultured pri-
mary cells. To probe the function of E1A in
transformation, plasmids containing the E1A re-
gions from Ad5hrl and Ad5hr440, as well as
cDNAs for the 12S and 13S E1A mRNAs, were
transfected into primary BRK cells alone and to-
gether with the polyoma middle T antigen and
T24 Ha-ras-1 genes. The results obtained indi-
cate that the establishment functions of E1A are
located in the aminoterminal segment of the pro-
tein.
To determine the minimal aminoterminal se-
quences required for oncogene cooperation, a se-
ries of deletion mutants have been constructed.
A plasmid containing the E1A region was linear-
ized at the Smal site, located within the 13S
unique coding region, and deletions were gener-
ated by digesting with the exonuclease BAL-31.
A linker encoding a termination codon was in-
serted and the plasmids were recircularized, re-
sulting in plasmids coding for truncated E1A
proteins. The extent of the deletions was deter-
mined by sequencing using the dideoxy method.
The ability of these E1A mutants to cooperate
in transformation was assayed by cotransfecting
plasmids containing the E1A mutants and the T24
Ha-ras-1 gene into primary BRK cells and scoring
for transformed foci.
We have determined the minimal aminoter-
minal sequence of E1A necessary for oncogene
cooperation. This region is common to both 12S
and 13S mRNAs and is different from the E1A
functions necessary for transcriptional activation
of the viral early-region genes. These mutants are
currently being used to investigate the relation-
ship between functions required for oncogene co-
operation and in vitro establishment of primary
cells.
Adenovirus E1A Blocks In Vitro
Differentiation of Rat PC12 Cells
K. Maruyama, H.E. Ruiey
Adenovirus E1A and genes related to the myc on-
cogene of avian myelocytomatosis virus express
establishment functions that circumvent the com-
mitment of cultured primary cells to growth ar-
rest and senescence. To investigate the role of es-
tablishment functions in the regulation of cell
proliferation further, we have introduced E1A
and myc genes into cell lines that can be induced
to differentiate in vitro and that experience
growth arrest in the process.
PC12 is a rat adrenal pheochromocytoma cell
line that differentiates in response to both nerve-
growth factor (NGF) and dibutyryl cyclic AMP
(dcAMP) by extending neuronal processes and by
cell growth arrest. Plasmids, containing E1A and
myc genes, linked to the bacterial neomycin phos-
photransferase (neo) gene, were introduced into
PC12 cells, and G418-resistant clones were iso-
lated. Clones were characterized for E1A and
myc expression and for the ability to differentiate
in response to NGF and dcAMP. In the case of
E1A, clones expressing moderate-to-high levels of
E1A-related RNA failed to differentiate in re-
sponse to even high levels of NGF and dcAMP,
whereas clones expressing lower levels of E1A -re-
lated RNA responded only weakly to NGF. Var-
iation in the ability of myc-neo transfectants to
differentiate was also observed, and we are pres-
ently measuring the levels of myc-related RNA to
correlate myc expression with the inability to dif-
ferentiate in vitro.
Cellular Immortality Is Not Sufficient
for Oncogenic Transformation
by the T24 Ha-ras-1 Gene
H.E. Ruley, R. Franza, J. Garrels
Although the functions required by the Ha-ras-1
gene to transform primary cells have not been
separated from functions that promote in vitro
establishment, we have recently demonstrated
that the REF52 cell line behaves like primary cells
with regard to transformation by the T24 Ha-ras-
1 oncogene. Thus, the T24 Ha-ras-1 gene alone
is unable to transform REF52 cells, but the ad-
enovirus E1A gene enables the T24 oncogene to
transform. These results indicate that in vitro es-
tablishment is not a sufficient prerequisite for
transformation of cultured cells by the T24 Ha-
ras-1 gene and suggest that the role of E1A in pri-
mary cell transformation extends beyond in vitro
establishment.
Initial evidence that the T24 Ha-ras gene is un-
able to transform REF52 cells came from mi-
croinjection studies. Microinjection of the T24
oncogene plasmid induced neither transient nor
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permanent morphological transformants. In
contrast, 1-2% of the cells microinjected by a
combination of the T24 Ha-ras-1 and adenovirus
E1A genes transiently acquired the rounded mor-
phology of highly transformed cells, and approx-
imately 0.1% of the microinjected cells grew pro-
gressively as morphological transformants.
To probe the requirements for transformation
of REF52 further, the T24 Ha-ras-1 and adeno-
virus E1A genes were linked to the bacterial ami-
noglycoside transferase gene (apt) from the Tn5
transposon expressed from the SV40 early pro-
moter (SVapt). Plasmids were transfected into
REF52 cells by the calcium phosphate coprecipi-
tation method. Phenotypic transformation was
scored either by focus formation on cell mono-
layers or following selection in G418. The follow-
ing results were obtained: (1) The T24 Ha-ras and
Ad5E1A genes individually are unable to trans-
form REF52 cells. Indeed, REF cells expressing
the T24 Ha-ras p21 protein (T24REF) have been
isolated. They are indistinguishable from REF52
cells expressing the SVapt gene (REFneo) with re-
gard to growth rate, saturation density, failure to
grow in 1% serum, and failure to form tumors in
syngeneic rats. Cell lines expressing the E1A gene
(1AREF) have also been isolated. These cells are
morphologically altered but remain flat and are
similar to REFneo cells with regard to growth rate
and saturation densities. (2) Transformation of
REF52 cells, like that of primary cells, can re-
quire at least two collaborating oncogenes. Thus,
transformants arose only from cultures cotrans-
fected with E1A and T24 Ha-ras-1 genes. The
transformants grew to high saturation density
(106/cm') and formed tumors in syngeneic rats;
however, the tumors regressed within 5 weeks. (3)
E1A does not collaborate with the T24 Ha-ras
gene in transformation by enabling the cell to
overcome some toxic consequence of introducing
the T24 Ha-ras-1 gene. Thus, neither E1A nor
T24 Ha-ras-1 was toxic to REF52 cells, as judged
by the fact that pKOneo (the SVapt gene alone),
p 1 Aneo, and pT24neo plasmids induced G418-
resistant colonies with similar frequencies.
T24REF cells differ from REFneo cells in at
least two respects. First, T24REF cells can be
transformed by plasmids containing the Ad5E1A
gene linked to the bacterial guanine phosphori-
bosyl transferase gene expressed from the SV40
early promoter (SV gpt), whereas REFneo cells
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cannot be transformed by E1A. This result indi-
cates that the T24 Ha-ras-1 gene and Ad5E1A can
transform REF52 cells in a stepwise manner.
Second, T24REF cells require much lower serum
concentrations to escape growth arrest induced by
1% serum. Over three times more serum was re-
quired to induce 50% of the REFneo cells to en-
ter S phase (within the labeling period) as com-
pared with T24REF cells (9-2.5%); 1AREF cells
were intermediate in their responsiveness, requir-
ing 5% serum. Experiments are in progress to
determine the physiological mechanisms under-
lying this responsiveness. It is possible that con-
stitutive expression of the E1A and T24 Ha-ras-1
genes complements specific serum growth factors
in the mitogenic response of serum-arrested cells.
Alternatively, the oncogene proteins may play
some role in growth-factor signal transduction
and thereby enhance the responsiveness to certain
serum growth factors.
Monoclonal Antibodies to the
Adenovirus E1A Proteins
E. Harlow, C. Schley
Following infection of mammalian cells with ad-
enovirus, the first virus-coded proteins that are
synthesized are the products of the E1A region.
To help in the studies of the E1A proteins, we
have constructed a number of monoclonal anti-
bodies specific for these polypeptides. A bacte-
rial expression plasmid (kindly supplied by K.
Spindler and A. Berk, University of California,
Los Angeles), which will direct the synthesis of a
fusion protein between the bacterial tryptophan
E gene product and a cDNA copy of the 13S
mRNA, was used as a source to purify an E1A-
related protein. This polypeptide was purified by
SDS-PAGE, electroeluted, and used to immunize
BALB/c mice. Hybridomas were prepared and
tissue-culture supernatants were screened for the
production of antibodies that would bind to the
fusion protein in a solid substrate radioimmu-
noassay. Eighty-three hybridomas secreting anti-
bodies specific for the fusion protein have been
isolated and single-cell-cloned. As demonstrated
by indirect immunofluorescence, 29 of these hy-
bridomas secrete antibodies that will bind to E1A
proteins synthesized in He La cells infected with
Ad5 virus. However, of these 29 antibodies, only
12 will efficiently immunoprecipitate the E1A
proteins from lytically infected or transformed
human cells. Analysis of the E1A polypeptides
by immunoprecipitation and two-dimensional
IEF/PAGE has shown that the E1A products can
be resolved into approximately 60 polypeptide
species (Fig. 1). We have used mutant viruses that
can only synthesize portions of the E1A region to
localize the binding sites of these antibodies. All
of the monoclonal antibodies will precipitate the
products of the 13S mRNA, but two of the hybri-
domas secrete antibodies that will not bind to the
12S polypeptides. In addition to the authentic
E1A proteins present in the immunoprecipitates
prepared from an adenovirus-transformed hu-
man cell line (293 cells), there are several copre-
cipitating proteins. These proteins are not im-
13S
12S
30 K
FIGURE 1 Two-dimensional analysis of the adenovirus El A
proteins. The adenovirus E1A proteins from Ad5-infected
HeLa cells were immunoprecipitated with M73 hybridoma
tissue-culture supernatant and separated by two-dimen-
sional IEF/PAGE. The region of the autoradiogram that con-
tains the E1A polypeptides is shown. The autoradiogram has
been annotated to show the polypeptides that are encoded
by the 12S and 13S mRNAs. The mRNAs that direct the syn-
thesis of the 30K and 35K-40K polypeptides have not been
identified.
Actin
munochemically related to the E1A polypeptides
and are precipitated from these cells because they
are stably bound to the E1A proteins. We are
currently investigating the possible roles of these
virus-host complexes.
Mutations in the Nuclear-envelope-
associated Adenovirus E1B 19K
Tumor Antigen Cause the Degradation
of Chromosomal DNA
T. Grodzicker [in collaboration with B. Stillman
and E. White]
We reported last year that the adenovirus mutant
Ad2ts111 contains a mutation in the early region
2A (E2A) gene that encodes the single-stranded
DNA-binding protein (which results in thermo-
labile replication of virus DNA) and a mutation
in early-region 1 (El) that causes the degradation
of intracellular DNA. A recombinant virus, Ad2-
cyt106 has been constructed that contains the
Ad2ts111 El mutation and the wild-type E2A gene
from Ad5. This virus, like its parent Ad2ts111,
has two phenotypes; first, it has the ability to
cause enhanced and unusual cytopathic effects on
the host cell (cytocidal phenotype, Cyt) and, sec-
ond, it induces degradation of cellular DNA
(DNA degradation phenotype, Deg). We have
mapped the mutation responsible for these phe-
notypes into the early region 1B (E1B) by mark-
er rescue, transferring the left-end adenovirus
DNA fragments from ts111 to wild-type DNA and
sequencing the relevant portion of ts111 E1B
DNA.
The mutation responsible for these phenotypes
is a single point mutation in the gene encoding
the adenovirus E1B 19K tumor antigen. This
mutation causes a change in the twentieth amino
acid from the amino terminus of the protein from
a serine to an asparagine. Three other mutants
that affect the ElB 19K protein function have also
been examined. The mutants Ad2/p5 and Ad5 -
d/337 (from G. Chinnadurai [St. Louis University
Medical Center] and T. Shenk [SUNY, Stony
Brook]) have both the cytocidal and DNA deg-
radation phenotypes (Cyt and Deg), whereas
Ad2/p3 only has the cytocidal phenotype and does
not induce degradation of cellular DNA (Cyt and
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Deg - ). Thus, the DNA degradation is not caused
by the altered cell morphology. Furthermore, the
mutant Ad5d1337 does not make any detectable
E1B 19K protein product, suggesting that the ab-
sence of E1B 19K protein function is responsible
for the mutant phenotypes. A fully functional
E1B 19K protein is not absolutely required for
lytic growth of Ad2 in HeLa cells. Although these
E1B mutants clearly play a role in affecting cell
morphology, the ts111 mutant, which has reduced
cytotoxicity because of the mutation in the DNA-
binding protein gene, can transform BRK cells at
the nonpermissive temperature.
Molecular Cloning and Expression of
the Human p53 Tumor Antigen
E. Harlow, N. Williamson, T. Adams
To study the biochemistry of the cellular tumor
antigen p53, we have begun experiments designed
to purify p53. Analysis of a number of cell lines
and animal tissues that might serve as good
sources for purification has shown that these cells
do not express high enough levels of p53 to allow
easy purification. Therefore, we have cloned a
cDNA copy of the p53 gene and plan to overex-
press the gene for p53 in mammalian expression
vectors. A cDNA copy of the mRNA for the hu-
man p53 from A431 cells was cloned in a bacterial
plasmid vector, and the sequence of the largest
insert was determined by the dideoxy-sequencing
method. Comparison of the predicted amino
acid sequence of this clone and the amino acid
sequence predicted from similar clones prepared
from mouse mRNA confirms the authenticity of
this clone. This comparison has also shown that
these two proteins have long regions of amino acid
homology, particularly in the aminoterminal 20
amino acids and in the carboxyterminal 200
amino acids. Preliminary results have shown that
this cDNA sequence may be difficult to express
in mammalian cells in its present form. There-
fore, we have isolated a number of subclones that
have deletions in both the 5'- and 3'-untranslated
regions, and we are studying the ability of these
sequences to direct the correct synthesis of hu-
man p53.
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Expression of p53-specific Transcripts
during Mouse Development
T.E. Adams
We have established the pattern of expression of
p53 during mouse embryogenesis and in adult tis-
sues. Polyadenylated mRNA was prepared from
total RNA isolated from a variety of adult mouse
tissues and from embryos at various stages of de-
velopment. p53-specific transcripts were identi-
fied by Northern blot hybridization using a cDNA
probe derived from 3'-coding sequences of the
mouse gene. The pattern of expression obtained
was in keeping with the concept of a role for p53
in cellular proliferation; highest levels of p53
transcripts were observed in embryos taken early
in development and postnatally in hematopoietic
and lymphopoietic tissues and in skin. Addition-
al studies on chemically transformed cell lines,
using both Northern hybridization and "sand-
wich" radioimmunoassays, have indicated post-
transcriptional regulation of the level of p53 in
these cell lines.
Transcriptional Modulation of Gene
Expression by the SV40 Enhancer:
Duplications in a Mutated Enhancer
Restore Its Activity
W. Herr, Y. GIL _man, J. Clarke
The SV40 enhancer contains two 8-bp stretches
of alternating purines and pyrimidines that have
been implicated in transcriptional activation
(Nordheim and Rich, Nature 303: 674 [1983]).
We investigated the role of these sequences in the
function of the enhancer by mutating two nucleo-
tides in each 8-bp segment such that the alterna-
tion of purines and pyrimidines was destroyed.
The relative potential of the wild-type and mu-
tant enhancers to activate transcription was
measured by placing them upstream of the hu-
man 6-globin gene, followed by measurement of
the levels of properly initiated 6-globin mRNA
after transient expression in HeLa cells. In this
assay, the mutated enhancer is four- to sixfold less
active than the wild-type enhancer. Furthermore,
SV40 carrying these four point mutations grows
very poorly in CV-1 cells.
Revertants with improved growth potential
could be obtained after passage of mutant virus
stocks in CV-1 cells. Analysis of the DNA from
18 plaque-purified revertants showed that the en-
hancer regions had rearranged. Each of these
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FIGURE 2 Structure of revertants of an SV40 enhancer
mutant. At the top of the figure is a diagram of an SV40 con-
trol region that contains only one copy of the 72-bp element.
Shown from right to left are the early transcriptional start site
(zigzag arrow), the origin of replication (on), the AT-rich TATA-
like element (A/T), the two GC-rich 21-bp repeats, and the
single 72-bp element. Hatched boxes indicate the location
of the two 8-bp stretches of alternating purines and pyrimi-
dines; directly below these boxes are the sequences of each
of these stretches and the base substitutions found in each
of these segments in the dpm12 mutant. The series of rec-
tangular boxes represents the extents of the tandemly dupli-
cated region in each of the 18 independent revertants of the
enhancer mutant. They are ordered from top to bottom by
size. The two series of double Xs identify the positions of the
original point mutations where duplicated. The stippled area
within each rectangular box corresponds to the 15-bp re-
gion that is common to all of the duplications; the sequence
of this region is shown at the bottom of the figure with a
bracket outlining the "core" element (Weiher et al., Science
219: 626 [1983]).
rearranged enhancer elements was studied in the
enhancer assay and exhibited increased transcrip-
tional activation of the 0-globin promoter in
HeLa cells. The nucleotide sequence of these re-
vertants showed that each rearrangement was due
to tandem duplication of the enhancer region in
which the mutations were preserved (see Fig. 2).
Although the duplicated regions range from 45
by to 135 by in length and the sequences con-
tained in each duplication vary, there is a 15-bp
sequence, TGTGGAAAGTCCCCA, that is con-
sistently duplicated in each reactivated enhancer.
This region contains the "core" sequence,
GTGGAAAG, that was initially suggested (Laim-
ins et al., Proc. Natl. Acad. Sci. 79: 6453 [1982])
to be functionally significant, since related se-
quences were identified in a variety of viral en-
hancers. Our results suggest that the core and
surrounding sequences are a cis-acting element
that can function independently of and compen-
sate for the alternating purine and pyrimidine se-
quences.
We have tested the hypothesis that the core ele-
ment is important for enhancer function by mak-
ing point mutations within this sequence and have
found that indeed these mutations are deleterious
to both SV40 growth and enhancer function. We
are presently analyzing the structure of revertants
of these core mutations to determine what alter-
ations of the SV40 genome can compensate for
these new defects. Preliminary results indicate
that duplication of either one or the other of the
regions containing the alternating purine and py-
rimidine sequences is able to compensate for the
mutations in the core element. These results sug-
gest that the SV40 enhancer is composed of mul-
tiple independent cis-acting elements that are able
to compensate for one another. At present, we
do not know whether these independent cis-act-
ing elements are interacting with the same or dif-
ferent complementary trans-acting factors.
Diethylpyrocarbonate as a Chemical
Probe for DNA Secondary Structure
W. Herr
Last year, Y. Gluzman and I reported a study in
which we analyzed the significance of two 8-bp
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alternating purine and pyrimidine sequences that
lie within the SV40 enhancer. These two se-
quences had been suggested by Nordheim and
Rich (Nature 303: 674 [1983]) to have the potential
to form left-handed Z-DNA, and these authors
proposed that Z-DNA may be functionally im-
portant for enhancer activity. We found that
transition mutations, which maintain the alter-
nating patterns of purines and pyrimidines, had
little effect on the potential of the SV40 enhancer
to activate transcription, whereas transversion
mutations, which destroy the alternation of pur-
ines and pyrimidines, had much greater deleteri-
ous effects. These results were consistent with the
possibility that Z-DNA is involved in enhancer
function, because alternating purine and pyrimi-
dine sequences favor the formation of Z-DNA.
However, analysis (with A. Nordheim and A.
Rich) of the ability of the mutant DNAs to form
Z-DNA using anti-Z-DNA antibodies has been
inconclusive because of the difficulty in identify-
ing the precise DNA-binding site of the anti-
bodies.
To identify more precisely sites of Z-DNA for-
mation, I searched for a chemical probe that
would discriminate between the B-DNA and Z-
DNA secondary structures. As a test substrate, I
used the plasmid pLP32 (Peck et al., Proc. Natl.
Acad. Sci. 79: 4560 [1982]) which carries a 32-bp
stretch of alternating GC residues. This 32-bp se-
quence is in the B conformation when the plas-
mid DNA is relaxed, but upon negative supercoil-
ing, it will flip to the Z conformation. I found
that diethylpyrocarbonate (DEPC), which modi-
fies the N7 position of adenines and gu'anines, is
hyperreactive to the 32-bp alternating GC se-
quence in the Z conformation, compared with the
same sequence in the B structure. The compara-
tive reactivity of DEPC to specific nucleotides
was displayed as follows: Linear and negatively
supercoiled pLP32 DNAs were partially modified
with DEPC, digested with a restriction enzyme,
and end-labeled, and the strands of singly end-
labeled molecules were cleaved as described by
Maxam and Gilbert (Proc. Natl. Acad. Sci. 74:
560 [1977]).
Reactivity of DEPC to natural sequences was
analyzed by examining the modification patterns
of a region of the plasmid pBR322 that has been
shown to bind anti-Z-DNA antibodies when the
plasmid is negatively supercoiled and contains a
36
9-bp stretch of alternating purines and pyrimi-
dines. pBR322 plasmid DNAs carrying increasing
densities of negative supercoils were modified
with DEPC. As the supercoil density increased,
DEPC exhibited hyperreactivity to the purines
within the 9-bp alternating purine and pyrimidine
sequence. Purines flanking the alternating purine
and pyrimidine sequence became hyperreactive at
higher supercoil densities. These results suggest
that Z-DNA is favored within the alternating pur-
ine and pyrimidine sequence and then spreads to
the adjacent nonalternating purine and pyrimi-
dine sequences as the supercoil density increases.
I am currently applying this technique to study
the Z-DNA potential of the SV40 enhancer re-
gion. In preliminary experiments, I have not de-
tected any differences in the reactivity of DEPC
to the enhancer and early promoter regions of re-
laxed and negatively supercoiled SV40 DNAs.
These results indicate a potential lack of correla-
tion between the binding to DNA of anti-Z-DNA
antibodies and the hyperreactivity of DEPC. This
enigma will hopefully be explained by further in-
vestigation.
SV40 Mutants That Differentiate the
Lytic and Transforming Functions
of Large T Antigen
M. Manos, Y. Gluzman
We have continued the analysis of DNA replica-
tion-defective, but transformation-competent,
SV40 mutants such as C2, C6, and C11 and have
isolated and analyzed two more such mutants
(C8/SV40 and T22/SV40). These mutants were
isolated from the C8 and T22 simian cell lines
that were transformed with UV-irradiated SV40.
Viral DNA was rescued by fusion of these lines
with COS-1 cells, which provide a functional T
antigen in trans and therefore allow mutant inser-
tions to excise and replicate in the heterokaryons.
The rescued SV40 inserts were cloned into the
plasmid vector pK1, restoring a complete SV40
genome containing the early region (BglI- BamHI)
from the mutants and a wild-type late region.
These DNAs were analyzed by marker-rescue and
DNA sequencing. The mutants contain lesions in
different parts of T antigen that render the pro-
tein defective for viral DNA replication but effi-
cient in transforming cells in vitro. The muta-
tions responsible for the defects in viral DNA
replication are His->Glu at residue 203 (T22) and
Lys->G1u at residue 224 (C8). There is an addi-
tional mutation in the C8 mutant that converts
glutamine (amino acid 660) to a stop codon;
therefore, C8 T antigen lacks the 49 carboxyter-
minal amino acids. These two mutations were sep-
arated to form mutants pC8A and pC8B. All
mutants, pC8, pC8A, pC8B, and pT22, are com-
parable to the recombinant wild-type SV40 DNA
in transforming primary mouse embryo fibro-
blasts or primary BRK cells. Whereas pC8, pC-
8A, and pT22 are completely defective in viral
DNA replication, pC8B is able to replicate viral
DNA but only at 10% wild-type efficiency. Al-
though C8B DNA replication occurs with the
same efficiency in both CV-1 and BSC-1 cells, vi-
rus only grows on BSC-1 cells. Thus, truncation
of 49 amino acids from the carboxyl terminus of
T antigen results in a host-range mutant pheno-
type. Analysis of the origin-binding activity of
mutant T antigen reveals that C8, C8A and C8B
T antigens bind to SV40 origin as efficiently as
wild-type T antigen, but T22 T antigen is com-
pletely defective in the origin-binding assay. All
mutants are positive in ATPase assay.
All of the replication-defective T antigen mu-
tants we have so far analyzed have been cloned
into an adenovirus expression vector, and large
quantities of mutant T antigen have been pro-
duced. In collaboration with C. Prives (Colum-
bia University), the biochemical properties of
these mutants are being further analyzed with
greater scrutiny.
Permissive Cell Lines That Inducibly
Express SV40 Antigen
R.D. Gerard, Y. Gluzman
We wanted to generate cell lines in which the rep-
lication of transfected SV40 origin sequences
could be controlled. One way to accomplish this
is to replace the SV40 early promoter with the
mouse methallothionein promoter to render
expression of T antigen inducible by heavy met-
als. Transformation of permissive monkey cells
with this chimeric gene has yielded cell lines
(CVMT and BSCMT) that synthesize three- to
tenfold more T antigen upon induction. Unin-
duced levels of T antigen are comparable to those
present in COS cells. Withdrawal of these cell
lines from inducer results in a rapid decay in the
rate of T-antigen synthesis, with estimates of the
half-time ranging from 3 hours to 5 hours, de-
pending on the clone. In addition, pulse-chase
experiments indicate that T antigen is stable, with
a half-life (20-30 hr) comparable to that in COS
cells.
The rate of replication of transfected SV40 on
sequences rapidly slows after heavy metals are
withdrawn even though T antigen is stable. The
rate of DNA replication decays with a half-time
of 5-8 hours and parallels the decay of the rate of
synthesis of T antigen. One explanation of this
phenomenon is that continual synthesis of T an-
tigen is required for DNA synthesis because only
newly synthesized T antigen will support DNA
replication. Further analysis of SV40 on repli-
cation in CVMT and BSCMT cell lines indicates
that induction of T-antigen synthesis by heavy
metals results in a 20-100-fold greater accumula-
tion of replicated DNA than obtained under un-
induced conditions after 48 hours. COS cells
replicate DNA to levels comparable to those pres-
ent in uninduced CVMT and BSCMT cells.
To examine the ability of these cell lines to
maintain SV40 on sequences in a episomal state,
we have transformed them with the neo gene car-
ried on an SV40 on plasmid (pON3). Low-mo-
lecular-weight DNA was isolated from G418-re-
sistant cultures and analyzed by both Southern
blotting and plasmid rescue. The results demon-
strate the persistence of pON3 DNA as an epi-
some and an increase of 20-100-fold in the copy
number of these sequences upon induction of T-
antigen synthesis by heavy metals. Although sig-
nificant rearrangement of the DNA sequences
sometimes occurs, the majority of these altera-
tions occur within plasmid sequences presumably
because alterations in the SV40 on and neo struc-
tural genes are selected against.
Transformation of CVMT and BSCMT cells
with a similar DNA construct containing the neo
gene under SV40 early promoter control, the
SV40 ori, and the influenza virus hemagglutinin
(HA) gene under SV40 late promoter control
(provided by M.-J. Gething, Molecular Genetics
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of Eukaryotic Cells Section) (neoHA DNA) has
also given rise to G418-resistant clones. Analysis
of low-molecular-weight DNA by Southern blot-
ting demonstrates the persistence of intact neoHA
DNA and a 10-100-fold amplification of these se-
quences after induction of T-antigen synthesis by
heavy metals for 48 hours. Synthesis of the HA
protein is easily assayed by immunoprecipitation
and gel electrophoresis and shows a 3-15-fold in-
crease above control levels upon heavy metal in-
duction.
Although we do not know if chromosomal in-
tegration of these sequences has occurred, these
observations suggest that CVMT and BSCMT cell
lines may be a useful system for maintaining
cloned genes in an amplifiable episomal state in
mammalian cells.
Monoclonal Antibodies Specific for
SV40 Nucleoprotein Complexes
R. Gerard, E. Harlow
During the lytic cycle of SV40 infection, the viral
DNA can be recovered from the nucleus as a nu-
cleoprotein complex. These complexes are het-
erogeneous in nature and include DNA that is
being actively replicated and transcribed. Con-
sequently, these complexes should contain a vari-
ety of eukaryotic proteins that are involved in
replication and transcription. We have begun an
analysis of the immunogenic proteins in these
complexes.
SV40 nucleoprotein complexes (NPCs) were
isolated from virus-infected CV-1 monkey cells
and were purified by sucrose gradient centrifu-
gation. After the complexes were fixed by formal-
dehyde treatment, they were used to immunize
a BALB/c mouse. Hybridomas were constructed,
and tissue-culture supernatants were screened for
antibodies specific for NPCs by indirect immu-
nofluorescence on SV40-infected CV-1 monolay-
ers. Of the 384 cultures examined, 36 hybrido-
mas produced antibodies recognizing antigens
present in SV40-infected cells. Among these were
antibodies specific for the SV40-coded large T
antigen and viral capsid proteins. Another hybri-
doma in this series produces antibodies that pre-
cipitate NPCs that have been pulse-labeled with
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[3II]thymidine. This antibody will immunopre-
cipitate a 70K phosphoprotein from infected or
mock-infected cells, and we are currently at-
tempting to identify this antigen.
An Adenovirus Vector That Expresses
the Protein Product of a Nonselected
Foreign Gene at a High Level:
Synthesis of HSV-1 Thymidine Kinase
and Human a-Chorionic Gonadotropin
M. Yamada, T. Grodzicker
We have been developing an adenovirus vector
system that can express foreign gene products to
a high level in mammalian cells. We have shown
previously that SV40 T antigen is produced at the
highest levels when its coding sequences are
placed adjacent to the third segment of the aden-
ovirus tripartite leader. We have also shown that
defective adenovirus-SV40 recombinants express-
ing SV40 large T antigen can be selected by virtue
of the large T helper function that allows adeno-
virus to grow on normally nonpermissive monkey
cells. To insert other foreign genes into the third
leader of the adenovirus genome, we used a com-
bination of in vivo and in vitro recombination,
followed by the selection of hybrid viruses that
also express the helper function of SV40 T anti-
gen (Thummel et al., Cell 33: 455 [1983]). We in-
serted the thymidine kinase (tk) gene of herpes
simplex virus I (HSV), the genomic sequences
coding for human a-chorionic gonadotropin (a-
HCG), or its cDNA form at the third segment of
the tripartite leader. These viruses also contain
the SV40 early promoter and T-antigen-coding
region downstream from the tk or a-HCG genes.
Human or monkey cells infected by one of the
adeno-tk hybrid viruses (AdTkSVR591) produced
in the late stage of infection (1) an abundant Tk
mRNA with the length expected for a molecule
containing both the tripartite leader sequence and
tk sequences, (2) a 45K protein that reacted with
anti-Tk antisera and with the same molecular
weight as that found in HSV-infected cells (see
Fig. 3), (3) a Tk protein that was synthesized to
high levels and represented the third most heavily
labeled protein in the cells, after hexon and fiber,
and (4) severalfold higher Tk activity than is
found in HSV-infected cells.
FIGURE 3 Analysis of hybrid-virus-encoded
Tk protein by gel electrophoresis. CV-1 cells
were infected with the virus indicated. After in-
cubation at 37°C for either 8 hr for HSV or 20
hr for adenovirus, cells were labeled with 100
[35S]methionine for 1 hr and lysed with NP-
40. An amount of supernatant fraction, equiv-
alent to 2 x 105 cells, was incubated with 2 pl of
anti-Tk antiserum at 4°C, and immunocom-
plexes were precipitated with an excess of pro-
tein A-Sepharose precoated with rabbit IgG
directed against goat IgG. The precipitate was
boiled in sample buffer and analyzed by elec-
trophoresis on a 10% acrylamide gel (A-E). An
amount of the same extract, equivalent to
2 x 104 cells, was also analyzed without immu-
noprecipitation by electrophoresis on the same
gel (F-1). Extracts were also prepared from
nonlabeled cells at 26 hr postinfection. An
amount equivalent to 2 x 105 cells (containing
about 70 mg protein) was analyzed on an 8%
acrylamide gel (J-L). (A,F,J) Mock; (B,G,) wild-
type adenovirus 1 x51 (moi = 50); (C,H,L)
AdSVR599 (contains SV40 T antigen se-
quences but no tk gene) (moi= 200, hyb =
10%); (0,1,K) AdTkSVR591 (contains SV40
T antigen sequences and HSV-1 tk gene),
(moi = 200, hyb = 30%); (E) HSV (moi = 10).
.<3
ABC DEF G HI
We also have stocks of virus that contain the a-
HCG gene. Populations are a mixture of hybrid
(30°7o) and helper virus. In CV-1 and HeLa cells
infected with these viruses, a-HCG can be de-
tected by immunoprecipitation of ["S]methio-
nine-labeled proteins from cell extracts and from
the culture medium. Time course experiments
show that a-HCG is synthesized as a late viral
protein. CV-1 cells do not synthesize cx-HCG, and
HeLa cells have low endogenous levels that are
turned off late in adenovirus infection. In both
cell types, large amounts of a-HCG are made,
equivalent in amount to late viral proteins; thus,
a-HCG can be detected among ['SS]methionine-
labeled infected cell proteins without immuno-
precipitation. The a-HCG made is glycosylated
and secreted as is cellular a-HCG, and several
forms are seen in both the cytoplasm and the me-
dium. The molecular-weight species (20K and
16K in the cytoplasm and 22K in the medium)
seen in a-HCG virus-infected HeLa cells are the
same as those of endogenous a-HCG. When in-
fected cells are treated with tunicamycin and la-
beled proteins are immunoprecipitated with a-
HCG antiserum, the predominant forms are ab-
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sent, but one lower-molecular-weight a-HCG
protein is detected in the cytoplasm. The se-
creted a-HCG is insensitive to treatment with en-
doglycosidase H, although some of the cyto-
plasmic forms are cleaved.
Construction of Defective Adenovirus
Recombinants That Express
Polyoma T Antigens
T. Grodzicker [in collaboration with S. Mansour and
R. Tjian, University of California, Berkeley]
We wanted to produce large amounts of polyoma
T antigens so that these proteins can be more eas-
ily purified and their biochemical properties
studied and compared to SV40 tumor antigens.
We have been able to overproduce SV40 T anti-
gen using adenovirus vectors, and we have now
constructed two defective adenovirus recombi-
nants that carry polyoma virus early coding se-
quences fused to the adenovirus third leader seg-
ment. These viruses also contain the SV40 early
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promoter and T-antigen-coding region to allow
helper function selection for recombinants.
One virus, RAdPySVR498, carries the entire
polyoma early coding region. This virus expres-
ses proteins that are immunoprecipitable with anti-
polyoma tumor serum and that comigrate with
the authentic polyoma T antigens on SDS-poly-
acrylamide gels. The hybrid virus, AdPySVR-
498, overproduces both middle T antigen (5-fold)
and small T antigen (20-fold) in infected cells.
Small T antigen can be detected among total
[35S]methionine- labeled infected cell proteins
without immunoprecipitation.
S1- nuclease analysis of the hybrid-virus-en-
coded mRNAs suggests that the polyoma splicing
signals are being correctly utilized and that the
mRNA levels reflect the levels of the three T-an-
tigen proteins. In addition, at least the third ad-
enovirus leader segment is present at the 5' end of
the mRNAs. It should be noted that, although
all three polyoma T antigens are synthesized in
AdPySVR498-infected human or monkey cells,
the ratios between the proteins are different from
those found in polyoma-infected mouse cells.
However, these lower levels of large T antigen rel-
ative to levels of middle and small T antigens cor-
respond to the amounts of the respective mRNAs
produced by the hybrid virus. This suggests that
the donor splice sites for large T antigen versus
middle- and small-T-antigen mRNAs are used
with different efficiencies in adenovirus-infected
cells. A similar situation is found with adenovi-
rus-5V40 hybrid virus-infected monkey cells,
where the donor splice sites for SV40 large and
small T antigens are differentially utilized (Thum-
mel et al., Cell 23: 825 [1981]).
The second virus, RAdLTSVR545, was con-
structed to carry a cDNA coding for the large T
antigen of polyoma virus rather than the entire
early coding region. Immunoprecipitation of pro-
teins late in an RAdLTSVP infection shows a
fivefold overproduction of 100K polyoma large T
antigen. S1- nuclease analysis of RAdLTSVR545-
encoded mRNA shows that the large T message
contains the adenovirus third leader at its 5' end.
Using a fragment immunoprecipitation assay, we
showed that the RAdLTSVP large T antigen binds
specifically to the polyoma noncoding region, i.e.,
to the region around the origin of viral DNA rep-
lication and the early and late promoters. Inde-
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pendent binding to fragments on both sides of the
Bgll site was observed.
We are currently attempting to purify suffi-
cient amounts of polyoma large T antigen from
RAdLTSVR545-infected HeLa spinner cells to
carry out detailed DNA-binding studies and to
determine whether this protein will repress tran-
scription from the polyoma early promoter in vi-
tro. The hybrid virus, AdLTSVR545, contains
pBR322 sequences downstream from the poly-
oma insert and represents less than 5% of the vi-
ral population. Thus, it is difficult to assess the
maximum amount of polyoma large T antigen
that could be produced. We do know that recom-
binant viruses containing the genes encoding
HSV-1 Tk or cx-HCG that constitute 10-20% of
the viral population make very high levels of these
proteins (Yamada and Grodzicker, see above).
Helper-free Ad5 Vectors: Expression
of Complete or Truncated SV40 T
Antigens by Recombinant Viruses
during Lytic Infection
J. Harper, Y. Gluzman
As we reported last year, large amounts of SV40
T antigen are synthesized late after infection of
human 293 cells with recombinant viruses car-
rying SV40-T-coding sequences. The largest
amount is produced in cells infected with the vi-
rus containing the Ad2 MLP with 2-1/2 leader
segments. Threefold less T antigen is produced
in cells infected by viruses containing the Ad2
MLP with only half of the first late leader seg-
ment. Analysis of T-antigen-specific mRNAs ex-
tracted late after infection of 293 cells by the re-
combinant viruses revealed that the amount of
these messages correlated with the amount of
protein produced in these cells. These data dem-
onstrate that under certain (as yet unknown) con-
ditions, the mRNA with 2-1/2 leaders is not
translated more efficiently than mRNA with only
half of the first late leader segment. In addition
to authentic T antigen, smaller polypeptides rec-
ognized by the large-T-specific monoclonal anti-
body PAb416 were seen in cells infected by viruses
carrying the SV40 insert in the left-to-right ori-
entation. The truncated T antigens produced by
viruses containing the Ad2 MLP + 2-1/2 leader
segments appear to be 26K, and T antigens pro-
duced by viruses containing the Ad2 MLP + 1/2
leader segment appear to be 20K. The correla-
tion between the orientation of the SV40 insert in
the vector and synthesis of truncated T-antigen
polypeptides suggested that the mRNA for these
proteins might be produced by aberrant splicing
of the SV40 RNA. Several examples of aberrant
splicing of the RNA encoded by genes inserted
into adenovirus have been reported (Thummel et
al., J. Mol. Appl. Genet. 1: 435 [1982]; Berkner
and Sharp, Nucleic Acids Res. 10: 1925 [1984];
Westphal, J. Virol. 40: 526 [1981]). We have ana-
lyzed the T-antigen-related polypeptides synthe-
sized in rabbit reticulocyte lysates primed with
RNA from cells infected by various recombinant
viruses. The occurrence, size, and relative
amounts of truncated T antigens synthesized in
vitro were similar to those of the in vivo products.
These data suggest that these proteins are pri-
mary translation products of RNA molecules spe-
cific to viruses that carry the SV40 insert in a left-
to-right orientation. Both the 20K and 26K trun-
cated T antigens contain the aminoterminal re-
gion of T antigen, since they are immunoprecipi-
tated by monoclonal antibodies PAb430 (which
recognizes both small T and large T antigens) and
PAb416 (which is specific for a large-T-antigen
determinant located within the aminoterminal
20% of the molecule), but are not immunoprecip-
itated by a mixture of carboxyterminal-specific T-
antigen monoclonal antibodies (PAb414, PAb431,
and PAb405).
S1- nuclease analysis of corresponding mRNAs
indicates that truncated RNA is produced by at
least two splicing reactions: removal of the nor-
mal large T intron and an additional splice using
a donor in the second exon approximately 150 nu-
cleotides downstream from the normal splice ac-
ceptor. A good splice donor consensus sequence
appears in the SV40 DNA sequence at approxi-
mately this position (nucleotide 4424). Use of a
splice donor in this region has been reported for
one of the Ad2 'ND, RNA species (Westphal, J.
Virol. 40: 526 [1981]).
Our data show no obvious differences between
RNAs encoding the 26K and 20K T antigens in
the SV40 HindIIIB region. Differences in the
protein-coding capacity of these RNAs may be
due to small differences in splice sites that are not
detected by this method, the use of different
splice sites in the SV40 sequences 3' to the region
probed, or the use of different splice acceptors in
the adenovirus E1B sequences. SI-nuclease ex-
periments are in progress to examine the latter
possibilities.
Integration and Stable Expression of
Foreign Genes Introduced by Helper
Independent Adenovirus Vectors
in a Variety of Mammalian Cells
K. Van Doren
Last year, we reported that recombinant adeno-
viruses containing a selectable marker for neo-
mycin resistance in El will integrate into the host-
cell genome. The data obtained from analysis of
the integrated viral DNA indicate that, in gen-
eral, the viral DNA is present as almost full-length
linear genomes. These observations suggest either
that the viral DNA is preferentially integrated
from the ends of the genome or that this occurs
due to a positive selective pressure created by hav-
ing the selectable gene at one end of the viral
chromosome. Recombinant viruses in which the
selectable marker for neomycin resistance re-
places early region 3 (E3) of the adenovirus vec-
tor were used to address this point. These recom-
binant viruses contain the selectable marker far
from the ends of the viral genome. Because the
selectable marker is not located at the end of the
viral chromosome, there should be no positive se-
lective pressure exerted for the integration of the
ends of the viral genome into the host-cell chro-
mosomes. Recombinant viruses containing the
neomycin resistance gene in E3 transformed CV-
1 cells to G418 resistance as efficiently as recom-
binant viruses containing the neomycin resistance
gene in El. Preliminary analysis of the viral DNA
contained in cell lines derived from these viruses
suggests that the pattern of integration is very
similar to that found for El replacement viruses.
This indicates that integration occurs preferen-
tially from the ends of the adenovirus genome.
Previously, we reported that a recombinant vi-
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rus containing the SV40 early region with a defec-
tive origin of replication, located in E1, would ef-
ficiently transform human fibroblasts and that
the pattern of integrated DNA was identical to
that reported for the neomycin recombinant vi-
ruses. Because human fibroblasts are semiper-
missive for SV40 DNA replication, we were un-
able to assess the state of the integrated DNA in
cells transformed by recombinant viruses con-
taining an SV40 functional origin of replication
due to the presence of large amounts of freely
replicating DNA. Upon subcloning of the paren-
tal transformed cell lines, we observed that two of
the three subcloned cell lines had lost the ability
to produce freely replicating SV40 DNA mole-
cules. The subclones contained T antigen as de-
tected by immunofluorescence, indicating that
they had not lost the SV40 DNA. It was possible
that a mutation occurred in a cellular permissiv-
ity factor or in the viral T antigen so that it could
no longer function in DNA replication. We fused
the subclones to either COS-1 or CV-1 cells and
found that the T antigen in the human cells had
mutated so that it no longer supported SV40 rep-
lication, which suggests that there is a strong se-
lective pressure against having a functional SV40
replication system in human cells. The pattern of
integrated viral DNA in these cells was found to
be identical to that observed for human cells
transformed by recombinant viruses containing a
defective SV40 origin of replication.
We are currently characterizing the use of a
double-replacement vector in which foreign genes
can be cloned into both El and E3. This vector
will make it possible to introduce nonselectable
genes into mammalian cells by using a selectable
marker in the second replacement site. Double
recombinant viruses containing the human )3 -glo-
bin gene with a selectable marker for either neo-
mycin resistance or methotrexate resistance
(DHFR) are being constructed and analyzed for
the ability of the viruses to introduce the globin
gene into a variety of cells. The feasibility of us-
ing the DHFR gene as a method to amplify the
integrated viral DNA will also be explored.
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DNA SYNTHESIS
S.W. Stillman P. Cotton G. Prelich
J. Diffley B. Faha
E. White S. Penzi
Over the past 5 years, we have concentrated our
studies on the biochemical analysis of eukaryotic
DNA replication using adenovirus as a model sys-
tem. This work is now at a stage where it is pos-
sible to replicate completely adenovirus DNA in
vitro with purified proteins. Three of these pro-
teins are encoded by the virus and two are pro-
duced by the host cell. Thus, despite the atypical
mechanism of adenovirus DNA replication, two
cellular proteins required for adenovirus DNA
replication have been identified, and it is possible
that these proteins function in important cellular
processes such as DNA replication. However, be-
cause adenovirus replicates its DNA differently
from the way a cell replicates its chromosomal
DNA, we have turned to the biochemical analysis
of DNA replication of another DNA tumor virus,
SV40, which provides an excellent model for
chromOsomal replication in cells. During this
year, we have developed a cell-free system for the
replication of SV40 DNA. Since the replication
of SV40 DNA and that of cellular DNA appear
to be similar, we expect that characterization of
this system will provide valuable insight into the
mechanism of initiation, elongation, and termi-
nation of eukaryotic DNA replication and ulti-
mately enable a molecular analysis of the control
of these processes.
In addition to our studies of DNA replication,
we have continued to probe the biochemical func-
tions of the adenovirus tumor antigens. One of
these proteins has been shown to be localized to
the nuclear envelope of infected and transformed
cells, and mutations in the protein induce the deg-
radation of cellular DNA. We have now found
that this DNA degradation is specific for the type
of human cell that is infected by the mutants.
Adenovirus DNA Replication
J. Diffley, G. Prelich, B. Stillman
Two cellular proteins are required for the com-
plete replication of adenovirus DNA in vitro.
One of these proteins, nuclear factor II, contains
a type I topoisomerase activity and is required for
complete elongation of nascent DNA strands.
The other protein, nuclear factor I, is a site-spe-
cific DNA-binding protein that binds to se-
quences within the origin of adenovirus DNA
replication, and this binding is required for effi-
cient initiation of replication. It is known that
the protein can bind specifically to cellular DNA
sequences that are present at approximately 1 in
every 100,000 base pairs in the human cell ge-
nome (Gronostajski et al., Proc. Natl. Acad. Sci.
81: 4013 [19801), but the function of the protein
in uninfected cells is not known. At present, the
only assay for this protein for purification pur-
poses is its ability to stimulate adenovirus DNA
replication in the presence of the three virus-en-
coded proteins, the single-stranded DNA-binding
protein (DBP), the adenovirus DNA polymerase
(Adpol), and the adenovirus precursor terminal
protein (pTP). However, this assay requires that
these three proteins be substantially pure prior to
purification of nuclear factor I. We have there-
fore developed a simple, more rapid assay for nu-
clear factor I that can detect the functional pro-
tein in crude extracts of human cells and is
independent of its role in initiation of adenovirus
DNA synthesis.
The assay for nuclear factor I utilizes its spe-
cific DNA-binding properties. Briefly, DNA
containing the binding site for nuclear factor I is
labeled at each terminus with 32P and mixed with
crude extracts derived from the nuclei of HeLa
cells and a mixture of synthetic homopolymers as
competitor DNA. The binding of nuclear factor
I to the "P-labeled DNA is assayed by a simple
nitrocellulose-filter-binding method, and the re-
tention of labeled-DNA-protein complexes on the
nitrocellulose is detected by autoradiography or
scintillation counting. The assay is dependent on
time and temperature, the presence of Mgr ,
and the concentration of NaC1 in the reaction
mixture. The competitor DNA is an equal mix-
ture of the synthetic homopolymers poly(dA):
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oligo(dT) and poly(dC):oligo(dG) and must be
added to the nuclear extract prior to the addition
of labeled DNA. It is preferable that the labeled
DNA be as short as possible, and we routinely use
fragments in the 35-200-bp range. As a control
for nonspecific binding to DNA of proteins pres-
ent in the crude extract, a labeled DNA fragment
that does not contain the binding site for nuclear
factor I is used, usually a DNA fragment contain-
ing a mutated binding site. The presence of nu-
clear factor I in the extract is observed when DNA
containing the binding site is preferentially re-
tained on nitrocellulose, but the control DNA
fragment fails to bind. Using this assay, we have
purified nuclear factor I from He La cells, and the
activity coelutes at every purification step with the
reconstitution of adenovirus DNA replication ac-
tivity of the protein. We are currently concen-
trating our efforts on determining the normal cel-
lular function of the nuclear-factor-I protein.
This assay for site-specific DNA-binding pro-
teins in extracts prepared from eukaryotic cells is
generally applicable to other proteins. Site-spe-
cific DNA-binding proteins have been shown to
regulate transcription of certain genes in eukary-
otes (Dynan and Tjian, Cell 35: 79 [1983]; Parker
and Topol, Cell 36: 357 [1984]) and may be im-
portant in other cellular processes such as DNA
replication and cellular differentiation. Using the
rapid filter-binding assay, we have detected in
crude extracts from HeLa cells a protein that
binds specifically to the 21-bp repeat region of the
SV40 early promoter, and it is most likely that
this protein corresponds to the transcription fac-
tor SP1 required for transcription of the SV40
early promoter in vitro (Dynan and Tjian, Cell
35: 79 [1983]). This will provide a rapid assay for
the purification of this protein and identification
of its molecular weight and any associated enzy-
matic activities.
In addition to biochemical analysis of these
cellular encoded proteins, structural and func-
tional studies on the adenovirus DBP are contin-
uing. This protein is required for elongation of
adenovirus DNA replication, and, in addition, it
is involved in the control of early mRNA synthe-
sis and late gene expression. We have now se-
quenced the mutation in the DBP from the mu-
tant Ad2ts111 and have found that it lies in the
middle of the protein sequence, away from the
other well-characterized DBP temperature-sensi-
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tive mutation in Ad5ts125. The Ad2ts111 muta-
tion lies adjacent to another mutation present in
Ad5ts23 (J. Williams, pers. comm.); we have ob-
tained this virus and are currently comparing the
in vitro biochemical properties of the mutant and
wild-type proteins. These studies should comple-
ment the structural studies on DBP by Tsern-
oglou et al. (J. Mol. Biol. 172: 237 [1984]), who
have crystallized a fragment of the DBP and are
currently determining the three-dimensional
structure of the protein.
SV40 DNA Replication
B. Stillman
The tumor virus SV40 contains a double-
stranded, circular DNA genome of 5243 by and
replicates efficiently in monkey cells. DNA rep-
lication can also be detected in some, but not all,
human cell lines but does not occur in mouse cells.
The viral DNA is part of a nucleoprotein complex
that is very similar in structure to the cell's chro-
mosome, and replication of SV40 DNA in vivo is
followed by duplication of the nucleosome struc-
ture. Replication proceeds from a single origin
of replication and is dependent on a single virus-
encoded protein, the SV40 tumor (T) antigen.
Because of these properties, it is most likely that
SV40 replicates its DNA in a similar way to cell
chromosomal DNA replication. We therefore set
out to prepare cell-free extracts that would sup-
port complete SV40 DNA replication and even-
tually study the mechanism and control of eu-
karyote DNA synthesis in some detail.
Recently, Li and Kelly (Proc. Natl. Acad. Sci.
81: 6973 [1984]) have developed a cell-free system
for the replication of SV40 DNA, using extracts
from monkey cells, and we have modified this
system for the use of human cells. We decided to
use human cells for SV40 DNA replication stud-
ies, since monkey cells proved to contain high lev-
els of protease activities and were difficult to
maintain in suspension cultures, which would be
necessary for obtaining large amounts of cellular
protein for purification purposes. It was shown
previously that human 293 cells could support ef-
ficient SV40 DNA replication in vivo but that
replication in human HeLa cells was very ineffi-
cient (J. Manley and M. Ca los, pers. comm.).
Human 293 cells, which are adenovirus-trans-
formed human embryo kidney cells that express
adenovirus tumor antigens encoded by the E1A
and E1B genes, were adapted for growth in sus-
pension cultures.
Because cell extracts were prepared from unin-
fected cells, it was necessary to supply the SV40
T antigen to reconstitute DNA replication. For
this purpose, a modified adenovirus that pro-
duces large amounts of SV40 T antigen was con-
structed by Y. Gluzman and his colleagues (this
section). The T antigen produced from this vec-
tor was purified to homogeneity by immunoaf-
finity chromatography on a protein A-Sepharose
column to which the anti-T monoclonal antibody
PAB419 had been covalently bound (Simanis and
Lane, Virology [1985] in press). With this puri-
fication procedure and the adenovirus vector sys-
tem, milligram quantities of highly active T anti-
gen can be purified with great ease.
Extracts prepared from both the nucleus and
cytoplasm of human 293 cells were used in com-
bination with the purified SV40 T antigen. In the
presence of the cytoplasmic extracts and SV40 T
antigen, replication of plasmids containing the
origin of DNA replication was achieved. Repli-
cation was shown to be very efficient; up to 70%
of the input DNA molecules could be replicated
(calculated on the basis of nucleotides incorpo-
rated per nucleotides added), and DNA synthesis
occurred in both directions from the origin re-
gion. Multiple rounds of SV40 DNA synthesis
were also observed, and the available data suggest
that replication proceeds in a manner similar to
that of SV40 DNA replication in vivo. Further-
more, initial studies with SV40 origin mutants
have demonstrated similar DNA sequence re-
quirements in vivo and in vitro.
The products of the replication reaction made
in the presence of SV40 T antigen and the cyto-
plasmic extract were shown to be covalently
closed, circular, but relaxed DNA. Addition of
an extract prepared from the nuclei of human 293
cells converted these relaxed circular DNA mole-
cules to negatively supercoiled DNAs (see Fig. 1).
The introduction of negative supercoils into rep-
licated DNA required factors from the cyto-
plasmic extracts because the nuclear extract alone
did not alter the topological state of the DNA.
Indeed, the process of negative supercoiling of the
pSV40
nuclear extract 0 .35 1.4 0 .35 1.4
(fug)
DNA synthesis
(pmol dAMP)
FIGURE 1 Replication and supercoiling of SV40 DNA in
vitro. Plasmid DNAs containing the entire SV40 genome
(pSV40) or a 200-bp fragment from the SV40 origin region
(pSVO+) were incubated for 2 hr at 37°C with an extract
derived from the cytoplasm of human 293 cells and purified
SV40 T antigen. In addition, the reactions contained either
0, 0.35, or 1.4 yg of an extract prepared from the nuclei of
293 cells as indicated. The reactions were stopped, and the
DNA was isolated and subjected to agarose gel electropho-
resis. The marker DNAs were pSV40 DNA (forms I and II)
and pSVO+ DNA (forms I and II) and adenovirus DNA or
HindlIl restriction fragments of adenovirus type-2 DNA. The
gel shows an autoradiogram of the 32P-labeled replication
products.
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DNA only occurs during the process of replica-
tion itself. It is thus likely that negative super-
coiling of the DNA in this in vitro system occurs
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concomitantly with DNA synthesis. This result
was of some interest because the negatively super-
coiled DNA was stable, even in the presence of
high levels of the type I topoisomerase in the ex-
tracts. This latter activity normally relaxes neg-
atively supercoiled DNA. It therefore seems that
a novel regulation of the higher order of structure
of DNA is occurring in these extracts. It will be
of interest to determine whether the DNA is su-
percoiled by a DNA gyrase activity that is present
in the extracts or whether the DNA is associated
with protein that causes the DNA to alter its to-
pological structure.
The SV40 replication system should prove use-
ful for the elucidation of the mechanism of DNA
synthesis in eukaryotic cells and eventually lead
to the identification of replicative proteins. It is
expected that a better understanding of the con-
trol of DNA replication and cell proliferation will
be obtained.
Adenovirus Tumor Antigens
E. White, P. Cotton, B. Faha, B. Stillman
In addition to our studies on DNA replication,
we have continued with the biochemical analysis
of the adenovirus tumor antigens that are pro-
duced from the E1B genes. Two tumor antigens
are synthesized from this early gene region and
both proteins appear to be required for complete
transformation of cells. In last year's Annual Re-
port, we described our studies on the El B 19,000-
dalton (19K) tumor antigen. Single point muta-
tions in, or a deletion within, the coding region
of the E1B 19K gene in the adenovirus genome
caused a drastic phenotype in infected cells. The
cellular morphology was severely altered, and
cellular DNA was degraded into low-molecular-
weight fragments during the course of infection
of human He La cells with these viral mutants.
We have characterized these phenotypes, which
are the result of two separable functions of the
E1B 19K protein: The cyt mutations caused an
altered cytopathic effect in mutant infected cells
and the deg mutations caused the degradation of
the cell's chromosomal DNA. All of the deg mu-
tants demonstrated the Cyt phenotype, but the cyt
mutant 1p3 did not induce degradation of cellular
DNA. The phenotype of these El B 19K mutants
is summarized in Table 1.
We had previously demonstrated by indirect
immunofluorescence at the light microscopic
level, and by biochemical fractionation, that the
E1B 19K protein in wild-type adenovirus-infected
He La cells was localized to the nuclear envelope;
50% of the protein was tightly associated with the
nuclear envelope lamina and the remaining frac-
tion was less tightly associated with the lamina
and was probably localized in (or on) the nu-
clear envelope membranes. In adenovirus-trans-
formed cells, the E1B 19K protein localized to the
nuclear envelope and also to a cytoplasmic mem-
brane structure. Nuclear envelope localization of
the tumor antigen in infected cells was confirmed
by immunoelectron microscopy, which was done
in collaboration with S. Blose (Cell Biology Sec-
tion). The protein localized to both the inner and
outer nuclear envelope membranes but did not lo-
calize in the interior of the nucleus (see Fig. 2).
TABLE 1 Phenotypes of E1B 19K Gene Mutants
Virus Cyt' Deg,
19K
protein Transformation.
Ad2 wild type Cyt * Deg - + Tra*
Ad2cyt106 Cyt Deg + Trod
Ad51p3 Cyt Deg* + Tra
Ad5/p5 Cyt Deg + Tra
Ad5dl337 Cyt Deg Tra
'The Cyt phenotype is an enhanced and abnormal cytopathic effect in infected cells. Wild-type phe-
notype is Cyt*.
,The Deg phenotype is the production of degraded cellular DNA during lytic infection. Wild-type
phenotype is Deg*.
'Tra' indicates that the virus has transforming potential.
dOnly when the mutation is in a temperature-sensitive background.
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FIGURE 2 Immunoperoxidase electron microscopic staining of the nuclear-envelope-associated El B 19K tu-
mor antigen. He La cells were infected with wild-type adenovirus for 41 hr or mock-infected, and the cells were
then fixed and stained with antibodies against either the El B 19K protein or the nuclear lamina. Electron micro-
graphs of thin sections through nuclei of Ad2 (A-D) or uninfected He La cells (E,F) stained with anti-19K protein
(A) or anti-lamin (C,E) antibodies. For comparison, the control panels represent reactions with goat anti-rabbit
(8) or rabbit anti-human (D,F) horseradish-peroxidase-conjugated second antibodies alone. The nucleus (Nu),
pore complex (p), virion (V), inner (in) and outer (out) nuclear membranes, and lamina (L) are indicated. Magni-
fication, 83,915 x .
These results confirmed our previous data and
combined suggest that the E1B 19K protein is as-
sociated with the nuclear lamina on the mem-
brane side of this structure, as well as with the
nuclear envelope membranes.
In addition to the E1B 19K tumor antigen, we
observed that late in infection, several adenovirus
structural proteins were also found associated
with the lamina. The precursor (but not the pro-
cessed forms of virion proteins VI and VII) and
protein IX were selectively enriched in the nuclear
lamina preparations. Furthermore, the major
nonstructural protein produced late in infection,
the 100K phosphoprotein, was shown to be en-
riched in nuclear envelope membrane prepara-
tions but not in the nuclear lamina preparations.
It is therefore likely that this protein is associated
with the nuclear envelope membranes. These ob-
servations suggest that certain aspects of virion
morphogenesis occur on either the nuclear enve-
lope or an internal nuclear structure that is part
of a nuclear matrix.
Of particular interest was the association of the
E1B 19K tumor antigen with the nuclear envelope
and the fact that mutations in the E1B 19K gene
caused degradation of cellular DNA. This cor-
relation was observed in virus-infected HeLa cells,
and in these cells, the yield of virus was only re-
duced about tenfold compared with the wild-type
virus. As part of a search to find a human cell
line in which the E1B 19K mutants were more de-
fective than wild type, it was noticed that in some
cells, the mutants did not induce degradation of
cellular DNA. When primary human embryo
kidney (HEK) cells, or WI38 human diploid fi-
broblast cells, were infected with the E1B 19K
mutants, the mutant viruses did not induce deg-
radation of cellular DNA and surprisingly grew
to significantly higher titers than the wild-type
virus. On the other hand, the E1B 19K mutants
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were extremely defective for virus production in
human KB cells and caused enhanced DNA deg-
radation, whereas wild-type virus grew efficiently
in these cells.
We have thus identified three classes of human
cells that respond in different ways to the E1B
19K mutants and that clearly demonstrate the
host-range phenotype of these mutants. The first
class, represented by HEK and WI38 cells, allow
the E1B 19K mutants to grow efficiently and es-
cape the events that lead to the degradation of
DNA seen in the other cells. In the second class,
represented by He La cells and 293 cells, the mu-
tants cause degradation of cellular DNA, but the
virus is able to grow at nearly wild-type levels. In
the third class of cells, represented by KB cells,
the mutant viruses are severely defective for
growth and cause enhanced destruction of the
cellular DNA. We are currently examining at
which stage of the lytic cycle the mutant viruses
are blocked in infected KB cells.
The identification of a cell line in which the
virus is defective should enable revertants of the
E1B 19K mutants to be isolated and character-
ized. The E1B 19K mutant, d1337, which does not
produce any 19K protein due to a large deletion
of coding sequences for this protein, can still in-
duce DNA degradation upon infection into He La
and KB cells. Thus, since the 19K protein is ab-
sent in ti1337-infected cells, another virus protein
(or proteins) must be responsible for causing the
Cyt and Deg phenotypes. It is hoped that the re-
vertants will identify this gene product. We are
also creating double mutants in vitro, in which
selected early gene products are mutated in the
d1337 or cyt106 viral genomes.
The other protein produced from the E1B re-
gion is the 57,000-dalton (57K) tumor antigen.
We have previously demonstrated that mutations
in this protein cause a delay in the onset of DNA
synthesis during lytic infection but that the pro-
tein is not required for DNA replication directly.
The E1B 57K protein also has been shown to as-
sociate with the p53 cellular tumor antigen, as
does the SV40 T antigen, so that it is possible that
SV40 T antigen and the E 1 B 57K protein share a
common biochemical activity. In an attempt to
identify a role for this protein in lytic infection
and cell transformation, we are currently exam-
ining methods of overexpressing the protein and
eventually purifying the protein. To this end, a
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number of monoclonal antibodies directed
against this protein have been isolated and are
currently being characterized.
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The BsuRI Restriction-Modification
System
A. Kiss
We hive continued the characterization of the
GGCC-specific BsuRI restriction-modification
system of Bacillus subtilis that we have cloned and
expressed in Escherichia coli. The BsuRI genes,
cloned originally on a 9.5-kb SphI-Sall fragment,
were localized to a 4.3-kb Hpal-Sall fragment.
Since the sequencing of the methylase gene, using
a clone that codes only for methylase (Kiss and
Baldauf, Gene 21: Ill [1983]), was already in pro-
gress in P. Venetianer's laboratory in Hungary,
we concentrated our efforts on the endonuclease
gene.
A detailed restriction map of the region has
been established, and specific fragments have
been cloned in the M13 phage vectors mp 18 and
mp 19 and sequenced by the chain-termination
method. The region we have sequenced is 2904
by in length and codes for the endonuclease and
the aminoterminal 32 amino acids of the methy-
lase. The endonuclease is coded by a 1728-bp
open reading frame specifying 576 amino acids.
The two genes are oriented in the same direction,
with the methylase gene being downstream from
the endonuclease gene. The coding regions of the
two genes are separated by 780 bp, which is longer
than any other intergenic region found so far in
restriction-modification systems. This region
contains an open reading frame coding for 146
amino acids. A Shine-Dalgarno sequence pre-
ceding this reading frame suggests that it may di-
rect the synthesis of a small protein, but experi-
ments with derivatives in which this reading frame
has been disrupted indicate that even if this pro-
tein is produced, it probably has no role in the
functioning of the BsuRI system. The open read-
ing frame coding for the methylase is preceded by
a strong Shine-Dalgarno sequence, whereas the
sequence preceding the start codon of the endo-
nuclease gene allows for only weak Shine-Dal-
garno interactions. This difference may be im-
portant in regulating the expression of the BsuRI
system.
We have not been able to clone the endonu-
clease in the absence of methylase, indicating that
the expression of the restriction enzyme is not de-
pendent on the presence of active methylase. The
two genes are expressed when cloned on two dif-
ferent plasmids in the same cell, suggesting that
they do not constitute an operon. Transcription
of the BsuRI genes is currently being studied by
analysis of the cDNA products synthesized on in
vivo RNA using specific oligonucleotide primers.
These experiments confirm that the two genes are
transcribed separately and indicate that the meth-
ylase-specific mRNA is more abundant in the B.
subtilis cell than the endonuclease-specific tran-
script.
Our main purpose in studying restriction and
modification enzymes is to find out how these
proteins recognize specific DNA sequences.
Comparison of different proteins interacting with
the same DNA sequence may be helpful in this
respect. A search of the amino acid sequences
derived from the DNA sequence revealed no ho-
mology between the BsuRI endonuclease and
methylase. However, regions of homology were
found between the BsuRI methylase and two
other GGCC-specific DNA methylases, the BspRI
and SPR methylases. We wish to use mutagenesis
of the cloned enzymes to determine which parts
of the proteins are responsible for sequence-spe-
cific DNA recognition.
The EcoRII Restriction-Modification
System and the dcm Gene
A Bhagwat
The EcoRII endonuclease, the EcoRII methylase,
and the product of the Escherichia coli dcm gene
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all recognize the sequence 5'- CC(A /T)GG -3'. The
EcoRII genes were originally found to reside on a
low-copy-number E. coli plasmid N3, and were
subsequently cloned onto multicopy plasmids.
The dcm gene, which resides at 43 minutes on the
E. coli chromosome, codes for a methylase with
the same specificity as EcoRII methylase. We have
found that despite this known identity in their
specificities, in vivo, the dcm gene is unable to
complement endonuclease methylase- (R "M -)
mutants of EcoRII.
To understand better the relationship between
these genes, we have cloned the dcm locus of wild-
type E. coli on to pBR322. From a Sau3A partial
library of E. coli DNA in pBR322, the clone car-
rying the dcm locus was selected by treating the
DNA from a mixture of clones with the EcoRII
endonuclease, followed by transformation into
a dcm deletion (Ddcm) strain. Of the 18 trans-
formants thus obtained, 1 carried a plasmid that
was found to be resistant to the EcoRII endonu-
clease. Restriction analysis showed that this plas-
mid, designated pDCM1, has an 11.3-kbp insert
at the BamHI site.
When used as a probe in Southern blots, this
plasmid hybridizes to several EcoRV fragments
from the chromosomal DNA of a dm' strain but
to only one EcoRV fragment from the DNA of
the Ddcm strain. We thus conclude that the in-
sert in pDCM1 is derived from the same region in
which the Ddcm strain has a deletion. On the
basis of genetic evidence, E. coli codes for only
one cytosine methylase, dcm; hence, we conclude
that pDCM1 must carry the dcm locus.
A probe containing the EcoRII methylase gene
does not hybridize to the insert within pDCM1,
nor does it hybridize to any EcoRV fragments of
E. coli chromosomal DNA. However, pDCM1 is
able to complement an R+M- mutant of EcoRII.
Thus, dcm is able to complement the EcoRII
methylase from a multicopy plasmid location but
not from the single-copy chromosomal location.
This is probably due to the greater production of
the enzyme from the plasmid. Finally, a host car-
rying pDCM1 does not restrict incoming phage,
which indicates the lack of any endonuclease. In
summary, the products of the dcm gene and the
EcoRII methylase gene share the same sequence
specificity, but the genes are not homologous.
From its chromosomal location, the dcm gene
product is not able to methylate all of its sub-
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strate sites, but it is able to do so from the plas-
mid location. There may be no endonuclease gene
linked with dcm.
We have constructed protein fusions between
the EcoRII endonuclease and 0-galactosidase of
E. coli. The endonuclease gene was cloned, in
both orientations, in front of the 0-galactosidase
gene lacking its promoter, initiator methionine
codon, and ribosome-binding site. The resulting
phenotype was R"Lac- . E. coli strains (Dlac)
carrying one of these two plasmids and a compat-
ible plasmid carrying the methylase gene were
streaked out on MacConkey-lactose plates. Sev-
eral red (Lac') colonies spontaneously grew up
for one of the orientations of the endonuclease
gene but not for the other. These Lac' colonies
were picked and analyzed. Seven independent
colonies contained plasmids with deletions at the
endonuclease-0-galactosidase junction ranging in
size from 50 by to 1.3 kb. Strains carrying these
plasmids gave rise to white colonies on tetrazo-
Hum plates, suggesting the equivalent of 400 or
more units of 13-galactosidase activity as analyzed
by the Miller assay. The two smallest deletions,
which may have up to 30 amino acids missing
from the carboxyl terminus of the endonuclease,
restrict incoming phage as well as the wild-type
gene. A deletion removing up to 66 amino acids
reduces the ability of the cell to restrict incoming
phage by a factor of 2 x 102 to 5 x 102. The plat-
ing efficiency of the phage is still 20-50-fold lower
on this strain compared with that on an R+ strain.
Larger deletions completely destroy the ability of
the cell to restrict phage. These protein fusions
define the direction of transcription of the en-
donuclease gene. They also suggest that the car-
boxyl terminus of the endonuclease may not be
essential for its action and argue that a hybrid
protein carrying both the endonucleolytic activity
and lactose metabolizing activity can be con-
structed.
Cloned Genes for the Mspl Restriction-
Modification System
P.M.- Lin, R.J. Roberts
The Mspl restriction-modification system recog-
nizes the sequence 5'-CCGG-3' and is found in an
organism originally characterized as a Moraxella
species, although there is now reason to believe
that this identification was incorrect. DNA from
this organism has been cloned in a random fash-
ion into the plasmid vector pUC9, and a clone has
been isolated that expresses both the methylase
and restriction endonuclease activities of the
Mspl restriction system. This original clone con-
tains a 15-kb insert. A series of subclones have
been prepared, and one of these, containing a 3-
kb insert, still expresses both activities. The en-
tire insert of this clone has been sequenced. Three
open reading frames are present, of which one,
encoding a polypeptide of 418 amino acids
(M, = 47,664), has been shown to encode Msp
methylase. A second open reading frame en-
codes a polypeptide of 262 amino acids (M, =
29,833) and is the restriction endonuclease gene.
A third open reading frame, of unknown func
tion, partially overlaps with the carboxyl termi-
nus of the restriction endonuclease gene and con-
tinues uninterrupted into the flanking pBR322
sequences.
The genes for the restriction enzyme and the
modification methylase are transcribed in oppo-
site directions, and the first methionines present
in each reading frame are separated by 110 nu-
cleotides. Upstream of both AUGs are sequences
that closely resemble the Pribnow box found in
Escherichia coli promoters. The two genes are
extremely AT-rich and show no obvious homol-
ogy with each other at either the nucleic acid level
or protein sequence level. Furthermore, they
show no clear homologies with any other restric-
tion enzyme or modification enzyme genes that
have been sequenced to date.
Restriction Endonucleases
P.A. Myers, B. Zerler, R.J. Roberts
The collection of restriction enzymes continues to
grow and more than 500 such enzymes are now
known; 116 different specificities have now been
characterized, including eight in the last year.
Among these new specificities, the recognition se-
quences for Bsml (GAATGC), Nhel (GTCTAGC),
Sspl (AATTATT), and Spel (ATCTAGT) have
been characterized, as part of a collaborative pro-
gram with I. Schildkraut and D. Comb (New
England BioLabs). In addition, we have shown
TABLE 1 Simple Hexanucleotide Palindromes
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that Mjal is an isoschizomer of Mael (CTAG),
Mjall is an isoschizomer of Asul (GGNCC), and
Nflal is an isoschizomer of EcoRV (GATATC).
As shown in Table 1, 44 of the possible 64 en-
zymes that could recognize hexanucleotide palin-
dromes have now been discovered.
In Vitro Splicing of Ad2 Late RNA
G.A. Freyer, K. Tohill
Extracts made from He La cell nuclei have been
used to study RNA splicing in vitro. The sub-
strate, which contains the first and second exon
and the first intron of the tripartite leader of Ad2
major late RNA, is synthesized in vitro using a
He La whole-cell extract. Additionally, we have
constructed recombinant plasmids that can pro-
duce similar precursor RNAs when driven by the
bacteriophage X promoter P, or the Salmonella
phage promoter SP6. All of these transcripts
contain a modified version of the first intron, in
which 934 of the 1020 nucleotides have been de-
leted. These substrates have all been shown to
splice efficiently and correctly.
When a "P-labeled runoff transcript of 168 nu-
cleotides is incubated in nuclear extracts, the cor-
rect joining of the first and second exons takes
place to generate the final splice product; in ad-
dition, three potential intermediates are detected.
On a 10% polyacrylamide-urea gel, these inter-
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mediates migrate with apparent lengths of 41, 68,
and 118 bases. Fingerprint analysis has shown
that the 41 species is the free first leader. The 68
species has not yet been completely character-
ized, although it appears to come from the 3' end
of the RNA. On the basis of electrophoretic mo-
bility and fingerprint analysis of the 118 band, it
appears to be a circular molecule, 63 bases in
length, which contains sequences from the 5' end
of the intron. It is almost certainly the circular
portion of the lariat molecules described by other
investigators (Krainer et al., Cell 36: 993 [1985];
Grabowski et al. Cell 37: 415 [1985]). These lar-
iats contain sequences from the complete intron
and the adjacent exon but have an unusual struc-
ture in that the 5' end of the intron has formed a
2'-5' linkage to an A residue close to the 3' end of
the intron; thus, they contain a circular RNA
structure with a tail. It is the tail that appears to
be missing in the 118 band. The lariat is believed
to be the intermediate that combines with the first
exon to form the final splice product. Its absence
in our system suggests either that it turns over ex-
tremely rapidly or that some other intermediate
may be involved. The 68-nucleotide-long RNA,
which contains the 3' end of the precursor, is the
most likely candidate for this role. Experiments
are under way to test this possibility.
To investigate the necessity of lariat formation,
we have synthesized a mutant template, in which
both A residues at and close to the lariat attach-
ment site were changed to G residues. When the
"P-labeled transcript, made from this plasmid,
was incubated in our splicing extract, the only
visible product was the 41-nucleotide band that
results from cleavage at the donor splice site for
the first leader RNA. Although this accumulated
to high levels, the remaining RNA was degraded
extensively. This result suggests that at least one
function of the lariat may be to protect the RNA
from degradation. It also argues that lariat for-
mation is essential for splicing.
Fate of Ad2 Introns In Vivo
G.A. Freyer, K. O'Neill, R.J. Roberts
Our initial interest in examining introns from in
vivo RNA was to test a hypothesis concerning the
mechanism of splicing. This model proposed a
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simple reciprocal cleavage and ligation event oc-
curring at the intron/exon boundary, leading to a
linear final splice product and a circular intron.
The system that we chose to examine was the tri-
partite leader from the major late RNA of Ad2.
Two oligonucleotides were synthesized that would
hybridize across the predicted junctions of circu-
lar introns corresponding to either the intron be-
tween leaders 1 and 2 or the intron between lead-
ers 2 and 3. Nuclear and cytoplasmic RNAs were
prepared separately from Ad2-infected HeLa
cells. The RNA was electrophoresed on denatur-
ing agarose gels, blotted, and probed with these
"P-labeled oligonucleotides. The oligonucleo-
tide, designed to probe the first intron, failed to
hybridize to any RNA species. This result is con-
sistent with the circularization of this intron at an
internal position as indicated above. However,
the oligonucleotide, designed to probe the second
intron, did hybridize to several RNA species. In
control experiments, it was shown that some of
these species were present in uninfected HeLa
cells. The structures of the Ad2-specific species
are under investigation.
To investigate the fate of the first intron se-
quences, two oligomers were synthesized, with se-
quences complementary to linear portions of the
first intron. These oligomers gave an interesting
and surprising result. They detected RNA spe-
cies that were present in abundance in the cyto-
plasm of Ad2-infected cells but were undetect-
able in the nucleus. Two species of 1000 and 1100
nucleotides were found, which is the approxi-
mate size of the linear intron. Although the pre-
cise structures of these RNAs are still being ex-
amined, one behaves like a linear molecule, and
the other migrates anomalously on gels and may
well be a circular molecule.
Both of these oligomers have been used as
primers in dideoxynucleotide sequence analysis of
these RNAs. A unique sequence was obtained
that begins near the 3' end of the oligomers and
extends up to the 5' penultimate nucleotide of the
intron. These results show that the oligomers are
hybridizing specifically and also indicate that the
structure of the intron at its 5' boundary is such
that it prevents further extension with reverse
transcriptase. Such a block could be a free 5' end
as might be found in a linear molecule cleaved at
the donor splice site or could be an unusual link-
age, such as the 2' -5' linkage that characterizes
lariat attachment sites. Additionally, it is clear
from these results that the oligomer is priming on
a processed intron, rather than merely detecting
the linear sequences from the precursor RNA.
Several other oligomers have been synthesized
and used to probe specific regions of these RNAs.
First, an oligomer complementary to the 23 nu-
cleotides between the lariat attachment site and
the 3' end of the RNA was used as a probe. Al-
though this oligomer hybridized to a high-molec-
ular-weight RNA in the nucleus, there was no de-
tectable hybridization to the cytoplasmic RNA.
An oligonucleotide complementary to the 3' re-
gion of the intron that spans the lariat attach-
ment site was used as a probe at low stringency
and was found to hybridize to both species, sug-
gesting that the boundary of these RNAs is at or
near the lariat attachment site. Finally, a third
oligomer was made that spans the lariat attach-
ment site by 13 nucleotides on either side. Under
low stringency, this oligomer was shown to hybri-
dize to only one RNA species.
From these results, we conclude that the two
intron species contain similar, if not identical, se-
quences and that the difference in mobilities is
likely due to a difference in structure, i.e., a lin-
ear and possibly circular RNA. Neither contains
the 3'-terminal fragment comprising the "handle"
of the lariat. However, both hybridize to a probe
near the 2' -5' junction. This is the first report of
the presence of free intron sequences in the cyto-
plasm of cells.
Ad2 E1A Gene Products
B. Zerler
The adenovirus E1A gene is required for adeno-
virus-induced cell transformation and is involved
in the regulation of other adenovirus gene prod-
ucts. Early in infection, two mRNAs are pro-
duced from E1A, the 12S and 13S products. Late
in infection, a 9S mRNA product is made. The
nucleotide sequence of the 12S and 13S products
indicate that they code for proteins 243 and 289
amino acids long, respectively. These proteins
differ only by the presence of an additional 46
amino acids unique to the 13S product. The 9S
product is predicted to encode a protein 55 amino
acids long, which as a result of splicing enters a
different reading frame from that of the 12S and
13S products. Therefore, only the aminoterminal
26 amino acids of the 9S protein are common to
the 12S and 13S proteins. Our aim is to distin-
guish the roles of the individual E1A products.
Last year, we separated the 12S and 13S products
by isolating the corresponding cDNAs. We also
constructed a 9S cDNA clone by using synthetic
oligomers that span the splice junction. These
cDNAs were subcloned into plasmids and also re-
built into the entire viral genome in place of the
genomic E1A region. For a detailed description
of our results on the biological roles of the indi-
vidual E1A gene products using these cDNA
plasmids and viruses, see Mathews et al. (this sec-
tion).
We are presently concentrating on expressing
E1A in other eukaryotic systems. We have re-
cently expressed the 12S and 13S E1A cDNA prod-
ucts in yeast in order to take advantage of the
extensive potential for genetic analysis of wild-
type and mutant E1A functions in this organism.
The E1A cDNAs were cloned into a yeast expres-
sion vector under transcriptional control of the
inducible GAL10 promoter. Expression of both
E1A gene products has been detected in yeast col-
onies by an immunological method described by
Lyons and Nelson (Proc. Natl. Acad. Sci. 81:
7426 [1984]). In addition, immunoprecipitation
and Western blot analysis show the presence of
two 13S-specific proteins with molecular weights
similar to those of the two major 13S proteins
present in HeLa cells during Ad2 infection. Sim-
ilar studies with the 125-E IA-encoded product in
Saccharomyces cerevisiae are in progress.
When grown under inducing conditions, S.
cerevisiae containing either of the E1A gene
products does not exhibit any observable pheno-
type. Generation time and morphology appear
similar to those of controls. We are currently in-
vestigating the ability of the E1A 13S and 12S
products to complement various yeast tempera-
ture-sensitive cdc mutants.
In addition to the above studies, we are cloning
E1A into mammalian high-expression vectors to
enable purification of the proteins. A BPV vector
containing genomic E1A has been constructed
and transfected into NIH-3T3 cells. Transform-
ants have been isolated and are currently being
screened by immunofluorescence and immuno-
precipitation for the presence of E1A proteins. In
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addition, we have completed construction of a
plasmid containing E1A and the amplifiable di-
hydrofolate reductase (DHFR) gene. This plas-
mid will be transfected into DHFR- Chinese
hamster ovary cells.
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M. Freedman
C.H. Herrmann
D.P. Pascucci
P.A. Reichel
We have continued to work on the regulation of
adenovirus infection and on the heat-shock
(stress) response of human cells. In addition, our
studies of autoantibodies in rheumatic disease
have expanded in depth and scope during the past
year.
Functional Analysis of the E1A Gene
E. Moran, C.V. Dery, T.M. Harrison, M.B. Mathews
The adenovirus E1A gene is required for virus-
induced cell transformation and for the transcrip-
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tion of other adenovirus genes. Early in infec-
tion, two mRNAs are made from E1A, the 12S
and 13S RNAs (see Fig. 1). Their nucleotide se-
quences indicate that they encode proteins 243
and 289 amino acids long, respectively, differing
only in that the larger protein contains an addi-
tional 46 amino acids between positions 140 and
185. Our aim is to examine the roles of the sepa-
rate E1A products. This goal is being pursued in
collaboration with B. Zerler, R. Roberts, and T.
Grodzicker (this section). Last year, we took the
first step, the isolation of cDNA clones corre-
sponding to the 12S and 13S cDNAs and the con-
struction of a cDNA clone corresponding to the
FIGURE 1 The adenovirus E1A gene. The
E1A gene is located at the left end of the ad-
enovirus genome, and some landmarks are in-
dicated on the top line. The structures of the
three spliced E1A mRNA5 are depicted by ar-
rows and their coding regions are shaded. The
coding regions of the 12S and 13S mRNA5
(hatched) are identical except that the first exon
of the 12S RNA is shorter; in both cases, the
codon for one amino acid is split between the
first and second exons. The amino terminus of
the 9S protein is identical with that of the 12S
and 13S products, but after the splice junction,
the 9S product enters a different reading frame
(stippled). Mutations of individual nucleotides
(numbered) and a deletion of the Cral/Xmal
fragment (shown as a bar) have been used to
study the functions of the 12S and 13S prod-
ucts (see text).
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9S mRNA synthesized by the E1A gene later in
infection. To allow further analysis, the cDNAs
were inserted into the viral genome in place of the
genomic E1A region, giving so-called 9S, 12S, and
13S viruses.
The simplest test of E1A gene function avail-
able at present is the transient expression assay,
to regulate transcription from other adenovirus
promoters. In one version of this assay, He La
(human) cells are transfected with an E1A deriv-
ative, together with the E3-cat plasmid in which
the adenovirus E3 promoter governs the expres-
sion of the readily assayed bacterial enzyme
chloramphenicol acetyltransferase (cat). As de-
scribed last year, plasmids carrying either the en-
tire E1A gene or the 13S cDNA stimulate E3-cat
expression, whereas the 12S and 9S cDNA plas-
mids do not. These experiments have now been
repeated with the E2-cat plasmid in which en-
zyme production is governed by a different ad-
enovirus early promoter. Again the results indi-
cate that transcriptional activation is a property
of the 13S product only. We are presently con-
structing a set of additional promoter-cat fusions
in order to assess the generality of this conclusion
and to measure the sensitivity of other promoters
to E1A stimulation.
The functions of the E1A gene were also stud-
ied during infection of human cells with the
cDNA viruses. The 13S virus is as competent as
wild-type virus for lytic growth in He La cells,
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whereas the 12S and 9S viruses are defective. In-
direct immunofluorescence studies indicate that
the 72K protein made by the adenovirus E2A gene
is present at comparable levels in cells infected
with 13S or wild-type virus, but the protein is not
detected after infection with 12S virus. As ex-
pected, corresponding differences are seen when
viral mRNA levels are compared. These results
confirm that the stimulation of expression of
other adenovirus early gene products is a func-
tion of the E1A 13S product but not of the 12S or
9S products.
The transforming activities of the cDNA plas-
mids and viruses were investigated in primary
baby rat kidney (BRK) cells. Both the 12S and
13S plasmids can establish BRK cells in culture in
a manner similar to that of the intact E1A gene,
and all three can cooperate with the ras oncogene
to generate stable transformants. Similar results
are obtained when the E1A promoter is replaced
by the mouse metallothionein promoter, implying
that the genetic element responsible for the trans-
forming function lies within the 12S and 13S cod-
ing sequences. Remarkably, the 12S virus trans-
forms BRK cells at an efficiency 50-100-fold
higher than wild-type virus. However, the estab-
lishment activity observed with the 13S plasmid is
not seen after infection with the 13S virus, prob-
ably because it is obscured by the cytopathic ef-
fect of this virus. No establishment activity has
been detected in the 9S cDNA plasmid or virus
constructs.
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From these results, we conclude that the estab-
lishment function, exhibited by both the 12S and
13S products, is separate from the function that
stimulates expression of other adenovirus early
genes and resides exclusively in the 13S product.
Presumably, the 13S unique region is required for
efficient stimulation of adenovirus early genes.
On the other hand, plasmids carrying the E1A re-
gion of an existing E1A mutant virus, hr-A, are
able to establish BRK cells and to cooperate with
ras to transform these cells stably. The hr-A mu-
tant fails to produce the 12S mRNA, and its 13S
mRNA encodes a truncated E1A product com-
prising the first 140 amino acids of the 289-amino-
acid protein. Thus, it appears that the first 140
amino acids of the 13S product (139 of which are
shared by the 12S product) are sufficient for this
activity and that the activity persists in the trun-
cated protein.
To dissect further the functions of E1A, we
have begun a mutational analysis of the gene. We
first excised the Clal to Xmal fragment of E1A,
producing an in-frame deletion mutant that lacks
the 12S splice donor site and amino acids 121-150
of the 289-amino-acid protein (Fig. 1). The mu-
tant plasmid fails to stimulate transient expres-
sion of E3-cat in He La cells even though it retains
coding information for 35 of the 46 amino acids
of the 13S unique region, including the five cys-
teine residues that are a distinctive feature of this
region. It also fails to cooperate with ras in
transformation of BRK cells. These results sug-
gest that amino acids 121-150 are required for
both functions and in particular that the section
from residue 121 to residue 140 is required for the
establishment activity.
The most striking feature of this sequence is a
string of six acidic amino acids from residue 133
to residue 138. The unusual concentration of
negative charges might form part of an active site.
Interestingly, the myc oncogene, which like E1A
can cooperate with ras to transform BRK cells,
has a similar run of acidic amino acids. We have
used oligonucleotide-directed, site-specific mu-
tagenesis to substitute lysine for glutamic acid at
position 135 (nucleotide 961) to discover whether
introduction of a positive charge in this nega-
tively charged region will disrupt activity. The
mutation was constructed in both E1A genomic
and 12S cDNA plasmids. The E1A-961 mutation
retains the ability to stimulate E3-cat activity, but
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both the E1A-961 plasmid and the 12S-961 plas-
mid are defective in the ability to cooperate with
ras to transform BRK cells. In addition, when
rebuilt into virus, the 12S-961 construct is also de-
fective in the ability to establish foci of immor-
talized BRK cells, compared with the wild-type
12S virus, although it does appear to give these
cells some extended growth potential. Immuno-
precipitation from infected He La and BRK cells
demonstrates that the mutant protein is produced
and is reasonably stable. Thus, the acidic-to-
basic amino acid change at position 135 has a
marked effect on the establishment function but
little or no effect on stimulation of E3-cat expres-
sion. The activity that stimulates adenovirus
early gene expression can be dissociated from the
establishment function, just as the establishment
function can be uncoupled from the early gene
stimulating activity. We are currently rebuilding
the E1A-961 construct into whole virus to dis-
cover whether the mutation affects the growth
properties of the virus.
We have also used oligonucleotides to change
the cysteine residue at position 124 (nucleotide
928) to glycine and the proline residue at position
130 (nucleotide 946) to alanine. These amino
acids are conserved in the adenovirus serotypes,
Ad2, Ad7, and Ad12, suggesting that they may
have functional significance. The E1A-928 plas-
mid construct has a phenotype similar to that of
E1A-961: It stimulates expression of E3-cat but is
defective in cooperating with ras to transform
BRK cells, again indicating that the ability to
stimulate early gene expression is not dependent
on the normal establishment activity. The 13S-
946 plasmid is able to stimulate expression of E3-
cat, but its establishment potential has not yet
been determined. Both mutations are currently
being incorporated into viruses to assess their lytic
and transforming functions.
We are continuing to use oligonucleotide-di-
rected mutagenesis as well as random mutagene-
sis procedures to isolate additional changes in the
region between the Clal and Xmal sites of E1A.
These mutants will be assayed for their lytic and
transforming functions and for their ability to
regulate expression of adenovirus genes, cotrans-
fected genes, and host-cell products. Further-
more, we have recently expressed the E1A cDNA
products in yeast in order to exploit the potential
for genetic analysis of wild-type and mutant E1A
functions in this organism. We also hope to ob-
tain a sufficient amount of E1A proteins for bio-
chemical analysis both from yeast and from
mammalian expression vectors. This will permit
analysis of the effects of E1A mutations on the
chemical modification and function of the E1A
proteins.
VA RNA and Translational Control
P.A. Reichel, R. O'Malley, M.B. Mathews
The "virus-associated" RNAs, VA RNA, and VA
RNA, are small, abundant adenovirus tran-
scripts that do not code for proteins. They are
transcribed by RNA polymerase III from two
closely spaced genes located between map units
29 and 31 on the viral chromosome. Both species
are about 160 nucleotides in length, exhibit exten-
sive secondary structure, and terminate with a run
of U residues that interacts with a cellular protein
known as the La antigen. Until recently, the role
of the VA RNAs was a matter for speculation,
but, as described in last year's report, work with
the Ad5 mutant d1331 (Thimmappaya et al., Cell
31: 543 [1982]) pointed to a role in protein syn-
thesis. Cells infected with the mutant virus lack
VA RNA,, the major VA RNA species, and at late
times of infection, they are defective in their abil-
ity to translate mRNAs of either viral or cellular
origin.
We have now pinpointed the level at which VA
RNA, functions in translation. Cell-free protein-
synthesizing extracts of d1331-infected He La cells,
like the intact cells from which they are derived,
suffer from a greatly reduced ability to initiate
translation of mRNA. Surprisingly, the defect
cannot be overcome by addition of VA RNA or
of VA RNA together with the La antigen, imply-
ing that the small RNA acts only indirectly. Fur-
thermore, mixing experiments indicated that
d1331 extracts contain an inhibitor capable of
blocking initiation in other cell extracts. The
mixing experiments also disclosed that protein
synthesis can be effectively restored by various
fractions from a rabbit reticulocyte extract, lead-
ing us to examine several highly purified reticu-
locyte initiation factors for their ability to rescue
protein synthesis in the d1331 extracts. These fac-
tors were kindly provided by W Merrick (Case
Western Reserve University) and J. Siekierka
(Roche Institute). The activity proved to reside
solely in eukaryotic initiation factor 2 (eIF-2) and
in an ancillary enzyme, the guanosine nucleotide
exchange factor (GEF), which enables "used" eIF-
2 to function catalytically in initiation.
Figure 2 summarizes the relationships between
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FIGURE 2 Function and control of initiation factor elF-2.
During the initiation process, this factor, composed of three
polypeptide subunits, forms a ternary complex with GTP and
the initiating tRNA (methionyl-tRNAF). The complex binds
mRNA, the 40S ribosomal subunit, and the 60S ribosomal
subunit to complete the initiation sequence. In the last step,
elF-2 is released bound to GDP, which must be replaced by
GTP before elF-2 can recycle. The replacement reaction is
catalyzed by GEE. If elF-2 is phosphorylated on its a-subunit
by the double-stranded RNA-activated inhibitor (DAI) or the
heme-controlled inhibitor (NCI), it sequesters GEE. The GTP/
GDP exchange reaction is then blocked, preventing other
molecules of elF-2 from recycling. VA RNA, prevents phos-
phorylation of elF-2 in adenovirus-infected cells. (Diagram
from Reichel et al., Nature 313: 196 [1985].)
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these two factors in the initiation process and il-
lustrates a mechanism whereby their activity can
be modulated through phosphorylation of eIF -2.
Two protein kinases are known to catalyze this
reaction and thereby block protein synthesis: DAI
is activated by double-stranded RNA, whereas
HCI is triggered by a multiplicity of effectors.
Working with T. Mariano and J. Siekierka (Roche
Institute), we have demonstrated the induction of
such an activity in d/331-infected cells and have
shown that it is able to block initiation. Al-
though the nature of the kinase is not yet certain,
in view of the extensively base-paired structure of
VA RNA and its ability to interact with viral
mRNA, our working hypothesis is that VA RNA
prevents activation of DAI during adenovirus in-
fection. We have also tested the possibility that
VA RNA, interacts directly with eIF-2 or GEF but
have failed to detect significant binding.
Studies begun last year of the interaction of VA
RNAs with specific viral mRNAs in vivo have
continued. A transient expression system was de-
veloped that allows us to detect changes in the
amount of the E2A-72K DNA-binding protein
(DBP) synthesized in response to VA RNA. A
plasmid containing the complete gene for the
DBP is cotransfected into human 293 cells to-
gether with plasmids encoding VA RNA, and the
synthesis of DBP is assayed by immunoblotting
or immunoprecipitation. In this assay, VA RNA
has little or no effect on DBP synthesis, whereas
VA RNA, increases the amount of DBP signifi-
cantly. Deletion mutants have allowed prelimi-
nary mapping of the VA RNA, sequences re-
quired for enhancement of DBP synthesis. The
region between nucleotides 79 and 157 in the 3'
half of the molecule appears to be especially im-
portant. More detailed analysis with new mu-
tants is projected for the near future, and rapid
screening and assay methods are currently under
development for this purpose.
Ribonucleoprotein Particles and
Autoimmunity
M.R. Sadaie, C.C. Bunn, M.B. Mathews
Because of our long-standing interest in VA RNA
and the La antigen that binds to it, the study of
autoantibodies has developed into a research
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project in its own right. Our work in this area
benefits from a close association with R. Bern-
stein and G.R.V. Hughes (Rheumatology Unit,
Hammersmith Hospital, London). Autoantibod-
ies circulate in the blood of patients suffering
from certain rheumatic and connective-tissue dis-
eases, including systemic lupus erythematosus
(SLE) and myositis. In these disorders, the built-
in safeguards of the immune system are breached,
permitting the production of normally "forbid-
den" antibodies that react with the body's own
cellular components. Examination of these anti-
bodies not only sheds light on the nature of au-
toimmune disease, but also affords valuable re-
agents for molecular and cytological research.
Current work is focused on the proliferating cell
nuclear antigen (PCNA) and antibodies charac-
teristic of the muscle-wasting diseases polymyos-
itis and dermatomyositis.
Last year, we reported that PCNA is a protein
with a molecular weight of 35,000, identical with
the protein "cyclin" that accumulates in dividing
and transformed cells. PCNA reacts with auto-
antibodies from a group of patients with SLE. Its
level and localization within the nucleus of cul-
tured Wil-2 cells and mitogen-stimulated human
B lymphocytes vary with the phases of the cell
cycle (Takasaki et al., J. Exp. Med. 154: 1899
[1981]). This protein is therefore of potential sig-
nificance in the regulation of cell division as well
as in autoimmunity.
We have begun to study the metabolism of
PCNA in He La cells. It is mainly, if not exclu-
sively, nuclear and can be released in large meas-
ure by digestion of DNA, which may point to an
association with chromatin. Indirect immuno-
fluorescence using anti-PCNA serum shows that
PCNA is distributed heterogeneously in asyn-
chronous cells, but in synchronized cells, several
distinct patterns are seen (Fig. 3). Particularly in-
triguing is its apparent migration into and out of
the nucleoli. This peripatetic behavior remains
to be explained, and the interpretation is further
clouded by the discovery that PCNA antibodies
are not entirely monospecific. A group of nine
nuclear proteins with molecular weights of
12,000-110,000 are detected by immunoblotting,
whereas PCNA alone is immunoprecipitated from
our cell extracts. Immunoprecipitation of pro-
teins synthesized in vitro gives a single protein
with the same electrophoretic mobility as PCNA.
FIGURE 3 Changes in PCNA distribution
through the cell cycle. He La cells synchro-
nized by mitotic shake-off were reseeded and
allowed to grow for various periods of time be-
fore staining with human anti-PCNA antibody
and a fluorescent second antibody. The pat-
terns illustrated correspond roughly to the fol-
lowing phases of the cell cycle: 1 hr, early G,;
6 hr, late Gl; 12 hr, late G, early S; 14 hr, late
S; 24 hr, G2; 96 hr, confluency (Go). Note the
intense nucleolar fluorescence beginning in GI,
the homogeneous nuclear staining in G2, and
nonnucleolar staining at confluency.
4h
This finding suggests that PCNA is neither made
from a larger precursor protein nor subject to
major posttranslational modifications. Our pre-
sent intention is to isolate a cDNA clone to deter-
mine the structure of the protein and to permit
more sophisticated analysis of its regulation.
In our work on myositis, we have now charac-
terized three autoantibody systems associated
with this disease (see Table 1). It is striking that
in each case the antibody reacts with a specific
aminoacyl-tRNA synthetase, the enzyme respon-
sible for charging a tRNA with its cognate amino
acid. In two cases, Jo-1 and PL-7, the corre-
sponding tRNA can immunoprecipitate with the
protein antigen but is not itself recognized by the
TABLE 1 Common Myositis-related Autoantibody
Systems
Frequency
System ( %) Antigens
Jo-1 -30 histidyl-tRNA
synthetase
PL-7 <5 threonyl-tRNA
synthetase
PL-12 <5 alanyl-tRNA synthetase
and tRNAAl.
The frequency of occurrence of the antibodies in polymyositis and
dermatomyositis is tabulated, together with their cellular antigenic
targets.
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antibody. PL-12 sera, on the other hand, recog-
nize alanine-accepting tRNA independently of the
synthetase protein. In these patients, the two
separate antibodies to tRNA and protein coexist,
suggesting that the autoimmune response was
originally mounted against the enzyme-tRNA
complex. An alternative theory proposing that
the initial immunogen is some unidentified cross-
reacting macromolecule seems much less likely.
With PL -12 as a possible exception, our data also
argue against the anti-idiotype model of autoim-
munity and favor the notion that the antigens are
seen as foreign (rather than "self") constituents
because they become associated with some for-
eign molecule. In the case of the myositis anti-
gens, the likeliest candidate for this role would
seem to be viral RNA, although firm evidence is
lacking.
The Mammalian Stress Response
J.M. Langstaff, D.P. Pascucci, M.B. Mathews, G.P. Thomas
As in past years, our interests in the mammalian
stress (or heat-shock) response have centered on
the mechanisms of translational control operat-
ing during stress and the analysis of genes encod-
ing the human stress-response proteins. Because
of the relative intractability of the former topic,
more emphasis has been placed this year on the
latter.
Probes for the gene encoding the 90,000-dalton
(90K) human stress-response protein have been
isolated through a "plus-minus" approach and
have been used to isolate bacteriophage clones
from a library of genomic DNA, as indicated in
previous Annual Reports. One such clone, con-
taining what appears to be the entire protein-cod-
ing sequence for the inducible 90K protein, in ad-
dition to about 10 kb of upstream sequence, has
been studied intensively. The protein-coding se-
quences have been identified through S1- nuclease
protection experiments coupled with nucleotide
sequencing. The sequence of a stretch of about
4.5 kb, including the coding regions and an ap-
proximately 1 -kb region upstream of the likely in-
itiator methionine, has been determined and is
largely complete.
Comparing this sequence with the recently
published sequences of its counterparts from
Drosophila (fruitfly) and Saccharomyces (yeast),
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we have identified the putative initiator methio-
nine (Fig. 4). The derived protein sequences are
very similar, and in some stretches more than 90%
conservation is observed. In Drosophila, the 90K
gene equivalent (HSP83K) is unique in that it is
the only heat-shock gene with an intervening se-
quence. Its mRNA initiates some thousand bases
upstream of the initiating ATG, but most of this
sequence is removed through splicing during
mRNA formation. In yeast, the transcript is not
spliced, and the protein-coding region follows
about 50 bases from the start of the mRNA. Our
upstream sequence does not contain likely
matches with the so-called "consensus" (CT-
GAA-TTC-AG) sequence implicated in the in-
duction of this type of gene, suggesting that the
90K gene may be activated by a different mecha-
nism. The alternative possibility, that our se-
quence may not extend far enough upstream to
contain this region, remains to be excluded, al-
though Si- nuclease protection has failed to reveal
its existence. We hope to resolve this issue in the
near future by primer extension and protection
experiments using fragments located even further
upstream than those used so far.
The 90K stress-response gene differs from many
other stress-response genes in that it is expressed
at fairly high levels under normal circumstances.
The 72K/73K family of stress proteins is subject
to subtle and varied controls: Some members are
expressed normally and repressed under stress,
others are expressed normally and seemingly un-
affected by stress, and yet others are greatly in-
duced during stress. The latter class has drawn
attention for two reasons. First, it is a favorable
model gene to investigate the mechanisms of in-
duction since the magnitude of induction exceeds
50-fold. Second, its protein product is the major
stress protein of many organisms, has been con-
served throughout evolution, and is required for
growth at elevated temperatures. The "nonindu-
cible" members of the family have yet to enjoy
such detailed study, yet are of no less interest, also
being well conserved and expressed at substantial
levels under normal circumstances. We have iso-
lated cDNA probes for both types of genes, the
induced form (72K) from He La cells treated with
the amino acid analog and, more recently, the un-
induced form (73K) from normal rat fibroblasts.
Using the 72K cDNA clone, we have isolated
genomic clones, and these are currently being
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FIGURE 4 Nucleotide sequence comparison of the human 90K stress protein gene and its counterparts from Drosophila
and yeast. We have compared the nucleotide sequences of the 90K genes of human, Drosophila, and yeast using the DIA-
GON program of Roger Staden. In essence, two sequences are laid at right angles and where they share a required degree
of homology, a dot is deposited; comparison of a given sequence with itself therefore generates a diagonal lying 45° from the
perpendicular and if the sequences are of different lengths the angle of the diagonal is dictated by their ratio. For the com-
parisons here, we have required that the two sequences be homologous to 75% or greater over a span of 17 nucleotides. (A)
Comparison of human and yeast; (8) comparison of human and fly (Drosophila); (C) comparison of yeast and fly. The yeast
sequence (Farrel ly and Finkelstein, J. Biol. Chem. 259: 5745) is 2734 nucleotides long and includes roughly 300 bases of
noncoding sequence on either side of the protein coding region. The Drosophila sequence (Hackett and Lis, Nucleic Acids
Res. 11: 7011) is 3275 nucleotides long, and the protein coding region starts at base 2151. The presumptive initiator ATG
and the beginning of open reading frame in the human sequence are at position 1557, and the presumptive initiator ATGs of
the other two sequences are indicated by the arrows. From the diagonal plots, the three sequences are seen to be closely
related, but not identical with extensive but interrupted regions of homology extending over the protein-coding sequences.
The predicted amino acid sequences display less fragmented homology, indicating better conservation of the protein se-
quence than the nucleotide sequence. This may prove to be a general feature of the stress proteins as a whole. No obvious
homologies upstream of the coding sequences were detected either by this analysis or by direct comparison of the sequences
in regions where, for the fly sequence at least, a so-called "Pelham" box has been identified. Each of the proteins has the
unusual (acidic ,)-(basic,) motif repeated in the region between amino acids 220 and 280.
mapped with a view to isolating their upstream
regulatory sequences. They are of particular in-
terest because the gene is induced both by stress
and as a result of infection with certain viruses.
Moreover, in the case of adenovirus, evidence
points to the involvement of E1A proteins in the
induction. Limited sequencing of the 72K cDNA
has identified protein-coding sequences that are
highly homologous to the corresponding genes of
Drosophila and yeast and has indicated that the
cDNA in hand contains all but the aminotermi-
nal 100 amino acids. In primer-extension exper-
iments aimed at creating a full-length copy, the
cDNA is extended by approximately 700 by when
induced cell (not uninduced cell) RNA is used as
template, implying that the cDNA is indeed the
major induced form of the 72K/73K family.
Similarly, as demonstrated by Northern blotting
of RNA from normal cells, very little 72K mRNA
is detected with this cDNA clone, whereas vast
quantities are found in RNA from stressed cells.
Under conditions of similar stringency, Southern
blotting of human genomic DNA reveals a large
number of bands. This may indicate the presence
of intervening sequences in the 72K protein gene
(unexpected if the Drosophila genes are an accu-
rate paradigm) or of multiple genes closely re-
lated to the inducible 72K protein gene. To re-
solve this issue and to characterize the 72K gene,
we are currently reexamining genomic digests as
well as the bacteriophage clones that we have al-
ready isolated, using shorter, more specific probes
from amino- and carboxyterminal regions of the
induced cDNA.
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PROTEIN CHEMISTRY
C. Slaughter T Fischer
C. Moomaw
A Protein Chemistry laboratory has been estab-
lished for the isolation and chemical character-
ization of the protein products of normal and
transformed cells. The facility has been equipped
both with conventional chromatography systems
to isolate proteins available in quantities large
enough for X-ray crystallography (100 mg or
more) and with high-performance liquid chro-
matography (HPLC) and electrophoresis systems
to isolate minor cell proteins in microgram quan-
tities for chemical analysis. Two automated
amino acid sequencers have been brought into
operation. The first, a Beckman model 890C,
which was on site previously, has been upgraded
to model 890M by the addition of a microproces-
sor controller and an autoconverter system. This
instrument is now being used to perform amino-
terminal amino acid sequence analyses on protein
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and peptide samples of between 500 pmoles and
5 nmoles. The second sequencer, an Applied
Biosystems model 470A, has been newly installed
and has been used for protein and peptide sam-
ples of between 10 pmoles and 20 nmoles. It has
been possible to identify up to 45 amino acids in
aminoterminal runs on unknown samples using
both instruments.
Phenylthiohydantoin (PTH)-amino acids gen-
erated by the sequencers are being identified on a
newly installed Waters automated HPLC system
by reverse-phase chromatography on a Waters
Nova Pak C18 column. The procedure has proved
to be capable of quantitating 10 pmoles of each
PTH amino acid on a routine basis and detects
considerably less. Since the turnaround time for
each analysis is 23 minutes, and the cycle time on
each sequencer is approximately 1 hour, it is
possible for the PTH-amino acid identification
system to keep pace with the simultaneous output
of both amino acid sequencers indefinitely.
Amino acid sequencing and PTH-amino acid
identification are being conducted by T. Fischer.
Estimation of amino acid composition of pep-
tides and proteins is being carried out on a newly
installed Waters automated HPLC system em-
ploying the PICO.TAG procedure. In this pro-
cedure, phenylthiocarbamate (PTC)-amino acid
derivatives are synthesized in a one-step manual
operation, and the derivatives are separated by re-
verse-phase chromatography on a Waters Nova
Pak C18 column. The PTC derivatives can be
quantitated in the low picomole range by their in-
trinsic absorption at 254 nm. The turnaround
time for the separation is 20 minutes.
The synthesis of peptides for the production of
sequence-specific antibodies has been initiated
using a Beckman model 990 solid-phase peptide
synthesizer. The peptides are subject to verifica-
tion prior to uncoupling from their solid support
by sequence analysis on the Applied Biosystems
model 470A. After hydrogen fluoride cleavage,
purity of the uncoupled peptides is subject to
further checking by reverse-phase HPLC and
by amino acid analysis. Amino acid analysis
and peptide synthesis are being conducted by
C. Moomaw.
We are currently exploring procedures for ex-
tended carboxyterminal amino acid sequencing of
both proteins and peptides using reverse-phase
HPLC to identify dipeptides cleaved from the
carboxyl terminus by dipeptidyl carboxypeptid-
ase digestion. We hope to be able to carry out
high-sensitivity sequence analyses at both amino
and carboxyl termini of all protein and peptide
samples studied in the laboratory.
Peptide-mapping procedures employing both
gel permeation and reverse-phase HPLC separa-
tions in volatile buffer systems have been estab-
lished. HPLC peptide mapping has the advan-
tage over traditional gel electrophoresis proce-
dures that the peptides are readily collected in a
form suitable for further chemical analysis. The
coupling of high-resolution peptide mapping with
high-sensitivity analytical procedures will provide
us with a powerful means of investigating the
structural alterations involved in the processing
of the protein products of oncogenes and tumor
viruses.
Our laboratory has performed 2566 cycles of
Edman degradation during its first 10 months of
operation and has been involved with nine proj-
ects, seven of which were performed in collabo-
ration with scientists on the grounds of Cold
Spring Harbor Laboratory. Work on the pro-
teins of interest in the field of cell growth has been
equally divided between the human alkaline
phosphatases, a family of cell-surface enzymes
that are used extensively as tumor markers in
clinical practice, and rat brain protein kinase C,
an intracellular enzyme of the plasma membrane
that is a receptor for phorbol ester tumor pro-
moters. The latter project is being undertaken in
collaboration with J. Feramisco's group (Cell Bi-
ology Section).
Structural Diversity of Human
Alkaline Phosphatases
C. Slaughter, S. Cheley, T. Fischer, C. Moomaw
The research on alkaline phosphatases (APs) rep-
resents the principal focus of the laboratory's in-
terest. APs are a family of membrane-associated
enzyme glycoproteins that hydrolyze phosphate
esters with a high pH optimum. APs from var-
ious tissues differ in biochemical, immunochem-
ical, and genetic characteristics, suggesting that
they are encoded by a family of related structural
genes. Some of these genes are expressed in a
highly tissue-specific manner, whereas others have
a more general pattern of expression. In addi-
tion, some members of the gene family are ex-
pressed ectopically in tumors and in cell lines de-
rived from tumors. In many respects, the APs
provide a useful model system for exploring the
general characteristics of multigene families. The
overall aim of the work is to determine the extent
of structural and genetic diversity in both normal
and ectopically expressed APs. This problem is
being approached at both the nucleic acid and
protein levels.
Aminoterminal amino acid sequences have
been obtained for the products of the principal
genes expressed in human placenta, intestine, and
liver. The results confirm the conclusion drawn
previously from genetic and biochemical evi-
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dence that different genes are involved in coding
for these tissue-specific forms of AP. The ami-
noterminal amino acid sequences of adult and fe-
tal intestinal APs have also been compared, and
although these proteins display distinct antigenic
properties and peptide-mapping patterns, their
sequences thus far appear identical at the amino
terminus. Placental AP has been subjected to
digestion with cyanogen bromide, and peptides
have been isolated by reverse-phase HPLC. In
this way, a variety of amino acid sequences from
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regions of the molecule other than the amino ter-
minus have been deduced. This information has
been used by M. Zoller (Molecular Genetics Sec-
tion) to synthesize oligonucleotides with which S.
Cheley, in collaboration with D. Helfman (Cell
Biology Section), is screening suitable cDNA li-
braries. The clones identified in this way will
provide the means of deducing the complete
amino acid sequences of human placental AP and
of investigating the genetic and structural com-
plexity of a major part of the AP family.
MOLECULAR GENETICS OF EUKARYOTIC CELLS
Included in this section are a diverse range of systems, spanning from yeast to
man, and topics, spanning from the control of protein localization to develop-
mental biology. The common thread is the application of new methods of molec-
ular genetics to long standing biological problems. J. Sambrook and M.-J. Ge-
thing (Protein Traffic) describe investigations of protein modification, localization,
secretion, and protein assembly in animal cells. Using an influenza hemagglu-
tinin gene expression system and mutants constructed in vitro, they are outlining
the pathways for these processes. J. Lewis (Cell-cycle-specific Expression) has
cloned the hamster thymidine kinase gene and is examining the mechanisms by
which expression of this gene is regulated during the cell cycle. D. Kurtz (Hor-
monal and Developmental Control of Gene Expression) describes the study of
hormonal and tissue-specific expression of a family of genes encoding closely
related proteins, the rat a2,, serum globulins. M. Wig ler (Genetics of Cell Prolifera-
tion) details studies on human oncogenes, their isolation, structure, and function.
The RAS oncogenes are highly conserved in evolution, and the function of horn-
clogs in yeast are also being explored. This work has been carried out in collabo-
ration with F. Tamanoi (Biochemistry of Yeast RAS Proteins). L. Silver (Mouse Ge-
netics) has been investigating the molecular basis of a group of closely linked
developmental mutants of mice, which together comprise the T locus. These mu-
tants are characterized by early developmental death in homozygotes, segrega-
tion distortion, and locus-specific inhibition of meiotic recombination. Finally, D.
Hanahan (Transgenic Mice) and his group are redesigning the mouse by placing
genes under new controls into the mouse germ line. This experimental system
promises to be one of the most powerful approaches to understanding gene
expression in the developing animal.
PROTEIN TRAFFIC
J. Sambrook
M.-J. Gething
E. Hunter
P Bird
P Gallagher
J. Hearing
M. Roth L. Rodgers
C. Doyle S. Sharma
J. Henneberry D. York
The general aims of our laboratory are to map the
major routes of protein traffic within mammal-
ian cells and to understand how proteins are di-
rected to specific destinations.
THE EXOCYTIC PATHWAY
Most of our work on the exocytic pathway in-
volves the hemagglutinin (HA) of influenza virus,
which is now the best studied of a large class of
integral membrane proteins. Until a few years
ago, work on HA depended almost entirely on the
techniques of protein chemistry (Waterfield et al.,
Br. Med. Bull. 35: 57 [1979]), but since the advent
of recombinant DNA techniques, the genes en-
coding the HAs of many strains of influenza vi-
rus have been cloned and sequenced, and this has
allowed the complete amino acid sequence of
many serotypes of the protein to be deduced (for
review, see Lamb, in Genetics of Influenza Vi-
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ruses, Academic Press, New York [1983]). At the
same time, techniques to produce monoclonal
antibodies became available, and such antibodies
raised against HA have led to a detailed analysis
of the antigenic structure of HA. In 1977, the gly-
coprotein spike of HA was crystallized, and a
three-dimensional structure has since been deter-
mined to a resolution of 3 A using X-ray crystal-
lography (Wiley et al., Nature 289: 373 [1981];
Wilson et al., Nature 289: 366 [1981]). The cul-
mination of all this work has been a detailed de-
scription of the physical domains of the molecule,
the location of its major antigenic sites, the points
at which it is glycosylated, its organization into
trimeric structures, and its orientation with re-
spect to the membrane.
The mature protein consists of three structural
domains (see Fig. 1). One of these is a large hy-
drophilic carbohydrate-containing domain lo-
cated on the external surface of the lipid bilayer
and is itself divided into three regions: a globular
portion that consists largely of an eight-stranded
antiparallel 0-pleated sheet, and a switch or hinge
region formed from two antiparallel chains that
connect the distal globular portion to the third
region- a fibrous stem. The upper part of this
stem is made from two antiparallel a-helices, and
the lower part consists of a compact globular fold
that includes a five-stranded, 0-pleated sheet.
The structure of the fibrous stem is buttressed by
extensive contacts among the three monomers
that comprise the trimer. Without these contacts
(which stabilize the fibrous stem into a triple-
stranded coiled coil), it seems unlikely that an in-
dividual monomer would form a stable stem.
Consequently, the protein molecule may raise it-
self from the surface of the membrane only when
it is assembled into a trimer.
The second structure is a small hydrophobic
domain of approximately 30 amino acids located
near the carboxyl terminus of the molecule and
spans the membrane. The third structure is a small
carboxyterminal hydrophilic domain of approxi-
mately 10 amino acids located on the internal side
of the membrane.
Characteristically of transmembrane proteins,
HA is synthesized on membrane-bound ribo-
somes as a precursor that includes an aminoter-
minal signal peptide; this peptide is subsequently
removed by a protease that is found only on the
luminal side of the endoplasmic reticulum (ER).
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FIGURE 1 Structure of A/Aichi/68 HA. A schematic dia-
gram of the HA trimer showing carbohydrate-addition sites
and the arrangement of the molecule with respect to the
membrane. (Modified from Wilson et al., Nature 289: 366
[1981]).
Each monomeric peptide chain is cotranslation-
ally glycosylated at several sites, all of which are
eventually located on the surface of the com-
pleted trimer (see Wiley et al., Nature 289: 366
[1981]).
In recent years, HA has been used increasingly
as a model to study the biosynthesis, modifica-
tion, and transport of integral membrane pro-
teins in mammalian cells (for review, see Gething
and Sambrook, in Genetics of Influenza Viruses,
Springer-Verlag, Berlin [1983]). The groundwork
for this approach was laid when it was shown that
the cloned gene for HA could be expressed from
eukaryotic vectors with very high efficiency. The
newly synthesized molecule was translocated
through the rough ER, modified, assembled into
trimers, and transported via the Golgi apparatus
to the cell surface along a pathway indistinguish-
able from that taken by a large number of endog-
enous cellular proteins.
These initial findings were extended to include
a number of mutant forms of HA, in which DNA
sequences coding for the putative hydrophobic
signal and anchor regions of the molecule were
deleted. Analysis of the expression of the result-
ing constructs led to the conclusions (1) that the 2.
hydrophobic aminoterminal sequences are neces-
sary to cause translocation of the newly synthe-
sized molecule across the membrane of the rough
ER and (2) that the hydrophobic carboxyterminal
sequences are sufficient to anchor the completed
molecule in the plasma membrane. Deletion of
these sequences results in secretion of a truncated
HA from the cell (Gething and Sambrook, Na-
ture 300: 598 [1982]).
ALTERATIONS TO THE AMINO TERMINUS AND
CYTOPLASMIC TAIL OF HA CAN AFFECT
TRANSPORT OF THE PROTEIN ALONG
THE EXOCYTIC PATHWAY
During the last year, we have constructed and
analyzed a number of additional mutant and chi-
meric forms of HA in which the DNA sequences
coding for the signal sequence, the transmem-
brane region, and the cytoplasmic domain were
mutated at specific sites or replaced by sequences
encoding analogous regions from other proteins.
The results of these experiments are summarized
in Table 1 and discussed briefly below:
1. Substitution of the signal sequence of HA with
those from other glycoproteins (the env gly-
coprotein of Rous sarcoma virus [RSV] or bo-
vine preprochymosin) yields chimeric proteins
that are translocated into the lumen of the ER,
where they undergo core glycosylation. In
both cases, the signal sequences are cleaved
from the precursor, leaving an HA in which
the first two amino acids have been replaced
by either 9 (in the case of RSV env) or 12 (pre-
prochymosin) novel residues. Neither of these
chimeric proteins is folded correctly (see be-
low) and neither is transported further along
the exocytic pathway to the Golgi apparatus.
However, by deleting the DNA sequences cod-
ing for the additional aminoterminal amino
acids, we have been able to restore the ability
of the env-HA protein to fold into a form that
is efficiently transported to the cell surface.
3.
We conclude that a signal sequence obtained
from a different eukaryotic protein is suffi-
cient to guarantee translocation of HA into the
lumen of the rough ER. Further movement of
HA along the exocytic pathway is highly de-
pendent on the configuration of the amino ter-
minus of the protein.
Replacement of the transmembrane region and
cytoplasmic tail of HA with analogous se-
quences from the G glycoprotein of vesicular
stomatitis virus (VSV) or the C glycoprotein of
herpes simplex virus yields chimeric glycopro-
teins that are transported to the cell surface,
where they are displayed in an antigenically
and biologically active state. The HA-G chi-
mera is transported to the surface as effi-
ciently as wild-type HA, whereas HA-gC trav-
erses the early part of the pathway (from the
ER to the Golgi apparatus) more slowly and
asynchronously. We conclude that the an-
choring function of the transmembrane re-
gions of HA can be provided by hydrophobic
sequences derived from different viral glyco-
proteins, without crippling the ability of the
chimeric molecule to move through the exocy-
tic pathway.
Certain alterations to the cytoplasmic tail of
HA drastically lower the rate at which the mol-
ecule travels from its site of synthesis to the
Golgi apparatus; other alterations affect
transport of HA from the Golgi apparatus to
the cell surface (see Table 1). These results can
be interpreted two ways: Either the cyto-
plasmic tail of HA carries signals that deter-
mine the rate or efficiency with which the en-
tire molecule progresses along the exocytic
pathway or the tail is important for the struc-
tural integrity of the molecule, and changes in
rates of transport are a consequence of an in-
ability to fold into or maintain a stable struc-
ture.
To distinguish between these possibilities, we
have used a number of approaches to compare
the three-dimensional structure and folding of
wild-type and mutant proteins. An antiserum
raised against denatured HA that recognizes an
epitope(s) cryptic in the external region of mature
wild-type HA reacts strongly with mutant pro-
teins that are blocked in the ER (env-HA and
HAxpBR). Second, these mutants, unlike wild-
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TABLE 1 Properties of HA Mutants
Mutant Description Phenotype Final location
HA-S- aminoterminal hydrophobic signal se-
quence deleted
env,HAl2 aminoterminal signal and first two amino
acids of mature HA replaced by
signal sequence and six amino
acids of RSV env glycoprotein
env,-HA16 aminoterminal signal of HA replaced by
that from RSV env; processed poly-
peptide identical to wild-type HA
HA-A- transmembrane anchor and cytoplas-
mic tail deleted and replaced
by 11 heterologous amino acids
Ha-G transmembrane anchor and cytoplasmic
tail of HA replaced by the analogous
regions of VSV G
HA gC transmembrane anchor and cyto-
plasmic tail of HA replaced by the
analogous regions of HSV-1
glycoprotein C
HA-Cg transmembrane anchor and cyto-
plasmic tail of HA replaced by 67
heterologous amino acids
HA152env cytoplasmic tail of HA replaced by
analogous region from the env
glycoprotein of RSV
HA71 three of the four final residues of cyto-
plasmic tail altered
HA11 cytoplasmic tail of HA deleted; three
heterologous amino acids added
HA477env cytoplasmic tail of RSV env added after
the penultimate residue of the HA
cytoplasmic domain
HA164 cytoplasmic domain of HA deleted;
replaced by 16 heterologous amino
acids
HAxpBR 16 heterologous amino acids added
to the HA cytoplasmic domain
protein not translocated to ER and not cytoplasm
glycosylated
protein translocated and core ER
glycosylated; signal cleaved; protein
not transported to Golgi
chimeric protein translocated and core cell surface
glycosylated; signal cleaved; protein
transported to cell surface with wild-
type kinetics
transport of protein between ER and medium
Golgi slowed; truncated protein
efficiently secreted from cell
chimeric protein anchored in lipid bi- cell surface
layer and transported to the cell
surface with kinetics identical to
those of wild-type HA; at cell
surface, chimeric protein anti-
genically and functionally active
chimeric protein anchored in the lipid cell surface
bilayer, but transport between ER
and Golgi slowed; at cell surface,
chimeric protein antigenically and
functionally active
transport of protein between ER and medium
Golgi slowed; protein efficiently
secreted from the cell
chimeric protein wild type in all cell surface
respects
altered protein wild type in all respects cell surface
transport of protein between ER and
Golgi slowed
transport of protein between ER and
Golgi slowed
cell surface
cell surface
transport of protein between ER and post-Golgi
Golgi slowed; terminally glyco- and vesicles
sylated molecules severely retarded and cell
in a post-Golgi compartment surface
transport of protein from ER blocked ER
type HA and normal amphipathic proteins, do
not partition into the detergent phase of Triton
X-114, perhaps because the transmembrane re-
gion of the malfolded proteins cannot form the
stacked triple helices that stabilize the protein in
the lipid bilayer (or the detergent). Finally, a
complex between the mutant molecules and a cel-
lular "binding protein" (BiP) found solely in the
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lumen of the ER can be immunoprecipitated from
cell extracts using either anti-HA sera or an anti-
BiP monoclonal antibody (kindly provided by L.
Hendershot and J. Kearney, University of Ala-
bama). BiP (M, = 77,000) is thought to bind to
newly synthesized proteins in the ER prior to
folding. These and other data show that there is
a relationship between the altered structure of
mutant forms of HA and their ability to be trans-
ported to the cell surface. Apparently, HA needs
to be correctly folded in order to move efficiently
along the exocytic pathway.
FOLDING PATHWAY OF HA
How a protein that is synthesized on one side of
a membrane folds into a specific three-dimen-
sional shape on the other is not known. The fol-
lowing is our current working model (see Fig. 2):
The monomeric polypeptide is translocated es-
sentially as a linear string of amino acids. It re-
mains attached to the luminal face of the mem-
brane not only by the carboxyterminal anchor,
but also by the aminoterminal hydrophobic sig-
nal. After primary glycosylation is completed,
but before trimerization has occurred, the distal
region of the molecule folds into its globular
shape and disulfide bonds form. The carboxy-
terminal hydrophobic domains of three mono-
mers then associate to form a triple-stranded hel-
ical coil within the membrane. The three stem
regions are then able to twist around each other
to form the coiled coil that comprises the bulk of
the external fibrous spike. After cleavage of the
-
signal peptide, the completed trimer is free to
move in the plane of the membrane of the ER
toward the Golgi apparatus. Trimerization is
therefore a prerequisite for movement. This
model is consistent with the structural analysis of
wild-type HA (Wilson et al., Nature 289: 366
[1981]; Wiley et al., Nature 289: 373 [1981]) and
provides a plausible explanation for the phe-
notype of the mutants. Thus, alterations to the
amino and carboxyl termini, although in regions
of the protein that reside on opposite sides of the
rough ER, might be expected to prevent or delay
folding and oligomerization of the molecule. In
the most severely affected mutants (HAxpBR and
env-HA), the molecule may be completely unable
to form trimers; in other cases (see Table 1) a dis-
ordered trimeric structure may retard movement
of the protein in the plane of the membrane or
obstruct its incorporation into transport vesicles
that ferry it from the ER to the Golgi apparatus.
These ideas raise many questions: How does the
cellular transport machinery distinguish between
molecules that are correctly folded and those that
are not? Does malfolding of HA affect its inter-
action with hypothetical sets of cellular receptors
that may be involved in movement of proteins
AAAA
FIGURE 2 A model for the folding of HA and assembly into monomers
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along the exocytic pathway? If so, are these re-
ceptors located in the lumen of the ER, within the
lipid bilayer, or on the cytoplasmic face of the
membrane? Are there distinct sets of receptors
that transport proteins through different stages
of the exocytic pathway? We hope that these
questions can be answered at least in part by fur-
ther mutational analysis of HA and the elucida-
tion of the mechanism by which the protein folds
and trimerizes.
ROLE OF CARBOHYDRATE IN THE STRUCTURE
AND BIOLOGICAL FUNCTION OF HA
Glycosylation of proteins is universal in eukar-
yotic organisms. The fact that such a complex
and expensive process has been conserved over
such a long period of evolutionary time suggests
strongly that glycosylation must be of considera-
ble advantage to higher organisms. However,
there is no evidence for a single function for gly-
cosylation. Instead, it appears (for review, see
Pollack and Atkinson, J. Cell Biol. 97: 293 [1983])
that N-linked oligosaccharides may play a variety
of roles including (1) the maintenance of the
structure and stability of glycoproteins, (2) the
direction of glycoproteins to various intracellular
organelles, and (3) the specific interaction be-
tween cells that occurs during tissue organiza-
tion.
The oligosaccharide groups attached to HA are
thought to serve two functions -to modulate an-
tigenicity by shielding potential antigenic sites
(Knossow et al., Nature 311: 678 [1984]) and to
stabilize the protein structure and thus facilitate
the transport of the protein along the exocytic
pathway. The magnitude of this latter effect var-
ies widely between HAs of different strains. Thus,
the nonglycosylated protein from the A/Aichi/68
strain is stable but does not reach the cell surface,
whereas that from the A/Japan/57 strain is trans-
ported to the cell membrane, albeit at a reduced
level. Most likely, lack of glycosylation prevents
Aichi HA from folding into its correct configu-
ration for transport; in the case of Japan HA, the
molecule is transported to the cell surface, but it
is more susceptible than wild-type HA to proteo-
lysis.
To study these problems further, we have used
site-directed mutagenesis to alter the canonical
sequences specifying each of the seven carbohy-
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drate attachment signal sites on Aichi HA. The
altered genes have been inserted into SV40 vec-
tors and expressed in CV-1 cells. The rate of bio-
synthesis, transport, cellular localization, and bi-
ological activity of these altered gene products is
being analyzed in terms of the contribution of the
individual side chains. We are also using site-di-
rected mutagenesis to create sites for oligosac-
charide addition in areas of the HA surface that
do not normally carry carbohydrate groups. We
hope to use the novel glycan side chains to shield
particular surfaces of the molecule, e.g., those in-
volved in transport signals or in the recognition
of HA on the membrane of histocompatible tar-
get cells by cytotoxic lymphocytes.
EXPRESSION OF HA IN POLARIZED
EPITHELIAL CELLS
The problem of protein traffic is particularly
acute in polarized epithelial cells, in which se-
creted and membrane-bound proteins are di-
rected to either of two distinct domains of the
plasmalemma. These two domains, the apical and
the basolateral, are separated by the zonula oc-
cludans, a circumferential belt of tight junctions
that serves as a barrier to lateral diffusion of pro-
teins and lipids in the plane of the plasma mem-
brane. Polarized epithelial cells direct both their
own endogenous surface proteins and the glyco-
proteins of the viruses that infect them to specific
domains of the plasma membrane (Rodriguez-
Boulan, in Modern Cell Biology, A.R. Liss, New
York [1983]). Thus, during the early stages of in-
fection of kidney epithelial cells by influenza vi-
rus, HA is expressed almost exclusively at the ap-
ical surface of the cell, through which the nascent
viral particles will later bud. The infected cell
recognizes HA as belonging to the "apical" set of
proteins, and this recognition has been shown to
be independent of either glycosylation of HA or
of the presence of other viral proteins (Roth et
al., Cell 33: 435 [1983]). The features of the HA
polypeptide recognized by the cellular sorting
machinery could reside either in the large ecto-
domain exposed to the luminal environment of
the exocytic pathway, in the transmembrane re-
gion, or in the small carboxyterminal cytoplasmic
domain. We have carried out two types of exper-
iments to investigate which regions of HA are im-
portant for sorting. First, we have determined the
pattern of secretion in polarized cells of a form
of HA lacking the transmembrane and cyto-
plasmic domains. This form of HA (HAwc) has
previously been shown to form trimers and to dis-
play all of the biological activities that reside ex-
clusively in the ectodomain (Gething and Sam-
brook, Nature 300: 598 [1982]). Second, in col-
laboration with E. Rodriguez-Boulan (Cornell
Medical School), we are investigating the distri-
bution on the surface of polarized cells of forms
of HA in which the transmembrane or cyto-
plasmic regions have been replaced with those of
another glycoprotein. During the early phase of
infection of MA104 rhesus monkey kidney cells
with a recombinant SV40 vector expressing
HFs."c, secretion of HAs'c is almost entirely from
the apical surface. Thus, the transmembrane and
cytoplasmic domains of HA are not needed for
the directional transport of HA in this system.
Preliminary results indicate that chimeric glyco-
proteins that contain transmembrane and cyto-
plasmic domains from viral glycoproteins nor-
mally expressed on the basolateral surface are
concentrated on the apical surface of infected
MA104 cells. A simple interpretation of these
observations is that the large ectodomain of HA
contains dominant features recognized by the cel-
lular sorting machinery. We conclude that dis-
crimination between apical and basolateral pro-
teins probably occurs within the lumen of the
organelle(s) of the exocytic pathway.
While analyzing the biosynthesis of these chi-
meric glycoproteins, we realized that they dif-
fered from wild-type HA in certain interesting re-
spects. In particular, a chimera consisting of the
ectodomain of HA and the transmembrane and
cytoplasmic regions of VSV G protein became
cleaved by protease, generating a protein consist-
ing of two subunits (HA, and HA,G) joined by a
disulfide bond. The transport of HA-G must
therefore at some stage diverge from that of wild-
type HA, causing the chimeric protein to enter a
cellular compartment in which the relevant pro-
tease(s) is active. The kinetics of cleavage are con-
sistent with the idea that the chimeric protein en-
ters this compartment at about the same rate as it
reaches the cell surface, raising the possibility that
HA-G is transported along the conventional exo-
cytic pathway and is then removed rapidly from
the cell surface by endocytosis: Proteolytic cleav-
age would therefore occur in endosomes. We are
currently trying to test aspects of this hypothesis
and to determine whether the signals that divert
HA-G into this novel compartment are carried on
the transmembrane region or the cytoplasmic tail
of the protein.
SV40 T ANTIGEN AND THE EXOCYTIC PATHWAY
Proteins tend to have singular locations in cells.
Thus, proteins present in one site (e.g., the cell
surface) are by and large not detected in signifi-
cant quantities elsewhere. Because specific loca-
tions are served by specific transport pathways,
proteins generally need to carry only one set of
transport signals. For example, proteins that are
destined for the cell surface almost always con-
tain hydrophobic regions that are readily identi-
fiable as signal sequences. The large T antigen of
SV40 does not fit easily into this simple pattern.
Newly synthesized T antigen is rapidly trans-
ported from the cytoplasm into the nucleus of in-
fected or transformed cells where it is believed to
associate with cellular p53 and with specific sets
of DNA sequences. However, a small proportion
of T antigen is also displayed on the surfaces of
transformed cells, where it can be detected in a
specific configuration by a variety of immuno-
logical and biochemical techniques (for review,
see Rigby and Lane, Adv. Viral Oncol. 3: 31
[1983]). However, in contrast to typical trans-
membrane proteins, T antigen carries no hydro-
phobic signal sequence at or near its amino ter-
minus and in fact it lacks any sequence of
hydrophobic or uncharged amino acids long
enough to span a membrane. There is no obvious
way to explain how considerable portions of T
antigen are translocated across a membrane or
where in the cell this process may occur.
To approach this problem, we decided to test
whether it would be possible to increase the effi-
ciency with which T antigen could be transported
to the cell surface by equipping it with a conven-
tional signal peptide at its amino terminus. We
therefore constructed a chimeric gene consisting
of the DNA sequences coding for the aminoter-
minal hydrophobic signal peptide of HA fused in-
frame to those coding for SV40 T antigen. The
gene was linked to the murine metallothionein
promoter and inserted into a plasmid containing
a transforming fragment of bovine papilloma vi-
rus (BPV) DNA. The resulting vector was used
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to establish lines of NIH-3T3 cells that express
large quantities (5 x 106 molecules per cell) of the
chimeric protein (HA-T antigen). The biochemi-
cal properties and intracellular location of HA-T
antigen were then compared with those of wild-
type T antigen synthesized in an identical vector.
As expected, the great majority of wild-type T
antigen is located in the cell nucleus, although a
small fraction can also be detected on the cell sur-
face by flow cytofluorometry. In contrast, HA-
T antigen is found virtually exclusively in the ER 2.
(see Fig. 3) in a form that is neither phosphoryl-
ated nor bound to cellular p53. HA-T antigen is
cotranslationally translocated across the mem-
brane of the rough ER into the lumen, where the
signal peptide is cleaved and a mannose-rich oli-
gosaccharide becomes attached to the polypep-
tide (T antigen contains one potential N-linked
glycosylation site at Asn-154). HA-T antigen does
not become terminally glycosylated or acylated,
and very little (if any) of it reaches the cell sur-
face. From these results we conclude:
1. The hydrophobic signal peptide of HA acts as
a cis-dominant marker that overrides other
transport signals in SV40 T antigen, e.g., the
nuclear transport signals that map in the seven
amino acids around Lys-128 (Kalderon et al.,
Cell 39: 499 [1984]). Almost certainly, this 3.
dominance stems from the location of the
signal peptide at the amino terminus of the
nascent protein, where it interacts with the sig-
nal-recognition particle and prevents further
synthesis of the polypeptide until the ribosome
is attached to a docking site on the membrane
of the rough ER. When translation resumes,
the polypeptide is cotranslationally trans-
ported through the membrane in a manner that
apparently affords no opportunity for down-
stream transport signals to function.
The translocation of T antigen through the
membrane is not sufficient to guarantee that
it will move further along the secretory path-
way. This conclusion is consistent with obser-
vations discussed above on chimeric and mu-
tant forms of HA, many of which show defects
in transport to the cell surface. The failure of
HA-T antigen to move from the ER can there-
fore be explained in two ways. First, HA-T
antigen is a protein that has been removed
from its normal milieu and placed in a foreign
environment. There would be no evolutionary
reason why the cellular structures that com-
prise the exocytic pathway should be equipped
to deal with HA-T antigen. Second, the pres-
ence of a bulky glycan may not be conducive
to proper folding of the polypeptide or effi-
cient oligomerization of the protein.
Because HA-T antigen fails to move along the
secretory pathway and because its biochemical
FIGURE 3 lmmunofluorescent staining of cells expressing wild-type T antigen or HA-T antigen.
NIH-313 cells expressing wild-type T antigen or HA-T antigen from BPV vectors were fixed and
stained by indirect immunofluorescence. (A) Cells expressing wild-type T antigen; (8) cells express-
ing HA-T antigen.
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properties are very different from those of
wild-type T antigen, it seems unlikely to us that
wild-type T antigen reaches the cell surface by
traveling along the conventional exocytic route.
We are therefore left with a paradox. At some
stage in its life, surface T antigen must cross a
membrane in order to be presented on the out-
side of the cell: Yet, it has none of the hall-
marks of an integral or transmembrane pro-
tein. We therefore postulate (see Fig. 4) that
in SV40-transformed cells, all newly synthe-
sized T antigen enters the nucleus, where it be-
comes associated either directly or via inter-
mediate molecules with the inner wall of the
nuclear membrane. At cell division, this
membrane is known to break down into small
vesicles that become dispersed throughout the
cytoplasm. If after cytokinesis, a minority of
these vesicles fuses directly with the plasma
membrane or with other vesicles that are
bound for the surface, their contents could be
everted onto the outer face of the plasma
membrane. If this hypothesis stands up to ex-
perimental test, it will be interesting to deter-
mine whether normal cellular proteins travel
along this novel pathway from the nucleus to
the cell surface.
MUTANTS OF MAMMALIAN CELLS THAT ARE
DEFECTIVE IN TRANSPORT OF PROTEINS
A complete understanding of the exocytic path-
way will require not only mutational analysis of
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proteins like HA, but also the identification and
analysis of cellular components involved in the
establishment and maintenance of the pathway.
A good way to identify such components would
be to isolate and characterize mutants that specif-
ically affect particular steps in the cell's exocytic
machinery. This approach, which has been ex-
traordinarily successful in studies of the secretory
pathway of Saccharomyces cerevisiae (for review,
see Schekman and Novick, in The Molecular Bi-
ology of the Yeast Saccharomyces cerevisiae,
Cold Spring Harbor Laboratory, Cold Spring
Harbor, New York [1982]), has not yet been fully
exploited in mammalian systems, partly because
of formidable technical difficulties and partly be-
cause of the lack of a good selective system to
isolate mutants of the correct type.
In an effort to solve some of these problems,
we have recently isolated and characterized sets
of murine and hamster cell lines that constitu-
tively express large quantities of HA on the cell
surface. An important feature of these cell lines
is that they carry multiple copies of the HA gene
(in BPV vectors) in either an integrated state or
an episomal state. Because it seems unlikely that
all of these copies could be mutated simultane-
ously, we should be able to avoid the problem of
isolating mutants that fail to express HA on their
surface merely because of mutations in HA itself.
These cell lines were originally selected for their
ability to express large quantities of HA on their
surface (approximately 107 molecules/cell in the
best case). This amount is more than 100 times
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FIGURE 4 A model to illustrate the intracellula location of HA-T antigen (A) and a possible scheme
for the transport of wild-type T antigen through the nucleus to the cell surface (B).
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the threshold required for detection of HA by
surface immunofluorescence and 10 times more
than the amount needed to bind erythrocytes.
However, a puzzling characteristic of the original
cell lines was the variation in expression of HA
from cell to cell, as detected by immunofluores-
cence. This problem was solved in September,
1984, when we obtained a Coulter Epics C fluo-
rescence-activated cell sorter (Fig. 5). This ma-
chine has been invaluable in allowing us to obtain
derivatives of the original cell lines that homoge-
neously express very high levels of HA on their
surfaces. Examples of typical data are shown in
Figure 6. We are at present analyzing these cell
populations to determine why they express HA so
efficiently. Among the more obvious possibili-
ties are (1) an increased number of vector mole-
cules per cell, (2) an increased amount of mRNA
coding for HA, and (3) an increase in the half-life
of HA on the cell surface. Whatever the mecha-
nism, the elevated expression of HA seems to be
a stable characteristic of these cell lines: Some of
the earlier isolates have now been maintained in
continuous culture for several months without a
noticeable decrease in HA production and with-
out a return to heterologous expression of HA.
Surprisingly, many of these cell lines bind red cells
very poorly. Apparently, they secrete a glycoca-
lyx containing a large amount of neuraminic acid
that shields HA expressed on the cell surface.
After the glycocalyx is removed by mild digestion
FIGURE 5 Eric Hunter, Linda Rodgers, and Janet Hearing
working with the Coulter Epics C fluorescence-activated cell
sorter.
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FIGURE 6 Analysis by flow cytometry of cell lines that ex-
press large amounts of HA on their surfaces. Each panel
shows the number of cells (vertical axis) that fluoresce with
a given intensity (horizontal axis). The intensity is displayed
in arbitrary units on a logarithmic scale stretching over three
log units. (A) Autofluorescence of a line of hamster cells ex-
pressing HA from a BPV vector. (8) Surface fluorescence of
the same cells stained with fluorescein-conjugated anti-HA
serum. (C) Binding of fluorescent erythrocytes to a line of
murine cells that show heterogeneous expression of HA on
its surface. The peak at the left consists of cells that have not
bound any fluorescent red cells; the complex series of peaks
at the right represents cells that have bound increasing num-
bers of fluorescent erythrocytes (1, 2, 3,...etc). (D) Same cells
after six rounds of selection and growth, in which cells that
bind erythrocytes efficiently were isolated and grown to mass
population. The proportion of cells that fail to bind red cells
is greatly reduced; the vast majority of the population bind
more than seven red cells.
with trypsin and/or neuraminidase, virtually all
of the cells in the population bind erythrocytes
very efficiently. In all of the murine and hamster
lines, HA is transported to the cell surface more
slowly than in simian cells infected with SV40-
HA recombinant vectors. There is also an ap-
proximately threefold difference in the rate of
transport of HA in different cell lines. The rea-
sons for these variations are under investigation.
We are currently using these cell lines to isolate
and identify mutant cells that display HA on the
cell surface in a temperature-conditional fashion.
Cells are mutagenized with ethylmethanesulfon-
ate, and after a period of growth at 32°C, they
are shifted to 39°C. Several of the selection pro-
cedures that we are using will work only if HA
displayed on the surface at the time of the tem-
perature shift is removed. This is done by incu-
bating the cells in the presence of excess anti-HA
antibody and allowing the cells to remove the
cross-linked antigen during a period of brief in-
cubation at 39°C. Preliminary evidence obtained
with one of the HA-producing cell lines indicates
that the HA-antibody complexes rapidly become
"capped" and then disappear from the cell sur-
face. Cells that are unable to reexpress HA dur-
ing further incubation at 39°C may then be iden-
tified and physically separated from the rest of
the population by flow cytofluorometry. These
cells are then grown into mass culture, and the
process is repeated to enrich for mutants in the
secretory pathway.
A second method for the isolation of cellular
secretory mutants takes advantage of the hemag-
glutinating and membrane-fusing activities of
HA. In collaboration with J. White and co-work-
ers (Yale University), we have shown that human
erythrocytes loaded with small proteins in vitro
can be made to fuse with lines of hamster and
murine cells expressing HA. The contents of the
red cells are then delivered into the cytoplasm.
We are using this method to introduce the toxic
A chain of the lectin ricin into cells that express
HA on their cell surface. Mutant cells that sur-
vive this selection should be either resistant to the
action of the toxin or defective in the biosynthesis
and transport of HA.
Finally, we have devised several schemes to iso-
late transport mutants of mammalian cells based
on the action of aminoglycoside-3'-phospho-
transferase, an enzyme that renders eukaryotic
cells resistant to the antibiotic G418. Under nor-
mal circumstances, this antibiotic kills cells by
binding to ribosomes and inhibiting protein syn-
thesis. Aminoglycoside-3'-phosphotransferase is
a cytoplasmic enzyme that modifies the antibiotic
and appears to block its entry into the cell. We
postulate that if the enzyme is directed to a dif-
ferent cellular compartment, entry of the anti-
biotic will not be blocked and the cell will once
again be sensitive to G418. By linking specific
dominant signal sequences (e.g., the hydrophobic
signal sequences of HA) to the amino terminus of
the near protein, we expect to synthesize a chi-
mera that (like HA-T antigen) crosses the ER.
However, cellular mutants that fail to compart-
mentalize the chimera in this way should be resis-
tant to the antibiotic. We are at present charac-
terizing a series of HA-near protein fusions to
determine their localization and activity within
cells. This approach can, in principle, be applied
to select mutants in other cellular transport path-
ways, by coupling to near, signals that direct pro-
teins to other cellular locations like the nucleus
or the mitochondria.
MECHANISM OF HA-MEDIATED CELL FUSION
Influenza viruses, like other enveloped animal vi-
ruses, enter and infect cells by a process involving
fusion of the viral membrane with a cellular
membrane. Following binding to sialic-acid-con-
taining receptors on the cell surface, the virions
are taken into the cell by endocytosis; entry into
the cytoplasm occurs through the membranes of
intracellular vesicles (like endosomes) where the
endogenous pH is low. Experimentally, this ac-
tivity can be manifested as cell-cell fusion when
monolayers of cells displaying HA on their
plasma membranes are transiently exposed to low
pH. Alternatively, as described above, fusion in-
duced by low pH can be assayed by red-cell-me-
diated delivery of horseradish peroxidase (HRP)
into cells expressing surface HA. We have previ-
ously shown, using cells expressing HA either
transiently from a recombinant SV40-HA viral
vector or constitutively from a recombinant BPV-
HA vector, that the HA molecule displays fusion
activity in the absence of any other influenza-
virus-coded components (White et al., Nature
300: 658 [1982]; Sambrook et al., EMBO J. 3:
[1985] in press). This fusion activity requires a
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posttranslational proteolytic cleavage of the hem-
agglutinin precursor, HA, into the active form of
the molecule, HA, which consists of two disul-
fide-bonded subunits, HA, and HA,. A new hy-
drophobic amino terminus, which has been im-
plicated in the fusion activity and which is highly
conserved in HAs from different virus strains, is
generated on the HA, subunit. A working hy-
pothesis for the mechanism of HA-mediated fu-
sion is shown in Figure 7. At low pH (< 5.2), the
QyQo
0
FIGURE 7 A model for the low-pH-induced fusion activity
of HA. This model is based largely on the work of A. Helen-
ius (Yale University) and his collaborators.
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protonation of one or more amino acid side
chains in the subunit interface causes a partial
dissociation of the HA trimer. As a result, the
aminoterminal "fusion peptide," which is nor-
mally tucked inside the trimer, becomes exposed
and is inserted into the target lipid bilayer. Thus,
HA becomes an integral component of two mem-
branes, presumably bringing them close enough
together to fuse.
To confirm the function of the fusion peptide
and to identify the role of individual amino acids
in the fusion activity, we have used oligonucleo-
tide-directed site-specific mutagenesis to alter the
nucleotide sequence coding for selected residues
at the amino terminus of HA,. Three mutants
have been constructed that contain single base al-
terations that result in nonconservative amino
acid changes in the fusion peptide. These changes
interrupt the hydrophobic stretch with charged
amino acids or extend the hydrophobic sequence
to 18 amino acids. The altered sequences were
used to replace wild-type sequences in an SV40-
HA recombinant vector, and the mutant HAs
were expressed in CV-1 cells. Immunofluores-
cence, red-cell-binding, protease sensitivity, and
fusion assays (in collaboration with J. White and
R. Doms, Yale University) have been used to es-
tablish the phenotype of the mutants. The sub-
stitution of glutamic acid for the glycine residue
at the amino terminus of HA, abolishes all fusion
activity, although a conformational change in the
protein (monitored by protease sensitivity) and
interaction of the fusion peptide with liposomes
can take place at pH 4.8. Substitution of glu-
tamic acid for the glycine residue at position 4 in
HA, shifts the threshold pH for cell-cell fusion or
erythrocyte delivery from approximately 5.2 (wild
type) to approximately 5.6. The efficiency of fu-
sion is significantly less than that observed with
the wild-type protein. Finally, extending the hy-
drophobic stretch by replacement of the glutamic
acid with glycine at position 11 yields a mutant
protein that induces red-cell-mediated delivery of
HRP with the same efficiency and pH profile as
the wild-type protein; however, this mutant was
unable to induce cell-cell fusion at any pH.
In a separate experiment, we have cloned and
sequenced the gene encoding a naturally occur-
ring variant of HA that induces cell-cell fusion at
an elevated pH of 5.6. Three amino acid altera-
tions were found when the deduced amino acid
sequence of the variant was compared with that
of wild-type HA. Two of the altered amino acids
are located on the external surface of HA, and
are unlikely to be involved in the altered fusion
activity. The third change involves the substitu-
tion of an uncharged glutamine residue for a glu-
tamic acid residue at position 132 in HA,. Ex-
change of restriction fragments between the
cloned genes encoding the wild-type and mutant
proteins, and expression of the reassorted genes
using SV40-HA recombinant vectors, confirmed
that this substitution was indeed the cause of fu-
sion at elevated pH. In the wild-type protein, this
glutamic acid residue is linked by a salt bridge to
an arginine at position 185 in the HA, of an ad-
jacent subunit of the trimer. The fact that aboli-
tion of this salt bridge allows the conformational
change to occur at pH 5.6 suggests that it may
play a crucial role in stabilizing the HA trimer.
These results suggest that fusion takes place in
at least three stages -a conformational change in
HA induced by low pH, which exposes the fusion
peptide; binding or insertion of this peptide into
the target membrane; and, finally, destabilization
and coalescence of the closely apposed lipid bi-
layers. Partial destabilization resulting in small
areas of membrane coalescence may be sufficient
for delivery of red cell contents; destabilization
and coalescence of more extended lengths of
membrane are required for cell-cell fusion and
polykaryon formation.
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CELL-CYCLE-SPECIFIC EXPRESSION
J.A. Lewis D.A. Matkovich
Genetics of Growth-phase-dependent
Thymidine Kinase Gene Expression
J.A. Lewis, D.A. Matkovich
Our laboratory is fundamentally interested in de-
fining the genetic determinants that govern the S-
phase specificity of thymidine kinase (tk) gene
expression in higher eukaryotic cells. To this end,
we have (1) cloned the Chinese hamster tk gene in
a recombinant phage vector, (2) cloned a nearly
full-length cDNA to the hamster tk mRNA in a
XGT10 vector and characterized this clone by di-
deoxynucleotide sequencing, and (3) sequenced
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selected restriction fragments of the hamster tk-
gene clone. This progression of experiments has
led us to a nearly complete resolution of the
structure of the Chinese hamster tk-gene pre-
sented in Figure 1. In brief, the hamster tk
mRNA sequences are distributed through the 11.2
kb of genomic DNA in at least seven exon seg-
ments that range in size from the 32-bp Exon II
to the 680-bp Exon VII. These exons are segre-
gated by intervening sequences that range in size
from the 5.4-kb intron which segregates Exons IV
and V to the 92-bp intervening sequence which
segregates Exons I and II. The nucleotide se-
quences that comprise the exon-intron bounda-
ries show extended homology with the consensus
sequences described for splice-donor and splice-
acceptor nucleotides.
In an attempt to resolve the structural details
at the extreme 5' end of the hamster tk gene and
to propose a site for tk-gene transcription initia-
tion, we have constructed a tk minigene, desig-
nated pHaTK2, that efficiently transforms a va-
riety of Tk - cells to Tic' and have prepared Exo
III/S, deletion mutants of pHaTK2 through the
promoter region. The endpoints of the deletions
are shown in Figure 1.
We find that mutant derivatives of pHaTK2
that retain at least 121 by 5' to the translation in-
itiator AUG transform LTk - cells as efficiently
as the pHaTK2 gene, whereas those that retain
only 79 by transform with a nearly 100-fold re-
duction in efficiency. It seems clear by this anal-
ysis that elements important to tk-gene transcrip-
tion are contained within the 42 by between - 79
6353
Exon I AGTTAACAAGCTAAACCTGCCCTGAAGG GAGAAAATGAGGAAACCAGGCACGTGGICTCCCGGAGGGGTGGTCGAGTGCCUCCTAACATTCCGGCCCG
L1262 A221
GGTTCTGGGCAGCTGCACCC CACCTACCTCTGCAGACAGGGICTTCCAGGGCGGCTCGCGC GGGGAGCGCAGAGGCTGCCATAGCCGGGTCCAGCTCA
A121
GAGGGCG
AI77
AGCAGCTCGCTTTGCAGGGACAGGGGGAGAGGGGCGGIGGCCCACATIGCGCCCTGGC CTIGGCACGCCTCCGTCTTCGGCTGCGATTGGT
679 142
CGGTGAGIT TTTAAA1GGAAAGCGCGAACCTGAGGACGCTTCCCACT CACCGACCCCGGACCTTGGCGCTCAGGCTCGCACAGCCGCCATGAATTACA
GGGGTGAGT
TCAATCTGCCCACCGTGCTGCCCGGCTCCCCCAGCAAGACCCGGGGCCAGATCCAGgtgoggggtccgggctgc
Exon II acttetctoctagGTGATCCTCGGACCCATGTTCTCAGGGAAAAGgtootgootgggcttggg
Exon III tgetgoctottgcogCACCGAGCTCATGAGGAGAGTCCGGCGCTICCAGATCGCCCAGAACAAATGCCTGGICATCAAGTATGCCAAAGA
CACGCGCTATAGCAGGAGCTTCTCCACACATGACCGgteogtcccaccacccc
Exon IV totttottottoccagGAACACCATGOACGCCCTGCCAGCCTGCCTGCTCCGGGATGTGGCCCAGGAGGCCCTGGGTGCGGCTGICATTG
GCATCGATGAAGGACAGTTTgtoagttggettgoo
Exon V tecoccoocttteccogTTCCCTGACATCGTGGAATTCTGTGAAGTGATGGCCAATGCAGGCAAGACAGTGATCGTGGCAGCATTAGACG
GAACTITCCAGAGAAAGytaaggtgtctcacc
Exon VI ecceetgtototatogGCTITCGOCAGCATCTTGAACCTGGTGCCCCTGOCTGAGAGTGTGGTGAAGCTGACTGCCGTGIGTATGGAGTG
CTICCGAGAAGCCGCCTACACCAAGAGGCTGGGCCTGGAGAAGGAGgtoccttettgtget
Exon VII tggeectgtococogGIGGAGGTGATTGGTGGAGGAGACAAGTACCACTCGGIGTGCCGCGTGIGTTACTTTAAGAAGTCCICGGTACAG
CCTGCTGGGCCAGACAACAAAGAGAACTGCCCGGTGCTGGGACAGCCTGGAGAGGCCTCAGCTGTCAGGAAGCTCTTCGCCCCTCAGCAAGTCCTACAGC
ACAACTCCACCAACTGAGAGGACCTGGGGCCTGCCAGCTCCTACCCCAGGTTGGATTCTCAGAGAGCAGAGGACGGGCTGGGACTGCCGTGCCTGATGGA
CAATGTGCCCTGGAGAGGCTCACCCGCTICTCACAGCCTIITTTAGTTCCCTICTIGGITGCTGAGATGCTTTAGCCCAGACTAGAGCCAGCGCCTGCCT
GGTGGITAGGGTTTGACATCCAGCCAGAGGTAGGACAAAGCCACAGGGTGTTGTGACACAGAGGTGCTGGCTICTTCCTICTTGGIGGCTICCAGTCTCA
AGGGCCCCGCCCCCGAGCAAGGCTICACAACCCTCACTITGTGCTGAAGCTTGACCCACAATGGCCCCTAGCGGIGICTTTACAAAGTGGTGCTGTTCTT
GCCCTACTCAGAGCCCCAAGACTCAGGACTCTIGGTGAGAGCCTGTGCTTCTTGTGCTATAGTGTAAAATGAATAATTAATAATATTAAAGTTTCTACTT
GACAG
FIGURE 1 The nucleotide sequence of the 380 by 5' to the translation initiator AUG of the hamster tk gene, the seven tk-
gene exons, and bordering intron sequences. The endpoints of the Exo III/S, 5' deletions described in the text are indicated
by a triangle, designated to reflect the number of nucleotides remaining 5' to the initiator AUG codon.
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and - 121 and that tk-gene transcription initia-
tion must occur within 121 by 5' to the translation
initiator AUG. Within this region, we find a T/A-
rich sequence at - 72/ - 79 that we suspect is a
hamster tk-gene homolog to the TATA sequence
described by Goldberg and Hogness. If we are
correct in this assumption, we propose that tk-
gene transcription is initiated at the A residue at
Eco RI
Hind III
Stu I
Eco RI
Cla I
Sst I
Salo I
Hoc I
Xho I
Eco RI
Hind III
Stu I
Eco RI
Clo I
Sal I
Sm. I
Spa IXho I
Eco RI
- 44, since this residue, by lying in a pyrimidine-
rich sequence within 29-33 by of the TATA se-
quence, strictly fulfills the consensus criteria for
a site of transcription initiation.
In addition to pHaTK2, we have constructed a
variety of other hamster tk minigenes shown in
Figure 2. These genes were developed to analyze
our unexpected finding that minigene pHaTK1
pHoTk 20
Eco RI
Hind 01
St. I
Eco RI
Cla I
Ssi I
Sma I
Hpa I
Eco RI
Hind CQ
Stu I
Eco RI
Cla I
Sst I
SrnaI
HpoIXho I
Hind III
Stu I
Eco RI
Clo I
Sot I
Sala I
Spa I
Eco RI
Ind III
Stu I
Eco RI
Clo I
Sat I
SmaI
Spa IXho I
xhol
Xho I
Hind III
Stu I
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Cla I
Sat I
Sma I
Hind LEt
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Coo RI
Ca I
Sat I
Smc
Hpo I
FIGURE 2 Partial restriction maps of various Chinese hamster tk minigenes. Thin lines represent sequences derived from
the Chinese hamster tk cDNA AoTK90; heavy lines represent sequences derived from the hamster tk-gene isolate AHaTK5.
Intervening sequences are indicated as open boxes within the heavy lines.
79
transforms LTk- cells 25-fold less efficiently than
pHaTK2. Since pHaTK1 is composed only of
hamster tk cDNA sequences fused to the hamster
tk-gene promoter, it differs significantly in struc-
ture from pHaTIC2, which contains all of the se-
quences of pHaTK1, introns e and f, as well as
3.5 kb of genomic DNA derived from the 3' end
of the hamster tk gene. To consider the contri-
bution of each of these variables to the transfor-
mation efficiency of pHaTK2, we introduced in-
trons e and f into pHaTK1 to create pHaTK2b
and in so doing developed a tk minigene that
transforms LTk- cells to Tic' with a 15-fold
greater efficiency than pHaTK1. At the same
time, we introduced introns a and b of the ham-
ster tk gene into pHaTK1 to create pHaTI(3,
which transforms LTk- cells nearly 8-fold more
efficiently than pHaTK1 and thereby demon-
strated the generality of the intervening sequence
Tk transformation-enhancement phenomenon.
Both pHaTK2b and pHaTK3 genes, however,
were measurably less efficient (2-3-fold) than
pHaTK2, a difference we attributed to the 3.5 kb
of genomic DNA contained in pHaTK2. To test
the effects of this DNA segment in other tk-
gene constructions, we introduced this DNA into
pHaTK1 to create pHaTKlc and into pHaTK3
to create pHaTK3a and found that through these
manipulations, we developed derivatives that
transformed 3-fold and 1.9-fold more efficiently
than the parental tk minigenes.
We do not yet understand the mechanistic basis
for the intervening sequence enhancement phe-
nomenon that makes the major contribution to
pHaTK2 minigene transformation efficiency.
Curiously, this phenomenon has been described
previously in transformation studies with dihy-
drofolate reductase (dhfr) minigenes, in which
context the introduction of dhfr intervening se-
quences into dhfr minigene constructions im-
proved transformation efficiencies as much as 30-
fold. We imagine that intervening sequences
either promote or facilitate the integration of the
trans fected DNAs into host genomic DNA,
thereby promoting the number of stable Tk*
transformants, or alternatively, intervening se-
quences in primary gene transcripts may increase
the efficiency with which these transcripts mature
to cytoplasmic mRNA.
We are just as ignorant about the basis of the
relatively minor 3.5-kb enhancement phenone-
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mon. We propose that sequences in this fragment
improve the efficiency with which the polyaden-
ylation signals contained in these minigenes are
recognized, which leads to an improvement in the
efficiency of primary transcript maturation.
Our compelling interest in the construction of
tk minigenes is of course to exploit them to define
the location and function of the genetic determi-
nants governing the growth-phase dependence of
tk-gene expression. Since the genetic determi-
nants of interest may be contained in 5'-flanking
DNA, 3'-flanking DNA, noncoding, coding, or
intervening sequences, our experimental plan is
to construct a minimal chimeric tk gene, contain-
ing only Chinese hamster coding and 3' noncod-
ing sequences, and to analyze the pattern of tk-
gene expression in Rat 4 Tk* cells stably trans-
formed with this gene. If necessary, we intend to
elaborate this minimal gene systematically, sup-
plying it with structural elements of the hamster
tk gene, until we develop a tk minigene whose
expression is growth-phase-dependent.
As a Tk recipient cell for the analysis of tk-
gene expression from our various tk-gene con-
structions, we have adopted the Rat 4 Tk cell
line derived here at Cold Spring Harbor Labora-
tory by W. Topp. This cell line can be readily
transformed to TIC , grows rapidly with a dou-
bling time of 14-16 hours, is strictly growth-ar-
rested at high density, is stable as a confluent
monolayer for 96-120 hours without serum re-
freshment, and can be induced to resume loga-
rithmic cell division if passed through fresh me-
dia at lower densities. We have generated Rat 4
Tk *- transformed lines using either the hamster
tk-gene clone, XHaTK5, the tk gene of herpes
simplex virus I, or a hamster/herpes chimeric
gene designated pHa06He (Fig. 3). This chimeric
gene consists of the herpes tk-gene promoter
fused to the coding and 3' noncoding nucleotides
of the Chinese hamster tk cDNA. As we ex-
pected, tk-gene expression in Rat 4 lines trans-
formed with the hamster Tk genomic clone
XHaTK5 is growth-phase-dependent by the fol-
lowing criteria. (1) Specific Tk activity in con-
fluent growth-arrested monolayers is only 5-10,7o
the specific Tk activity of logarithmically grow-
ing cultures; (2) the specific Tk activity of growth-
arrested cultures can be increased five- to tenfold
by serum refreshment or by replating at lower
density; (3) the specific Tk activity of growth-ar-
B. GCGCCTTGTAGAAGCG CCTCGAGG CCGCCATG
500 510
He Xho I Ha
FIGURE 3 Structure of the chimeric tk minigene pHaA6He.
This gene was constructed by combining a 700-bp BamH I-
Xhol fragment from the HSV tk-gene mutant Tk x 81 con-
taining the HSV tk-gene promoter and cap site with an Exo
111/S, deletion mutant of pHaTK1 that contains the complete
coding and 3' noncoding nucleotides of the hamster tk
mRNA and six nucleotides 5' to the translation initiator AUG
codon.
rested cultures can be increased five- to tenfold
by infection with adenovirus type 5. These find-
ings are characteristic of the pattern of endoge-
nous tk-gene expression that has been docu-
mented throughout a literature of nearly 20 years.
In contrast, the specific Tk activity in Rat 4 cell
lines transformed to Tk' with the tk gene of HSV-
1 is growth-phase-independent, being largely in-
variant under the variety of culture conditions de-
scribed above, results consistent with an extensive
literature as well.
We were intrigued to find that tk-gene expres-
sion in Rat 4 Ti' lines transformed with the chi-
meric pHaA6He gene is growth-phase-dependent,
by all the criteria established for the XHaTk-5-
transformed lines above. These findings consti-
tute the first evidence that the determinants of
tk-gene growth-phase-dependent expression are
contained exclusively within sequences of the ma-
ture tk mRNA. We have yet to establish precisely
the location of these determinants and the man-
ner in which they function, although experiments
to consider these fundamental issues are pres-
ently under way.
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HORMONAL AND DEVELOPMENTAL CONTROL
OF GENE EXPRESSION
D.T. Kurtz W. Addison J.-Z. Li
J. Maclnnes E. Nozik
D. Danna A. Louis
For the past several years, we have been studying
the hormonal and developmental control of the
expression of a rat gene family that codes for a
protein called an globulin. This protein was first
described as a very abundant protein (1-2% of
total protein synthesis) in adult male rats. The
synthesis in male rat liver is under complex hor-
monal control: Androgens, glucocorticoids,
growth hormone, and insulin all induce hepatic
a2u, whereas estrogens repress the synthesis of this
protein. We have previously shown that an is en-
coded by a multigene family (18-25 genes per
haploid complement) clustered on chromosome 5.
TISSUE-SPECIFIC EXPRESSION OF THE
a. GENE FAMILY
We have found that 02, is expressed in several
other tissues in rats besides the liver. The an pro-
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teins that are produced in the various tissues are
distinguishable by differences in isoelectric
points. We have shown that this is not due to
posttranslational modification of the same pri-
mary translation product by translating mRNA
from different a2u-producing tissues, immuno-
precipitating the ce2u made in vitro, and subjecting
it to isoelectric focusing. The same protein iso-
forms found in vivo are found in ce,,, produced in
the cell-free translational systems. It appears that
different ce2, genes are being transcribed in differ-
ent tissues.
Liver a, represents a family of four to five dif-
ferent proteins (pl 4.8-6.0). The hormonal con-
trol of hepatic oz2u is well documented by our lab-
oratory and several others. All of the different
a2u genes expressed in the liver rise and fall coor-
dinately; i.e., the multihormonal control of rat
liver a2, synthesis is apparently not due to differ-
ent hormones inducing different genes.
Salivary gland a, consists of four to five pro-
tein species with distinctly more acidic pls than
liver a,. The salivary gland proteins run as a
cluster between pH 4.0 and pH 4.8 on isoelectric
focusing gels. a2, represents about 0.03010 of total
protein synthesis in salivary gland, i.e., about
1/20 to 1/30 the level found in liver. The synthe-
sis of salivary gland a2u seems constitutive: Iden-
tical levels are found in both males and females,
and the levels do not seem to change during sev-
eral endocrine manipulations in intact animals.
Lachrymal gland 0,2, comprises a set of pro-
teins that look identical to those of salivary gland
a,. ce represents about 0.2010 of total protein
synthesis in lachrymal gland, i.e., about 1/5 the
level in liver. Male rats produce about three to
five times more lachrymal a, than do female rats.
This difference is apparently due to androgen in-
duction: Female rats given androgens produce
lachrymal a2, at the same rate as do males. All
isoelectric forms are induced coordinately.
Mammary glands in pregnant female rats at day
18 or 19 of gestation produce a2, at a very low
level (about 1/50 the level in male liver). Mam-
mary gland a2, is represented by a very large
number of protein isoforms: 15-18 different a2,
proteins can be distinguished (pI 4.0-8.0). The
hormonal modulation of mammary gland ce2,, is
currently under investigation. The synthesis
peaks, sharply at day 18 or 19 of gestation and
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then falls rapidly until, by day 21 and following
parturition, no mammary gland ce,u is detectable.
This timing is consistent with a model in which
progesterone is inducing Ol2u and then a surge in
prolactin, which is known to occur about day 17
or 18, represses a2u synthesis.
The preputial gland is the most abundant
source of ce2, proteins that we have found. It rep-
resents about 5-10010 of total protein synthesis in
this tissue, and the synthesis seems to be consti-
tutive. Preputial gland a2u proteins separate into
the same complex protein isoforms that are found
in mammary glands. The number of different
protein isoforms distinguishable in the preputial
gland is close to the number of ci2u genes that we
have estimated to be in the genome. It thus ap-
pears that the preputial gland (and perhaps mam-
mary gland) transcribes nearly the entire comple-
ment of ce,,, genes present in the genome, whereas
the liver, salivary gland, and lachrymal gland
transcribe much smaller and distinct subsets.
TISSUE-SPECIFIC EXPRESSION OF CLONED
a20 GENES
We have cloned 18 different ce, genes from a li-
brary of the rat genome. Identifying which gene
is being transcribed in which tissue has proved to
be difficult: The protein-coding regions of the
different ce2, genes are for the most part very
highly conserved. Thus, one cloned gene will hy-
bridize to mRNA from all a2u-producing tissues;
raising the stringency of hybridization has no dis-
cernible effect. Surprisingly, the introns are also
highly conserved. Intron-specific probes made
from different cloned genes cannot be used to
distinguish different az, transcripts in nuclear
RNAs from various tissues. The 5' and 3' non-
coding regions of the different mRNAs are iden-
tical in length, as assayed by 51-nuclease and by
primer-extension analyses.
We have used two approaches to identify the
tissue of expression of specific cloned (y2,, genes:
We have sequenced the extreme 5' ends of 12 of
the 18 cloned genes. In a stretch of approxi-
mately 200 nucleotides from the cap site (essen-
tially the entire first exon), no two genes are ex-
actly identical, although the sequences are very
similar. We are currently sequencing the corre-
sponding regions of several tissue cDNAs to
match up the sequences in this region. Sequence
differences in exon III may also prove to be di-
agnostic.
Another approach is to use the pI differences
in the a, proteins that are made in the various
tissues. We have used COS-2 cells as a linked
transcription-translation system to produce 02,,
protein from the individual ce2u genes. COS cells
constitutively produce SV40 T antigen and will
thus effect the replication of any cloned segment
of DNA containing the SV40 origin of replica-
tion. We have constructed several SV40-02u fu-
sion genes (driven by the SV40 early promoter)
and have produced a, protein in COS cells. In
the course of this research, we made the surpris-
ing discovery that adenovirus VA I and VA II
RNAs greatly increase the efficiency of transla-
tion of transfected genes in COS cells. If the
SV40-a2 hybrid construct is cotransfected into
COS cells with an adenovirus fragment contain-
ing the VA genes, the level of a2u protein pro-
duced is increased 15-20-fold, although there is
no discernible difference in the extent of replica-
tion of, or transcription from, the SV40-a2u hy-
brid gene. This finding that adenovirus VA RNA
can have a nonspecific enhancing effect on trans-
lation has now been seen in other systems.
IN VIVO TRANSFECTION OF CLONED a2, GENES
Once we have identified specific genes as being
transcribed in different tissues, we will attempt to
determine the molecular basis of this tissue-spe-
cific expression, i.e., to identify the specific DNA
sequences responsible for the tissue specificity.
There are many recent examples of "tissue-spe-
cific enhancers" that greatly increase transcrip-
tion in a given tissue but are not part of the pro-
moter region per se.
To study this, we would need analogs of the
various tissues in which a2u is produced. This is
not a trivial problem, since "liver cells" that have
been put into culture very seldom retain their
differentiated properties. It was recently shown
that calcium-phosphate-precipitated polyoma
DNA, when resuspended in a buffer containing
collagenase and hyaluronidase, can be injected
directly into the liver and spleen of mice. The
polyoma DNA is able to replicate and remains
apparently extrachromosomal for several days.
We have managed to duplicate this finding (in
both rats and mice) and, further, we have found
that if a cloned segment of DNA containing the
polyoma origin is coprecipitated with the entire
polyoma genome, the T antigen produced by the
polyoma DNA can act in trans and effect the rep-
lication of the coinjected plasmid.
We have also had success injecting bovine pap-
illoma virus (BPV)-containing plasmids directly
into mouse liver. We have used the "69%"
BamHI-HindIII fragment of BPV, which is
known to be sufficient for BPV replication in cul-
tured mouse cells. When cloned DNA containing
this fragment is injected into mouse liver, extra-
chromosomal BPV DNA is detectable on South-
ern blots 2 days after injection. This should be a
very direct and simple method by which to study
the tissue-specific expression of cloned liver 0211
genes. We can further use this to study which
DNA sequences are required for the hormonal
modulation of 02 transcription in liver. Our
studies of the hormonal modulation of a2u syn-
thesis following transfection into tissue-culture
cells have been limited by the lack of cell lines
that contain various hormone receptors. If 02,,
genes injected into liver retain their hormonal in-
ducibility, we should be able to use this system to
study DNA sequences that are required for the
response of liver a2u genes to many different hor-
mones.
CONTROL OF RAT TROPOMYOSIN GENE
EXPRESSION
In collaboration with D. Helfman (Cell Biology
Section), we are studying the mechanism by which
adenovirus infection shuts down the synthesis of
tropomyosin I expression, while not affecting the
expression of other tropomyosin forms. We have
introduced a cloned rat tropomyosin I gene into
He La cells using DNA-mediated gene transfer,
and we are in the process of determining whether
this transfected gene is negatively controlled fol-
lowing adenovirus infection. If so, it should be
possible to determine which DNA regions of this
tropomyosin gene are responsible for its negative
regulation.
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Scientists in our section study oncogenes, genes
that drastically alter the proliferative capacity of
normal cells. In particular, we have concentrated
our efforts on the RAS oncogenes, which were
among the first genes implicated in human can-
cer. The study of RAS has been facilitated by the
recent discovery that close homologs exist in the
yeast Saccharomyces cerevisiae, an organism
readily subjected to thorough genetic analysis.
Studies of the RAS pathway in yeast have led us
to examine the cAMP pathway in fine detail. In
addition to the above, we have recently isolated
and are now studying three new human onco-
genes. Much of the work on the yeast RAS was
done in collaboration with F. Tamanoi (this sec-
tion), J. Broach (Princeton University), K. Mat-
sumoto (Tottori University, Japan), and I. Uno
and T. Ishikawa (University of Tokyo, Japan);
some of the work with associated yeast genes was
done in collaboration with M. Zoller (Molecular
Genetics Section); and the work on other verte-
brate oncogenes was performed in collaboration
with J. Fogh (Sloan Kettering Institute, Rye, New
York).
Yeast RAS Genes
D. Broek, S. Cameron, T. Kataoka, S. Powers,
T. Toda, M. Wig ler
In the yeast S. cerevisiae, there are two genes,
RASI and RAS2, that are closely homologous to
the mammalian RAS genes (Defeo-Jones et al.,
Nature 306: 707 [1983]; Dhar et al., Nucleic Acids
Res. 12: 3611 [1984]; Powers et al., Cell 36: 607
[1984]). We have cloned both genes (RASI and
RAS2) from plasmid libraries and have deter-
mined the complete nucleotide sequence of their
coding regions. They encode proteins that have
nearly 90% homology with the first 80 positions
of the mammalian RAS proteins, and nearly 50%
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homology with the next 80 amino acids. Yeast
RASI and RAS2 proteins are more homologous
to each other, with about 90% homology for the
first 180 positions. After this, at nearly the same
position that the mammalian RAS proteins begin
to diverge from each other, the two yeast RAS
proteins diverge radically. The yeast RAS pro-
teins, like the proteins encoded by the mammal-
ian genes, terminate with the sequence CysAAX,
where A is an aliphatic amino acid. Thus, the
yeast RAS proteins have the same overall struc-
ture and interrelationship as the family of mam-
malian RAS proteins. The domains of diver-
gence may correspond to functional domains of
the RAS proteins. Monoclonal antibody directed
against mammalian RAS proteins immunopre-
cipitates protein in yeast cells containing high
copy numbers of the yeast RAS2 gene.
We and other investigators have previously
shown that at least one functional RAS gene is
essential for the germination of haploid yeast
spores (Kataoka et al., Cell 37: 437 [1984]; Tatch-
ell et al., Nature 309: 523 [1984]). This was dem-
onstrated by constructing doubly heterozygous
diploid yeast cells containing wild-type RASI and
RAS2 alleles and RASI and RAS2 alleles each
disrupted by a different auxotrophic marker.
These diploid cells were then sporulated, and the
resulting tetrads were analyzed. Only spores con-
taining at least one functional RAS gene could
germinate. We then introduced into these doubly
heterozygous diploid cells a RAS2 gene under the
transcriptional control of the galactose inducible
GAL10 promoter (see Kataoka et al., Cell 40: 19
[1985]) linked to a third auxotrophic marker.
These diploid cells were then sporulated, and te-
trads were germinated on either glucose-contain-
ing medium (YPD) or galactose-containing me-
dium (YPGa1). The results confirm that at least
one functional RAS gene is required for germi-
nation. rasl - ras2- GAL 10-RAS2 spores ger-
minate only in the presence of galactose, the in-
ducer for the GAL10 promoter. Cells with the
genotype rasl- ras2- GALIO-RAS2 were grown
in YPGa1 and then shifted to YPD. The growth
of these cells was then monitored, and cultures
were plated on to YPGaI agar to measure cell vi-
ability. Within several cell generations, cell
growth ceased and cells lost viability. These ex-
periments indicated that the RAS genes are
needed not only for spore germination, but also
for the continued growth and viability of yeast
cells.
Certain missense mutations drastically alter the
biological activity of mammalian RAS genes. In
particular, the Ha-nova"' gene, which encodes va-
line instead of glycine at the twelfth codon of the
human Ha-ras gene, can induce the tumorigenic
transformation of NIH-3T3 cells. To test the con-
sequences of a similar mutation of RAS2 on the
properties of yeast cells, we constructed the
RAS2va19 gene using site-directed mutagenesis
(Kataoka et al., Cell 37: 437 [1984]). RAS2va19
thus encodes valine instead of glycine at position
19, which corresponds to position 12 of the mam-
malian Ha-ras protein. We then examined the ef-
fects of introducing this gene into yeast cells. Our
first observation was that diploid cells containing
RAS2va"9 could not be induced to sporulate by
incubation under conditions of nutritional depri-
vation (Kataoka et al., Ce1137: 437 [1984]). Next,
we observed that haploid cells carrying RAS2va"9
lost viability if starved for nitrogen, sulfur, or
phosphorus and failed to arrest in G, under those
conditions. Wild-type cells normally arrest in G,
and retain viability for long periods when nutri-
tionally deprived. In addition to these pheno-
types, we also noted that cells carrying RAS2van9
failed to accumulate carbohydrate stores as cells
entered the stationary growth phase (Toda et al.,
Cell 40: 27 [1985]). Thus, in general, RAS2'119
cells appeared to show a defective response to nu-
tritional stress.
The cluster of cellular properties just described
closely resemble the phenotype of cells carrying
the bcyl mutation (Matsumoto et al., Proc. Natl.
Acad. Sci. 79: 2355 [1982], Cell 32: 417 [1983],
Exp. Cell Res. 146: 151 [1983]; Uno et al., J. Biol.
Chem. 258: 10867 [1983]). The bcyl mutation
was first isolated by Matsumoto and co-workers
as a mutation that suppresses the lethality that
otherwise results from the disruption of adenyl-
ate cyclase (Matsumoto et al., Proc. Natl. Acad.
Sci. 79: 2355 [1982]). Cells carrying bcyl appear
to lack the regulatory subunit of the cAMP-de-
pendent protein kinase and hence have lost the
requirement for cAMP (Uno et al., J. Biol. Chem.
257: 14110 [1982]). These observations suggest
that the RAS genes might be participating in the
cAMP pathway. In support of this idea, we found
that bcyl suppressed the lethality that otherwise
results from disruption of both RAS genes.
The adenylate cyclase activity of the yeast S.
cerevisiae is stimulated by guanine nucleotides in
the presence of magnesium (Casperson et al., J.
Biol. Chem. 258: 7911 [1983]). In this respect,
yeast adenylate cyclase resembles the adenylate
cyclase of mammalian cells, which can be stimu-
lated by a guanine-nucleotide-binding complex
called G, (Gilman, Cell 36: 577 [1984]). Since the
yeast RAS proteins also bind guanine nucleotides
(Tamanoi et al., Proc. Natl. Acad. Sci. 81: 6924
[1984]), we reasoned that they might also modu-
late adenylate cyclase. This was tested directly by
the assay of membranes from wild-type yeast cells
and rasl- ras2- cells. Membranes from either
contained appreciable adenylate cyclase activity
when assayed in the presence of manganese ion,
but rasl- ras2- membranes displayed negligible
levels of activity when assayed in the presence of
magnesium and a nonhydrolyzable guanine nu-
cleotide analog. These results were confirmed in
a striking manner by membrane-mixing experi-
ments. We prepared membranes from RAS1
RAS2 yeast carrying the cyrl-1 mutation and
membranes from rasl- ras2- yeast. The cyrl-1
mutation disrupts the catalytic subunit of aden-
ylate cyclase. Membranes from these two sources
were assayed separately and together after mem-
brane mixing and fusion. The data indicate that
membrane mixing and fusion regenerate a guan-
ine-nucleotide-stimulated adenylate cyclase activ-
ity (Toda et al., Cell 40: 27 [1985]).
The addition of purified yeast RAS2 protein to
membranes from bcyl rasl- ras2- cells restores
adenylate cyclase activity to about 50-fold above
background level (Broek et al., Cell [1985] in
press). Adenylate cyclase activity in the bcyl
rasl- ras2- membranes can also be increased
dramatically by addition of yeast RAS1 protein.
Restoration of adenylate cyclase activity by RAS
proteins is dependent on the presence of guanine
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nucleotide, with the nonhydrolyzable GTP ana-
log, GppNp, yielding twice the activity of that
observed in the presence of GDP. Incubation of
the RAS2 protein with GTP prior to mixing with
the bcyl rasl- ras2- membranes results in aden-
ylate cyclase activity comparable to that restored
with RAS2 bound to GDP. In contrast, preincu-
bation of RAS2va19 with GTP results in activation
of adenylate cyclase to levels identical to that in-
duced by RAS2 proteins bound to GppNp. These
results confirm our genetic studies and indicate
that there are proteins in membranes that can dis-
tinguish between RAS proteins complexed with
GTP and RAS proteins complexed with GDP;
furthermore, they provide for the first time an in
vitro bioassay for the effector function of RAS.
Yeast Genes in the RAS/cAMP Pathway
T. Kataoka, S. Powers, P. Sass, T. Toda, M. Wig ler
In our effort to understand thoroughly the func-
tion of RAS in yeast, we have begun cloning genes
which encode proteins that operate along the
RAS/cAMP pathway. To do this, we have used
standard genetic strategies.
BCYI was cloned from a centromere-linked li-
brary (constructed by M. Rose, Massachusetts In-
stitute of Technology, and generously provided by
him) by transforming bcyl cells with the library
and selecting cells capable of resistance to heat
shock. bcyl cells, like RAS21a19 cells, are heat-
shock-sensitive (55°C for 30 min), presumably
because they cannot enter G5. We obtained one
clone that displays all of the genetic features ex-
pected of a BCYI clone. Gene disruptions of
BCYI were constructed and used to transform
haploid yeast cells by gene replacement. The
transformants display the same phenotype of cells
containing the spontaneously occurring bcyl mu-
tation.
CYRI, the gene encoding adenylate cyclase,
was cloned in a similar manner by transforming
cyrl -2 mutants (temperature-sensitive for aden-
ylate cyclase) with centromere-linked libraries and
selecting cells that grew at the nonpermissive tem-
perature. The nucleotide sequence of this gene
has been determined ( >6000 bp), and an amino
acid sequence of the product has been deduced.
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We are not yet certain which methionine repre-
sents the start codon. Aminoterminal deletion
mutants of the adenylate cyclase gene give rise to
proteins that are catalytically active but do not
appear to be regulated by RAS. High-level ex-
pression of such genes suppresses the lethality of
the double rasl- ras2- mutation. We conclude
from this that, in yeast, all of the lethal effects
due to loss of RAS function are mediated through
adenylate cyclase. We have succeeded in express-
ing enzymatically active yeast adenylate cyclase in
Escherichia coli.
CAKI, a cAMP-dependent protein kinase cat-
alytic subunit, was cloned by complementation of
cdc25, a cell-division control mutant that arrests
in GI at the nonpermissive temperature. cdc25 is
suppressed by RAS2'19 and by high-level expres-
sion of adenylate cyclase. We therefore reasoned
that CAKI would suppress cdc25, which it does.
The nucleotide sequencing of this gene is nearly
complete, and it shows extensive homology with
the sequence of the bovine cAMP-dependent
protein kinase catalytic subunit. Gene-disruption
experiments indicate that cells lacking CAKI are
viable. We therefore conclude that cells must
contain a second cAMP-dependent protein ki-
nase. Indeed, we observe by hybridization anal-
ysis another yeast gene weakly homologous to
CAKI, which we are now cloning. High-copy
plasmids of CAK1 suppress lethality due to loss
of endogenous RAS function or loss of adenylate
cyclase. These results are formal proof that the
effects of adenylate cyclase and hence cAMP are
mediated through the cAMP-dependent protein
kinase system.
CDC25 was cloned together with CAKI by
transforming a cdc25 strain with a centromere-
linked library. CDC25 is not one of the known
genes in the adenylate cyclase pathway. We are
nearly finished with its nucleotide sequence, and
this work and the work on CAKI are proceeding
in collaboration with M. Zoller (Molecular Ge-
netics Section).
In addition to the genes described above, four
recessive mutations, supA, B, C, and D, have been
isolated that suppress the phenotype of RAS2va19.
One gene, PS1, has been isolated that, in high
copy, suppresses RAS2'"9. The relationship of
these genes to the classic cAMP pathway has yet
to be determined.
Studies of the Vertebrate RAS Proteins
C. Birchmeier, D. Broek, 0. Fasano, T. Kataoka, M. Wig ler
Some tumor cells contain mutant RAS genes that
are capable of transforming NIH-3T3 cells.
Those genes that have been analyzed arise from
the wild-type nontransforming RAS genes by mu-
tations producing single amino acid substitutions
at position 12 or 61 of the encoded protein. We
have performed random bisulfite-induced muta-
genesis on the cloned wild-type human Ha-ras
gene to determine whether mutations at other po-
sitions can activate the transforming potential of
that gene (Fasano et al., Proc. Natl. Acad. Sci.
81: 4008 [1984]). Most mutations are not activat-
ing, but mutations that specify single amino acid
substitutions at position 12, 13, 59, or 63 of the
encoded protein do activate the transforming po-
tential of the Ha-ras gene. Some, but not all,
mutant RAS proteins show an altered electropho-
retic mobility in SDS-polyacrylamide gels.
Using the approach described in the previous
section, we have been able to test if expression of
the normal mammalian Ha-ras protein is suffi-
cient for viability in yeast cells lacking their own
endogenous RAS genes. To this end, we con-
structed a GAL10-Ha-ras transcription unit that
utilized a full-length cDNA clone of the human
Ha-ras mRNA under the control of the galactose-
inducible GALIO promoter. This unit, closely
linked to a LEU2 marker, was inserted into dip-
loid yeast cells that were doubly heterozyous for
their endogenous RAS genes. Cells were induced
to sporulate, and tetrads were examined after ger-
mination on YPD or YPGa1 plates. Approxi-
mately 40% of spores with the genotype rasl-
ras2- GAL10-Ha-ras were capable of germina-
tion when plated on YPGa1, from which we con-
clude that the human Ha-ras protein can supply
essential RAS function to yeast. Direct biochem-
ical experiments yielded the same result. Aden-
ylate cyclase activity in bcyl rasl- ras2- mem-
branes was dramatically increased by the addition
of purified human Ha-ras protein. These results
indicate that the effector function of yeast and
mammalian RAS proteins has been conserved in
evolution. In particular, these results suggest that
RAS proteins may be involved in regulating aden-
ylate cyclase in vertebrates.
To test our ideas about RAS function derived
from studies in yeast, we have developed a frog
oocyte microinjection system. We have found
that purified mammalian Ha-ras proteins (Gross
et al., Mol. Cell. Biol. 5: 1015 [1985]) can induce
immature oocytes to progress from prophase to
metaphase. The Ha-rasv.12 is 200-fold more po-
tent than Ha-rasGw2 in inducing oocyte matura-
tion. This effect is blocked by cholera toxin,
which increases cAMP production in oocytes. We
have observed no significant changes in cAMP
concentrations due to injection of Ha-ras protein
and conclude that the yeast RAS system is not
entirely functionally analogous to the mammal-
ian system. Nevertheless, it is clear that the oo-
cyte system provides an excellent model system
for testing ideas concerning RAS protein func-
tion.
Isolation and Characterization of
Other Oncogenes
C. Birchmeier, D. Birnbaum, S. Efrat, 0. Fasano
M. Wig ler, D. Young
The transfer of genomic DNA into NIH-3T3 cells
has led to the discovery that genes present in some
tumor cells are capable of inducing foci of mor-
phologically transformed NIH-3T3 cells. Most of
the transforming genes detected in this way have
now been identified as members of the RAS gene
family, either Ha -ras, Ki -ras, or N-ras. The trans-
forming RAS genes detected by the NIH-3T3 fo-
cus assay have structural gene mutations that ac-
count for their transforming activity. Since the
great majority of tumor DNAs tested fail to in-
duce transformed foci, we have speculated that
the focus assay has a bias for RAS genes contain-
ing structural mutations. Therefore, we have be-
gun a series of experiments to explore alternative
assays for transforming genes present in NIH-3T3
cells after DNA transfer. The system is a modi-
fication of the one described by D. Blair and co-
workers (National Institutes of Health). Like
theirs, our assay also relies on the ability of trans-
formed NIH-3T3 cells to form tumors in nude
mice, but it incorporates methods of cotransfec-
tion to heighten sensitivity. Using this assay, we
have detected three human transforming genes
from the DNA of MCF-7, a human breast carci-
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noma cell line. One of these is N-ras, which is
amplified in MCF-7 cells but does not appear to
contain structural mutations. We have not yet es-
tablished whether the other two genes, which we
have called mcf2 and mcf3, are associated with
any genetic abnormality in MCF-7.
We are still in the process of characterizing
mcf2 and mcf3. mcf3 appears to be the human
homolog of the v-ros gene and has the structure
predicted for a transmembrane receptor. It has
been activated by a gene rearrangement resulting
in truncation of the region encoding the putative
extracellular domain. In addition, we have iso-
lated and are characterizing a gene called masl,
which was isolated from a human mastoid epider-
mal carcinoma.
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BIOCHEMISTRY OF YEAST RAS PROTEINS
F. Tamanoi A. Fujiyama N. Samiy
M. Rao M. Walsh
Structural and Functional Analyses of
Yeast RAS Proteins
F. Tamanoi, A. Fujiyama, M. Rao, N. Samiy, M. Walsh
A product of the ras oncogene continues to be a
source of intellectual excitement from several
standpoints. First, it is a membrane-bound pro-
tein that contains covalently bound fatty acids,
which raises the question of how it travels to and
interacts with the membrane. Second, it is a GTP-
binding protein, as well as a GTPase, and is a
member of the GTP-binding proteins that regu-
late various biochemical reactions within a cell.
Finally, a single amino acid alteration is known
to convert a normal protein to a form active in
transformation. Why such a small change results
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in dramatic effects on the physiology of cells has
been a tantalizing question to us. Our research
effort is focused on carrying out physical and
chemical studies of the ras protein.
In last year's Annual Report, we described
expression of the ras gene in Escherichia coli
aimed at preparing a large amount of the pure
protein. During the past year, our emphasis has
been to analyze products of ras-oncogene homo-
logs in the yeast, Saccharomyces cerevisiae. The
yeast homologs, RAS1 and RAS2, code for pro-
teins that have at their amino termini more than
90% homology with the mammalian ras protein.
Furthermore, alteration of a 19th amino acid on
the yeast RAS2 protein from glycine to valine, a
mutation analogous to the one found with the
transforming ras protein, results in dramatic
changes in the growth properties of yeast cells.
Thus, mechanistic aspects of the action of ras
proteins could be elucidated using the yeast hom-
ologs. Two advances have recently been made.
First, we have shown that the yeast RAS proteins
exhibit GTP binding and GTP hydrolysis activi-
ties similar to those seen with the mammalian
protein, which establishes similarities in bio-
chemical activities between the yeast and mam-
malian proteins. Second, in collaboration with
D. Broek and M. Wig ler (this section), we have
developed an adenylate cyclase system from yeast
membranes that is dependent on the RAS pro-
teins.
OVERPRODUCTION AND PURIFICATION OF
YEAST RAS PROTEINS
Since the amount of RAS proteins produced in
wild-type yeast cells is very low, we decided to over-
produce these proteins. To accomplish this, the
RAS2 gene was cloned into a YEp51 plasmid that
contained a galactose-inducible GALIO pro-
moter. The construct directed the synthesis of a
protein with an apparent molecular weight of
41,000 that was immunoprecipitable by a mono-
clonal antibody raised against the
protein. The 41,000-molecular-weight protein
appears to be a primary translation product, since
cell-free translation of mRNA extracted from
yeast cells expressing the cloned RAS2 gene re-
sulted in the production of a protein that comi-
grated with the 41,000-molecular-weight protein
on SDS-polyacrylamide gels. Overproducing the
RASI protein, on the other hand, required the
manipulation of the gene, since no suitable re-
striction sites were available close to the start of
the gene. By using synthetic oligonucleotides, we
created a Sphl restriction site at the start of the
gene. After recloning into Ml3mpl8 to add a Sall
site, the gene was cloned into the YEp51 plasmid
DNA. The construct directed the synthesis of a
protein with an apparent molecular weight of
34,000.
Expression in E. coli provides an alternative
and powerful means to produce the RAS proteins
in large amounts. Furthermore, it is relatively
easy to purify a protein from E. coli. Our first
construction utilized a lac promoter that is induc-
ible by the addition of isopropyl-O-o-thiogalac-
toside. The yeast RAS2 gene was inserted into
the EcoRI site of pUC8 plasmid, which directed
the synthesis of a protein containing 20 extra
amino acids added to its amino terminus. A sim-
ilar construct was made with the RASI gene,
which directed the synthesis of a protein contain-
ing five extra amino acids added to its amino ter-
minus. We also constructed an expression vector
that produced intact RASI or RAS2 protein in E.
coli. The expression is under the control of a
recA promoter that can be induced by the addi-
tion of nalidixic acid.
Extracts prepared from cells carrying the above
constructs exhibited a high level of GDP-binding
activity. This provided an assay to purify the
RAS proteins. Several column chromatography
methods, such as phosphocellulose, DEAE-cel-
lulose, and gel filtration, are being employed for
the purification. The fusion RAS2 protein has
been purified to approximately 70% purity as
judged from densitometric scanning of a stained
gel. Further attempts to purify the proteins us-
ing high-performance liquid chromatography
(HPLC) and GTP agarose are being made.
MODIFICATION OF RAS PROTEINS
The mammalian ras proteins
bound palmitic acid. The fatty acylation most
probably takes place on a cysteine residue located
close to the carboxy terminus, since mutation of
this cysteine destroys the modification. In con-
trast to the ras protein, a product of another on-
cogene (src) contains myristic acid. In this case,
the fatty acylation occurs on a glycine residue
close to its amino terminus. Whether there exist
two distinct types of fatty acylations and whether
they are related to the difference in their func-
tions are two questions we would like to address.
As a first step toward investigating these points,
we established that fatty acylation also occurs in
yeast RAS proteins. First, both RASI and RAS2
proteins could be labeled with [3H]palmitic acid.
Furthermore, we were able to recover the radio-
activity on the protein as palmitic acid after mild
alkali treatment. Currently, we are investigating
the site of modification as well as the nature of
linkage. We are also making use of secretory mu-
tants of yeast with the hope of gaining insight into
the transport of the protein.
It has recently been reported that yeast RASI
protein is produced as a 34K protein that is later
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modified to a 39K protein (Temeles et al., Mol.
Cell. Biol. 4: 2298 [1984]). This suggests that an-
other type of modification is taking place. In
agreement with this observation, we found a sim-
ilar 39K protein using our construction. How-
ever, we only detected a minor portion of the
RAS1 protein modified, and the majority of the
protein remains as a 34K protein even after a long
chase. The cause for this discrepancy is currently
being investigated.
BIOCHEMICAL ACTIVITIES OF RAS PROTEINS
Using the RAS2 protein purified from E. coli, we
have carried out a detailed characterization of its
enzymatic activities. First, the RAS2 protein
binds GDP and GTP. The binding was depen-
dent on incubation temperature; very little bind-
ing was observed at 0°C, whereas maximum bind-
ing was observed at 45°C. The pH optimum was
7.6. Optimum binding was observed in the pres-
ence of 0.5 mm Mg", but some binding was also
observed in the presence of EDTA. A Scatchard
plot of GDP binding was consistent with single-
site binding kinetics, which gave a calculated Kd
value of 4.7 x 10-8 wt. Kd for a nonhydrolyzable
GTP analog, Gpp(NH)p, was 8.7 x 10-8 M. Thus,
the RAS2 protein appears to bind GDP and GTP
with a similar affinity. This is in contrast to other
GTP-binding proteins, such as elongation factor
EF-Tu, which binds GDP much more tightly than
GTP. Another biochemical activity that the RAS2
protein exhibits is a GTPase. The hydrolysis was
specific to GTP or dGTP and no hydrolysis of
ATP, CTP, dATP, dCTP, or dTTP was observed.
The products of hydrolysis were GDP and inor-
ganic phosphate. The maximum level of GTPase
activity was obtained at 45°C and in the presence
of 0.5 mm Mg**. The rate of GTPase activity
was calculated to be 60 mmoles/min/mole of
protein.
By incubating at low temperature and using
Sephadex column chromatography, we were able
to isolate a stable complex between the RAS2
protein and GTE. Subsequent incubation at 37°C
resulted in the conversion of the bound GTP to
GDR. The GDP was still bound to the RAS2 pro-
tein as revealed by nitrocellulose assay. We fur-
ther showed that a GDP bound to the RAS2 pro-
tein could be exchanged with a fresh GTP. Thus,
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the RAS2 protein is capable of shuttling between
two forms: the GTP-bound form and the GDP-
bound form. We are currently interested in de-
termining whether there are any differences, such
as protein conformation, between the two forms.
The shuttling between the GTP-bound form
and the GDP-bound form appears to be an im-
portant aspect of RAS protein action, since this
is precisely the process that is impaired with mu-
tant RAS proteins containing an amino acid al-
teration at either the 19th (Gly -Val) or 66th
(Ala --Thr) residues. Expression of these mutant
proteins results in a dramatic change in the
growth properties of yeast cells, including de-
creased sporulation efficiency, increased sensitiv-
ity to nutrient starvation, and failure to accumu-
late carbohydrate reserves. The mutant proteins
purified after their expression in E. coli exhibited
GDP-binding activity similar to that seen with the
wild-type protein. In addition, GDP bound to
the mutant proteins could be exchanged with free
GTP with an efficiency comparable to that seen
with the wild-type protein. However, a signifi-
cant difference was observed in their GTPase ac-
tivities. The activity of the valine mutant was
about 1501s of that of the wild-type protein, and
the threonine mutant displayed further reduced
GTPase activity.
EFFECT OF RAS PROTEINS ON YEAST
ADENYLATE CYCLASE
Genetic and biochemical studies carried out by
M. Wigler's group (this section) have indicated
that the yeast RAS genes are involved in the con-
trol of adenylate cyclase. Thus, membranes of
yeast cells lacking both RAS1 and RAS2 genes
fail to show any detectable level of adenylate cy-
clase (Toda et al., Cell 40: 27 [1985]). In collab-
oration with D. Broek and M. Wigler, we were
able to demonstrate that the purified RAS2 pro-
teins are capable of revitalizing this adenylate-
cyclase-defective membrane. RAS2 protein pu-
rified from E. coli, as well as the protein purified
from yeast, was capable of complementing the
adenylate-cyclase-defective membrane. The
complementing activity absolutely required the
presence of the nonhydrolyzable GTP analog,
Gpp(NH)p. Replacing Gpp(NH)p with GDP re-
duced the stimulation to 50010 of that obtained
with Gpp(NH)p. Thus, RAS2-GTP is more ef-
fective in stimulating the adenylate cyclase than
RAS2-GDP. Wild-type RAS2 protein preincu-
bated with GTP stimulated adenylate cyclase
only to the level obtained with GDP, presumably
because GTP hydrolysis took place during the
preincubation. The valine mutant protein prein-
cubated with GTP, on the other hand, gave the
same level of stimulation obtained when Gpp-
(NH)p was used. Thus, the mutant proteins over-
activate adenylate cyclase, which might be re-
sponsible for causing changes in the physiology
of yeast cells. A large amount of purified RAS
proteins provide an invaluable tool to investigate
their function within yeast membranes.
MOUSE GENETICS
L. Silver V. Bautch
J. Bahrenberg
L. Cisek
H. Fox
C. Jackson
D. Lukralle
P. Mains
S. Panzer
N. Sarvetnick
Mouse t haplotypes are naturally occurring,
highly variant forms of a region of mouse chro-
mosome 17 that has multiple and interacting loci
with profound effects on embryogenesis and
sperm differentiation. The t haplotypes main-
tain themselves as discrete genomic entities
through recombination suppression, and these
chromosomal units are propagated through wild
populations by a male-specific transmission ratio
distortion in their favor. Our understanding of t
haplotypes has undergone radical changes re-
cently, and it is now possible to focus research
efforts in attempts to answer specific questions
through the combined use of molecular and ge-
netic technitues. Although we have chosen to
concentrate our efforts on the t complex, we ex-
pect many of our results to be indicative of gen-
eral principles of mammalian genome structure
and function.
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Integration of Retroviral Sequences into
the DNA of Early Mouse Embryos
V. Bautch, L. Silver
One approach to the study of mammalian devel-
opment is to identify mutations that disrupt the
normal program of embryogenesis. Insertional
mutations also provide a molecular marker for
the recovery of genes disrupted by the mutation.
However, in order to be able to clone the preinte-
gration site and analyze the disrupted gene, the
integration event must preserve the linear order
of cellular sequences in a recognizable way. Re-
troviral genomes are particularly useful as poten-
tial agents of insertional mutation because retro-
viruses integrate with only a small (4 to 9 bp)
duplication of cellular DNA. We are generating
insertions in mice using a breeding scheme (N.
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Jenkins and N. Copeland, pers. comm.) that al-
lows for the de novo integration of endogenous
retroviral genomes into the DNA of early em-
bryos at a relatively high frequency. A subset of
retroviral genomes called ecotropic proviruses
has been followed because most inbred strains of
mice contain a few (0-6) copies that can be easily
followed using molecular techniques.
Mice of the RF/J strain contain three ecotropic
proviruses. Two of these loci, Emv-16 and Emv-
17, are genetically linked and have been impli-
cated in integration events in early embryos. We
have crossed male RF/J mice to females of two
different strains (CBA/CaJ and SWR/J) that are
negative for endogenous ecotropic proviruses.
The F, progeny were backcrossed to the ecotropic
virus-negative strains. The proviral sequences of
the N, offspring were analyzed by hybridizing
genomic DNAs prepared from tail clips to an eco-
tropic virus-specific probe. N, females carrying
Emv-16 and Emv-17 were then backcrossed to
produce N, progeny that were analyzed for newly
integrated proviruses.
We have scored a total of 29 ecotropic provirus
(EP) fragments not found in parental DNAs from
184 mice (15.8%). Analysis of the results led to
the following conclusions: (1) New proviral inte-
gration events occur when Emv-16 and Emv -17
are carried in the maternal genome but not when
carried in the paternal genome. (2) Crossing
Emv-16 and Emv-17 onto the SWR/J strain for
three generations results in a higher frequency of
integration events (15.8%) than the equivalent
crosses onto the CBA/CaJ strain (0%). (3) N,
integration events appear to be distributed non-
randomly with respect to breeding pairs and lit-
ters. (4) The presence or absence of Emv-16 and
Emv-17 in the embryonic genome does not affect
the probability of a de novo integration in that
genome. These findings suggest that both ge-
netic and epigenetic events contribute to this phe-
nomenon. The results are consistent with a
mechanism of reintegration involving infection of
the egg or early embryo by maternal tissues shed-
ding virus, although other possibilities exist.
The EP fragments were visualized at 5-50% the
intensity of homozygous bands run on the same
gel, with an average at approximately 20%. This
heterogeneity shows that there is variation in the
stage of embryonic development during which the
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integration event occurs, with those fragments at
50% intensity of homozygous bands most prob-
ably integrating at the one-cell stage. In practical
terms, we can predict, assuming that genomic
DNA from tails is representative of germ-line
DNA, that we will see germ-line transmission of
the new loci at these levels. We have been able to
pass 12 of the EP fragments through the germ line
to date, and preliminary results suggest that in
fact germ-line transmission parallels the repre-
sentation of these fragments in tail DNA. There-
fore, we should be able to pass most of the scored
EP fragments through the germ line.
We are currently establishing mouse lines con-
taining these new proviral loci and plan to ana-
lyze them for insertional mutations. Unfortu-
nately, mutations cannot be easily selected for in
mice; however, we can check several parameters.
First, visible structural or behavioral mutations
cosegregating with new loci can be identified as
dominant mutations if found in heterozygotes
and as recessive mutations if found in homozy-
gotes. We can also check for recessive lethal mu-
tations by using molecular and genetic techniques
to score a homozygous class of offspring. The
absence of this class in the appropriate cross will
be indicative of a recessive lethal mutation. Fi-
nally, we can score any X-chromosome-linked le-
thal mutations by deviations in the sex ratios of
offspring.
A Partial t Haplotype Contains
Both Copies of a Polymorphic
Genomic DNA Sequence
V. Bautch, L. Silver
We have been using short low-copy genomic DNA
sequence clones (microclones) to dissect the
structure of the partial t haplotypes. Partial t
haplotypes are the result of rare recombination
events between complete t haplotypes and wild-
type chromosome 17. Because t chromosomes
contain an inversion in the distal region of the
complex and a hypothesized inversion in the
proximal region, it is proposed that these rare re-
combination events result in duplication of some
DNA sequences and deletion of other sequences.
One of these partial t haplotypes, t"8, contains
the proximal portion of the t complex and carries
a recessive lethal mutation that maps in the vicin-
ity of the breakpoint between t DNA and wild-
type DNA. Recently, one of the microclones,
designated 89S, was shown to hybridize to gen-
omic sequences that also map near the break-
point in this chromosome. This was done using
a restriction-fragment-length polymorphism
(RFLP) between t DNA and DNA from mice of
the 129 inbred strain, which carries the twm hap-
lotype. Genomic DNAs from mice with the t'18
chromosome and either the wild-type chromo-
some 17 ( + 129/tw'8) or a complete t haplotype
(t'/r/8) were analyzed with a probe made from
the 89S microclone. As expected, the ( + 129/tw'8)
DNA contained fragments specific for both the
wild-type chromosome 17 and t-haplotype DNA;
however, the (t'it'8) DNA also contained both
sets of fragments. Since ( + 129/ + 129) DNA con-
tains only wild-type fragments hybridizing to
the 89S probe, and since DNA of mice with two
complete t haplotypes (t'/t°) contains only the t-
DNA-specific fragments, the wild-type bands in
the (t"8/t"'") DNA must have been contributed by
the tw'8 chromosome. Therefore, the recombina-
tion event generating this partial 1 haplotype was
probably an unequal crossing-over resulting in the
presence of both sets of these fragments on the
1'8 chromosome. Subsequently, several other in-
vestigators (H. Fox, this section, and H. Lehrach,
European Molecular Biology Laboratory, Heidel-
berg) have shown that three other independently
derived microclones are also duplicated in the r"
chromosome, suggesting that this chromosome
contains a substantial amount of duplicated
DNA. Current studies are aimed at determining
the extent of the duplication. Preliminary results
from Lehrach's laboratory indicate that the 89S
microclone maps to the TLA region of the H-2
complex on wild-type chromosome 17. We are
currently analyzing the r" chromosome with H-
2 DNA probes to determine whether any of these
sequences are also duplicated. Because the reces-
sive lethality carried by the t'18 chromosome is as-
sociated with the recombination breakpoint, it is
possible that either the duplication or the pro-
posed corresponding deletion of sequences could
be responsible for the lethal phenotype.
Characterization of t Haplotypes with
t Complex Clones
H. Fox, L.M. Silver [in collaboration with G.R. Martin,
University of California, San Francisco]
Last year, we described the mapping of DNA
clones obtained by chromosome microdissection
(by H. Lehrach et al., European Molecular Biol-
ogy Laboratory, Heidelberg) to the t complex by
identifying restriction fragment length poly-
morphisms with these clones in the DNA of mice
congenic for t haplotypes. Specific restriction
fragments identified by these clones were found
to be t-specific, since they were present in all
complete t haplotypes but replaced by other re-
striction fragments in all of the wild-type inbred
strains tested. However, there were no restriction
fragments present in wild-type or t that were not
found in the other, and the level of polymorphism
observed between t haplotypes and wild type is
roughly comparable to that observed between
inbred strains. Thus, the t haplotypes appear to
have a similar origin and have not diverged greatly
from other mice.
These clones have been used to classify partial
t haplotypes, which are derived from rare re-
combinant events between complete t haplotypes
and wild-type chromosomes. Partial 1 haplotypes
were found to contain subsets of the t-specific re-
striction fragments, and each could be classified
according to the t-specific fragments it contains.
This is the first molecular evidence that inde-
pendent partial t haplotypes contain different
lengths of t haplotype DNA and confirms the ge-
netic studies of M. Lyon (Harwell), who has used
partial t haplotypes to elucidate the genetic basis
of the t haplotype phenotypes.
In a recent survey of wild mice, J. Klein (Tub-
ingen) has identified t haplotypes at a frequency
of approximately 25% in mouse populations
throughout the world. We have analyzed these
new t haplotypes with our molecular probes and
found that all of the mice resemble the previously
characterized t haplotypes except one. This t
haplotype, originally isolated in Haifa, is unique
in that it only carries a subset of the t-specific
markers. Genetic studies indicate that it similarly
only expresses a subset of the t-specific pheno-
types. Several lines of evidence support the the-
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ory that this haplotype may be an intermediate in
the formation of t haplotypes in the wild.
Evidence for a Proximal t Haplotype
Inversion
N. Sarvetnick, L.M. Silver
Recently, the product of one rare recombination
event between a t haplotype and wild type (named
twLub2) was characterized and found to express two
unusual phenotypes not associated with either of
the parental chromosomes from which it was de-
rived. First, the twLub2 chromosome suppresses the
dominant, short-tail phenotype expressed by mu-
tations at the Brachyury (T) locus so that animals
doubly heterozygous for T and twLub2 are born
with tails of normal length. Second, the twLub2
chromosome expresses a dominant lethal effect
(Tme) in all embryos that inherit the mutant
chromosome from their mother, so that hetero-
zygous females cannot transmit twLub2 to their
offspring. Embryos that receive either mutant
chromosome from their mother develop in an ap-
parently normal fashion until late in gestation
when death inevitably occurs. At the time of
death, mutant embryos are edematous and show
an increase in weight relative to their normal
littermates. In contrast, when embryos receive
either mutant chromosome from their father, de-
velopment proceeds normally to the birth of
healthy and fertile individuals.
To gain a better understanding of the genetic
basis for the various phenotypes expressed by the
twLub2 chromosome, we have used several molecu-
lar probes to analyze the structure of this unusual
chromosome. Our genetic and biochemical anal-
yses of twLub2-containing mice have generated evi-
dence that the chromosome contains a deletion.
First, twLub2 expresses a new lethality not ex-
pressed by its parental t haplotype. Second, the
chromosome fails to complement the lethality as-
sociated with another t haplotype, tw", that maps
in the proximal region. Finally, the chromosome
fails to express either known form of the TCP-1
protein. Clustered mutations are most simply ex-
plained by a deletion.
We have further investigated the structure of
the twLub2 chromosome by performing a genetic
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analysis with a cDNA clone (pMK174) that hy-
bridizes to sequences located in the proximal por-
tion of chromosome 17. The results indicate that
the twLub2 chromosome must contain both t-spe-
cific and wild-type alleles at this locus. These
data demonstrate that the twLub2 chromosome
carries a duplication of genetic material, with
both wild-type and t-specific forms of the
pMK174 locus.
The accumulated data indicate that a recombi-
nation event between a t haplotype and a wild-
type chromosome caused the duplication of cer-
tain genetic loci (T and pMK174 sequences), as
well as the deletion of other loci (Tme, Tcp-1, and
the tw" lethal locus) in the generation of the twLub2
chromosome. However, a simple, unequal re-
combination event between homologous chro-
mosomes would cause either a duplication or a
deletion but not both. To explain the generation
of twLub2, we postulate the existence of an inver-
sion over the proximal region of t haplotypes, ex-
tending from the T locus and pMK174 sequences
to the loci of Tcp-1 and Tme. A correctly ori-
ented recombination event between these two sets
of inverted loci would produce a chromosome
with all of the genetic properties of twLub2 (see Fig.
1 below).
Studies performed in a similar manner indicate
that the Tt°" haplotype appears to have a struc-
ture reciprocal to that of twLub2. Our model for the
generation of both twLub2 and Tt°" predicts that
the crossover event occurred while the two chro-
mosomes were paired in this type of linear, non-
homologous fashion. The demonstration of non-
homologous chromosomal pairing in t heter-
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Figure 1 Representation of the proximal region of mouse
chromosome 17. The loci inverted in t haplotypes relative
to wild type are indicated, with the postulated recombination
event that generated twLub2 and Tt°".
ozygotes makes it possible to explain the mecha-
nism by which rare recombination occurs in this
region. The accumulated molecular data suggest
that many rare recombination events have oc-
curred within the well-characterized inverted re-
gions, with the production of partial t haplotypes
that have both duplicated and deleted loci. These
events can be explained by the occasional, chance
pairing and recombination of nonallelic members
of a repetitive DNA family. It is important to em-
phasize that such events will occur only rarely,
and only a fraction will produce viable recombi-
nant products.
Genetic Analysis of a Mouse Dominant
Maternal Effect
N. Sarvetnick
The detailed structural analysis of t""" and an-
other partial t haplotype, Tt'', has implied that
the two chromosomes represent reciprocal recom-
bination products. Thus, a duplication of a func-
tional Tine locus may be present on the Tt°'
chromosome. If the lack of maternal transmis-
sion of t""" were purely a dosage problem, then
the duplication could be utilized to complement
the defect. We designed a series of breeding pro-
tocols to explore the potential of the Tt °" chro-
mosome to alter the penetrance of the t'L"b2 ma-
ternal effect.
When Ttf/rL"2 females were mated with wild-
type males, 94% of the 188 animals born had the
short-tail phenotype indicative of the T-carrying
chromosome. The remaining 6% of the animals
had normal tails and appeared healthy; all that
could be analyzed were found to have a recombi-
nant chromosome that carried neither I " 1"' nor
T. Hence, with this mating, there is no evidence
for the survival of any twLuw-carrying individuals
to the time of birth.
When Ttf/twLu" females were mated to Tt°"tf/
+ tf males, a third phenotypic class of neonatal
mice was observed. Of 195 offspring, 16% had a
tail of normal length, but were much larger than
their littermates and appeared edematous; all died
within 48 hours after birth. This phenotype is
reminiscent of that observed in utero for mater-
nally derived twL"' embryos from other crosses.
Another 5% of the offspring had tails of normal
length, but were healthy, and when tested, they
were found not to carry the t"'" chromosome.
The total fraction of mice born with normal tails
from this cross (21%) is too large to be accounted
for by crossing-over alone, and the majority of
these mice express the characteristic r"b2 phe-
notype. It appears that the presence of a Tt °"
chromosome in the father allows a percentage of
the maternally derived t"'"" individuals to sur-
vive to birth.
To determine whether the presence of the Tt°"
chromosome in the mother's genotype has any ef-
fect on the survival of t'ub2 individuals, Tt°' /
t"L °b2 females were mated to wild-type males. No
animals were born with the twl-"b2 phenotype.
Only 1 (2%) of the 45 offspring born had a nor-
mal tail, and when tested, this animal was found
to have a recombinant chromosome without the
t'u" haplotype. Hence, the presence of Tt°" in
the primary oocyte is not sufficient to rescue em-
bryos that receive the alternative t''Lub2 homolog
from a doubly heterozygous mother.
There are two possible mechanisms by which
the t"'""2 maternal effect could be expressed. The
first mechanism is dependent on an absolute re-
quirement for a functional Tine locus during the
haploid phase of oogenesis; this condition is not
met when tv-ub2 is inherited maternally. The sec-
ond mechanism requires the differential func-
tioning of the maternally and paternally inherited
forms of Tine at some critical stage of embryoge-
nesis; e.g., if the paternal locus is inactive, em-
bryos having no maternal form will die.
Several facts argue against the first mechanism
described above. First, it seems unlikely that a
molecule produced (or not produced) during oo-
genesis could begin to have a dramatic effect on
an embryo that is 10,000 times larger at 15-19 days
after conception. Second, nuclear transplant re-
sults obtained by J. McGrath and D. Solter (Wis-
tar) indicate that a wild-type cytoplasm and
membrane are not sufficient to rescue a mutant
nucleus. Finally, our results indicate that a spe-
cific paternal genome can alter the penetrance of
the t""" phenotype. This experiment provides
support for the model of a differential function-
ing of the Tme locus dependent on the parent
from which it is inherited. If the maternal allele
is thought of as fully activated and the paternal
allele as relatively inactive, then the embryo hav-
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ing a maternally derived t"'"" chromosome must
survive solely on the paternal allele, resulting in
lethality. In our experiment, the double dose of
the relatively inactive Tme paternal locus par-
tially complements the deficiency and increases
the mean life span, so that a large percentage of
the P4-.2-containing embryos are born.
Cis-Trans Analysis of t Haplotype
Lethal Genes
P. Mains
It has long been noted that the viability of mice
heterozygous for complementing t haplotypes
generally ranges from 18% to 85%. A previous
study tested whether this viability could be im-
proved by placing two lethal mutations together
on one chromosome (in cis) rather than on sepa-
rate chromosomes (in trans). It was found that
the complementation between two different le-
thals was increased to 100% if they were on the
same chromosome when they are heterozygous
with a fully wild-type chromosome. This would
indicate that the wild-type alleles work more ef-
ficiently when they are on one chromosome (in
cis) than when they are on separate chromosomes
(inirans). Other investigators interpreted this cis-
trans effect as indicating that the two loci were
part of a single functional unit, even though they
map 10-20-cM apart. They proposed that the ne-
cessity for the alleles at widely separated loca-
tions to be on the same chromosome in order to
function efficiently may be indicative of a gen-
omic rearrangement.
An alternative interpretation of the cis-trans
test is that t haplotypes may carry additional "sub-
optimal" alleles at loci other than their uncondi-
tional lethal mutations. The incomplete comple-
mentation of two lethal haplotypes could result
from a requirement for a cis interaction of wild-
type alleles or from an effect of other deleterious
genes associated with the t haplotypes. To con-
trol for this, a t chromosome lacking either lethal
is required to provide both "wild-type" alleles in
a cis arrangement. This chromosome would be
the reciprocal crossover of the t chromosome car-
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rying the two lethals in cis. However, because of
the limited genetic resolution in the mouse, pre-
cise, or even nearly precise, reciprocal crossovers
cannot be easily isolated. Any two reciprocal
pairs will contain overlapping regions that can
complicate the interpretation of the data. We re-
peated the cis-trans test using several independent
recombinant chromosomes in different pairwise
combinations. The different combinations are
likely to share different regions of overlap. We
found that some combinations improve the com-
plementation of two t lethal alleles, whereas oth-
ers did not. We believe that the data can be ex-
plained simply by the presence of a slightly del-
eterious gene(s) within the overlap, or they may
reflect the effect of genetic background.
The minor differences in the viability of the cis
and trans heterozygotes are unlikely to be caused
by a rigorous requirement that they be carried on
the same chromosome to function efficiently.
Instead, it may be due to additional deleterious
genes carried by t haplotypes. t haplotypes are
effectively isolated from the gene pool of mice due
to the suppression of recombination with the
wild-type chromosome 17. This may allow the t-
bearing chromosomes to acquire deleterious mu-
tations at loci in addition to their unconditional
lethal mutations. In fact, some t chromosomes
have been found to carry multiple lethal alleles.
These other deleterious alleles may be unique to
certain t haplotypes, or they could be shared by
all, and could account for the decrease in the vi-
ability of the trans heterozygote compared with
the cis.
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TRANSGENIC MICE
D. Hanahan S. Alpert M. Lacy
S. Efrat V. Bautch
Cold Spring Harbor laboratory has established
and is expanding a group that is studying various
aspects of gene expression and its consequences
using the mouse as an experimental organism.
Currently, the major approach of this group in-
volves transferring cloned and often-altered genes
back into the mouse germ line, so as to examine
their effects in that context. This is being accom-
plished by injecting a solution of DNA into a
pronucleus of a one-cell embryo, which is then
reimplanted into a foster mouse and allowed to
develop. Mice that heritably carry the new ge-
netic information (so-called transgenic mice) arise
from about 10% of those born from embryos in-
jected with the DNA. Transgenic mice are being
used to examine control of gene expression, the
consequences of oncogene expression, and the
prospects for using insertional mutagenesis by
DNA microinjection as a genetic tool.
Recombinant Insulin SV40 Oncogenes
in Transgenic Mice
D. Hanahan, S. Alpert, S. Efrat, M. Lacy
Hybrid oncogenes composed of regulatory infor-
mation flanking the rat insulin (II) gene linked to
protein-coding information for SV40 T antigen
have been transferred into the mouse germ line.
The rationale for employing such combinations is
(1) to identify elements associated with the insulin
gene that mediate its correct tissue-specific ex-
pression in the insulin-producing 3 cells of the
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endocrine pancreas, (2) to examine the conse-
quences of oncogene expression in /3 cells, and (3)
to address the prospect that oncogene expression
can be employed to facilitate the establishment of
cultured 0 cell lines.
Transgenic mice were produced that harbor two
different insulin/SV40 T-antigen genes. One
(called RIPI-Tag) carries the insulin gene pro-
moter aligned so as to transcribe the T-antigen
gene. The second (called RIR-Tag) has the insu-
lin promoter inverted with respect to the SV40-
coding information. Both recombinant genes
elicit the heritable formation of solid 3 -cell tu-
mors in transgenic mice that harbor them, sug-
gesting that the tissue specificity element(s) can
act bidirectionally. Expression of T antigen is de-
tected only in the insulin-producing f3 cells. The
hybrid genes are expressing in virtually all (3 cells
prior to tumor formation, which occurs in only a
few of the several hundred islets of Langerhans
that comprise the endocrine pancreas. This indi-
cates that secondary events are necessary to con-
vert a collection of islet cells expressing SV40 T
antigen into a solid, well-vascularized tumor. It
is possible that a cellular oncogene is involved.
The other major cell types normally found in is-
lets - glucagon-producing a cells and somatosta-
tin-producing S cells -are rare and disordered in
these transgenic mice.
In summary, sequences located within 660 by 5'
to the transcribed portion of the rat insulin gene
are sufficient to elicit cell-type-specific expres-
sion in transgenic mice, and the synthesis of T
antigen produces islet disruption and tumor for-
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mation. These transgenic mice should provide
further insight into the development of the en-
docrine pancreas and on the mechanisms of on-
cogenesis.
Analysis of DNA Microinjection into
Mouse Embryos to Create
Insertional Mutants
V. Bautch, D. Hanahan
It is known that insertion of DNA into the mouse
germ line via microinjection can result in inser-
tional mutations. Microinjected DNA is usually
found as 5-50 copies in a head-to-tail tandem
array at a single integration site, and the 5' and
3' ends of the array are sometimes missing se-
quences. Limited analyses by several investiga-
tors indicate that approximately 10% of trans-
genic mice carry a recessive-lethal mutation that
cosegregates with the inserted DNA. However, in
no line has the integrity of the flanking cellular
sequences been adequately analyzed. This pa-
rameter is important with respect to insertional
mutagenesis, because only if integration of DNA
preserves the linear order of cellular sequences or
gives rise to small deletions or rearrangements
(e.g., no larger than cosmid size) will it be possi-
ble to clone the preintegration site easily and ana-
lyze the disrupted gene(s). Therefore, we plan to
investigate both the rate of generating recessive-
lethal mutations and the integrity of flanking se-
quences after integration of microinjected DNA.
We have therefore constructed a plasmid vector
that can be used to rescue, by transformation of
Escherichia coli, the inserted DNA and flanking
cellular sequences. Although this vector is de-
rived from pBR322, it has been altered so that
deletion of some plasmid sequences from the end
of a tandem array by "nibbling" prior to integra-
tion should not affect the ability to rescue this
plasmid. The vector contains three different drug
resistance genes, and each gene contains several
restriction enzyme sites unique to the plasmid. In
addition, a suppressor tRNA gene has been in-
serted that can complement bacteriophage X mu-
tations and provide an additional selection. A
polylinker containing unique restriction sites has
been inserted between two of the drug resistance
markers in order to linearize the plasmid prior
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to microinjection. It is expected that the DNA
will integrate in a head-to-tail tandem repeat so
that the linear order after integration will be
-kank-ori-sup'-ampR-tetR- . The genomic DNA
will be digested with a restriction enzyme whose
site is in a drug resistance gene and religated. Any
internal copies of the tandem DNA should recir-
cularize to yield plasmids resistant to all three
drugs upon transformation; however, each end
should contain some cellular DNA and also be
uniquely sensitive to the drug whose resistance
gene was originally cleaved. For example, digest-
ing with an enzyme that cleaves the tee gene
should yield a DNA fragment containing a trun-
cated tetR gene at one end and flanking cellular
DNA at the other end. This fragment will ligate
to form a plasmid with cellular DNA that is amp",
kanR, and tets. Moreover, in this scheme, a sec-
ond rescue using an enzyme that cleaves the kanR
gene should yield a plasmid containing cellular
DNA from the opposite end of the tandem array.
In the event that plasmid sequences are altered by
the integration so as to make plasmid rescue im-
possible, it should be possible to retrieve the
flanking DNA by cloning into phage containing
a nonsense mutation and selecting for the sup-
of sup-
pressor tRNA sequences makes phage rescue im-
possible, the flanking DNA can be retrieved by
making a library of genomic DNA from the
transgenic mouse and screening with the plasmid
as a probe.
We plan to generate and analyze 10-20 lines of
transgenic mice containing this vector. The
flanking sequences will be cloned and their coli-
nearity with the preintegration site will be as-
sessed. We will also use breeding and molecular
analysis to determine the efficiency of generating
insertional mutants in mice using this technique.
Insulin/SV40 T-antigen Hybrid Gene
Expression in the Developing
Mouse Pancreas
S. Alpert, D. Hanahan
Transgenic mice containing an insulin/SV40 T-
antigen hybrid gene will be used to investigate the
developmental control of insulin. In mammals,
there are two developmental phases of insulin se-
cretion. The first stage is a low level of insulin
production detected at about day 14 of gestation
in mice. This correlates with the early develop-
ment of the pancreas. The second phase is a
striking increase in insulin synthesis at approxi-
mately the 16th day of gestation; cells are first
apparent at this time. During the last 4 days of
gestation, insulin synthesis remains high. The
molecular mechanism controlling this develop-
mental sequence has yet to be explained.
Our experimental approach is to compare the
developmental expression of the endogenous in-
sulin genes to that of the recombinant insulin
gene. This hybrid gene contains 660 by of the 5'-
flanking region of the insulin gene joined to the
coding region for SV40 large T antigen. Analysis
of transgenic mice carrying this gene has shown
that the sequences required for tissue-specific
regulation are present in the 5'-flanking region of
the insulin gene (see above report by D. Hanahan
et al). The mouse pancreata will be excised and
examined throughout pre- and postnatal de-
velopment. Immunohistology to sections of the
pancreata will be used to characterize the expres-
sion of insulin and other hormone products of
the endocrine pancreas. If the sequences that
elicit proper developmental expression of the in-
sulin gene are contained in this recombinant gene,
we would expect to see T antigen expressed in the
same temporal manner as insulin. Various con-
structions of the hybrid gene containing different
pieces of the insulin gene and its flanking regions
should allow us to identify the sequences required
for the developmental regulation of insulin. The
influence of the altered cells on the develop-
ment of the islets of Langerhans will be assessed.
This will provide more information of the bioge-
nesis of the disordered islets found in the trans-
genic mice.
Establishment of (3 Cell Lines from
Transgenic Mice
S Alpert, D. Hanahan
Permanent lines of the 3 cells of the pancreas, as
well as biochemical studies on insulin gene
expression, can provide a useful tool for diabetes
research. Islet-cell cultures have been maintained
for fairly long periods of time in culture (Farkas
and Joo, Diabetes 33: 1165 [1984]), but estab-
lished cell lines do not arise from these cultures.
Rat insulinomas have been used to create insulin-
secreting (3 cell lines. However, these cell lines do
not appear to be glucose-inducible, which is an
important attribute of authentic cells (Gazdar
et al., Proc. Natl. Acad. Sci. 77(6): 3519 [1980]).
The use of a hybrid gene containing a tissue-spe-
cific promoter to regulate an oncogene could be
a tool for expanding different primary cell types
into established cell lines.
As transgenic mice containing the insulin/SV40
T-antigen hybrid gene express T antigen specifi-
cally in the ,8 cells of the pancreas, we plan to
culture the islets of Langerhans in an attempt to
establish authentic glucose-inducible 13 cell lines.
This will involve verification of cultured cell iden-
tity by determining (1) that the endogenous insu-
lin gene is glucose-inducible, (2) that the trans-
gene is glucose-inducible, and (3) that glucagon
and somatostatin are not secreted by the cells.
Further RNA and protein analyses will be per-
formed to quantitate the basal- and glucose-chal-
langed levels of insulin and T antigen.
Bovine Papilloma Virus in
Transgenic Mice
S. Alpert, D. Hanahan
Bovine papilloma virus (BPV) is an 8-kb double-
stranded DNA virus. In the natural host, BPV
induces epithelial or fibroepithelial tumors by
abortively infecting the epidermal germinal cells.
BPV usually remains a free circular molecule, but
it can integrate into the genome in certain cases.
Although there is no in vitro system for virus pro-
duction, C127, an epithelial mouse cell line, can
support BPV replication. This replication re-
quires both cis- and trans-acting factors.
We have injected a BPV plasmid containing a
partial tandem repeat of the BPV genome (BPV
1.69; a gift from D. DiMiao, Yale University) into
mouse embryos. The injections produced two
mice positive for the BPV molecule. Only one
of these mice, containing approximately five cop-
ies of BPV 1.69 integrated into high-molecular-
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weight DNA, survived to adulthood. We have
performed analyses on the offspring of this
mouse, and have observed no episomal BPV mol-
ecules in total DNA preparations, or low-molec-
ular-weight (Hirt) DNA extractions, from 16
mouse tissues. We are now assessing the expres-
sion of the BPV genome in this transgenic mouse
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line, and preliminary results indicate that BPV
transcripts are present in the testes of BPV-posi-
tive mice. We also plan to try to superinject cir-
cular BPV plasmids into this transgenic mouse
line to maintain extrachromosomal BPV mole-
cules by complementation with the integrated
copies.
MOLECULAR GENETICS
Classic genetics experiments conducted at Cold Spring Harbor Laboratory in the
early 1940s on bacteriophage by DelbrOck, Luria, and Hershey and on maize by
McClintock have paved the way for the field of molecular biology. In recent
years, the tools of genetic engineering have allowed the analysis of genes at the
nucleotide level. These tools consist of DNA-mediated transformation, gene clon-
ing by complementation, site-directed DNA mutagenesis, transposon tagging,
and phenotypic analysis of in-vitro-produced mutations. They have been applied
at Cold Spring Harbor Laboratory to dissect the genetic mechanisms, in molecu-
lar terms, of various biological systems. We summarize here the results of the
past year, involving various eukaryotic organisms (the yeast mating types and
cell-cycle genes, maize transposable elements, and somatic-cell genetics of to-
bacco) and the prokaryotic organisms Clostridium sp., Rhodopseudomonas, E.
co/i, and Azotobactor sp.
YEAST GENETICS
A. Klar
J. Hicks
D. Beach
J. Ivy
M. McLeod
G. Livi
R. Booher
J. Gould
S. Kakar
M. Kelly
C.-1.13. Lin
L. Miglio
C. Stevens
Research by the Delbruck Laboratory Yeast
Group during 1984 continued to focus on the
mechanism of mating-type switching and its re-
lationship to the cell-division cycle, but changes
were developing in the profile of the group and
the building. In the Spring, Jeff Strathern and
his family left Cold Spring Harbor Laboratory
for the Frederick Cancer Research Center in
Frederick, Maryland. Jeff was appointed Direc-
tor of Eukaryotic Genetics and is charged with
developing a large research effort on eukaryotic
microorganisms. Our group and the Laboratory
as a whole will miss Jeff scientifically and so-
cially. He was constantly acting as a catalyst for
interdisciplinary discussions and used his broad
background in biology to see the relationships
among seemingly disparate observations. We wish
him well in his challenging new job.
Another development occurred when the plans
for the Plant Group to move to nearby Uplands
Farm were altered and it was realized that a new
addition to Delbruck Laboratory might be re-
quired, similar to that which allowed the Yeast
Group to have permanent quarters in 1982. Plans
have been drawn for a north wing that would pro-
vide laboratory space for the Plant Group to dou-
ble in size while retaining the Uplands Farm land
and buildings as a working field station. The next
step is to develop funding for this planned expan-
sion in addition to the support for Uplands Farm
that was provided by the National Science Foun-
dation last year.
Finally, 1984 was the last full year that the re-
search group studying the the cell-division cycle
of fission yeast occupied the Delbruck Labora-
tory. This group, headed by D. Beach, will move
to the newly renovated quarters in the Demerec
Laboratory in 1985. The growth of this research
program, along with the cell-cycle studies of yeast
oncogenes in M. Wigler's laboratory, will keep
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Cold Spring Harbor Laboratory at the forefront
of efforts to use these simple microorganisms to
uncover the reasons behind the unchecked growth
of human cancer cells.
SUM/: Regulator of the HML and HMR
Loci of Saccharomyces cerevisiae
A. Klar, J. Hicks, S. Kakar, J. Ivy, G. Lim.
0,-I.P. Lin, L. Miglio
In previous years' reports, we have shown that
both MATa and MAT code for two transcripts
divergently transcribed from within the Y region
(Fig. 1), suggesting that their promoters proba-
bly lie within Y. The structure of the silent coun-
terparts of MAT, HML, and HMR is, but for a
few bases, identical to that of the constitutively
expressed MAT locus, yet the HM loci are unex-
pressed. The task of keeping the HM loci unex-
pressed is assigned to at least four trans-acting
MAR/SIR loci and cis-acting E and I sites (see
Fig. 1).
To determine possible interactions between the
MAR/SIR gene functions and to search for new
loci required for regulating the HM loci, we
sought extragenic suppressors of the marl-I mu-
tation. The following selection scheme was used:
The HMLa MATa HMRa marl-1 strain exhibits
a sterile phenotype because of the simultaneous
expression of a and a information. A mutant
that exhibits the a phenotype, and therefore has
repressed the HM loci, was isolated. The muta-
tion is unlinked to MAT, to the HM loci, or to
the known MAR/SIR genes. We designate the
new locus as defined by the mutation as SUM/
(SUpressor of Mar). The mutation sum/4 is al-
lele nonspecific because it also suppresses a marl
deletion mutation. Even more interesting, the
mart (sir3) and sir4 mutations are also sup-
pressed. To account for these data, we suggest
that the MAR/SIR functions negatively regulate
MAR-SIR
REPRESSION
ZI Z2
E W X YO< ZI Z2 I W X Y°A<A,* E X Ya ZI I
HMLoc MATo<
kwot Yo ZI Z2
W X AM
HMRa
MATa
FIGURE 1 Structure of chromosome III showing the mating-type cassettes. The HML and the HMR
copies of the mating-type genes are normally kept silent by the MAR /SIR genes and the cis-acting E
and I sites. Interconversion of MATa and MATa involves a unidirectional transposition-substitution
event from HML or HMR to MAT.
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the SUM1 gene function, which in turn is re-
quired to "turn on" the HM loci by a positive
control. Similarly, we have been successful in
isolating suppressors of the mar2 (sir3) mutation.
Future genetic and molecular studies will allow us
to understand more fully the regulation of the
HM loci.
Analysis of MAR/SIR Gene Clones
J. Ivy, G. Livi, C. Stephens, M. Kelly, J. Hicks, A. Klar
As described in previous Annual Reports, we have
isolated and identified the MAR/SIR genes of S.
cerevisiae from within a cloned genomic library
of DNA fragments by their ability to complement
MAR/SIR mutations in vivo. MAR/SIR mutant
strains, which are normally nonmaters due to
expression of HML and HMR, become mating
proficient when they contain an extrachromo-
somal, independently replicating plasmid bearing
a wild-type MAR/SIR gene. Using the four
MAR/SIR gene clones, we have examined the
possibility of a cascade of regulation among
them. RNA blot analysis, however, has ruled out
a cascade of transcriptional regulation.
One observation that multiple copies of SIR3
will suppress SIR4 mutations has suggested the
possibility that Sir4 combines with Sir3 to alter it
sterically and to enhance its activity. Overprod-
uction of Sir3 in the high-copy-number SIR3
transformants might obviate the need for the
steric enhancement of Sir3 activity. In support of
the idea that Sir4 combines with other SIR gene
products in a dimer or multimer is the observa-
tion that a cloned, truncated SIR4 gene has an
Antimar activity; transformation of wild-type
SIR strains with Antimar results in expression of
the silent cassettes.
We have constructed null mutations in the four
MAR/SIR genes by altering and transplacing
such disruptions into the genome. Null muta-
tions in all four genes are viable, and marl (sir2),
mar2(sir3), and sir4 null mutations have a non-
mating phenotype. Cells with a null mutation in
sirl, however, still retain partial regulation of the
silent cassettes. We conjecture that a regulatory
complex still forms in the absence of Sir I but that
it is not stable.
MAR1(SIR2) and MAR2(SIR3) have been
mapped by standard genetic analysis, taking ad-
vantage of the fact that crosses can be made with
mar-mutant spores if the spores came from a het-
erozygous MAR/mar diploid. The cloned genes
have provided us with an alternate means of map-
ping these loci. By "tagging" the SIRI and SIR4
loci by chromosomal integration of plasmids and
mapping the plasmids' selectable marker, we have
made unnecessary the mapping of mutations that
normally render the strain a nonmater. SIR1 has
been assigned to the tip of the right arm of chro-
mosome XI and SIR4 has been assigned to the
middle of the right arm of chromosome IV;
MAR1 is on the left arm of chromosome IV and
MAR2 is located distal to URA4 on chromosome
XII.
To understand more fully the mechanisms in-
volved in regulating silent mating-type gene
expression, we have begun experiments to iden-
tify and purify each of the MAR/SIR gene prod-
ucts. DNA fragments containing functional se-
quences of SIR], SIR2, and SIR3 have been
subcloned into the open-reading-frame vectors
constructed by M. Berman and colleagues (Wein-
stock et al., Proc. Natl. Acad. Sci. 80: 4432
[1983]), which allow the expression (in Esche-
richia colt) of open-reading-frame DNA as a tri-
hybrid protein containing sequences from the E.
coli proteins ompF and 0-galactosidase. Anti-
sera raised against purified fusion proteins will be
used to purify the yeast MAR/SIR gene products
and to study MAR/SIR protein synthesis, locali-
zation, and DNA-binding properties.
In our screen of the gene bank for sequences
able to suppress MAR/SIR mutations in vivo, we
found one other cloned gene that could do so.
Disruption in this locus is lethal to the cell, indi-
cating that it encodes an essential function. It
suppresses mutation in all four MAR/SIR loci,
but it does not correspond to any of them. Ge-
netic evidence indicates that the suppression of
MAR/SIR mutations is not caused by restoration
of MAR/SIR regulation. Rather, it appears that
regulation of mating functions by MAT is dis-
rupted. Since all transformants have displayed a
weak a mating type, this sequence formally be-
haves as an antagonist of MATa1 function;
hence, our working designation for the locus is
antagonist of al (ANA). We are presently trying
to distinguish between the possibilities that either
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a truncated gene product or the cloned sequences
themselves disrupt regulation of mating func-
tions.
To determine if the E and I sites are able to
regulate expression of genes other than the mat-
ing-type genes, we replaced the mating-type a in-
formation normally found at HMR with the HIS3
gene. We found that in one orientation, E and I
could repress the expression of the HIS3 gene.
These results indicate that promoters other than
the mating-type promoters can come under the
control of E and I.
Behavior of the Double-stranded
DNA Breaks at MAT in
Schizosaccharomyces pombe
A. Klar, D. Beach, L. Miglio
During the past year, we reported three classes of
mutants in fission yeast that are defective in mat-
ing-type switching: (1) those that lacked the abil-
ity to make double-stranded breaks at MAT, (2)
those that had the break but apparently did not
switch, and (3) those that were defective in reso-
lution. The second class is quite paradoxical-
either they switch only homologously or this yeast
can heal the broken ends without obligately
switching. To distinguish between these possibil-
ities, we deleted both MAT2 and MAT3 in Swi -
(switching-deficient mutants) and Swi' strains.
The deletions were made by first cloning a bit
of sequence proximal to MAT2 and a small se-
quence distal to MAT3. Between these se-
quences, a selectable marker (the Saccharomyces
cerevisiae LEU2 gene, which complements the
leul defect of Schizosaccharomyces pombe) was
inserted. The in-vitro-made construct was then
cut out of the vector and transformed into appro-
priate strains by selecting for the Leu+ pheno-
type. As shown in Figure 2, MAT2 and MAT3
were deleted, and a new fusion band of the con-
struct was found. A quite interesting result is that
Swi' strains with the deletion maintain a stable
mating type, still generate the wild-type level of
DNA cut at MAT, and do not exhibit lethality.
The presence of the swi mutation in these strains
has no additional phenotype. Thus, this yeast can
easily heal the broken ends without switching. We
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FIGURE 2 Southern blot analysis demonstrating deletions
of MAT2 and MAT3 loci. smt-s is a cis-acting mutation that
reduces the level of the double-stranded break at MAT. hs°
is a wild-type strain and is shown to contain a double-
stranded break at MAT1 in about 200/0 of its DNA (marked
by SMT, lane G). h-s is a strain that contains a fusion be-
tween MAT2 and MAT3. DNA displayed in B-F, H, and J
show deletions of MAT2 and MAT3.
therefore propose that mutations in the second
class (which comprise three complementation
groups) are defective in using the double-strand
broken ends for switching.
In both S. cerevisiae and S. pombe, we have
shown that double-stranded breaks are highly re-
combinogenic during mitotic growth (see pre-
vious years' reports). Most of the recombination
studies in fungi, however, are conducted in
meiosis. The question arises as to whether the
double-stranded DNA breaks are also recombi-
nogenic in meiosis. To address this question, we
used the MAT2, MAT3 deletion strains of S.
pombe. In these strains, the double-stranded
breaks at MAT cannot be healed by switching be-
cause of the lack of the donor loci. We tested
these breaks to determine whether they can be
used for recombination in meiosis. Tetrad dissec-
tion of appropriate hybrids of these deletion
strains has shown that MAT gives gene conver-
sion of the 3:1 and 1:3 types in about 20% of the
asci, whereas standard wild-type strains hardly
generate such events. If we reduce the amount of
the in-vivo-cut DNA, either by using the appro-
priate swi mutations or by using the cis-acting
speckled mutation, the gene conversion fre-
quency is correspondingly reduced. Thus, the
double-stranded breaks can also promote effi-
cient gene conversion in meiosis. Similar obser-
vations have been made recently in our colla-
borative work with A. Kolodkin and E Stahl
(University of Oregon) in the S. cerevisiae system.
Control of the Mitotic Cell Cycle and
Meiosis in Fission Yeast
D. Beach, M. McLeod, R. Booher, J. Gould
This year's work concentrated on two key genes
of fission yeast, cdc2 and rani. cdc2' is required
for progression through both the G, and G,
phases of the mitotic cell cycle, and rani' inhib-
its the transition from mitotic cell division to
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meiosis. In the absence of ran]', a haploid cell
undergoes premeiotic S phase, partial meiosis,
and sporulation, despite the lack of all the nor-
mal meiotic requirements (e.g., diploidy, hetero-
zygosity at the mating-type locus, and nutritional
starvation).
The cdc2 gene, which is homologous to the
cdc28 gene of S. cerevisiae, is predicted to encode
a protein kinase on the basis of homology with
known mammalian kinases. An intron-less form
of the cdc2 gene has been constructed in an E.
coli expression vector, and a new kinase activity
is currently being sought in bacterial extracts.
In vitro mutagenesis has been used to create
nonphosphorylatable residues at two potential
sites of phosphorylation in the cdc2 protein. One
site (Tyr-166-,-Phe; identified by homology with
the major site of phosphorylation in src and fps)
was mutated with no effect. Mutation of the
h+i h
c.
h rnei2 /h mei2
2c 4c 2c 4c 2c 4c
FIGURE 3 Analysis of propidium-iodide-stained cells on the EPICS cell sorter. Three strains, h-/h-, h./h-,
and h+mei21h-mei2, were starved of a nitrogen source and analyzed at intervals. In h-/h-, cells accumulate in
G,, and in h +/h-, cells accumulate in G, but then undergo premeiotic DNA synthesis. In the mei2 mutant (C),
premeiotic DNA synthesis does not occur.
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FIGURE 4 Sequence homologies between fission yeast rant, cdc2, and bovine cAMP-dependent protein kinase. The region
of homology contains the known site of ATP binding in the mammalian kinase.
neighboring site (Thr-167-+Val; identified by ho-
mology with the major site of phosphorylation in
bovine cAMP-dependent protein kinase) gave a
phenotype of cell-cycle arrest. It is unknown at
present whether Thr-167 is indeed a site of phos-
phorylation in cdc2, but the inability of cells car-
rying a mutation at this site to undergo DNA syn-
thesis raises the interesting possibility that
of cdc2 may be required for cell-
cycle progression.
The EPICS cell sorter (James Laboratory) has
been used to characterize the transition of cells
from the mitotic cell cycle to meiosis (see Fig. 3).
It has been confirmed that initiation of meiosis is
signaled by a round of DNA replication (pre-
meiotic S phase) that does not take place in non-
sporulating cells. We have found that the pre-
meiotic S phase and meiosis I, induced in a
temperature-sensitive rani- strain, do not require
the activity of the cdc2' gene. This feature dis-
tinguishes the premeiotic S phase and meiosis I
from the mitotic S phase and mitotic cell divi-
sion, both of which require cdc2' function. The
rani' gene has been shown to produce a 4.3-kb
RNA transcript. The gene has been partially se-
quenced, and a small region of homology with
the cdc2 gene has been observed (Fig. 4). This
region is particularly significant as it represents
the site of ATP binding in a family of protein kin-
ases. The homology suggests that rani' proba-
bly encodes a protein with ATPase activity.
A mass of genetic evidence suggests that
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meiosis is initiated by turning off the rani' prod-
uct. We have shown that this inhibition does not
occur at the transcriptional level. Future work
will be directed at identifying the rank' protein
product and attempting to understand its bio-
chemical activity.
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PLANT GENETICS
S.L. Dellaporta A.C. Hiatt J. Mclndoo
J.B. Hicks P.S. Chomet J. Wood
R.L. Malmberg
Maize controlling elements have been the subject
of genetic studies for more than 40 years. How-
ever, work on the molecular biology of maize
controlling elements is relatively recent. In a
few short years, several controlling elements, in-
cluding the first controlling element system de-
scribed, Activator-Dissociation (Ac/ Ds), by
McClintock (Cold Spring Harbor Symp. Quant.
Biol. 16: 13[1951]), have been isolated and char-
acterized at the nucleotide level. Several studies
have shown that autonomous controlling ele-
ments, such as Ac, are transposable elements that
share homology with dispersed middle repetitive
DNA sequences. Autonomous elements such as
Ac can transactivate nonautonomous elements
such as Ds that are genetically inactive in the ab-
sence of the autonomous Ac element. There ap-
pear to be two classes of Ds elements: Ds ele-
ments that are structural derivatives of Ac (most
appear to be deletion derivatives) and a family of
Ds elements that shares little homology with Ac
DNA, except for the 11-bp inverted terminal re-
peats characteristic of all Ac/Ds elements. This
type of Ds element has been named Dsl, since it
represents the first Ds element cloned (Peacock et
al., Cold Spring Harbor Symp. Quant. Biol. 49:
347[1984]). Interestingly, the Ds1 element hy-
bridizes to approximately 40 conserved DNA ele-
ments in the maize genome.
Ds1 Element at the waxy Locus
S.L. Dellaporta [in collaboration with S. Wessler,
University of Georgia]
We have isolated another Dsl element which was
found as an insertion in the waxy mutation, wx-
ml, first isolated by McClintock (Carnegie Inst.
Wash. Year Book 47: 155[1948]). This insertion
is approximately 400 bp, contains the expected 11-
bp inverted terminal repeats of Ac/Ds elements,
and is flanked by 8-bp direct repeats. The direct
repeats represent a target-site duplication caused
during integration of Ds.
In the presence of an active Ac element, the wx-
ml allele is somatically and germinally unstable.
This germinal instability reflects the Ac-mediated
excision of Ds1 from the waxy locus. We have
cloned and sequenced several germinal Wx mu-
tations from plants containing an Ac element and
the wx -ml allele. These mutations were selected
for partial, rather than full, restoration of the Wx
phenotype. Sequence analysis showed that these
excision events are not precise, leaving the 8-bp
direct repeats in modified form (Fig. 1). In each
case, however, the modifications represent the
addition of nucleotides in multiples of three. We
predict that the insertion lies within exon se-
quences and that the partial restoration of the Wx
Wx TAR GET SITE
wx-m I
wx-m l(G M1)
wx-m l(G M2)
GCATCACC
GCATCACC tagggatgaaa...Ds...tttcatcccta GCATCACC
G CATCACG GCCATCACC
GCATCACC ATCACC
FIGURE 1 Sequence analysis of the wx-m 1 mutation and germinal mutations to partial Wx activity. Partial sequence is shown
for the insertion termini of the Ds element found in the wx-m/ mutation. The 11-bp inverted terminal repeats (lowercase) are
flanked by 8-bp direct repeats (uppercase). Ac-mediated germinal mutations of the wx-ml allele can be recovered that show
partial Wx activity. Sequence analysis of the excision sites of two partial Wx alleles (GM1 and GM2) are shown. Both mutations
have lost Ds sequences but leave behind the 8-bp direct repeats in modified form. The modifications result in the addition of
nucleotides in multiples of three. This may affect Wx gene action by introducing additional amino acids into the primary
sequence of the Wx protein.
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phenotype is due to the addition of amino acid
residues to the Wx protein. We are presently test-
ing this hypothesis by examining a number of wx-
ml germinal mutations and by cDNA analysis of
the region of the waxy gene near the Ds1 inser-
tion.
Gene Cloning by Transposon Tagging
S.L. Dellaporta [in collaboration with S. Wessler,
University of Georgia, and I. Greenblatt,
University of Connecticut, Storrs]
The autonomous controlling element Ac contains
internal DNA sequences that are present in as few
0 R-nj
mR-nj
YFG
as 8-10 copies per maize genome, even if the plant
does not contain an Ac element. The active Ac
element can be distinguished from these related,
but inactive, sequences by structural features such
as the presence of unique restriction fragments
and the state of DNA methylation (see below).
The presence of relatively few sequences related
to internal Ac DNA and the ability to distinguish
the active form of Ac from the inactive cryptic
Ac -like sequences are criteria that can be used to
clone genes containing Ac insertions.
We have used Ac tagging to clone the R locus ,
of maize. This locus is one of several epistatic
genes involved in the anthocyanin biosynthetic
pathway. Our interest in R stems from previous
genetic analysis of this locus which suggests that
R conditions tissue-specific expression of antho-
+ Ac
\ /
clone Ac -like DNA
specific
probes
Identify Ac
FIGURE 2 Gene cloning strategy using Ac tagging. A functional allele of the R locus is coupled
with an active Ac element by using maize stocks containing reciprocal translocations between a
donor allele (P-vv locus located on chromosome 1) and the recipient locus (R-nj locus located on
chromosome 10). Transposition of Ac from donor to recipient site results in an unstable R-nj pheno-
type that shows the genetic characteristics of Ac-induced mutations. (1) The mutation shows a
characteristic dosage effect; with increasing copies of Ac-induced mutation, the apparent frequency
and developmental timing of somatic and germinal mutation is delayed; (2) the Ac-induced mutation
is capable of mediating Ds transposition in trans. Once an Ac-induced R mutation is genetically
identified, recombinant clones are isolated from genomic libraries with low-copy internal Ac DNA
probes. The recombinant clone containing the R allele is identified by screening recombinants for
the canonical Ac sequences by restriction site analysis. DNA flanking the Ac element is used as an
R-specific probe to isolate a functional R allele.
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cyanin in both seed and plant organs. The locus
can be fractionated by meiotic recombination into
distinct seed and plant components, suggesting
that these regions may represent tandem dis-
placements of homologous sequences with di-
vergent function. Hence, the availability of a
molecular probe to R DNA may prove to be a
valuable tool to examine the tissue-specific com-
ponents and regulation of gene expression in de-
veloping plant tissues.
Because the product(s) of the R locus is un-
known and may be expressed in trace amounts in
plant tissues, conventional cloning by immuno-
logical cDNA screening seemed inappropriate.
Therefore, we used the strategy outlined in Figure
2 to clone the R locus. This strategy requires an
insertion of the Ac element at the R locus. This
event was dictated by (1) the transposition pat-
terns of an Ac element, (2) the availability of the
target site to Ac insertion, and (3) the ability to
identify an Ac- induced mutation at the R locus.
Previous studies demonstrated that the majority
of Ac transpositions from the P locus on chro-
mosome 1 are intrachromosomal events that ex-
hibit a preference for short-range distal events. I.
Greenblatt (unpubl.) obtained an Ac insertion at
R by using strains carrying a reciprocal translo-
cation involving breakpoints proximal to the long
arm of chromosome 10 (containing the R locus)
and distal to the P locus on chromosome 1 (con-
taining an Ac- induced unstable P mutation).
Several putative transpositions of Ac from the
P locus to the R locus were obtained. An au-
tonomous unstable allele of R was genetically
characterized as Ac- induced by the ability of the
element located at R to transactivate the standard
Ds element located on chromosome 9. This mu-
tation also exhibited a dosage pattern character-
istic of Ac- induced mutations.
Several recombinant clones were isolated from
genomic libraries, constructed with DNA from
plants homozygous for the Ac-induced mutable
R mutation, and screened with a low-copy inter-
nal Ac probe. One recombinant contained a can-
onical Ac element as judged from restriction en-
zyme analysis. DNA flanking the Ac element was
determined to be R-specific on the basis of a
structural comparison of various transposon-in-
duced R mutations and their respective rever-
tants. We are now in the process of determining
the structure and are cloning the tissue-specific
components of the standard R locus.
Active and Inactive Ac Elements
P.S. Chomet, S.L. Dellaporta
Changes in phase refers to the ability of an Ac
element to cycle from an active state to an inac-
tive state. In the active state, the Ac element is
capable of transposition and transactivation of Ds
elements (Fig. 3). This ability is thought to be
due to the production of an unidentified transpos-
ase referred to as the mutator component of Ac.
Ac can cycle from an active phase to an inactive
phase where no mutator function is genetically
detectable. We examined an Ac element at the
waxy locus, isolated by McClintock (Carnegie
Inst. Wash. Year Book 63: 59211964]), in both the
active and inactive phases. The active and inac-
tive Ac elements were identical in both size and
position at the waxy locus. However, the Ac in
the inactive phase has undergone DNA modifi-
cation. This modification was detected with re-
striction enzymes sensitive to 5-methylcytosine.
The modified Ac DNA was found in much re-
duced amounts during the active phase at waxy.
Examination of a number of active Ac elements
at other loci shows that extensive modification
was specific for the inactive phase of Ac.
Tz Elements of Maize
S.L. Dellaporta, P.S. Chomet, J.B. Hicks [in collaboration
with J. Mottinger, University of Rhode Island]
Last year, we described the molecular character-
ization of several unstable mutations at the
shrunken locus in maize. These mutations were
selected in maize lines descendant from plants
systemically infected with barley stripe mosaic vi-
rus (BSMV). BSMV infection in maize was as-
sociated with high rates of genetic instability, in-
cluding spontaneous mutations. Three shrunken
mutations were caused by insertion elements that
are structurally unrelated. The insertion sites and
elements are shown in Figure 4.
Genomic clones of the mutant sh-5586 allele
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FIGURE 3 Changes in phase of Ac activity at the waxy locus. An Ac element insertion at the
waxy locus [(Ac)wx-m7] has been identified by McClintock (Carnegie Inst. Wash. Year Book 62:
486[1964]) and shown to undergo changes in phase of activity. The cycling activity of Ac can
be seen in kernels A-C. Each kernel has an endosperm genotype: al- m3 /al -m3 /al wxlwxl
(Ac)wx-m7. In kernel A, the Ac at waxy remained active throughout endosperm development.
The activity 'of Ac can be monitored by the instability of Ds at the al-m3 mutation. In the pres-
ence of an active Ac element, the Ds at al-m3 is somatically unstable, giving the kernel a
variegated colored phenotype. When the Ac cycles from active to inactive, the Ds at al-m3 is
stable, inhibiting At gene action. This can be seen as a colorless sector in kernel B. Kernel C
represents an allele of (Ac)wx-m7 that is both somatically and germinally inactive. This kernel
shows no Ac activity and is fully colorless. Molecular analyses (see text) of Ac at wx-m7 indicate
that DNA modification of Ac DNA occurs in the inactive phase. This modification is detectable
with restriction enzymes that are sensitive to 5-methylcytosine.
containing the Tz86 element were characterized
by restriction mapping, genomic blot analysis,
and M13 dideoxy-sequencing. We have shown
that Tz86 is a 3.6-kb element flanked by 10-bp
direct repeats. This 10-bp sequence was found
once in the progenitor Sh allele, indicating that
Tz86 causes a 10-bp duplication of target Sh DNA
upon insertion. Unlike other maize transposable
elements, Tz86 does not contain terminal in-
verted or direct repeats. When subclones of Tz86
B E
I I
5 2Kb
Tz84 Bc B2 H3
I I I
2 0 Kb
Tz82
were hybridized to genomic blots of maize DNA,
we found that Tz86 DNA represents dispersed
middle repetitive DNA. Internal subclones of
Tz86 hybridize to relatively fewer copies, perhaps
10 fragments or less, depending on the strain ex-
amined. This situation is similar to that in other
maize controlling elements and suggests that viral
infection may destabilize these components in the
maize genome and contribute to high rates of ge-
netic instability. Moreover, Tz86 continues to
; 7 T3
K X H3
I I t
3.6 Kb
Tz 86
Illy AllObi r AlEr AMIE
Mexon 0 intron
FIGURE 4 Relative position of the Tz insertion element at the shrunken-1 locus. (The intron/exon
borders of the Sh gene have been previously determined by W. Werr et al., pers. comm.) We position
several insertion elements at Sh by restriction mapping and dideoxy-sequence analysis of mutant sh
alleles (sh-5582, sh-5584, sh-5586) recovered from virus-infected progeny (see text). The size of
Tz84 is a minimum value and has not been precisely determined. On the basis of restriction mapping
and hybridization analysis, we find no significant homology among these elements. Yet each element
hybridizes to multiple genomic sequences of maize DNA.
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show germinal instability in advanced progeny.
This instability often restores the Sh phenotype
(plump kernels) and is usually accompanied by
excision of Tz86 from the shrunken locus. Se-
quence analysis of one such event showed a res-
toration of the DNA sequence of the progenitor
Sh DNA, except for a single-base substitution in
the 10-bp target sequence.
Cell and Developmental Genetics
of Tobacco
A.0 Hiatt, R.L. Malmberg, J. Mclndoo
For the past few years, we have been studying the
polyamine synthesis pathway in tobacco. Our
approach was to focus on genetics: the isolation
of mutants that are in some manner altered in the
pathway. As documented in the 1982 and 1983
Annual Reports, we have developed successful
mutagenesis and selection protocols. These make
use of some powerful features of the tobacco so-
matic-cell system and some useful features of the
polyamine pathway. Tobacco is relatively easy to
manipulate in somatic-cell culture and can be
subsequently regenerated into a whole plant for
developmental and genetic analyses. The poly-
amine pathway has been intensively studied bio-
chemically in mammalian systems, and there exist
specific inhibitors for four of the six enzymes in
the pathway. Figure 5 shows a simplified dia-
gram of the pathway and the inhibitors. Our re-
search during the past year has been concerned
with the molecular and biochemical characteriza-
tion of the mutants we have isolated previously
and with the developmental genetics of the regen-
erated mutant plants.
DEVELOPMENTAL REGULATION OF ORNITHINE
AND ARGININE DECARBOXYLASES
One interesting feature of the pathway is that
tobacco synthesizes putrescine in two ways: via
ornithine decarboxylase (OrnDC) or arginine de-
carboxylase (ArgDC). We have analyzed the dis-
tribution of these two enzymes in different tissues
of the whole plant and in cell cultures. The re-
sults, shown in Figure 6, reveal that OrnDC is
preferentially found in flowers and in cell cul-
Putrescine
Saim2 DC, C) M6B6
SpSyn 10 DCHA
Spermidine
Spermine
Mgr3301
FIGURE 5 Polyamine synthesis pathway. Abbreviations: (OrnDC) ornithine decar-
boxylase; (ArgDC) arginine decarboxylase; (SamDC) S-adenosylmethionine decar-
boxylase; (DFMO) difluoromethylornithine; (DFMA) difluoromethylarginine; (MGBG)
methylglyoxal-bis(guanyihydrazone).
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ENZYME SPECIFIC ACTIVITIES
RATIO OF OrnDC TO ArgDC
flowers 1,81
floral buds 1,75
shoots 0.04
roots 0.04
cell cultures 1.70
FIGURE 6 Developmental regulation of OrnDC and ArgDC in tobacco.
tures but not in leaves, stems, or roots. ArgDC is
found in all tissues. Two independently isolated
mutants (ts4 and Dfrl) each have near-zero levels
of OrnDC in cell cultures. These two mutants re-
generate into very similar plants (dwarf, small
leaves), and they have not flowered under normal
growth conditions. This suggests that OrnDC is
not only a flower-specific enzyme but may ac-
tually be required for flowering. We also exam-
ined the effects of the inhibitors of these enzymes
on cell cultures. DFMO inhibits the growth of
cultures after a delay of several generations, but
DFMA does not. Thus, even though both en-
zymes are found in culture, OrnDC is required,
but ArgDC is normally not.
We have used the known tissue distribution of
OrnDC (and the existence of two mutants with
low levels of OrnDC) as an aid to molecular clon-
ing of the gene encoding the enzyme. L. Mc-
Conlogue and P. Coffino (University of Califor-
nia, San Francisco) have previously obtained
cDNA clones for the mouse OrnDC. We have
used their clone as a probe against RNA isolated
from different tissues of the plant and against
RNA from wild-type and mutant cell cultures.
When washed at moderate stringency, the mouse
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OrnDC hybridized in a pattern identical to that
predicted by the distribution of the enzyme activ-
ities. This suggested that developmental regula-
tion was occurring at a pretranslational level and
that we could use the mouse OrnDC cDNA as an
interkingdom probe to isolate the tobacco gene.
With this strategy, we have found two tobacco
genomic clones that hybridize to the mouse probe
and to tobacco RNA in the pattern predicted by
measurements of enzyme activity. We are cur-
rently in the process of sequencing the tobacco
genomic clones for OrnDC.
EFFECTS OF MGBG ON ENZYME TURNOVER
We had previously found that wild-type cells
grown on sublethal levels of MGBG overprod-
uced a polypeptide of about 35,000 daltons. To
examine this increase in abundance, we carried
out a series of protein-labeling experiments, with
and without MGBG. These experiments demon-
strated that the increase in abundance of the 35-
kD polypeptide was due not to new synthesis but
to an accumulation of the previously made poly-
peptide. Apparently, the MGBG was stabilizing
the polypeptide. This mode of regulation sug-
gested that the polypeptide was in fact S-adeno-
sylmethionine decarboxylase (SamDC), since a
similar phenomenon has been noted in mammal-
ian cells. To prove this with tobacco, we partially
purified SamDC via standard biochemical tech-
niques to an approximate 4000-fold increase in
specific activity. Although this was not abso-
lutely pure, the predominant band on an SDS gel
was 35 kD, making it likely that the originally ob-
served band was SamDC.
As a further confirmation of the effect of
MGBG on SamDC turnover, we measured en-
zyme specific activities for OrnDC, SamDC, and
ArgDC, following the addition of cycloheximide
to the tobacco cultures. This allowed us to esti-
mate values for the half lives of the enzymes after
shutting down protein synthesis in normal media:
OrnDC, 2 hours; ArgDC, 5.5 hours; SamDC
(normal media), 0.7 hours; and SamDC (plus
MGBG), 9 hours. When the cells were grown in
the presence of MGBG, the half-life of SamDC
increased from 0.7 hours to 9 hours. Thus, all of
our evidence is consistent with a model of SamDC
being a 35-kD polypeptide that is stabilized by the
presence of its inhibitor MGBG.
WHOLE-PLANT PHENOTYPES OF POLYAMINE
SYNTHESIS MUTANTS
Our current mutant collection includes a temper-
ature-sensitive cell line (ts4), its revertant (Rtl), a
DFMO-resistant line (Dfr1), 32 MGBG-resistant
lines (Mgrl through Mgr32), and some DCHA-
resistant lines (Dcr). In cell culture, we are at-
tempting to characterize polyamine synthesis in
these lines systematically to determine the nature
of the lesions in each case. When these mutants
were regenerated into whole plants, they provided
an astonishing array of phenotypes, particularly
including developmental switches in the flower.
A summary of the observed phenotypes is given
in Table 1.
The whole-plant phenotypes naturally fall into
four groups. Class I plants do not regenerate well
but maintain a coral-like morphology on regen-
eration medium. Class II includes the two lines
deficient in OrnDC; these are dwarf plants and
do not flower. Class III plants are also dwarf, but
they do flower with a phenotype we call puzzle
box. These flowers have sepals, petals, and sta-
men that appear normal; however, the carpel is a
TABLE 1 Whole-plant Phenotypes of Polyamine Synthesis Variants
Strain
Very Petal
Coral-like dwarf sepal
Extra Petal Stigma
petal anther anther
Stamen Puzzle
ovule box
Class I
Mgr5 -RO
Mgr6 -RO
Mgr23 -RO
Class II
Dfr1-R0
ts4-RO
Class III
Mgr15-R0
Mgr21-R0
Class IV
Mgr25 -RO
Rt1-R0
Mgr3 -RO
Mgr3-F1
Mgr31-R0
Mgr9-R0
Mgr12-R0
Mgr12-F1
Mgr1-R0
Mgr27 -RO
X
RO indicates plants regenerated from culture, and Fl indicates progeny from a cross of an RO plant to wild type.
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hollow cylinder that does not appear to have
fused properly during development. Inside the
hollow carpel is a second, and sometimes a third,
row of stamen. Apparently, these mutants can-
not finish carpel development correctly and thus
repeat the previous stage of stamen.
Class IV phenotypes represent a range of de-
velopmental switches, including stamenoid
ovules, stigmoid anthers, petaloid anthers, extra-
petals, petaloid sepals, and simple sterilities.
There is overlap within this group; e.g., one plant
may have petaloid anthers, another may have
stigmoid anthers, and yet another may have both
phenotypes, as well as others. Thus, the class IV
phenotypes mutually overlap in a way that sug-
gests they are related. The sterilities generated
have hampered sexual crossing and conventional
genetic analysis. However, in two cases, Mgr3
and Mgr12, we have generated a small F, popu-
lation from crosses to wild type. In these cases,
the polyamine phenotype and the abnormal
flower cosegregate as nuclear dominant muta-
tions.
The possible role of polyamines in altering the
expression of floral meristems is indicated by the
fact that all of the polyamine mutants that do
flower have some sort of abnormal flower. Var-
ious artifacts are possible: double mutants, cell-
culture-induced variation, and nongenetic regen-
eration abnormalities. Thus, the most critical ex-
periments to be performed in the future will in-
volve further meiotic genetic analysis of the
mutants to test the nature of the suggested link-
age between polyamine synthesis and floral de-
velopment.
SITE-SPECIFIC MUTAGENESIS
M. Zoller K. Johnson
R. Kostriken
DNA/Protein Interactions: Recognition
and Cleavage of MATa DNA by
HO Endonuclease
M. Zoller, K. Johnson, R. Kostriken
Our research is aimed at the problem of how a
protein recognizes a specific sequence of DNA.
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FLORAL MONOCLONAL ANTIBODIES
Our mutant collection should allow us to dissect
floral development genetically, regardless of the
physiological connection to the polyamine syn-
thesis pathway. As an aid to analysis of the ab-
normal structures seen in the mutant flowers,
we are making monoclonal antibodies against flo-
ral antigens, in collaboration with S. Hockfield
(Neurobiology Section). The strategy is the fa-
miliar one of immunizing mice with floral ex-
tract, and then screening the resulting hybrido-
mas against extracts from individual parts of the
flower. In our initial experiment, we were able to
find an antibody that recognizes sepal and petal
extracts, but not other tissues; we also found two
antibodies that reacted with only carpel extracts.
We are currently using these antibodies to optim-
ize histoimmunological techniques with sections
of tobacco flowers.
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Much has been learned from the study of prokar-
yotic proteins such as the K repressor and EcoRI
endonuclease. The interaction between a eukar-
yotic protein and a specific sequence of DNA has
yet to be defined to the same extent. Toward this
goal, we are investigating the manner in which the
HO endonuclease from the yeast Saccharomyces
cerevisiae binds to and cleaves MAT DNA. HO
endonuclease is one of a number of elements re-
quired for mating-type switching in S. cerevisiae.
A model has been proposed in which the forma-
tion of a specific double-strand break in the chro-
mosome at MAT is an initiating event in the
process. The formation of this break is thought
to be catalyzed by HO endonuclease. R. Kostri-
ken and F. Heffron (Research Institute of Scripps
Clinic) demonstrated that HO endonuclease
cleaved MAT DNA in vitro. Through biochemi-
cal as well as genetic experiments, the specific site
of the HO cut has been localized.
The biochemical events involved in HO-de-
pendent DNA transposition are not fully under-
stood. The problem is being approached from
two directions. (1) What are the determinants
within the HO cut site that are important for rec-
ognition and cleavage? (2) What are the specific
amino acid residues within HO endonuclease that
are responsible for recognition and cleavage?
MUTATIONS IN MATa THAT AFFECT HO
CLEAVAGE IN VITRO
Since genetic approaches yielded only two point
mutations within the HO cut site that affected
switching and cutting, we used oligonucleotide-
directed mutagenesis to saturate this region with
single base changes. The ability of each mutant
to serve as a substrate for HO endonuclease was
assessed in vitro using a yeast extract from an HO
strain and an Escherichia coli extract from a
strain engineered to express the HO-gene product
(see below). Qualitatively, both the yeast- and the
E. coli- produced enzymes cleaved the mutants in
a similar manner. Figure 1 shows the analysis of
all 17 mutant substrates after incubation with HO
endonuclease produced in E. coll. The mutant
substrates can be grouped into three categories on
the basis of the rate with which each is cleaved
compared with wild type. Four mutations com-
pleted inhibited cleavage, nine mutations resulted
in a reduced rate of cleavage, and the remaining
four mutations had no effect on the rate of cleav-
age as compared with wild type. These data re-
veal that the core of the recognition sequence is
CGCNNC, since alteration of any one of the four
bases completely inhibited cleavage. Further-
more, the sequence TTTCCGCAACAGT repre-
sents the region in close contact with the enzyme,
volZ1
WWCT TTCCGCAACAIGTAAAATMT TGA AAGGCGITTGTCATITT A
_uncut
-11.5 kb
- 3.4 kb
FIGURE 1 Agarose gel analysis of MAT substrates cleaved
in vitro with HO endonuclease expressed in E. coli. (1) DNA
cleaved with Hindlll for markers; (2,3) BamHI-cleaved wild-
type MATa DNA without and with HO endonuclease, re-
spectively; (4-22) mutant MATa substrates cleaved with HO
endonuclease. The corresponding wild-type MATa se-
quence is shown above each lane.
since alteration of noncore positions in this re-
gion affected the rate of cleavage. It is signifi-
cant to note that the extent of the contact region
spans the so-called Y/Z boundary into the allele-
specific Ya region. Does the enzyme recognize
MATa in the same manner? A parallel set of mu-
tations have not been made in MATa to answer
this question. However, inspection of the allele-
specific DNA sequences of MATa and MARX in
the region of the Y/Z boundary revealed the same
sequence (CTT) at positions - 5, - 4, and -3
(with respect to the Y/Z boundary). As shown in
Figure 1 only the mutations at -4 and -3 af-
fected cleavage.
Future studies will assess the effect of each
point mutation on the frequency of mating-type
switching in vivo. Currently, we are integrating
each of the mutant MATa substrates into the
chromosome, thereby replacing the wild-type
MATa sequences. We predict that the frequency
of switching will correlate with the efficiency of
cleavage in vitro.
CHARACTERIZATION OF THE HO ENDONUCLEASE
The concentration of HO endonuclease in yeast
is too low to serve as a source for purified pro-
tein. Therefore, we have engineered the HO gene
to be expressed in E. coll. The gene was placed
under the isopropyl-O-D-thiogalactoside (IPTG)-
inducible lac operator/trp promoter of the vector
pKK233-2 (courtesy of J. Brosius, Columbia Uni-
versity). This construction yielded approxi-
mately 50-100 times higher expression per gram
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of wet cells compared with yeast. Expression
from this vector was 5 times better than that of
an earlier plasmid utilizing the XP, promoter.
Currently, we are purifying HO endonuclease.
Future experiments will involve (1) determination
of native stoichiometry and molecular size and
shape, (2) alkylation protection studies using the
wild-type and mutant recognition sequences, (3)
quantitative binding studies with mutant sub-
strates, (4) investigation of domains by limited
proteolysis, and (5) active-site affinity labeling
using synthetic recognition sequences.
Oligonucleotide-directed Mutagenesis
M. Zoller
In vitro mutagenesis of cloned DNA has become
a standard tool in the functional analysis of
nucleic acids and proteins. A number of ap-
proaches exist that can be broadly grouped into
random and site-directed methods. The reper-
toire of procedures to mutagenize a fragment of
DNA randomly continues to grow each year.
These random techniques are used to identify the
location and boundaries of a particular function.
Once an important region has been identified,
site-directed mutagenesis can be employed to de-
termine the role of specific nucleotides (or amino
acids). The construction of cloned DNA bearing
a specific alteration is best accomplished by either
gene synthesis or oligonucleotide-directed muta-
genesis.
The availability of reliable procedures for man-
ual oligonucleotide synthesis, along with an in-
creasing access to DNA synthesizers, has made
gene synthesis a reasonable method to produce
specific mutations. The gene is constructed using
segments of oligonucleotides that are ligated to-
gether, and thus an entire gene can be synthesized
that contains a desired change. In addition, a
simple construct can be produced that allows for
the replacement of segments by a number of mu-
tated "oligonucleotide cartridges" positioned be-
tween restriction endonuclease sites.
Oligonucleotide-directed mutagenesis is similar
in principle to mutagenesis by gene synthesis in
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that an oligonucleotide that bears the desired
mutant sequence is inserted into a cloned gene.
However, oligonucleotide-directed mutagenesis
differs from gene synthesis in the manner in which
the cloning is accomplished. In this case, an oli-
gonucleotide consisting of the mutant sequence is
hybridized to its complementary sequence in a
clone of wild-type DNA, thereby forming a mu-
tant-wild-type heteroduplex. The oligonucleo-
tide serves as a primer for in vitro enzymatic DNA
synthesis of regions that are to remain genotypi-
cally wild type. A double-stranded heteroduplex
is formed, which is subsequently segregated in
vivo into separate mutant and wild-type clones.
The two can be distinguished by a number of
screening procedures.
The basic strategy of oligonucleotide-directed
mutagenesis was developed using the single-
stranded phage OX174. The technique has been
successfully applied to genes cloned into either
plasmid or phage vectors. Previously, I developed
an efficient procedure for oligonucleotide-di-
rected mutagenesis using M13-derived vectors.
The major features of this method were the use
of single-stranded clone DNA as template, the
purification of in-vitro-synthesized covalently
closed, circular DNA by alkaline sucrose gradient
centrifugation, and the use of the mutagenic oli-
gonucleotide to screen for mutants by hybridiza-
tion.
I have developed a variation of the original
method that is simpler, faster, and of equal effi-
ciency (Zoller and Smith, DNA 3: 479 [1984]). It
is based on the use of two primers, one of which
is the mutagenic oligonucleotide and the other is
a standard sequencing primer (see Fig. 2). Both
primers are simultaneously annealed to single-
stranded template DNA, extended by DNA poly-
merase I (large fragment), and ligated together to
form a mutant/wild-type gapped heteroduplex.
E. coli is transformed directly with this DNA.
Mutants are identified by plaque-lift hybridiza-
tion using the mutagenic oligonucleotide as a
probe. The same procedure can be used without
modification to create site-specific insertions as
well as deletions. This method obviates the need
to isolate covalently closed, circular DNA to ob-
tain mutants in high yield and retains the conven-
ience of the M13 system for template isolation,
sequencing, and screening.
HO Sequencing
P Mutagenic
Oligonucleotide
Anneal
(55 °C /5 mint
OH
Extend / Ligase (15°C/6-I2 hrs)
Klenow, DNA Ligase
dNTPs, rATP
Transform
E coli
Screen plaques
for mutants
FIGURE 2 Scheme for oligonucleotide-directed mutage-
nesis using two primers and a single-stranded template.
DNA Synthesis Facility
M. Zoller
Synthetic oligonucleotides have expanded the
ability of the molecular biologist to produce
cloned DNA with a precisely defined sequence.
Applications include the construction of point
mutations in a gene, custom-designed linkers, and
the precise fusion of promoter and coding se-
quences. In addition, oligonucleotides have been
to used to detect a specific gene within a library.
Although procedures exist for the manual synthe-
sis of oligonucleotides, the operations have been
automated, thereby freeing the scientist for more
important problems. In December of 1983, I be-
gan operating an Applied Biosystems DNA Syn-
thesizer, which initially served my laboratory
primarily. However, during 1984, about 300
oligonucleotides were synthesized for more than
30 individual scientists at the Laboratory. Oli-
gonucleotides were produced at about one-tenth
the cost charged by commercial sources and were
obtained much faster, usually within 1 week. In-
itially, the machine synthesized only a single oli-
gomer at a time; however, the capability was ex-
panded so that three separate oligonucleotides
could be synthesized at once. This has decreased
the waiting time for an individual oligonucleotide
and has made usage of solvents more efficient.
The chemistry of the Applied Biosystems DNA
Synthesizer is the solid-phase phosphite triester
method based on procedures developed by M.
Caruthers (University of Colorado). Currently,
the scale is 1 /mole of starting material and syn-
thesis proceeds at 20 minutes per cycle; oligo-
mers as long as 100 bases have been successfully
produced on this machine. In the future, a 0.1-
Amo le scale synthesis will be offered in conjunc-
tion with a 6-minute cycle, which will result in
faster syntheses and a 50% reduction in the cost
per oligonucleotide. The small-scale synthesis
will be especially useful for producing short oli-
gonucleotides for sequencing projects. We have
found that the efficiency of synthesis is high
enough that the crude (nonpurified) sample can
be used as a primer for M13 dideoxy sequencing
experiments. In addition to the small-scale syn-
thesis, a 10-Amo le scale synthesis is available for
producing oligonucleotides to be used for struc-
tural experiments on nucleic acids.
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Molecular Genetics of Cytochrome c2
of Rhodopseudomonas capsulate
F. Daldal, J. Applebaum, S. Cheng.
Cytochrome c2 is an electron carrier common to
the photosynthetic and respiratory machinery of
Rhodopseudomonas capsulata. It is structurally
homologous and functionally analogous to the
cytochrome c of mitochrondria and to the plas-
tocyanin of chloroplasts. During photosynthesis,
c2 is the primary electron donor to the reaction
center, and during respiration, it is an important
component of the c-type cytochrome-containing
respiratory chain. This implies that c2, an evolu-
tionarily well-conserved heme-containing pro-
tein, must be evolved in such a way that, when
required, it can interact with the components of
the reaction center, of the ubiquinol:cytochrome
c2 oxidoreductase (bc, complex), and of the cyto-
chrome oxidase. Even though cytochrome c2 of
photosynthetic bacteria has been well studied
biochemically, biophysically, and immunological-
ly, genetic data are still scarce. Until recently, no
mutant deficient solely in cytochrome c2 was
available, and schemes devised to select c,- mu-
tants often yielded pleiotropic mutants devoid of
all known c-type cytochromes. Therefore, the in
vivo role of c2 on photosynthesis has remained
untested.
To isolate a c2- structural mutant, we have
taken a "reverse genetic" approach. First, the c2
structural gene of R. capsulata was cloned by us-
ing synthetic mixed oligonucleotide probes and
then its nucleotide sequence was determined. The
deduced amino acid sequence was found to be in
perfect agreement with the known amino acid se-
quence obtained from the purified c2 protein.
Moreover, the nucleotide sequence of the amino-
terminal part of the c2 gene indicated the presence
of a 21-amino-acid "signal sequence." Therefore,
in agreement with its known periplasmic loca-
tion, the c2 protein is synthesized in the cyto-
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plasm as a precursor and is then processed during
its secretion to the periplasm.
Using the cloned gene, we constructed in vitro
c2 genes containing insertion and insertion-dele-
tion mutations, and we used these to replace the
chromosomal wild-type allele by genetic crosses
mediated by the "gene-transfer agents" (defective
phage-like particles specific to R. capsulata).
This led us to the isolation of the first known c2
structural mutants of a photosynthetic bacte-
rium. In these mutants, the absence of the c2 gene
was confirmed by Southern analysis using either
the cloned c2 gene or the inserted kanamycin
marker as probes. Furthermore, the absence of
the c2 gene product was proved by immunoprecip-
itation using polyclonal antibodies raised against
the purified c2 protein, by c-type cytochrome
staining of SDS-polyacrylamide gels of total cell
extracts, and by reduced oxidized spectrum anal-
ysis.
c2- mutants are stable and can grow well by
photosynthesis and by cytochrome-c-dependent
respiration. Considering the fact that during pho-
tosynthesis, cytochrome c2 is the primary electron
donor to the reaction center, these mutants show
that in the absence of c2, R. capsulate may have
alternative ways unknown until now to reduce the
oxidized photosynthetic reaction center. To un-
derstand this interesting observation, several hy-
potheses, such as the presence of other cyto-
chromes functionally analogous to c2 or the
nonessentiality of a mobile carrier in photosyn-
thesis, are currently under investigation.
Clostridium pasteurianum
Galactokinase
F Daldal, J. Applebaum
Until now, no gene from a bacterium like Clostri-
dium pasteurianum, which has a very high A + T
content (70%), has been isolated. To study the
structure of a clostridial gene, to assess the pos-
sibility of its expression in other hosts, and even-
tually to use it as a genetic tool, we have cloned
the C. pasteurianum galactokinase by comple-
mentation of an Escherichia coli mutant deficient
in galactokinase. Restriction enzyme analysis,
subcloning, and Tn5 mutagenesis indicated that
the gene was located on a 1.8-kb Clal-Sau3A
fragment that encoded a polypeptide with an ap-
parent molecular weight of approximately 40,000.
Although they have similar subunit molecular
weights, Southern hybridization analysis indi-
cated no strong homology between the C. pasteu-
rianum and the E. coli galactokinases. In E. coli,
the Gal' phenotype provided by this clostridial
galactokinase was found to be unstable, and we
have shown that spontaneous Gal- derivatives
were originated by insertion sequences (IS/ and
IS5) inactivating the clostridial galactokinase.
Even though this clone was able to complement a
galK mutant of E. coli, it expressed the clostridial
galactokinase at a low level in this host. Using as
a probe a DNA fragment internal to the clostri-
dial galactokinase, we isolated by hybridization
another clone carrying (presumably) the wild-type
gene. This latter clone was not able to grow on
galactose-containing media due to the overprod-
uction of the clostridial galactokinase and the
concomitant inhibition of the E. coli host by
"galactosemia."
Comparison of these two plasmids producing
low and high amounts of galactokinase revealed
that the low-level producer carries a deletion of
approximately 300 by located in the 5'-proximal
part of the gene. Operon fusions constructed be-
tween this region where the deletion is localized
and a promoterless E. coli galactokinase gene in-
dicated that these clostridial DNA sequences have
promoter activity in E. coli and that the over-
expression of the clostridia] galactokinase is at
least partly transcriptional in this latter clone.
The nucleotide sequences of the 5'-proximal
part of the galactokinase gene from several clones
producing high, low, or undetectable amounts of
galactokinase were determined. Their compari-
son revealed that the clone producing high
amounts of galactokinase has clostridial nucleo-
tide sequences very homologous to the E. coli
consensus promoter sequences. The role of these
sequences in Clostridium is not yet known, but
fusion studies demonstrated that they mediate the
expression of the clostridial galactokinase in E.
coli. Therefore, considering that the transcrip-
tion of a gene is an important barrier in hetero-
logous expression systems, the A + T richness of
the clostridial genome appears to be a lucky situ-
ation when the chosen host is E. coll. This work
shows that the complementation of E. coli mu-
tants by the clostridial genes is feasible and is a
good way to isolate clostridial genes whenever ap-
propriate mutants are available. It remains to be
seen whether the C. pasteurianum galactokinase
gene will turn out to be a useful genetic marker
for the study, by gene fusions, of the structure
and the regulation of other clostridial genes in
Clostridium using the recently developed trans-
formation technique.
Finally, the cloning and characterization of the
C. pasteurianum galactokinase indicate that in
this organism, galactose is used through the "Le-
Loir pathway" via galactose-l-phosphate.
Characterization of MT113, a Ps-
Mutant of R. capsulata That
Lacks a Functional bc, Complex
and c-type Cytochromes
E. Davidson, F. Daldal
MT113, a nonphotosynthetic mutant of Rhodo-
pseudomonas capsulata, not mapping in the
known cluster of photosynthetic-machinery-re-
lated genes, was isolated previously by Marrs et
al. (FEBS Lett. 113: 289 [1980]) and was shown
by spectroscopic analysis to lack cytochrome c2.
However, with the later establishment that cyto-
chrome c,, a component of the bc, complex, also
absorbs at the same wavelength (550 nm) as c2, it
became clear that MT113 also lacks cytochrome
c,. Therefore, we decided to ascertain, in collab-
oration with R. Prince and B. Marrs (Exxon Re-
search and Engineering Co.), whether other com-
ponents of the bc, complex were also missing in
this mutant.
Electron paramagnetic resonance (EPR) spec-
troscopy indicated that membranes derived from
MT113 contained the Rieske Fe-S center at a much
lower amount (< 10%) than the wild-type mem-
branes. This lack of the Rieske Fe-S center can-
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not be attributed to a general defect in the syn-
thesis of Fe-S clusters, since the same mutant
contains an almost normal amount of total Fe-S
clusters. Similarly, on the basis of EPR spectro-
scopy, an antimycin-sensitive signal characteristic
of the anionic semiquinone Qc - was not detecta-
ble in MT113 membranes. Absorption spectros-
copy showed that, even though an almost normal
amount of b-type cytochromes was present in this
mutant, the antimycin-induced red shift of the
cytochrome b560 of the bc, complex was absent.
Analysis of the MT113 membrane proteins by
nondenaturing polyacrylamide gels (LDS-PAGE)
coupled to a heme-specific staining procedure in-
dicated a general lack of c-type cytochromes. To
determine whether the lack of a functional bc,
complex was related to the absence of specific ap-
oproteins corresponding to the bc,-complex com-
ponents, cell extracts were submitted to Western
analysis using antibodies raised against purified
cytochrome c2 of R. capsulata and cytochrome b,
cytochrome c and Rieske Fe-S proteins of Rho-
dopseudomonas sphaeroides. The apoprotein of
c2 was not detected, but those of the bc,-complex
components were present, suggesting that MT113
was able to synthesize the analyzed bc,-complex
components but was not able to assemble them as
a functional complex. Genetic analysis using the
gene-transfer agent of R. capsulata and several
plasmids carrying the structural genes for cyto-
chrome c2 and for at least some of the bc,-com-
plex components (Rieske Fe-S gene) clearly indi-
cated that the primary effect of the single
pleiotropic mutation in MT113 is unlikely to be
related to the structural genes of the cytochrome
c2 and of the bc,-complex components. The na-
ture of this mutation is still unknown, but a gen-
eral lack of c-type (but not b-type) cytochrome in
MT113 suggests that it could be related to the late
steps of c-type cytochrome biosynthesis.
Cartridge Mutagenesis and Deletion of
the Photosynthetic Reaction-center
and Light-harvesting Genes
from R. capsulata
D.C. Youvan, S. Ismail
Our purpose in constructing photosynthetic ap-
paratus deletion strains is to provide back-
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grounds for the assay of in-vitro-mutagenized re-
action-center and light-harvesting genes carried
by plasmid vectors (Fig. 1). The nucleotide se-
quence and deduced polypeptide sequences for all
of the reaction-center and light-harvesting struc-
tural polypeptides have been determined (Youvan
et al., Cell 37: 949 [1984]; Youvan and Ismail,
Proc. Natl. Acad. Sci. 82: 58 [1985]). On the ba-
sis of primary sequence data, models have al-
ready been proposed for reaction-center quinone
binding and light-harvesting bacteriochlorophyll
binding. The three-dimensional structure of the
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FIGURE 1 Construction and complementation of photo-
synthetic deletion strains. Deletion backgrounds con-
structed by cartridge mutagenesis may be complemented
by the wild-type reaction-center or light-harvesting operons
in trans. Alternatively, in-vitro-mutagenized plasmids may be
returned to the deletion strain in order to assay the affect of
engineered point mutations.
reaction center is being solved by X-ray crystal-
lography. We anticipate that it will be essential
to test reaction-center and light-harvesting struc-
ture-function models by in vitro mutagenesis of
the structural genes. Progress in this rapidly
advancing multidisciplinary field has been re-
viewed recently (Youvan and Marrs, Cell 39: 1
[1984]; Youvan and Marrs, in Molecular Biology
of the Photosyntheic Apparatus, Cold Spring
Harbor Laboratory, Cold Spring Harbor, New
York [1985] in press).
Deletion strains were constructed using the car-
tridge mutagenesis technique of P. Scolnik (this
section). This procedure employs the gene-trans-
fer agent (GTA) that is specific to Rhodopseudo-
monas capsulata. The GTA is similar to a gen-
eralized transducing phage, randomly packaging
4.6-kb DNA segments from the chromosome.
Plasmids carrying R. capsulata genes are muta-
genized in vitro by the insertion of small (2-4 kb)
restriction fragments specifying resistance to
kanamycin or spectinomycin (from Tn5 or Tn 7,
respectively). These plasmids are then transferred
via conjugation from Escherichia coli to a GTA
overproducer strain. GTA from the overproducer
is crossed with a suitable recipient, and transduc-
tants are selected for the appropriate antibiotic
marker. Antibiotic-resistant transductants have
incorporated the mutagenized copy of the gene
into their chromosome by homologous recombi-
nation, and the corresponding wild-type alleles
are lost. Cartridge mutagenesis need not be lim-
ited to simple insertional interruption of genes:
Deletions may be engineered through ligation of
the cartridge in place of a target restriction frag-
ment.
Strains have been constructed wherein all or
part of the reaction-center (RC), light-harvesting
I (LHI), and light-harvesting II (LHII) structural
genes have been deleted. In one series of strains,
the 2778-bp Apal fragment bearing more than
90% of the rxcA operon (promoter and structural
genes for LHI 6, LHI a, RC L, and RC M) has
been deleted from the chromosome. When the
rxcA operon is deleted from the wild type, result-
ant strains possess only LHII and are photosyn-
thetically defective. The rxcA deletion in a LHII-
background results in a strain lacking all light-
harvesting antennae and reaction-center sub-
units. As expected, this strain has no near-in-
frared absorption characteristic of light-harvest-
ing or reaction-center bacteriochlorophyll. The
rxcA deletion may be complemented by a pBR322
derivative (pU21) carrying the entire rxcA ope-
ron. In a second series of deletion strains, the
2500-bp BstEll-Stul fragment, including the 6
and a structural genes for LHII, has been deleted
from the chromosome. In the wild-type back-
ground, the functional reaction center and LHI
are expressed. LHII may be restored by return-
ing the plasmid pU2 that carries the LHII ope-
ron.
Characterization of the Photosynthetic
Reaction Center
D.C. Youvan
Photosynthetic reaction centers from the purple
nonsulfur bacterium Rhodopseudomonas cap-
sulata have been purified to near homogeneity
in amounts (100 mg) suitable for biophysical
analysis. Photosynthetic membranes (chromato-
phores) can be prepared by differential centrifu-
gation using a cartridge mutant (U34) lacking the
LHII antenna. Otherwise, reaction centers and
LHI are wild type. Membrane proteins are solu-
bilized in the anionic detergent lauryl-dimethy-
lamine-N-oxide (LDAO), and reaction-center
proteins may be purified by affinity chromatog-
raphy on horse heart cytochrome c2 coupled to
Sepharose 4B. This procedure was originally de-
veloped by Brudvig et al. (Proc. Natl. Acad. Sci.
80: 683 [1983]) for reaction centers from Rhodo-
pseudomonas sphaeroides.
Reaction centers purified by affinity chroma-
tography are very pure and photochemically ac-
tive. No contaminating light-harvesting polypep-
tides or bacteriochlorophyll is observed by SDS-
PAGE or absorption spectroscopy. The purified
reaction centers are capable of the initial photo-
synthesis reaction involving charge separation:
The 870-nm absorption band assigned to the spe-
cial pair is photobleached by actinic light.
Reaction centers have been crystallized from
two species, Rhodopseudomonas viridis and R.
sphaeroides. The detailed biophysics of the pho-
toelectron cycle is best characterized in the latter
species. This is somewhat of an unfortunate
situation since genetics is best developed in R.
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capsulata. The amino acid sequence of the pho-
tosynthetic reaction-center polypeptides is com-
pleted for only R. capsulata. We believe that
genetics is an essential feature for future struc-
ture-function problems; hence, X-ray crystallog-
raphy should be repeated using R. capsulata
reaction centers. The ability to prepare large
quantities of purified R. capsulata reaction cen-
ters should help to remedy the problem.
In Vitro Mutagenesis of the
Photosynthetic Reaction-center
and Light-harvesting I Genes
E.J. Bylina, D.C. Youvan
We are using in vitro mutagenesis to address
the fundamental question: How are proteins in-
volved in the primary light reactions of photosyn-
thesis? In the light reactions, membrane proteins
and cofactors (chlorophyll, quinone, and caro-
tenoids) interact in a highly efficient way to har-
vest light energy and to transduce this energy in-
to a biochemically useful reductant. Presumably,
the exact placement of the cofactors by the mem-
brane proteins facilitates the unprecedented pho-
tochemical efficiency of the photosynthetic ap-
paratus (quantum yield approaching unity).
Some of the amino acid residues within the mem-
brane proteins may play more than a structural
role and participate directly in the photochemical
reactions, facilitating proton and electron con-
duction.
We have recently developed in vitro mutagene-
sis procedures and bacterial strains to assay the
phenotype of plasmid-borne rxcA operons. This
3000-bp operon carries the structural genes en-
coding four membrane polypeptides: the photo-
chemical core of the reaction center (L and M
subunits) and LHI (a and f3 subunits). The cloned
rxcA operon may be returned to rxcA deletion
strains in order to assay the phenotype of the
plasmid genes in trans.
The plasmid bearing the rxcA operon (pU21)
has been mutagenized in vitro by oligonucleo-
tide-mediated site-directed mutagenesis. Plas-
mid pU21 is nicked with EcoRI in the presence of
ethidium bromide, and exonuclease III is then
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used to convert the nicked DNA into gapped
DNA. The mutagenic oligonucleotide is an-
nealed to this gapped region, and the gap is then
repaired with Klenow and ligase. The mutagen-
ized plasmids are transformed, and the trans-
formants are screened by colony hybridization
using the mutagenic oligonucleotide as the probe.
Direct mutagenesis of the plasmid avoids shut-
tling, since pU21 may be conjugated from an E.
coli donor to the deletion background with the
help of a mobilizing plasmid. Hence, the pheno-
type of a light-harvesting or reaction-center mu-
tation may be rapidly assayed. Additionally, re-
vertants may be selected and the sequence of pU21
redetermined.
Experiments have been initiated to test the light-
harvesting bacteriochlorophyll-binding model of
Theiler and Zuber (Hoppe-Seyler's Z. Physiol.
Chem. 365: 721 [1984]). The proposed binding
site Ala-X-X-X-His has been targeted by in vitro
mutagenesis of pU21, assayed in the deletion
background. A histidine-to-aspartic acid change
in the LHI ca- subunit results in the loss of this
antenna. This is consistent with the model which
proposed that the a and polypeptides interact
through a chlorophyll dimer, each bound to a his-
tidine lone pair on both polypeptides. The loss
of LHI also causes the pleiotropic derangement
of the reaction center and a photosynthesis-de-
fective (PS -) phenotype. PS revertants have
been subsequently isolated by direct selection.
We plan to sequence the site of reversion in order
to determine whether histidine is the only func-
tional residue for chlorophyll binding.
Future in vitro mutagenesis targets include the
reaction-center putative quinone-binding site Pro-
Phe-His-Met-Leu, which is conserved with higher
plants. Mutations in this sequence may affect
herbicide resistance, since these chemicals are
competitive inhibitors of quinone binding. An-
other possible target of particular interest to
spectroscopists is a possible carotenoid binding
site in LHII: Tyr-Arg. The arginine residue is be-
lieved to be the point charge responsible for the
carotenoid electrochromic band shift that is
sensitive to membrane potential. As crystallo-
graphic data become available, mutagenesis
should play an increasingly important role in test-
ing light-harvesting and reaction-center struc-
ture-function models.
Cartridge Mutagenesis in R. capsulata
P.A. Scolnik
Modern genetic approaches require the capability
of selectively inactivating genes by insertions or
deletions. I have developed a system for intro-
ducing gene cartridges into the chromosome of
Rhodopseudomonas capsulata by homologous
recombination (Scolnik and Haselkorn, Nature
307: 289 [1984]). This method takes advantage
of a defective transducing phage (gene-transfer
agent, GTA) produced only by this bacterium.
GTA transduces linear double-stranded segments
of DNA of 4.5 kbp, which by homologous recom-
bination are integrated into the chromosome of
the recipient cell. I determined that DNA from
recombinant plasmids, introduced into the cell by
conjugation, are also packaged into GTA heads.
Consequently, the following method (Fig. 2) was
developed: (1) A gene cartridge is introduced in
vitro into a cloned sequence by standard recom-
binant DNA techniques, generating either an in-
sertion or a deletion. (2) The resulting plasmid is
transformed into Escherichia colt and then intro-
duced into an R. capsulata GTA overproducer by
conjugation. (3) GTA is then prepared and used
to treat wild-type recipient cells, selecting for the
antibiotic resistance of the gene cartridge. (4)
Since the incoming molecule is not a replicon, an-
tibiotic resistance cells can only be the product of
homologous recombination with the host chro-
mosome.
This method has two main advantages over
A. B.
GTA
transposon mutagenesis. First, the insertions or
deletions can be engineered in vitro using restric-
tion sites. Second, since this method does not in-
volve the introduction of plasmids into the cell,
the mutants obtained can be used for comple-
mentation studies with recombinant plasmids. I
have successfully used kanamycin resistance from
Tn5 and spectinomycin resistance from Tn7 as
gene cartridges.
Maximum efficiency (10-3 with respect to the
efficiency of transduction of a point mutation) is
obtained when both ends of the molecule contain
R. capsulata rather than vector DNA, probably
reflecting the fact that the free ends are recombi-
nogenic. However, insertions have been obtained
with as little as 250 by of homologous DNA
flanking the gene cartridge, indicating that either
internal recombination occurs or the linear mol-
ecule is attacked by exonucleases, generating free
ends.
Cryptic Genes and Gene Rearrangements
in Response of a Bacterial Genome
to Stress: Precise Excision
of a Gene Cartridge
P.A. Scolnik, J. Schumann
Rhodopseudomonas capsulata can fix atmospher-
ic nitrogen through the enzyme nitrogenase. We
have cloned the structural genes (nil HDK) and
have determined that they are organized in a tran-
scriptional unit (Scolnik and Haselkorn, Nature
C. D.
I Plasmid Vector R. capsulata DNA i Gene Cartridge
FIGURE 2 Strategy for site-directed gene cartridge mutagenesis in R. capsulata (see text).
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307: 289 [1984]; J. Bacteriol. 156: 251 [1983]),
entirely contained within a 12-kbp HindIII frag-
ment. Insertions and deletions within this frag-
ment (produced by the cartridge mutagenesis
method using kanamycin as the selection marker)
give rise to a Nif- phenotype and introduce into
the region an additional HindIII site that is pres-
ent in the cartridge.
These mutants are stable in their phenotype
when grown in medium supplemented with fixed
nitrogen. However, Nit.* pseudorevertants can be
isolated by challenging these cells to grow in am-
monia-free medium. A time-course experiment
starting with an insertional mutation grown in
ammonia-free medium showed that the first class
of pseudorevertants appears within the first few
hours of selection. These cells are resistant to
kanamycin, and the gene cartridge remains in the
original place of insertion, as shown by Southern
hybridization; however, a low (10% of wild-type
levels) nitrogenase activity can be detected. Kan-
amycin-sensitive cells, with full nitrogenase activ-
ity, are observed after at least 2 days of growth.
Southern hybridization shows that the gene car-
tridge has been deleted from the genome, and two
new HindIII bands (12 and 16 kbp) are observed.
The 16-kbp fragment is a transient form, which
resolves in the 12-kbp band upon further incuba-
tion. Cells containing this 12-kbp band are indis-
tinct from wild types.
We interpret these results as follows: When the
nif genes are inactivated by cartridge insertion,
R. capsulata will respond to the need for nitrogen
by bringing a cryptic nif gene(s) into operation,
and this event is responsible for the low level of
nitrogenase activity initially observed. That this
response does not involve some type of activation
of the inactivated nif genes is evident because it
will occur whenever these genes are deleted. Sub-
sequently, the gene cartridge is excised from the
genome, probably by translocation of a 4-kbp
element into the site of kanamycin insertion.
This event generates a 16-kbp band, which in turn
resolves (probably by excision of the 4-kbp ele-
ment) into a 12-kbp HindIII band, and the full
nitrogenase activity phenotype is restored. The
activation of the cryptic gene provides the neces-
sary energy for the process of gene rearrangement
to take place.
Since nitrogenase activity is fully restored, the
excision of this cartridge must be precise or near
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precise. The fact that this process occurs indi-
cates that gene cartridges as well as transposons
can be excised from the genome, and therefore
transposon activity is not required. We are cur-
rently characterizing the excision process, and we
have sequenced the nifH and nifD genes in order
to be able to determine the nature of the rear-
rangement observed.
The nature of the cryptic gene remains unclear.
Southern hybrydization of nif structural genes to
total genomic DNA shows several (at least eight)
HindIII bands that contain homology with all
three nifH, nifD, and nifK genes. We have cloned
one of them and have determined that, although
it contains 65-80% homology with nifH at the
nucleotide level, it does not have the capability of
coding for a nitrogenase gene. There are four
copies of this element in the genome, and cosmid
cloning shows that they are dispersed in the chro-
mosome. Insertions in this region have no phe-
notype (P. Schumann and P. Scolnik, in prep.). It
is possible that this element constitutes a nif ho-
mologous insertion sequence, a possibility cur-
rently being explored.
Cloning Prokaryotic Genes by
Complementation with a
Cosmid Library
P.A. Scolnik
A situation often exists in which no physical probe
to clone a certain gene is available, but a mutant
with the desired phenotype has been obtained. A
gene complementing such a mutation can be eas-
ily isolated from a genomic library, provided a
method exists to introduce this library massively
into the mutant cells. In most gram-negative bac-
teria, transformation, at least at high efficiency,
is not available. However, wide-host-range plas-
mids (developed by D. Helinski's group, Univer-
sity of California, San Diego) can be mobilized
by conjugation from E. colt. I have constructed
a genomic library from R. capsulata in a cosmid
derivative of these vectors and designed a proto-
col that allows cloning of the mutants by comple-
mentation. In conjunction with cartridge muta-
genesis, this method can be used to clone and to
identify R. capsulata genes unequivocally. More
than ten different sequences, affecting both
photosynthesis and nitrogen fixation, have been
cloned using this approach.
A Study of Bacterioferritin from
Azotobacter vinelandii
S. Hinton, C. Slaughter, T. Fischer
Bacterioferritin is a b-type cytochrome, but it also
closely resembles mammalian ferritin because of
its quaternary structure (24 identical subunits)
and contains an average of 1600 Fe atoms in an
oxide-hydroxide-phosphate core. Bacterioferritin
differs from mammalian ferritin in that it con-
tains heme and has the ability to take up hundreds
of electrons at a low redox potential, which sug-
gests that it may function as an electron storage
protein for use in respiration, biosynthesis, and
nitrogen fixation. It has been proposed that bac-
terioferritin may also be an iron storage protein
for Azotobacter vinelandii.
We are initiating structure-function studies of
bacterioferritin to understand how it resembles
and differs from ferritin, as well as biochemical
studies to establish its physiological role. Bacter-
ioferritin was purified and crystallized. The ami-
noterminal amino acid sequence was determined,
and antibodies were raised against the purified
protein. Oligonucleotides were synthesized based
on the aminoterminal amino acid sequence of the
protein, and antibodies recognizing bacteriofer-
ritin are being used to screen various genomic li-
braries of A. vinelandii. The complete primary
structure of bacterioferritin will be determined
by amino acid sequencing as well as by gene
sequencing. Future experiments will include
site-directed mutagenesis for structure-function
studies to determine the effect mutations have on
nitrogen fixation, respiration, and iron metabo-
lism.
Molybdenum Metabolism in
Clostridium pasteurianum
S. Hinton, C. Slaughter, G. Freyer, W. Eisner, T. Fischer
There are two distinct cofactors for various redox
enzymes. The molybdenum-iron protein of ni-
trogenase contains a unique iron-molybdenum
cofactor, FeMo-co, whereas all other known mol-
ybdoenzymes contain a common molybdenum
cofactor, Mo-co, a molybdenum-pterin species.
We have proposed a hypothesis that during the
biogenesis of Mo cofactors, precursors are pro-
tein-bound. We have identified four molybdo-
proteins in crude extracts of Clostridium pasteu-
rianum that have characteristics which suggest
that they may play a role in Mo metabolism.
The major Mo-binding protein (Mop) in C.
pasteurianum, suspected to be involved in Mo
metabolism, was purified and biochemically
characterized, and the mop gene was cloned and
sequenced. Our studies have shown that the iso-
lated Mo protein contains Mo as well as a pterin-
like fluorescent chromophore. Spectroscopic
analysis indicates that the Mo environment and
the pterin-derivative associated with Mop are
similiar to the components of the Mo-co isolated
from clostridial formate dehydrogenase. The
Mo-co dissociated from formate dehydrogenase
was used to reconstitute the activity of Mo-co-
deficient nitrate reductase (biological assay for
catalytically active Mo-co). The molybdopterin
species dissociated from Mop was not active in
the Mo-co reconstitution assay. The results sug-
gest that the catalytically inactive molybdopterin
species associated with Mop might be a precursor
to Mo-co.
We identified an expression clone in Esche-
richia coli cross-reacting with Mop antibodies by
immunoscreening genomic libraries of C. pasteu-
rianum. Western blot analysis showed that the
clone produced a protein recognized by the anti-
body with the same effective electrophoretic mo-
bility as purified Mop. DNA sequence analysis
of the expression clone revealed an open reading
frame coding for 67 amino acids (m.w. ^-,8000).
The aminoterminal amino acid sequence of the
protein showed perfect alignment with the first 12
codons in the open reading frame. Amino acid
sequence analysis also showed that there appear
to be two amino acid residues at six different po-
sitions. The DNA sequence predicts only one of
the amino acid residues identified at each of these
positions. This ambiguity suggests that there are
two or more related proteins in the purified pro-
tein preparation. Southern blot analysis of C.
pasteurianum chromosomal DNA showed that
the original (Mop) clone hybridized to two DNA
125
fragments. The results indicate that the mop gene
has been duplicated and the two variant Mo pro-
teins copurify. We have cloned and are presently
sequencing what appears to be the second copy
of the mop gene.
Amino acid sequence analysis of Mop main-
tained under anaerobic conditions showed that at
positions where the DNA sequence predicted a
glutamic acid residue, an amino acid phenylthio-
hydantoin (PTH) derivative was identified that
did not correspond to any known standard. The
modified glutamic acid appears to be oxygen-sen-
sitive because glutamic acid PTH was identified
in the positions predicted by the gene sequence
when the protein was not handled under anaero-
bic conditions. It is interesting to note that Mo
binding to Mop was also oxygen-sensitive. Cur-
rently, we are determining the structure of the
glutamic acid derivative by fast-atom bombard-
ment mass spectroscopy and nuclear magnetic
resonance analysis.
Biogenesis of the Molybdenum
Cofactor in Escherichia coli
S. Hinton, S. Johann
The molybdenum cofactor, Mo-co, common to a
variety of molybdoenzymes, contains an as yet
undefined pterin derivative associated with a mo-
lybdenum (Mo) atom. The products of at least
five genes (chi A, B, D, E, and G) in Escherichia
coli are needed for Mo-co biogenesis. It has been
proposed that the gene products of chlA and chlE
are involved early in Mo-co synthesis, possibly
modifying the pterin. The ch1D, ch1G, and chlB
gene products are thought to be involved in sta-
bilizing the pterin-derivative in the absence of Mo,
inserting Mo into the cofactor, and inserting the
Mo-co into the apoenzyme, respectively. Our
goal is to understand the biology and bioinor-
ganic chemistry in the transformation of molyb-
date, MoO, , into Mo-co. To achieve this end,
we are studying the role the chi gene products
have in Mo metabolism by identifying the gene
products, determining the DNA sequence of the
genes, and studying the effect each chi mutant has
on Mo accumulation in E. coli.
Genomic libraries of E. coli DNA were con-
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structed in a pUC expression vector, several clones
that complemented the chi (Mu insertion) mu-
tants were identified, and complementation was
shown to be dependent on the inserts of E. coli
DNA. Southern hybridization analysis showed
that the clones contained fragments of E. coli
DNA that have sequence homology with chro-
mosomal DNA flanking the Mu insertion in their
respective chi mutant. Maxicell experiments
showed that the plasmids which conferred com-
plementation encoded proteins with apparent
molecular weights of 24,000 and 10,000 with the
chlB clone, 26,000 with the chlD clone, 44,000 and
23,000 with the chlE clone, and 25,000 and 6,500
with the ch1G clone. Restriction analysis, sub-
cloning, and site-specific mutagenesis have been
performed to localize the chi genes further for fu-
ture maxicell and DNA-sequencing experiments.
DNA-sequencing analyses of the chlD and ch1G
genes are in progress.
Radioisotope "Mo-labeling experiments in
conjunction with native (anaerobic) multiphasic
gel electrophoresis are being used to identify the
molybdoproteins in crude extracts of E. coli. We
are interested in determining whether any of the
chi gene products are molybdoproteins possibly
binding a precursor of Mo-co.
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CELL BIOLOGY
The focus of the Cell Biology Group has slowly evolved from solely the analysis
of cell structure to the analysis of cell growth control. During the past year, vir-
tually all of our work involved some aspect of normal- or transformed-cell growth-
control pathways. The biochemical and cell biological roles of the ras proteins
have been studied in great detail. Analysis of the effects of adenovirus El A pro-
teins and genes and those of the human oncogene, c-myc, in living cells has just
begun. Analyses of these proteins and their effects on cells are also being stud-
ied by computerized two-dimensional gels. The role and properties of protein ki-
nase C (and of the inositol phospholipids) in cellular functions are also areas of
active research by the Group. Investigations into the molecular components of
the heat shock or stress response of cells, which characteristically leads to a tem-
porary shutoff of growth, are continuing at a fast pace. In addition, cloning, ge-
netic organizational studies, and protein biochemical analysis of the actin-bind-
ing proteins, the tropomyosins, are being pursued with vigor. The expression of
the tropomyosins is rapidly and dramatically changed during the transformation
process. Progress is being made, but the complexity of the molecular events that
must be involved in mammalian cell-growth control is so great that the field will
continue at a high pitch here and elsewhere for some time.
GENES FOR MAJOR STRUCTURAL PROTEINS
D.M. Helfman Y. Yamawaki-Kataoka
L. Finn
Isolation and Characterization of
cDNA Clones Encoding
Nonmuscle Tropomyosin
Y. Yamawaki-Kataoka, L. Finn, D.M. Helfman
Rat embryonic fibroblasts contain five forms of
tropomyosin, TM-1 (M, = 40,000), TM-2 (M, =
36,500), TM-3 (M, = 35,000), TM-4 (M, = 32,400),
and TM-5 (Mr= 32,000). The structure and func-
tional significance of the different forms of
tropomyosin in nonmuscle cells remain to be de-
termined. In addition, recent studies have indi-
cated significant alterations in the pattern of
tropomyosins expressed in cells transformed by
various DNA and RNA tumor viruses. These al-
terations in tropomyosin expression may in part
be responsible for the reduction of microfilament
bundles (stress fibers) and alterations of cell shape
characteristic of transformed cells. The mecha-
nism(s) responsible for the altered patterns of
tropomyosin synthesis in transformed cells is un-
known. With these questions in mind, we have
been studying tropomyosins in nonmuscle cells
(rat embryonic fibroblasts) and the genes that en-
code these proteins. To isolate cDNA clones en-
coding nonmuscle tropomyosins, we constructed
a rat embryonic fibroblast cDNA expression li-
brary using the plasmid expression vectors pUC8
and pUC9. Using both an immunological screen-
ing procedure and "P-labeled cDNA probes, we
have identified and isolated cDNA clones en-
coding three of the five tropomyosins found in
rat embryonic fibroblasts. By hybrid-selection
translation and analysis of the translation prod-
ucts by one- and two-dimensional gel electropho-
resis, we have identified clones that contain se-
quences complementary to TM-I, TM-2, and TM-
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4. Northern blot analysis indicated transcripts of
1.1, 1.8, and 2.2 kb for TM-1, TM-2, and TM-4,
respectively. We have identified overlapping
clones for the entire coding region of rat TM-1
and have determined the complete amino acid se-
quence of the protein deduced from nucleic acid
sequence analysis (see below). In addition, we
have sequenced cDNA clones encoding a portion
of TM-2 and TM-4. Comparison of the nucleic
acid sequences of clones for TM-1, TM-2, and
TM-4 indicates differences in their coding re-
gions, although their predicted amino acid se-
quences show more than 85% homology. South-
ern blot analysis of rat DNA showed several
unique fragments hybridizing to each probe made
from cDNA clones encoding TM-1, TM-2, or TM-
4. These results indicate that these proteins are
encoded by separate but related genes and that
tropomyosin species present in rat embryonic fi-
broblasts are encoded by at least three separate
genes. We are currently analyzing genomic clones
that encode nonmuscle tropomyosins (see below).
Rat Embryonic Fibroblast Tropomyosin
1: cDNA and Complete Primary
Amino Acid Sequence
Y. Yamawaki-Kataoka, D.M. Helfman
A first step in understanding the molecular basis
for the differences in the various forms of tropo-
myosin in rat embryonic fibroblasts will be a de-
termination of their primary structure. Using
overlapping cDNA clones for TM-1, we have de-
termined the sequence of the entire coding region
of 852 bp, 61 by of 5'-untranslated sequences, and
73 by of the 3'-untranslated region (Yamawaki-
Kataoka and Helfman, J. Biol. Chem. [1985]
submitted). Since the 3'-untranslated sequence
contains a poly(A) track and the polyadenyla-
tion signal AATAAA is found 14 by from the
poly(A) track, we conclude that our clones con-
tain the complete 3'-untranslated sequence. Thus,
TM-1 has a relatively short (73 bp) 3'-untrans-
lated region. Comparison of the deduced amino
acid sequence of the rat TM-1 with those of
tropomyosins isolated from chicken smooth mus-
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cle, chicken and rabbit skeletal muscle, and
equine platelet indicates extensive homology
among the various tropomyosin isoforms. TM-1,
like smooth- and skeletal-muscle tropomyosins,
was found to contain 284 amino acids. On the
other hand, platelet tropomyosin has been re-
ported to contain only 247 amino acids. The
tropomyosin most homologous to rat TM-1 is
chicken smooth-muscle a-tropomyosin (95% ho-
mology); in contrast, rat TM-1 shows only 77%
and 78% homology with skeletal-muscle and
platelet tropomyosins, respectively. Interestingly,
TM-1, smooth-muscle, and platelet tropomyosins
were found to be highly homologous at their car-
boxyterminal domains, compared with skeletal-
muscle tropomyosins. Whether all nonmuscle
and smooth-muscle tropomyosins share this fea-
ture remains to be determined. In this respect,
we have also determined the sequence of the car-
boxyterminal end of rat embryonic fibroblast
TM-4. This sequence is also highly homologous
to TM-1, smooth-muscle, and platelet tropo-
myosins. These differences in sequence correlate
well with work from other laboratories showing
that skeletal-muscle troponin T binds strongly
to the carboxyterminal end of skeletal-muscle
tropomyosin. In contrast, troponin T interacts
poorly with smooth-muscle and nonmuscle
tropomyosins. Work is currently under way to
isolate and characterize cDNA clones encoding
the other nonmuscle tropomyosins.
A Single Rat Tropomyosin Gene
Specifies Two Different
Tissue-specific mRNAs
D.M. Helfman. L. Finn
To isolate the gene encoding rat embryonic fibro-
blast tropomyosin 1 (TM-1), we screened a rat
genomic library for sequences complementary to
our cloned tropomyosin cDNAs. Analysis of
genomic clones indicates there are two separate
loci in the rat genome that contain sequences
complementary to TM-1. One appears to contain
a functional gene and the other represents a pro-
cessed pseudogene. The functional gene is ap-
proximately 10 kb long. Northern blot analysis
using "P-labeled cDNA probes encoding TM-1
revealed that rat embryonic fibroblasts and
smooth muscle (stomach or uterus) contain a sin-
gle transcript of 1.1 kb. In contrast, skeletal mus-
cle contains a single transcript of 1.3 kb. Si pro-
tection experiments indicate that the skeletal-
muscle transcript differs from both the fibroblast
and smooth-muscle messages only at the 3' end
(corresponding to a region from approximately
amino acid 190 to 284); This is supported by se-
quence comparisons demonstrating that skeletal-
muscle I3- tropomyosin is virtually identical with
rat TM-1 from amino acid 1 to 190, but differs
substantially at the carboxyterminal end. We
have now identified two distinct exons at the 3'
end of the gene; one is specific for the 1.1-kb tran-
script in rat embryonic fibroblasts and smooth
muscle and the other is specific for the 1.3-kb
transcript in skeletal muscle. In addition, there
are at least two exons common to the 1.1-kb and
1.3-kb transcripts. Thus, a single gene encodes
two different transcripts, whose expression is reg-
ulated by a tissue-specific mechanism. We are
continuing to characterize the genomic clones
fully and plan to study cis- and trans-acting ele-
ments involved in the regulation of this gene.
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BIOLOGY OF THE CYTOSKELETON
F. Matsumura S. Yamashiro-Matsumura
Physical and Chemical Properties of
Normal- and Transformed-cell
Tropomyosin
F. Matsumura, S. Yamashiro-Matsumura
We have previously shown that multiple forms of
tropomyosin are differentially expressed upon
many types of oncogenic transformation (Matsu-
mura et al., J. Biol. Chem. 258: 13954 [1983]; Lin
et al., Cancer Cells 1: 57 [1984]). Generally, the
levels of tropomyosin with higher apparent mo-
lecular weights (prominent in normal cells) are
decreased in transformed cells, whereas the levels
of tropomyosin with lower apparent molecular
weights (minor tropomyosins in normal cells) be-
come predominant. Of the five forms of rat cul-
tured-cell tropomyosin (TM-1-TM-5) (Matsu-
mura et al., J. Biol. Chem. 258: 6636 [1983]),
TM-1 (M, = 40,000) and TM-2 (M, = 36,000) are
high-molecular-weight tropomyosins (prominent
in normal cells) and TM-4 (M, = 32,400) and TM-
5 (M, = 32,000) are low-molecular-weight tro-
pomyosins (prominent in transformed cells). To
elucidate how the changes in tropomyosin expres-
sion affect the altered organization of microfila-
ments observed in transformed cells, we have ex-
amined the physical and chemical properties of
these normal- and transformed-cell tropomyos-
ins. We have also tested whether the changes in
tropomyosin pattern in microfilaments alter the
interactions between actin and other actin-bind-
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ing proteins, which may cause the alteration in
the assembly state of microfilaments in trans-
formed cells.
Five forms of rat cultured-cell tropomyosins are
found to share many physical and chemical prop-
erties, including (1) similar isoelectric focusing
points (pI (2) heat stability, (3) similar
amino acid compositions, (4) homodimer forma-
tion, (5) rod-like molecular shapes, and (6) cross-
reactivities to polyclonal antibodies to muscle or
nonmuscle tropomyosin. However, we have
found several important differences in the prop-
erties of high-molecular-weight tropomyosins
(TM-1, TM-2, and TM-3) and low-molecular-
weight tropomyosins (TM-4 and TM-5).
First, these tropomyosin variants show differ-
ent extents of polymerization. Table 1 shows the
Stokes' radii and sedimentation coefficients of the
five forms of tropomyosin measured by gel filtra-
tion and by sucrose density gradient centrifuga-
tion, respectively. Low-molecular-weight tro-
pomyosins (TM-4 and TM-5) show a lesser extent
of salt-dependent polymerization than high-mo-
lecular-weight tropomyosins (TM-1, TM-2, and
TM-3). The Stokes' radius of high-molecular-
weight tropomyosins increased from 7.5 nm to
12.3 nm when the NaC1 concentration was low-
ered from 0.6 to 0.1 rvi, whereas that of low-
molecular-weight tropomyosins changed from 6.2
nm to 8.2 nm. The sedimentation coefficients
also showed the difference in salt dependency be-
tween high- and low-molecular-weight tropo-
myosins. With a decrease of NaCI concentra-
tions, the sedimentation Coefficients of high-mo-
lecular-weight tropomyosins changed from 3.4 to
3.7, whereas those of low-molecular-weight tropo-
myosins remained constant = 3.4). These
results were also confirmed by electron micros-
copy using a rotary-shadowing technique. Al-
TABLE 1 Physical Properties of Tropomyosin
Variants
TM-1, TM-2, TM-3 TM-4, TM-5
Stokes' radius
(nm)
Sedimentation
coefficient
M, on SDS gels
0.1 M 0.5 M 0.1 M 0.5 M
NaCI NaCI NaCI NaCI
12.3 7.5 8.2 6.2
3.7 3.4 3.4 3.4
40K-35K 32K
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though rod-like molecules (,,40 nm long; char-
acteristic of tropomyosin) were observed in
specimens from both kinds of tropomyosins, lin-
ear polymers as long as 500 nm were frequently
seen only in specimens from high-molecular-
weight tropomyosins.
Second, we have found that high-molecular-
weight tropomyosins show a higher affinity to ac-
tin than low-molecular-weight tropomyosins (Fig.
1). The lower actin -affinity and the lower poly-
merizability of the low-molecular-weight tropom-
yosins (prominent in transformed cells) suggest
that these tropomyosins do not stabilize the struc-
ture of microfilaments in transformed cells as
high-molecular-weight tropomyosins do in nor-
mal cells. Such changes in stability may result in
the disorganization of actin cables observed in
transformed cells.
We next examined if different forms of tro-
pomyosin affect the activity of other actin-bind-
ing proteins. For this purpose, we first chose a
new actin-binding 55-kD protein purified from
He La cells because this protein makes actin fila-
ments aggregate into bundles (Yamashiro-Matsu-
mura and Matsumura, J. Biol. Chem. [1985] in
press) and may function as a structural compo-
nent of the actin bundles present in stress fibers
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FIGURE 1 Actin binding of tropomyosin variants. Actin (1
mg/ml) was incubated with different isoforms of tropomyosin
at the indicated concentrations and ultracentrifuged at
140,000g for 20 min. Both supernatants and pellets were
analyzed by SDS-PAGE. The amounts of tropomyosin bound
to actin were quantitated by densitometry and plotted as a
percentage of full binding. The actin affinity of high-molecu-
lar-weight tropomyosins (TM-1 and TM-2) is higher than that
of low-molecular-weight tropomyosins (TM-4 and TM-5).
or philopodia. The bundling activity of the 55-
kD protein was measured by low-speed centrifu-
gation (Fig. 2, lane 1), where bundles of actin fil-
aments are pelleted (lane lb) while free actin re-
mains in the supernatant (Fig. 2, lane la). Actin
was first complexed with either high- or low-mo-
lecular-weight tropomyosins and then the 55-kD
protein was added. When the 55-kD protein was
mixed with the actin/TM-4/TM-5 complex, it
chased out TM-4 and TM-5 from actin and made
bundles of actin filaments free of tropomyosin
(Fig. 2, lane 2). In contrast, when the 55-kD pro-
tein was mixed with the actin/TM-1/TM-2/TM-3
complex, it made bundles of actin filaments con-
taining these tropomyosins (Fig. 2, lane 3). We
have further examined the effect of skeletal-mus-
cle tropomyosin on bundling activity. Interest-
ingly, skeletal-muscle tropomyosin inhibited the
bundling activity of the 55-kD protein. As lane 4
1 2 3 4 5
ab ab ab ab
-"`" 55K
-1110 -Ow -111111rar-.Actin
- ATM
.40a -.TM
FIGURE 2 The interaction between the 55-kD protein and
different forms of tropomyosin. Actin (1 mg/ml) was first
complexed with different forms of tropomyosin (0.5 mg/ml)
and then the 55-kD protein (0.2 mg/ml) was added. The ac-
tivity of actin bundling was examined by low-speed centrif-
ugation (12,000g for 15 min). Both pellets (lane a) and su-
pernatants (lane b) were analyzed on SDS-polyacrylamide
gels. (1) Control without tropomyosin (actin bundles were
precipitated with the 55-kD protein [lane bp; (2) actin plus
TM-4 and TM-5; (3) actin plus TM-3, TM-4, and TM-5; (4)
actin plus TM-1 and TM -2; (5) actin plus rabbit skeletal-mus-
cle tropomyosin. Note that TM-4 and TM-5 were chased out
by the 55-kD protein, whereas TM-1, TM-2, and TM-3 bind
to actin bundles made with the 55-kD protein. Skeletal-mus-
cle tropomyosin, in contrast, inhibits the bundling activity of
55-kD protein.
shows, most actin remains in the supernatant
(lane 4a).
The modification of the interaction between
actin and the 55-kD protein by the multiple forms
of tropomyosin may be involved in the regulation
of microfilament assembly. We are now studying
whether multiple forms of tropomyosin change
the interaction of actin with other types of actin-
binding protein (actin-filament-severing protein
such as gelsolin).
Intracellular Localization of a New
Actin-bundling 55-kD Protein
in Cultured Cells
S. Yamashiro-Matsumura, F. Matsumura
Last year, we reported the purification and char-
acterization of a new actin-bundling 55-kD pro-
tein from HeLa cells (Yamashiro-Matsumura and
Matsumura, J. Biol. Chem. [1985] in press). To
determine the intracellular localization of this
protein in cultured cells, we have made both po-
lyclonal and monoclonal antibodies to the 55-kD
protein. Indirect immunofluorescence using both
polyclonal and monoclonal antibodies shows the
predominant localization of this protein in phil-
opodia and retraction fibers, as well as in stress
fibers (Fig. 3B).
The 55-kD protein is very similar to fimbrin in
that both proteins are actin-bundling proteins and
show similar localization in cultured cells. Al-
though biochemical characterization suggests that
they are different proteins, we have tested the 55-
kD protein by immunoblot analysis to determine
if it is immunologically related to fimbrin. Anti-
55-kD protein antibody was reactive with the 55-
kD protein but not with fimbrin. Likewise, anti-
fimbrin antibody reacted with fimbrin but not
with the 55-kD protein. Furthermore, indirect
immunofluorescence of chemically transformed
human fibroblasts double-stained with poly-
clonal anti-fimbrin and with monoclonal anti-55-
kD protein showed similar but different localiza-
tion. Although both antibodies stained micro-
spikes, the anti-55-kD protein antibody stained
the stress fibers, but the anti-fimbrin staining was
very weak. These results indicate that the 55-kD
protein and fimbrin are not related to each other
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FIGURE 3 Phase-contrast (A,D) and immunofluorescent (B,C,E,F) micrographs of CCL-gerbil fi-
broma cells double-stained with mouse monoclonal antibody to the 55-kD protein (B,E) and with
rabbit polyclonal antibody to tropomyosin (C,F). Arrowheads in E and F show the center of polygonal
networks, where the 55-kD protein is present but tropomyosin is absent.
and that both proteins are structural components
of microspikes in cultured cells.
As described above, the interaction of 55-kD
protein with actin is modified by tropomyosin.
The localization of the 55-kD protein was there-
fore compared with that of tropomyosin by dou-
ble-labeled immunofluorescence, using mouse
monoclonal antibody against the 55-kD protein
and rabbit polyclonal antibody against tropo-
myosin. The staining patterns of these two anti-
bodies are different, although both antibodies
stained the same stress fibers (Fig. 3). The stain-
ing patterns of stress fibers are different in the
fine structure. While tropomyosin antibody gives
clear periodic staining of stress fibers, such peri-
134
odic staining is not as clear with the anti-55-kD
protein antibody. Furthermore, as Figure 3, E and
F, shows, the center (arrow) of polygonal net-
works is stained with the anti-55-kD protein an-
tibody but not with the anti-tropomyosin anti-
body.
It is tempting to speculate that the 55-kD pro-
tein, together with the differential expression of
tropomyosin isoforms, regulates the microfila-
ment assembly in normal and transformed cells.
Immunofluorescence shows that tropomyosin is
localized in stress fibers but is absent in the mov-
able portions of cells, such as ruffling mem-
branes and microspikes. This observation, cou-
pled with the ability of this protein to stabilize
actin filaments, suggests that tropomyosin may
regulate the organization of microfilaments into
stress fibers. In normal cells with well-spread
morphology, where high-molecular-weight tro-
pomyosins are predominant, the 55-kD protein
probably makes bundles of actin filaments con-
taining high-molecular-weight tropomyosins.
These tropomyosin-containing bundles may be
stable enough to form stress fibers. In contrast,
in transformed cells where high-molecular-weight
tropomyosins are substituted by low-molecular-
weight tropomyosins, the 55-kD protein chases
out the tropomyosin from actin and makes actin
bundles without tropomyosin. Such tropomyo-
sin-free bundles may not be stable enough to form
stress fibers but may be used for the formation of
microspikes that are prominent in many trans-
formed cells. We are currently examining this hy-
pothesis through the combined use of biochemi-
cal, cell biological, and immunological methods.
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Intrinsic GTPase Activity of the ras
Proteins: A Biochemical Analogy
to the "G" Protein Family
T. Kamata, G. Binns, J.R. Feramisco [in collaboration with
R.W. Sweet, S. Yokoyama, M. Rosenberg, and M. Gross,
Smith, Kline and French Laboratories, Pennsylvania]
Ha-ras is a member of a multigene family in man
that encodes highly related proteins of 189 amino
acids (p21). In vitro, ras proteins bind GTP and
p21 mutants with threonine at position 59 and
autophosphorylate at that residue. Mutation (at
amino acids 12 or 61) and elevated expression of
ras genes result in cell transformation in culture
and are also observed in many types of human
tumors. Normal and mutant transforming ras
proteins show no differences in localization, lipi-
dation, or GTP binding. However, mutations at
position 12 in recombinant (Thr-59) p21 mole-
cules were observed to affect autophosphoryla-
tion. We have expressed the full-length normal
and T24 transforming (Gly --Val at position 12)
Ha-ras proteins in Escherichia coli and have pu-
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rified them to homogeneity; these proteins bound
GTP with approximately molar stoichiometry and
with an affinity comparable to that of partially
purified mammalian proteins. Microinjection of
the T24 protein into quiescent rodent fibroblasts
resulted in a rapid alteration in cell morphology,
stimulation of DNA synthesis, and cell division;
in contrast, little response was observed with the
normal protein. We now report that the normal
ras protein has an intrinsic GTPase activity, yield-
ing GDP and P whereas the T24 transforming
protein is reduced tenfold in this activity (Fig. 1).
We suggest that this deficiency in GTPase is the
probable cause for the transforming phenotype of
the T24 protein.
The tenfold reduction in GTPase activity of the
T24 protein represents the first major biochemi-
cal differentiation between the products of a nor-
mal and a transforming mutant ras gene. It is
tempting to speculate on the consequence of this
altered activity by drawing a functional analogy
to transducin and the G stimulatory protein -
both of these proteins are activators of enzymes
affecting cyclic nucleotide pools. This activation
requires GTP binding (or exchange of GTP for
bound GDP) and appears to terminate on hydro-
lysis to GDP. If the ras proteins have an analo-
gous regulatory function in whichever prolifera-
tive control pathway they participate, then the
deficiency in GTPase activity of the T24 mutant
could result in prolonged stimulation of an oth-
erwise regulatable activity. As shown for the G
stimulatory protein, perhaps modulation of ras
activity itself occurs through interactions with
other proteins, and these interactions may be sen-
sitive to whether GTP and GDP (or neither) oc-
cupies the nucleotide binding site.
Molecular Characterization of Ha-ras
Proteins: Proteolytic Substructure
D. Bar-Sagi, J.R. Feramisco
Oncogenic ras-encoded proteins differ from their
normal homologs by an amino acid substitution
for Gly-12, Ala-59, or Gln -61. To provide insight
into the structural requirements involved in the
oncogenic activation of ras proteins, we have ini-
tiated studies concerning the characterization of
their structural and functional domains. From
this analysis, we hope to build a framework to
study the function of ras proteins.
We have purified to homogeneity the protoon-
cogenic and oncogenic (T24) forms of Ha-ras
proteins produced in Escherichia coli. Both pro-
teins were subjected to digestion by trypsin under
mild conditions. Figure 2A displays the products
of limited tryptic digestion of the proteins at
different times during proteolysis. The results
indicate a progressive disappearance of the intact
Ha-ras proteins (24 kD) and the appearance of
23.5-kD and 21-kD polypeptides. The 23.5-kD
polypeptide is likely to be an intermediate in the
hydrolysis of Ha-ras protein as its appearance
precedes that of the 21-kD polypeptide. It then
declines in amount, and by 2 hours it has vir-
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FIGURE 1 GTP hydrolysis catalyzed by the ras pro-
teins. PEI-cellulose thin-layer analyses of incubations of
la-32PIGTP with the normal ras protein (lane 1), with the
activated oncogene ras protein (lane 2), or with BSA
(lane 3) are shown, Notice the low GTPase activity of
the oncogene protein.
FIGURE 2 (A) Time course of proteolysis of
Ha-ras protein by trypsin. Purified Ha-ras pro-
teins (normal and oncogenic) were digested
with trypsin at a ratio of enzyme to substrate of
1:100. The digestion was terminated at the in-
dicated intervals by boiling the samples in SDS-
solubilizing buffer. The samples were electro-
phoresed on a 17% SDS gel and polypep-
tides were visualized by Coomassie blue stain.
(8) Effect of tryptic digestion of normal Ha-ras
protein on the GTPase activity. The conditions
for proteolysis were the same as those de-
scribed in A. At the times indicated, the proteo-
lysis was terminated by the addition of trypsin
inhibitor. Aliquots from each sample were in-
cubated with [0,-32P]GTP for 1 hr and analyzed
for GTPase activity by thin-layer chromatogra-
phy. (C) V8 protease cleavage of the intact Ha-
ras protein (1) and the trypsin-resistant frag-
ment (2). Samples were digested with 5µg of
V8 protease for 90 min. The cleavage products
were resolved on 17% SDS gel, and polypep-
tides were visualized by silver stain.
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tually disappeared from the digestion mixture.
The 21-kD polypeptide accumulates during the
digestion, accounting for approximately 90% of
the stained material on the gel, and is resistant to
further cleavage even at higher concentrations of
the enzyme. Recently, we and others have ob-
served that normal ras protein exhibits GTPase
activity that is significantly reduced by the onco-
genic substitution Val-12. As shown in Figure 2B,
the 21-kD trypsin-resistant fragment of the nor-
mal ras protein retains GTPase activity. To de-
termine which portion of the Ha-ras protein is
represented in the 21-kD trypsin-resistant frag-
ment, we analyzed the protein by hydrolysis with
Staphylococcus aureus V8 protease. Cleavage of
the Ha-ras protein with V8 protease generates a
major 13-kD peptide that is derived from the
carboxyterminal half of the molecule. Figure 2C
shows that the major V8 peptide of the trypsin-
resistant fragment is smaller than the V8 peptide
of the intact protein by approximately 3 kD. It
therefore appears that the 21-kD proteolytic resis-
tant fragment is derived from the Ha-ras protein
by the loss of the 3-kD fragment from the car-
boxy terminus of the molecule.
In summary, we have demonstrated that the
carboxyterminal 3 kD of Ha-ras protein is not es-
sential for the catalytic activity of the protein.
Our results indicate that the catalytic domain of
the protein has a conformation that confers pro-
tection against limited conditions of hydrolysis.
In view of the fact that the Ha-ras protein is as-
sociated with the plasma membrane, it is intrigu-
ing to speculate that sequences located within 3
kD of the carboxyl terminus have a structural role
in membrane anchorage of the protein, whereas
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the GTPase activity is carried by a portion of the
amino terminus.
Microinjection of the ras Oncogene
Protein into Quiescent Cells
Results in Rapid Proliferation
J.R. Feramisco, N. Kronenberg, C. Hallaran, G. Binns,
T. Kamata [in collaboration with M. Gross,
M. Rosenberg, and R.W. Sweet, Smith, Kline
and French Laboratories, Pennsylvania]
Although the function of the ras proteins is not
yet known, several observations concerning their
possible role in cell proliferation have been de-
scribed. Epidermal growth factor or insulin stim-
ulates the GTP-dependent phosphorylation of the
murine v-ras protein and the guanine-nucleotide-
'binding activity of the ras proteins in ras-trans-
formed cells or membranes derived thereof. A
second observation is that (with only limited in-
formation available) there is some structural
homology between the ras proteins and the G
protein, which is known to regulate the hor-
mone-sensitive adenylate cyclase activity. These
observations suggest that the ras proteins may be
involved in growth-factor receptor activity, be it
at the level of the receptor(s) itself or in the sig-
nal transduction that may follow receptor acti-
vation with a mechanism that may employ a G-
like activity, and/or may be directly regulating the
adenylate cyclase system as deduced by M. Wig ler
and his colleagues (Molecular Genetics of Eukar-
yotic Cells Section).
To study the biochemical and biological activi-
ties of the human protooncogenic and oncogenic
forms of the Ha-ras proteins, we have begun to
examine the effects of the purified Ha-ras pro-
teins in living, normal cells by needle microinjec-
tion. Here, we show that the oncogenic form of
the human Ha-ras protein (T24) produced in and
purified from Escherichia coli causes rapid mor-
phological changes and induces cell division when
injected into quiescent, contact-inhibited cells
(see Fig. 3). In certain established cell lines, the
protein completely obviates the need for growth
factors in the proliferation process. In contrast,
microinjection of the wild-type protooncogenic
form of Ha-ras exhibits little, if any, effect on
these cells.
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Cooperation of the ras Oncogene
Protein with the Adenovirus El A
Oncogene Protein following
Microinjection into Quiescent
Nonestablished Cells
J.R. Feramisco, D. Bar-Sagi, W.J. Welch, T. Kamata
[in collaboration with N.F. Sullivan, R.W. Sweet,
T.L. Chao, B.Q. Ferguson, M.S. Gross, and
M. Rosenberg, Smith, Kline and French
Laboratories, Pennsylvania]
We have shown that early-passage nonestablished
rat embryo fibroblasts respond to microinjection
of Escherichia coli-made ras oncogene protein by
synthesizing DNA but not undergoing division.
This effect is specific to ras oncogene protein
since no response is observed upon injection of
comparable levels of the ras protooncogene pro-
tein. In contrast, microinjection of ras oncogene
protein into late-passage REF cells caused both
DNA synthesis and cell division. Early-passage
REF cells could be stimulated to divide in re-
sponse to oncogenic ras by either preincubation
in conditioned medium from late-passage cells or
coinjection experiments using the adenovirus E IA
13S mRNA gene product in combination with ras
oncogene protein. The localization
proteins in single cells after microinjection is
shown in Figure 4.
Of the two known growth-factor pathways, i.e.,
competence as induced by platelet-derived growth
factor (PDGF) and progression as induced by ep-
idermal growth factor (EGF), insulin, and soma-
tomadin C, only the progression pathway can be
blocked by cycloheximide. Since cycloheximide
blocks DNA synthesis in response to microin-
jected oncogenic ras, we believe that the ras pro-
tein must be involved in the progression pathway
of cell growth. In addition, ras must act before
the proposed restriction point between G, and S,
since after this point DNA synthesis cannot be
blocked by cycloheximide. Furthermore, since
oncogenic ras stimulates DNA synthesis with only
trace amounts of serum, it can apparently bypass
the need for exogenous competence and progres-
sion factors. Previous studies have indicated that
EGF and insulin treatment of cell membranes
leads to effects on the guanine-nucleotide-bind-
ing activity of the ras protein, observations that
tend to support some role for ras in these growth-
factor pathways.
- '
FIGURE 3 Stimulation of DNA synthesis and cell proliferation by microinjected ras
oncogene protein. Confluent NIH-3T3 cells were injected with the activated ras on-
cogene protein (A-D) or with the normal ras protein (E-H) and incubated with
[3H]thymidine. The fields were photographed at 0, 8, and 24 hr postinjection (A,B,C or
F,G, respectively). At 24 hr the cells were fixed, processed for emulsion autoradiog-
raphy, and rephotographed (D or H, respectively). Notice the proliferation induced by
the oncogene form of the ras protein.
Most strikingly, our microinjection studies have
shown that late-passage REF cells are more re-
sponsive to ras oncogene protein than their early-
passage counterparts. This may be due to the de
novo secretion of a growth factor(s) induced by
continued passage. We have not yet classified this
molecule(s), but it might be similar to 0-TGF,
since microinjection of ras oncogene protein into
early-passage cells grown in serum-free media
supplemented with EGF and 13-TGF results in cell
proliferation. These results suggest that upon re-
moval from native tissue culture in vitro, the cells
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FIGURE 4 Localization of the adenovirus E1A protein and
the ras oncogene protein after comicroinjection into living
cells. Purified adenovirus El A protein and the ras oncogene
protein (both purified from E. coil after expression) were
comicroinjected into primary rat embryo fibroblasts. Two
hours later, the cells were fixed and analyzed by double-
label immunofluorescence to detect the E1A protein (b) or
the ras protein (c).
immediately begin to change with respect to their
growth-responsive properties and continue to
change as passage number increases. Whether
this reflects a decrease in the cellular division
potential remains to be determined. Our results
suggest a possible explanation for previous re-
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sults which indicated that rat embryo fibroblasts
can be transformed at low frequency by over-
expression of the ras oncogene alone. Perhaps
complete transformation of REF cells in tissue
culture (even at early passage) may result from
cooperation between oncogenic ras and the in-
duced growth-factor response described here.
Inactivation of the ras Oncogene
Protein in Living Transformed
Cells via Antibody Microinjection
J.R. Feramisco [in collaboration with R. Clark, G. Wong,
N. Arnheim, R. Mil ley, and F. McCormick,
Cetus Corporation, California]
To obtain a biochemical probe capable of distin-
guishing the normal and oncogenic forms of the
ras proteins, antibodies were raised (by the Cetus
group) against ras (p21)-related peptides that dif-
fered at position 12. The antibody designated
anti-p21-ser was affinity-purified from the serum
of rabbits immunized with the peptide Lys6-Leu-
Val-Val-Gly-Ala-Ser12-Gly-Val -Gly-Lys I6-Cys-Ser
(serine at position 12) covalently coupled to car-
rier protein. The production and characterization
of this antibody will be described in detail by
R. Clark et al. (in prep.). Anti-p21-ser was found
to bind the v-Ki-ras protein (serine at position 12)
but not the v-Ha-ras protein (arginine at position
12) or the ras protein containing glycine (normal)
at position 12. In addition, biochemical studies
showed that this antibody blocked both the GTP-
dependent autophosphorylation and GTP-bind-
ing activities of the v-Ki-ras protein, suggesting
that the antibody and GTP bind to the same re-
gion of the protein.
With this high degree of specificity displayed
by the affinity-purified antibody preparation to-
ward the oncogenic v-Ki-ras protein, as well as
the ability of the antibody to inhibit the GTP-
binding activity of the v-Ki-ras protein, it seemed
possible that introduction of this antibody prep-
aration into living, transformed cells would block
the biochemical action of the ras oncogene pro-
tein in vivo, without affecting the function of the
protooncogene product. Using microneedle in-
jection procedures, we injected approximately
5 x 105 molecules of purified IgG (either anti-p21-
ser or nonimmune) into the cytoplasm of NRK
cells transformed by the v-Ki-ras oncogene (called
Ki-NRK cells). This represents a five- to tenfold
excess of antibody over the estimated amount of
the ras protein in these cells. Within 15 hours,
and persisting for 48 hours after injection of the
anti-p21-ser antibodies, the Ki-NRK cells showed
a flattened, normal morphology, and after 48
hours, the cells eventually returned to their
rounded morphology. In contrast, cells on the
same dish injected with control IgG showed no
obvious change in morphology. (Control Ig Gs
included goat anti-mouse IgG and rabbit nonim-
mune IgG.) Inspection of the photographs taken
from these types of experiments indicated that in
addition to the reversion of the transformed phe-
notype, the flattened cells appeared to grow at a
slower rate than cells injected with control IgG or
in surrounding uninjected cells. Considering the
data from the genetic analysis of the yeast ras
genes which indicated that complete elimination
of ras gene expression leads to nonviable cells (see
M. Wig ler et al., Molecular Genetics of Eukar-
yotic Cells Section), we might predict that anti-
bodies that block the function of both the normal
and oncogenic forms of the ras proteins would
kill or prevent growth of microinjected, trans-
formed mammalian cells. However, the cells in-
jected with the anti-p21-ser preparation are capa-
ble of growth, a result that is in keeping with the
biochemical experiments which showed that this
antibody only binds to the oncogenic form of the
ras protein with serine at position 12.
By utilizing immunofluorescence microscopy,
we determined exactly which cells were inocu-
lated with the two antibody preparations. An ex-
act correlation between the cells inoculated with
the anti-p21-ser preparation and the morphologi-
cally normal, flattened cells was seen (Fig. 5).
Again, cells inoculated with the control IgG re-
tained their rounded, transformed appearance.
(.1.4
FIGURE 5 Injection of antibodies specific for the ras oncogene protein causes reversion of the transformed phenotype of
ras-transformed cells. Ki-ras-transformed NRK cells were injected either with nonimmune IgG (A,B) or with IgG specific for the
Ki-ras oncogene protein (C,D). Twenty-four hours later, the cells were fixed and analyzed by immunofluorescence to detect
the injected IgGs. Notice the flat, normal appearance of the cells injected with the anti-ras IgG.
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Protein Kinase C
K. Matlack, T Kamata, M. Wooten, D. Bar-Sagi,
D.M. Helfman, S. Smith, J.R. Feramisco
As our interest in the molecular mechanisms of
growth control widens, we have undertaken stud-
ies to examine the role of phospholipids and pro-
tein kinase C in the cell. A wide variety of exper-
iments have suggested regulatory roles for protein
kinase C, phospholipids, and their breakdown
products in growth-factor action and thus have
captured our attention. Here and in the follow-
ing report, we describe the purification, charac-
terization, and cloning of protein kinase C.
One of the major problems one faces in work-
ing with protein kinase C is a lack of purified,
stable enzyme. To overcome this problem, we
designed a protocol applicable to many tissues
and sources that enabled us to generate relatively
large quantities of purified protein kinase C.
The principal feature of the purification proce-
dure is an affinity column utilizing protamine at-
tached to a solid support. Protamine is the one
known substrate that is utilized by protein kin-
ase C in the absence of Ca' or phospholipids.
Thus, protein kinase C binds tightly to the affin-
ity support in the absence of any added activators
of the enzyme. It is eluted from the column when
MgATP is added, which most likely reflects a
lower affinity of the enzyme to protamine after
phosphorylation (i.e., product release). By com-
bining this step with several steps taken from the
original, lengthy procedure of Y. Nishizuka (Kobe
University, Okazaki, Japan), we can easily purify
relatively large quantities (,,500 jug) in less than 1
week (Fig. 6).
Isolation of cDNA Clones Encoding
Protein Kinase C
D.M. Helfman, T. Kamata, M. Wooten, S. Smith, M. Zoller,
C. Slaughter, T. Fischer, J.R. Feramisco [in collaboration
with J.F. Kuo, P Girard, and I.C. Gonsalus, Department of
Pharmacology, Emory University School of Medicine]
To isolate cDNA clones encoding protein kinase
C, we constructed a cDNA expression library of
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FIGURE 6 Purified protein kinase C. Approxirnately 5µg of
rat brain protein kinase C was applied to an SDS-polyacryl-
amide gel; the resultant gel was stained with Coomassie blue.
approximately 80,000 members from adult rat
brain using the plasmid expression vectors pUC8
and pUC9. Using antisera for brain protein ki-
nase C, we have identified and isolated six bacte-
rial colonies producing protein products antigen-
ically related to protein kinase C. The plasmids
were isolated, and the cDNA inserts ranged in size
from 0.6 kb to 2.7 kb. The fusion proteins pro-
duced in bacteria have a molecular weight rang-
ing from 17,000 to 80,000. The size of the cDNA
inserts correlated with the size of the fusion pro-
teins. Three independent colonies were found to
produce a fusion protein with a molecular weight
of about 80,000, approximately the size of au-
thentic protein kinase C. Comparison by peptide
mapping of the 80,000-molecular-weight bacte-
rial fusion proteins with authentic protein kinase
C isolated from rat brain indicated that the two
proteins were indeed related. In addition, the
cDNA clones encoding the large fusion protein
were found to cross-hybridize to a synthetic oli-
gonucleotide probe prepared from direct amino
acid sequence analysis of purified brain protein
kinase C. We are continuing to characterize these
putative cDNA clones encoding protein kinase C.
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Cell Biology of the Mammalian
Stress Response
W.J. Welch, J.R. Feramisco, G. Binns,
N. Kronenberg, C. Hallaran
Mammalian cells, when confronted with adverse
environmental conditions, undergo what is re-
ferred to as "stress response." This universal re-
sponse is characterized by the rapid, increased
transcription and translation of a small number
of genes, resulting in the increased synthesis and
accumulation of a group of proteins, the stress
GTPase and the T24 oncogenic mutant is deficient in this
activity. Nature 311: 273-275.
Welch, W.J. and J.R. Feramisco. 1984. Nuclear and nudes-
lar localization of the 72,000-dalton heat shock protein in
heat-shocked mammalian cells. J. Biol. Chem. 259:
4501-4513.
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proteins. Although the function of any one of
the individual stress proteins is unknown, collec-
tively, these proteins appear to serve some pro-
tective capacity both during and after recovery
of a particular environmental insult. We have
continued to study and define many of the basic
changes occurring in the stressed cell. In addi-
tion, using both biochemical and immunological
approaches, we have paid considerable attention
to the structure, properties, and intracellular lo-
cation of the individual stress proteins with the
eventual aim to determine the function these pro-
teins serve in the cell.
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Morphological Studies
W.J. Welch, J.P. Suhan
To get a better feeling of the many events occur-
ring in the stressed cell, we have been examining
basic morphological changes that accompany in-
duction of the stress response, using both light
and electron microscopy. We have characterized
a number of interesting alterations occurring in
both the cytoplasm and nucleus of cells following
heat-shock treatment. For example, we have ob-
served that incubation of rat fibroblasts at 42°C
for 3 hours results in a fragmentation and vesi-
cularization of intracellular membranous organ-
elles, including the endoplasmic reticulum and
Golgi complex. The disruption in these organ-
elles is of interest since two of the mammalian
stress proteins, the 80-kD and 100-kD proteins,
are associated with the endoplasmic reticulum
and Golgi complex, respectively (Welch et al., J.
Biol. Chem. 258: 7102 [1983]). We have also ob-
served changes that occur in the mitochondria of
cells following heat-shock treatment, including
a general swelling of the mitochondria, an in-
creased electron density of the individual cristae,
and an accompanying increase in the intramem-
brane space between individual cristae. These
subtle changes in the structure of the mitochon-
dria may turn out to be significant, since it has
been suggested that changes in mitochondrial
function per se may be involved in the trigger-
ing of the stress response. We are continuing to
investigate this possibility by analyzing changes
in mitochondrial activity using various biochem-
ical techniques. Numerous changes with respect
to various cytoskeletal components in stressed
mammalian cells have also been found, including
an increase in the number of actin-containing
stress fibers that span the cytoplasm of the
stressed cell, indicative of the growth-arrested
state of the cells (Thomas et al., Cold Spring
Harbor Symp. Quant. Biol. 46: 985 [1982]). In
addition, there is a complete reorganization in the
distribution of the vimentin-containing interme-
diate filaments following physiological stress. The
filaments are observed to collapse around the nu-
cleus, with large aggregated bundles of filaments
very near the nuclear membrane. Removal of the
stress agent and incubation of the cells under nor-
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mal conditions result in a gradual restoration of
normal intermediate filament distribution.
Considerable alterations also occur within the
nucleus of the cells following heat-shock treat-
ment. For example, we have observed unusual nu-
clear inclusion bodies that are composed of bun-
dles of parallel filaments. Using biochemical and
immunological techniques, we have determined
that these structures consist of finely packed ac-
tin-containing filaments (see Fig. 1). These bun-
dles of actin filaments were never observed to ex-
tend through the nuclear membrane into the
cytoplasm. Suffice it to say, we as yet do not un-
derstand the significance of these structures with
respect to the other changes occurring within the
stressed cell. We have also found that dramatic
changes occur within the nucleoli of cells follow-
ing physiological stress, including a decondensa-
tion of the nucleoli and an accompanying swell-
ing and/or unraveling of the nucleoli, a dimin-
ishment in the number of granular components,
and changes in the organization of the fibrillar
reticulum. These nucleolar alterations may be
significant, since there is an accompanying inhi-
bition of ribosomal RNA synthesis and ribo-
somal assembly following physiological stress.
Moreover, these nucleolar alterations are of con-
siderable interest since two of the major mam-
malian stress proteins, the 72-kD and 110-kD pro-
teins, localize within the nucleolus in cells both
during and after recovery from physiological
stress (Welch and Suhan, J. Cell Biol. [1985] sub-
mitted).
Purification, Characterization, and
Intracellular Localization of the
Major Mammalian Stress Protein
W.J. Welch, J.R. Feramisco, G. Binns
Mammalian cells placed under stress synthesize
(and accumulate) proteins with apparent molec-
ular masses of 28, 72, 73, 80, 90, 100, and 110 kD.
All of these proteins, with the exception of the 72-
kD species, are synthesized at appreciable levels
in cells grown under "normal" conditions. Their
presence in normal cells suggests that many of the
stress proteins probably serve some function(s) in
FIGURE 1 Intranuclear inclusions in heat-treated cells are composed of actin. Rat embryo
fibroblasts were grown on plastic dishes at 42°C for 3 hr, and sections through the nucleus
were analyzed by electron microscopy (1a,lb). Similarly heat-treated fibroblasts were fixed,
extracted, and incubated with heavy meromyosin (/c). Note the typical arrowhead decoration
of the actin filaments. The phase-contrast (1d) and corresponding fluorescent micrograph
(/e) of a heat-treated cell analyzed by indirect immunofluorescence using a mouse monoclo-
nal antibody specific for actin are shown. The phase-dense nuclear actin inclusion bodies are
evident in ld and stained with the anti-actin antibody in le. Bars: (1a,lb) 5 pm; (1c) 1 pm.
normal cells distinct from their role during stress. levels of glucose, calcium, or even various growth
Indeed, we have found that the synthesis and/or factors. In the case of the most highly induced
posttranslational modifications of some of the stress protein of 72 kD, its synthesis appears lim-
stress proteins appear sensitive to extracellular ited to cells experiencing stress; therefore, we have
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paid considerable attention to the properties of
this protein (Welch and Feramisco, J. Biol. Chem.
257: 14949 [1982]). We and others have found
that the 72-kD protein appears to interact in vivo
with nucleic acids, specifically RNA. In addition,
we have recently observed that the 72-kD protein
and its partially related counterpart (73 kD) inter-
act with various nucleotides in vitro. We have
taken advantage of their affinity for nucleotides
and have now developed a rapid two-step purifi-
cation of the 72-kD and 73-kD proteins, utilizing
affinity chromatography on ATP agarose. In ad-
dition, this purification procedure has allowed us
to purify one of the other major mammalian
stress proteins, the 80-kD protein, as well as a
noninduced protein, the 75-kD protein, which in-
terestingly appears to be related to both the 72-
kD and 73-kD proteins (Welch and Feramisco,
Mol. Cell. Biol. [1985] in press).
We have raised both polyclonal and monoclo-
nal antibodies to several of the mammalian stress
proteins, including the major-induced 72-kD spe-
cies. Using these antibodies, we have shown that
the 72-kD protein localizes to the nucleolus in
stressed cells and also during the recovery period
following stress (Welch and Feramisco, J. Biol.
Chem. 259: 4501 [1984]). More recently, we have
found a number of significant differences with
respect to the localization of the 72-kD protein in
cells recovering from stress after prior exposure
to either heat shock, amino acid analogs, or so-
dium arsenite (W.J. Welch, in prep.). We are con-
tinuing to examine the nuclear, nucleolar, and cy-
toplasmic distribution of the 72-kD protein and
have defined some of the basic parameters gov-
erning its intracellular localization. First, we have
found that the nucleolar deposition of the 72-kD
protein is a stress-specific phenomenon. For ex-
ample, microinjection of purified and fluores-
cently labeled 72-kD protein into the cytoplasm
of cells incubated at 37°C resulted in the protein
being distributed throughout the cytoplasm and
the nucleus, but not the nucleolus. Following
heat treatment of the cells, however, the fluores-
cently labeled 72-kD protein migrated into the
nucleolus (see Fig. 2). This migration appears to
be independent of the synthesis of the other stress
proteins, since prior treatment with cyclohexa-
mide and subsequent heat-shock treatment still
resulted in the 72-kD protein being deposited
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within the nucleolus. We are currently assessing
the effects of transcriptional inhibitors on the in-
tranucleolar distribution of the 72-kD protein and
are determining whether its distribution is af-
fected by RNase and/or DNase treatment of the
cells. In addition, using immunoelectron micros-
copy, we are very carefully examining where in
the nucleolus the 72-kD protein localizes. Specif-
ically, is the protein located within the granular
or fibrillar regions? If in the granular region, this
would be indicative of the protein migrating to
the nucleolus to be assembled into some sort of
ribonucleoprotein component. We find this pos-
sibility most plausible considering that the pro-
tein does show an affinity for RNA and that the
nucleolus is the site of assembly of many different
ribonucleoprotein complexes. Preliminary im-
munoelectron microscopy studies, as well as bio-
chemical studies analyzing stabilized UV cross-
linked ribonucleoprotein complexes, are consis-
tent with this idea.
Changes in the Small 28-kD Stress
Protein in Response to Mitogens
and Growth Factors
W.J. Welch
We are paying considerable attention to the small
28-kD stress protein of mammalian cells. This
protein, which contains no methionine, is com-
posed of at least three highly related isoforms, two
of which are heavily phosphorylated. During in-
duction and recovery from stress, synthesis of the
28-kD protein increases approximately tenfold,
yet there appears to be little change in the net
phosphorylation of the protein. Interestingly, we
have found that the phosphorylation of this pro-
tein, but not its synthesis, increases in quiescent
cells following refeeding with fresh serum or af-
ter exposure of the cells to either phorbol esters
or calcium ionophores (Welch, J. Biol. Chem.
260: 3058 [1985]). In addition, preliminary data
in conjunction with J.R. Feramisco (this section)
have shown an increased phosphorylation of the
28-kD protein in cells induced to proliferate fol-
lowing microinjection of the oncogenic form of
the ras protein. Our excitement regarding these
AC
FIGURE 2 Microinjection of fluorescently labeled 72-kD and 73-kD stress proteins. The purified 72-kD and 73-kD stress
proteins were conjugated with the chromophore tetramethyl rhodamine isothiocyanate, and the fluorescently labeled proteins
were microinjected into the cytoplasm of rat embryo fibroblasts (37°C). The cells were then incubated either at 37°C (A,B) or
at 42°C (C,D). The proteins were visualized by fluorescent microscopy using the appropriate filters. (A,C) Phase-contrast
micrographs; (B,D) corresponding fluorescent micrographs.
observations is twofold. First, we think it is in-
teresting that synthesis or phosphorylation of the
same protein is affected in growth-arrested cells
(i.e., following heat shock) or in proliferating
cells. Perhaps the 28-kD protein plays some cen-
tral role in these seemingly opposed phenomena.
Second, in Drosophila melanogaster, some of the
analogous small stress proteins have been impli-
cated in various development and/or differentia-
tion processes. Hence, it will be interesting to see
if the mammalian 28-kD stress protein similarly
plays some role in growth processes, especially
during development. To facilitate these types of
studies, we are currently in the process of purify-
ing the 28-kD protein and characterizing its var-
ious biochemical properties; we are also trying to
prepare monoclonal antibodies specific for this
protein.
Presence of the 90-kD Stress Protein in
Steroid Hormone Receptor Complexes
W.J. Welch, J.R. Feramisco [in collaboration with E. Baulieu
and M. Catelli, Inserum Lab, Bicetre, France]
Two forms of steroid hormone receptor appear to
exist within cells: a nontransformed 8S form and
a transformed or activated 4S form, which ap-
pears to be derived from the 8S form. SDS-PAGE
of the 8S receptor shows a number of protein
constituents, the major species having apparent
molecular masses of 80, 90, and 110 kD. In the
case of the 4S form of the receptor, only the 80-
kD and 110-kD species are evident, with these two
polypeptides showing affinity for various ste-
roids. Using biochemical and immunological
techniques, we have shown that the 90-kD protein
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component present in the 8S progesterone recep-
tor complex is in fact the 90-kD stress protein
(Cate lli et al., Nature [1985] submitted). It would
appear that the 90-kD protein, which itself does
not show an affinity for steroids, is lost from the
8S complex following binding of the steroid and
the accompanying conversion to the 4S form of
the receptor. Precedence for a transient associa-
tion of the 90-kD stress protein with other ma-
cromolecules has been demonstrated. For exam-
ple, investigators in many laboratories have shown
that a number of retrovirus transforming pro-
teins, all of which are tyrosine-specific kinases,
are transiently associated with the 90-kD protein
following their synthesis on free polysomes in the
cytoplasm. This complex, containing the partic-
ular tyrosine kinase, the 90-kD stress protein, and
another cellular protein of 50 kD, appears to be
involved in the translocation of the oncogene pro-
tein from its site of synthesis to its final destina-
tion in the plasma membrane. Interestingly, when
associated with the 90-kD and 50-kD proteins, the
particular tyrosine kinase shows diminished ac-
tivity. Thus, we now have a second example in
which the 90-kD stress protein displays a tran-
sient association with other biologically impor-
tant macromolecules, that being the steroid re-
ceptor. We are currently determining whether the
8S form of the steroid receptor also contains an
associated tyrosine kinase activity.
Production of Monoclonal Antibodies
to the Mammalian Stress Proteins
W.J. Welch, N. Kronenberg
To facilitate our studies on their structure, func-
tion, and intracellular location, we are preparing
monoclonal antibodies to the various stress pro-
teins. These efforts are now beginning to show
success. Currently, we have obtained at least 20
different monoclonal antibodies to the major in-
duced 72-kD stress protein. We are in the process
of characterizing these antibodies with respect to
their antigenic site within the molecule. In addi-
tion, we are in the process of making monoclonal
antibodies specific to the 73-, 80-, and 90-kD
stress proteins.
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Comparison of the Stress Response
in Normal and Transformed Cells
W.J. Welch, J.R. Feramisco
As we discussed in last year's report, transformed
cells, in general, appear much more thermosensi-
tive than do their nontransformed counterparts.
However, the basis for this difference in thermal
sensitivity is not at all clear. Athough synthesis
of the stress proteins appears to occur in the
transformed cells placed under stress, there do
appear to be some differences with respect to the
intracellular location of at least the 72-kD and
110-kD stress proteins. For example, whereas
most all of the normal rat fibroblasts show a nu-
cleolar locale of 72 kD during and after recovery
from heat-shock treatment, only about 5% of
either SV40- or adenovirus-transformed rat fi-
broblasts show a nucleolar distribution of the
protein. Similar differences in the intranucleolar
distribution of the 110-kD stress protein in nor-
mal and transformed cells have also been ob-
served. Interestingly, the few transformed cells
that did show the 72-kD nucleolar staining are al-
ways found in close association with one another,
indicative perhaps of there being some correla-
tion between the cell cycle and the ability of the
cells to exhibit the nucleolar staining. Therefore,
we are in the process of examining more carefully
the possible correlation between induction and/
or proper localization of the stress proteins as a
function of the cell cycle in both normal and
transformed cells. In addition, we should point
out, with regard to cell cycle, that physiological
stress itself seems to somehow arrest cells at a
particular point in the cell cycle (W.J. Welch and
J.R. Feramisco, in prep.).
We are also pursuing the possibility that basic
differences in certain metabolic pathways of the
transformed cells may be responsible for their ob-
served high thermosensitivity. For example, it has
been well established that transformed cells ap-
pear more dependent on glycolytic rather than
respiratory metabolism, and therefore the cells
utilize high levels of extracellular carbon sources
such as glucose. Due to their high glycolytic ac-
tivity (and consequent lactic acid production), the
transformed cells tend to acidify their extracellu-
lar medium. Hence, we have been asking whether
these metabolic differences exhibited by the
transformed cells could be at all responsible for
their thermosensitivity. Therefore, we have ma-
nipulated the environment of the normal cells to
mimic that found for the transformed cells and
asked whether the cells will now exhibit thermo-
FIGURE 3 The 72-kD stress protein is trans-
located to the nucleus/nucleolus in heat-
treated cells containing a disrupted cytoske-
leton. REF52 cells growing on glass cover-
slips at 37°C were treated with colcemid (2
/1M for 5 hr; i.e., no microtubules and col-
lapsed intermediate filaments), cytochalasin
E (2 pg/m1 for 2 hr; i.e., no actin microfila-
ments), or with a mixture of colcemid and cy-
tochalasin (2 pm for 5 hr and 2 pg/m1 for 2 hr,
respectively; i.e., disruption of all three cyto-
skeletal networks). The cells, in the presence
of the drugs, were then incubated at 42°C for
3 hr. Following heat-shock treatment, the cells
were fixed and processed for indirect immu-
nofluorescence using a polyclonal antibody
specific for the 72-kD heat-shock protein.
(A,C,E,G) Phase-contrast micrographs;
(B,D,F,H) fluorescence micrographs. (A,B)
Control, untreated heat-shocked cells; (C,D)
heat-shocked cells treated with 2 pm col-
cemid; (E,F) heat-shocked cells treated with
2 µg /ml of cytochalasin E; (G,H) heat-shocked
cells treated with a mixture of colcemid (2 pilvI)
and cytochalasin E (2 ',gimp.
sensitivities similar to that observed for the trans-
formed cells. Indeed, we have found that inhibit-
ing the ability of the normal cells to respire (by
addition of agents that block mitochondrial func-
tion) or simply lowering the pH of the normal
cells markedly increases the cells sensitivity to a
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heat-shock challenge. We are continuing these
types of studies in hope of defining the basic pa-
rameters responsible for the high thermal sensi-
tivities exhibited by the transformed cells.
Use of the Heat-shock Response to
Study the Cytoskeleton
W.J. Welch, J.R. Feramisco
As mentioned above, physiological stress results
in a collapse of the vimentin-containing inter-
mediate filaments. We therefore asked whether
other agents that similarly result in collapse of the
intermediate filaments would also result in an in-
duction of the stress response. Others have shown
that treatment of the cells with various drugs that
depolymerize microtubules (colcemid, colchicine,
etc.) also cause a collapse of the intermediate fil-
aments. However, we found that treatment of rat
fibroblasts with these drugs did not result in an
induction of the stress response. Moreover, there
appeared to be little or no change in the overall
pattern of protein synthesis in those cells treated
with these cytoskeletal disrupting drugs. This was
somewhat surprising since investigators in other
laboratories have suggested that translational
machinery in eukaryotic cells functions when in
association with cytoskeletal elements. Using the
heat-shock response to induce de novo transcrip-
tion and translation events, we asked whether cells
containing a disrupted cytoskeleton could faith-
fully make and translate new mRNAs even when
the cells contain no integral and intact macro-
cytoskeleton. For these experiments, cells were
treated with drugs that disrupt the actin-contain-
ing microfilaments, vimentin-containing inter-
mediate filaments, and microtubules; they were
placed under heat shock and then labeled with ra-
dioactive amino acids. Despite the absence of an
intact cytoskeleton, the cells were still able to rec-
ognize and respond to the heat treatment as as-
sayed by the vigorous production of the stress
proteins. In addition, the drug-treated cells, after
heat-shock treatment, were still able to translo-
cate the 72-kD stress protein from the cytoplasm
into the nucleus and nucleolus (see Fig. 3). These
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results thus raise doubts with regard to previous
suggestions implicating a dependence of new
translational events and the association of trans-
lational machinery with the cytoskeleton. They
also demonstrate that some protein translocation
events, specifically, migration of proteins from
their site of synthesis in the cytoplasm into the
nucleus, can occur in the absence of any integral
cytoskeletal networks (Welch and Feramisco,
Mol. Cell. Biol. [1985] in press).
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QUEST TWO-DIMENSIONAL GEL LABORATORY
J.I. Garrels C. Chang P. Smith
B.R. Franza, Jr. L. Cascio H. Wenzel
The Quest System for Two-dimensional
Gel Analysis
J.I. Garrels, B.R. Franza, Jr., P. Smith,
L. Cascio, H. Wenzel
DEVELOPMENT OF PROTEIN DATABASES
During 1984, our program for development of
protein databases derived from two-dimensional
gel analysis has turned from software develop-
ment to problems of data management, distribu-
tion, and presentation. In our laboratory, the
production of standardized two-dimensional gels
has been routine, and the computer software for
spot quantitation and matching has been highly
refined. Although our computer system has been
much too small for the size of the programs re-
quired and for the amount of data to be ana-
lyzed, the hardware limitations will be overcome
in 1985 (see below). Even with the relatively small
database that we now have, it has been clear that
the next major area of technical development
must be in the handling of the databases them-
selves. Here, we present several forms of analyses
of our rat fibroblast protein database, illustrating
some of the ways we have found to present large
amounts of two-dimensional gel data reduced to
an easily understood form. In addition, we dis-
cuss the hierarchical strategy we have developed
for the management of much larger databases.
Most of the data in our rat fibroblast database
come from an intensive study of the REF52 cell
line and its transformed derivatives. The lines are
described in our previous reports and in the fol-
lowing report. A number of experiments on these
lines have been analyzed and some of the data are
presented in Figure 1. This example points out
the magnitude of the data we must manage. The
output, of which only a small portion is shown,
presents the quantitative changes for more than
900 proteins in 16 different experiments. Each
small graph shows how the relative incorporation
into a given protein changed throughout the
course of an experiment. We find that the graphs,
each scaled to put the highest point at full scale,
are easily scanned visually for interesting regula-
tory patterns. The large array of graphs, with a
different spot on each row and a different exper-
iment on each column, can be quickly scanned in
either dimension for changes of interest. Al-
though the amount of data presented in this way
is still large, it is vastly reduced from the original
image data represented on hundreds of films.
The fact that data in this form is usable and in-
teresting can be seen by examination of the graphs
for any particular spot.
The protein PCNA (proliferating cell nuclear
antigen), spot 388, has been studied previously in
our system. We find that its rate of synthesis de-
creases at confluence in normal cells (graph in
column 1) but that its rate of synthesis does not
decrease in proportion to density in transformed
cells (next nine columns). The last two columns
show the relative rates of synthesis of PCNA in
normal and in nine transformed cells during
growth phase on day 3 (column 15) or day 4 (col-
umn 16) after plating. These two graphs show al-
most identical patterns because little change in
rates of protein synthesis occurs from one day to
the next during the proliferative phase. The other
experiments presented here are described in Fig-
ure 1.
When viewed on the graphics screen, the user
can point to graphs of interest and have the com-
puter display the appropriate regions of the gel
images. Having found a protein of particular in-
terest, the user can ask for more information
about the protein, or having found an interesting
pattern of change, the user can ask the computer
to highlight other proteins that change in similar
ways. The reader can see that other proteins in
Figure 1 show interesting regulatory patterns, in-
cluding the tropomyosins (spots 448, 350, 398,
328, 320, 420 for tropomyosins 1 through 6, re-
spectively).
In another look at the data from REF52 and
the nine viral transformants, we asked the com-
puter to count the number of proteins that re-
spond to fresh serum (after being deprived of
serum) in normal REF52 cells and how many of
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FIGURE 1 Spot graphs showing patterns of incorporation into 15 proteins
throughout the course of 16 experiments. Numbers at the left are the standard spot
number, and each column (1-16) represents a different experiment. In each exper-
iment, six to ten samples were radiolabeled and analyzed by quantitative two-di-
The graphs are scaled to put the highest point at full
scale. These small graphs are designed to present visually recognizable regulatory
patterns that can be compared among experiments and among proteins. The ex-
periments are as follows: (1 -10) Growth curves for REF52, REF52-WT2, REF52 -
AG2, REF52-NU2, REF52-WT6, REF52-AG6, REF52-NU6, REF52-Ki-MSV, REF52-
Ad5D.4A, and REF52-Ad5W4A; (11,12) comparisons of REF52 with six SV40 trans-
formants in normal and defined medium, respectively; (13) comparison of REF52
cells in normal and defined medium, followed by REF52-SV1A cells in normal and
defined medium, followed by REF52-SV2A cells in normal and defined medium; (14)
REF52 cells labeled for 30 min (two samples), 2 hr (two samples), 24 hr (two sam-
ples), and 24 hr followed by a 48-hr chase (two samples); (15, 16) comparisons of
REF52 cells and the nine transformed lines mentioned above on days 3 and 4,
respectively, after plating. For proteins not detected in a given sample, the data
point is plotted at the base line. When a protein was not detected in any of the
samples of the experiment, no graph is plotted.
these proteins are still serum-sensitive in each of
the transformants. We find that analysis of dy-
namic differences (changes in the response of a
protein to a stimulus) is often more rewarding
than just the analysis of static differences
(changes in the level of a protein). In the analysis
of response to serum stimulation, we reduced the
data from about 60 films to yield the results
shown in Table 1. Of the 77 proteins that in-
crease in rate of synthesis after addition of fresh
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serum to REF52 cells, only about 50% are in-
duced in cells minimally transformed by SV40
(WT2 and WT6), only 35% are induced in SV40
cells selected for growth in soft agar (AG2 and
AG6), and only 25-30% are induced in SV40-
transformed cells selected for tumorigenicity
(NU2 and NU6). The adenovirus-transformed
REF52 cells are even less responsive to serum
stimulation, and in one adenovirus transformant
(a mutant lacking the 57K E I B protein), only 1 of
TABLE 1 Loss of Response to Fresh Serum in
Transformants
REF52 responses
remaining in transformant
increases decreases
REF52 77 (100%) 59 (100%)
WT2 45 (58%) 26 (44%)
AG2 26 (34%) 8 (14%)
NU2 20 (26%) 24 (41%)
WT6 39 (51%) 7 (12%)
AG6 27 (35%) 6 (10%)
NU6 25 (32%) 11 (19%)
KIR 27 (35%) 7 (12%)
A5D 12 (16%) 10 (17%)
A5W (- E1B57K) 1 (1%) 10 (17%)
the 77 responses could be found. These changes
follow in order of the apparent "degree of trans-
formation," determined by overall relatedness of
the protein pattern of each line to normal REF52.
Among the proteins of REF52 cells that de-
crease when serum is added, even fewer of the re-
sponses remained in the transformants, although
the percentage of responses remaining was less
well ranked. The proteins that increase in fresh
serum must include many needed for return to
rapid growth, whereas those that decrease in fresh
serum include many of the possible indicators of
the "differentiated" state, such as smooth-muscle
actin, vinculin, and some of the tropomyosins.
This type of analysis helps greatly to understand
coordinate control and reveals which regulatory
pathways may be affected by each form of trans-
formation. The reproducibility of the regulatory
changes found among several different lines
transformed by the same virus indicates that these
changes are fundamental to the transformed state.
In a third analysis, we compared the responses
of normal and SV40-transformed REF52 cells to
the effects of cell density. AG6 cells were refed
every 48 hours to prevent media depletion and
were labeled several times during growth to con-
fluence. At confluence, REF52 cells became qui-
escent. The SV40-transformed cells did not stop
dividing, but their rate was slowed considerably.
Our hypothesis was that fewer changes would oc-
cur in the transformed cells because their growth
rate is less affected by density. Accordingly, we
expected to find many changes occurring in
REF52 cells as a function of density that did not
occur in AG6 cells.
The results in Table 2 show that SV40-trans-
formed cells change by just as much as REF52
cells when they reach confluence but that the pro-
teins involved are quite different. In both lines,
more than 20% of the proteins show changes by
more than twofold, but the difference between
the two lines at confluence is much greater than
it was during proliferation. The computer has re-
vealed several interesting proteins that are de-
tected at low levels in dividing or confluent
REF52 cells and in dividing AG6 cells, but at dra-
matically higher levels in confluent AG6 cells.
Analysis of other experiments being added to the
database can shed more light on the regulation of
these proteins.
A HIERARCHY OF DATABASES
The data presented above came from a series of
studies of the REF52 cell line, and all experiments
were matched to a single standard pattern. Ide-
ally, all experiments with rat cells would be
matched to the same standard pattern to form a
comprehensive rat protein database. Unfortu-
nately, a single standard map for rat cells is im-
practical, because (1) it becomes very complex and
(2) its integrity is difficult to maintain in a mul-
tiuser environment if any user is allowed to add
TABLE 2 Relatedness of Normal and Transformed
Cells during Proliferation and at Confluence
Comparison
Standard
deviation.
Differences
(>twofold)°
Qualitative
differences°
REF52 dividing
vs.
AG6 dividing 0.97 18 9
REF52 dividing
vs.
REF52 confluent 1.11 22 4
AG6 dividing
vs.
AG6 confluent 1.01 22 7
REF52 confluent
vs.
AG6 confluent 1.26 29 13
Based on logarithm (base 2) of spot ratios (",650 spots compared).
bPercentage of matched spots with ratios less than 0.5 or greater
than 2.0 (,,650 spots compared).
aProteins prominent in one sample (300 most abundant) but not
detected in other sample.
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new spots to it. Most users first need their own
standard pattern so that they can compare the gels
of one experiment among themselves, and only
secondarily do they need to match their data to
the standard patterns used for the higher-level da-
tabases. Therefore, we have developed our sys-
tem to support an unlimited number of standard
patterns. Using programs that allow standard
patterns to be matched to one another, a hierar-
chical database structure becomes supportable.
The lowest level of the hierarchical database
structure is the individual experiment. The typi-
cal experiment involves a related group of sam-
ples that can be easily compared with one an-
other. A standard pattern representing all the
spots detected in the experiment is automatically
generated, and a mini-database is generated by
matching each of the gels of the experiment to
this standard. At this level, users can plot the
changes of each protein throughout the course of
the experiment and can find interesting differ-
ences. When users have highly related experi-
ments and have used the same standard for each,
they can plot the changes of each protein in sev-
eral experiments. The procedures for analysis of
a single experiment are simple enough that most
users can build their own standards and analyze
their own experiments with minimal help from the
computer staff. Such a database should be pri-
vate, accessible only to the scientists involved in
the project.
At the second level, users may want to compare
their data with other data in the system. These
may be data from other experiments that were
done using different standard patterns, as well as
data made available from other investigators. To
serve these needs, larger databases must be built
up from individual experiments. These will be
called public databases, because they contain data
accessible to all investigators. Again, these data-
bases must not be too general but should be fo-
cused in targeted areas, such as rat fibroblasts,
mouse embryo cells, and human diploid fibro-
blasts. Microorganisms such as yeast or Esche-
richia coli can probably be handled as a single
database, but a single database encompassing all
proteins of a multicellular organism is still too
complex. When data from a private database are
made available to the public, the data can be en-
tered into the public database by matching the
standard patterns. This must be done by a trained
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staff person who can use special features of the
system to check the quality of each spot and the
correctness of the matches. Whenever possible,
additional information about each spot, such as
characteristic regulatory patterns, subcellular lo-
calization, or amino acid composition will be used
to confirm the match to the appropriate spot in
the higher database. Users of the private data-
bases can perform preliminary matches of their
standards to the public standards in order to
compare their data to the public databases before
releasing their data to the public.
At the third level, a species database is needed.
This should encompass as many of the proteins
as can be unambiguously identified in the diverse
cell types and tissues studied within a single spe-
cies. Most of the major proteins and many of the
less abundant proteins will fall into this category.
Proteins that are under intensive investigation
often can be identified by antibodies, by compo-
sition, or by characteristic regulatory properties
in many different cell types. The species data-
base would contain the names of most identified
proteins and would provide, as much as is possi-
ble, a cross-referencing between the lower-level
public databases. Proteins in the species data-
base would be identified on the species standard
map as well as on the standard maps for one or
more of the lower databases. Through the spe-
cies database, a researcher working with NIH-3T3
cells could cross-reference from that database into
the databases for mouse embryos, mouse eryth-
roleukemia cells, or mouse muscle cells to ask how
the proteins of interest are regulated in other cell
types.
A NEW RESOURCE FACILITY
Our present computer facility has served well for
program development, but falls far short of the
capacity needed to analyze whole experiments
routinely. Furthermore, scientists from other in-
stitutions have expressed strong interest in the use
of our system and our databases. We felt that we
were ready for an expanded program devoted pri-
marily to database development and that if the
two-dimensional gel databases were to find gen-
eral utility, they would need to be made more
readily available. During 1984, we made a pro-
posal to become a Biotechnology Resource and
were awarded 5 years of funding from the Na-
tional Institutes of Health for such a facility, be-
ginning in January, 1985. The new facility will
contain three computer workstation systems, each
tenfold more powerful than our present computer
system. A staff will be hired to operate the facil-
ity, to serve the outside users, and to manage the
public databases. Core research funds will be
used to build up the public databases and to put
many more identified proteins on the maps. The
planning for this facility and the work we have
done on database methods during this year should
help us to build large multiuser databases in sev-
eral areas of key scientific interest during the next
year.
Response of Cellular Proteins to
Oncogene Expression
B.R. Franza, Jr., H.E. Ruley, J. Moomaw, C. Chang,
H. Wenzel, J.I. Garrets
One of the major goals of our research is to study
the effects of expression of different oncogenes
on cellular proteins. The REF52 cell line has been
used in much of this work because of its stability
in tissue culture, because individual oncogenes
such as T24 Ha-ras-1 or Ad5E1A will not onco-
genically transform these cells, and because com-
binations of oncogenes result in a variety of
transformed phenotypes, some of which are on-
cogenic. We have now isolated single cell clones
of REF52 that contain either the T24 Ha-ras4 or
Ad5E1A oncogene. We have also isolated a num-
ber of transformants that result from coexpres-
sion of these two oncogenes. For the first time,
we are able to compare systematically the effects
of each oncogene, expressed alone or together, on
cellular proteins. Here, we present a brief de-
scription of a few of the interesting observations
we have already been able to make.
The motivation for comparing the cells under
normal as well as heat-shock conditions primarily
was the previously reported adenovirus effect on
expression of the "HSP7OK" gene. Work done in
the past in collaboration with W.J. Welch (this
section) had already revealed that one protein
("73K") in REF52 cells, though expressed at 37°C,
is substantially increased in response to heat
shock, and another protein("72K") is synthesized
at detectable levels only when the cells are
stressed. We therefore wanted to know if either
of these two proteins would respond to constitu-
tive expression of Ad5E1A, and if so, would this
in any way alter their synthesis during heat shock.
Analysis of the experiment described in Figure
2 revealed that expression of Ad5E1A alone re-
sulted in changes in protein synthesis that were in
some cases exactly the opposite of those induced
FIGURE 2 Graphic analysis of certain cellular proteins al-
tered by oncogene expression. A display of database infor-
mation for five cellular proteins is presented. A region of the
standard REF52 protein map was displayed on the graphics
monitor, the five spots were individually selected, and their
corresponding graphs were displayed. After displaying all
five graphs the photograph shown in this figure was made.
Each graph shows the relative intensity for that spot in each
of the samples analyzed, with the highest intensity set at full
scale. The experiment reported herein involves metaboli-
cally labeling of 70% confluent, dividing cells with [31-1]-
1eucine for 2 hr. Cells exposed to elevated temperature for 4
hr were labeled for the final 2 hr of the heat shock. (A) Nor-
mal REF52 cells, 37°C; (8) normal REF52 cells, 42°C; (C)
REF52 cells expressing Ad5E1A, 37°C; (D) REF52 cells ex-
pressing Ad5E1A, 42°C; (E) REF52 cells expressing T24 Ha-
ras-1, 37°C; (F) REF52 cells expressing T24 Ha-ras-1, 42°C;
(G) REF52-transformed cells expressing both Ad5E1A and
T24 Ha-ras-1, 37°C; (H) REF52-transformed cells express-
ing both Ad5E1A and T24 Ha-ras-1, 42°C. The response of
the following proteins are shown in the graphs: tropomyosin
1 (858), stress-response protein, 73K (3708), stress-re-
sponse protein, 72K (4678), stress-response protein, 28K
(4208), and previously unidentified transformation-sensitive
protein, 50K (9618).
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by T24 Ha-ras-1 expression. Spot 858 (shown in
Fig. 2) demonstrates the reduction in synthesis of
the cytoskeleton protein, tropomyosin 1, in cells
expressing Ad5E1A, and an increase in synthesis
in cells expressing T24 Ha-ras-1. The same result
was observed with the sm-Actin (smooth muscle
form) synthesized in REF52 cells. We have al-
ready demonstrated that these two proteins are
coordinately regulated in growth-curve experi-
ments, in serum-stimulation experiments, and
in SV40 and adenovirus DNA transformants of
REF52. Interestingly, in the AD5E1A + T24 Ha-
ras-1 transformant, the prevailing effect on tro-
pomyosin 1 is that seen in the Ad5E1A-expressing
cells, i.e., decreased synthesis. In the case of sm-
Actin, no detectable synthesis occurs in the trans-
formant. Therefore, expression of each onco-
gene alone can exert effects that are exactly the
opposite of the other. In addition, their co-
expression is not the simple summation of ef-
fects. The interaction of two oncogenes in a
transformed cell should therefore be thought of
in terms of comodulation of cellular protein syn-
thesis. The predominant effect, of one oncogene
or the other when coexpressed in the transformed
cell, is discernible as a result of having each on-
cogene individually expressed in cell lines derived
from the same parent as the transformant.
Spot 3708 presents data on the synthesis of 73K
in each of the cell lines under study. As shown
in Figure 2, cells expressing Ad5E1A synthesize
slightly more 73K than do normal cells at 37°C.
In addition, the induced expression at 42°C is
higher than in normal cells. The transformant
(expressing both oncogenes) shows even greater
synthesis of 73K at 37°C, but coexpression of T24
Ha-ras-1 may account for the reduction in the
level synthesized during heat shock. Comparison
of the results shown in the graph of spot 4678 for
72K clearly shows that these two proteins are reg-
ulated differently. Ad5E1A-containing cells show
higher induction of 72K than normal cells when
both are exposed to 42°C, and T24 Ha-ras-1 cells
show an even greater induction of 72K when heat-
shocked. In all the T24 Ha -ras -1 + Ad5E1A-trans-
formed REF52 clones, the level of 72K induced
by heat shock is less than that seen in clones con-
taining one or the other gene, and in the case of
this particular transformant, it is not detectable.
In this particular transformant, the level of the
heat-shock 110K proteins (graph not shown) is
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substantial even at 37°C, although it is not de-
tectable in the other lines shown in this study un-
less they are heat-shocked. It may be that consti-
tutive production of 110K at 37°C is the result of
coexpression of the two oncogenes and affects the
inducibility of 72K in these cells.
The graph of spot 9618 represents a previously
unidentified transformation-sensitive protein,
"50K." Interestingly, this protein is synthesized
at 37°C in the transformed cell line (much like
110K mentioned above) but not in other lines. In
the transformant, 50K is also inducible by ele-
vated temperature to even higher levels of synthe-
sis. 50K and 110K therefore represent proteins
whose regulation is sensitive to both stress and
coexpression of two oncogenes.
The final protein presented here is known as
"28K" and its response is shown in graph 4208.
The two spots immediately to the left of 28K (see
Fig. 2) are its phosphorylated forms. The identi-
fication of these phosphate-modified forms was
done in collaboration with W.J. Welch (this sec-
tion). He has shown that serum, stress, and 12-
0-tetradecanoylphorbol-13-acetate (TPA) can in-
duce increased phosphorylation of 28K. Indeed,
in experiments in which we have compared the ef-
fects of serum, platelet-derived growth factor
(PDGF), and TPA, within 3 minutes of exposure
to any of these agents, a significant increase in
the density of the spots representing the phospho-
rylated forms of 28K occurs. It was therefore
very interesting to see that the synthesis of the
nonphosophorylated 28K was substantially re-
duced in cells expressing Ad5E1A but was in-
duced in the cells expressing T24 Ha-ras-1 alone.
The prevailing influence in the transformant
seems to be Ad5E1A. The response of this pro-
tein to 42°C in each line is also shown and indi-
cates again the complexity of coexpression versus
individual expression of the two oncogenes under
study.
Normal REF52 cells require fetal calf serum for
growth. W. Topp (Otisville Biotech, Inc.) and D.
McClure (W. Alton Jones Cell Science Center)
have shown that in defined media, PDGF will not
induce REF52 cells to leave density-arrest. They
have also shown that in defined media, dividing
REF52 cells do not require PDGF for continued
growth and cell division. Cells expressing the T24
Ha-ras-1 oncogene, either stably incorporated or
after microinjection, demonstrate a substantial
increase in serum dependence. Serum depriva-
tion causes the cells to flatten out, to develop sig-
nificant cytoplasmic vacuolization, and to accu-
mulate multiple nuclei in individual cells. The
serum deprivation response is induced if the me-
dia containing 10% fetal calf serum is not
changed every other day. Cells expressing the
Ad5E1A gene alone also show increased serum
dependence, but their response to fresh serum as
well as serum deprivation is different. When
plated in fresh serum, these cells are often small,
more refractile, and show a greater number of
mitotic forms. One to two days after serum is
added they begin to flatten out and divide more
slowly. Unless the cells are refed with fresh serum
they become round, detach from the plastic, and
die. Thus, the effects of the Ad5E1A gene and
the T24 Ha-ras-1 gene are distinctly different with
respect to morphology and survival in serum-de-
pleted medium. Cells coexpressing both genes are
fully transformed and serum-independent.
Analysis of proteins such as "28K" may help us
sort out the differences in growth control exhib-
ited by cells expressing either Ad5E1A or T24 Ha-
ras-1. We are currently studying the response of
28K in experiments in which PDGF is added to
the cells to see if the phosphorylation that occurs
in the cells expressing Ad5E1A is substantially
different from that seen in the cells expressing T24
Ha-ras-1. When these results are placed in the
context of the other induced changes in phospho-
rylation/dephosphorylation of cellular proteins
acutely exposed to different growth-promoting or
retarding agents, we expect that sets of proteins
specifically altered in cells expressing each onco-
gene will be identified. Such knowledge will al-
low us to begin defining the proteins involved in
the growth-control pathways of the cell.
Among the applications available once the
above analysis is complete is a strategy for more
efficient and alrected isolation of the genes en-
coding proteins involved in cellular growth con-
trol. It will employ two-dimensional analysis of
in vitro translates of cellular mRNA prepared
from each of the different cell types exposed to
various conditions to determine quantitatively
when the message for a particular protein is most
abundant. From this information, protocols for
differential hybridization can be optimized, and
the resultant hybrid-selected mRNA can be trans-
lated and analyzed on two-dimensional gels to
ensure that the proteins of interest are indeed en-
coded by the selected cDNA.
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NEUROBIOLOGY
During mammalian neurogenesis, a plate of approximately 105 morphologically
homogeneous cells gives rise to 1012 morphologically and physiologically hetero-
geneous neurons in the adult brain. Estimates of mRNA complexity indicate that
the adult mammalian brain contains more than 30,000 different brain-specific
proteins. The studies of the Neurobiology Group continue to explore several fea-
tures of this enormous molecular diversity using both vertebrate and, simpler, in-
vertebrate nervous systems. Our previous studies showed that in contrast to the
immune system, where molecular diversity among lymphocytes is expressed
within a single class of molecule (immunoglobulin), diversity in the nervous sys-
tem is not confined to one class of molecule (such as neurotransmitter), as anti-
genic heterogeneity is manifest in many different subcellular structures.
One of the potential uses of cell-specific markers is to trace lineage relation-
ships through development. Somewhat surprising was our finding that all of our
markers that differentiate between adult mammalian neurons recognize antigens
that are first expressed relatively late in development. Some of these antigens
first appear long after the apparent establishment of adult structure, In the last
year, we have focused increasingly on developmental issues. Our developmental
studies suggest that the temporal control of antigen expression and the transient
presence of some classes of cells are importantly related to the normal develop-
ment of the adult nervous system. One of the most exciting observations in the
last year was the demonstration that the expression of an antigen recognized by
one of our monoclonal antibodies is controlled by early visual experience. This
suggests that the mechanisms of experience-induced negronal development
may be accessible to molecular analysis.
Our studies using invertebrate nervous systems have addressed issues that
are not easily accessible in the mammalian brain. Using the moth, we are explor-
ing the basis of sexual dimorphism in the central nervous system (CNS). Our
studies on the leech CNS continue to examine features of the segmental organi-
zation of nervous systems.
VERTEBRATES
S. Hockfield B. Friedman C. Bautista
R. McKay S. Zaremba E. Waldvogel
A MARKER FOR EARLY AXONS ALLOWS US
TO VISUALIZE THE FIRST EVENTS IN
AXON OUTGROWTH
One of the great difficulties in studying how con-
nections are made in the developing mammalian
nervous system has been the inability to identify
the earliest axons reproducibly and unambigu-
ously. Available methods have severe limitations.
Using electron microscopy at very early stages of
development, one cannot reliably discriminate
between axons and other profiles. Neither neu-
rofibrillary stains nor intra-axonal tracers can be
used to detect axons at their earliest stages of
growth. We have generated a monoclonal anti-
body, Rat-202, that identifies axons at the earliest
stages of axon growth. The antibody binds to an
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antigen distributed throughout growing axons,
including the growth cone and filopodia, the
structures believed to be responsible for axon
navigation.
Studies in tissue culture of growing axons have
described the morphology and behavior of growth
cones and filopodia. These studies have demon-
strated that growing axons show a preference for
particular substrates. Due to the vastly greater
complexity of the intact nervous system, similar
studies in tissue sections were not possible. Using
antibody Rat-202, we have been able to identify
and study growth cones and filopodia in sections.
One of the advantages of antibody identification
is that histological analyses can be carried to the
ultrastructural level. Electron microscopic exam-
ination of Rat-202-stained material shows that
the filopodia of growth cones in the developing
spinal cord contact nonneuronal profiles. Using
double-labeling techniques, we are now trying to
identify simultaneously these nonneuronal pro-
files and early axons to determine the structures
filopodia contact to guide axon growth in the
CNS.
A NONNEURONAL CELL MAY SUPPORT INITIAL
AXON GROWTH AND AXON REGENERATION
IN THE PERIPHERY
Axon regrowth after injury occurs in the periph-
eral nervous system, but not in the CNS, of adult
mammals. Accumulating evidence indicates that
axon growth depends on environmental factors
such as nonneuronal cells and extracellular ma-
trix present in peripheral nerve. However, the
mechanism of axon interaction with the periph-
eral nerve environment is not well understood.
One unsettled question is whether axons contact
one specific class of nonneuronal cells during
growth in immature or regenerating peripheral
nerves and/or whether they preferentially contact
noncellular, extracellular matrix components se-
creted by these nonneuronal cells. In the past,
these questions have been inaccessible to study
because early nonneuronal cell types cannot be
reliably distinguished on morphological grounds
and there was no ready means to generate mark-
ers for peripheral nerve nonneuronal cells or ex-
tracellular matrix components. The development
of hybridoma technology has provided a useful
tool to generate anatomical probes for the study
160
of early events during peripheral nerve develop-
ment and regeneration.
Monoclonal antibody Rat-401, generated in our
laboratory by immunizing mice with paraformal-
dehyde-fixed spinal cord from rats at day 15 of
gestation, recognizes nonneuronal cells in both
the developing peripheral nervous system and the
CNS. Rat-401-stained cells are present in periph-
eral nerve roots as early as day 11 of gestation.
Rat-401-positive nonneuronal cells are present be-
fore axons grow into the peripheral nerve. Inter-
estingly, as the early axons enter the nerve roots,
they contact Rat-401-stained cells. Thus, these
nonneuronal cells are in a position where they
may guide or support initial peripheral axonal
growth. Embryonic optic nerve and other CNS
axon tracts contain Rat-401-stained cells, an in-
dication that Rat-401-positive cells may also assist
axon growth in the CNS.
Rat-401-stained cells in the developing CNS are
present in the early neural tube and are morpho-
logically similar to the radial glial cells. The ra-
dial glial cells act as guides for neuronal migra-
tion in the CNS, suggesting that the cells that
guide axon outgrowth and neuronal migration are
related. Our earlier studies in the leech suggested
that axons may selectively fasciculate with one
another through diverse surface-recognition mol-
ecules. The observations with Rat -40l raise the
possibility that initial axon outgrowth and navi-
gation occur in relation to a nonneuronal cell, and
subsequent navigation may be mediated by inter-
axonal interactions. We have now established
cultures of Rat-401 cells from the embryonic CNS
so that the role of these cells in cell migration and
neurite outgrowth can be studied and manipu-
lated in vitro.
The adult CNS lacks Rat-401-stained cells,
which is consistent with the absence of neuronal
cell migration and axon regeneration following
injury in the mature CNS. In contrast, the ma-
ture peripheral nerve (where axon regeneration
does occur) contains Rat-401-positive process.
Rat-401-stained cells in the sciatic nerve are lo-
cated external to myelin sheathes in a configu-
ration similar to that of Schwann cells, a non-
neuronal cell type that ensheathes axons. This
suggests that a set of the embryonic Rat-401 cells
develop into myelin-related Schwann cells. We
have now shown that cultured Schwann cells, but
not fibroblasts, are Rat-401-positive, increasing
our confidence that Rat-401 is a Schwann cell
marker. We are now determining if Rat-401 cross-
reacts with human Schwann cells. A well-char-
acterized Schwann cell marker could be useful to
clinicians for the rapid diagnosis of Schwann cell
tumors at the light microscopic levels, thus avoid-
ing the expensive, time-consuming electron mi-
croscopic methods currently used to identify such
tumors. In addition, we are examining Rat -401-
stained cells in relation to axons in injured pe-
ripheral and central nerve tissue. By continuing
to generate new monoclonal antibodies to embry-
onic peripheral nerve tissue and to regenerating
the adult peripheral nerve, we hope to obtain ad-
ditional markers for nonneuronal cells and for
growing axons.
EXPRESSION OF THE ANTIGEN RECOGNIZED BY
MONOCLONAL ANTIBODY CAT-301 REQUIRES
NORMAL VISUAL EXPERIENCE
Once growing axons have reached their targets,
they make synapses. In most areas that have been
studied, the number of synapses initially made far
exceeds the number maintained into adulthood.
One of the most philosophically compelling dis-
coveries of modern neuroscience is that the early
of an organism plays a critical role in
determining the adult synaptic structure. Expe-
rience-induced developmental processes have been
well documented in the mammalian visual sys-
tem.
A
Monoclonal antibody Cat-301 recognizes a
morphologically distinct population of neurons in
the cat and primate lateral geniculate nucleus
(LGN), a central relay nucleus in visual process-
ing. During the past year, we have identified Cat-
301-positive neurons in the cat LGN as the (phys-
iologically defined) Y cells, using morphometric
and tract-tracing techniques. The size, shape, lo-
cation, and projection to specific cortical areas
of antibody-positive neurons correlate well with
described features of Y cells. We also have now
shown that the onset of Cat-301 staining parallels
the development of Y cells.
Detailed physiological and morphological
studies have shown that normal Y-cell develop-
ment is closely correlated with exposure to nor-
mal visual environments. Y-cell development is
perturbed in cats that have been reared from birth
in the dark or with one or both eyes sutured
closed. We have now demonstrated that the char-
acteristic Cat-301-staining pattern does not de-
velop in animals reared in visually deprived set-
tings. In animals reared in the dark from birth,
Cat-301 staining is virtually absent throughout the
LGN. In animals reared in the light with one eye
sutured at birth, the cell layers in the LGN that
receive input from the closed eye fail to develop
Cat-301 staining (Fig. 1). The expression of the
antigen recognized by antibody Cat-301 corre-
lates with the development of mature Y-cell char-
acteristics, perhaps reflecting the maintenance of
B
MIN
FIGURE 1 Monocular deprivation at birth results in a depletion of Cat-301 immunoreactivity in deprived LGN laminae. (A)
LGN ipsilateral to the deprived eye (at 1 year of age) shows decreased Cat-301 staining in lamina Al. The reduction in staining
in Al allows the staining of lamina C to be clearly seen. (B) LGN contralateral to the deprived eye shows a decrease in Cat-
301 immunoreactivity in laminae A and C relative to Al. Both contralaterally and ipsilaterally immunoreactivities are also lost
in the MIN.
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the mature set of synaptic connections. This
finding has important implications for the eluci-
dation of the mechanisms of neuronal develop-
ment. It shows that antigen expression correlates
with events at critical periods of development and
opens the possibility that the molecular biology
of experience-determined neuronal development
may be accessible to study.
Experiments are in progress to determine
whether normal synaptic development in vivo can
be retarded or disrupted by administration of Cat-
301 or its antigen. Our preliminary studies have
shown that Cat-301 specifically binds to subsets
of neurons when administered in vivo. Anti-
body-mediated cell killing will be attempted by
injection of antibody coupled to toxins to deter-
mine the role of the affected cells in neural devel-
opment and in visual processing.
Efforts are now being directed toward purifi-
cation of the antigen recognized by Cat-301. His-
tochemical examination indicates that the antigen
is relatively rare within whole brain. Direct West-
ern blot analysis of unfractionated tissue thus far
has not identified the antigen. However, deter-
gent extracts of guinea pig brain stem, when con-
centrated 10-20-fold by ultrafiltration, demon-
strate Cat-301 immunoreactivity on nitrocellulose
dot blots. Such an assay is being used to monitor
antigen purification by immunoaffinity chroma-
tography. The purpose of this purification effort
is to generate monospecific polyclonal sera that
in turn will enable us to identify the gene respon-
sible for Cat-301 antigen expression in a brain
cDNA library. In addition, we will be asking
whether structurally homologous antigens exist in
other brain areas and whether they are involved
in the development of normal adult synaptic con-
nections.
FIGURE 2 Human visual cortex contains Cat-301-positive neurons. (A) Sections of human visual cortex stained with Cat-
301 contain patches of antibody-positive neurons. The high level of background staining results from fixation by immersion
rather than by perfusion. (8) At higher magnification, Cat-301-positive neurons (arrows) display the same surface staining
characteristics that have been demonstrated in cat and monkey CNS. This conservation of subcellular localization suggests
that Cat-301 recognizes the same, or closely related, antigens in all three species.
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MARKING AREAL BOUNDARIES WITH
MONOCLONAL ANTIBODIES
Classical neurobiology has provided maps of the
vertebrate cerebral cortex that divide the brain
into areas with specific functions and body rep-
resentations. Nonspecific cell stains have illus-
trated different neuronal cell types in the cortex
and their organization. Hybridoma technology
provides a means of selectively staining identified
neuronal types and establishing a molecular basis
for their anatomical and physiological diversity.
Monoclonal antibodies have shown differences
among cell populations that were heretofore un-
recognized.
Previously, we have reported that in the pri-
mate visual cortex, Cat-301 identifies neurons in
a pattern that reflects the ocular dominance or-
ganization of the primary visual cortical area
(VI). A dramatic shift in staining patterns marks
the boundary between VI and the adjacent sec-
ond visual cortical area (V2). This boundary can
be resolved using more classical techniques, but
elsewhere in the primate cortex, Cat-301 stain-
ing marks boundaries between less well resolved
areas. For example, the boundaries between areas
MT and MST and between V3 and V4 appear to
be marked by changes in Cat-301-staining pat-
terns. Currently, electrophysiological and tract-
tracing techniques are being used in conjunction
with Cat-301 immunohistochemistry to confirm
these areal borders.
One of the difficulties in understanding human
cortical function has been the inability to set nor-
mal ranges for the size and location of cortical
areas. In experimental animals, areal boundaries
have been determined by invasive methods, such
as electrophysiological recording and tract-trac-
ing studies. The conservation of antigens through
evolution may allow us to use markers like Cat-
301 to study the organization of the human cor-
tex in postmortem material. We have already
shown that Cat-301 recognizes an antigen in hu-
man cortex (Fig. 2) that is related to the antigen
recognized in cat and monkey. The cells that ex-
press the Cat-301 antigen in human area VI have
a patchy distribution similar to that seen in the
macaque monkey. Our current studies are aimed
at establishing rapid, reproducible criteria for
mapping areal boundaries in the human cortex.
Another recently generated monoclonal anti-
body, Rat-203, recognizes subsets of neurons in
the rat CNS and shows sharply defined cortical
boundaries in rat cortex. The antibody, which
identifies a 180,000-molecular-weight polypep-
tide in Western blot experiments, recognizes pro-
jection neurons in rat neocortex, but not in pa-
leocortical areas such as the olfactory cortex and
dentate gyrus. In the cerebellar cortex, Rat-203
recognizes a small group of interneurons in the
paleocerebellar area, but not in the archicerebel-
lar area, whereas projection neurons are Rat-203-
positive throughout the cerebellum.
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Monoclonal Antibodies Demonstrate
Sexually Dimorphic Structures
in the Moth CNS
A. Hishinuma, S. Hockfield, R. McKay
The relative simplicity of the invertebrate CNS
compared with the vertebrate CNS often makes
basic problems in neurobiology more accessible
to study. The existence of sexual dimorphism in
the CNS is a highly charged issue, but several
studies have shown differences between sexes in
both invertebrate and vertebrate systems. In the
moth, Manduca sexta, male-specific sensory neu-
rons in the antennae, which respond to the female
sex pheromone, connect to male-specific neurons
in the antennal lobes of the CNS at the male-spe-
cific synaptic region, the macroglomerular com-
plex (MGC). Previous studies showed that sur-
gical transplantation of the imaginal disks of the
male antennae into female hosts gives rise to
MGC-like structures in the gynandromorphic
female antennal lobe. To obtain reagents with
which to study the mechanisms that govern the
development of sexually dimorphic structures,
monoclonal antibodies were generated to the male
moth CNS.
The olfactory-specific antibody (OSA) stains
the primary olfactory neurons both in males and
females. Cell bodies, proximal parts of den-
drites, and axons are recognized by this antibody.
The intracranial portion of the antennal nerve
contains sensory axons of two different modali-
ties. Here, the olfactory axons are stained by the
OSA but the mechanosensory axons are not. In
the antennal lobe, the olfactory axons make syn-
aptic contacts in structures called glomeruli. The
OSA recognizes every glomerulus (Fig. 1A). Cell
bodies of another set of primary olfactory neu-
rons are located in a part of the mouth, the labial
pulp organ, which also sends axons into the an-
tennal lobe. The tracts from the labial pulp or-
gan to the antennal lobes are also stained by the
OSA antibody. To confirm the specificity of OSA
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for olfactory structures, the whole brain and the
thoracic ganglion were tested. OSA staining was
confined to the primary olfactory neurons. At
the electron microscopic level, OSA staining is
associated with the external side of the plasma
membrane of cell bodies and axons. As in our
previous studies in the leech, axons with surface
OSA staining travel together in fascicles. We have
previously suggested that such axonal surface
molecules may be chemoaffinity molecules by
which axons navigate along specific routes to
their targets. The synaptic terminals of the pri-
mary olfactory neurons in the glomeruli of the
antennal lobe, which cannot be resolved at the
light microscopic level, can be identified by the
presence of antibody staining at the electron mi-
croscopic level.
The male-specific antibody (MSA) stains the
primary olfactory neurons in males but not in
females. The MSA recognizes cell bodies, den-
drites, and axons. There are two types of hair-
like sensillae in the antennae; longer ones are
found only in males and shorter ones in both
sexes. The dendrites of the primary olfactory
neurons that lie in long sensillae are stained by
MSA. In females, primary olfactory neurons are
not stained by MSA. In the antennal lobe, only
the male-specific glomerulus is stained by MSA
(Fig. 1B). The ordinary glomeruli, which are
common to males and females, are unstained.
Another cell type, associated with the limiting
membrane of the antennae, is stained in both
males and females. The position and develop-
mental appearance of this second type of MSA-
positive cell suggest that these cells are develop-
mentally related to the primary olfactory neu-
rons, perhaps being an undifferentiated progeni-
tor cell.
At present, we are characterizing the antigens
recognized by these antibodies by Western blot
analysis and studying the expression of their an-
tigens in the development of the moth. We hope
to be able to describe developmental events that
give rise to male-specific structures.
FIGURE 1 Monoclonal antibodies recognize
olfactory structures in male and female (A) and
male-specific structures (B) in mature CNS. (A)
Olfactory-specific antibody recognizes primary
olfactory neurons, their axons in the antennal
nerve (AN), and their terminals in the male-spe-
cific glomerulus (MGC) and in the glomeruli
common to both males and females (G). (8) In
contrast, the male-specific antibody (MSA) only
recognizes profiles in the male-specific MGC
and not in the common glomeruli.
B
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D
FIGURE 2 A variety of monoclonal antibodies immunocytologically label sets of antigenically
homologous neurons in the leech CNS. Three such neuron sets are indicated in this plate.
Pressure-sensitive mechanosensory neurons are contained in cell sets labeled with Laz2-1 (A)
and Lan3-5 (8) and are exclusively labeled by LazF-12 (C). Cell sets Laz2-1 and Lan3-5 inter-
sect, and their intersection contains cell set LazF-12 (D).
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Cellular Organizing Systems in the
Leech: Are Nervous Systems Built by
Interactions among Antigenically
Related, Functionally Heterogeneous
Sets of Neurons?
G. Bablanian, T. Flanagan, B. Zipser
An extension of classic approaches to the study
of nervous system networks has been the appli-
cation of immunocytological probes to define sets
of immunochemically related cells. In the leech,
we have identified 11 different antigenically re-
lated neuron sets. Such sets vary in size, contain-
ing from 2 to 50 neurons. We have identified in-
dividual neurons within these sets and we realize
that antigenically related neurons can serve di-
verse physiological functions. Some identified
neurons belong to more than one set of antigeni-
cally related cells. In the leech, antigenically re-
lated cell sets are thus either intersected by or
contained within other antigenically related cell
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FIGURE 3 Immunocytologically labeled neurons that ap-
pear in nonadjacent ganglia along the axis of the leech CNS
suggest the existence of segmental counting mechanisms.
One such mechanism assigns immunoreactive neurons to
even-numbered ganglia, counting through the CNS in two-
segment units (top). Another such mechanism assigns im-
munoreactive neurons to seven-segment units within the mid-
body ganglionic chain (middle). A third mechanism counts off
two-segment units from the origin of the cephalic and mid-
body ganglionic series (bottom).
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sets (see Fig. 2). We have recently identified a
pair of neurons that are common to a dispropor-
tionately large number of antigenically related cell
sets. Why do these cells (which we call a cells)
carry such a rich array of set-specific antigens?
Do these antigens correlate with or specify syn-
aptic connections? If such a correlation exists,
then these a cells function in a variety of neu-
ronal networks. Perhaps they play a pivotal role
in activating one of several mutually exclusive be-
havioral networks. Electrophysiological analysis
will be able to address this hypothesis in future
studies of the leech nervous system. At present,
the broader question of the significance of di-
verse and intersecting antigenically related cell
sets remains unanswered. As we expand our cat-
alog of antigenically related cell sets, we are con-
tinually searching for clues (such as a cells) that
might suggest the biological basis for this phe-
nomenon.
Supersegmental Organizing Systems
in the Leech: Immunocytologically
Identified Neurons That Appear in
Serially Repeated Multiganglion
Units Along the Segmental Axis of the
Leech CNS Suggest the Existence of
Supersegmental Counting Mechanisms
T. Flanagan, C. Schley, B. Zipser
The leech central nervous system (CNS) is com-
posed of a series of 32 homologous ganglia that
are each derived from one of the 32 embryonic
segments that form the leech body axis. Each
ganglion consists of a core population of about
400 individually identifiable neurons and an ad-
ditional set of specialized cells restricted to se-
lected ganglia. We have used immunocytological
methods to identify three sets of specialized cells
that are serially expressed in nonadjacent ganglia
throughout the leech CNS. The distribution of
these cells define multisegmental units within the
leech CNS and suggest the existence of superseg-
mentation counting mechanisms that individually
label each leech ganglion (Fig. 3). We have begun
electrophysiological analysis of these specialized
counting neurons, and we now realize that they
are interganglionic interneurons. Some of these
cells project pervasively throughout the axis of the
CNS. We suspect that such cells contact and re-
press the expression of their segmental homologs
in adjacent ganglia and thus sculpture repeating
patterns in nonadjacent ganglia throughout the
CNS. Our hypothesis predicts that transection of
interganglionic connectives in embryonic leech
will prevent cellular interactions among intergan-
glionic homologs and will alter the supersegmen-
tal structure of the leech CNS.
Vertebrate Neurotransmitter Substances
in the Leech: A Substance-P-like
Peptide in Leech Interneurons
T. Flanagan [in collaboration with R. Stewart
and E. Macagno, Columbia University, and
E. Floor and S. Leeman, University of
Massachusetts Medical Center]
Polyclonal antisera raised against substance P
(RD2-C1) was screened immunocytologically on
leech ganglia to identify neurons that contain a
substance-P-like antigen. This immunoreactivity
is confined to four identifiable cephalic interneu-
rons and is fully blocked when antisera is pread-
sorbed with substance P. Homogenates of leech
CNS were analyzed by radioimmunoassay to cor-
roborate immunocytological observations, and,
subsequently, 150 leech nerve cords were pooled
and fractionated on Sephadex G-25 to determine
20 25 30 35
Fractions
FIGURE 4 Polyclonal antiserum raised against substance P
(RD2-C1) was used in a radioimmunoassay to identify a pep-
tide antigen from homogenates of a leech CNS that comi-
grates with vetebrate substance P This antiserum also rec-
ognizes a high-molecular-weight antigen that may be a pre-
cursor to the leech substance-P-like peptide.
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the size of the leech substance-P-like antigen
(Fig. 4). These studies indicate that the leech can
now be added to the list of invertebrates that con-
tain a neuronal peptide antigenically homolo-
gous to vertebrate substance P. Future studies in-
clude plans first to identify leech substance-P tar-
get cells and then to characterize their receptors
pharmacologically. The precision with which cel-
lular circuits can be analyzed in the leech prom-
ises that these studies will contribute a solid ref-
erence for the biology and evolution of phylo-
genically conserved peptide transmitter systems.
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The principle of genetic linkage in Mendelian inheritance was established by T.H.
Morgan in 1911. That genetic recombination occurs by chromosomal crossing-
over events was first shown in two independent studies, both published in
1931 -one by H.S. Creighton and B. McClintock working with maize and the
other by C. Stern working with Drosophilia. Since that time a small, elite group of
geneticists have thought about and experimentally analyzed genetic recombina-
tion with such profound consequences that introductory genetics was, and still is,
learned by studying chromosome recombination.
Publication by R. Holliday in 1964 of the first conceptual framework to explain
genetic recombination in molecular terms spurred an ever-increasing number of
scientists to work in this area. However, the main tool of investigation remained
strictly transmission genetics until the dawn of recombination in molecular detail.
Our choice of the topic "Recombination at the DNA Level" for the 49th annual
Symposium underscores these recent achievements as well as the future pros-
pects in this field. In planning this Symposium, we emphasized primarily the bio-
chemical aspects of recombination, including systems ranging from bacterio-
phage to mammalian cells.
To make this meeting most exciting and informative, we called upon the ad-
vice of our colleagues in the field. In particular we wish to acknowledge the won-
derful counsel given by Charles Radding, Nick Cozzarelli, Barbara McClintock,
and Bob Weisberg. The formal meeting program contained 94 excellent presen-
tations, with a high proportion of attendees staying through to the very end of
this rather lengthy meeting. The introductory remarks by Bruce Alberts and the
summary delivered by Allan Campbell were most appropriate; we thank them for
their efforts.
Financial support for this year's meeting was provided by the National Cancer
Institute, Fogarty International Center, the Department of Energy, and the Na-
tional Science Foundation.
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sity of California, Berkeley: Genes
of the RecF pathway of recombi-
nation in E, coll.
Kushner, S.R., Dykstra, C.C., Dept. of
Genetics, University of Georgia,
Athens: Purification and character-
ization of exonuclease V from E.
coil K-12.
Lloyd, R., Picksley, S., Attfield, P.,
Benson, F, Buckman, C., Dept. of
Genetics, University of Not-
tingham, England: Genetic analy-
sis and regulation of inducible re-
combination in E. co/i.
Hays, J.B., Smith, A.T., Friedman,
S.F., Lee, E., Coffman, G.L., Dept.
of Chemistry, University of Mary-
land-Baltimore County, Catons-
ville, Maryland: Recombination of
nonreplicating UV-irradiated bac-
teriophage A DNA.
Smith, G.R., Amundsen, S.K., Chau-
dhury, A.M., Cheng, K.C., Ponti-
celli, A.S., Roberts, C.M., Schultz,
D.W., Taylor, A.F., Fred Hutchinson
SESSION 9 recA
Cancer Research Center, Seattle,
Washington: Roles of RecBC en-
zyme and Chi sites in homologous
recombination.
Kobayashi, I., Stahl, M.M., Stahl, F.W.,
Institute of Molecular Biology, Uni-
versity of Oregon, Eugene: Spe-
cial sites in homologous recombi-
nation-Mechanism of the Chi-cos
interaction in RecA-RecBC-me-
diated recombination in bacterio-
phage 1.
Top: S. Shaner, R. Kahn, S. Honigberg, R.P. Cunningham, D. Gonda, J. Flory,
C.M. Radding, T. Shibata, M. Leahy
Bottom: M. Bianchi, C. DasGupta, S. Chow
Chairperson: C. Radding, Yale University, New Haven, Connecticut
Muniyappa, K., Tsang, S.S., Shaner,
S., Radding, C., Depts. of Human
Genetics and Molecular Biophys-
ics and Biochemistry, Yale Univer-
sity School of Medicine, New Ha-
ven, Connecticut: Relationship of
secondary structure, aggregation,
and conjunction of DNA molecules
to the mechanism of homologous
pairing promoted by recA protein.
Morrical, S., Neuendorf, S., Cox, M.,
Dept. of Biochemistry, University
of Wisconsin, Madison: Light-scat-
tering studies of recA protein fila-
ments in the presence and ab-
sence of ssDNA.
Bryant, F.R., Riddles, P.W., Lehman,
I.R., Dept. of Biochemistry, Stan-
ford University School of Medi-
cine, California: Studies of the
mechanism of strand exchange
promoted by the recA protein of E.
co /i.
Shibata, T.,1 Makino, O.,' Ohtani, T.,'
Iwabuchi, M.,1 lkawa, S.,' Ando,
T.,' Shibata, Y,2 Maeda, H.,'
'Dept. of Microbiology, Riken Insti-
tute, Saitama; 2Blood Transfusion
Service, Tokyo University Hospital,
Japan: Roles of processive un-
winding by E. coli recA protein in
homologous recombination.
Griffith, J., Chrysogelos, S., Register,
J. III., Welsh, G., Lineberger Can-
cer Research Center, University of
North Carolina, Chapel Hill: A hy-
brid complex involving SSB and
RecA proteins bound to ssDNA in-
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SESSION 10 REPAIR
Chairperson: S. Linn, University of California, Berkeley
Linn, S., Samson, L., Brooks, P, Mos-
baugh, D., Evans, D., Dept. of Bio-
chemistry, University of California,
Berkeley: Enzymology of DNA ex-
cision repair in mammalian cells.
Lu, A.-L., Welsh, K., Su, M., Clark, S.,
Modrich, P., Dept. of Biochemistry,
Duke University Medical Center,
Durham, North Carolina: Repair of
DNA base-pair mismatches in vitro.
Walker, G.C., Pang, RP., Tsen, S.D.,
Dept. of Biology, Massachusetts
Institute of Technology, Cam-
bridge: Mismatch repair genes of
S. typhimurium.
Fishel, R.A., Kolodner, R., Laboratory
of Molecular Genetics, Dana Far-
ber Cancer Institute, and Dept. of
Biological Chemistry, Harvard
Medical School, Boston, Massa-
chusetts: An E. coil cell-free sys-
tem that catalyzes the repair of
symmetrically methylated hetero-
duplex DNA.
Radman, M., Mutagenes Group, Insti-
tut Jacques Nomod, RBM, Paris,
itiates the proper assembly of
RecA-DNA filaments.
Stasiak, A., Stasiak, A.Z., Koller, T., In-
stitute for Cell Biology, Zurich,
Switzerland: Complexes of recA
with DNA under condition of in vi-
tro recombination.
Howard-Flanders, P., West, S.C.,
Rusche, J.R., Dept. of Molecular
Biophysics and Biochemistry, and
Dept. of Therapeutic Radiology,
Yale University, New Haven, Con-
necticut: recA protein can promote
strand-exchange reactions past
double-strand breaks in certain
positions, indicating that each
recA monomer may have two non-
equivalent DNA-binding sites.
France: Genetic consequences of
mismatch repair in E. coli.
Kunes, S., Botstein, D., Fox, M.S.,
Dept. of Biology, Massachusetts
Institute of Technology, Cam-
bridge: Inverted dimer formation
and interplasmid recombination in
the repair of linearized plasmids
during yeast transformation.
Rothstein, R., Dept. of Microbiology,
New Jersey Medical School, New-
ark: Double-strand-break repair
and recombination.
SESSION 11 EUCARYOTIC ENZYMES
Chairperson: R. Holliday, National Institute for Medical Research, London, England
Resnick, M., Chow, T., Nitiss, J., Na-
tional Institute of Environmental
Health Sciences, Research Trian-
gle Park, North Carolina: Changes
in chromosomal DNA during
meiosis in repair mutants and the
possible role of a deoxyribonucle-
ase.
Skalka, A.M.,' Duyk, G.,2 Longiaru,
M.,' DeHaseth, F,2 Terry, R.,' Leis,
J.,2 'Dept. of Molecular Genetics,
Hoffmann-La Roche Inc., Roche
Research Center, Nutley, New Jer-
sey; 2Dept. of Biochemistry, Case
Western Reserve University,
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Cleveland, Ohio: Integrative re-
combination-A role for the retro-
viral reverse transcriptase.
Honjo, T, Kataoka, T, Konda, S.,
Nishi, M., Kodaira, M., Dept. of
Genetics, Osaka University Medi-
cal School, Japan: In vitro studies
on immunoglobulin gene rear-
rangement.
Holliday, R.,' Taylor, S.Y.,' Kmiec, E.,2
Holloman, W.K.,2 'National Insti-
tute for Medical Research, Lon-
don, England; 2Dept. of Immunol-
ogy and Medical Microbiology,
University of Florida, Gainesville:
Characterization of red mutants
and recl protein of U. maydis.
Kmiec, E., Kroeger, F, Holloman, W.,
University of Florida, Gainesville:
Interaction between Ustilago recl
protein and Z-DNA.
Ferro, A.M., McElwain, M.C., Reid,
E.J., Olivera, B.M., Dept. of Biol-
ogy, University of Utah, Salt Lake
City: Poly ADP-ribose synthetase,
DNA topoisomerase I and the
suppression of strand-exchange
events in somatic cells.
SESSION 12 INTEGRATION AND EXCISION OF BACTERIOPHAGE
Chairperson: H. Nash, National Institutes of Health, Bethesda, Maryland
Miller, H.I., Dept. of Molecular Biol- nism of recombination by A Int and
ogy, Genentech Inc., South San Tn3 resolvase.
Francisco, California: himA gene Spengler, S.,1 Stasiak, A.,2 Cozzarelli,
of E. coli-Gene structure and reg- N.,"Dept. of Molecular Biology,
ulation, homology with DNA-bind- University of California, Berkeley;
ing proteins, and role in site-spe-
cific recombination and gene
regulation.
Leong, J.,' Nunes-Duby, S.,' Oser,
A.,1 Lesser, C.,' Youderian, P.,2
Susskind, M.,2 Landy, A.,"Dept.
of Molecular and Cell Biology,
Brown University, Providence,
Rhode Island; 2Dept. of Microbiol-
ogy, University of Massachusetts,
Worcester: Site-specific recombi-
nation systems of +80, P22, and A.
de Massy, B.,1 Studier, F.W.,2 Dorgai,
L.,' Appelbaum, E.,' Weisberg,
R.,' 'NICHD, National Institutes of
Health, Bethesda, Maryland;
'Dept. of Biology, Brookhaven Na-
tional Laboratory, Upton, New
York: Role of Holliday structures in
recombination.
Echols, H.,1 Dodson, M.,' Roberts,
J.D.,2 McMacken, R.,2 'Dept. of
Molecular Biology, University of
California, Berkeley; 2Dept. of Bio-
chemistry, Johns Hopkins School
of Hygiene and Public Health, Bal-
timore, Maryland: Role of special-
ized nucleoprotein structures in
site-specific recombination and ini-
tiation of DNA replication.
Nash, H.A., Kitts, P., Richet, E., Na-
tional Institute of Mental Health,
Bethesda, Maryland: A Integrative
recombination-Approaches to
the synaptic mechanism.
Spengler, S.,' Stasiak, A.,2 Benjamin,
H.,' Wasserman, S.,' Gerrard, S.,'
Dungan, J.,' Matzuk, M.,' Kras-
now, M.,' Cozzarelli, N.,"Dept. of
Molecular Biology, University of
California, Berkeley; 2lnstitute for
Cell Biology, Zurich, Switzerland:
Topological tests of the mecha-
2Institute for Cell Biology, Zurich,
Switzerland: Structure of knots
and catenanes produced by A
Int-Implications for mechanism
and DNA structure.
Wine and Cheese Party
SESSION 13 SITE-SPECIFIC RECOMBINATION
Chairperson: J. Broach, State University of New York, Stony Brook, New York
Johnson, R., Bruist, M., Glaccum, M.,
Simon, M., Biology Division, Cali-
fornia Institute of Technology, Pas-
adena: Molecular mechanism of
phase variation.
Hoess, R., Abremski, K., Sternberg,
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N., NCI, Frederick Cancer Re-
search Facility, Frederick, Mary-
land: Studies on the Cre-/ox site-
specific recombination system of
bacteriophage
lida, S., Huber, H., Hiestand-Nauer,
R., Meyer, J., Bickle, T., Arber, W.,
Biozentrum, University of Basel,
Switzerland: Sequences used in
crossover by the site-specific cin
recombinase of bacteriophage P1.
McLeod, M., Volkert, F., Broach, J.,
Dept. of Microbiology, State Uni-
versity of New York, Stony Brook:
Analysis of the FLP recombination
system of the yeast plasmid 2-pm
circle.
Sadowski, R, Lee, D., Beatty, L., An-
drews, B., Babineau, D., Protean,
G., Vetter, D., Dept. of Medical Ge-
netics, University of Toronto, Can-
SESSION 14 RECOMBINATION IN VITRO
Chairperson: M. Gellert, National Institutes of Health, Bethesda, Maryland
Kolodner, R., Symington, L., Howard,
M., Muster-Nassal, C., Dana Far-
ber Cancer Institute, Dept. of Bio-
logical Chemistry, Harvard Medi-
cal School, Boston,
Massachusetts: Plasmid recombi-
nation catalyzed by cell-free ex-
tracts of yeast.
Kemper, B., Depka, M.V., Hoffmann,
H., Jensch, F., Institute of Ge-
netics, University of Cologne, Fed-
eral Republic of Germany: Resolu-
tion of Holliday structures in
cruciform DNA by endonuclease
VII.
Higgins, N.P.," Krause, H.M.,1 Oliv-
era, B.M.,2 'Dept.of Biochemistry,
University of Alabama, Birming-
ham; 2Dept. of Biology, University
of Utah, Salt Lake City: Definition
of the Mu operator and the use of
repressor in analyzing in vivo and
in vitro intermediates of transposi-
tion.
Mizuuchi, K., Mizuuchi, M., Craigie,
R., NIADDK, National Institutes of
Summary: A. Campbell, Stanford University, Stanford, California
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ada: Genetic recombination of
bacteriophage T7 and yeast 2-pm
circle DNA in vitro.
Cox, M., Bruckner, R., Meyer-Leon,
L., Senecoff, J., Dept. of Biochem-
istry, University of Wisconsin,
Madison: Purification and proper-
ties of the FLP protein of the yeast
2-pm plasmid.
Health, Bethesda, Maryland:
Mechanism of transposition of
bacteriophage Mu-Site-specific
recognition of Mu ends by the Mu
A-gene product and polarity of the
strand-transfer reaction.
Rosenberg, J., Dept. of Biological Sci-
ences, University of Pittsburgh,
Pennsylvania: Kinked DNA in
crystalline complex with EcoRI en-
donuclease.
MEETINGS
Molecular Biology of the Cytoskeleton
April 25-April 29
ARRANGED BY
Gary Borisy, University of Wisconsin
Don Cleveland, Johns Hopkins Medical School
Douglas Murphy, Johns Hopkins Medical School
122 participants
The meeting Molecular Biology of the Cytoskeleton sought to bring together a
diverse group of researchers whose principal interests center on some molecular
aspect of cytoskeletal elements, but who by virtue of the particular experimental
approach or organism employed do not have an opportunity for scientific ex-
change at other meetings. To this end, 122 investigators were assembled whose
efforts included: genetic approaches to determination of function of cytoskeletal
proteins in a diverse number of genetic systems, determination of the dynamics
of assembly of cytoskeletal components both in vivo and in vitro, biochemical
analysis of various cytoskeletal proteins and their variants, and finally, dissection
of the regulatory pathways that control cytoskeletal gene expression. Overall, the
congregation of investigators using diverse approaches to study cytoskeletal
function and regulation achieved the original goal of introducing workers in each
area of cytoskeletal investigation to alternative approaches and concepts.
This meeting was supported in part by the National Science Foundation and
the following divisions of the National Institutes of Health: Fogarty International
Center, National Cancer Institute, and the National Institute of General Medical
Sciences.
Welcoming Remarks: D. Murphy, Johns Hopkins Medical School, Baltimore, Maryland
SESSION 1 STRUCTURE AND DYNAMICS OF THE CYTOSKELETON
Chairperson: G. Borisy, University of Wisconsin, Madison, Wisconsin
Borisy, G., Kronebusch, P., Labora-
tory of Molecular Biology, Univer-
sity of Wisconsin, Madison: Micro-
tubule dynamics in vivo.
Kirschner, M., Mitchison, T., Dept. of
Biochemistry, University of Califor-
nia, San Francisco: Microtubule
dynamics in vitro.
Weber, K., Osborn, M., Geis ler, N.,
Max-Planck-Institute, Goettingen,
Federal Republic of Germany: In-
termediate filaments-Structural
and immunological analysis.
Kreis, TE.,' Schlessinger, J.,2 Geiger,
B.,2 'European Molecular Biology
Laboratory, Heidelberg, Federal
Republic of Germany; 2Dept. of
Chemical Immunology, Weizmann
Institute of Science, Rehovot, Is-
rael: Dynamic properties of actin,
a-actinin, and vinculin in focal con-
tact areas.
Salmon, E.D.,' Saxton, W.M.,2 Leslie,
R.J.,2 Karow, M.L.,2 Neighbors,
B.,2 McIntosh, J.R.,2 'Dept. of Bi-
ology, University of North Caro-
lina, Chapel Hill; 2Dept. of Molecu-
lar, Cellular, and Developmental
Biology, University of Colorado,
Boulder: Measurements of spindle
microtubule dynamics by fluores-
cence redistribution after photo-
bleaching.
S. Ward, R Anderson
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SESSION 2 MOSTLY MOLDS: MOLECULAR GENETICS
Chairperson: D. Botstein, Massachusetts Institute of Technology, Cambridge,
Massachusetts
Botstein, D., Shortie, D., Novick, P.,
Thomas, J.H., Huffaker, T., Schatz,
P., Dept. of Biology, Massachu-
setts Institute of Technology, Cam-
bridge: Applying old and new
genetic technology toward under-
standing the cytoskeleton of yeast.
Kilmartin, J.V., MRC Laboratory of
Molecular Biology, Cambridge,
England: Microtubules and actin
filaments during the yeast cell
cycle.
Pringle, J.R., Coleman, K., Lillie, S.,
Haarer, B., Adams, A., Jacobs, C.,
Robinson, J., Evans, C., Stapleton,
A., Division of Biological Sciences,
University of Michigan, Ann Arbor:
Cellular morphogenesis and the
cytoskeleton in yeast.
Thomas, J.H., Botstein, D., Dept. of
Biology, Massachusetts Institute of
Technology, Cambridge: Yeast
mutants affecting spindle function.
Novick, P.J., Osmond, B., Botstein,
D., Dept. of Biology, Massachu-
setts Institute of Technology, Cam-
bridge: Genetic analysis of actin
and interacting proteins.
Rose, M., Fink, G.R., Whitehead Insti-
tute for Biomedical Research and
Massachusetts Institute of Technol-
ogy, Cambridge: Mutations affect-
ing nuclear fusion in yeast.
Birkett, C.R.,' Boston, R.S.,2 Burland,
TG.,2 Dove, W.F.,2 Foster, K.E.,'
Green, L.,2 Gull, K.,' Johnston,
L.,2 Paul, E.C.A.,' Roobol, A.,'
Schedl, T.,2 Wilcox, M.,'
'Biological Laboratory, University
of Kent, Canterbury, England;
2McArdle Laboratory, University of
Wisconsin, Madison: Differential
expression of the tubulin gene
family in the life cycle of Physarum
polycephalum.
Bur land, TG.,' Schedl, T.,' Gull, K.,2
SESSION 3 MOSTLY MITOSIS: CENTROMERES AND KINETOCHORES
Chairperson: M. Kirschner, University of California, San Francisco, California
Amaya, E., Bloom, K., Dept. of Biol-
ogy, University of North Carolina,
Chapel Hill: Molecular architecture
of a yeast centromere.
Valdivia, M.M.,' Sykes, R.C.,2 Chi-
nault, A.C.,2-3 Brinkley, B.R.,'
Depts. of 'Cell Biology,
2Biochemistry, 3Medicine, Baylor
College of Medicine, Houston,
Texas: Biochemical studies of the
kinetochore/centromere of mam-
malian chromosomes.
Cox, J.V., Olmsted, J.B., Dept. of Biol-
ogy, University of Rochester, New
York: Kinetochore antigens-Syn-
thesis, phosphorylation, and evo-
lutionary conservation.
Vandre, D.D.,' Davis, F.M.,2 Borisy,
G.G.,"Laboratory of Molecular
Biology, University of Wisconsin,
Madison; 2University of Texas,
M.D. Anderson Hospital and Tu-
mor Institute, Houston: Phospho-
proteins are components of micro-
SESSION 4 MOSTLY WORMS: MOLECULAR GENETICS IN WORMS AND HIGHER
EUKARYOTES
Chairperson: E. Raff, Indiana University, Bloomington, Indiana
Raff, E.C., Fuller, M.T, Caulton, J.H.,
Rudolph, J.E., Kimble, M., Hutch-
ens, J.A., Dept. of Biology, Indiana
University, Bloomington: Tubulin
gene expression and microtubule
function in Drosophila.
Cox, K.H., Angerer, L.M., Angerer,
R.C., Dept. of Biology, University
of Rochester, New York: Individual
180
actin gene expression-Markers
for early differentiation of cell lin-
eages in developing sea urchin
embryos.
Bejsovec, A., Eide, D., Anderson, P.,
Dept. of Genetics, University of
Wisconsin, Madison: Genetic tech-
niques for analysis of nematode
muscle.
Dove, W.F.,"McArdie Laboratory,
University of Wisconsin, Madison;
2Biological Laboratory, University
of Kent, Canterbury, England: Ge-
netics of the tubulin gene families
in Physarum.
Morris, N.R., Weatherbee, J.A., Gam-
bino, J., Bergen, L.G., Dept. of
Pharmacology, UMDNJ-Rutgers
Medical School, Piscataway, New
Jersey: Tubulins of Aspergillus ni-
dulans-Genetics, biochemistry,
and function.
Lai, E.Y., Remillard, S.P., Fulton, C.,
Dept. of Biology, Brandeis Univer-
sity, Waltham, Massachusetts: The
a-tubulin gene family of Naegleria
and its expression during differen-
tiation.
tubule organizing centers of the
mitotic spindle in Chinese hamster
ovary cells.
Mitchison, T.J., Kirschner, M., Dept. of
Biochemistry, University of Califor-
nia, San Francisco: Kinetochores
as in vitro microtubule organizing
centers.
Ward, S., Dept. of Embryology, Car-
negie Institution of Washington,
Baltimore, Maryland: Acquisition
of cellular asymmetry during C.
elegans spermatogenesis.
Epstein, H.F, Ortiz, I., Berliner, G.C.,
Miller, D.M. III, Dept. of Neurology,
Baylor College of Medicine, Hous-
ton, Texas: Functionally distinct
myosins in C. elegans analyzed
through mutants.
Honda, S., Berman, S.A., Epstein,
H.F., Dept. of Neurology, Baylor
College of Medicine, Houston,
Texas: Regulation of myosin
heavy-chain expression in C. ele-
gans.
Krause, M.,' Wild, M.,' Hirsh, D.,' Wa-
terston, R.,' 'Dept. of Molecular,
SESSION 5 MOSTLY CHO AND CHLAMY: MOLECULAR GENETICS OF
CYTOSKELETAL PROTEINS
Chairperson: J. Rosenbaum, Yale University, New Haven, Connecticut
Cabral, F., Schibler, M., Division of
Endocrinology, University of Texas
Medical School, Houston: Analysis
of the role of microtubules in mito-
sis using CHO mutants requiring
taxol for cell growth.
Gottesman, M.M.,1 Abraham, I.,' Kuri-
yama, R.,2 Mackensen, S.,' Whit-
field, C.,"NCI, National Institutes
of Health, Bethesda, Maryland;
'Dept. of Molecular Biology, Uni-
versity of Wisconsin, Madison: Ge-
netic analysis of microtubule func-
tion in CHO cells.
Abraham, I., McClurkin, C., Gottes-
man, M.M., NCI, National Insti-
tutes of Health, Bethesda, Mary-
land: Cross-resistance of CHO
cells with tubulin mutations.
Whitfield, C., Doherty, P., Gottesman,
M.M., NCI, National Institutes of
Health, Bethesda, Maryland: Clon-
ing wild-type and mutant tubulins
from CHO cells.
Elliott, E.M.,' Okayama, H.,' Sarangi,
F.,' Henderson, G.,' Ling, V.,1
'Dept. of Medical Biophysics, Uni-
versity of Toronto and Ontario
Cancer Institute, Canada;
'National Institutes of Health, Be-
thesda, Maryland: Expression of
multiple a-tubulin genes in CHO
cells.
Dutcher, S.K.,1 Ramanis, Z.,' Luck,
D.J.L.,2 'Dept. of Molecular, Cellu-
lar, and Developmental Biology,
University of Colorado, Boulder;
'Rockefeller University, New York:
Flagellar mutants of C. reinhardtii
that show altered molecular phe-
notypes in isolated basal body
preparations.
Youngblom, J.,' Schloss, J.,2 Silflow,
C.,"Dept. of Genetics and Cell
Biology, University of Minnesota,
St. Paul; 'Dept. of Biology, Yale
University, New Haven, Connecti-
cut: Comparison of the two f3-tubu-
lin genes in Chlamydomonas.
Brunke, K.,12 Anthony, J.,1,2 Stern-
berg, Weeks, D.,2 'Institute
for Cancer Research, Fox Chase
SESSION 6 PROTEIN ISOFORMS
Chairperson: D. Murphy, Johns Hopkins Medical School, Baltimore, Maryland
Murphy, D.B., Grasser, W.A., Wallis,
K.T., Dept. of Cell Biology and
Anatomy, Johns Hopkins Medical
School, Baltimore, Maryland:
Expression of a unique /3-tubulin
variant in chicken-red-cell devel-
opment.
Craig, S.W.,' Pardo, J.V.,2 Pittenger,
M.F.,"Johns Hopkins Medical
School, Baltimore, Maryland;
'Duke Medical School, Durham,
North Carolina: Suellular sorting of
isoactins.
Blose, S.H., Matsumura, F., Cold
Spring Harbor Laboratory, New
York: Molecular analysis of micro-
tubules rapidly purified from cells
using monoclonal-antibody-in-
duced aggregation.
Vallee, R., Bloom, G., Luca, F., Cell Bi-
ology Group, Worcester Founda-
tion for Experimental Biology,
Shrewsbury, Massachusetts: Dif-
ferential cellular and suellular dis-
tribution of microtubule-associated
proteins.
Lazarides, E., Nelson, W.J., Kasa-
matsu, T., Division of Biology, Cali-
fornia Institute of Technology, Pas-
adena: Expression, assembly, and
topogenesis of membrane-cyto-
skeletal domains in neurons.
Piperno, G., Rockefeller University,
New York: Analysis of the mitotic
Cellular, and Developmental Biol-
ogy, University of Colorado, Boul-
der; 'Dept. of Genetics, Washing-
ton School of Medicine, St. Louis,
Missouri: C. elegans actin genes.
Cancer Center, Philadelphia,
Pennsylvania; 2Zoecon Corp., Palo
Alto, California; 3Smith-Kline and
French Laboratories, Swede land,
Pennsylvania: Coordinate expres-
sion of the four tubulin genes in
Chlamydomonas.
Lefebvre, P. Barsel, S., Stuckey, M.,
Swartz, L., Dept. of Genetics and
Cell Biology, University of Minne-
sota, St. Paul: Isolation and char-
acterization of mutants of Chlamy-
domonas defective in the
regulation of flagellar gene expres-
sion.
Kuchka, M., Jarvik, J., Dept. of Bio-
logical Sciences, Carnegie-Mellon
University, Pittsburgh, Pennsylva-
nia: Genetic analysis of flagellar
size control in C. reinhardtii.
Baldwin, D., Chojnacki, B., Jarvik, J.,
Dept. of Biological Sciences, Car-
negie-Mellon University, Pitts-
burgh, Pennsylvania: Defective fla-
gellar assembly in stumpy flagella
mutants of C. reinhardtii.
apparatus by monoclonal anti-
bodies to components of flagellar
axonemes.
Wiche, G.,' Briones, E.,' Koszka, C.,'
Leichtfried, FE.,1 Krepler, R.,' Art-
lieb, U.,2 'Institute of Biochemistry;
'Dept. of Pathology, University of
Vienna, Austria: Widespread oc-
currence of microtubule-associ-
ated proteins MAP 1 and MAP 2 in
nonneuronal cells/tissues and as-
sociation of both polypeptides with
microtubules polymerized in vitro.
Aebi, U.,' Salvo, H.,' Leavitt, J.,2
'Dept. of Cell Biology and Anat-
omy, Johns Hopkins Medical
School, Baltimore, Maryland;
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2Linus Pau ling Institute of Science
and Medicine, Palo Alto, Califor-
nia: In vitro characterization of a
mutant f3 -actin expressed in a ma-
lignant human fibroblast cell line.
Cappuccinelli, P., Institute of Medical
Microbiology, University of Sas-
sari, Sardinia, Italy: Immunological
heterogeneity of cytoskeletal pro-
teins in eukaryotic microorga-
nisms.
Owens, R.J., Totty, N., Waterfield,
M.D., Crumpton, M.J., Imperial
Cancer Research Fund, Lincoln's
Inn Fields, London, United King-
dom: Structural characterization of
SESSION 7 MOSTLY MAMMALIAN GENE EXPRESSION AND REGULATION
Chairperson: D. Cleveland, Johns Hopkins Medical School, Baltimore, Maryland
Cleveland, D.W.,' Pittenger, M.F,'
Feramisco, J.R.,2 Havercroft,
J.C.,"Dept. of Physiological
Chemistry, Johns Hopkins Univer-
sity School of Medicine, Baltimore,
Maryland; 2Cold Spring Harbor
Laboratory, New York: Autoregu-
lated expression of vertebrate tu-
bulins.
Lee, M.G.-S., Cowan, N.J., Dept. of
Biochemistry, New York University
Medical Center, New York: Modu-
lation of mRNA levels transcribed
from a human /3- tubulin gene
cloned in a eukaryotic shuttle vec-
tor.
J. Spudich
Baker, E., Bandziulis, R., Keller, L.,
Rosenbaum, J., Schloss, J., Dept.
of Biology, Yale University, New
Haven, Connecticut: Synthesis
and accumulation of mRNAs for
flagellar proteins during flagellar
regeneration in Chlamydomonas.
Schedl, T,' Burland, T.G.,, Gull, K.,2
Dove, W.F.,' McArdle Laboratory,
University of Wisconsin, Madison;
?Biological Laboratory, University
of Kent, Canterbury, England:
Regulation of tubulin expression in
the Physarum cell cycle.
Landfear, S.M., Wirth, D.F, Harvard
School of Public Health, Boston,
Massachusetts: Structure and de-
velopmental regulation of tubulin
genes in the parasitic protozoon
Leishmania enriettii.
Farmer, S.R., Bond, J.F., Robinson,
G.S., Mbangkollo, D., Fenton,
M.J., Knight , G.B., Berkowitz,
E.M., Dept. of Biochemistry, Bos-
ton University Medical School,
Massachusetts: Differential
expression of the p-tubulin multi-
gene family during rat brain devel-
opment-Identification of neural
specific and constitutive mRNAs.
Sullivan, K.F., Lau, J.T.Y., Cleveland,
D.W., Dept. of Physiological
Chemistry, Johns Hopkins Univer-
sity, School of Medicine, Balti-
more, Maryland: Primary structure
of a vertebrate p-tubulin gene fam-
SESSION 8 MOSTLY MUSCLE' GENE STRUCTURE AND EXPRESSION
Chairperson: S. Penman, Massachusetts Institute of Technology, Cambridge,
Massachusetts
Penman, S., Dept. of Biology, Massa-
chusetts Institute of Technology,
Cambridge: Morphology and pro-
tein composition of the structural
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elements of cytoplasm and nu-
cleus in cells and tissues.
Zimmer, W.E., Jr., Chang, K.S.,
Bergsma, D., Schwartz, R., Dept.
p68, a new Ca2+-binding protein
of the cytoskeleton.
Maruta, H., Knoerzer, W., Isenberg,
G., Max-Planck-Institute, Munich,
Federal Republic of Germany:
Nonpolymerizable variants regu-
late actin polymerization in Physa-
rum.
ily-At least three divergent ( -tu-
bulin isotypes are expressed in the
chicken.
Havercroft, J.C., Cleveland, D.W.,
Dept. of Physiological Chemistry,
Johns Hopkins University School
of Medicine, Baltimore, Maryland:
Programmed expression of (3-tu-
bulin genes during development
and differentiation of the chicken.
Ginzburg, I., Littauer, U.Z., Dept. of
Neurobiology, Weizmann Institute
of Science, Rehovot, Israel:
Expression and cellular regulation
of microtubule proteins.
Drubin, D.,' Feinstein, 5.,2 Shooter,
E.,2 Kirschner, M.,' 'Dept. of Bio-
chemistry, University of California,
San Francisco; 2Dept. of Neuro-
biology, Stanford University, Cali-
fornia: Expression of tau protein
and tau mRNA during PC12 differ-
entiation.
Holtzer, H., Friedman, T, Forry-
Schaudies, S., Pacifici, M., Dept.
of Anatomy, University of Pennsyl-
vania Medical School, Philadel-
phia: Effects of Colcemid and
taxol on the synthesis and assem-
bly of tubulin, vimentin, and des-
min during chondrogenesis and
myogenesis.
Welch, W.J., Blose, S., Feramisco,
J.R., Cold Spring Harbor Labora-
tory, New York: Heat-shock re-
sponse and the cytoskeleton.
of Cell Biology, Baylor College of
Medicine, Houston, Texas: Organi-
zation and expression of the
chicken actin multigene family.
Leavitt, J.,1 Ng, S.-Y.,1 Lin, C.-S.,'
Gunning, P.,2 Kedes, L.,2 1Linus
Pau ling Institute of Science and
Medicine, Palo Alto, California;
'Dept. of Medicine, Stanford Medi-
cal School and Veterans Adminis-
tration Medical Center, California:
Isolation and characterization of
wild-type and mutant human a -ac-
tin genes.
Gunning, P.,1 Hickey, R.,2 Ng, 5.-Y,3
Ponte, P.,1 Minty, A.,1 Erba, H.,'
Leavitt, J.,3 Skoultchi, A.,2 Kedes,
L.,"Stanford Medical School and
Veterans Administration Medical
Center, Palo Alto, California;
'Albert Einstein School of Medi-
cine, Bronx, New York; 3Linus
Pau ling Institute of Science and
Medicine, Palo Alto, California:
Human actin-gene structure, evo-
lution, and expression in heterolo-
gous cells.
Helfman, D.M., Feramisco, J.R., Kost,
T.A., Yamawaki-Kataoka, Y., Ricci,
W.M., Hughes, S.H., Cold Spring
Harbor Laboratory, New York:
Cloning by immunological screen-
ing of cDNA expression libraries-
Analysis of smooth-muscle a- and
p-tropomyosins.
MacLeod, A.R., Talbot, K., Ludwig In-
stitute for Cancer Research, MRC,
Cambridge, England: Human cy-
toskeletal tropomyosin genes.
G. Borisy, D. Cleveland, D. Murphy
Cooper, T., Ordahl, C., Dept. of Anat-
omy, University of California, San
Francisco: Genomic structure of a
troponin-T isogene expressed ac-
cording to two regulatory pro-
grams in heart and skeletal mus-
cle development.
Hammer, J.A. III, Korn, E.D., Pater-
son, B.M., National Institutes of
Health, Bethesda, Maryland: Clon-
ing of the Acanthamoeba myosin
heavy-chain genes.
Leinwand, L.,' de Lozanne, A.,2
SESSION 9 ENTIRELY INTERMEDIATE FILAMENTS
Chairperson: E. Fuchs, University of Chicago, Chicago, Illinois
Fuchs, E., Marchuk, D., Tyner, A.,
McCrohon, S., Dept. of Biochemis-
try, University of Chicago, Illinois:
Expression of keratin genes in hu-
man epithelia.
Steinert, P.,' Roop, D.,2 'Dermatology
Branch; 'NCI, National Institutes
of Health, Bethesda, Maryland:
Amino acid sequences of epider-
mal keratins correlate with their
developmental expression.
Jorcano, J.L., 1,2 Rieger, M.,2 Franz,
J.K.,2 Magin,T.M.,2 Schiller, D.L.,2
Franke, W.W.,2 'Center of Molecu-
lar Biology, University of Heidel-
berg; 'Institute of Cell and Tumor
Biology, German Cancer Research
Center, Heidelberg, Federal Re-
public of Germany: Principles of
cytokeratin expression and cyto-
keratin relationships.
Zehner, Z.,' Paterson, B.,2 'Medical
College of Virginia, Virginia Com-
monwealth University, Richmond;
'NCI, National Institutes of Health,
Bethesda, Maryland: Sequence of
the chicken vimentin gene.
Lazarides, E., Capetanaki, Y.G., Ngai,
J., Division of Biology, California
Institute of Technology, Pasadena:
Vimentin- From gene to morpho-
genesis.
Quax, W., Quax-Jeuken, Y., Egberts,
W.V., van den Heuvel, R., Hen-
driks, W., Bloemendal, H., Dept. of
Biochemistry, University of Nijme-
Lewis, M.,' Saez, L.,' Spudich, J.,2
'Albert Einstein College of Medi-
cine, Bronx, New York; 'Stanford
University School of Medicine,
California: Isolation and character-
ization of nonmuscle myosin
heavy-chain cDNA clones from
Dictyostelium.
Izant, J.G., Dept. of Genetics, Fred
Hutchinson Cancer Research
Center, Seattle, Washington: Anti-
sense gene transcription as a tool
for molecular analysis.
gen, Netherlands: Genes for vi-
mentin and desmin.
Ben-Ze'ev, A., Dept. of Genetics,
Weizmann Institute of Science, Re-
hovot, Israel: Differential control of
cytokeratins and vimentin synthe-
sis by cell-cell contact and cell
spreading in cultured epithelial
cells.
Roop, D.R.,1 Toftgard, R.,' Kronen-
berg, M.S.,' Clark, J.H.,2 Yuspa,
S.H.," NCI, National Institutes of
Health, Bethesda, Maryland;
'Dept. of Cell Biology, Baylor Col-
lege of Medicine, Houston, Texas:
Changes in keratin gene expres-
sion during differentiation.
Closing Remarks: D. Cleveland, Johns Hopkins Medical School, Baltimore, Maryland
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Ciliate Molecular Genetics
May 2-May 6
ARRANGED BY
Peter Bruns, Cornell University
Martin Gorovsky, University of Rochester
98 participants
Investigators from laboratories in the United States, Europe, and Japan attended
the Ciliate Molecular Genetics meeting. Among the many high points of the meet-
ing were: reports of telomere location for Paramecium surface antigens; indica-
tions from three different laboratories that ciliates may have a somewhat unique
genetic code (unspliced termination codons in coding regions); the description of
two remarkable cases (one partly characterized at the molecular level) of cyto-
plasmic mutants that alter macronuclear development; report of a Tetrahymena
gene that is expressed only during conjugation and that appears to be homolo-
gous to the zeste locus in Drosophila; demonstration that E. coil CAP binds in a
sequence-specific manner to the promoter of Tetrahymena rDNA; purification of
gamones responsible for mating in a hypotrichous ciliate; and demonstration of a
topoisomerase-like molecule bound to specific sequences in the promoter region
of the Tetrahymena rDNA.
The meeting was reviewed both in Nature and Genetics.
Funding for this meeting was supplied in part by Amicon Corporation; J.T.
Baker Chemical Co.; Boehringer Mannheim Biochemicals; Fotodyne, Inc.; H.P.
Genenchem; Hans Biologics, Inc.; Kontes Scientific Glassware; Nikon, Inc.; Pro-
mega Biotech; Schleicher & Schuell; Society for Developmental Biology, Inc.;
and the following divisions of the National Institutes of Health: Fogarty Interna-
tional Center and National Institute of General Medical Sciences.
SESSION 1 OVERVIEW
Chairperson: J. Engberg, University of Copenhagen, Copenhagen, Denmark
Gall, J.G., Dept. of Embryology, Car-
negie Institution, Baltimore, Mary-
land: Ciliate molecular genetics.
Prescott, D.M., Swanton, M.T., Roth,
M., Klobutcher, L.A., Dept. of Mo-
lecular, Cellular, and Develop-
mental Biology, University of Colo-
rado, Boulder: Modification of
DNA in ciliate development.
'Freer, J., Jr., Dept. of Biology, Indiana
University, Bloomington: Over-
view-Immobilization antigens.
Nanney, D.L., Dept. of Genetics and
Development, University of Illinois,
SESSION 2 GENOME ORGANIZATION AND REORGANIZATION
Chairperson: S.L. Allen, University of Michigan, Ann Arbor, Michigan
Klobutcher, L.,' Jahn, C.,2 Prescott,
D.,3 'Dept. of Biochemistry, Uni-
versity of Connecticut Health Cen-
ter, Farmington; 2Dept. of Biologi-
cal Sciences, University of Illinois,
Chicago; 3Dept. of Molecular, Cel-
lular, and Developmental Biology,
University of Colorado, Boulder:
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DNA sequence elimination and
addition are both involved in gene
maturation during macronuclear
development in Oxytricha nova.
Cartinhour, S., Herrick, G., Dept. of
Cellular, Viral, and Molecular Biol-
ogy, University of Utah, Salt Lake
City: Alternate juxtaposition of ma-
Urbana; Humboldt Fellow, Zoolo-
gisches Institut, Universitat Muns-
ter, Federal Republic of Germany:
Evolutionary genetics of the cil-
iates.
cronuclear sequences in Oxytricha
fallax.
Lipps, H.J., Kraut, H., Institut fOr Biol-
ogie III, Tubingen, Federal Repub-
lic of Germany: DNA reorganiza-
tion during macronuclear
development of Stylonychia.
Yao, M.-C., Altschuler, M., Auster-
berry, C., Dept. of Biology, Wash-
ington University, St. Louis, Mis-
souri: DNA rearrangement in
Tetrahymena.
Blackburn, E., Bliska, J., Challoner, P.,
Cherry, J.M., Ryan, T., Spangler,
E., Dept. of Molecular Biology,
University of California, Berkeley:
Sequence analysis and synthesis
of macronuclear telomeres.
Diamond, C.H., Ohashi, RS., Rose,
A., Tsao, N.N.G.,Pearlman, R.E.,
Dept. of Biology, York University,
Toronto, Canada: Analysis of a mi-
cronucleus limited sequence from
Tetrahymena thermophila.
SESSION 3 POSTER SESSION
Ammermann, D., Institute of Biologie
III, University of TObingen, Federal
Republic of Germany: Is the chro-
mosome elimination in Stylonychia
lemnae dependent on the micron-
uclear DNA content?
Bruns, P.J., Section of Genetics and
Development, Cornell University,
Ithaca, New York: Genetic maps of
Tetrahymena thermophila.
Allen, S.L., Ervin, RR., McLaren,
N.C., Division of Biological Sci-
ences, University of Michigan,
East Lansing: Organization of the
5S rRNA gene clusters in the
germ-line and somatic genomes of
Tetrahymena thermophila.
Pederson, D.S., Bannon, G.A.,
Bowen, J.K., Shupe, K., Gorovsky,
M.A., Dept. of Biology, University
of Rochester, New York: Relation-
ship of DNAse I hypersensitive
sites to transcription of 5S and hi-
stone genes in Tetrahymena ther-
mophila.
Hufschmid, J.-D., de Haller, G., Labo-
ratory of Protozoology, University
of Geneva, Switzerland: Studies
on the DNA of the heterotrich cil-
iate Climacostomum virens.
Dawson, D., Herrick, G., Dept. of Cel-
lular, Viral, and Molecular Biology,
University of Utah, Salt Lake City:
Rare internal C,A4 repeats in the
micronuclear genome of Oxytricha
fallax.
Tschunko, A., Allen, S., University of
Michigan, Ann Arbor: Structure
and genomic organization of an in-
verted repeated DNA sequence of
Tetrahymena thermophila.
White, T, Allen, S., University of Mich-
igan, Ann Arbor: Eliminated DNA
sequences and a specific site of
methylation in the macronucleus
of Tetrahymena thermophila.
Yaeger, P,' Orias, E.,' Larson, D.,2
Howard, E.A.,2 Blackburn, E.H.,2
,Dept. of Biological Sciences, Uni-
versity of California, Santa Bar-
bara; 2Dept. of Molecular Biology,
University of California, Berkeley:
Mutations affecting rDNA amplifi-
cation in Tetrahymena thermo-
phila.
Olins, D.E., Allen, R.L., Cadilla, C.L.,
Olins, A.L., University of Tennes-
see-Oak Ridge Graduate School
of Biomedical Sciences and Biol-
ogy Division, Oak Ridge: Macron-
uclear and chromatin structure in
Euplotes eurystomus.
Gottschling, D.E., Cech, T.R., Dept. of
Chemistry, University of Colorado,
Boulder: A complex at the molecu-
lar ends of Oxytricha macronu-
clear DNA imparts nucleosome
phasing.
Poster Session
Haller, B.L., Orias, E., Dept. of Biolog-
ical Sciences, University of Califor-
nia, Santa Barbara: Aphidicolin af-
fects differential amplification of
rDNA molecules in B/C3 heterozy-
gotes of Tetrahymena thermo-
phila.
Conover, R.K., Brunk, C.F., Dept. of
Biology, University of California,
Los Angeles: Isolation of telom-
eres from Tetrahymena thermo-
phila.
Rogers, M., Karrer, K., Dept. of Biol-
ogy, Brandeis University, Waltham,
Massachusetts: Adolescence in
Tetrahymena thermophila.
Suhr-Jessen, P., Dept. of Anatomy
and Cytology, University of
Odense, Denmark: Stage-specific
changes in protein synthesis pat-
tern during conjugation in Tetrahy-
mena thermophila.
Gutierrez, J.C., Orias, E., Dept. of Bi-
ological Sciences, University of
California, Santa Barbara: Doublet
cells of Tetrahymena thermophila
originated after capsule induction
on conjugating pairs.
Hamilton, E.P., Orias, E., Dept. of Bio-
logical Sciences, University of Cal-
ifornia, Santa Barbara: Macronu-
clear retention and other
developmental effects induced by
vinblastine in conjugating Tetrahy-
mena.
Eustice, D.C., Wilhelm, J.M. Dept. of
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Microbiology, University of Roch-
ester, New York: Mechanism ofac-
tion of aminoglycoside antibiotics
with wild-type Tetrahymena ther-
mophila and drug-resistant mu-
tants.
Skelley, S., Wilhelm, J.M., Dept. of Mi-
crobiology, University of Roches-
ter, New York: Multiple mutations
in Tetrahymena thermophila con-
SESSION 4 CONJUGATION
ferring resistance to aminoglyco-
side antibiotics.
Sripati, C.E., Institut de Biologie phys-
ico-chimique, Paris, France: Invivo
stability of ribosomes in Tetrahy-
mena thermophila.
Cleffmann, G., Palissa, H., Institute of
Animal Physiology, University of
Giessen, Federal Republic of Ger-
many: Division mutants as tools to
Chairperson: A. Miyake, University di Camerino, Camerino, Italy
Miyake, A., Dipartimento di Biologia
Cellulare, University di Camerino,
Italy: Ciliate conjugation-Intro-
ductory remarks.
Heckmann, K., Zoological Institute,
University of MOnster, Federal Re-
public of Germany: Towards the
molecular basis of cell recognition
in Euplotes octocarinatus.
Luporini, P., Miceli, C., Dipartimento
di Biologia Cellulare, University di
Camerino (MC), Italy: The molecu-
lar mechanism of sexual interac-
tion in Euplotes.
Miceli, C., Luporini, P., Dipartimento
di Biologia Cellulare, University di
Camerino, Italy: Isogamones in
Euplotes raikovi.
Fujishima, M., lwao, Y., Biological In-
stitute, Faculty of Science, Yama-
guchi University, Japan: Induction
of reinitiation of meiosis in toad
oocytes by injection of Parame-
cium extracts.
Eckert, W.A., Weiske-Benner, A., Insti-
tute of Zoology, University of Hei-
delberg, Federal Republic of Ger-
many: Differentiation and
transcriptional activity of nuclei
during conjugation in Tetrahy-
mena thermophila.
Allis, C.D., Wiggins, J.C., Richman,
SESSION 5 RIBOSOMES, RIBOSOMAL GENES, AND MITOCHONDRIAL GENES
Chairperson: R. Hallberg, Iowa State University, Ames, Iowa
Amin, A.A., Pearlman, R.E., Dept. of
Biology, York University, Toronto,
Canada: Autonomously replicating
segments from Tetrahymena ther-
mophila rDNA-Sequence, struc-
ture, and function.
P.J. Bruns
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study cell cycle control in Tetrahy-
mena.
Smith-Sonneborn, J., Dept. of Zool-
ogy and Physiology, University of
Wyoming, Laramie: Clonal age-
and cell-specific response to low-
frequency electromagnetic fields.
Dyer, B.D., Dept. of Biology, Boston
University, Massachusetts: Anaer-
obic, sulfide -tolerant ciliates.
R., Chicoine, L., Wenkert, D., Bay-
lor College of Medicine, Texas
Medical Center, Houston: Histone
rearrangements accompany nu-
clear differentiation and dediffer-
entiationin Tetrahymena thermo-
phila.
Martindale, D.W.,1.2 Goldberg, M.,'
Martindale, H.,1,2 Bruns, P.J.,"
Dept. of Genetics and Develop-
ment, Cornell University, Ithaca,
New York; 2Dept. of Microbiology,
McGill University, Quebec, Can-
ada: Sequence conservation of a
conjugation-specific gene from Te-
trahymena.
Engberg, J., Nielsen, H., Jeppesen,
C., Biochemical Institute B, Univer-
sity of Copenhagen, Denmark:
The ribosomal RNA genes of Te-
trahymena - Structure and func-
tion.
Higashinakagawa, T., Matsuura, T.,
Matsumoto, K., Matsuda, R., Dept.
of Biology, Tokyo Metropolitan
University, Japan: Structure and
expression of Tetrahymena ribo-
somal DNA.
Niles, E.G., Matusick, L., Dept. of Bio-
chemistry, State University of New
York, Buffalo: CAP binding to the
Tetrahymena pyriformis rDNA pro-
moter.
Gocke, E., Bonven, B.J., Wester-
gaard, 0., Dept. of Molecular Biol-
ogy and Plant Physiology, Univer-
sity of Aarhus, Denmark: Is rRNA
synthesis in Tetrahymena regu-
lated by a sequence-specific topo-
isomerase I framing the gene?
K ster, K.-P, Eckert, W.A., Dept. of
Physiology, Institute of Zoology,
Heidelberg, Federal Republic of
Germany: In vitro processing of
precursor rRNA in isolated ma-
cronuclei of Tetrahymena thermo-
phila.
Zaug, A.J., Kent, J.R., Cech, T.R.,
Dept. of Chemistry, University of
Colorado, Boulder: Auto-reopen-
ing of the circular intervening se-
quence of Tetrahymena- lmplica-
Lions for the mechanism of RNA
self-splicing.
Wilhelm, J.M., Kelly, E., Skelly, S.,
Dept. of Microbiology, University
of Rochester, New York: Ribo-
somal proteins from antibiotic-re-
sistant strains of Tetrahymena
thermophila- Absence of starva-
tion-induced protein phosphoryla-
tion.
Suyama, Y, Dept. of Biology, Univer-
SESSION 6 BEHAVIOR, CELL SURFACE, AND CELL ARCHITECTURE
Chairperson: C. Kung, University of Wisconsin, Madison, Wisconsin
Kung, C., Dept. of Genetics, Labora-
tory of Molecular Biology, Univer-
sity of Wisconsin, Madison: Behav-
ioral genetics of Paramecium -
Ancient and recent history.
Haga, N.,' Forte, M.,2 Ramanathan,
R.,' Saimi, Y.,' Kung, C.,'
'Laboratory of Molecular Biology,
University of Wisconsin, Madison;
2Dept. of Biology, Case Western
Reserve University, Cleveland,
Ohio: Purification of a soluble pro-
tein controlling Ca" channel ac-
tivity in Paramecium.
Saimi, Y., Hinrichsen, R.D., Labora-
tory of Molecular Biology, Univer-
sity of Wisconsin, Madison: Ge-
netic dissection of electrogenesis
and characterization of mutants in
Paramecium.
Schultz, J.E., Grunemund, R., Gier-
lich, D., Klumpp, S., Pharmaceuti-
cal Institute, University of TObin-
gen, Federal Republic of
Germany: Ionic regulation of the
cyclic nucleotide system in Para-
mecium tetraurelia.
Bonini, N.M., Gustin, M.C., Mason, P,
Nelson, D.L., Piper, L., Dept. of
Biochemistry, University of Wis-
consin, Madison: A possible role
for cyclic AMP in the regulation of
the ciliary beat in Paramecium te-
traurelia.
SESSION 7 GENE ORGANIZATION AND EXPRESSION
Chairperson: E. Orias, University of California, Santa Barbara, California
Caron, F., Meyer, E., Centre de Gend-
tique Moleculaire, CNRS, Gif-sur-
Yvette, France: Cloning of the en-
tire structural gene of the G sur-
face antigen and its expression in
E. coli.
Find ly, R.C., Dept. of Biology, Yale
University, New Haven, Connecti-
cut: Genomic organization of the
Tetrahymena hsp70 heat-shock
genes.
Hallberg, R., Kraus, K., Dept. of Zool-
ogy, Iowa State University, Ames:
Regulation of heat-shock protein
mRNA utilization in Tetrahymena
thermophila.
Galego, L., Rodriques-Pousada, C.,
Dept. of Microbiology, Instituto
Gulbenkian de Ciencia, Oeiras,
Portugal: Stress response in Tetra-
hymena pyriformis- Differences
between starvation and heat
shock.
Ness, J.C., Morse, D.E., Dept. of Bio-
logical Sciences, University of Cal-
ifornia, Santa Barbara: Biochemi-
cal analysis of the regulation of
galactokinase gene expression in
Tetrahymena thermophila.
Cupples, C., Pearlman, R.E., Dept. of
Biology, York University, Toronto,
Canada: Actinlike sequences in
Tetrahymena.
Helftenbein, E., Institut fur Biologie III,
Universitat TObingen, Federal Re-
public of Germany: Nucleotide se-
quence of a macronuclear gene-
sized DNA molecule coding for a-
tubulin in Stylonychia lemnae.
Seyfert, H.-M., Institute of Animal
Physiology, University of Giessen,
Federal Republic of Germany:
sity of Pennsylvania, Philadelphia:
Genes and genome organization
of Tetrahymena mitochondrial
DNA.
Heinonen, T.Y.K., Young, P.G., Dept.
of Biology, Queen's University,
Kingston, Canada: Transcription
map of Tetrahymena mitochon-
dria! DNA.
Van Houten, J., Schulz, S., Preston,
R., Dept. of Zoology, University of
Vermont, Burlington: Role of mem-
brane in Paramecium chemore-
ception.
Kaneshiro, E.S., Matesic, D.F., Dept.
of Biological Sciences, University
of Cincinnati, Ohio: The sphingo-
lipids of the Paramecium baA mu-
tant.
Frankel, J., Jenkins, L.M., Nelsen,
E.M., Lansing, T.J., Bakowska, J.,
Dept. of Biology, University of
Iowa, Iowa City: Mutations affect-
ing patterning of cell-surface struc-
tures in Tetrahymena thermophila.
M.A. Gorovsky
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Regulation of tubulin synthesis versity of Rochester, New York:
throughout ciliary regeneration in Regulation of tubulin synthesis
Tetrahymena. during cilia regeneration in
Calzone, F.J., Callahan, R.C., Gorov- starved Tetrahymena thermophila.
sky, M.A., Dept. of Biology, Uni- Orias, E., Baum, M.P., Dept. of Bio-
SESSION 8 SECRETION AND CYTOPLASMIC PHENOMENA
Chairperson: B.H. Satir, Albert Einstein College of Medicine, Bronx, New York
Adoutte, A.,' Garreau de Loubresse,
N.,2 Beisson, J.,"Centre de
Genetique Moleculaire du CNRS,
Gif-sur-Yvette; 2Centre de Cytolo-
gie Experimentale du CNRS, Ivry-
sur-Seine, France: Proteolytic
cleavage and maturation of the
crystalline secretion products of
Paramecium.
Garofalo, R.S., Satir, B.H., Dept. of
Anatomy, Albert Einstein College
of Medicine, Bronx, New York:
Quantitative studies on trichocyst
matrix expansion in vitro and its
regulation by Ca" and pH.
Aufderheide, K.J., Dept. of Biology,
Institute of Developmental Biology,
Texas A&M University, College
Station: Genetic and cortical phe-
notypes associated with early
clonal death in Paramecium te-
traurelia.
Kanabrocki, J.A., Quackenbush, R.L.,
Dept. of Microbiology, University
SESSION 9 TRANSFORMATION WORKSHOP
Chairperson: R.E. Pearlman, York University, Toronto, Canada
Killeen, M.T.,1 Duda, E.,2 Pearlman,
R.E.,"Dept. of Biology, York Uni-
versity, Toronto, Canada; 2Institute
of Biochemistry, Hungarian Acad-
emy of Sciences, Szeged, Hun-
gary: Attempts to genetically
transform Tetrahymena.
Duda, E.G.,' Pearlman, R.,2 'Institute
of Biochemistry, Biological Re-
search Center, Szeged, Hungary;
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2Dept. of Biology, York University,
Downsview, Canada: Transforma-
tion of Tetrahymena thermophila.
Luehrsen, K.R., Orias, E., Dept. of Bi-
ological Sciences, University of
California, Santa Barbara-At-
tempts to transform Tetrahymena:
A progress report.
Brunk, C.F., Conover, R.K., Dept. of
Biology, University of California,
logical Sciences, University of Cal-
ifornia, Santa Barbara: The "first
replicated, most amplified" hypoth-
esis for caryonidal mating type de-
termination.
of South Dakota, School of Medi-
cine, Vermillion, South Dakota: R-
body synthesis in E. coli.
Hufnagel, L.A., Dept. of Microbiology,
University of Rhode Island, Kings-
ton, and Marine Biological Labora-
tory, Woods Hole, Massachus-
setts: Ciliary rosettes-A new type
of intramembranous particle array
in starved and mating Tetrahy-
mena thermophila.
Forney, J.D., Epstein, L.M., Dept. of
Biology, lndiania University,
Bloomington: Cytoplasmic inherit-
ance of a macronuclear deletion in
Paramecium.
Williams, N.E.,' Ron, A.,2 'Dept. of
Zoology, University of Iowa, Iowa
City; 2Dept. of Anatomy and Em-
bryology, Hebrew University-Had-
assah Medical School, Jerusalem,
Israel: Synthesis and deployment
of immobilization antigen H3 in
transforming Tetrahymena thermo-
phila cells.
Meyer, E., Caron, F., Guiard, B.,
Centre de Genetique Moleculaire,
CNRS, Gif-sur-Yvette, France: In
vitro translation of Paramecium
messenger RNAs is blocked at
precise sites.
Kaney, A.R., Dept. of Biology, Bryn
Mawr College, Pennsylvania: Unu-
sual mating behavior in an ami-
cronucleate strain of Tetrahymena
thermophila.
Los Angeles: Transformation of Te-
trahymena to paromomycin resist-
ance with pSV2-neo DNA.
WOnning, I.U., Lipps, H.J., Institut fiir
Biologie III, Universitat TObingen,
Federal Republic of Germany: A
transformation system for the hy-
potrichous ciliate Stylonychia myti-
lus.
Molecular Biology of the Photosynthetic Apparatus
May 9-May 13
ARRANGED BY
Charles Arntzen, DOE/Plant Research Laboratory, Michigan State University
Lawrence Bogorad, The Biological Laboratories, Harvard University
Susan Bonitz, Cold Spring Harbor Laboratory
146 participants
The process of photosynthesis involves many reactions-light absorption, elec-
tron transfers, energy-coupling processes leading to ATP synthesis, and enzy-
matic reactions leading to CO, fixation and substrate and product cycling. The
main purpose of this meeting was to emphasize the advancements that have oc-
curred in the study of photosynthesis using new tools of molecular biology. Spe-
cial emphasis was placed on organizing sessions in which specialists in the anal-
ysis of the functional components of the photosynthetic processes presented
recent data in parallel with reports by molecular biologists dealing with the ge-
netic basis and developmental events that lead to the synthesis and stable inte-
gration of these components.
This meeting was supported in part by the Advanced Genetic Sciences, Inc.;
Amoco; Arco Solar, Inc.; CIBA-GEIGY; Dow Chemical Co.; Exxon Research and
Engineering; National Science Foundation; N.A,T.O.; Rhone-Poulenc, Inc.; Shell
Development Co.; Stauffer Chemical Co.; and U.S. Dept. of Agriculture.
SESSION 1 DNA REPLICATION, TRANSCRIPTION, AND PROTEIN SYNTHESIS
IN PLASMIDS
Chairperson: J. Weil, University of Strasbourg, Strasbourg, France
Gillham, N.,' Palmer, J.,' Boynton,
J.,2 Harris, E.,2 Depts. of 'Zoology,
2Botany, Duke University, Durham,
North Carolina: Organization of
plastid chromosomes.
Bogorad, L., Crossland, L.D., Russell,
D., Stirdivant, S., Harvard Univer-
sity, Cambridge, Massachusetts:
Transcription of chloroplast genes.
Hallick, R.B., Johanningmeier, U.,
Karabin, G.D., Nickoloff, J.A., Pas-
savant, C., Dept. of Chemistry,
University of Colorado, Boulder:
Transcription of chloroplast genes.
Orozco, E.M., Jr., Hanley-Bowdoin,
L., Poulsen, C., Mullet, J.E., Chua,
N.-H., Laboratory of Plant Molecu-
lar Biology, Rockefeller University,
New York, New York: In vitro tran-
scriptional analysis of the rL and
atpB genes from spinach and
maize.
Rodermel, S.R., Bogorad, L., Dept. of
Cellular and Developmental Biol-
ogy, Harvard University, Cam-
bridge, Massachusetts: Photore-
gulation of transcript levels during
light-induced plastid development
in maize.
Greenberg, B.,' Narita, J.,' DeLuca-
Flaherty, C.,'Gruissem, W.,2 Hal-
lick, R.,"Dept. of Chemistry, Uni-
versity of Colorado, Boulder;
2Dept. of Botany, University of Cal-
ifornia, Berkeley: Properties of two
chloroplast RNA polymerase activ-
ities.
Coffee break
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SESSION 2 THE FUNCTIONAL ORGANIZATION OF THE PHOTOSYNTHETIC ENERGY
TRANSDUCING APPARATUS
Chairperson: B. Cramer, Purdue University, West Lafayette, Indiana
Arntzen, C.J., DOE/Plant Research
Laboratory, Michigan State Uni-
versity, East Lansing: Chloroplast
membrane structure and function.
Andersson, B., Akerlund, H.-E., Jans-
son, C., Dept. of Biochemistry,
University of Lund, Sweden: Poly-
peptides on the oxidizing side of
PSII.
Herrmann, R., Botanishes Institut,
University of Dusseldorf, Federal
Republic of Germany: Plastid
genes for PSII proteins.
Erickson, J.M.,' Rochaix, J.-D.,'
Mets, L.,2 'Depts. of Molecular Bi-
ology and Plant Biology, University
of Geneva, Switzerland; 2Dept. of
Biology, University of Chicago, Illi-
B. Andersson, C. Arntzen, J. Bennett
SESSION 3 POSTER SESSION
Crossland, L., Rodermel, S., Bogo-
rad, L., Dept. of Cellular and De-
velopmental Biology, Harvard Uni-
versity, Cambridge,
Massachusetts: Single gene for
the large subunit of RuBP carbox-
ylase in maize yields two mRNAs.
Gingrich, J.C., Hal lick, R.B., Dept. of
Chemistry, University of Colorado,
Boulder: The E. gracilis ribulose-
1,5-bisphosphate carboxylase
gene-Nine introns in a chloro-
plast protein gene.
Passavant, C.W., Hal lick, R.B., Dept.
of Chemistry, University of Colo-
rado, Boulder: Analysis of four
structural genes encoded in the E.
gracilis chloroplast chromosome.
Mullet, J.E., Boyer, S., Dept.of Bio-
chemistry and Biophysics, Texas
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A &M University, College Station: In
vitro transcription of the chloro-
plast psbA gene.
Hanley-Bowdoin, L., Chua, N.-H.,
Laboratory of Plant Molecular Biol-
ogy, Rockefeller University, New
York, New York: A 109-bp chloro-
plast sequence contains the pro-
moter for the maize rL gene.
Woessner, J.,1 Masson, A.,3 Harris,
E.,2 Bennoun, P,3 Gillham, N.,'
Boynton, J.,2 Depts. of 'Zoology,
2Botany, Duke University, Durham,
North Carolina; 3lnstitut de Biolo-
gie Physico-Chimique, Paris,
France: Molecular and genetic
analysis of the chloroplast ATPase
of Chlamydomonas.
Margulies, M.M., Smithsonian Envi-
ronmental Research Center, Rock-
nois: Using mutants to probe the
functional structure of the 32 kilo-
dalton protein of PSII.
Cohen, B.N., Bloom, M.V., Coleman,
T, Weissbach, H., Roche Institute
of Molecular Biology, Nutley, New
Jersey: Analysis of in vitro chloro-
plast gene expression using a sim-
plified dipeptide synthesis system.
Golden, S.S.,1 Sherman, L.A.,2 Hasel-
korn, R.," Dept. of Biophysics,
University of Chicago, Illinois;
2Division of Biological Sciences,
University of Missouri, Columbia:
Analysis of A. nidulans R2 psbA
genes from wild-type and DCMU-
resistant strains.
Mattoo, A.K.,' Marder, J.B.,2 Edel-
man, M.,' 'University of Maryland,
College Park, and Plant Hormone
Laboratory, USDA Agricultural Re-
search Service, Beltsville, Mary-
land; 2Dept. of Plant Genetics,
Weizmann Institute of Science, Re-
hovot, Israel: Light and the 32K
herbicide binding protein-Metab-
olism and function.
Kyle, D.J., DOE/Plant Research Labo-
ratory, Michigan State University,
East Lansing: Light-induced mem-
brane damage and repair; photo-
inhibition.
ville, Maryland: The function of
chloroplast membrane-bound ri-
bosomes.
Edwards, C.A.,' Bellemare, G.,2
Dharm, B.,' Chua, N.-H.,'
'Laboratory of Plant Molecular Bi-
ology, Rockefeller University, New
York, New York; 2Dept. of Bio-
chemistry, Laval University, Que-
bec, Canada: Chloroplast DNA-
dependent RNA polymerase con-
tains subunits that cross-react with
the subunits of E. coli RNA poly-
merase.
Muskavitch, K.M.T., Krebbers, E.T.,
Bogorad, L., The Biological Labo-
ratories, Harvard University, Cam-
bridge, Massachusetts: Light-stim-
ulated transcription of a region of
the Z. mays chloroplast genome.
McKown, R.L., Tewari, K.K., Dept. of
Molecular Biology and Biochemis-
try, University of California, Irvine:
Purification and properties of a
pea chloroplast single-stranded
DNA-binding protein.
Larrinua, I.M., Bogorad, L., The Bio-
logical Laboratories, Harvard Uni-
versity, Cambridge, Massachu-
setts: The characterization of
translational signals for higher
plant plastid genes.
Graan, T., Ort, D.R., Dept. of Plant Bi-
ology, USDA/ARS, University of Il-
linois, Urbana: Quantitation of the
rapid electron donors to P700, the
functional plastoquinone pool, and
the ratio of the photosystems in
spinach chloroplasts.
Wolber, P.K., Steinback, K.E., Ad-
vanced Genetic Sciences, Oak-
land, California: Analysis of a tryp-
tic peptide photoaffinity-labeled by
azidoatrazine.
Williams, J.C.,' Steiner, L.A.,2 Simon,
M.I.,2 Feher, G.,' 'University of
California, San Diego;
2Massachusetts Institute of Tech-
nology, Cambridge; 3Agouron In-
stitute, La Jolla, California: Se-
quencing of the genes encoding
the subunits of the reaction center
from R. sphaeroides.
Worland, S.,' Wilson, K.,2 Hearst, J.,'
Sauer, K.,"Division of Chemical
Biodynamics, Lawrence Berkeley
Laboratory, and Dept. of Chemis-
try, University of California, Berke-
ley; 2Cetus Corporation, Emery-
ville, California: Amino-terminal
sequences of reaction-center poly-
peptides from R. capsulate.
Zsebo, K.M.,' Wu, F.,2 Hearst, J.,2
'Group in Comparative Biochem-
SESSION 4 BACTERIAL PHOTOSYNTHESIS
Chairperson: S. Kaplan, University of Illinois, Urbana, Illinois
Crews, G., Peters, J., Dierstein, R., In-
stitute of Biology, Albert-Ludwigs
University, Freiburg, Federal Re-
public of Germany: Organization
and synthesis of the photosyn-
thetic apparatus of R. capsulate.
Youvan, D.C., Cold Spring Harbor
Laboratory, New York, and Exxon
Research and Engineering Com-
pany, Clinton, New Jersey: Reac-
tion-center, B870 and B800 and
B850 genes and deduced poly-
peptide sequences from R. capsu-
late.
Feher, G., Allen, J.R, Dept. of Phys-
ics, University of California, San
Diego: Crystallization of reaction
centers from R. sphaeroides; Pre-
liminary characterization.
Donohue, T.J.,' Chory, J.,' Varga,
A.R.,2Staehelin, A.L.,2 Kaplan,
S.,"University of Illinois, Urbana;
2University of Colorado, Boulder:
Biochemical and morphological
studies of the induction of the pho-
tosynthetic membrane of R.
sphaeroides.
Fuller, R.C., Red linger, T.E., Dept. of
Biochemistry, University of Massa-
chusetts, Amherst: The develop-
ment and topology of the photo-
synthetic apparatus of C.
aurantiacus.
Hearst, J.E., University of California,
Berkeley: The relationship be-
tween amino acid sequences and
quinone binding in photosynthetic
membranes.
Gilbert, C.W.,' Brown, A.E.,2Wy-
drzynski, T.J.,1 Williams, K.,'
istry; 2Dept..of Chemistry, Univer-
sity of California, Berkeley: Ge-
netic-physical mapping of a
photosynthetic gene cluster from
R. capsulate.
Kiley, P.J., Kaplan, S., University of Illi-
nois, Urbana: Identification of
light-harvesting polypeptides
within the chromatophores of R.
sphaeroides by analysis of light-
harvesting mutants.
Salvucci, M.E., Ogren, W.L., USDA/
ARS and Agronomy Dept., Univer-
sity of Illinois, Urbana: Biochemi-
cal characterization of two Chia-
mydomonas Calvin cycle mutants.
Chattoo, B.B., Hohn, B., Friedrich
Miescher-Institut, Basel, Switzer-
land: Molecular basis for an unsta-
ble chloroplast phenotype in petu-
nia hybrida.
Arntzen, C.J.,"Michigan State
University, East Lansing; 2Auburn
University, Alabama: Molecular
analysis of triazine herbicide re-
sistance in the photosynthetic bac-
terium R. sphaeroides.
Poster Discussion
Vannevar Bush Lecture Hall
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SESSION 5 NUCLEAR GENE REGULATION
Chairperson: E. Tobin, University of California, Los Angeles, California
Boynton, J.,' Schmidt, R.,' Myers,
A.,2 Hosier, J.,' Gil lham, N.,2
Depts. of 'Botany, 2Zoology, Duke
University, Durham, North Caro-
lina: Biogenesis of chloroplast ri-
bosomes-Cooperation of chloro-
plast and nuclear genes.
Jenkins, G.I.,' Bennett, J.,2 'Dept. of
Biological Sciences, University of
Warwick, Coventry, England;
2Dept. of Biology, Brookhaven Na-
tional Laboratory, Upton, New
York: Photoregulation of chloro-
SESSION 6 POSTER SESSION
Chory, J., Muller, E.D., Kaplan, S.,
Dept. of Microbiology, University
of Illinois, Urbana: Cloning,
expression, and assembly of the
form II ribulose-1,5-bisphosphate
carboxylase from R. sphaeroides.
Andrews, T.J., Bailment, B., Austra-
lian Institute of Marine Science,
Townsville: Reassembly of Rub-
isco from isolated subunits- Car-
bamate formation and 2-CABP
binding by isolated large-subunit
octamers.
Gutteridge, S., Sigal, I., Thomas, B.,
Arentzen, R., Cordova, A., Lori-
mer, G., Central Research and De-
velopment Dept., E.I. du Pont de
Nemours and Company, Wilming-
ton, Delaware: Directed mutage-
nesis of the carbamate-metal-ion-
binding site of RuBP carboxylase.
Pierce, J., Reddy, G.S., Central Re-
search and Development Division,
E.I. du Pont de Nemours and
Company, Wilmington, Delaware:
A structure for the catalytic com-
plex of RuBP carboxylase.
Coughlan, S.J., Clark, R.D., Hawkes-
ford, M.J., Bennett, J., Hind, G.,
Dept. of Biology, Brookhaven Na-
tional Laboratory, Upton, New
York: Identification of ferre-
doxin : NADP oxidoreductase as a
component of a 5-polypeptide cy-
tochrome b/f complex.
Sen, A., Dept. of Biophysics, Roswell
Park Memorial Institute, Buffalo,
New York: Polymorphic phase be-
havior of chloroplast thylakoid
membrane lipids.
Chia, C.F., Arntzen, C.J., DOE/Plant
Research Laboratory, Michigan
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plast proteins-mRNA levels, pro-
tein stability, and phosphorylation.
Morelli, G., Coruzzi, G., Broglie, R.,
Moses, P., Chua, N.-H., Labora-
tory of Plant Molecular Biology,
Rockefeller University, New York,
New York: The expression of rS
genes in vivo and in transformed
plant cells.
Cashmore, A., Timko, M., Hand, M.,
Kausch, A., Fassler, J., Laboratory
of Cell Biology, Rockefeller Univer-
sity, New York, New York: Nuclear
State University, East Lansing: Ac-
celerated membrane protein turn-
over in a chloroplast-encoded mu-
tant.
Leto, K.J.,1 Bell, E.,2 McIntosh, L.,2
'DuPont Company, Central Re-
search and Development, Wil-
mington, Delaware; 2Michigan
State University, East Lansing:
Failure to assemble PSII in a nu-
clear maize mutant is accom-
panied by accelerated turnover of
chloroplast-encoded PSII polypep-
tides.
Clark, R.D., Bennett, J., Hind, G.,
Dept. of Biology, Brookhaven Na-
tional Laboratory, Upton, New
York: Extraction and purification of
a spinach thylakoid kinase that
can phosphorylate light-harvesting
chlorophyll a/b protein (LHCP) in
vitro.
Abbott, M.S.,' Czarnecki, J.J.,2 Sel-
man, B. R.,' of Biochemis-
try, 2lnstitute for Enzyme Re-
search, University of Wisconsin,
Madison: Localization of the high-
affinity binding site for ADP and
ATP on the (3 subunit of the chloro-
plast CF1.
Merchant, S., Selman-Reimer, S., Ab-
bott, M.S., Selman, B.R., Dept. of
Biochemistry, University of Wis-
consin, Madison: Analysis of the
chloroplast CF1 in C. reinhardtii.
Tobin, E.M., Neumann, G.A., Kohorn,
B.D., Thornber, J.P., Dept. of Biol-
ogy, University of California, Los
Angeles: Sequence and structure
of an intron containing chlorophyll
a/b-protein gene expressed in L.
gibba.
genes encoding the light-harvest-
ing chlorophyll a/b-binding poly-
peptides and the small subunit of
ribulose-1,5-bisphosphate carbox-
ylase.
Herrera-Estrella, L.,1 Van den Broeck,
G.,1 Maenhaut, R.,1 Timko, M.,2
Cashmore, A.,2 Van Montagu, M.,1
Schell, J.,"Laboratorium voor
Genetica, Gent, Belgium;
2Rockefeller University, New York,
New York: Photoregulation of nu-
clear gene expression.
Anderson, L.,1 Eiserling, F.,1.2
'Molecular Biology Institute,2Dept.
of Microbiology, University of Cali-
fornia, Los Angeles: Assembly in-
teractions in Synechocystis 6701
phycobilisomes.
Kaufman, L.S., Watson, J.C., Briggs,
W.R., Thompson, W.F., Carnegie
Institution of Washington, Stan-
ford, California: Photoregulation of
nuclear genes in developing pea
buds.
Wimpee, C.F., Tobin, E.M., Dept. of
Biology, University of California,
Los Angeles: Structure and
expression of genes encoding the
small subunit of RuBP carboxylase
from L. gibba.
Yen, H.-C.B., Huggins, B.J., Georgen,
K.N., Corporate Research, Stand-
ard Oil Company, Naperville, Illi-
nois: Genetic transformation of for-
eign DNA in the photosynthetic
bacterium R. sphaeroides.
Ausich, R.L., Murphy, R.M., Corpo-
rate Research, Standard Oil Com-
pany, Naperville, Illinois: Experi-
ments on the transformation of C.
reinhardtii.
Gold, B., Bogorad, L., The Biological
Laboratories, Harvard University,
Cambridge, Massachusetts: Maize
chloroplast DNA fragments are ca-
pable of acting as autonomously
replicating sequences in yeast.
Cushman, J.C., Reardon, E.M., Miller,
M.E., Price, C.A., Waksman Insti-
tute, Rutgers University, Piscata-
way, New Jersey: Proline mimics
the effect of light in the regulation
of plastid protein synthesis in Eu-
glena.
SESSION 7 RUBISCO STRUCTURE AND FUNCTION
Chairperson: W. Ogren, University of Illinois, Urbana, Illinois
Ellis, R.J., Gallagher, T.F., Robinson,
C., Jenkins, G.I., Hemmingsen, S.,
Dept. of Biological Sciences, Uni-
versity of Warwick, Coventry, Eng-
land: Synthesis, processing, and
assembly of Rubisco subunits.
Nierzwicki-Bauer, S.A.,' Curtis, S.E.,2
Haselkorn, R.,"Dept. of Biophys-
ics, University of Chicago, Illinois;
2Dept. of Genetics, North Carolina
State University, Raleigh: Cotran-
scription of genes coding for the
large and small subunits of RuBP
carboxylase in the cyanobacter-
ium Anabaena 7120.
Poster Discussion
Lorimer, G., Pierce, J., Gutteridge, S.,
Central Research and Develop-
ment Division, E.I. du Pont de
Nemours and Company, Wilming-
SESSION 8 CYTOCHROME but AND PHOTOSYSTEM I
Chairperson: W. Krogman, Purdue University, West Lafayette, Indiana
Hauska, G., Dept. of Biology, Univer-
sity of Regensburg, Federal Re-
public of Germany: Organization
and function of the cytochrome b6f
complex.
Clark, R.D., Hind, G., Hawkesford,
M.J., Bennett, J., Dept. of Biology,
Brookhaven National Laboratory,
Upton, New York: Ferredoxin :
NADP oxidoreductase of chloro-
plasts is also a protein kinase.
nese.
Ortiz, W., Lam, E., Malkin, R., Division
of Molecular Plant Biology, Univer-
sity of California, Berkeley: Organi-
zation of the thylakoid PSI com-
plex.
Lundell, D.J.,' Glazer, A.N.,' Melis,
A.,2 Malkin, R.,2 'Dept. of Microbi-
ology and Immunology; 2Division
of Molecular Plant Biology, Univer-
sity of California, Berkeley: Char-
acterization of a cyanobacterial
PS1 complex.
Fish, L.E.,1 Kuck, U.,2 Bogorad, L.,1
'Dept. of Cellular and Develop-
mental Biology, Harvard Univer-
sity, Cambridge, Massachusetts;
2Lehrstuhl fur Allegemeine Bo-
tanik, Bochum, Federal Republic
of Germany: Structural analysis of
two adjacent light-inducible chlo-
roplast genes in maize with partial
amino acid homology encoding
polypeptides of the CPI complex
of PSI.
Jagendorf, A.T., Anthon, G., Section
of Plant Biology, Cornell Univer-
sity, Ithaca, New York: Unresolved
problems in photophosphoryla-
tion.
Selman-Reimer, S., Selman, B.R.,
Dept. of Biochemistry, University
of Wisconsin, Madison: Reversible
conformational changes of chloro-
plast CF1 induced by selective or-
ganic solvents.
Bottom ley, W.,' Zurawski, G.,2 Mason,
J.G.,' Whitfeld, P.R.,' 'Division of
Plant Industry, CSIRO, Canberra,
Australia; 2DNAX Research Insti-
tute, Palo Alto, California: Organi-
zation and structure of the chloro-
plast-encoded subunits of ATP
synthase.
Walker, J.E., Gay, N.J., Hampe, A.,
SESSION 9 LIGHT HARVESTING SYSTEMS IN CYANOBACTERIA
Chairperson: B. Zilinskas, Cook College, New Brunswick, New Jersey
Glazer, A.N., Dept. of Microbiology
and Immunology, University of
California, Berkeley: Phycobilipro-
teins as PBS components and as
purified proteins.
Gantt, E., Red linger, T, Lipschultz,
C.A., Smithsonian Environmental
Research Center, Rockville, Mary-
land: Phycobilisomes-A compari-
son of the terminal acceptor pig-
ment in red algae and cyano-
bacteria.
Lemaux, P.G.,12 Grossman, A.R.,'
'Carnegie Institution of Washing-
ton, Stanford, California; 2Dept. of
Biological Sciences, Stanford Uni-
versity, California: Isolation of
genes encoding phycobiliprotein
subunits.
Chang, 5.5.,' Kycia, J.H.,' Ledbetter,
ton, Delaware: RuBP carboxyl-
ase-Stereochemical aspects and
the involvement of the carbamate-
metal-ion complex in catalysis.
Hanks, J.F., Somerville, C.R., Mc-
Intosh, L., DOE/Plant Research
Laboratory, Michigan State Uni-
versity, East Lansing: Site-specific
mutagenesis of RuBP carboxyl-
ase/oxygenase.
Falk, G., Runswick, M.J., Tybulew-
icz, V.L.J., MRC, Laboratory of
Molecular Biology, Cambridge,
England: Polypeptides of coupling
factors and their genes.
H. Zuber
M.C.,' Feldmann, R.J.,2 Siegel-
man, H.W.,"Dept. of Biology,
Brookhaven National Laboratory,
Upton, New York; 2Division of
Computer Research and Technol-
ogy, National Institutes of Health,
Bethesda, Maryland: Cyanobac-
terial PBS.
de Lorimier, R.,' Bryant, D.A.,' Porter,
R.D.,' Fields, P.I.,' Liu, W.-Y,2 Jay,
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L. Bogorad, C. Arntzen, S. Bonitz
SESSION 10 TRANSFORMATION SYSTEMS AND DIFFERENTIATION OF THE
PHOTOSYNTHETIC APPARATUS
Chairperson: I. Ohad, Hebrew University, Jerusalem, Israel
Kolowsky, K.S., Williams, J.G.K., Sza-
lay, A.A., Boyce Thompson Insti-
tute for Plant Research, Cornell
University, Ithaca, New York: Sta-
ble integration of foreign DNA into
the chromosome of cyanobac-
teria.
Flores, E., Wolk, C.P., DOE/Plant Re-
search Laboratory, Michigan State
University, East Lansing: Ap-
proach to the genetic analysis of
oxygenic photosynthesis-Trans-
fer of plasmid vectors from E. coli
to facultatively heterotrophic cy-
anobacteria.
Taylor, W., Mayfield, S., Martineau, B.,
Harpster, M., Nelson, T, Yamagu-
chi, J., Dept. of Genetics, Univer-
sity of California, Berkeley: Onto-
genetically regulated genes.
Watson, J.C., Kaufman, L.S., Thomp-
son, W.F., Dept. of Plant Biology,
Concluding Discussion: The Use of Genetic Transformation in Understanding
Photosynthetic Complexity
RNA Processing Meeting
May 16-May 20
ARRANGED BY
Michael Mathews, Cold Spring Harbor Laboratory
Hugh Robertson, Rockefeller University
Aaron Shatkin, Roche Institute
258 participants
E.,2 Stevens, S.E., Jr.,'
'Microbiology Program, Pennsyl-
vania State University, University
Park; 2Dept. of Chemistry, Univer-
sity of New Brunswick, Frederic-
ton, Canada: Genes for the a and
I3 subunits of PC.
Zuber, H., Sid ler, W., FOglistaller, P.,
Brunisholz, R., Theiler, R., Institut
fur Molekularbiologie and Biophy-
sik, Eidgen Technische Hochs-
chule, Zurich, Switzerland: Struc-
tural studies on the light-
harvesting polypeptides from cy-
anobacteria and bacteria.
Loach, R, Parkes, P., Miller, J., Hin-
chigeri, S., Callahan, P., Dept. of
Biochemistry, Molecular Biology
and Cell Biology, Northwestern
University, Evanston, Illinois:
Structure-function relationships of
the light-harvesting complexes in
photosynthetic bacteria.
Carnegie Institution of Washing-
ton, Stanford, California: Organiza-
tion and expression of light-regu-
lated nuclear genes in pea and
mung bean.
Horsch, R.B., Fraley, R.T., Rogers,
S.G., Monsanto Company, St.
Louis, Missouri: Inheritance of
functional foreign genes in plants.
This year's meeting, the third of the series, attracted nearly 250 scientists and
created a great deal of excitement. The field's prosaic-sounding name does less
than justice to metamorphoses that transform RNA molecules both structurally
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and functionally. Primary transcripts, simple copies of the nucleotide sequence in
the gene, are modified by chemical substitution, by addition or deletion of
stretches of RNA, and by splicing-the joining of previously distant RNA se-
quences.
One high point this year was the recognition of the catalytic role played by the
RNA moiety of the RNase P enzyme in transfer RNA maturation. This molecule
now joins what is likely to be a growing list of RNA molecules with catalytic func-
tion in cleavage and splicing reactions. The self-splicing reaction of the inaugural
member of this group, Tetrahymena ribosomal RNA, was subjected to close
scrutiny, and the candidacy of some further RNAs was advanced. A second
peak was reached with the development of cell-free extracts capable of efficiently
splicing mammalian messenger RNAs. Intense interest was occasioned by the
discovery of unexpected chemical bonds and lariat-like intermediate structures
formed during the splicing reaction, echoing illustrations of rope-makers' art on
the cover of the abstract book. Progress was seen in areas such as ribonucleo-
protein particle assembly and ribosomal RNA processing, and considerable de-
bate was stirred by experiments implying the existence of a splicing mechanism
in phage-infected bacteria. Particularly promising was the development of an in
vitro system for the processing of mRNA 3' ends, which will undoubtedly aug-
ment the elegant genetic studies of this event in the future.
This conference, the third to be held here in consecutive years, firmly estab-
lished the need for an annual meeting on RNA processing, The series has cre-
ated a vital forum for discussion of a range of topics related to RNA metabolism,
and its success is founded on the dynamism and broad scope of the field. With
some reluctance on this side of the ocean, it was decided that the 1985 meeting
will be held in Rome. The meeting will return to its original venue in 1986, possi-
bly launching an annual alternation between a European site and Cold Spring
Harbor.
This meeting was supported in part by funds from the National Science Foun-
dation and the following divisions of the National Institutes of Health: Fogarty In-
ternational Center and National Institute of General Medical Sciences.
Introduction: T. Cech, University of Colorado, Boulder, Colorado
SESSION 1 RNA CATALYZED REACTIONS
Chairperson: J. Steitz, Yale University, New Haven, Connecticut
Price, J.,' Engberg, J.,3 Kieft, G.,2
Sievers, E.,2 Kent, J.,2 Morin, G.,2
Been, M.,2 Cech, T.,1,2 Depts. of
'Molecular, Cellular, and Develop-
mental Biology; 2Chemistry, Uni-
versity of Colorado Boulder;
3Blochemical Institute, Panum In-
stitute, University of Copenhagen,
Denmark: The effects of deletions
and insertions on the in vitro self-
splicing of T. thermophila pre-
rRNA.
Sullivan, F.X., Cech, T.R., Dept. of
Chemistry, University of Colorado,
Boulder: The covalent addition of
an oligoribonucleotide to the circu-
lar IVS of Tetrahymena is a fully re-
versible reaction mediated by the
RNA.
Allen, L.C., Haydock, K., Dept. of
Chemistry, Princeton University,
New Jersey: Molecular mecha-
nisms of catalysis by RNA.
Garriga, G., Collins, R., Lambowitz,
A., Dept. of Biochemistry, St. Louis
University School of Medicine,
Missouri: RNA splicing in Neuro-
spora mitochondria.
Perlman, P., Haldi, M., Jarrell, R.,
Morawiec, A., Dept. of Genetics,
MCDB Program, Ohio State Uni-
versity, Columbus: Studies of mito-
chondrial intron structure.
Guerrier-Takada, C., Baer, M., Law-
rence, N., Altman, S., Dept. of Bi-
ology, Yale University, New Haven,
Connecticut: Structure and func-
tion of the RNA component of
RNase P from E. coil.
Pace, N.R., Gardiner, K., Marsh, TL.,
National Jewish Hospital and Re-
search Center, and University of
Colorado Health Sciences Center,
Denver: The B. subtilis RNase P.
Prody, G.A., Bakos, J.T., Buzayan,
J.M., Schneider, I.R., Bruening,
G., Dept. of Biochemistry and Bio-
physics, University of California,
Davis: Self-processing of multi-
meric forms of satellite tobacco
ringspot virus RNA.
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SESSION 2 STRUCTURE AND MECHANISM
Chairperson: 0. Uhlenbeck, University of Illinois, Urbana, Illinois
Munroe, S.H., Dept. of Biology, Mar-
quette University, Milwaukee, Wis-
consin: Higher-order structure of
RNA sequences at splice sites of
adenoviral pre-mRNA.
Shelness, G.S., Williams, D.L., Dept.
of Pharmacological Sciences,
State University of New York,
Stony Brook: Structure mapping of
an estrogen-stabilized mRNA.
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sequences during in vitro splicing.
Grabowski, P.J., Padgett, R.A., Sharp,
P.A., Dept. of Biology, Massachu-
SESSION 8 mRNA PROCESSING AND METABOLISM
Chairperson: W. Le Stourgeon, Vanderbilt University, Nashville, Tennessee and
National Science Foundation, Washington, D.C.
Halbreich, A., Grandchamp, C.,
Foucher, M., Centre de Genetique
Moleculaire du CNRS, Gif-sur-
Yvette, France: Yeast mitochondria
contain a linear RNA strand com-
plementary to the circular, intronic
b11 RNA of cytochrome b.
Simon, M., Faye, G., Institut Curie, Or-
say, France: Organization and pro-
cessing of the OX13/0L12 multi-
genic transcript in yeast
mitochondria.
Last, R., Woolford, J.L., Dept. of Bio-
logical Sciences, Carnegie-Mellon
University, Pittsburgh, Pennsylva-
nia: Evidence for related functions
of the RNA2, RNA3, and RNA4
gene products of S. cerevisiae.
Pape, L.K., Tzagoloff, A., Dept. of Bi-
ological Sciences, Columbia Uni-
versity, New York, New York: A nu-
clear gene required for processing
of the S. cerevisiae mitochondrial
apocytochrome b pre-mRNA.
Anderson, K.P., Klessig, D.F., Dept. of
Cellular, Viral and Molecular Biol-
ogy, University of Utah School of
Medicine, Salt Lake City: Altered
mRNA splicing in monkey cells
SESSION 9 SMALL RNAs AND RNPs
abortively infected with human ad-
enovirus may be responsible for
inefficient synthesis of the virion fi-
ber polypeptide.
Dreyfuss, G., Choi, Y-D., Adam, S.A.,
Dept. of Biochemistry, Molecular
and Cell Biology, Northwestern
University, Evanston, Illinois: Char-
acterization of the protein com-
plexes of hnRNA in vivo with
monoclonal antibodies.
Raziuddin, A.K., Thomas, J.0., Szer,
W., Dept. of Biochemistry, New
York University School of Medi-
cine, New York: Functional do-
mains of HD40, the major core
hnRNP protein of Artemia.
Greenberg, J.R., Carroll, E. III, Cell
Biology Group, Worcester Foun-
dation for Experimental Biology,
Shrewsbury, Massachusetts: Re-
constitution of functional mRNP-
protein complexes.
GOrlach, M., Schulze, G., Sarre, T.,
Hilse, K., Institute kir Biology UN-
versitat, Freiburg, Federal Repub-
lic of Germany: Characterization of
cytoplasmic mRNPs from two dif-
ferent erythropoietic systems (rab-
Chairperson: R. Geste land, University of Utah, Salt Lake City, Utah
Patterson, B., Tollervey, D., Swerdlow,
H., Wise, WA., Guthrie, C., Dept.
of Biochemistry and Biophysics,
University of California, San Fran-
cisco: A genetic analysis of snRNA
function in yeast.
Skuzeski, WM.,' Lund, E.,' de Vegvar,
H.E.N.,' Murphy, J.T,2 Steinberg,
T.,2 Dahlberg, J.E.,"Dept. of
Physiological Chemistry; 2McArdle
Laboratory, University of Wiscon-
sin, Madison: Signals for transcrip-
tion and maturation of U1 RNA.
Perez-Stable, C., Hess, J., Ayres,
TM., Shen, C.-K.J., Dept. of Ge-
netics, University of California,
Davis: Novel features of in vitro
synthesis of human a/u family
small RNAs-Distinctive promoter
organization and a new eukaryotic
class III terminator.
Luhrmann, R., Appel, B., Rinke, J.,
Reuter, R., Theissen, H., Bring-
mann, P., Max-Planck-Institut, Ber-
lin, Federal Republic of Germany:
Structure of U-snRNPs- Evidence
setts Institute of Technology, Cam-
bridge: mRNA splicing in vitro-
An excised intervening sequence
and a potential intermediate.
bit reticulocytes/murine erythroleu-
kemia cells).
Katze, M.G., Chen, Y. -T., Krug, R.M.,
Memorial Sloan-Kettering Cancer
Center, New York, New York: The
processing and expression of
RNA polymerase II transcripts in
influenza virus infected cells.
H. Robertson
for the existence of snRNAs U4
and U6 in a single RNP complex.
Fisher, D.E., Conner, G.E., Reeves,
W.H., Blobel, G., Kunkel, H.G.,
Rockefeller University, New York,
New York: SnRNP assembly is a
two-step process, accompanied
by posttranslational modification.
Kloetzel, P.M., Schult, C., Bautz,
E.K.F, Dept. of Molecular Ge-
netics, University of Heidelberg,
Federal Republic of Germany:
Analysis of specific RNP-com-
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plexes in heat-shocked Drosophila Sm- and U1- specific snRNP anti-
cells. gens at transcription sites, includ-
Martin, T.E., Monsma, S.A., Leser, ing some lacking introns.
G.P., Dept. of Biology, University Masukata, H., Tomizawa, J., NIADDK,
of Chicago, Illinois: Localization of National Institutes of Health, Be-
SESSION 10 POLY A AND 3' ENDS
Chairperson: R. Perry, Institute for Cancer Research, Philadelphia, Pennsylvania
Mott, J., Galloway, J.L. Farnham, RJ.,
Platt, T., Dept. of Molecular Bio-
physics and Biochemistry, Yale
University, New Haven, Connecti-
cut: RNA termination and process-
ing at the 3' end of tryptophan op-
eron mRNA.
Higgins, C.F., Dept. of Biochemistry,
University of Dundee, Scotland: A
novel structure (the "REP" se-
quence) present in a large number
of bacterial mRNA species may
regulate mRNA processing and
degradation.
Aloni, Y., Hay, N., Bengal, E., Laub,
O., Dept. of Genetics, Weizmann
Institute of Science, Rehovot, Is-
rael: Attenuation and transcription-
termination in the control of eukar-
yotic gene expression -SV40 as a
model system.
Frayne, E.G.,' Leys, E.J.,' Crouse,
G.F.,2 Kellems, R.E.,"Dept. of
RNA Tumor Viruses
May 22-May 27, 1984
ARRANGED BY
Biochemistry, Baylor College of
Medicine, Houston, Texas; 2NCI,
Frederick, Maryland: Transcription
of the dhfr gene proceeds uninter-
rupted through all seven poly(A)
sites and terminates further down-
stream.
Wickens, M., Stephenson, P, Dept. of
Biochemistry, University of Wis-
consin, Madison: Point mutations
in any one of three positions of the
AAUAAA sequence prevent cleav-
age of SV40 late pre-mRNAs in
Xenopus oocytes.
McDevitt, M.A., Imperiale, M.J., Ali,
H., Nevins, J.R., Rockefeller Uni-
versity, New York, New York: Re-
quirement of a downstream se-
quence for generation of a poly(A)
addition site.
Sadofsky, M., Alwine, J.C., Dept. of
Microbiology, University of Penn-
sylvania, Philadelphia: Deletions of
thesda, Maryland: Alteration in
RNA structure affects primer for-
mation for ColEl DNA replication.
SV40 DNA downstream from the
late AAUAAA, including a region
of U4 RNA homology, decrease
the efficiency of 3'-end process-
ing.
Moore, C., Sharp, PA., Dept. of Biol-
ogy, Massachusetts Institute of
Technology, Cambridge: Site-spe-
cific poladenylation in a cell-free
reaction.
Manley, J.L., Yu, H., Ryner, L., Dept.
of Biological Sciences, Columbia
University, New York, New York:
The hexanucleotide AAUAAA
forms part of a "promoter" for
mRNA polyadenylation in vitro.
Nordstrom, J.L., Kessler, M.M., Wes-
thafer, M.A., Dept. of Biochemistry
and Biophysics, Texas A&M Uni-
versity, College Station: The 3' end
of the sea urchin H2A gene serves
as a polyadenylation signal in COS
cells.
Tony Hunter, Salk Institute
Steve Martin, University of California, Berkeley
434 participants
RNA tumor virus research continues to be an exciting and rapidly moving field.
This was the ninth RNA tumor virus meeting, and its continuing popularity was
demonstrated by the large number of attendees and presentations.
More than half of the presentations were concerned with work on viral and
cellular oncogenes. Recurring themes included: the different mechanisms that
result in the activation of proto-oncogenes; the use of in vitro mutagenesis tech-
niques to define functional domains within viral transforming proteins; and the
discovery of new, common integration sites for viruses without one genes. The
demonstration that mutations in the yeast RAS genes have marked phenotypic
effects underscored the advantages of simple eukaryote models for studies on
the cellular functions of oncogenes. Another exciting observation was the finding
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that the Philadelphia translocation in chronic myelogenous leukemia results in a
unique c-ab/ transcript and an altered and apparently activated c-ab/ protein.
Although work on oncogenes received the lion's share of attention, there were
novel findings in other areas: the requirement for po/ endonuclease activity for
DNA integration; the role of the MLV po/ protease in the processing of gag pre-
cursors; and the tissue specificity of the enhancer elements within viral LTRs as a
basis for the tissue tropism of these viruses, Considerable progress was also re-
ported in the characterization of the human T-cell lymphotropic viruses (HTLV
and LAV) and their roles in T-cell leukemia and AIDS.
Funding was provided in part by the Cold Spring Harbor Laboratory Cancer
Center Grant from the National Cancer Institute, National Institutes of Health.
SESSION 1 ONCOGENES (src, rel, fps, abl)
Chairperson: H. Hanafusa, Rockefeller University, New York, New York
lba, H.,' Cross, F.R.,1 Takeya, T.,2
Hanafusa, T.,1 Hanafusa, H.,"
'Rockefeller University, New York,
New York; 2lnstitute for Chemical
Research, Kyoto University, Ja-
pan: Low protein kinase activity in
vivo may be correlated to the ina-
bility of p60c-sre to transform CEF.
Yaciuk, P., Coussens, P.M., Shalloway,
D., Molecular and Cell Biology
Program, Pennsylvania State Uni-
versity, University Park: Effects of
modifying the pp6Osrc carboxyl ter-
minus.
Coussens, P.M., Johnson, P.J., Shallo-
way, D., Molecular and Cell Biol-
ogy Program, Pennsylvania State
University, University Park: Highly
efficient c-src expression plasmids
induce low-level transformation.
Jakobovits, E.B., Majors, J.E., Var-
mus, H.E., Dept. of Microbiology
and Immunology, University of
California, San Francisco: Hor-
monal regulation of the RSV src
gene via the MMTV promoter de-
fines a threshold dose for transfor-
mation.
Wilhelmsen, K.C., Tarp ley, W.G.,
Miller, C.K., Temin, H.M., McArdle
Laboratory, University of Wiscon-
sin, Madison: Identification of
some of the parameters governing
transformation by oncogenes in
retroviruses.
Yonemoto, W.,' Jarvis-Morar, M.,1
Bolen, J.,2 Israel, M.,2 Brugge, J.,'
'Dept. of Microbiology, State Uni-
versity of New York, Stony Brook;
2NCI, National Institutes of Health,
Bethesda, Maryland: Association
of the cellular src gene product
with the middle T antigen of poly-
oma virus results in enhancement
of associated tyrosine-specific ki-
nase activity and modification of
the cellular src protein.
lijima, S., Wang, L.-H., Rockefeller
University, New York, New York:
Tissue-specific expression of c-src
mRNA by alternative splicing.
Rohrschneider, L., Reynolds, S.,
Rothwell, V., Fred Hutchinson
Cancer Research Center, Seattle,
Washington: Regulation of cellular
morphology by the RSV src gene
product-Analysis of fusiform mu-
tants.
Cross, FR., Garber, E.A., Pellman, D.,
Hanafusa, H., Rockefeller Univer-
sity, New York, New York: The ex-
treme amino terminus of the RSV-
transforming protein is required
for myristylation, membrane asso-
ciation, and transformation.
Garber, E.A., Cross, FR., Pellman, D.,
Hanafusa, H., Rockefeller Univer-
sity, New York, New York: Myristy-
lation of p6Osrc and its role in mem-
brane association-Comparison of
wild-type RSV and in vitro con-
structed aminoterminal deletion
mutants.
Snyder, M.A., Bishop, J.M., George
William Hooper Research Founda-
tion, Dept. of Microbiology and
Immunology, University of Califor-
nia, San Francisco: A mutation at
the major phosphotyrosine site in
pp60v-sm alters oncogenic poten-
tial.
Stone, J.C.,' Atkinson, T.,2 Smith, M.,2
Pawson, T.,' Depts. of
'Microbiology, 2Biochemistry, Uni-
versity of British Columbia, Van-
couver, Canada: Identification of
functional regions in the transform-
ing protein of FuSV by in-phase in-
sertion mutagenesis.
Weinmaster, G.,' Zoller, M.,3 Smith,
M.,2 Pawson, T.,' Depts. of
'Microbiology, 2Biochemistry, Uni-
versity of British Columbia, Van-
couver, Canada; 3Cold Spring
Harbor Laboratory, New York:
Site-directed mutagenesis of FuSV
reveals that tyrosine phosphoryla-
tion of p1309a9 -fPs modulates its
enzymatic and biological activities.
Foster, D.A., Shibuya, M., Hanafusa,
H., Rockefeller University, New
York, New York: The structure and
transformation potential of cellular
DNA sequences homologous to
the fps gene of FuSV.
Feldman, R.A.,1,2 Gabrilove, J.L.,3
Tam, J.,2 Moore, M.A.S.,3 Hana-
fusa, H.,2 'NCI, National Institutes
of Health, Bethesda, Maryland;
2Rockefeller University; 3Memorial
Sloan-Kettering Cancer Center,
New York, New York: Differential
expression of the cellular fps/fes-
encoded protein in human hema-
topoietic tumors.
Mathey-Prevot, B., Baltimore, D.,
Whitehead Institute for Biomedical
Research, Massachusetts Institute
of Technology, Cambridge: Effect
of replacing the abl sequence by
the avian sequences src or fps in
Ab-MLV.
Prywes, R.,' Hoag, J.,1 Rosenberg,
N.,2 Baltimore, D.,"Whitehead In-
stitute for Biomedical Research,
Massachusetts Institute of Technol-
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ogy, Cambridge; 2Tufts University
School of Medicine, Boston: The
p15 region of gag is required for
lymphoid transformation by Ab-
MLV.
Foulkes, J.G.,' Baltimore, D.,' Mailer,
J.L.,2 'Whitehead Institute for
Biomedical Research, Massachu-
setts Institute of Technology, Cam-
bridge; 2Dept. of Pharmacology,
University of Colorado, School of
Medicine, Denver: Microinjection
SESSION 2 REPLICATION AND INTEGRATION
Chairperson: H. Varmus, University of California, San Francisco, California
Lobel, L.I., Tanese, N., Goff, S.P.,
Dept. of Biochemistry, Columbia
University College of Physicians
and Surgeons, New York, New
York: Transfer of mutations from
the 5' LTR to the 3' LTR during rep-
lication of Mo-MLV-Strong-stop
DNAs may "jump" prematurely.
Smith, J.K., Cywinski, A., Taylor, J.M.,
Institute for Cancer Research, Fox
Chase Cancer Center, Philadel-
phia, Pennsylvania: The specificity
of initiation of strong-stop plus
DNA by RSV.
Resnick, R.M., Faras, A.J., Dept. of
Microbiology, University of Minne-
sota, Minneapolis: Recognition
binding sites for reverse transcrip-
tase during RNase H-mediated
(+) DNA synthesis in vitro.
Panganiban, A., Temin, H.M., Mc-
Ardle Laboratory for Cancer Re-
search, University of Wisconsin,
Madison: Sequences required for
integration of SNV DNA.
Colicelli, J., Goff, S.P., Dept. of Bio-
chemistry, Columbia University,
College of Physicians and Sur-
geons, New York, New York: Mu-
tants of Mo-MLV bearing a single
base pair change at the LTR tip
can still integrate into host DNA.
SESSION 3 POSTER SESSION I
Dolberg, D.S., Bissell, M.J., Dept. of
Biology and Medicine, Lawerence
Berkeley Laboratory, University of
California, Berkeley: The role of
wounding in RSV-induced tumor
formation.
Kirschmeier, P.T., Perkins, A.S.,
Shane, E., Bilezikian, J.P., Wein-
stein, I.B., Columbia University
College of Physicians and Sur-
geons, New York, New York:
Suppression of the transformed
phenotype by the Salmonella ty-
phimurium adenyl cyclase gene.
Laugier, D.,' Poirier, F.,' Marx, M.,2
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Longiaru, M.,' Duyk, G.,2 Leis, J.,2
Skalka, A.M.,"Dept. of Molecular
Genetics, Hoffman-La Roche Inc.,
Roche Research Center, Nutley,
New Jersey; 2Case Western Re-
serve University School of Medi-
cine, Cleveland, Ohio: Selective
cleavage of wild-type and mutated
double-strand retroviral LTR DNA
by the endonuclease associated
with AMV reverse transcriptase.
Duyk, G.,' Longiaru, M.,2 DeHaseth,
P.,' Terry, R.,2 Shalka, A.,2 Leis,
J.,"Case Western Reserve Uni-
versity School of Medicine, Cleve-
land, Ohio; 3Floche Institute of Mo-
lecular Biology, Nutley, New
Jersey: Sequence requirements
for site selective cleavage of the
RAV-2 LTR by the reverse tran-
scriptase endonuclease.
Donehower, L.A., Varmus, H.E., Dept.
of Microbiology and Immunology,
University of California, San Fran-
cisco: poi mutants of MLV are de-
fective for integration.
Hippenmeyer, P.J., Grandgenett, D.P.,
Institute for Molecular Virology, St.
Louis, Missouri: Amino terminus
and mutational analysis of the ASV
pp32 protein.
Levin, J.G.,' Hu, S.C.,' Rein, A.,2
Genvrin, P.,1 Dambrine, G.,3 Cal-
othy, G.,' 'Institut Curie, Orsay;
2CNRS, ICIG, Villejuif; 3Station de
Pathologie Aviaire de l'INRA Mon-
naie, France: A RSV mutant with
host cell-dependent transforming
capacity.
Stoker, A.W., Enrietto, P.J., Wyke,
J.A., Dept. of Tumour Virology, Im-
perial Cancer Research Fund,
London, England: Temperature-
sensitive mutations in functional
domains of pp60v-s.
Hughes, S.,' Mellstrom, K.,2 Kosik,
E.,' Tamanoi, F.,' Brugge, J.,2
of Ab-MLV tyrosyl-protein kinase
into Xenopus oocytes induces
phosphorylation of ribosomal pro-
tein S6 on serine residues.
Messer, L.I.,1 Gerwin, B.l.,3
1NICHD, National Institutes of
Health, Bethesda; 2Frederick Can-
cer Research Facility, Frederick;
31\11C, National Institutes of Health,
Bethesda, Maryland: Functional
mapping of MLV poi gene by char-
acterization of a frameshift mutant.
Crawford, S., Goff, S.P., Dept. of Bio-
chemistry, Columbia University,
College of Physicians and Sur-
geons, New York, New York: A
deletion mutation in the 5' part of
the poi gene of Mo-MLV prevents
processing of the Pr659a9 precur-
sor polyprotein.
Yoshinaka, Y, Katoh, I., Copeland,
T.D., Oroszlan, S., NCI, Frederick
Cancer Research Facility, Freder-
ick, Maryland: Purification, bio-
chemical and structural character-
ization of Mo-MLV protease
encoded by the gag -poi gene.
Leis, J.,' Fu, X.,' Traugh, J.,3 'Case
Western Reserve University
School of Medicine, Cleveland,
Ohio; 2University of California, Riv-
erside: The RNA-binding proper-
ties of the avian retrovirus pp12
are regulated by phosphorylation
of a specific serine residue.
'Cold Spring Harbor Laboratory; 2
Dept. of Microbiology, State Uni-
versity of New York, Stony Brook:
Mutation of a termination codon
affects src initiation.
Perez, L., Wills, J.W., Hunter, E., Dept.
of Microbiology, University of Ala-
bama, Birmingham: Effects of up-
stream initiation codons on the
expression of the RSV env gene.
Feuerman, M.,' Davis, B.,' Patten-
gale, P.,2 Fan, H.,"Dept. of Mo-
lecular Biology and Biochemistry,
University of California, Irvine;
2University of Southern California,
Los Angeles: Transformation and
pathogenicity of in vitro recombi-
nant retrovirus.
Tanaka, A.,' Gibbs, C.,2 Anderson,
S.K.,' Kung, H.-J.,2 Fujita, D.J.,'
'Cancer Research Laboratory,
Dept. of Biochemistry, University
of Western Ontario, London, Can-
ada; 2Dept. of Biochemistry, Michi-
gan State University, East Lansing:
Structural analysis and nucleotide
sequencing of a human c-src
gene.
Parvin, J.,' lijima, S.,2 Wang, L.-H.,2
'Mount Sinai School of Medicine;
2Rockefeller University, New York,
New York: Mechanisms for the
generation of src-deletion mutants
and recombination between viral
and c-src sequences.
Kotler, M., Roguel, N., Relevy, H.,
Dept. of Molecular Genetics, He-
brew University-Hadassah Medi-
cal School, Jerusalem, Israel: Am-
plification of proviruses and their
methylated state in avian sarcoma-
transformed rat cells.
Mannino, R.J., Winters, L., Dept. of
Microbiology and Immunology, Al-
bany Medical College, New York:
Regulation of src expression ac-
companies growth inhibition of
RSV-transformed cells.
Barnekow, A., Gessler, M., Institut fOr
Medical Virologie, Giessen, Fed-
eral Republic of Germany: Differ-
ences in expression of c-src and c-
yes during chicken development.
Maness, P,' Fults, 0.,2 'Dept. of Bio-
chemistry, University of North Car-
olina School of Medicine, Chapel
Hill; 2Dept. of Neurosurgery, Bow-
man Gray School of Medicine,
Winston-Salem: pp60c-s'° is local-
ized in processes of developing
cerebellar neurons.
Cotton, P.C., Brugge, J.S., Dept. of
Microbiology, State University of
New York, Stony Brook: Neural tis-
sues express a modified form of
the cellular src gene product
pp60c-s' c.
Gould, K.,' Cooper, J.A.,' Hunter, T.,'
Bretscher, A.,2 'Molecular Biology
and Virology Laboratory, Salk In-
stitute, San Diego, California;
2Section of Biochemistry, Molecu-
lar and Cell Biology, Cornell Uni-
versity, Ithaca, New York: Tyrosine
protein kinase substrate p81 is ho-
mologous to a chicken microvillar
core protein.
Burr, J.G., Lui, J.C., Linder, M.E.,
Dept. of Biology, University of
Texas, Dallas: In situ phosphoryla-
tion of cytoskeleton-associated
proteins by pp60sr..
Chackalaparampil, I., Poirier, Y., Ba-
nerjee, D., Mukherjee, B.B., Dept.
of Biology, and Centre for Human
Genetics, McGill University, Mon-
treal, Canada: Alteration in the se-
cretion of a specific phosphopro-
tein in RSV-transformed rat cells
which had undergone reversible
loss of anchorage-independent
growth after retinoic acid treat-
ment.
Jarosik, G., Morar, M.J., Broach, J.,
Brugge, J., Dept. of Microbiology,
State University of New York,
Stony Brook: Functional expres-
sion of the RSV src gene in yeast.
Huang, C.-C., Hammond, C., Bishop,
J.M., George William Hooper
Foundation, Dept. of Microbiology,
University of California, San Fran-
cisco: The nucleotide sequence
and topography of chicken c-fps.
Goh, W.C., Sodroski, J., Haseltine,
W.A., Dana-Farber Cancer Insti-
tute, Boston, Massachusetts: Se-
quence organization of the human
c-fps/fes gene.
Young, J., Moss, P., Martin, G.S.,
Dept. of Zoology, University of
California, Berkeley: Relationship
between the intracellular location
of polypeptides containing fps se-
quences and transforming activity.
Bergold, P.J.,1 Wang, J.Y.J.,2 John-
son, E.M.,. Littau, V.C.,3 Hardy,
W.D., Jr.,' Besmer, P.,' Laborato-
ries of 'Molecular Oncology,
2University of California, San
Diego; 3Flockefeller University,
New York; 'Veterinary Oncology,
Memorial Sloan-Kettering Cancer
Center, New York, New York;
Structural analysis of the abl insert
of HZ2-FeSV and an alteration of
c-ab/ in a primary acute lympho-
cytic leukemia.
Lederman, L.,' Zuckerman, E.E.,2
Hardy, W.D., Jr.,2 Snyder, H.W.,
Jr.,3 Pilch, P.F.,"Dept. of Bio-
chemistry, Boston University Medi-
cal School, Massachusetts;
2Laboratory of Veterinary Oncol-
ogy, Memorial Sloan-Kettering
Cancer Center, New York, New
York; 3lmmune Response Pro-
gram, Pacific Northwest Research
Foundation, Seattle, Washington:
Interaction of HZ2-FeSV P98 gag-
abl translation product and associ-
ated protein kinase activity with
cellular membranes, cytoskeleton,
and a possible cytoskeletal sub-
strate.
Tidmarsh, G., Pillemer, E., Whitlock,
C., Dailey, M., Weissman, I., Labo-
ratory of Experimental Oncology,
Stanford University School of Med-
icine, California: A novel surface
antigen on Ab-MLV and sponta-
neous B-cell lymphomas.
Schiff-Maker, L.,' Konopka, J.B.,2
Davis, R.L.,2 Watanabe, S.M.,2
Ponticelli, A.S.,2 Witte, 0.N.,2 Ro-
senberg, N.,"Cancer Research
Center, Immunology Graduate
Program, Tufts University School
of Medicine, Boston, Massachu-
setts; 2Dept. of Microbiology and
Molecular Biology Institute, Uni-
versity of California, Los Angeles:
Membrane localization of the Abel-
son protein.
Lamph, W.W., Arfsten, A., Green, P.L.,
Shilling, J., Risser, R., McArdle
Laboratory for Cancer Research,
University of Wisconsin, Madison:
Monoclonal antibodies to a cellular
in vitro kinase found in Abelson
lymphoma cells.
Watanabe, S.M., Konopka, J.B.,
Witte, 0.N., Molecular Biology In-
stitute, University of California, Los
Angeles: Antisera specific for se-
quences within the Ab-MLV 3'
open reading frame.
Neckameyer, W.,' Shibuya, M.,2 Hsu,
M.-T,' Wang, L. -H.,' Rockefeller
University, New York, New York;
2University of Tokyo, Japan: Nu-
cleotide sequence of the trans-
forming gene of ASV UR2 and
structural analysis of its cellular
homolog.
Propst, F., Vande Woude, G., NCI,
Frederick Cancer Research Facil-
ity, Frederick, Maryland: A cluster
of mouse repetitive sequences
downstream from the c-mos locus
contains a novel repeat inter-
rupted by an LTR element.
Dean, M., Vande Woude, G.F., LBI-
Basic Research Program, NCI,
Frederick Cancer Research Facil-
ity, Frederick, Maryland: Multiple
sites in front of the v-mos gene
can serve as transcription initiation
points.
Seth, A., Zweig, M., Showalter, S.,
Vande Woude, G., NCI, Frederick
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Cancer Research Facility, Freder-
ick, Maryland: Production of anti-
sera with v-mos protein synthe-
sized in E.coli.
Brizzard, B.L., Nash, M.A., Cizdziel,
PE., Murphy, E.C., Jr., Dept. of Tu-
mor Biology/Virology Section, Uni-
versity of Texas System Cancer
Center, M.D. Anderson Hospital
and Tumor Institute, Houston: Or-
ganization of viral DNA in MSV
ts110-infected cell lines.
Singh, B.,' Escobedo, J.,2 Dina, D.,2
Arlinghaus, R.B.,1 'Dept. of Molec-
ular Biology, Scripps Clinic and
Research Foundation, La Jolla;
2Chiron Corp., Emeryville, Califor-
nia: Reduced level of a 55,000-
dalton cellular protein upon infec-
tion by Mo-MSV.
Papkoff, J., Ringold, G., Dept. of
Pharmacology, Stanford University
School of Medicine, California:
Use of the MMTV LTR to promote
steroid-inducible expression of v-
mos.
Righi, M.,1 Coll, J.,' Dozier, C.,1 Gali-
bert, F.,2 Stehelin, D.,1 lOncologie
Moleculaire, INSERM, Institut Pas-
teur, Lille; 2Centre Hayem, Hopital
St. Louis, Paris, France: Analysis
of the mil oncogene of MH2 and
its cellular counterpart.
S. Hughes
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Kan, N.,' Rovigatti, U.,' Duesberg,
P.,2 Papas, T.,"NCI, Frederick
Cancer Research Facility, Freder-
ick, Maryland; 2Dept. of Molecular
Biology, University of California,
Berkeley: Avian carcinoma virus
MH2 contains two onc-specific
genes, myc and mht, which are
closely related to the transforming
genes of the avian MC29 and mu-
rine sarcoma 3611 viruses.
Walther, N., Jansen, H.W., Greiner, E.,
Patschinsky, T, Bister, K., Max-
Planck-Institut, Berlin, Federal Re-
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N.,1-2-3 Francis, D.P.,2-3 Homma,
T.,' Essex, M.,' 'Dept. of Cancer
Biology, Harvard University
School of Public Health, Boston,
Massachusetts; 'Miyazaki Medical
School, Japan; 3Center for Dis-
ease Control, Atlanta, Georgia:
Relative immunogenicity of HTLV-
specific proteins in adult T-cell leu-
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August 15-August 19
ARRANGED BY
Terri Grodzicker, Cold Spring Harbor Laboratory
Michael Botchan, University of California, Berkeley
401 participants
The meeting on the molecular biology of SV40, polyoma, and adenoviruses,
which is held in alternate years at the Cold Spring Harbor Laboratory, was at-
tended by more than 400 scientists. The small DNA tumor viruses continue to be
intensively studied model systems for investigating mechanisms of eukaryotic
gene control, replication, and transformation. Many papers were presented on
active areas of research, such as: control of transcription and RNA splicing both
in vivo and in vitro; analysis and purification of viral and cellular transcription fac-
tors; properties of viral and cellular enhancers; regulation of gene expression by
the adenoviral E1A protein; control of translation of VA RNAs; replication of viral
DNAs in vitro; the role of viral transforming proteins in immortalization, transfor-
mation, and cooperation with other oncogenes; and association of tumor anti-
gens with cellular proteins such as p53 and c-src. Several viral transforming pro-
teins have been overproduced by using a variety of prokaryotic and eukaryotic
expression vectors. The adenovirus E1A protein and SV40 T antigen have been
purified and their functions in a variety of cells as well as in in vitro transcription
and replication systems are being intensively investigated.
This meeting was supported in part by the Cancer Center Grant to Cold
Spring Harbor Laboratory from the National Cancer Institute, National Institutes
of Health.
SESSION 1 ADENOVIRUSES: TRANSCRIPTION
Chairperson: J. Manley, Columbia University, New York, New York
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Ad5 E1A is regulated in cis by two
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by the E1A gene products.
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PA., Center for Cancer Research,
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heat-shock-protein-70 gene
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early genes by an E1A-dependent Cancer Research, Massachusetts
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York: Extraction and quantitation J.E., Jr.,"Rockefeller University,
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man, N.P, NIAID, NCI, National
Institutes of Health, Bethesda,
Maryland: Proximal and distal do-
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adenylation signal substitution on
transcription initiating from the late
promoter in rat cells transfected
with chimeric plasmids.
F. Sherman, M. Botchan, T. Grodzicker
221
SESSION 3 POSTER SESSION I
Duprey, E., Hearing, P., Shenk, T.,
Dept. of Microbiology, State Uni-
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Reich, N.C.,' Babich, A.,' Weinber-
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feller University, New York, New
York: The effect of pseudorabies
virus infection on in vitro transcrip-
tion.
Bondopadhyay, S., Spector, D.J.,
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Roberts, R.J., Cold Spring Harbor
Laboratory, New York: In vitro and
in vivo studies of Ad2 major late
mRNA splicing.
Lee, R., Concino, M., Weinmann, R.,
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ate School of Medical Sciences,
New York, New York: Premature
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Fraser, N.W., Owen, J.L., Dressler,
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Pennsylvania: Transcriptional ter-
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Bertuch, A., Hansen, U., Dana-Farber
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ing assay for the cellular protein(s)
specifically binding the 21-bp re-
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moters.
Nobel, J., Prives, C., Manley, J.L.,
Dept. of Biological Sciences, Co-
lumbia University, New York, New
York: In vitro splicing and poly-
adenylation of an SV40 early pre-
mRNA.
Hay, N., King, D., Aloni, Y., Dept. of
Genetics, Weizmann Institute of
Science, Rehovot, Israel: Efficient
and accurate in vitro excision of
SV40-associated small RNA (SAS-
RNA).
Somasekhar, M.B., Mertz, J.E., Mc-
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search, University of Wisconsin,
Madison: Factors involved in splic-
ing of the SV40 late transcripts.
Laub, 0,, Hay, N., Bengal, E., Aloni,
Y., Dept. of Genetics, Weizmann
Institute of Science, Rehovot, Is-
rael: Attenuation and transcription-
termination in the control of SV40
gene expression.
Grass, D.S., Manley, J.L., Dept. of Bi-
ological Sciences, Columbia Uni-
versity, New York, New York: Inser-
tion of the Ad2 late promoter into
the SV40 late leader region and its
effect on late mRNA synthesis.
Lamarche, M.F., Bourgaux-Ramoisy,
D., Bourgaux, P, Faculte de Me-
decine, Universite de Sherbrooke,
Canada: Activity of a late promoter
in integrated polyoma DNA.
Bergeron, J.L., Acheson, N.H., Dept.
of Microbiology and Immunology,
McGill University, Montreal, Can-
ada: Viable insertion mutants of
polyoma virus containing a sec-
ond copy of the signal for poly-
adenylation of RNA.
Skarnes, W.C., Tessier, D.C., Ache-
son, N.H., Dept. of Microbiology
and Immunology, McGill Univer-
sity, Montreal, Canada: Pausing or
premature termination of RNA po-
lymerase II nearby the early and
late promoters of polyoma virus
RNA.
Cunningham, T.P., Pipas, J.M., Dept.
of Biological Sciences, University
of Pittsburgh, Pennsylvania: SA12
is a BK-like papovavirus which
replicates in monkey cells.
Delmas, V.,' Bastien, C.,1Scherneck,
5.,2 Feunteun, J.,"IRSC, Villejuif,
France; 'Academy of Sciences of
the German Democratic Republic,
Berlin: Sequence and genetic or-
ganization of HapV, a papovavirus
causing lesions in Syrian ham-
sters.
Davies, B.,' Arrand, J.,2 Griffiths, M.,1
Fried, M.,' 'Dept. of Tumor Virus
Genetics, Imperial Cancer Re-
search Fund, London; 2Paterson
Laboratories, Christie Hospital,
Manchester, England: Sequence
of enhancer and origin regions of
polyoma virus defectives.
von Hoyningen-Huene, V.,' Ruley, E.,2
Davies, B.,' Griffiths, M.,' Fried,
M.,1 'Dept. of Tumour Virus Ge-
netics, Imperial Cancer Research
Fund, London, England; 2Cold
Spring Harbor Laboratory, New
York: Enhancer activity of duplica-
ted sequences in the polyoma vi-
rus noncoding region.
Herbomel, F, Bourachot, B., Yaniv,
M., Dept. of Molecular Biology,
Pasteur Institute, Paris, France:
Homologous and heterologous
transactivation and transrepres-
sion of early and late transcription.
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Glenn, G.M., Ricciardi, R.R, Wistar In-
stitute, Philadelphia, Pennsylvania:
Location of the functional nucleo-
tide defects in Ad5 El A host-
range mutants.
Smith, D., Velcich, A., Kegler, D., Ziff,
E., Kaplan Cancer Center, Dept. of
Biochemistry, New York University
Medical Center, New York: Com-
plementation of the Ad5 El A mu-
tant d/312 by vectors that express
Passananti, C., Maione, R.,. Pozzi, L.,
De Simone, V., Amati, F, Dept. di
Biopatologia Umana, University
La Sapienza, Roma, Italy: Poly-
oma mutants selected in differen-
tiated cell lines.
Boehnlein, E., Chowdhury, K., Gruss,
P., Institute for Microbiology,
ZMBH, Heidelberg, Federal Re-
public of Germany: Structural and
functional analysis of a polyoma
enhancer/promoter mutation re-
quired for growth in embryonal
carcinoma cells.
Templeton, D.,' Eckhart, W.,' Blangy,
D.,' 'Salk Institute, San Diego,
California; 2IRSC, Villejuif, France:
Mouse sequences can functionally
substitute polyoma enhancer se-
quences.
Dandolo, L., Aghion, J., Blangy, D.,
IRSC, Villejuif, France: Regulation
of polyoma virus late expression in
embryonal carcinoma cells.
Zenke, M., GrundstrOm, T., Wintzerith,
M., Matthes, H., Chambon, F, IN-
SERM, Faculte de M6decine,
Strasbourg, France: Point muta-
tion scanning of the SV40 enhan-
cer.
Hen, R,. Borelli, E., Chambon, P., IN-
SERM, Faculte de Medecine,
Strasbourg, France: Blocking of
SV40 and polyoma enhancer ac-
tivity by the Ad2 E1A products.
Axelrod, N., Farabaugh, P., Dept. of
Microbiology, University of Con-
necticut Health Center, Farming-
ton: Can SV40 enhancer se-
quences substitute for yeast
enhancerlike sequences (up-
stream activation sites)?
Sergeant, A.,' Bohmann, D.,' Zent-
graf, H.,2 Keller, W.,' 'Institute of
Cell and Tumor Biology, 2lnstitute
of Virology, German Cancer Re-
search Center, Heidelberg, Fed-
linker insertion mutants of the Ad5
E1A gene.
Krippl, B.,' Ferguson, B.,2 Westphal,
H.,' Rosenberg, M.,2 Jones, N.,3
'NICHD, NCI, National Institutes of
Health, Bethesda, Maryland;
2Dept. of Molecular Genetics,
Smith Kline and French Laborato-
ries, Philadelphia, Pennsylvania;
3Purdue University, West Lafay-
ette, Indiana: Functionalcharac-
eral Republic of Germany: The.ef-
fects of chromatin assembly and
of the SV40 enhancer on tran-
scription of homologous and het-
erologous genes in vitro.
Kenny, S.,' Natarajan, V.,1 Strike, D.,'
Khoury, G.,2 Salzman, N.R,'
'Laboratory of Biology of Viruses,
'Laboratory of Molecular Virology,
National Institutes of Health, Be-
thesda, Maryland: JC virus enhan-
cer active in human brain cells.
Dabrowski, C.E., Blankenhorn, E.R,
Alwine, J.C., Dept. of Microbiol-
ogy, University of Pennsylvania
Medical School, Philadelphia:
Analysis of the efficiency of trans-
lational initiation in SV40-contain-
ing transient expression vectors.
Litzkas, P., Jha, K.K., Ozer, H.L.,
Dept. of Biological Sciences,
Hunter College, City University of
New York, New York: Efficient
transfer of clones SV40 and non-
viral DNA into human diploid cells.
Dalie, B., Harter, M.L., Dept. of Micro-
biology, University of Medicine
and Dentistry of New Jersey, New-
ark: Expression of Ad2 E1A and
El B gene products from an SV40
vector.
Lebkowski, J., DuBridge, R., Greisen,
K., Antell, E., Cabs, M., Dept. of
Genetics, Stanford University
School of Medicine, California:
Studying mutation with viral vec-
tors.
Reddy, V.B., Garramone, A.J., Beck,
A.K., Vellussi, V., Bernstine, E.G.,
Integrated Genetics, Framingham,
Massachusetts: Expression of di-
meric, biologically active human
choriogonadotropin (hCG) in CV-1
cells, using a single SV40 vector.
terization of the EtA proteins of
human adenovirus.
Schmitt, R.C., Fahnestock, M.L.,
Lewis, J.B., Fred Hutchinson Can-
cer Research Center, Seattle,
Washington: Ad2 E1A proteins lo-
calized using antipeptide antisera.
Tsukamoto, A., Berk, A.J., Molecular
Biology Institute, University of Cali-
fornia, Los Angeles: A colony blot
method for the selection of mono-
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El A proteins and their use in puri-
fication.
Harlow, E., Schley, C., Cold Spring
Harbor Laboratory, New York:
Monoclonal antibodies to the ad-
enoviral El A proteins.
Yee, S.-P., Tremblay, M.L., Mc Glade,
J., Branton, P.E., Dept. of Pathol-
ogy, McMaster University, Hamil-
ton, Canada: Analysis of Ad5 El
proteins, using antipeptide sera.
Subramanian, T.,' Kuppuswamy, M.,1
Gysbers, J.,2 Mak, 5.,2Chinnadu-
rai, G.,' 'Institute for Molecular Vi-
rology, St. Louis University Medi-
cal Center, Missouri; 2Dept. of
Biology, McMaster University,
Hamilton, Canada: 175R T antigen
coded by adenoviral El B plays a
dual role in viral DNA replication.
D'Halluin, J.C., Milleville, M., Labora-
toire de Virologie Moleculaire, IN-
SERM, Lille, France: An Ad2 El B
gene product is involved in the
control of cell endonuclease activ-
ity.
Barker, D., Berk, A.J., Molecular Biol-
ogy Institute, University of Califor-
nia, Los Angeles: The role of Ad2
El B gene products during infec-
tion and transformation.
Virtanen, A., Pettersson, U., Dept. of
Medical Genetics, University of
Uppsala, Sweden: Novel mRNAs
from the transforming region El B
of human Ad2.
Deutscher, S.L.,' Kapoor, Q.S.,2 Cla-
daras, C.,2 Wold, W.S.M.,2
'Edward A. Doisy Dept. of Bio-
chemistry; 2lnstitute for Molecular
Virology, St. Louis University Medi-
cal School, Missouri: The 19K gly-
coprotein coded by region E3 of
adenovirus-Purification, charac-
terization, and structural analysis.
Chatterjee, D., Maize', J.V., Jr.,
NICHD, NCI, National Institutes of
Health, Bethesda, Maryland: The
adenoviral E3 glycoprotein is ho-
mologous to HLA-DR heavy chain.
Cutt, J.R., Halbert, D.N., Shenk, T.E.,
Dept. of Microbiology, State Uni-
versity of New York, Stony Brook:
Analysis of adenoviral E4 mutants.
Lewis, J.B.,' Fahnestock, M.L.,'
Hardy, M.M.,2 Anderson, C.W.,2
'Fred Hutchinson Cancer Re-
search Center, Seattle, Washing-
ton; 2Dept. of Biology, Brookhaven
National Laboratory, Upton, New
York: Nonvirion protein products
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resulting from expression of the
Ad2 major late promoter at early
times after the infection of He La
cells.
Silverman, L.,' Johnston, J.M.,' An-
derson, K.P.,1 Deppert, W.,2 Kles-
sig, D.F.,"Dept. of Cellular, Viral
and Molecular Biology, University
of Utah, Salt Lake City; 2Dept. of
Biochemistry, University of Ulm,
Federal Republic of Germany:
Characterization of the block to
replication of human adenovirus in
abortively infected monkey cells.
Bhat, R.A., Domer, P., Thimappaya,
B., Cancer Center, Northwestern
University Medical School, Chi-
cago, Illinois: Structural require-
ments of adenoviral VA, RNA for
its translation enhancement func-
tion.
Rohan, R.M., Ketner, G., Dept. of Bi-
ology, Johns Hopkins University,
Baltimore, Maryland: Point muta-
tions in the adenoviral VA, pro-
moter region.
Horvath, J., Weber, J., Dept. de Mi-
crobiologie, Faculte de Medecine,
University de Sherbrooke, Can-
ada: Ad2 complementary DNA se-
quences in human B and T lym-
phocytes.
Signas, C.,' Akusjarvi, G.,' Petters-
son, U.,2 Depts. of 'Microbiology,
2Medical Genetics, University of
Uppsala, Sweden: The gene for
Ad3 fiber.
van Loon, A.E., Rozijn, T.H., Sussen-
bach, J.S., Laboratory for Physio-
logical Chemistry, State University
of Utrecht, The Netherlands: Gen-
eral characterization of DNAs of
the enteric Ad40 and Ad41.
Belak, 5.,1 Virtanen, A.,3 Berencsi,
G.,2 Pettersson, U.,3 'Dept. of Epi-
zootiology, University of Veterinary
Science, 2lnstitute of Microbiology,
Semmelweis Medical University,
Budapest, Hungary; 3Dept. of
Medical Genetics, University of
Uppsala, Sweden: Sequence ho-
mology between bovine adenovi-
ruses with different species
specificity-Importance of region
E3.
Becerra, S.P.,' Anderson, C.W.,2
Rose, J.A.,"NIAID, NCI, National
Institutes of Health, Bethesda,
Maryland; 2Dept. of Biology,
Brookhaven National Laboratory,
Upton, New York: Direct mapping
and mechanism of origin of the
adeno-associated viral structural
proteins.
Ko, J.-L., Coles, R.S., Harter, M.L.,
Dept. of Microbiology, University
of Medicine and Dentistry of New
Jersey, Newark: Improved meth-
ods for maximizing expression of
cloned Ad2 E1A and El B genes
in E. coll.
Vasavada, R.,' Barbanti-Brodano,
G.,2 Ricciardi, R.,' 'Wistar Insti-
tute, Philadelphia, Pennsylvania;
2lnstitute of Microbiology, Univer-
sity of Ferrara, Italy: Construction
of human cell lines that express
the Ad12 E1A proteins, using a
novel BK-plasmid vector.
VanDoren, K., Solnick, D., Reich!, H.,
Gluzman, Y., Cold Spring Harbor
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Veldman, G.,' Lupton, 5.,2 Kamen,
R.,"Genetics Institute, Boston,
Massachusetts; 2Dept. of Microbi-
ology, State University of New
York, Stony Brook: The polyoma
enhancer contains multiple, redun-
dant sequence elements that acti-
vate both viral DNA replication
and gene expression.
Muller, W.J., Hassell, J.A., Dept. of
Microbiology and Immunology,
McGill University, Montreal, Can-
ada: Structural requirements for
the function of the polyoma virus
origin for DNA replication.
Lee, G.J., Woodworth-Gutai, M.,
Dept. of Cell and Tumor Biology,
Roswell Park Memorial Institute,
Buffalo, New York: Eukaryotic reg-
ulation elements that enhance
DNA replication.
Magnusson, G., Nilsson, S., Sand-
berg, G., Dept. of Virology, Upps-
ala University Biomedical Center,
Sweden: Activities of polyoma vi-
rus T antigens in lytic infection.
Vakalopoulou, E., Vogt, B., Schneider,
J., Mertz, R., Sperka, S., Huber,
B., Winnacker, E.-L., Fanning, E.,
Institute for Biochemistry, Munich,
Federal Republic of Germany:
Binding of SV40 T antigen to viral
and synthetic DNA sequences.
Chalifour, L.E., Wirak, D.O., Wassar-
man, P.M., DePamphilis, M.L.,
Dept. of Biological Chemistry, Har-
vard Medical School, Boston,
Massachusetts: Replication and
expression of SV40 and polyoma
virus DNA in mouse embryonic
cells.
Bradley, M., Hudson, J., Livingston,
D., Dana-Farber Cancer Institute,
Harvard Medical School, Boston,
Massachusetts: Specific in vitro
adenylation of SV40 large T anti-
gen.
Clertant, P.,' Guizani, I.,' May, E.,2
Cuzin, F.,"INSERM, Centre de
Biochimie, Universite de Nice;
'Institut de Recherche Scientifique
sur le Cancer du CNRS, Villejuif,
France: The nucleotide binding
activity of polyoma and SV40 large
T proteins.
Levitt, A., Chen, S., Blanck, G.,
George, D., Pollack, R., Dept. of
Biological Sciences, Columbia
transforming genes from DNA tu-
mor viruses.
Cherington, V.,' Mahoney, M.,' Ka-
plan, D.,' Corbley, M.,' Morgan,
B.,' Schaffhausen, B.,2 Roberts,
T,"Dana-Farber Cancer Institute,
'Tufts New England Medical Cen-
ter, Boston, Massachusetts: Retro-
viral shuttle vector for polyoma
early region proteins and neomy-
cin resistance.
Roberts, T.M.,' Kaplan, D.,' Pallas,
D.,' Mahoney, M.,' Bockus, B.,2
Bolen, J.,3 Schaffhausen, B.,2
'Dana-Farber Cancer Institute,
'Dept. of Biochemistry and Phar-
macology, Tufts University, Bos-
ton, Massachusetts; 'NCI, Na-
tional Institutes of Health,
Bethesda, Maryland: Isolation of
polyoma T antigens from prokar-
yotic and eukaryotic sources.
University, New York, New York:
Two integrated, partial repeats of
SV40 together code for a super-T
antigen.
Cereghini, S., Yaniv, M., Dept. of Mo-
lecular Biology, Pasteur Institute,
Paris, France: Chromatin assem-
bly of transfected DNA-Structural
changes in the origin/promoter/en-
hancer region of SV40 upon repli-
cation.
Bryan, P.,' Folk, W.,2 'Dept. of Molec-
ular Genetics, Genex Corporation,
Gaithersburg, Maryland; 'Dept. of
Biological Chemistry, University of
Michigan, Ann Arbor: Sequences
required for the DNase I hyper-
sensitive structure in polyoma.
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SESSION 10 TRANSFORMATION. I
Chairperson: J. Butel, Baylor College of Medicine, Houston, Texas
Butel, J.S.,1 Lanford, R.E.,2 'Dept. of
Virology and Epidemiology, Baylor
College of Medicine, Houston;
'Dept. of Microbiology, Southwest
Foundation for Biomedical Re-
search, San Antonio, Texas: Trans-
forming potential of an SV40 mu-
tant unable to transport T antigen
to the nucleus.
Richardson, W.D., Kalderon, D., Rob-
erts, B., Paucha, E., Col ledge,
W.H., Smith, A.E., National Insti-
tute for Medical Research, Lon-
don, England: Sequence require-
ments for nuclear location of SV40
large T
Krieg ler, M.,' Perez, C.F.,' Hardy, C.,'
Feinberg, M.,2 Botchan, M.,'
'Dept. of Molecular Biology, Uni-
versity of California, Berkeley;
'Dept. of Radiology, Stanford Uni-
versity Medical Center, California:
Transformation mediated by the
SV40 T antigens-Separation of
the overlapping SV40 early genes
with a retroviral vector.
Ryan, K., Brockman, W., University of
Michigan Medical School, Ann Ar-
bor: Isolation of a cell line resistant
to transformation by SV40 T anti-
gens.
SESSION 11 TRANSFORMATION. II
Sharma, S., Rodgers, L., Cold Spring
Harbor Laboratory, New York: Cell
lines that express exclusively a
membrane-bound form of SV40
large T antigen.
Raptis, L., Benjamin, T.L., Dept. of Pa-
thology, Harvard Medical School,
Boston, Massachusetts: Regulated
expression of middle T antigen in
a line of rat fibroblasts.
Gelinas, C., Bouchard, L., Bastin, M.,
Dept. of Microbiology, University
of Sherbrooke, Canada: Stabiliza-
tion of polyoma middle T antigen
by a cellular factor is required for
transformation.
Dailey, L.,' Brugge, J.S.,2 Basilico,
0.," Dept. of Pathology, New York
University Medical Center, New
York; 'Dept. of Microbiology, State
University of New York, Stony
Brook: The amino terminus of
polyoma middle T antigen is re-
quired for formation of active c-
xrc /middle T complexes and poly-
oma-mediated transformation.
Schaffhausen, B.,' Parsons, S.,3 Rob-
erts, T.,2 Bockus, B.," Dept. of
Biochemistry and Pharmacology,
Tufts Medical School, 'Dana-Far-
ber Cancer Institute, Boston, Mas-
Chairperson: M. Fried, Imperial Cancer Research Fund, London, England
Kimelman, D.,' Miller, J.,' Cepko, C.,'
Mulligan, R.,2 Roberts, B.,"Dept.
of Biological Chemistry, Harvard
Medical School, 'Center for Can-
cer Research, Massachusetts Insti-
tute of Technology, Boston: Indi-
vidual Ad5 Et A gene products
elicit distinct alterations of cellular
morphology and gene expression.
Maruyama, K., Ruley, E., Cold Spring
Harbor Laboratory, New York: Ad-
enoviral E1A blocks in vitro differ-
entiation of rat PC12.
Kao, H.-T, Capasso, 0., Heintz, N.,
Nevins, J.R., Rockefeller Univer-
sity, New York, New York: Control
of cellular gene expression in ad-
enovirally transformed cells.
Vassen, R.T.M.J., Houweling, A., Ber-
nards, R., Jochemsen, A.G., Of-
fringa, R., van der Eb, A.J., Dept.
of Medical Biochemistry, Sylvius
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Laboratories, State University of
Leiden, The Netherlands: Regula-
tion of MHC expression in adeno-
virally transformed cells.
Cook, J.L.,' Lewis, A.M., Jr.,'
'National Jewish Hospital and Re-
search Center, Denver, Colorado;
2NIAID, NCI, National Institutes of
Health, Bethesda, Maryland: Dif-
ferential hosts' inflammatory-cell
killing of hamster cells infected
with or transformed by nononco-
genic or highly oncogenic adeno-
viral species- Implications for T
antigen function.
Simanis, V., Lane, D.P., CRC Eukar-
yotic Molecular Genetics Group,
Dept. of Biochemistry, Imperial
College of Science and Technol-
ogy, London, England: Cloning of
cellular sequences to which SV40
large T antigen is bound in the
sachusetts; 3Dept. of Microbiol-
ogy, University of Virginia,
Charlottesville: Association of
polyoma middle T with c-src.
Grussenmeyer, T,' Walter, G.,2 Hutch-
inson, M.A.,3 Templeton, D.,3 Eck-
hart, W.,3 'Institut fur Immunbiolo-
gie, Universitat Freiburg, Federal
Republic of Germany; 'Dept. of
Pathology, University of California,
San Diego, La Jolla; 3Salk Insti-
tute, San Diego, California: Prop-
erties of polyoma virus medium T
antigen protein kinase purified by
affinity chromatography using two
antipeptine monoclonal anti-
bodies.
Wilson, J.B.,' Courtneidge, S.,2 Grif-
fiths, M.,1 Fried, M.,"Imperial
Cancer Research Fund, 2Medical
Research Council, London, Eng-
land: Analysis of unstable, flat re-
vertants of a polyoma-transformed
cell line.
chromatin of SV40-transformed
cells.
Glaichenhaus, N.,' Masiakowski, P.,2
Mougneau, E.,' Lawrence, J.-J.,3
Cuzin, F.,"INSERM, Centre de
Biochimie, Universite de Nice;
2Labortoire de Genetique Molecu-
laire des Eucaryotes, Faculte de
Medecine, Strasbourg; 3Centre
d'Etudes Nucleaires, Grenoble,
France: Differential expression of
cellular genes in the G2 and 01
phases of the cell cycles, modified
in cells expressing the large T pro-
tein of polyoma virus.
Singh, K., Saragosti, S., Carey, M.,
Botchan, M., Dept. of Molecular
Biology, University of California,
Berkeley: Enhanced levels of poly-
merase III transcripts derived from
the B2 repetitive element in SV40
transformed mouse cell lines.
Van Dyke, T.,' Levine, A.J.,' Brinster,
R.,2 Chen, H.Y.,2 Messing, A.,2 Pal-
miter, R.D.,3 'Dept. of Microbiol-
ogy, State University of New York,
Stony Brook; 'School of Veterinary
Medicine, University of Pennsylva-
SESSION 12
Chairperson:
nia, Philadelphia; 3Howard
Hughes Medical Institute, Univer-
sity of Washington, Seattle: Trans-
genic mice containing the SV40
early region genes develop tu-
mors of the choroid plexus.
ADENOVIRUSES: REPLICATION
Garrels, J., Franza, B.R., Jr., Cold
Spring Harbor Laboratory, New
York: A two-dimensional gel data-
base for proteins of normal and
virally transformed rat cells.
B. Stillman, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
Nagata, K., Guggenheimer, R.A.,
Kenny, M., Field, J., Lindenbaum,
J., Murakami, Y., Gronostajski,
R.M., Hurwitz, J., Dept. of Devel-
opmental Biology, Albert Einstein
College of Medicine, Bronx, New
York: Enzymatic DNA replication
of adenoviral DNA.
Rawlins, D.R.,' Rosenfeld, P.J.,'
Wides, R.J.,' Challberg, M.D.,'
Kelly, T.J., Jr.,"Dept. of Molecular
Biology and Genetics, Johns Hop-
kins University School of Medi-
cine, Baltimore, Maryland; 'Dept.
of Microbiology and Molecular Bi-
ology, Tufts University School of
Medicine, Boston, Massachusetts:
Sequence analysis of the adeno-
viral origin of replication.
Gronostajski, R.M., Nagata, K., Ad-
hya, S., Guggenheimer, R.A., Hur-
witz, J., Dept. of Developmental
Biology and Cancer, Albert Ein-
stein College of Medicine, Bronx,
New York: Characterization of the
He La cell DNA sequences homol-
ogous to the replication origin of
Ad5.
Leegwater, P.A.J., de Vries, E., van
Driel, W., van Wijnen, A., Kwant,
M.M., van der Vliet, P.C., Labora-
tory for Physiological Chemistry,
University of Utrecht, The Nether-
lands: Replication of adenoviral
DNA with purified proteins-Origin
sequences and stimulation by
RNA.
Schneider, R., Dorper, T., Groger, W.,
Winnacker, E.-L., Institut fOr Bioch-
emie, Universitat Munchen, Fed-
eral Republic of Germany: Struc-
ture and function of the adenoviral
replicon.
Hay, R.T., Medical Research Council
Virology Unit, Glasgow, Scotland:
The initiation of adenoviral DNA
replication in vivo.
Bernstein, J., Porter, J. Challberg,
Phage and Bacterial Regulatory Mechanisms
M.D., Dept. of Molecular Biology
and Microbiology, Tufts Medical
School, Boston, Massachusetts:
Nucleotide sequence require-
ments for the replication of plas-
mid DNA in Ad5-infected He La
cells.
Rekosh, D., Mertz, L., Brewster, J.,
Prestine, L., Dept. of Biochemistry,
State University of New York, Buf-
falo: Cloning and expression in E.
coli of the gene encoding the ad-
enoviral DNA polymerase.
Chow, K.-C., Pearson, G.D., Dept. of
Biochemistry and Biophysics, Ore-
gon State University, Corvallis: Ad-
enoviral infection elevates He La
topoisomerase activity.
Graham, FL., Depts. of Biology and
Pathology, McMaster University,
Hamilton, Canada: Covalent ly
closed circles of human adeno-
viral DNA are infectious.
August 21-August 26
ARRANGED BY
Sankar Adhya, National Cancer Institute
Harrison Echols, University of California, Berkeley
289 participants
The study of bacteriophage stands as a cornerstone of our present knowledge of
the biological universe, and investigating gene structure and behavior in phage
continues to be enormously satisfying and rewarding. What emerged at this
year's phage meeting was testament to this fact. It was apparent from the pres-
entations that both genetic and biochemical problems are being studied at a mo-
lecular detail that was only a dream in the last decade. Because the regulatory
mechanisms of phage are now known to be so intricately related to host regula-
tory machinery and because host genes and proteins are also being studied at a
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similar level of sophistication, it was thus proper that the meeting had wider par-
ticipation.
In the new format the sessions were arranged not according to organism, as
has been the usual practice, but by biochemical processes; e.g., recombination,
replication, and transcription initiation and termination. Of course, it was difficult
to draw a line between these processes, which are so interdependent. Each of
the sessions was chaired by one of the veterans, whose direct participation in the
discussions, instant analysis of the situation, and summary of the take-home les-
sons showed that a chairperson can make a significant difference.
Finally, the meeting brought back the "nonphage" prokaryotic molecular biolo-
gists to Cold Spring Harbor and provided a forum in which they and the phage
biologists can interact, sharing problems as well as excitement with each other.
This meeting was supported in part by the Robertson Research Fund.
SESSION 1 BACTERIOPHAGE Mu
Goosen, N., van Heuvel, M., Moo le-
naar, G.F., van de Putte, P., Labo-
ratory of Molecular Genetics, State
University of Leiden, The Nether-
lands: The regulation of early and
repressor transcriptions of bacte-
riophage Mu.
Schumann, W., Institut fur Organ
Chemie and Biochemie, Tech-
nische Hochschule Darnstadt,
Federal Republic of Germany:
Regulation of the early functions of
temperate E. coli phage
Priess, H., Schmidt, C., Li, G.-Di.,
Kamp, D., Max-Planck-Institut,
Martinsried, Federal Republic of
Germany: Structure and some as-
pects of regulation of the early re-
gion of phage Mu.
Hattman, S., Ives, J., Dept. of Biology,
University of Rochester, New York:
Regulation of the methylation-sen-
sitive DNA modification function of
bacteriophage Mu.
Kahmann, R., Heisig, P., Seiler, A.,
Max-Planck-Institut, Berlin, Fed-
eral Republic of Germany: The
mom gene of bacteriophage Mu-
A complex regulatory cascade to
control a lethal function.
Kahmann, R., Rudt, F, Mertens, G.,
Max-Planck-Institut, Berlin, Fed-
eral Republic of Germany: Site-
specific recombination in bacterio-
phage Mu-G inversion in vitro.
Grundy, F.J., Howe, M.M., Dept. of
Bacteriology, University of Wiscon-
sin, Madison: The role of invertible
G-segment genes in the determi-
nation of phage Mu tail fiber struc-
ture and host specificity.
Castilho, B., Casadaban, M., Dept. of
Molecular Genetics and Cell Biol-
ogy, University of Chicago, Illinois:
The specificity of bacteriophage
Mu insertion.
Craigie, R., Mizuuchi, M., Mizuuchi,
K., NCI, National Institutes of
Health, Bethesda, Maryland: Site-
specific interactions between the
bacteriophage Mu A protein and
the Mu ends.
Desmet, L.,' Toussaint, A.,' Pato, M.,2
Waggoner, B.,2 'Universite libre de
Bruxelles, Laboratoire de GOne-
tique, Belgium; 2National Jewish
Hospital and Research Center,
Denver, Colorado: Requirement of
primase for phage Mu replication
and transposition.
Pato, M., Reich, C., Waggoner, B.,
National Jewish Hospital and Re-
SESSION 2 DNA REPLICATION AND REPAIR
Dodson, M.,' Echols, H.,' Roberts,
J.D.,2 McMacken, R.,2 'Dept. of
Molecular Biology, University of
California, Berkeley; 2Dept. of Bio-
chemistry, Johns Hopkins School
of Hygiene and Public Health, Bal-
timore, Maryland: Specialized nu-
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cleoprotein structures at the repli-
cation origin of bacteriophage x.
Zylicz, M., Yamamoto, T, Sell, S.,
Georgopoulos, C., Dept. of Cellu-
lar, Viral, and Molecular Biology,
University of Utah Medical Center,
Salt Lake City: In vitro Adv DNA
search Center, Denver, Colorado:
Replicative transposition of bacte-
riophage Mu DNA.
Harshey, R.M., Scripps Clinic and Re-
search Foundation, Dept. of Mo-
lecular Biology, La Jolla, Califor-
nia: Nonreplicative DNA
transposition-Integration of in-
fecting bacteriophage Mu.
Burlingame, R., Lynn, D.L., Obukow-
icz, M.G., Howe, M.M., Properties
of phages with cis-dominant point
Mu replication.
Glasgow, A.C., Miller, J.L., Howe,
M.M., Dept. of Bacteriology, Uni-
versity of Wisconsin, Madison: Mu-
specific sites and functions in-
volved in growth inhibition of
A.::mini-Mu.
Shore, S.H., Ross, W., Howe, M.M.,
Dept. of Bacteriology, University of
Wisconsin, Madison: E. coli DNA
gyrase mutations that inhibit the
growth of bacteriophage Mu.
Yoshida, R.K., Howe, M.M., Dept. of
Bacteriology, University of Wiscon-
sin, Madison: Analysis of the block
to phage Mu development in E.
coli himA mutant strains.
replication dependent on the E.
coli dnaJ and dnaK proteins.
Wickner, S., NCI, National Institutes of
Health, Bethesda, Maryland: Lim-
its of A origin DNA required for the
initiation of replication in vitro.
Macdonald, P., Mosig, G., Dept. of
Molecular Biology, Vanderbilt Uni-
versity, Nashville, Tennessee: Sig-
nals in a DNA replication origin of
phage T4.
Hinton, D., Nossal, N., NCI, National
Institutes of Health, Bethesda,
Maryland: Cloning of T4 DNA en-
coding the T4 primase proteins,
genes 41 and 61, and a DNA-
binding protein of 46 kD.
Se lick, H.E., Nakanishi, M., Kreuzer,
K.N., Alberts, B.M., Dept. of Bio-
chemistry and Biophysics, Univer-
sity of California, San Francisco:
Molecular dissection of potential
T4 replication genes.
Kreuzer, K.N., Alberts, B.M., Dept. of
Biochemistry and Biophysics, Uni-
versity of California, San Fran-
cisco: Molecular cloning and anal-
ysis of phage T4 replication
origins.
Fulford, W., Model, F, Rockefeller
University, New York, New York:
Gene x of bacteriophage fl is re-
quired for phage DNA synthesis-
Mutagenesis of in-frame overlap-
ping genes.
Horiuchi, K., Rockefeller University,
New York, New York: Dissection of
functional domains of DNA repli-
cation origin in bacteriophage fl.
Scheuermann, R.H., Young, K.,
Echols, H., Dept. of Molecular Bi-
ology, University of California,
Berkeley: The role of the c-subunit
SESSION 3 PHAGE MORPHOGENESIS
Feiss, M., Sippy, J., Miller, G., Dept. of
Microbiology, University of Iowa,
Iowa City: Terminase readthrough
during sequential packaging of
bacteriophage A chromosomes.
Gold, M., Parris, W., Dept. of Medical
Genetics, University of Toronto,
Canada: A bacterial protein re-
quirement for bacteriophage A ter-
minase activity in vitro.
Rosenberg, S.M., Stahl, F.W., Institute
of Molecular Biology, University of
Oregon, Eugene: A monomers
cannot be packaged in vitro.
Stahl, F.W.,' Stahl, M.M.,' Kobayashi,
I.,2 Thaler, D.," Institute of Molec-
ular Biology, University of Oregon,
Eugene; 2Dept. of Bacteriology,
University of Tokyo Faculty of
Medicine, Japan: Recombination
and packaging of phage A.
of E. colt DNA polymerase III in
the fidelity of DNA replication.
Panayotatos, N., Fontaine, A., Dept.
of Molecular Biology, Bingen S.A.,
Switzerland: Expression of an en-
donuclease in E. colt damages the
DNA and induces the SOS re-
sponse.
Ennis, D.G.,' Fisher, B.L.,' Mount,
D.W.,1.2 Depts. of 'Molecular and
Cellular Biology, 2Biochemistry,
University of Arizona, Tucson: Di-
rect involvement of recA protein in
umuCD or pkm101-mediated in-
ducible mutagenesis.
Bhatia, K., Martin, S., Lee, E., Hays,
J., Dept. of Chemistry, University
of Maryland Baltimore County, Ca-
tonsville: uvr, phr, and sos func-
tion in the dark repair of nonrepli-
cating uv-irradiated phage A DNA.
Wong, A., Lemmermann, L., Maurer,
R., Dept. of Molecular Biology and
Microbiology, Case Western Re-
serve University, Cleveland, Ohio:
Requirement for dnaC proteins in
S. typhimurium harboring a strong
suppressor mutation in dnaB.
Engstrom, J., Maurer, R., Dept. of
Molecular Biology and Microbiol-
ogy, Case Western Reserve Uni-
versity School of Medicine, Cleve-
land, Ohio: Mutations in the dnaA-
dnaN region in S. typhimurium
suppress dnaZ(ts).
Pruss, G.J., Drlica, K., Dept. of Biol-
Russel, M., Model, P., Rockefeller Uni-
versity, New York, New York: Thio-
redoxin is required for filamentous
phage assembly.
Smith, G.P., Division of Biological Sci-
ences, University of Missouri, Co-
lumbia: Filamentous phage mor-
phogenesis-Which genes are
really essential?
Wyckoff, E., Casjens, S., Dept. of Cel-
lular, Viral, and Molecular Biology,
University of Utah Medical Center,
Salt Lake City: Expression of hy-
brid scaffolding protein-p-Galac-
tosidase gene is regulated by un-
assembled scaffolding protein.
Berget, P.B., Kylberg, R.W., Rang-
wala, S.H., Plishker, M.F., Dept. of
Biochemistry and Molecular Biol-
ogy, University of Texas Medical
School, Houston: In vitro analysis
S. Adhya
ogy, Unviersity of Rochester, New
York: Extremely high levels of neg-
ative supercoiling in supX mu-
tants.
GOnthert, U., Max-Planck-Institut, Ber-
lin, Federal Republic of Germany:
The DNA methyltransferase gene
of the B. subtilis phage SPR.
Kellman, S.I., Margolin, P., Public
Health Research Institute of the
City of New York, New York: Toler-
ance of S. typhimurium to the ab-
sence of DNA topoisomerase I
and the effect on prophage induc-
tion.
of the sequential assembly of pro-
teins of the bacteriophage T4 ba-
seplate.
Davis, N., Model, P., Rockefeller Uni-
versity, New York, New York: Anal-
ysis of the membrane anchoring
requirements of a model integral
membrane protein.
Kurnit, D.,' Neve, R.,' Lagos, R.,2
Lee, S.-J.,2 Goldstein, R.,2
'Genetics Division, Children's Hos-
pital, °Dept. of Microbiology and
Molecular Genetics, Harvard Med-
ical School, Boston, Massachu-
setts: Plasmid cloning vector P4
vir1 sid amt -supF dosage me-
diates capsid size.
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SESSION 4 TRANSPOSITION
Dalyrmple, B., Mollet, B., Ida, S., Ar-
ber, W., Dept. of Microbiology,
Biozentrum of the University of
Basel, Switzerland: Structure and
functions of the prokaryotic is ele-
ments IS26 and IS30.
Shen, M., Raleigh, E., Kleckner, N.,
Dept. of Biochemistry and Molecu-
lar Biology, Harvard University,
Cambridge, Massachusetts: Anal-
ysis of unselected IS10 rearrange-
ments.
Roberts, D., Kleckner, N., Dept. of
Biochemistry and Molecular Biol-
ogy, Harvard University, Cam-
bridge, Massachusetts: Effects of
adenine methylation on activity of
IS10.
Raleigh, E.A., Kleckner, N., Dept. of
Biochemistry and Molecular Biol-
ogy, Harvard University, Cam-
bridge, Massachusetts: Rate of
transcription and translation of
IS10- right.
Kittle, J.D., Jr., Kleckner, N., Dept. of
Biochemistry and Molecular Biol-
ogy, Harvard University, Cam-
bridge, Massachusetts: Pairing be-
tween IS/O's PIN and Po,
transcripts in vitro.
Morisato, D., Kleckner, N., Dept. of
Biochemistry and Molecular Biol-
SESSION 5 REGULATION I
Ebright, R.H.,1 Miller, J.,3 'Harvard
Medical School, Boston, Massa-
chusetts; 3University of California,
Los Angeles: Putative contact be-
tween GIn18 of lac repressor and
base pair 7 of /ac operator.
Majumdar, A., Polymeropoulos, M.,
Adhya, S., NCI, National Institutes
of Health, Bethesda, Maryland: In-
teraction between repressor and
operators of gal operon of E. coli.
Garges, S., Adhya, S., NCI, National
Institutes of Health, Bethesda,
Maryland: Analysis of mutations in
crp gene of E. coll.
Ebright, R.H.,12 Krakow, J.,3 Kunkel,
T.,4 Cossart, P.,2 Gicquel-Sanzey,
B.,2 Beckwith, J.,' Buc, H.,2
'Harvard Medical School, Boston,
Massachusetts; 2lnstitute Pasteur,
Paris, France; 3Hunter College,
New York, New York; 4National In-
stitutes of Environmental Health
Sciences, Research Triangle Park,
North Carolina: Ligand binding,
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ogy, Harvard University, Cam-
bridge, Massachusetts: Physical
analysis of Tn10 transposition.
Davis, M.A., Simons, R.W., Kleckner,
N., Dept. of Biochemistry and Mo-
lecular Biology, Harvard Univer-
sity, Cambridge, Massachusetts:
ISIO protects itself at two levels
from fortuitous activation by exter-
nal promoters.
Bender, J., Kleckner, N., Dept. of Bio-
chemistry and Molecular Biology,
Harvard University, Cambridge,
Massachusetts: Tn10 transposition
products contain information from
both strands of donor transposon
molecule.
Mazodier, P., Giraud, E., Gasser, F.,
Dept. de Biochimie et Gen4tique
Moleculaire, Institut Pasteur, Paris,
France: Genetic organization,
DNA sequence, and expression of
the three resistance genes of the
central region of Tn5.
Nag, D.K., Dasgupta, U., Berg, D.E.,
Dept. of Microbiology, Washington
University, St. Louis, Missouri:
IS50-mediated inverse transposi-
tion-Specificity and precision.
Amundsen, S.K.,1 Ennis, D.G.,2
Smith, G.R.,"Fred Hutchinson
Cancer Research Center, Seattle,
conformation, and altered DNA-
sequence recognition properties
of CAP(G1u181-.Leu) and
CAP(Glu181-.Val).
Okamoto, K., Pondo, C., Freundlich,
M., Dept. of Biochemistry, State
University of New York, Stony
Brook: LexA protein represses
transcription of the crp gene.
Wertman, K.F., Mount, D.W., Dept. of
Molecular and Cellular Biology,
University of Arizona, Tucson:
Identification of the nucleotide se-
quence determinants of site-spe-
cific binding of lexA protein to
DNA.
Martin, K., Schleif, R., Dept. of Bio-
chemistry, Brandeis University,
Waltham, Massachusetts: Repres-
sion-negative mutations of the
araBAD operon lie in multiple re-
gions.
Schleif, R., Dept. of Biochemistry,
Brandeis University, Waltham,
Massachusetts: Addition of DNA
Washington; 3University of Ari-
zona, Tucson: Analysis of factors
influencing inversion of a A DNA
segment flanked by inverted re-
peats.
Lichens, A., Syvanen, M., Dept. of Mi-
crobiology and Molecular Ge-
netics, Harvard Medical School,
Boston, Massachusetts: Isolation
of a novel bacteriophage l plas-
mid that contains the right stem of
Tn5.
Selwin Thomas, P., Shanmugasun-
daram, S., Lakshmanan, M.,
School of Biological Sciences,
Madurai Kamaraj University, India:
Transposon mutagenesis in A.
chroococcum using Mud(Ap.lac).
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This second meeting on Modern Approaches to Vaccines included presentations
that described the identification, molecular cloning, and sequence analysis of
genes coding for antigens that are specific for each stage of the life cycle of the
malaria parasite. Many problems remain to be solved in the development of a
malaria vaccine, but it should be noted that several encouraging findings were
described. Progress was also reported in the construction of viable bacterial
deletion mutants that lack the sequences for exotoxin. Other encouraging events
in the development of modern bacterial vaccines included the synthesis of anti-
genic peptides that correspond to active regions of bacterial toxins or adhesion
proteins.
The meeting was also concerned with the rapidly moving area of viral vac-
cines. Significant progress was reported for candidate vaccinia-viral gene recom-
binant vaccines as well as viral host range and reassortant vaccines. In addition,
a number of presentations described advances in the current understanding of
protective antigenic sites on viral surface proteins. Finally, the molecular basis for
attenuation of one of the major licensed live-virus vaccines (i.e., poliovirus vac-
cine) now appears to be coming into focus.
At the conclusion of the conference the organizers and members of the Cold
Spring Harbor Laboratory staff decided that further annual meetings would be
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held during the next 5 years in order to bring together scientists from different
disciplines who might interact to accelerate progress in vaccine development.
Funding for this meeting was provided in part by Johnson & Johnson Biotech-
nology Center, Inc.; Wellcome Biotechnology Ltd.; and the following divisions of
the National Institutes of Health: Fogarty International Center and the National
Institute of Allergy and Infectious Diseases.
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Growth Factors and Transformation
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Charles Stiles, Dana-Farber Cancer Institute
208 participants
The rapidly accumulating evidence of the intimate connection between cellular
growth factors and transformation provided the impetus as well as the focus for
organizing the second in the series of meetings devoted to the cancer cell. Inves-
tigators from various disciplines, including cell biologists, molecular biologists,
and tumor virologists, came together to present their latest findings in these con-
verging fields. Topics covered at the meeting included oncogenes, kinases, lym-
phokines, PDGF, EGF, TGF, insulin, and a concluding session that explored
promising lines of future research. Among the highlights of the conference were:
(1) the correlation of the expression of the c-fos and c-myc proto-oncogenes with
the stimulation of cells by growth factors; (2) the involvement of the ras oncogene
with adenylate cyclase in yeast; and (3) the demonstration that microinjection of
the oncogenic form of ras protein into normal cells causes rapid proliferation of
these cells without the need for growth factors.
This second Cancer Cells meeting was an exciting demonstration of the fact
that this area of research has reached a detailed molecular level. The first pro-
posals of the molecular mechanisms of the oncogenes sis, erb-B, and ras in cell
proliferation have been stated, and it is clear that further research in the areas of
growth factors and oncogenes will yield tremendous new information in the mo-
lecular biology of cancer. This series of meetings will certainly serve as a main-
stay for the presentation of this work.
Funding for this meeting was supplied in part by the Cold Spring Harbor Can-
cer Center Grant from the National Cancer Institute, National Institutes of Health.
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formed cells.
Williams, LT.,' Garrett, J.S.,' Cough-
lin, &R.: Wang, J.Y.H.,2 Frackel-
ton, A.R.,' Daniel, TO.,' 'Howard
Hughes Medical Institute, Univer-
sity of California, San Francisco;
2Dept. of Biology, University of
California, San Diego: Blockade of
autocrine stimulation in SSV-trans-
formed cells reverses downregula-
tion of PDGF receptors.
Wang, J.Y.J.,' Williams, LT.,' 'Dept.
of Biology, University of California,
San Diego; 2Howard Hughes
Medical Institute, University of Cal-
ifornia, San Francisco: Biological
activity of v-sis-encoded protein
produced in bacteria.
Bowen-Pope, D.F., DiCorleto, P.E.,
Harlan, J.M., Reidy, M.A., Ross,
R., Schwartz, S.M., Seifert, R.A.,
Vogel, A., Walker, L.N., Dept. of
Pathology, University of Washing.
SESSION 6 EGF
Chairperson: B. Ozanne, University
Ullrich, A.,' Coussens, L.,' Hayflick,
J.S.,' Dull, T.J.,' Gray, A.,' Tam,
A.W.,' Lee, J.,' Yarden, Y,2 Liber-
mann, T.A.,2 Schlessinger, J.,2
Downward, J.,3 Mayes, E.L.V.,3
Whittle, N.,3 Waterfield, M.D.,3
Seeburg, RH.,' 'Dept. of Molecu-
lar Biology, Genentech, Incorpo-
rated, South San Francisco, Cali-
fornia; 2Dept. of Chemical
Immunology, Weizmann Institute of
Science, Rehovot, Israel; 3Protein
Chemistry Laboratory, Imperial
Cancer Research Fund, London,
England: Structure and expression
of the human EGF receptor.
Gill, G.N., Dept. of Medicine, Univer-
sity of California School of Medi-
SESSION 7 TGF
Chairperson: G. Todaro, Oncogen,
Assoian, R., Roberts, A., Anzano, M.,
Frolik, C., Wakefield, L., Sporn, M.,
NCI, National Institutes of Health,
Bethesda, Maryland: Structure
and action of transforming growth
factor-p.
Moses, H.L., Shipley, G.D., Tucker,
R.F., Dept. of Cell Biology, Mayo
B. Ozanne, C.S. Richards
ton, Seattle: Nonplatelet sources
of PDGF-Possible roles in trans-
formation, normal development,
and response to injury.
Pledger, W.J., Herman, B., University
of North Carolina, Chapel Hill:
PDGF-stimulated cellular events
initiate proliferation.
of Texas, Dallas, Texas
cine San Diego, La Jolla: Charac-
Merlino, G.T,' Xu, Y. -H.,' Ishii, S.,'
Clark, A.,' Wilson, R.,2 Ma, D.P.,2
Roe, B.,2 Knutsen, T,' Whang-
Peng, J.,' Pastan, I.,"NCI, Na-
tional Institutes of Health, Be-
thesda, Maryland; 2Dept. of
Chemistry, University of Okla-
homa, Norman: Cloning and char-
acterization of EGF receptor gene
sequences in A431 human carci-
noma cells.
Gilmore, T., DeClue, J., Martin, G.S.,
Dept. of Zoology, University of
California, Berkeley: Tyrosine
phosphorylation induced by the v-
erb-B protein in vivo and in vitro.
Seattle, Washington
Foundation and Medical School,
Rochester, Minnesota: Type-p
transforming growth factor is a
growth stimulator and a growth in-
hibitor.
Massague, J., Dept. of Biochemistry,
University of Massachusetts Medi-
cal Center, Worcester: Identifica-
Armelin, M.C.S.,' Armelin, H.,' Coch-
ran, B.H.,2 Stiles, C.D.,2 'Dept. of
Bioquimica, Universidade de Sao
Paulo, Brazil; 2Dana-Farber Can-
cer Institute, Harvard Medical
School, Boston, Massachusetts:
Intracellular mediators of the mito-
genic response to PDGF
Novak-Hofer, I., Martin Perez, J.,
Thomas, G., Fried-
rich Miescher-Institut, Basel, Switz-
erland: EGF-mediated phosphoryl-
ation of 40S ribosomal protein S6
phosphorylation in Swiss mouse
3T3 cells.
Hendler, F.,' Shum, A.,' Richards,
Cassells, D.,' Gusterson,
B.,2 Ozanne, B.,"Depts. of Inter-
nal Medicine and Microbiology,
Universiy of Texas Health Science
Center, Dallas; 2Ludwig Institute,
Sutton, England: Evidence for in-
creased EGF receptor in epider-
moid malignancies.
Lion of membrane receptors for
type-p transforming growth factor
in target cells.
Derynck, R.,' Roberts, A.B.,3 Winkler,
M.E.,2 Chen, E.Y.,' Goeddel,
D.V.,' Depts. of 'Molecular Biol-
ogy, 2Protein Biochemistry, Ge-
nentech, Incorporated, South San
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Francisco, California; 'NCI, Na-
tional Institutes of Health, Be-
thesda, Maryland: Human trans-
forming growth factor -a-
Precursor structure and heterolo-
gous expression.
Adkins, B.,',2 Leutz, A.,' Graf, T,'
'European Molecular Biology Lab-
oratory, Heidelberg, Federal Re-
SESSION 8 INSULIN
public of Germany; 'Dept. of Pa-
thology, Stanford University,
California: Viruses carrying v-src-
related oncogenes induce auto-
crine growth in transformed
chicken myeloid cells.
Sager, R., Craig, R., Dana-Farber
Cancer Institute, Harvard Medical
School, Boston, Massachusetts:
Chairperson: 0. Rosen, Albert Einstein College of Medicine, Bronx, New York
Czech, M.P., Mottola, C., Oka, Y., Yu,
K.-T., Davis, R., MacDonald, R.G.,
Dept. of Biochemistry, University
of Massachusetts Medical School,
Worcester: Mechanisms that regu-
late the receptors for insulin and
the insulinlike growth factors.
Roth, R.A.,' Morgan, D.O.,' Masara-
chia, R.A.,2 'Dept. of Pharmacol-
ogy, Stanford University School of
Medicine, California; 'Dept. of Bio-
chemistry, North Texas State Uni-
versity, Denton: Monoclonal anti-
bodies as probes of the structure
and function of the insulin recep-
tor.
SESSION 9 FUTURES
Rosen, 0.M., Ganguly, S., Herrera,
R., Petruzzelli, L.M., Stadtmauer,
L., Memorial Sloan-Kettering Can-
cer Center, New York, New York:
The insulin-dependent tyrosine
protein kinase of human placenta.
Fujita-Yamaguchi, Y., Kathuria, S.,
Beckman Research Institute of the
City of Hope, Duarte, California:
Relationship between insulin re-
ceptor structure and its protein ki-
nase activity.
Bruni, C.B.,' Frunzio, R.,' Whitfield,
H.J.,2 Rechler, M.M.,2 'Centro di
Endocrinologia ed Oncologia
Sperimentale, CNR, Naples, Italy;
Chairperson: A. Pardee, Dana-Farber Cancer Institute, Boston, Massachusetts
Pardee, A.B., Dana-Farber Cancer In-
stitute, Harvard Medical School,
Boston, Massachusetts: New di-
252
rections-Molecular. basis of
growth regulation.
Cunningham, D., Thompson, J., Hira-
moto, S., Van Nostrand, K., Dept.
of Microbiology and Molecular Ge-
netics, University of California, Ir-
vine: Thrombin-stimulated cell divi-
sion.
Pouyssegur, J., Chambard, J.-C.,
Franchi, A., L'Allemain, G., Paris,
S., Van Obberghen-Schilling, E.,
Centre de Biochimie, CNRS, Nice,
France: Growth factor activation of
the Na' /H' antiporter controls
growth of fibroblasts by regulating
intracellular pH.
Jakobovits, A., Martin, G.R., Dept. of
Anatomy, University of California,
San Francisco: Embryonal carci-
noma-derived growth factors-
Specific growth-promoting and dif-
ferentiation-inhibiting activities.
Villereal, M., Owen, N., Vic.entini, L.,
Mix-Muldoon, L., Jamieson, G.,
Genetic suppression of tumori-
genicity in hybrids from fusions of
normal x EJ-transformed CHEF/
18 cells.
2NIADDKD, National Institutes of
Health, Bethesda, Maryland:
Structure and expression of rat in-
sulinlike growth factor-II gene.
Jacobs, S., Wellcome Research Labo-
ratories, Research Triangle Park,
North Carolina: Phorbol ester-stim-
ulated phosphorylation of recep-
tors for insulin and IGF-I.
Dept. of Pharmacology and Phys-
iological Science, University of
Chicago, Illinois: Mechanism for
growth factor-induced increase of
Na+/H + exchange and in Ca+ +
activity in cultured human fibro-
blasts.
O'Brian, C., Columbia University Col-
lege of Physicians & Surgeons,
New York, New York: Studies on
PKC and their relevance to tumor
promotion.
Maness, P.F., Dept. of Biochemistry,
University of North Carolina
School of Medicine, Chapel Hill:
Expression of pp60c-src inthe de-
veloping nervous system.
Chen, L.B., Weiss, M.J., Davis, S.,
Shepherd, E.L., Walker, E.S.,
Dana-Farber Cancer Institute, Har-
vard Medical School, Boston,
Massachusetts: The use of rhoda-
mine-123 to probe mitochondria!
bioenergetics in living cells.
BANBURY
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Recto: Detail of Sammis Hall guest house at Banbury Center.
BANBURY CENTER
DIRECTOR'S REPORT
This was the seventh consecutive year of operation of the Banbury Center of
Cold Spring Harbor Laboratory. Throughout this period, there has been a contin-
ual expansion of the Center's conference programs and publications, particularly
in the realms of health risk assessment and carcinogenesis, as well as in the im-
pact upon these areas of recent developments in molecular biology. That this
program has been able to flourish during a period when governmental support
has become increasingly scarce and problematic is due, to a large extent, to the
response the Center has been fortunate in eliciting from private sector sources. A
particularly important step in 1984 was the partial consolidation of such support
under the Cold Spring Harbor Laboratory Corporate Sponsor Program. This and
the ongoing essential contributions from Core Supporters of the Banbury Center
and specific corporate contributions toward particular programs remain crucial
for the continuance and further development of the Banbury program.
It is perhaps fitting that the 1984 schedule began with the first meeting of the
newly initiated Corporate Sponsor Program. This, the first of three such Sponsor
meetings, was on Site-directed Mutagenesis and Protein Structure and Function.
The meeting was almost prototypic of those to be held within this program, which
enables the development of small scientific conferences in the rapidly develop-
ing field of molecular biology, especially in the area of recombinant DNA method-
ologies and their applications. These emphases were reflected in the remaining
two Sponsor meetings of the year, a June conference on Yeast Expression Vec-
tors and a November meeting on Transport and Secretion of Proteins.
Robertson House provides
housing and dining
accommodations at
Banbury Center
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Sammis Hall, guest house
The Sponsor Program thus acted as a rich complement to the ongoing Ban-
bury concern with human health risk assessment in addition to the Center's in-
creasing interest in newly emerging areas in the biological sciences that may
particularly bear social or regulatory implications. The first major conference of
the year in these areas was an April conference on the Biological Mechanisms of
Dioxin Action. Organized jointly by Dr. Alan Poland (McArdle Laboratory of the
University of Wisconsin) and Dr. Renate Kimbrough (Centers for Disease Con-
trol), this conference focused on the specific mechanisms by which the dioxins
and closely related halogenated aromatic hydrocarbons bring about their broad
range of biological effects. These compounds represent potentially far-reaching
human health consequences and are among the most highly publicized and inci-
tive of environmental pollutants. Bringing epidemiological and public health
points of view together with major cellular and molecular research approaches,
in the nonadversarial yet highly interactive setting of a small Banbury confer-
ence, was the impetus for this important conference. The papers and discussions
of this meeting will appear early in 1985 as volume 18 in the Banbury Reports
series.
The second major risk assessment conference of the year, to be published in
1985 as Banbury Report 19, was a mid-May conference on Risk Quantitation
and Regulatory Policy. Organized by Dean Richard Merrill (University of Virginia
School of Law) and Dr. David Hoel (Director of the Biometry and Risk Assess-
ment Program of the National Institute of Environmental Health Sciences), this
conference brought together legal, regulatory, and research representatives to
consider the most efficacious ways to make the evolving science of risk assess-
ment accessible and amenable to incorporation into regulatory policy formula-
tions. The papers and discussions of this meeting proved a most useful compen-
dium of centralized information and ideas in an area that has otherwise become
a frequent source of public consternation and institutional conflict.
The final 1984 conference, also to be published in the Banbury series, was an
October meeting organized by Dr. Frank Costantini (Columbia University) and Dr.
Rudolph Jaenisch (now of the Whitehead Institute) on the Genetic Manipulation
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of the Mammalian Ovum and Early Embryo. This relatively new and rapidly ad-
vancing research area has already received considerable public attention. Yet
this attention has rarely focused on the new abilities that such advances have
been bringing to current approaches toward an understanding of gene regula-
tion and the genetic control of development. Given the nature and potentially far-
reaching impact of this field, a present-state assessment and consideration of its
likely future developments seemed especially appropriate at this particular time.
The 1984 Banbury program was rounded out by a full complement of summer
courses and a series of smaller workshops held throughout the year. Among
these smaller workshops was one held in early spring on the large T antigen of
the SV40 oncogenic virus, followed by a National Institute of Mental Health Work-
shop on Single Unit Activity and Behavior, an Alfred P Sloan Foundation Compu-
tational Neuroscience Workshop, and a late October workshop on the Structure
and Function of Gap Junctions. The meeting year concluded at the end of No-
vember with a further Journalists' Workshop in the series held under the auspices
of an ongoing grant from the Alfred P Sloan Foundation. As previously men-
tioned, public confusion and concern often arises over issues of en-
vironmental health risk assessment. This is especially true in areas of occupa-
tional and environmental carcinogenesis. This year's journalists' workshop topic
was thus "Assessing Risk Assessment". The workshop again proved to be both
an intense and enjoyable few days, leading to considerably greater journalistic
sophistication concerning the strengths and weaknesses in the quantitation of
risk.
1984 Support
As noted earlier, the ability to carry on such an overall program is due largely to
support that the Banbury Center has been fortunate to receive from private sec-
tor sources. The donation to Cold Spring Harbor Laboratory of the Banbury es-
tate by Charles S. Robertson generously included an endowment for the mainte-
nance of the grounds and of Robertson House. Funding of actual programs,
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Robertson House Library
Robertson House hall
Banbury Center Meeting House
however, as well as maintenance and operation of the Meeting House and of
Sammis Hall remain the responsibility of the Banbury Center itself. It is thus with
considerable gratitude that I take this opportunity to thank the Corporate Spon-
sors and Core Supporters of the Center. The names of these companies are
listed separately in this report. It is also with great thanks that I acknowledge the
support of specific programs from the following sources: Biological Mechanisms
of Dioxin Action was supported by contributions from Hoffmann-La Roche Inc.,
Monsanto Company, the Dow Chemical Company, and Diamond Shamrock Cor-
poration; Risk Quantitation and Regulatory Policy was supported in part by a
grant from the U.S. Department of Energy, together with contributions from the
Monsanto Company and National Distillers and Chemical Corporation; and Ge-
netic Manipulation of the Mammalian Ovum and Early Embryo was held under
grants from the March of Dimes Birth Defects Foundation, the Fogarty Interna-
tional Center, and the National Institute of Child Health and Human Develop-
ment.
Michael Shodell
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MEETINGS
SV40 Large T Antigen
March 8-March 11
ARRANGED BY
E. Harlow, Cold Spring Harbor Laboratory, New York
SESSION 1 MUTANTS
Chairperson: P. Tegtmeyer, State University of New York, Stony Brook
C. Cole, Dartmouth Medical School,
Hanover, New Hampshire
D. Kalderon, MRC National Institute
for Medical Research, London,
England
R. Lanford, Baylor College of Medi-
cine, Houston, Texas
M. Manor, Cold Spring Harbor Labo-
ratory, New York
K. Peden, Johns Hopkins University,
Baltimore, Maryland
T. Shenk, State University of New
York, Stony Brook
A.E. Smith, MRC National Institute for
Medical Research, London, Eng-
land
SESSION 2 TRANSFORMATION
Chairperson: C. Prives, Columbia University, New York, New York
R. Baserga, Temple University Medi- juif, France
cal School, Philadelphia, Pennsyl- J. Pipas, University of Pittsburgh,
vania Pennsylvania
F Birg, INSERM, Marseille, France R. Pollack, Columbia University, New
M. Botchan, University of California, York, New York
Berkeley
J. Feunteun, Institut de Recherches
Scientifiques sur le Cancer, Ville-
SESSION 3 SURFACE T
Chairperson: E. Harlow, Cold Spring Harbor Laboratory, New York
J. Butel, Baylor College of Medicine,
Houston, Texas
W. Deppert, Universitat Ulm, Federal
Republic of Germany
L. Gooding, Emory University, At-
lanta, Georgia
SESSION 4 EXPRESSION SYSTEMS
B. Knowles, Wistar Institute, Philadel-
phia, Pennsylvania
S. Tevethia, Pennsylvania State Uni-
versity, Hershey
Chairperson: E. Harlow, Cold Spring Harbor Laboratory, New York
Y. Gluzman, Cold Spring Harbor Lab-
oratory, New York Laboratory, New York ley
P. Rigby, Imperial College, London,
England
L. Sompayrac, University of Colo-
rado, Boulder
T. Grodzicker, Cold Spring Harbor D. Rio, University of California, Berke-
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SESSION 5 DNA BINDING AND REGULATION
Chairperson: T. Shenk, State University of New York, Stony Brook
J.C. Alwine, University of Pennsylva-
nia, Philadelphia
J. Brady, Laboratory of Molecular Vi-
rology, National Institutes of
Health, Bethesda, Maryland
R. Dixon, Merck Sharp & Dohme,
West Point, Pennsylvania
E. Fanning, Ludwig Maximillian Uni-
versity, Munich, Federal Republic
of Germany
D.P. Lane, Imperial College, London,
England
D.M. Livingston, Sidney Farber Can-
cer Institute, Boston, Massachu-
setts
J.L. Manley, Columbia University,
New York, New York
D. Rio, University of California, Berke-
ley
J. Stringer, University of Cincinnati,
Ohio
P. Tegtmeyer, State University of New
York, Stony Brook
SESSION 6 MODIFICATIONS WORKSHOP
Chairperson: D.M. Livingston, Sidney Farber Cancer Institute, Boston, Massachusetts
R.B. Carroll, New York University E. May, Institut de Recherches Scien-
Medical Center, New York tifiques sur le Cancer, Villejuif,
W. Deppert, Universitat Ulm, Federal France
Republic of Germany D. Simmons, University of Delaware,
R. Henning, Universitat Ulm, Federal Newark
Republic of Germany
SESSION 7 ANTIBODIES WORKSHOP
Chairperson: D.P. Lane, Imperial College, London, England
L. Gooding, Emory University, At- E. Paucha, MRC National Institute for
lanta, Georgia Medical Research, London, Eng-
E. Gurney, Institut de Recherches land
Scientifiques sur le Cancer, Ville-
juif, France
SESSION 8 SEQUENCES WORKSHOP
Chairperson: S. Weissman, Yale University, New Haven, Connecticut
G. Walter, University of California, San
Diego, La Jolla
Site-directed Mutagenesis and Protein Structure and Function
March 18-March 21
ARRANGED BY
R.T. Sauer, Massachusetts Institute of Technology, Cambridge
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SESSION 1 ALTERATIONS OF ENZYMATIC PROPERTIES I
Chairperson: M. Smith, University of British Columbia, Vancouver, Canada
M. Smith, University of British Colum-
bia, Vancouver, Canada: Oligonu-
cleotide mutagenesis and the
study of heme proteins.
S.J. Benkovic, Pennsylvania State
University, Hershey: Strategies for
mutagenesis: Preliminary results
on dihydrofolate reductase.
S.A. Benner, Harvard University,
Cambridge, Massachusetts: Syn-
thetic genes for fundamental stud-
ies in protein chemistry.
G.A. Petsko, Massachusetts Institute
of Technology, Cambridge: Site-di-
rected alteration of enzymatic
properties.
M.L. Sinnott, University of Bristol,
England: The catalytic conse-
quences of experimental evalua-
tion of the ebg gene of E. coli.
SESSION 2 ALTERATIONS OF ENZYMATIC PROPERTIES II
Chairperson: J.R. Knowles, Harvard University, Cambridge, Massachusetts
J.R. Knowles, Harvard University,
Cambridge, Massachusetts: Re-
gional mutagenesis in the signal
codons of the fl-lactamase gene.
A.R. Fersht, Imperial College of Sci-
ence and Technology, London,
England: Structure and activity of
tyrosyl-tRNA synthetase.
M. Zoller, Cold Spring Harbor Labora-
tory, New York: Specific DNA/pro-
tein interactions in yeast. Point mu-
tations in the DNA recognition
sequence of the "HO" endonu-
clease.
P.R. Schimmel, Massachusetts Insti-
tute of Technology, Cambridge:
Domain structure of amino acyl
tRNA synthetase.
R. Wetzel, Genentech, Inc., South San
Francisco, California: Thermosta-
bility of phage T4 lysozyme.
J.H. Richards, California Institute of
Technology, Pasadena: /3-lacta-
mase: Mutagenic strategies and
properties of mutants-Process-
ing, secretion, stability, catalysis.
J.A. Ger lt, Yale University, New Ha-'
ven, Connecticut: Genetic studies
of nucleotidyl transferases.
D. Shortie, State University of New
York, Stony Brook: Physical chem-
ical genetics of staphylococcal nu-
clease.
SESSION 3 NONENZYME STRUCTURE/ACTIVITY CORRELATIONS
J.N. Abelson, California Institute of
Technology, Pasadena.
J. Kraut, University of California, San
Diego, La Jolla: Site-directed mu-
tagenesis of E. col/ dihydrofolate
reductase.
W.J. Rutter, University of California,
San Francisco: Altering trypsin
proteolytic specificity.
Chairperson: H.O. Smith, Johns Hopkins University School of Medicine, Baltimore,
Maryland
P.B. Berget, University of Texas Medi- Technology, Cambridge: Using
cal School, Houston: Structure/ mutants to probe the stability and
function relationships in the bacte- activities of DNA-binding proteins.
riophage P22 tail protein. R.H. Ebright, Harvard Medical
J.M. Pipas, University of Pittsburgh, School, Boston, Massachusetts:
Pennsylvania: The large tumor an- Mutations that alter the DNA se-
tigen of simian virus 40-Genetic quence specificity of the catabolite
analysis of a viral oncogene. gene activator protein of E. col /.
G.K. Ackers, Johns Hopkins Univer- M. Ptashne, Harvard University, Cam-
sity, Baltimore, Maryland: Hemo- bridge, Massachusetts: Repres-
globin mutants and cooperative sors and cro proteins-Structure
energies. and function.
P.A. Youderian, University of Southern S.C. Harrison, Harvard University,
California, Los Angeles: Altering Cambridge, Massachusetts: Struc-
DNA-binding specificities of re- tural organization of spherical
pressor proteins. plant viruses.
R.T. Sauer, Massachusetts Institute of
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SESSION 4 PROTEIN FOLDING DYNAMICS AND STABILITY
Chairperson: R.L. Baldwin, Stanford University Medical Center, California
R. Matthews, Stanford University M. Karplus, Harvard University, Cam-
Medical Center, California: Protein bridge, Massachusetts: Protein
alteration and folding of dihydro- folding: Some model studies.
folate reductase. M. Levitt, Weizmann Institute of Sci-
B.T. Nall, University of Texas Medical ence, Rehovot, Israel: Computer
School, Houston: Folding of yeast modeling of mutant proteins.
cytochrome c. J.B. Matthew, Genex Corporation,
I.B. Kingston, MRC Laboratory of Mo- Gaithersburg, Maryland: Electro-
lecular Biology, Cambridge, Eng- static contribution to protein stabil-
land. ity and macromolecular assembly.
SESSION 5 NOVEL PEPTIDES
G. Rose, Pennsylvania State Univer-
sity, Hershey: Toward a taxonomy
of protein structure.
H.A. Scheraga, Cornell University, Ith-
aca, New York: Molecular recogni-
tion in proteins.
Chairperson: M.F. Perutz, MRC Laboratory of Molecular Biology, Cambridge, England
M. Eigen, Max-Planck-Institut fur bio-
physikalische Chemie, Gottingen,
Federal Republic of Germany:
Evolving systems.
E.T. Kaiser, Rockefeller University,
New York, New York: Amphiphilic
secondary structures-The design
of biologically active peptides.
C.O. Pabo, Johns Hopkins Medical
School, Baltimore, Maryland: De-
signing novel peptides.
SESSION 6 HEMOGLOBIN AND PROTEIN EVOLUTION
J.S. Richardson, Duke University,
Durham, North Carolina: Design
criteria for inventing a protein.
Chairperson: M.F. Perutz, MRC Laboratory of Molecular Biology, Cambridge, England
M.F. Perutz, MRC Laboratory of Mo-
lecular Biology, Cambridge, Eng-
land: The structural basis of pro-
tein evolution.
R.F. Doolittle, University of California,
San Diego, La Jolla: Evolving pro-
teins with novel functions.
Biological Mechanisms of Dioxin Action
April 1-April 4
ARRANGED BY
A. Poland, University of Wisconsin, Madison
R.D. Kimbrough, Centers for Disease Control, Atlanta, Georgia
SESSION 1 CHEMISTRY AND GENERAL PATHOLOGY I
Chairperson: R.D. Kimbrough, Centers for Disease Control, Atlanta, Georgia
D. Firestone, U.S. Food and Drug
Administration, Washington, D.C.:
Chlorinated aromatic compounds
and related dioxins and furans-
Production, uses, and environ-
mental exposure.
C
E.
. Rappe, University of Umea, Swe-
den: Chemistry and analysis of
polychlorinated dioxins and diben-
zofurans in biological samples.
E. McConnell, National Institute of
Environmental Health Sciences,
SESSION 2 CHEMISTRY AND GENERAL PATHOLOGY II
Chairperson: J.A. Moore, Environmental Protection Agency, Washington, D.C.
H. Poiger, Federal Institute of Technol- Switzerland: The metabolism of
ogy and the University of Zurich, TCDD in the dog and rat.
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Research Triangle Park, North
Carolina: Clinicopathologic con-
cepts of dibenzo-p-dioxin intoxica-
tion.
R.A. Neal, Chemical Industry Institute
of Toxicology, Research Triangle
Park, North Carolina: Metabolism
of TCCD intoxication.
R.M. Pratt, National Institute of Envi-
ronmental Health Sciences, Re-
SESSION 3 RECEPTOR BINDING
search Triangle Park, North Caro-
lina: Mechanism of TCDD-induced
cleft palate in the mouse.
R.J. Kociba, Dow Chemical USA,
Chairperson: A. Poland, University of Wisconsin, Madison
D.R. Koop, University of Michigan
Medical School, Ann Arbor: Iden-
tity of cytochromes P-450 induced
by diverse xenobiotics.
B.A. Taylor, Jackson Laboratory, Bar
Harbor, Maine: The aryl hydrocar-
bon hydroxylase inducibility locus
(Ah) of the mouse, a genetic per-
spective.
A. Poland, University of Wisconsin,
Madison: Reflections on the mech-
anisms of action of halogenated
aromatic hydrocarbons.
J.A. Goldstein, National Institute of
Environmental Health Sciences,
Research Triangle Park, North
Carolina: Regulation of a multi-
gene family of P-450 isozymes by
TCDD and related compounds.
S.H. Safe, Texas A&M University, Col-
lege Station: Binding to the TCDD
receptor and AHH/EROD induc-
tion-In vitro QSAR.
SESSION 4 ENZYME INDUCTION
Midland, Michigan: Evaluation of
the carcinogenic and mutagenic
potential of TODD and other chlor-
inated dioxins.
Chairperson: J.A. Goldstein, National Institute of Environmental Health Sciences,
Research Triangle Park, North Carolina
J.-A. Gustafsson, Huddinge Univer-
sity Hospital, Sweden: Physico-
chemical characteristics of the
TCDD receptor.
T.A. Gasiewicz, University of Roches-
ter Medical Center, New York: Evi-
dence for a homologous nature of
Ah receptors among various mam-
malian species.
A. Schecter, State University of New
York, Binghamton: Ultrastructural
alterations of liver mitochondria in
response to dioxins, furans, PCBs,
and biphenylenes.
J.P. Whitlock, Jr., Stanford University
School of Medicine, California:
TODD regulates cytochrome P,-
450 gene expression.
SESSION 5 BIOCHEMICAL CHANGES IN LIVER
Chairperson: J.B. Greig, MRC Toxicology Unit, Carshalton, England
S. Sassa, Rockefeller University, New
York, New York: Inhibition of uro-
porphyrinogen decarboxylase ac-
tivity in polyhalogenated aromated
hydrocarbon poisoning.
G.D. Sweeney, McMaster University,
Hamilton, Canada: Mechanisms
underlying the hepatotoxicity of
TCDD.
S.J. Stohs, University of Nebraska
Medical Center, Omaha: Induction
of lipid peroxidation and inhibition
of glutathione peroxidase by
TCDD.
A.B. Rifkind, Cornell University Medi-
cal Center, New York, New York:
The chick embryo as a model for
PCB and dioxin toxicity-Evidence
H.J. Eisen, National Institute of Child
Health and Human Development,
Bethesda, Maryland: The nuclear
TODD Ah receptor complex and
the induction of cytochrome P,-
450 mRNA.
of cardiotoxicity and increased
prostaglandin synthesis.
F. Matsumura, Michigan State Univer-
sity, East Lansing: Toxicological
significance of pleiotropic changes
of plasma membrane functions,
particularly that of EGF receptor
caused by TCDD.
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SESSION 6 LIPID METABOLISM AND WASTING DISEASE
Chairperson: R.E. Peterson, University of Wisconsin, Madison
R.E. Peterson, University of Wiscon-
sin, Madison: The wasting syn-
drome in TCDD toxicity-Basic
features and their interpretation.
S.D. Aust, Michigan State University,
East Lansing: On the mechanism
of anorexia and toxicity of TODD
and related compounds.
C.M. Schiller, National Institute of En-
vironmental Health Sciences, Re-
search Triangle Park, North Caro-
lina: Metabolic impairment
associated with a low dose of
TCDD in adult male Fischer rats.
T. Thunberg, Karolinska Institute,
Stockholm, Sweden: Effect of
SESSION 7 SKIN AND IN VITRO RESPONSES
Chairperson: E.E. McConnell, National Insitute of Environmental Health Sciences,
Research Triangle Park, North Carolina
R.D. Kimbrough, Centers for Disease
Control, Atlanta, Georgia: Skin le-
sions in animals and humans: A R.
brief overview.
W.F. Greenlee, Chemical Industry In-
stitute of Toxicology, Research Tri-
angle Park, North Carolina: Stud- J.
ies on the mechanisms of toxicity
of TCDD to human epidermis.
H. Rice, Harvard School of Public
Health, Boston, Massachusetts:
Response of malignant epidermal
keratinocytes to TCDD.
Knutson, University of Wisconsin,
SESSION 8 IMMUNOLOGICAL MECHANISMS
TCDD on vitamin A and its relation
to TCDD toxicity.
K.K. Rozman, University of Kansas
Medical Center, Kansas City: Role
of thyroid hormones and brown
adipose tissue in the toxicity of
TCDD.
Madison: XB cells-An in vitro
model for the differentiation and
proliferation response to TCDD.
J.B. Greig, MRC Toxicology Unit, Car-
shalton, England: Differences be-
tween skin and liver toxicity of
TCDD in mice.
Chairperson: J.G. Vos, National Institute of Public Health, Bilthoven, The Netherlands
J.G. Vos, National Institute of Public
Health, Bilthoven, The Nether-
lands: Dioxin-induced thymic atro-
phy and suppression of thymus-
dependent immunity.
M.I. Luster, National Institute of Envi-
ronmental Health Sciences, Re-
search Triangle Park, North Caro-
SESSION 9 EPIDEMIOLOGY
lina: In vivo and in vitro effects of
TCDD on stem cell and B cell dif-
ferentiation.
G.D. Sweeney, McMaster University,
Hamilton, Canada: Dose re-
sponse, time-course, and mecha-
nism for suppression of cytotoxic T
cell generation by TCDD.
Chairperson: N. Nelson, New York University Medical Center, New York
H. Falk, Centers for Disease Control,
Atlanta, Georgia: A pilot epidemio-
logic study of health effects due to
TCDD contamination in Missouri.
M.A. Fingerhut, National Institute for
Occupational Safety and Health,
Cincinnati, Ohio: An evaluation of
reports of dioxin exposure and
soft tissue sarcoma pathology in
U.S. chemical workers.
Risk Quantitation and Regulatory Policy
W.F. Greenlee, Chemical Industry In-
stitute of Toxicology, Research Tri-
angle Park, North Carolina: A pro-
posed model for the actions of
TCDD on epidermal and thymic
epithelial target cells.
G.D. Lathrop, Brooks Air Force Base,
San Antonio, Texas: An epidemio-
logic investigation of health effects
in Air Force personnel following
exposure to herbicides.
May 13-May 16
ARRANGED BY
D. Hoel, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina
R.A. Merrill, University of Virginia, Charlottesville
M.C. Pike, Imperial Cancer Research Fund, Oxford, England
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SESSION 1 REGULATORY PROGRAMS UTILIZING RISK ASSESSMENT
Chairperson: L.B. Lave, Carnegie-Mellon University, Pittsburgh, Pennsylvania
L.B. Lave, Carnegie-Mellon Univer-
sity, Pittsburgh, Pennsylvania:
Quantitative risk assessment in
regulation.
P.B. Hutt, Covington & Burling, Wash-
ington, D.C.: Use of quantitative
risk assessment in regulatory deci-
sion making under federal health
and safety statutes.
M.R. Taylor, King & Spalding, Wash-
ington, D.C.: The use of risk as-
sessment in food safety decision
making: The scope of FDA's dis-
cretion and the safeguards against
abuse.
R.A. Merrill, University of Virginia
School of Law, Charlottesville: The
significance of risk quantitation in
health and environmental regula-
tion.
SESSION 2 EPIDEMIOLOGY IN RISK ESTIMATION I
Chairperson: M.C. Pike, Imperial Cancer Research Fund, Oxford, England
M.C. Pike, Imperial Cancer Research
Fund, Oxford, England: Epide-
miology and risk assessment: Esti-
mation of GI cancer risk from as-
bestos in drinking water.
P. Landrigan, National Institute for Oc-
cupational Safety and Health, Cin-
cinnati, Ohio: Approaches to the
evaluation of dose in occupational
epidemiology.
SESSION 3 EPIDEMIOLOGY IN RISK ESTIMATION II
Chairperson: M.C. Pike, Imperial Cancer Research Fund, Oxford, England
J.M. Kaldor, International Agency for
Research on Cancer, Lyon,
France: The use of epidemiologi-
cal data for the assessment of hu-
man cancer risk.
J. Peto, Institute of Cancer Research,
Sutton, England: Limitations in the
quantitation of carcinogenic risk-
The asbestos data base.
SESSION 4 MODELING AND EXTRAPOLATION
Chairperson: R. Wilson, Harvard University, Cambridge, Massachusetts
M.D. Hogan, National Institute of En-
vironmental Health Sciences, Re-
search Triangle Park, North Caro-
lina: Risk estimation models in
epidemiology studies.
J. Van Ryzin, Columbia University
School of Public Health, New York,
New York: Consequences of non-
linear kinetic dose response
models on carcinogenic risk as-
sessment.
R. Wilson, Harvard University, Cam-
bridge, Massachusetts: Expres-
sion of uncertainty in risk assess-
ment.
SESSION 5 MUTAGENIC RISK IN HUMAN POPULATIONS
Chairperson: F.P. Perera, Columbia University School of Public Health, New York,
New York
M.F. Lyon, MRC Radiobiology Unit,
Harwell, England: Attempts to esti-
mate genetic risks caused by mu-
tagens to later generations.
J.V. Neel, University of Michigan
Medical School, Ann Arbor: How
do we get better human genetic
risk data, and how then do we use
the data?
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SESSION 6 TOXICOLOGY AND BIOLOGICAL MECHANISMS I
Chairperson: I.B. Weinstein, College
New York, New York
I.F.H. Purchase, Imperial Chemical In
dustries PLC, Macclesfield, Eng-
land: The toxicologist's contribu-
tion to risk quantitation.
R.L. Dedrick, National Institutes of
Health, Bethesda, Maryland: Ap-
plication of model systems in phar.
macokinetics.
of Physicians & Surgeons, Columbia University,
J.R. Gillette, National Institutes of
Health, Bethesda, Maryland: Bio-
logical variation: The unsolvable
problem in quantitative extrapola-
tions from laboratory animals and
other surrogate systems to human
populations.
SESSION 7 TOXICOLOGY AND BIOLOGICAL MECHANISMS II
Chairperson: B.D. Goldstein, Environmental Protection Agency, Washington, D.C.
I.B. Weinstein, College of Physicians
& Surgeons, Columbia University,
New York, New York: Relevance of
SESSION 8 SPECIFIC CASE HISTORIES
mechanisms of action of tumor
promoters to risk assessment.
R.H. Reitz, Dow Chemical Company,
F.P. Perera, Columbia University
School of Public Health, New York,
New York: Methods of measuring
biologically effective doses of car-
cinogenic substances-Monitoring
using DNA adducts.
Midland, Michigan: Mechanistic
considerations in the formulation
of carcinogenic risk estimations.
Chairperson: P.W. Preuss, Consumer Product Safety Commission, Bethesda, Maryland
J.A. Swenberg, Chemical Industry In-
stitute of Toxicology, Research Tri-
angle Park, North Carolina: A sci-
entific approach to formaldehyde
risk assessment.
M. Cohn, Consumer Product Safety
Commission, Bethesda, Maryland:
Risk assessment and the formal-
dehyde data base.
M. Corn, Johns Hopkins University,
Baltimore, Maryland: Human ex-
posure estimates in hazardous
waste site risk assessment.
B.D. Goldstein, Environmental Protec-
tion Agency, Washington, D.C.:
Risk assessment and risk manage-
ment of benzene by the EPA.
SESSION 9 RISK QUANTITATION AND THE DYNAMICS OF POLICY FORMULATION
Chairperson: R.S. Merrill, University of Virginia School of Law, Charlottesville
R.E. Albert, New York University Med- EPA's guidelines for carcinogen
ical Center, New York: Issues of risk assessment.
concern in the revision of the U.S. P.W. Preuss, Consumer Product
Yeast Expression Vectors
Safety Commission, Bethesda,
Maryland: The changing role of risk
assessment in Federal regulation.
June 21-June 24
ARRANGED BY
J. Strathern, Cold Spring Harbor Laboratory, New York
J.R. Broach, State University of New York, Stony Brook
SESSION 1 VECTORS
M.V. Olson, Washington University
School of Medicine, St. Louis, Mis-
souri
R. Rothstein, New Jersey Medical
School, Newark
S. Weisbrod, Cold Spring Harbor
Laboratory, New York
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K. Bloom, University of North Caro- V.A. Zakian, Fred Hutchinson Cancer
lina, Chapel Hill Research Center, Seattle, Wash-
R.W. Davis, Stanford University Medi- ington
cal Center, California
C.P. Hollenberg, Universitat Dussel-
dorf, Federal Republic of Germany
SESSION 2 PROMOTERS
L.P. Guarente, Massachusetts Insti-
tute of Technology, Cambridge
A. Hinnen, Ciba-Geigy AG, Basel,
Switzerland
F Sherman, University of Rochester
School of Medicine, New York
J. Hopper, Pennsylvania State Univer-
sity, Hershey
J.R. Broach, State University of New
York, Stony Brook
S. Fields, University of California, San
Francisco, School of Medicine
SESSION 3 PROMOTERS II
P. Silver, Harvard University, Cam-
bridge, Massachusetts
A. Kingsman, University of Oxford,
England
G.R. Fink, Massachusetts Institute of
Technology, Cambridge
K. Nasmyth, Laboratory of Molecular
Biology, Cambridge, England
SESSION 4 PROTEIN LOCALIZATION AND SECRETION
J. Thorner, University of California,
Berkeley
R.W. Schekman, University of Califor-
nia, Berkeley
SESSION 5 EXPRESSION SYSTEMS
R.A. Hitzeman, Genentech, Inc.,
South San Francisco, California
G.A. Bitter, Applied Molecular Ge-
S. Emr, California Institute of Technol-
ogy, Pasadena
G. Sprague, Jr., University of Oregon,
Eugene
netics, Inc., Thousand Oaks, Cali-
fornia
M. Duncan, Collaborative Research,
J. Abraham, California Biotechnology,
Inc., Palo Alto
L. Hereford, Dana-Farber Cancer In-
stitute, Boston, Massachusetts
K. Bostian, Brown University, Provi-
dence, Rhode Island
Inc., Lexington, Massachusetts
G. Ammerer, ZymoGenetics, Inc., Se-
attle, Washington
U.S. Environmental Protection Agency Workshop on "Possible
Short-term Evolutionary Consequences of Biotechnology"
August 28-August 31
ARRANGED BY
J.R. Fowle III, U.S. Environmental Protection Agency, Washington, D.C.
Chairperson: P. Regal, University of Minnesota, Minneapolis
PARTICIPANTS
D. Archer, Food and Drug Administra-
tion, Washington, D.C.
F. Betz, U.S. Environmental Protec-
tion Agency, Washington, D.C.
R. Bierbaum, Office of Technology
Assessment, Washington,
D.C.
A.W. Bourquin, U.S. Environmental
Protection Agency, Gulf Breeze,
Florida
J. Brown, University of Arizona, Tuc-
son
E. Carlson, State University of New
York, Stony Brook
R. Colwell, University of California,
Berkeley
M.A. Dane llo, Food and Drug Admin-
istration, Washington, D.C.
J.R. Fowle III, U.S. Environmental
Protection Agency, Washington,
D.C.
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M. Gough, Office of Technology As-
sessment, Washington, D.C.
L.L. Greenlee, Agrigenetics Corp.,
Boulder, Colorado
F Harris, National Science Founda-
tion, Washington, D.C.
A. Hollander, U.S. Environmental Pro-
tection Agency, Washington, D.C.
D. Kamely, U.S. Environmental Pro-
tection Agency, Washington, D.C.
D. Kaplan, Dow Chemical Company,
Midland, Michigan
National Institute of Mental Health Workshop
on "Single Unit Activity and Behavior"
R. Lensky, University of Massachu-
setts, Amherst
B.R. Levin, University of Massachu-
setts, Amherst
M. Levin, House Subcommittee on In-
vestigations and Oversight, U.S.
Congress, Washington, D.C.
M. Lloyd, University of Chicago, Illi-
nois
D. MacKenzie, Louisiana State Uni-
versity, Baton Rouge
B. McClintock, Cold Spring Harbor
Laboratory, New York
A. Mc Daniels, U.S. Environmental
Protection Agency, Washington,
D.C.
E Milewski, National Institutes of
Health, Washington, D.C.
S. Panem, U.S. Environmental Protec-
tion Agency, Washington, D.C.
J. Rissler, U.S. Environmental Protec-
tion Agency, Washington, D.C.
A. Rose, Department of Health and
Human Services, Washington,
D.C.
D Simberloff, Florida State University,
Tallahassee
Z. Vaituzis, U.S. Environmental Pro-
tection Agency, Washington, D.C.
September 9-September 11
ARRANGED BY
R. Schoenfeld, National Institute of Mental Health, Rockville, Maryland
Chairpersons: B.S. Bunney, Yale University School of Medicine, New Haven,
Connecticut
B.L. Jacobs, Princeton University, New Jersey
PARTICIPANTS
N. Bernick, National Institute of Men-
tal Health, Rockville, Maryland
M.R. De Long, Johns Hopkins Hospi-
tal, Baltimore, Maryland
P.S. Goldman-Rakic, Yale University
School of Medicine, New Haven,
Connecticut
M. Konishi, California Institute of
Technology, Pasadena
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S.H. Koslow, National Institute of
Mental Health, Rockville, Mary-
land
I. Kupfermann, College of Physicians
& Surgeons, Columbia University,
New York, New York
J.B. Ranck, State University of New
York, Downstate Medical Center,
Brooklyn
R. Schoenfeld, National Institute of
Mental Health, Rockville, Mary-
land
R.F. Thompson, Stanford University,
California
T.N. Wiesel, Rockfeller University,
New York, New York
D.J. Woodward, University of Texas
Health Science Center, Dallas
Alfred P. Sloan Foundation Computational
Neuroscience Workshop
September 28-September 30
ARRANGED BY
E. Wanner, Alfred P. Sloan Foundation, New York, New York
SESSION 1 VISION
Organizers: T. Poggio, Massachusetts Institute of Technology, Cambridge
T. Sejnowski, Johns Hopkins University, Baltimore, Maryland
PARTICIPANTS
D. Ballard, University of Rochester,
New York
H.B. Barlow, Cambridge University,
England
C. Gilbert, Rockefeller University,
New York, New York
D.A. Glaser, University of California,
Berkeley
E. Hildreth, Massachusetts Institute of
Technology, Cambridge
A.J. Movshon, New York University,
New York
G.F. Poggio, Johns Hopkins Univer-
sity School of Medicine, Baltimore,
Maryland
T. Poggio, Massachusetts Institute of
Technology, Cambridge
T Sejnowski, Johns Hopkins Univer-
sity, Baltimore, Maryland
C.F. Stevens, Yale University School
SESSION 2 VESTIBULO-OCULAR PROCESSING
Organizer: D.A. Robinson, Johns Hopkins Hospital, Baltimore, Maryland
PARTICIPANTS
A.F. Fuchs, University of Washington,
Seattle
H. Galiana, McGill University, Mon-
treal, Canada
E.L. Keller, Medical Research Institute
of San Francisco at Pacific Medi-
cal Center, California
G.E. Loeb, National Institute of Neu-
SESSION 3 MOTOR CONTROL
rological and Communicative Dis-
orders and Stroke, Bethesda,
Maryland
L.M. Optican, National Eye Institute,
Bethesda, Maryland
D.A. Robinson, Johns Hopkins Hospi-
tal, Baltimore, Maryland
Organizers: E. Bizzi, Massachusetts Institute of Technology, Cambridge
J.M. Hollerbach, Massachusetts Institute of Technology, Cambridge
PARTICIPANTS
E. Bizzi, Massachusetts Institute of
Technology, Cambridge
E.V. Evarts, National Institutes of
Health, Bethesda, Maryland
L. Finkel, Rockefeller University, New
York, New York
C. Ghez, College of Physicians & Sur-
geons, Columbia University, New
York, New York
N. Hogan, Massachusetts Institute of
Technology, Cambridge
J.M. Hollerbach, Massachusetts Insti-
tute of Technology, Cambridge
J.C. Houk, Northwestern University,
Chicago, Illinois
R.W. Mann, Massachusetts Institute of
Technology, Cambridge
M.H. Raibert, Carnegie-Mellon Uni-
versity, Pittsburgh, Pennsylvania
of Medicine, New Haven, Con-
necticut
V. Torre, Universita di Genova, Italy
S. Ullman, Massachusetts Institute of
Technology, Cambridge
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Genetic Manipulation of the Mammalian Ovum and Early Embryo
October 7-October 10
ARRANGED BY
F. Costantini, Columbia University, New York, New York
R. Jaenisch, Heinrich-Pette-Institut, Hamburg, Federal Republic of Germany
SESSION 1 DEVELOPMENTAL GENETICS
Chairperson: L. Silver, Princeton University, New Jersey
L. Silver, Princeton University, New
Jersey: The origin and evolution of
mouse t haplotypes.
V.E. Chapman, Roswell Park Memo-
rial Institute, Buffalo, New York: X-
chromosome regulation in female
mammals.
S.M. Tilghman, Fox Chase Cancer
Center, Philadelphia, Pennsylva-
nia: Tissue-specific expression of
cloned AFP genes in cells and
mice,
M.J. Evans, University of Cambridge,
England: EK cell contribution to
chimaeric mice: From tissue cul-
ture to sperm.
D. Solter, The Wistar Institute of Anat-
omy and Biology, Philadelphia,
Pennsylvania: Capacity of nuclei
from preimplantation mouse em-
bryos to support normal develop-
ment.
A. Surani, Institute of Animal Physiol-
ogy, Cambridge, England: Regula-
tion of embryogenesis by maternal
and paternal genomes in the
mouse.
SESSION 2 ENDOGENOUS VIRUSES AND VIRAL VECTORS
Chairperson: P.W.J. Rigby, Imperial College of Science and Technology, London,
England
N.A. Jenkins, University of Cincinnati
College of Medicine, Ohio: Insta-
bility of ecotropic proviruses in RF/
J-derived hybrid mice.
N.G. Copeland, University of Cincin-
nati College of Medicine, Ohio:
Molecular genetic approaches to
the study of murine lymphoid cell
neoplasms.
R. Jaenisch, Heinrich -Pette- Institut,
Hamburg, Federal Republic of
Germany: Recombinant viral
probes of gene regulation and
methylation patterns in the mouse.
SESSION 3 INTRODUCTION OF CLONED GENES INTO THE MAMMALIAN
GERM LINE I
Chairperson: F.H. Rudd le, Yale University, New Haven, Connecticut
R.L. Brinster, University of Pennsylva-
nia, Philadelphia: Introduction of
SV40 genes into mice.
R.D. Palmiter, University of Washing-
ton, Seattle: Expression of growth-
hormone genes in mice.
D. Hanahan, Cold Spring Harbor
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Laboratory, New York: Expression
of insulin-SV40 T-antigen hybrid
genes in transgenic mice.
T.A. Stewart, Genentech, Inc., South
San Francisco, California: Trans-
genic mice carrying MTV/myc fu-
K. Willison, Chester Beatty Labora-
tory, London, England: Haploid
gene expression and the mouse t
complex.
E. F. Wagner, European Molecular Bi-
ology Laboratory, Heidelberg,
Federal Republic of Germany: In-
troducing and expressing genes in
stem cells and mice.
sion genes develop mammary ad-
enocarcinomas.
R. Evans, Salk Institute, San Diego,
California: Novel tissue-specific
expression of growth-hormone
genes in transgenic animals.
SESSION 4 INTRODUCTION OF CLONED GENES INTO THE MAMMALIAN
GERM LINE II
Chairperson: A.J. Levine, Princeton University, New Jersey
F Costantini, Columbia University, expression of human HPRT in
New York, New York: Regulated CNS of transgenic mice.
expression of a foreign (3-globin D.C. Kraemer, Texas A&M University,
gene in transgenic mice. College Station: Gene transfer in
D. Baltimore, Massachusetts Institute cattle and sheep.
of Technology, Cambridge: Tissue- C. Polge, Institute of Animal Physiol-
specific expression of immuno- ogy, Cambridge, England: Gene
globulin genes in transgenic mice transfer approaches in farm ani-
and cultured cells. mall.
U. Storb, University of Washington,
Seattle: Expression of a microin-
jected immunoglobulin x gene in
transgenic mice.
C.T. Caskey, Baylor College of Medi-
cine, Houston, Texas: Elevated
SESSION 5 NONMAMMALIAN SYSTEMS
Chairperson: E. Davidson, California Institute of Technology, Pasadena
E. Davidson, California Institute of
Technology, Pasadena: Transfer
and expression of cloned se-
quences in the sea urchin embryo.
J. Newport, University of California,
San Diego: Nuclear formation in
the Xenopus embryo.
D.T. Stinchcomb, Harvard University,
Cambridge, Massachusetts: DNA
transformation of C. elegans; ex-
trachromosomal arrays are repli-
cated, segregated, and ex-
pressed.
T Maniatis, Harvard University, Cam-
bridge, Massachusetts: Analysis of
Drosophila alcohol dehydrogen-
ase gene expression by P-element
transformation.
Gap Junctions
October 21-October 24
ARRANGED BY
M.V.L. Bennett, Kennedy Center, Bronx, New York
SESSION 1 STRUCTURE
Chairperson: M.V.L. Bennett, Kennedy Center, Bronx, New York
L. Makowski, College of Physicians & domains in gap junctions and im-
Surgeons, Columbia University, plications for gating.
New York, New York: Structural G. Zampighi, University of California,
Los Angeles, School of Medicine:
Structure of lens and liver junc-
tional proteins.
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R. Hanna, State University of New
York College of Environmental Sci-
ence and Forestry, Syracuse, New
York: Fast-frozen gap junctions.
S.B. Yancey, and J. -P. Revel, Califor-
SESSION 2 BIOCHEMISTRY
Chairperson: J.-P. Revel, California
E.L. Hertzberg, Baylor College of
Medicine, Houston, Texas: Tissues
and species specificity of gap
junctional proteins.
K. Willecke, Universitat Essen, Fed-
eral Republic of Germany: Immu-
nochemical characterization of
gap junction protein from different
mammalian tissues.
SESSION 3 BIOPHYSICS
nia Institute of Technology, Pasa-
dena: Organization of junctional
proteins in the membrane as de-
duced from sequence data.
Institute of Technology, Pasadena
M. Finbow, Beatson Institute for Can-
cer Research, Glasgow, Scotland:
Tissue, species, and phylogenetic
variation of gap junctional pro-
teins.
R.G. Johnson, University of Minne-
sota, St. Paul: Lens junctions-
Antibodies to and phosphorylation
of MP26.
Chairperson: R. Llinas, New York University Medical Center, New York
P Brink, State University of New York,
Stony Brook: Solvent effects on
junctional permeability.
D.C. Spray, Kennedy Center, Bronx,
New York: Gating by voltage and
chemical agents.
F. Ramon, Centro de Investlgacion y
de Estudios Avanzados Del IPN,
SESSION 4 CONTROL OF FORMATION
J.
J.
Mexico City, Mexico: Physiological
control mechanisms.
Wojtchak, Rockefeller University,
New York, New York: Electrical un-
coupling induced by general an-
esthetics-A calcium independent
process?
E. Hall, University of California, Ir-
Chairperson A. Warner, University College London, England
J. Sheridan, University of Minnesota,
Minneapolis: Altered junctional
permeability between virally trans-
formed cells.
J.D. Pitts, Beatson Institute for Can-
cer Research, Glasgow, Scotland:
Tissue specificity.
W. Coles, McMaster University, Hamil-
ton, Canada: Alterations in cou-
pling in uterine muscle.
J. Kessler, Kennedy Center, Bronx,
New York: Coupling between cul-
tured vertebrate neurons.
S.B. Kater, University of Iowa, Iowa
City: Specificity of coupling at mol-
luscan neurons.
SESSION 5 ROLE IN INTERCELLULAR COMMUNICATION AND DEVELOPMENT
E. Page, University of Chicago, Illi-
nois: Structure and protein com-
position of cardiac gap junctions.
D. Paul, Harvard University Medical
School, Boston, Massachusetts:
Proteolytic cleavage of junctional
proteins from lens and liver.
vine: Channel reconstitution from
junctional proteins.
C. Peracchia, University of Rochester
Medical School, New York: Phos-
phorylation and reconstitution of
lens junctions.
Chairperson: J.D. Pitts, Beatson Institute for Cancer Research, Glasgow, Scotland
C.W. Lo, University of Pennsylvania,
Philadelphia: Compartmentaliza-
tion in embryos.
S. Caveney, University of Western On-
tario, London, Canada: Control of
molecular movement within and
between developmental compart-
ments.
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A. Warner, University College Lon-
don, England: Antibodies to gap
junction proteins-Probes for
studying development.
W.J. Larsen, University of Cincinnati
College of Medicine, Ohio: Rela-
tionships of gap junction modula-
tion to cell and tissue function.
W. Beers, New York University, New
York: Gap junctions and ovulation.
O.H. Petersen, University of Liver-
pool, England: Communication in
secretory epithelia.
SESSION 6 ELECTROTONIC SYNAPSES
Chairperson: D.C. Spray, Kennedy Center, Bronx, New York
F.E. Dudek, Tulane University School
of Medicine, New Orleans, Louisi-
ana: Electrical interactions and
synchronization of hippocampal
neurons-Electrotonic coupling
vs. field effects.
R. Llinas, New York University Medi-
cal Center, New York: Functional
significance of coupling in the
inferior olive.
M.V.L. Bennett, Kennedy Center,
Bronx, New York: Interactions
among chemical and electrotonic
synapses.
C. Giaume, Institut Pasteur, Paris,
France: The rectifying electrotonic
synapse of crayfish.
H.M. Gerschenfeld and J. Neyton,
Eco le Norma le Superieure, Paris,
France: Dopaminergic control of
coupling between horizontal cells.
E. Lasater and J. Dowling, Harvard
University, Cambridge, Massachu-
setts: Characteristics of coupling
between pairs of cultured horizon-
tal cells.
Transport and Secretion of Proteins
November 7-November 10
ARRANGED BY
M.-J. Gething, Cold Spring Harbor Laboratory, New York
SESSION 1 TRANSLOCATION OF PROTEINS ACROSS THE LIPID BILAYER
Chairperson: G. Blobel, Rockefeller University, New York, New York
P. Walter, University of California, San
Francisco: Targeting of nascent
secretory proteins to the endo-
plasmic reticulum membrane.
D. Meyer, European Molecular Biol-
ogy Laboratory, Heidelberg, Fed-
eral Republic of Germany: Factors
mediating protein translocation in
the endoplasmic reticulum -The
docking protein and beyond.
R. Gilmore, Rockefeller University,
New York, New York: Evidence for
the existence of a signal receptor
in the microsomal membrane.
S. Benson, Princeton University, New
Jersey: Intragenic information re-
quired for the export of LamB to
the outer membrane of E. coli.
W. Wickner, University of California,
Los Angeles, School of Medi-
cine-Mechanisms of bacterial
cell-surface assembly.
S. Ferro-Novick, Harvard Medical
School, Boston, Massachusetts:
Genetic evidence for the coupling
of the synthesis and secretion of
proteins in E. coli.
M. Inouye, State University of New
York, Stony Brook: Functional and
structural analysis of the signal
peptide.
C. Kaiser, Massachusetts Institute of
Technology, Cambridge: Muta-
tions in the signal sequence affect-
ing the localization of invertase.
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SESSION 2 TRANSPORT FROM THE ENDOPLASMIC RETICULUM TO THE PLASMA
MEMBRANE
Chairperson: H.F. Lodish, Whitehead Institute for Biomedical Research, Cambridge,
Massachusetts
I. Schauer, University of California,
Berkeley: Invertase sequence sub-
stitutions interfere with transport of
active enzyme from the ER.
J. Sambrook, Cold Spring Harbor
Laboratory, New York: How to get
SV40 T antigen into membranes.
J. Rose, Salk Institute, San Diego,
California: Redesigning transport
signals in the VSV glycoprotein.
P Berman, Genentech, Inc., South
San Francisco, California: Pro-
cessing and export of membrane-
bound and secreted forms of
cloned HSV-1 glycoprotein D in
continuous cell lines.
M.-J. Gething, Cold Spring Harbor
Laboratory, New York: Site-di-
rected mutagenesis of the hemag-
glutinin of influenza virus-Effects
on transport through the cell.
A. Brake, Chiron Corporation, Emery-
SESSION 3 STRUCTURES INVOLVED IN TRANSPORT AND ENDOCYTOSIS
Chairperson: G.E. Pa lade, Yale University School of Medicine, New Haven,
Connecticut
P.W. Robbins, Massachusetts Institute I. Mellman, Yale University School of
of Technology, Cambridge: Protein Medicine, New Haven, Connecti-
glycosylation. cut: Fc receptor transport, proton
M.G. Farquahar, Yale University transport, and the control of intra-
School of Medicine, New Haven, cellular membrane traffic.
Connecticut: Receptor traffic to G. Warren, European Molecular Biol-
Golgi subcompartments. ogy Laboratory, Heidelberg, Fed-
W.S. Sly, St. Louis University School eral Republic of Germany: Recon-
of Medicine, Missouri: Mannose-6- struction of an endocytic fusion
P receptor-mediated sorting and event in a cell-free system.
transport of lysosomal enzymes. S. Schmid, Stanford University School
SESSION 4 DIRECTED TRANSPORT I
Chairperson: D. Sabatini, New York University Medical Center, New York
D. Sabatini, New York University Med-
ical Center, New York: Intracellular
sorting and distinct recycling pat-
terns of viral glycoproteins in po-
larized epithelial cells.
K. Mostov, Whitehead Institute for
Biomedical Research, Cambridge,
Massachusetts: Transepithelial
transport of IgA and IgM.
H.-P. Moore, University of California,
San Francisco: Sorting and trans-
port of proteins in regulated secre-
tory cells.
J.-P. Kraehenbuhl, University of Lau-
sanne, Switzerland: Biogenesis of
(Na,,K+)-ATPase in ion-transport-
ing epithelia.
D. Louvard, Institut Pasteur, Paris,
France: Basolateral membrane
protein markers are expressed at
the surface of undifferentiated pre-
cursors of enterocytes in vitro,
whereas transport of apical mark-
ers is abortive.
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ville, California: Sequence of two
genes encoding precursors to the
yeast peptide mating pheromone
a factor.
J. Thorner, University of California,
Berkeley: Cell biology and enzy-
mology of the specific endopepti-
dase required for processing of
yeast precursor proteins at pairs
of basic residues.
of Medicine, California: Enzymatic
recycling of clathrin from coated
vesicles.
P.C. Tai, Boston Biomedical Research
Institute, Massachusetts: Clathrin
in B.subtilis? Bacterial protein
translocation.
E. Rodriguez-Boulan, Cornell Univer-
sity Medical College, New York,
New York: Vectorial exocytosis of
plasma membrane glycoproteins
in epithelial cells.
K. Simons, European Molecular Biol-
ogy Laboratory, Heidelberg, Fed-
eral Republic of Germany: Sorting
of apical and basolateral proteins
in MDCK cells,
SESSION 5 DIRECTED TRANSPORT II
Chairperson: D. Botstein, Massachusetts Institute of Technology, Cambridge
S.D. Emr, California Institute of Tech-
nology, Pasadena: Use of gene fu-
sions to study protein traffic in
yeast.
T.H. Stevens, University of Oregon,
Eugene: Yeast mutants defective
in the sorting of vacuolar proteins.
M.N. Hall, University of California,
San Francisco: Studies on the
mechanism of nuclear protein lo-
calization in yeast.
E.C. Hurt, University of Basel, Switz-
erland: Import of proteins into mi-
tochondria.
J. Kaput, Rockefeller University, New
York, New York: Trans location of
nuclearly encoded mitochrondrial
proteins translated from SP6-pro-
moted transcripts.
M.G. Douglas, University of Texas
Health Sciences Center, San Anto-
nio: The biochemistry and ge-
netics of protein import into mito-
chondria.
Journalists' Workshop on "Assessing Health Risk Assessment"
November 28-November 30
ARRANGED BY
M. Shodell, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1
D.P. Rall, National Institute of Environ-
mental Health Sciences, Research
Triangle Park, North Carolina: An
introduction to the principles of
risk assessment.
J.A. Swenberg, Chemical Industry In-
stitute of Toxicology, Research Tri-
angle Park, North Carolina:
Models in biological risk assess-
ment.
SESSION 2
I.C.T. Nisbet, Clement Associates,
Inc., Arlington, Virginia: Assessing
the models used for assessing
risk.
F.P. Perera, Columbia University
School of Public Health, New York,
New York: New approaches in risk
assesssment.
SESSION 3
R.E. Albert, New York University Med-
ical Center, New York, New York:
Risk assessment in the regulation
of carcinogens.
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Recto: James laboratory, erected in 1929, houses the Laboratory's tumor virology program
and a number of summer postgraduate research courses. The Annex (shown here), built in
1971, contains offices, a seminar room, and a library.
Postgraduate Courses
The summer program of Postgraduate Courses at Cold Spring Harbor Labora-
tory is aimed at meeting the special need for training in interdisciplinary subjects
that are either so new or so specialized that they are not adequately treated by
universities. Our aim is to provide intensive study in the most recent develop-
ments and techniques in these subjects and to prepare students to enter directly
into research in a particular area. To ensure up-to-date coverage of current re-
search work, we bring together a workshop staff from many laboratories around
the world and supplement this staff with a series of seminar speakers.
Immunoglobulins: Molecular Probes of the Nervous System
June 8-June 28
INSTRUCTORS
Hockfield, Susan, Ph.D., Cold Spring Harbor Laboratory, New York
Kintner, Chris, Ph.D., Medical Research Council, Kings College London, England
Silbertstein, Laura, Ph.D., Stanford Medical Center, California
Weber Eckard, M.D., Stanford Medical School, California
ASSISTANT
Evans, Chris, Ph.D., Stanford University, California
Over the last decade, antibodies have become powerful and popular reagents in
neurobiological research. This course, intended for research scientists of all lev-
els, was designed to provide an advanced understanding of the power and limi-
tations of immunoglobulins both as biochemical and anatomical reagents.
Through laboratory work and lectures, we explored immunochemical and immu-
nohistochemical techniques in detail and the application of these techniques to
current issues in neurobiology.
The laboratory work included: generation of monoclonal antibodies; prepara-
tion and characterization of antibodies to synthetic peptides and to complex anti-
gens; solid-phase immunoassays; antibody characterization and purification; an-
tigen purification using antibody affinity methods; Western blotting; antibody
conjugation; biochemical characterization of neuropeptides using R IA; light and
electron microscopic immunohistochemistry using peroxidase, fluorescence, and
biotin-avidin techniques; and methods for the colocalization of multiple anti-
bodies.
A series of lectures by invited speakers covered: structure and function of im-
munoglobulins; molecular genetics of antibody diversity; cellular regulation of the
immune response; hybridoma technology; studies using synthetic peptides; im-
munological characterization of the acetylcholine receptor and the neuromuscu-
lar junction; and immunological characterization of cellular diversity in vertebrate
and invertebrate nervous systems and in cell culture.
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PARTICIPANTS
Drysdale, Rachel A., B.A., University
of Wisconsin, Madison
Flanagan, Thomas R., Ph.D., Cold
Spring Harbor Laboratory, New
York
Kalil, Katherine, Ph.D., University of
Wisconsin, Madison
Messing, Albee, Ph.D., University of
Pennsylvania School of Medicine,
Philadelphia
Milner, Teresa Ann, Ph.D., Cornell
University School of Medicine,
New York, New York
Ridgway, Richard L., Ph.D., Washing-
ton State University, Pullman
Simonds, William F., M.D., National In-
stitutes of Health, Bethesda, Mary-
land
Thompson, Wesley J., Ph.D., Univer-
sity of Texas, Austin
Treiman, Marek, M.D., Rockefeller
University, New York, New York
Wahle, Petra, Msc., Max-Planck-Insti-
tut fOr Biophysikalische Chemie,
Frankfurt, Federal Republic of
Germany
SEMINARS
Wilson, D., University of Pennsylva-
nia. Cellular immunology.
lmmanishi-Karl, T., Massachusetts In-
stitute of Technology. Molecular
immunology.
Davis, D., National Institutes of
Health. 3-D structure of immuno-
globulins.
Lindstrom, J., Salk Institute. Using
monoclonal antibodies to study
acetylcholine receptors.
Burden, S., Massachusetts Institute of
Technology. Subsynaptic protein
at nerve-muscle synapses.
Matthews, B., Harvard Medical
School. Monoclonal antibodies
used to study neurite-promoting
factors.
Hendry, S., University of California, Ir-
Molecular Biology of Plants
vine. Immunocytochemical studies
of the mammalian cerebral cortex.
Jessel, T., Harvard University Medical
School. Probes for mammalian
dorsal root ganglion cells.
Pickel, V., Cornell University School of
Medicine. Use of combined immu-
nocytochemical techniques for the
localization of more than one anti-
gen.
Karten, H., State University of New
York, Stony Brook. Immunochemi-
cal analysis of the retina.
June 8-June 28
INSTRUCTORS
Malmberg, Russell, Ph.D., Cold Spring Harbor Laboratory, New York
Messing, Joachim, Ph.D., University of Minnesota, St. Paul
Sussex, Ian, Ph.D., Yale University, New Haven, Connecticut
ASSISTANTS
Boylan, Margaret, Ph.D., Yale University, New Haven, Connecticut
Mclndoo, Jean, B.S., Cold Spring Harbor Laboratory, New York
Zarowitz, Michael, Ph.D., University of Minnesota, St. Paul
This course provided an introduction to current techniques for the manipulation
of plant material as applied to experiments in molecular biology and genetics. It
was designed primarily for scientists working in other areas who wish to pursue
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research in plants. It was assumed that applicants had a general working knowl-
edge of molecular biology, but no previous experience with plants was required.
Experiments were designed to emphasize aspects unique to plant systems, in-
cluding mutagenesis and analysis of mutants, tissue-culture techniques, proto-
plast isolation and culture, regeneration of plants from culture, DNA and RNA
isolation and cloning procedures, crown gall tumorigenesis, chloroplast genetics,
and nitrogen fixation. Guest lecturers provided a background in plant morphoge-
nesis, physiology, pathology, genetics, and cytology. Different plant species were
used to illustrate particular experimental techniques, but the course emphasized
tobacco and maize as model systems.
PARTICIPANTS
Avivi, Aaron A., Ph.D., Weizmann In-
stitute of Science, Rehovot, Israel
Choi, Cha Yong, Ph.D., Seoul Na-
tional University, Korea
DasSarma, Shiladitya, B.S., Massa-
chusetts Institute of Technology,
Cambridge
De Block, M., Ph.D., Rijksuniversiteit
Gent, The Netherlands
Dilworth, Machi F., U.S. Department
of Agriculture, Washington, D.C.
Dynan, William S., Ph.D., University of
California, Berkeley
Hille, Jacques, Ph.D., University of
Wageningen, The Netherlands
Jones, Davy, Ph.D., University of Ken-
tucky, Lexington
Kakidani, Hitoshi, Ph.D., Sagami
Chemical Research Center, Japan
Lammers, Peter ,J., Ph.D., University
of Chicago, Illinois
Lee, Nancy, Ph.D., Interferon Sci-
ences, Inc., New Brunswick, New
Jersey
Mindrinos, Michael N., Ph.D., Boston
College, Massachusetts
Peterson, Thomas A., B.S., University
of California, Davis
Sugar, Anurag, M.S., Rockefeller Uni-
versity, New York, New York
Tavantzis, Stellos M., Ph.D., Univer-
sity of Maine, Orono
Thirion, J.-P, Ph.D., Centre Hospital-
ier Universitaire, Sherbrooke, Can-
ada
SEMINARS
van Montagu, M., Rijksuniversiteit
Gent. Agrobacterium and crown
gall disease.
Sims, T, University of California, Los
Angeles. Soybean embryonic
genes.
Gengenbach, B., University of Minne-
sota. Embryogenesis in Zea tissue
cultures.
. Mutant selection in Zea tissue
cultures.
Broglie, R., L. Hanley-Bowdoin, Rock-
efeller University. Nuclear and
chloroplast gene regulation.
Walbot, V., Stanford University. Devel-
opmental genetics of maize.
Long, S., Stanford University. Rhizo-
bium-legume developmental ge-
netics.
Quail, P, University of Wisconsin.
Phytochrome gene expression.
Lonsdale, D., Plant Breeding Institute.
The mitochondrial genome.
Crouch, M., University of Indiana.
Compatibility/incompatibility sys-
tems.
Phillips, R., University of Minnesota.
Somaclonal variation.
. Cytogenetics of plant cells in
culture.
Ellingboe, A., University of Wisconsin,
Genetics of plant-pathogen inter-
actions.
Hanson, M., University of Virginia. Or-
ganelle genetics.
Ho, D., Washington University. Hor-
mone response mutants.
Palukaitis, P, Cornell University. Plant
viruses.
Miles, D., University of Missouri. Pho-
tosynthesis.
Donner, H., Advanced Genetic Sci-
ences. Controlling elements of
maize.
Binns, A., University of Pennsylvania.
Biology of transformed plants.
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Molecular Cloning of Eukaryotic Genes
June 8-June 28
INSTRUCTORS
Bothwell, Al, Ph.D., Yale Medical School, New Haven, Connecticut
Alt, Fred, Ph.D., Columbia University College of Physicians & Surgeons, New York, New
York
Mullins, James, Ph.D., Harvard School of Public Health, Boston, Massachusetts
ASSISTANTS
LeClair, Ken, B.A., Yale Medical School, New Haven, Connecticut
Yancopoulos, George, B.A., Columbia University, New York, New York
Bruck, Claudine, Ph.D., Harvard Medical School, Boston, Massachusetts
This laboratory and lecture course covered the principles of recombinant DNA
technology and the application of these procedures to the study of eukaryotic
genes. The isolation and characterization of lymphocyte-specific genes were em-
phasized. Among the topics covered were: construction of cDNA libraries in
plasmid or bacteriophage A vectors, construction of bacteriophage A and cosmid
libraries of high-molecular-weight eukaryotic DNA, screening DNA libraries with
gene-specific hybridization probes and by recombination, purification, and char-
acterization of recombinant clones using restriction endonuclease and blot hy-
bridization analyses, and reintroduction and expression of cloned genes in heter-
ologous systems. Strategies for isolating genes that encode rare mRNA
sequences were discussed. Guest lecturers discussed the application of molecu-
lar cloning procedures to the study of specific eukaryotic gene systems.
PARTICIPANTS
Bignami, Margherita, Ph.D., Istituto
Superiore Di Sanita, Rome, Italy
Binninger, Dorothea, M.S., Paul-Ehr-
lich-Institut, Frankfurt, Federal Re-
public of Germany
Cox, Diane W., Ph.D., Hospital for
Sick Children, Toronto, Canada
Crittenden, Lyman B., Ph.D., USDA
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Regional Poultry Research Labo-
ratory, East Lansing, Michigan
Foster, Patricia L., Ph.D., Boston Uni-
versity School of Public Health,
Massachusetts
Iscove, Norman N., Basel Institute for
Immunology, Switzerland
Jalkanen, Markku T., Ph.D., Stanford
University Medical Center, Califor-
nia
Kasuga, Masato, M.D., University of
Tokyo, Japan
Lever, Julia E., Ph.D., University of
Texas Medical School, Houston
Nelson, David L., M.D., National Can-
cer Institute, Bethesda, Maryland
ole-MoiYoi, Onesmo, M.D., Interna-
tional Laboratories for Research
on Animal Diseases, Nairobi,
Kenya
Prusiner, Stanley B., M.D., University
of California, San Francisco
Remold, Heinz G., Ph.D., Harvard
Medical School, Boston, Massa-
chusetts
Schuurmann, R.K.B., Ph.D., Univer-
sity Hospital Leiden, The Nether-
lands
Sidman, Charles L., Ph.D., Jackson
Laboratory, Bar Harbor, Maine
Zingales, Bianca, D.Sc., Institute De
Quimica, Brazil
SEMINARS
Lehrach, H., EMBL. Molecular clon-
ing of the T Locus.
Botstein, D., Massachusetts Institute
of Technology. Reverse genetics:
cloning of cytoskeletal genes.
Goff, S., Columbia University. In vitro
mutagenesis of retroviral genes.
Reth, M., Columbia University. Anti-
bodies and Western blotting.
Baltimore, D., Massachusetts Institute
of Technology. Expression of Ig
genes introduced into the germ-
line.
Miyada, G., City of Hope Hospital.
Use of synthetic oligonucleotides
for cloning and expression of mu-
rine MHC genes.
Lacy, E., Memorial Sloan-Kettering
Cancer Center. Gene transfer into
mice.
Rubin, J., University of California,
Berkeley. P- element -mediated
gene transfer in Drosophila.
Schimke, B., Stanford University. Mo-
lecular mechanisms of gene am-
plification.
Maniatis, T., Harvard University. Glo-
bin gene transcription and RNA
splicing.
Schwarzbauer, J., Massachusetts In-
stitute of Technology.Transfer of
genes into hematopoeitic stem
cells.
Seed, B., Massachusetts General
Hospital. Recovery and manipula-
tion of recombinant DNA in vivo.
Neurobiology of Human Disease
Gluzman, Y., Cold Spring Harbor Lab-
oratory. Eukaryotic cloning vec-
tors.
Hughes, S., Frederick Cancer Re-
search Facility. Oncogenes.
Messing, J., University of Minnesota.
M13 vectors.
McKnight, S., Hutchinson Cancer Re-
search Institute. Regulation of
transcription.
Wahl, G., Salk Institute. Gene transfer
technology.
Hamyln, J., University of Virginia. Iso-
lation of eukaryotic origins of repli-
cation.
Mullins, J., Harvard School of Public
Health. FeLV, AIDS, and HTLV.
Ruley, E., Cold Spring Harbor Labora-
tory. Transformation and oncoge-
nesis.
Wig ler, M., Cold Spring Harbor Labo-
ratory. Yeast RAS genes.
Szostak, J., Dana-Farber Cancer Insti-
tute. Replication and segregation
of linear chromosomes in yeast.
June 8-June 17
INSTRUCTORS
Breakfield, Xandra 0., Ph.D., E.K. Shriver Center and Harvard Medical School, Boston,
Massachusetts
Black, Ira B., M.D., Cornell University School of Medicine, New York, New York
Gusella, James, Ph.D., Massachusetts General Hospital, Boston
This intensive seminar course explored the molecular and cellular basis of abnor-
mal neural function. It focused on basic scientific studies that have provided in-
sight into the etiology and pathogenesis and neurologic and psychiatric dis-
eases. Topics included: (1) molecular pathology of neurotransmitter
derangement; (2) developmental plasticity and choice of neurotransmitter pheno-
type; (3) synthesis and regulation of neuropeptides; (4) cellular events in neural
regeneration and brain transplantation; (5) neural pathways involved in pain syn-
dromes; (6) genetic linkage analysis using DNA polymorphisms; (7) defects in
DNA repair and activation of one genes; (8) biochemistry of the lipidoses; (9) au-
toimmune diseases; (10) brain imaging and metabolism; (11) epilepsy and sei-
zure disorders; (12) cell death in degenerative disorders; (13) viral infections of
the nervous system; and (14) experimental models of learning and memory.
PARTICIPANTS
Arias, Clorinda, M.D., Universidad
Nacional Autonoma de Mexico,
Mexico City
Bellini, Fabrizio, Ph.D., Fidia Re-
search Laboratories, Terme, Italy
Cambi, Franca, M.D., E.K. Shriver
Center, Harvard Medical School,
Boston, Massachusetts
Desan, Paul, Ph.D., Harvard Medical
School, Boston, Massachusetts
Foxman, Brett T, M.D., Cornell Medi-
cal Center, New York, New York
Kagan, Bruce L., Ph.D., University of
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California Neuropsychiatric Insti-
tute, Los Angeles
Kremer, Norbert E., Ph.D., State Uni-
versity of New York, Stony Brook
Kurlan, Roger M., M.D., University of
Rochester Medical Center, New
York
Maehlen, Jan, M.D., Institute of Neu-
rophysiology, Oslo, Norway
Mangun, George R., B.S., University
of California, San Diego
Moroi, Sayoko E., B.A., Medical
Administration Center, Columbus,
Ohio
Nakajima, Gene A., M.D., Johns Hop-
kins Medical School, Baltimore,
Maryland
Oliver, Eugene J., Ph.D., National In-
stitutes of Health, Bethesda, Mary-
land
Sanes, Dan H., M.A., Princeton Uni-
versity, New Jersey
Segal, Rosalind A., B.A., Rockefeller
University, New York, New York
Sims, Stephen J., B.A., Downstate
Medical Center, New York, New
York
Singh, Dyal N.P., Ph.D., University of
Alberta, Canada
SEMINARS
Gage, F., Lund University. Brain trans-
plantation.
Aguayo, A., Montreal General Hospi-
tal. Neural regeneration.
Norwich, A., Yale University School of
Medicine. Molecular genetic ap-
proaches to organic acidemias.
Sokoloff, L., National Institute of Men-
tal Health. Brain metabolism and
imaging.
Advanced Bacterial Genetics
Phelps, M., University of California
Medical School, Los Angeles.
Brain metabolism and imaging.
Coyle, J., Johns Hopkins University
School of Medicine. Movement
disorders and degenerative dis-
eases: experimental models.
Wexler, N., Hereditary Disease Foun-
dation. Huntington's disease in
Venezuela.
Ginns, E., National Institutes of
Health. Lipidoses.
Basbaume, A., University of Califor-
nia, San Francisco. Pain syn-
dromes and neuropeptides.
Jessell, T, Harvard Medical School.
Pain syndromes and neuropep-
tides.
Herbert, E., University of Oregon.
Neuroendocrinology.
Lindstrom, J., Salk Institute. Autoim-
mune diseases: myasthenia
gravis.
McNamara, J., Duke University Medi-
cal Center. Epilepsy and seizure
disorders,
Crill, W., University of Washington
School of Medicine. Epilepsy and
seizure disorders.
Hawkins, R., Columbia University Col-
lege of Physicians and Surgeons.
Learning and memory: experi-
mental models.
Mishkin, M., National Institute of Men-
tal Health. Learning and memory:
primate models.
Gazziniga, M., Cornell University
Medical College. Cognitive disor-
ders.
Haase, A., Veterans Administration
Medical Center, San Francisco.
Viral infections: latency and defec-
tive particles.
Fields, B., Harvard Medical School.
Neurotropic viruses.
July 1-July 21
INSTRUCTORS
Bear, Susan, Ph.D., National Institutes of Health, Bethesda, Maryland
Berman, Michael, Ph.D., Frederick Cancer Research Facility, Frederick, Maryland
Enquist, Lynn, Ph.D., National Institutes of Health, Bethesda, Maryland
Silhavy, Thomas, Ph.D., Frederick Cancer Research Facility, Frederick, Maryland
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ASSISTANTS
Trun, Nancy, Frederick Cancer Research Facility, Frederick, Maryland
Zagursky, Bob Frederick Cancer Research Facility, Frederick Maryland
This course demonstrated the use of gene fusions, transposable elements, and
recombinant DNA for genetic analysis in Escherichia coli. Students learned to
construct gene fusions both in vivo and in vitro. Subsequent experiments
stressed the use of these fusions for monitoring gene expression and, in conjunc-
tion with transposable elements, for obtaining defined mutations (nonsense, dele-
tion, and insertion) either in the target gene or in regulatory genes. Recombinant
DNA was applied to clone and define physically the target gene, the regulatory
genes, and the sites of action of the regulatory proteins at the target gene. In
addition, the cloned DNA and the defined mutations were used to analyze the
genes and the regulatory system genetically. For the sake of clarity, the course
focused on a particular region; however, the experimental techniques presented
are sufficiently general to be applicable to any gene in E. coli for which there
exists a mutation conferring a recognizable phenotype.
PARTICIPANTS
Bardwell, James, B.S., University of
Wisconsin, Madison
Booth, Ian R., Ph.D., University of Ab-
erdeen, Scotland
Edwards, Mary Francis, B.S., Stan-
ford University, California
Gardiol, Alicia E., B.S., Michigan
State University, East Lansing
Hsiung, Hansen M., Ph.D., Eli Lilly
and Co., Indianapolis, Indiana
Jones, Helen M., B.S., University of
California, Los Angeles
Kirschner, Richard J., Ph.D., Upjohn
Co., Kalamazoo, Michigan
Niesel, David W., Ph.D., University of
Texas Medical Branch, Galveston
Olmedo, Gabriela, B.S., Centro De
Estudios Avanzados del I.P.N.,
Mexico City, Mexico
Sanfacon, Helene, B.Sc., Laval Uni-
versity, Quebec, Canada
Selvaraj, Gopalan, Ph.D., Carleton
University, Ottawa, Canada
Seto-Young, Donna L.T., Ph.D., Na-
tional Research Council of Can-
ada, Ottawa
Skvirsky, Rachel C., Ph.D., Simmons
College, Boston, Massachusetts
Stout, Valerie G., B.S., Kansas State
University, Manhattan
Vary, Patricia S., Ph.D., Northern Illi-
nois University, De Kalb
Welkos, Susan L., Ph.D., U.S. Army
Medical Research Institute, Fred-
erick, Maryland
SEMINARS
Austin, S., Frederick Cancer Re-
search Facility. Stability and main-
tenance of bacterial plasmids.
Howe, M., University of Wisconsin.
Bacteriophage Mu: properties and
uses.
Friedman, D., University of Michigan.
Protein and nucleic acid signals in
transcription termination and anti-
termination.
Wolf, R., Jr., University of Maryland.
Growth-rate-dependent regulation
of an E. coli central metabolism
gene, gnd.
Youdarian, R, University of Southern
California. Genetic analysis of pro-
tein-DNA interactions.
Beckwith, J., Harvard Medical
School. Genetic studies on the ba-
sis of the specificity of a DNA
binding protein, CAP
Roth, J., University of Utah. Selection
and analysis of bacterial chromo-
some inversions.
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Neurobiology of Drosophila
July 1-July 21
INSTRUCTORS
Jan, Lily Yeh, Ph.D., University of California, San Francisco
Jan, Yuh Nung, Ph.D., University of California, San Francisco
O'Farrell, Patrick H., Ph.D., University of California, San Francisco
Greenspan, Ralph J., Ph.D., Princeton University, New Jersey
ASSISTANT
Royden, Stanzi, University of California, San Francisco
This laboratory/lecture course was designed for people who may want to use
Drosophila as an experimental system for studying function or development of
the nervous system. One major aim was to introduce students to the various ge-
netic, molecular, and physiological techniques that are currently available in Dro-
sophila research and that make it distinctive.
The course began with a crash course on Drosophila genetics (a series of lec-
tures supplemented with laboratory demonstrations and exercises) to familiarize
the students with classical genetics of Drosophila, strategies of mutant isolation,
methods used to analyze newly isolated mutations, and mosaic analysis. This
was followed by workshops and laboratory projects on molecular genetics and
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electrophysiology. In the area of molecular genetics topics covered were strate-
gies and techniques for cloning genes, in situ hybridization to polytene chromo-
somes, PM hybrid dysgenesis, and DNA-mediated transformation, while the
electrophysiology section covered neuromuscular transmission and voltage
clamp analysis, as applied to mutants with altered ion channels. Additionally, a
series of lectures by invited speakers illustrated the application of these tech-
niques to current research. The research topics included: molecular and func-
tional analysis of mutants with distinctive ion channels, establishment of neuronal
pathways in the developing embryo as well as in imaginal discs, analysis of be-
havioral mutants, maternal and zygotic mutations that alter polarity and segmen-
tation, homeotic mutations, and the use of DNA transformation for the study of
gene expression.
PARTICIPANTS
Bredesen, Dale, M.D., San Francisco
General Hospital, California
Burnell, Anne, M.Sc., St. Patrick's Col-
lege, Kildare, Ireland
Caudy, Michael, B.S., University of
California, Berkeley
DiNardo, Stephen, Ph.D., University
of California, San Francisco
Hasan, Gaiti, Ph.D., Tata Institute of
Fundamental Research, Bombay,
India
Nash, Howard, Ph.D., National Insti-
tutes of Mental Health, Bethesda,
Maryland
Pollock,
versity, New York
Roof, Dorothy, Ph.D., Purdue Univer-
sity, Lafayette, Indiana
Shelton, David, B.A., University of
California, San Francisco
Taylor, Barbara, B.A., University of
California, San Diego
SEMINARS
Hall, J., Brandeis University. Muta-
tions affecting sexual behavior
and circadian rhythm.
Timpe, L., University of California,
San Francisco. Voltage-clamp
studies of Drosophila mutants.
Quinn, W., Princeton University.
Learning mutants.
Pak, W., Purdue University. Visual mu-
tants.
Spradling, A., Carnegie Institution of
Washington. Hybrid dysgenesis
and P-element transformation.
Use of transformation to dis-
amplification.
Cherbas, P., R. Schultz, Harvard Uni-
versity. Complexities of eukaryotic
transcription units and techniques
for studying transcription.
Ecdysone-inducible transcrip-
tion.
Molecular Biology of the Nervous System
July 5-July 18
INSTRUCTORS
Kelly, Regis B., Ph.D., University of California, San Francisco
McKay, Ronald D., Ph.D., Cold Spring Harbor Laboratory, New York
Levine, M., University of California,
Berkeley. In situ localization of
transcripts.
. Engrailed and homeotic loci.
Pardue, M.L., Massachusetts Institute
of Technology. Cytogenetics.
Bender, W., Harvard Medical School.
Molecular biology of mutation.
. Combining classical genetics
with molecular biology, homeotic
mutations.
Ghysen, A., University Libre de Brux-
elles. Sensory projections in hom-
eotic mutants.
Wyman, R., Yale University. Early em-
bryogenesis, segmentation mutants.
Thomas, J., Stanford University. Neu-
rogenesis in embryos.
Horvitz, R., Massachusetts Institute of
Technology. Cell lineage in nema-
tode.
Goodman, C., Stanford University.
Pathway formation in grasshopper
embryos.
The technologies of patch-clamping and immunochemistry have revolutionized
molecular neurobiology. Increasingly, the tools of recombinant DNA technology
and molecular genetics are being used to identify and characterize molecules
involved in neuronal function and development. The aim of this lecture course
was to familiarize the participants with recent developments in molecular biology
and to discuss their application to neurobiological problems.
287
The following topics were discussed: patch-clamping living cells and channels
in bilayers, gene cloning, DNA sequencing, regulation of gene expression, in vi-
tro mutagenesis, expressing foreign genes in heterologous hosts, in situ hybridi-
zation, transposable elements and hybrid dysgenesis, in vitro immunization, anti-
idiotype antibodies, T cell/B cell interaction, new optical and electron microscope
techniques, the cytoskeleton, organelle sorting and movement, regulation of
transmitter release, growth factors, cell lineages in development, assaying syn-
aptogenesis in vitro, surface molecules and the extracellular matrix.
PARTICIPANTS
Amador, Roberto, M.D., Rockefeller
University, New York, New York
Audigier, Yves, Ph.D., CNRS-INSERM
de Pharmacologie/Endocrinolo-
gie, Montpellier, France
Baldwin, Timothy, B.Sc., University
College London, England
Breer, Heinza, Ph.D., University Os-
nabruck, Federal Republic of Ger-
many
Calof, Anne, M.S., University of Cali-
fornia School of Medicine, San
Francisco
Cohen-Cory, Susana, B.S., Centro de
Investigation sobre Ingenieria Ge-
netica y Biotecnologia, UNAM,
Mexico City, Mexico
Earnest, Thomas, M.A., Boston Uni-
versity, Massachusetts
Estacion, Mark, B.S., University of
California, Irvine
Hescheler, Jurgen, Universitat des
Saarlandes, Hamburg, Federal
Republic of Germany
Hsiao, Karen Ke-jui, Ph.D., University
of California, San Francisco
Jennings, Charles, B.A., University
College of London, England
Kadan, Michael, B.S., Johns Hopkins
University, Baltimore, Maryland
La Gamma, Edmund, M.D., Cornell
University, Ithaca, New York
Lai, Yvonne, M.S., Rockefeller Univer-
sity, New York, New York
Maelicke, Alfred, Ph.D., Max-Planck
Institut, Dortmund, Federal Re-
public of Germany
McCabe, Joseph, Ph.D., Rockefeller
University, New York, New York
Michelsohn, Arie, B.A., California
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Institute of Technology, Pasadena
Miller, Stephen, B.S., California Insti-
tute of Technology, Pasadena
Sarlieve, Louis, Ph.D., INSERM et
Centre de Neurochimie du CNRS,
Strasbourg, France
Silverstein, Faye, M.D., University of
Michigan, Ann Arbor
Tipnis, Ulka, Ph.D., University of
Texas Health Science Center, Dal-
las
SEMINARS
Claudio, T., Columbia University, R.
Scheller, Stanford University. Char-
acterization of DNA. Cloning.
. Northerns. Southerns. Re-
striction maps.
. Mapping. Synthetic DNA.
cDNA and genomic libraries.
. Sequencing DNA. Electron
microscopy.
. Hybridization section.
Angerer, R., University of Rochester.
In situ hybridization.
Claudio, T., Columbia University. In-
troducing foreign genes into cells.
Costantini, F., E. Lacy, Columbia Uni-
versity. Introducing foreign genes
into the germ line.
Sharp, P., Massachusetts Institute of
Technology. Introduction to eukar-
yotic gene expression: processing
on the mRNA level.
Maniatis, T., Harvard University. Role
of DNA sequences in regulating
gene expression.
Evans, R., Salk Institute. Genomic
expression and regulation in bac-
teria.
Scheller, R., Stanford University, R.
Evans, Salk Institute. Current mo-
lecular research on the nervous
system.
Kennedy, M., California Institute of
Technology. Protein phosphoryla-
tion.
Solomon, F., Massachusetts Institute
of Technology. Cytoskeleton modi-
fication.
Siegelbau, S., Columbia University.
Phosphorylation and learning.
Getter, M., Massachusetts Institute of
Technology. Nature of the immune
response.
. Cell interactions in the im-
mune response.
Schinnick, T, Scripps, Clinic and Re-
search Center. Synthetic peptides
as antigens.
Alt, F., Columbia University. Molecular
basis of antibody diversity.
Lindstrom, J., Salk Institute. Func-
tional domains of the AChR.
Aldrich, R., Yale University. Introduc-
tion to patch-clamping.
Miller, C., Brandeis University. Recon-
stitution of channels in mem-
branes.
White, M., California Institute of Tech-
nology. Synthesizing and injecting
mRNA.
Khorana, G., Massachusetts Institute
of Technology. Genetic modifica-
tion of a proton pump.
Bender, W., Harvard University. Ge-
Molecular Embryology of the Mouse
netic approaches to development
using Drosophila.
Jan, L., University of California. Iden-
tifying the K" channel in Droso-
phila.
Gusella, J., Massachusetts General
Hospital. Mapping human genetic
defects.
Horvitz, R., Massachusetts Institute of
Technology. Genetics of nematode
development.
July 8-July 21
INSTRUCTORS
Hogan, Brigid, Ph.D., ICRF, Mill Hill, England
Costantini, Frank, Ph.D., Columbia University College of Physicians & Surgeons, New
York, New York
Lacy, Liz, Ph.D., Memorial Sloan-Kettering Cancer Center, New York, New York
ASSISTANTS
Robertson, Liz, University of Cambridge, England
Chada, Kiran, Columbia University, New York, New York
This course was designed for biochemists, molecular biologists, and cell biolo-
gists interested in applying their expertise to the study of mouse development. In
particular, the genetic manipulation of the mouse through the introduction of for-
eign genes and cells in early embryos was stressed. Through laboratory exer-
cises and lectures, the participants were introduced to the following procedures
and their possible applications: the isolation and in vitro culture of germ cells and
preimplantation and early postimplantation embryos, the microinjection of DNA
into fertilized eggs, nuclear transplantation, the formation of chimeras, dissection
of germ layers, the localization of antigens and mRNAs in embryonic tissue sec-
tions, and basic mouse handling and breeding techniques. Guest speakers dis-
cussed current research in related fields.
PARTICIPANTS
Brulet, Philippe, Ph.D., Institut Pas-
teur, Paris, France
Emerson, Beverly, Ph.D., National In-
stitutes of Health, Bethesda, Mary-
land
Gimlich, Robert, B.A., University of
California, Berkeley
Gross, Kenneth, Ph.D., Roswell Park
Memorial Institute, Buffalo, New
York
Linney, Elwood, Ph.D., La Jolla Can-
cer Research Foundation, Califor-
nia
Mendel, Jane, B.A., Massachusetts
Institute of Technology, Cambridge
Murray, Ben, Ph.D., Rockefeller Uni-
versity, New York, New York
Nepveu, Alain, Ph.D., Centre Hospi-
talier Universitaire, Sherbrooke,
Canada
Seising, Erik, Ph.D., Brandeis Univer-
sity, Waltham, Massachusetts
Sorge, Joe, M.D., Scripps Research
Institute, La Jolla, California
Vogt, Thomas, B.S., Fox Chase Can-
cer Institute, Philadelphia, Penn-
sylvania
Weaver, David, Ph.D., Massachusetts
Institute of Technology, Cambridge
Kollias, George, National Institute of
Medical Research, London, Eng-
land
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SEMINARS
Wasserman, P.M., Harvard Medical
School. Nature and expression of
the egg's receptor for sperm.
Damsky, C., Wistar Institute. Cell
adhesion molecules in embryonic
tissues.
Chapman, V., Roswell Park Memorial
Institute. Cell adhesion molecules
in embryonic tissues.
Silvery, L., Cold Spring Harbor Labo-
ratory. Mouse genetics.
Stuhlman, H., Whitehead Institute. Mi-
croinjection.
Copeland, N., University of Cincin-
Developmental Neurobiology
nati. Demonstration of blastocyst
injection.
Jenkins, N., University of Cincinnati.
Uterine transfer.
Solter, D., Wistar Institute. Post-im-
plantation mouse development.
. Transnuclear mice.
Silver, L., Cold Spring Harbor Labora-
tory. The T complex.
McLaren, A., MRC Mammalian Devel-
opment Unit. Origin and differen-
tiation of germ cells.
. Sex determination.
Mulligan, R., Whitehead Institute. Re-
troviral vectors.
Adamson, E., La Jolla Cancer Center.
Expression of growth factors, their
receptors, and oncogenes in
mouse embryos and teratocarci-
noma cells,
Rigby, Imperial College. Microinjec-
tion.
Posakony, J., Harvard University.
Gene insertion in Drosophila.
July 20-August 2
INSTRUCTORS
Purees, Dale, M.D., Washington University School of Medicine, St. Louis, Missouri
Patterson, Paul H., Ph.D., California Institute of Technology, Pasadena
The aim of this intensive two-week course is to expose a group of approximately
20 students to the history of ideas and classical literature on neural development,
with special emphasis on recent advances and controversies in this rapidly grow-
ing field. The course is offered every other year, and the session in 1984 repre-
sented its fourth cycle. In general, the information covered is not readily available
in a coherent form to students (especially those from abroad) because (1) many
important results are quite new, and (2) results both old and new rely on a wide
variety of technical approaches and are therefore not encompassed in any sys-
tematic way in courses arranged along conventional lines (e.g., courses on neu-
rocytology and neurophysiology). The course on developmental neurobiology
seeks to fill this gap inviting about 15 guest lecturers, distinguished by their di-
dactic skills as well as by their scientific accomplishments, to present their area of
interest to students in a relatively informal setting where student-faculty inter-
change and discussion are much encouraged. The lecturers are required to
teach their material as broadly as possible so the students will take away some
idea of the overall direction of research in neural development rather than spe-
cific accounts of the endeavors of a few individuals.
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This year's class of 23 students (a somewhat larger number of students were
accepted in 1984 because of the quantity of outstanding applicants) was com-
posed of 7 women and 16 men from 7 countries. The students were about
equally divided between postdoctoral fellows and advanced graduate students
already involved in some phase of developmental neurobiology. The research in-
terests of the students were extremely varied, ranging from behavior to molecular
biology; the only common denominator was an interest in pursuing research re-
lated to neural development.
PARTICIPANTS
Bovolenta, Paola, Ph.D., New York
University, New York
Buxbaum, Joseph, M.S., Weizmann
Institute, Rehovot, Israel
Camp, Ann, B.A., Vanderbilt Univer-
sity, Nashville, Tennessee
Coopersmith, Robert, B.S., University
of California, Irvine
DeGennaro, Louis, Ph.D., Max-
Planck-Institut, Martinsried, Fed-
eral Republic of Germany
Ferrari, Giovanna, Ph.D. New York
University, New York
Fladby, Tormod, University of Oslo,
Norway
Geijo, Emilio, M.D., University of Ali-
cante, Spain
Hitchcock, Peter, Ph.D., Salk Institute,
San Diego, California
Janowsky, Jeri, B.A., Cornell Medical
Center, New York, New York
LaMantia, Anthony-Samuel, B.A., Yale
University, New Haven, Connecti-
cut
Lefcort, Francis, B.A., University of
California, Berkeley
Levy, Daniel, Ph.D., Harvard Univer-
sity, Cambridge, Massachusetts
Lo, Donald, B.S., Yale University, New
Haven, Connecticut
Mack ler, Scott, B.A., University of
Pennsylvania, Philadelphia
Mikkelsen, Bente, M.D., University of
Oslo, Norway
New, Helen, B.S., University College
London, England
Ross, Jenny, B.S., University of
Otago, New Zealand
Schrank, Ethan, B.S., University of
North Carolina, Chapel Hill
Stretavan, David, B.S., Stanford Uni-
versity, California
Tessier-Levigne, Marc, B.S., Univer-
sity College London, England
Voyvodic, James, B.S., Washington
University, St. Louis, Missouri
Wolf, Werner, M.D., Max-Planck-Insti-
tut, G6ttingen, Federal Republic of
Germany
SEMINARS
Jacobson, M., University of Utah.
Early events in embryogenesis.
Rakic, P., Yale University. Cell prolifer-
ation and neuronal migration.
Bate, M., Cambridge University, Gra-
dients, compartments, and posi-
tional information in morphogene-
sis.
Horvitz, R., Massachusetts Institute of
Technology. Studies of cell lineage
in C. elegans.
Goodman, C., Stanford University.
Development of the grasshopper
nervous system.
Stent, G., University of California,
Berkeley. Development of the
leech nervous system.
Bray, D., Kings College, The growth
cone and mechanisms of axon
elongation.
Advanced Electrophysiological Methods
Landmesser, L.T, University of Con-
necticut. Axon outgrowth in verte-
brates.
Goodman, C., Stanford University.
Axon outgrowth in invertebrates.
Aguayo, A., McGill University. Axon
elongation in the central and pe-
ripheral nervous systems of mam-
mals: the role of glial cells and
other factors.
Greene, L., New York University Me-
dial Center. Studies of the mecha-
nism of action of nerve growth fac-
tor.
Sanes, J.R., Washington University
School of Medicine. Formation of
synapses in the central and pe-
ripheral nervous system.
Easter, S., University of Michigan.
Specificity in the retinotectal sys-
tem.
Edelman, G., Rockefeller University.
CAM and its role in development.
Nirenberg, M., National Heart and
Lung Institute. A possible molecu-
lar basis of positional information.
Shatz, C., Stanford University School
of Medicine. Development of the
mammalian visual system.
Hildebrand, J., Columbia University.
The development of behavior in in-
sects.
Nottebohm, F, Rockefeller University.
The development of birdsong and
its relevance to learning.
July 24-August 13
INSTRUCTORS
Ascher, Phillippe, D. Sc., Ecole Norma le Superieure, Paris, France
Schuetze, Stephen, Ph.D., Columbia University, New York, New York
Siegelbaum, Steven, Ph.D., Columbia University, New York, New York
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In this experimental course, students were introduced to the various electrophys-
iological techniques that are currently applied to the study of transmitter action
on ion channels in skeletal muscle and invertebrate neurons. They used both
basic voltage-clamp techniques (including a single microelectrode voltage
clamp) as well as the patch-clamp technique for single-channel recording. As-
pects of the theory of the techniques as well as some basic biochemical and bio-
physical principles of transmitter actions were also covered.
Advanced Techniques in Molecular Cloning
July 24-August 13
INSTRUCTORS
Atkinson, Thomas, B.S., University of British Columbia, Vancouver, Canada
Fiddes, John, Ph.D., California Biotechnology, Inc., Palo Alto
Short le, David,, Ph.D., State University of New York, Stony Brook
Smith, Michael, Ph.D., University of British Columbia, Vancouver, Canada
Zoller, Mark, Ph.D., Cold Spring Harbor Laboratory, New York
ASSISTANT
Pielak, Gary, University of British Columbia, Vancouver
PARTICIPANTS
Chuman, Mary, Ph.D., Rush Presby-
terian St. Luke's Medical Center,
Chicago, Illinois
Frederiksen, Kristen, M.S., Cold
Spring Harbor Laboratory, New
York
Hay, Bruce, B.A., University of Califor-
nia, San Francisco
Madison, Daniel, Ph.D., University of
California, San Francisco
Marshall, Cameron, B.S., Brown Uni-
versity, Providence, Rhode Island
Pitchford, Simon, B.S., University of
Bristol, England
Sigihara, Izumi, M.D., Tokyo Medical
School, Japan
Tobin, Thomas, Ph.D., State Univer-
sity of New York Downstate Medi-
cal Center, New York
Worley, Jennings, B.S., University of
Maryland, College Park
Zeitoun, Irene, M.S., Tel Aviv Univer-
sity, Israel
This was a laboratory and lecture course on advanced aspects of molecular
cloning designed for scientists who are familiar with basic recombinant DNA
techniques. It included the chemical synthesis of oligodeoxyribonucleotides of
defined sequence and their characterization by the Maxam-Gilbert sequencing
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method. These oligonucleotides were used in various ways, including their use
as probes for the isolation of specific genes from libraries and as reagents for
directing site-specific in vitro mutagenesis. Specific mutants were isolated, and
the sequence of the altered genes was determined. Other methods of in vitro mu-
tagenesis such as nucleotide misincorporation into DNA, sodium bisulfate treat-
ment of DNA, and linker insertion were covered in both laboratory exercises and
lectures.
Guest lectures and demonstrations covered the application of these tech-
niques to analysis of various cloned genes, as well as the use of alternate meth-
ods of mutagenesis, expression, and analysis of cloned genes by immunological
screening.
PARTICIPANTS
Cane, Jerome, B.S., Indiana Univer-
sity, Bloomington
Chaudhuri, Bhabatosh, Ph.D., Fried-
rich Miescher Institut, Basel, Switz-
erland
Dean, Carolyn, Ph.D., Advanced Ge-
netic Sciences, Oakland, Califor-
nia
Geller, Ruth, Ph.D., Walter Reed Army
Institute of Research, Washington,
D.C.
Giroux, Craig N., Ph.D., NIEHS, Re-
search Triangle Park, North Caro-
lina
Goff, Stephen, Ph.D., Harvard Medi-
cal School, Boston, Massachusetts
Hilt, Dana, M.D., National Institutes of
Health, Bethesda, Maryland
Hopper, Peggy, B.S., Tufts University,
Medford, Massachusetts
Mostov, Keith, Ph.D., Rockefeller Uni-
versity, New York, New York
Mroczkowski, Barbara, Ph.D., Van-
derbilt University, Nashville, Ten-
nessee
Rdest, Ursula, Ph.D., University of
Wurzberg, Federal Republic of
Germany
Robinson, Mary Ann, Ph.D., National
Institutes of Health, Bethesda,
Maryland
SEMINARS
Gumport, R., University of Illinois. The
role of homology in bacteriophage
site-specific recombination.
Goff, S., Columbia University. Muta-
tions in the gag and po/ genes of
Moloney murine leukemia virus.
Bogenhagen, Daniel, State University
of New York, Stony Brook. Tran-
scription of vertebrate mitochon-
dria! DNA.
Russell, D., University of Texas, Dal-
las. The structure of human low-
density lipoprotein receptor.
Davis, M., Stanford University. Isola-
tion and characterization of the T-
cell receptor gene.
Essigmann, J., Massachusetts Insti-
tute of Technology. Extrachromo-
somal probes for mutagenesis by
chemical carcinogens.
Meyers, R., Harvard University. Satu-
ration mutagenesis of eukaryotic
regulatory sequences.
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Yeast Genetics
July 24-August 13
INSTRUCTORS
Sherman, Fred, Ph.D., University of Rochester, New York
Fink, Gerald, Ph.D., Massachusetts Institute of Technology, Cambridge
Hicks, James, Ph.D., Cold Spring Harbor Laboratory, New York
ASSISTANT
Chiu, Isabel, Massachusetts Institute of Technology, Cambridge
The major laboratory techniques used in the genetic analysis of yeast were stud-
ied, including the isolation and characterization of chromosomal and mitochon-
dria) mutants, tetrad analysis, chromosomal mapping, mitotic recombination, and
test of allelism and complementation. Micromanipulation used in tetrad analysis
was carried out by all students. Recombinant DNA techniques, including yeast
transformation, filter hybridization, and gel electrophoresis, were applied to clon-
ing and genetic analysis of yeast DNA. Lectures on fundamental aspects of yeast
genetics were presented along with seminars given by outside speakers on top-
ics of current interest.
PARTICIPANTS
Bibus, Claudia, B.A., University of
Basel, Switzerland
Butt, Tauseef, Ph.D., Smith Kline &
French Laboratories, Philadelphia,
Pennsylvania
Chin, Jean, Ph.D., Harvard Univer-
sity, Cambridge, Massachusetts
Eisenberg, Shlomo, Ph.D., Weizmann
Institute, Rehovot, Israel
Folger, Kim, Ph.D., University of Utah,
Salt Lake City
Harmony, Judith, PH.D., University of
Cincinnati, Ohio
LaPorte, David, Ph.D., University of
Minnesota, Minneapolis
Lautenberger, Jams, Ph.D., National
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Cancer Institute, Bethesda, Mary-
land
Martin, Charles, Ph.D., Rutgers Uni-
versity, New Brunswick, New Jer-
sey
Nelson, Daniel, Ph.D., University of
Houston, Texas
Nolan, Catherine, Ph.D., National
Cancer Institute, Bethesda, Mary-
land
Pines, Ophrey, Ph.D., State University
of New York, Stony Brook
Rosendahl, Mary, Ph.D., Rockefeller
University, New York, New York
Sawadogo, Michele, Ph.D., Rockefel-
ler University, New York, New York
Varshaysky, Alexander, Ph.D., Massa-
chusetts Institute of Technology,
Cambridge
SEMINARS
Fox, T, Cornell University. Mitochon-
dria( genetics.
Warner, J., Albert Einstein College of
Medicine. Ribosomal genes: struc-
ture and regulation.
Kolodner, R., Dana Farber Cancer In-
stitute. Genetic recombination cat-
alyzed by cell-free extracts.
Wig ler, M., Cold Spring Harbor Labo-
ratory. RAS oncogenes in yeast.
Cantor, C., Columbia University. Sep-
aration of chromosome-sized DNA
molecules.
Fitzgerald-Hayes, M., University of
Massachusetts. Base-specific mu-
tations affecting centromere func-
tions.
Carlson, M., Columbia University.
Regulation and structure of yeast
invertase genes.
Lindquist, S., University of Chicago.
Yeast sporulation. heat shock pro-
teins and a whole lot more.
Tye, B.-K., Cornell University. Func-
tional components of yeast chro-
mosomes.
Broach, J., State University of New
York, Stony Brook. Control of plas-
mid replication in yeast.
Zoller, M., Cold Spring Harbor Labo-
ratory. Mutagenesis of the HO cut
site.
Botstein, D., Massachusetts Institute
of Technology. Genetics of the cy-
toskeleton and cell cycle.
Szostak, J., Dana Farber Cancer Insti-
tute. Yeast telomeres and artificial
chromosomes.
Silver, F, Harvard University. Nuclear
localization of proteins in yeast.
Prakash, S., University of Rochester.
Structure and regulation of DNA
repair genes.
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Seminars
Cold Spring Harbor Seminars were initiated to provide a semiformal avenue for
communication between the various research groups at the Laboratory. They are
particularly useful for research personnel who have joined the Laboratory during
the summer. The seminars also afford a necessary opportunity for the graduate
students and postgraduate staff to develop their skills in defending, organizing,
and presenting their research. In addition to those listed below, seminars were
given by many others involved in research at this Laboratory.
1983 -1984
September
Tom Curran, Salk Institute, San Diego, California: A com-
parative analysis of the viral and cellular fos oncogenes.
Richard Treisman, Harvard University, Cambridge, Massa-
chusetts: Expression of cloned globin genes in cultured
cells.
October
James Alwine, University of Pennsylvania, Philadelphia:
Control of Simian virus 40 late gene expression.
Edward Trifonov, Weisman Institute, Rehovot, Israel: Typical
secondary structures around splicing junctions.
Pat Hearing, State University of New York, Stony Brook:
Analysis of the Ad5 E1A-transcriptional control region
and sequences required for packaging of viral DNA.
Rob Jackson, Albert Einstein College of Medicine, Bronx,
New York: A genetic analysis of voltage sensitive so-
dium channels in Drosophila.
Pat Levitt, Medical College of Pennsylvania, Philadelphia:
Molecular specificity in stem cells in functional systems
of the brain.
Sayeeda Zain, University of Rochester School of Medicine
and Dentistry, New York:
I. Two different human liver mRNAs encode serum al-
bumin.
II. Development of a simple and efficient in vitro mRNA
splicing system.
November
Eric Hunter, University of Alabama, Birmingham: Mutations
that alter the biosynthesis of the Rous sarcoma virus en-
velope glycoprotein.
Saran Narang, National Research Council of Canada, Ot-
tawa: Total synthesis, cloning, and expression of human
preproinsulin.
Nils Loneberg, Harvard University, Cambridge, Massachu-
setts: Pyruvate kinase genes.
Elizabeth Blackburn, University of California, Berkeley: Mo-
lecular structures of telomeres in lower eukaryotes.
Paul Ludden, University of Wisconsin, Madison: Regulation
of nitrogenase in photosynthetic bacteria.
David Lowe, University of Toronto, Canada: The mouse hsp
70 gene family: Cloning of cDNAs from inducible and
constitutive mRNAs.
Rob Jackson, Albert Einstein College of Medicine, Bronx,
New York: A genetic analysis of voltage sensitive so-
dium channels in Drosophila.
Claude Dery, University of Sherbrooke, Quebec, Canada:
Structure of adenovirus chromatin in lytic infection.
December
Michael Young, Rockefeller University, New York, New
York: Transposable elements and mutations of a com-
plex locus in Drosophila.
Dirk Elseviers, New York University Medical College, New
York: Readthrough of nonsense codons: A tool for ge-
netics of proteins.
Neil Copeland, University of Cincinnati, Ohio: Endogenous
murine retroviruses: Molecular probes for dissecting the
mammalian genome.
Nancy Jenkins, University of Cincinnati, Ohio: Retroviruses
as insertional mutagens of mice.
Fred Alt, Columbia University, New York: Rearrangement of
endogenous and introduced heavy chain variable re-
gion gene segments in pre-B cell lines,
David Grumwald, University of Oregon, Eugene: Genetics
of zebra fish: A new approach to the study of vertebrate
development.
January
Hans Lehrach, European Molecular Biology Laboratory,
Heidelburg, Federal Republic of Germany: Molecular
studies of mouse chromosome 17.
Joe Moscal, National Institutes of Health, Bethesda, Mary-
land: Characterization and purification of a topographi-
cally distributed molecule in chick retina.
Richard Novick, Public Health Research Institute of the City
of New York, New York: Counter transcription regulation
of plasmid replication.
Bertrand Jordan, Center of Immunology, Marseille, France:
Structure and expression of human histocompatibility
genes.
James McCubrey, Basel Institute for Immunology, Sweden:
Gene transfer experiments with the functionally rear-
ranged immunoglobulin genes.
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February
Joanne Williams, University of California, San Diego: Reac-
tion center genes from Rhodopseudomonas sphae-
roides.
Walter Keller, German Cancer Research Center, Heidel-
berg, Federal Republic of Germany: In vitro splicing of
mRNA precursors.
Malcolm Casadaban, University of Chicago, Illinois: In vivo
genetics manipulations with bacteria phage Mu,
March
Marcel lo Siniscalco, Memorial Sloan-Kettering Cancer Cen-
ter, New York, New York: Fragile sites of human chromo-
somes and meiotic recombination.
Michael A. Lischwe, Baylor College of Medicine, Houston,
Texas: Nucleolar proteins: Phosphorylation, arginine
methylation, immunofluorescence, and scleroderma an-
tigen.
Charles Craik, University of California, San Francisco:
Expression and site-specific mutagenesis of rat pan-
creatic trypsin.
April
Kirsten Fischer Lindahl, Basel Institute for Immunology,
Sweden: Mitochondria and the mouse MHC.
Adrian Heyday, Massachusetts Institute of Technology Can-
cer Center, Cambridge: Activation of c-myc in human B-
cell lymphoma.
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Alan Senior, University of Rochester School of Medicine,
New York: The use of mutants in studies of E. coli pro-
ton-ATPase.
Masayori Inouye, State University of New York, Stony
Brook: A novel regulatory mechanism using an RNA
transcript complementary to a specific mRNA (micRNA).
Rick Myers, Harvard University, Cambridge, Massachu-
setts: Saturation mutagenesis of eukaryotic regulatory
sequences.
David Housman, Massachusetts Institute of Technology
Cancer Center, Cambridge: Gene mapping in mouse
and man.
Paul Bingham, State University of New York, Stony Brook:
Molecular Genetics of Drosophila transposons.
Tom Braciole, Washington University, St. Louis, Missouri:
Major histocompatability complex restricted cytotoxic T-
cells: What do they see?
May
Steve Cheley, University of Western Ontario, London, Can-
ada: Intracellular mouse hepatitis virus polypeptides
and RNAs.
Leone llo Bossi, University of Utah, Salt Lake City: Unusual
conformation of the DNA in a region upstream from a
bacterial promoter is associated with maximal levels of
expression.
June
Dave Pauza, MRC University Medical School, Cambridge,
England: Early events in human lymphocyte activation.
Undergraduate Research
An important aspect of the summer program at the Laboratory is the participation of
college undergraduate students in active research projects under the supervision of
full-time laboratory staff members. The program was initiated in 1959. Since that
year, 260 students have completed the course, and many have gone on to creative
careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the
fundamental principles of biology, (2) an increased awareness of major problem
areas under investigation, (3) better understanding of the physical and intellectual
tools for modern research and the pertinence of this information to future training,
and (4) a personal acquaintance with research, research workers, and centers for
study.
The following students, selected from a large number of applicants, took part in
the program, which was supported by the J.M. Foundation, Burroughs Wellcome
Fund, and Bayer Aspirin (Glen Brook Labs). Students are listed below with their
Laboratory sponsors and topics of research.
Mark Alfenito, Cornell University
Research Advisor: S. Dellaporta
Genetic and molecular study of maize controlling elements.
Catherine Chen, Massachusetts Institute of Technology
Research Advisor: B. Stillman
Analysis of the deg phenotype associated with mutations in
the gene encoding the adenovirus E1B 19K tumor anti-
gen.
Shinta Cheng, Yale University
Research Advisor: F. Daldal
Molecular genetics of cytochrome C2 of Rhodopseudomonas
capsulata.
Susan Euling, Columbia University
Research Advisor: D. Kurtz
Determination of tissue-specific alpha 2,1 globulin.
William Howell, University of Wisconsin
Research Advisor: P. Scolnik
Characterization of the end-sites of the DNA of the gene trans-
fer agent of Rhodopseudomonas capsulata.
Phyllis Kristal, Massachusetts Institute of Technology
Research Advisor: L. Silver
Developmental analysis of lethal mutations on mouse chromo-
some 17.
Mark Montgomery, Princeton University
Research Advisor: J. Lewis
Transcription studies with the cell-cycle-regulated Chinese
hamster thymidine kinase gene.
Ramona Morfeld, Wheaton College
Research Advisor: J. Hicks
Investigation of a transformation system in maize.
Jon Rubin, Harvard University
Research Advisor: D. Helfman
Isolation and characterization of cDNA clones encoding non-
muscle tropomyosin.
David Southern, University of Glasgow
Research Advisor: R. Sadaie
PCNA: The need for research.
Olney Fellow
Nasrollah Samiy, Harvard University
Research Advisor: F. Tamanoi
Expression in two oncogenes.
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Cold Spring Harbor Curriculum Study
The lag time between new discoveries in the laboratory-the basic stuff of sci-
ence-and their effective integration into secondary science teaching can be as
much as 10-15 years. Unfortunately, during this interval there has occurred a
revolution in biology whose vast social and economic implications promise to in-
fluence the lives of the current generation of youth profoundly.
The explosive advent of powerful techniques to probe the molecular structure
of DNA and proteins has fundamentally changed the focus of modern biology.
Unfortunately, present school curricula do not reflect this significant revolution or
its product- biotechnology. We are faced with an untenable situation: The biol-
ogy now being taught in high schools is of a different era and of a separate mind-
set than that which is currently being practiced at the laboratory bench.
In an effort to help close this gap, Cold Spring Harbor Laboratory has joined
with eight Long Island school districts in forming the Cold Spring Harbor Curricu-
lum Study-a cooperative project to improve teacher competence and to de-
velop model curricula on molecular biology, recombinant DNA, and biotechnol-
ogy. The program is funded by a $10,000 grant from Citibank, N.A., and
appropriations from the participating school districts: Cold Spring Harbor, East
Williston, Great Neck, Herricks, Jericho, Northport-East Northport, Oyster Bay,
and Syosset. Included in the $90,000 budget for the Curriculum Study's initial
year is over $40,000 in equipment needed to perform state-of-the-art experi-
ments that culminate in the production of recombinant DNA molecules.
For many years, the Laboratory was considered an ivory-tower institution,
aloof in an esoteric cloud from the average person. Now, through the Curriculum
Study, the institution is reaching out to share its knowledge and expertise with
the local community. By acting as a resource for public schools, we hope to help
establish Long Island as a nationwide leader in advanced science education.
The largest coordinated effort in the country to teach the "new biology," the Cur-
riculum Study will serve as a model for similar efforts, and the materials devel-
oped will find use in schools throughout the United States. The program is de-
signed to take a broad approach to the problems of biology education by
improving teacher competence and by developing new classroom materials and
methods. It is hoped that by effecting change at the top of the education pyra-
mid-at the level of administrators, science chairpersons, and teachers-benefits
will filter down to the largest number of students.
Teachers from participating districts take part in seminars presented by Cold
Spring Harbor Laboratory staff members and meet regularly to develop laborato-
ries and instructional materials. Enrichment activities for students include "honors
colloquia" at the Laboratory, a site visit to each school district by a Cold Spring
Harbor staff scientist, and an intensive 6-day workshop to be held during the
summer.
Science and Society
Few would argue the extent to which scientific advancements and new technolo-
gies affect our socioeconomic environment. On a personal level, technology
reorders our life-styles at a bewildering rate. On a public level, science- and tech-
nology-related issues play an increasingly important role in public policy. Al-
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though our involvement in technology is increasing at an exponential rate, public
understanding of the scientific factors that shape our lives lags far behind. Thus,
another goal of the Curriculum Study is to prepare students to evaluate more ac-
curately the social and ethical issues generated by the new biology."
Recent survey data indicate that Americans attribute our global prestige and
influence to our technological know-how. However, there is mounting evidence
that the United States is beginning to lose its advantage in international techno-
logical competition. Clearly, maintaining our technological edge demands a
strong commitment to developing new scientific talent. Yet, it appears that we are
failing to stimulate expansion of our scientific base at a grass-roots level in our
elementary and secondary schools. We seem to have forgotten that increased
emphasis on science education is the only way to keep up with the technological
realities of our rapidly changing world. Our technological competitors have long
realized this fact and have taken pains to expand their science curricula. Yet, we
have been too smug or too blind to see that we are in the same race with tech-
nology; science curricula in our secondary schools are steadily shrinking.
American students are required to take far fewer science and math courses
than are their peers in other countries. In Japan; the Soviet Union, and East Ger-
many, the vast majority of high school graduates have taken chemistry, physics,
and biology; the majority of American students take only 1 year of biology. Spec-
ialized science study in these countries begins in the 6th grade, with separate
courses in biology, chemistry, and physics.
Science Education Coming Full Circle
The scenario is not new. The launch of the Soviet satellite Sputnik in 1957 trig-
gered similar fears that the United States was losing its position as world leader
in technology. A public outcry demanded increased support of science educa-
tion. During the 1960s, an infusion of federal funds and leadership from the Na-
tional Science Foundation (NSF) stimulated a renaissance in secondary science
education-new curricular materials were developed and science teaching was
brought up-to-date.
By the mid-1970s, concern was replaced by complacency. The spectacular re-
sults of the space program and great advances in computer technology seemed
to indicate that we were, once again, ahead in the technology race. In an era of
social unrest, NSF-developed curricula were increasingly attacked as a source of
breakdown in traditional values. The NSF precollege program declined and was
essentially dismantled between 1980-82; curriculum development ground to a
halt.
Now we have come full circle. We stand at another watershed in science edu-
cation in this country. Over the past several years, numerous major assessments
of precollege science education have pointed to the urgent need for new efforts
to update science teaching. The government appears to have heeded the call;
the NSF budget for precollege education rose from $15 million in 1983 to over
$54 million in 1984. The Cold Spring Harbor Curriculum Study will stand at the
headwaters of this new surge in American science education.
Why Johnny Doesn't Learn Science
Children start out as "natural scientists." They routinely carry out investigations to
understand the world around them. Although science teaching should build on
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this natural inquisitiveness, recent surveys indicate that children acquire a dislike
for formal science at an early age and that these negative attitudes increase with
schooling. For the majority of students, there appears to be little growth in inter-
est or knowledge of science during the high school years.
The lack of student interest in science may stem, in large part, from inadequa-
cies in the way it is taught. The vast majority of science teachers rely heavily on
standard texts that tend to stress terminology and definitions. Thus, rote learning
of terms, which emphasizes only the academic aspects of science, is the major
component of precollege biology education. Little attention is paid to the real-
world applications of biology or its underlying unity with the chemical and physi-
cal sciences.
Although learning by doing has long been a goal of effective science teaching,
the sad fact is that our schools place too little emphasis on discovery learning.
Too often, teachers faced with overambitious syllabi and large classes opt to skip
the laboratory work that could make science more relevant to students. Short-
ages in supplies and equipment have drastically reduced laboratory time in the
secondary schools. Even when laboratories are used, they tend to be demon-
strations of information already presented, rather than true discovery learning. It
seems clear that although they may impart some formal knowledge of science,
current secondary biology curricula are failing miserably to prepare individuals to
understand better or participate in an increasingly technological world.
Why Teach Molecular Biology?
Despite the fact that DNA is the starting point of all life, its seminal importance is
not emphasized in current science curricula. Intuitively, it makes great sense to
focus biology teaching more closely on DNA. It provides a molecular basis upon
which can be built the major concepts of biology: the difference between living
and nonliving, development and the differentiation of tissues, reproduction, the
relationship between structure and function, and the diversity of life.
One criticism of science education is that it has become too aligned with dis-
crete academic disciplines. Survey data indicate that high school students are
frightfully ignorant of chemistry as it relates to life. This is a shame, because, in
practice, science is becoming less and less compartmentalized. A synthesis of
several disciplines, including genetics, microbiology, biochemistry, physical
chemistry, and physics, molecular biology highlights the unity of science. Since
many high school students' only introduction to science is in a general biology
course, it makes sense to stress chemistry and physics as it relates to life. Thus,
emphasizing a molecular biological approach would be a step toward teaching
"integrated" science, By providing an entrée to biotechnology, such a molecular
approach would feed students' interest in technology and demand for practical
relevance.
In addition to increasing knowledge of the pivotal role of DNA in life processes,
a major aim of the Curriculum Study is to stimulate awareness of career oppor-
tunities in biotechnology. Molecular biology is a science that will figure largely in
the future economic development of this nation. Like the explosive growth of
computer technology, biotechnology will provide unprecedented professional
opportunities in research and development. Students who participate in this proj-
ect will have a clear advantage in the competition for acceptance in science pro-
grams at prestigious universities. These students will be well prepared to pursue
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other enrichment activities, such as individualized research, projects for science
competitions, and part-time work at research institutions. This experience will be
especially crucial for students planning careers in biological research.
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Nature Study Program
The Nature Study Program gives elementary and secondary school students the opportunity
to acquire a greater knowledge and understanding of their environment. Through a series of
specialized field courses, students can engage in such introductory programs as Nature De-
tectives, Seashore Life, and Pebble Pups, as well as more advanced programs such as Marine
Biology, Nature Photography, and the Geology of Long Island.
During the summer of 1984 a new high of 525 students participated in the Nature Study
Program. Most classes were held outdoors, when weather permitted, or at the Uplands Farm
Nature Preserve of the Long Island Chapter of the Nature Conservancy. The Laboratory has
equipped and maintains a darkroom and classroom/laboratories at Uplands Farm. This facility
is used as a base for the student's exploration of the local environment. Field classes are held
on Laboratory grounds, St. John's Preserve, Shu Swamp Preserve, Montauk Point State Park,
the Long Island Pine Barrens, Caumsett Park, and in other area parks.
In addition to the four-week courses, a series of one-day marine biology workshops was
offered to students. Studies on the marine ecology of L.I. Sound were conducted aboard the
100 foot Sloop Clearwater chartered from Hudson River Sloop Clearwater, Inc. of Poughkeep-
sie, New York. Students were able to study the Sound chemically, physically, and biologically
using the ship's instrumentation. The three-day Adventure Education class took children on an
18 mile bike hike to Caumsett State Park, a six-mile canoe trip on the Nissequogue River, and
a day of sailing on the Sloop Clearwater.
PROGRAM DIRECTOR
Edward Tronolone, M.S., RD., Science Curriculum Associate,
East Williston Public Schools
INSTRUCTORS
Kathryn Bott, M.S., science teacher, Friends Academy
Ruth Burgess, B.A., naturalist, Nassau County BOCES
Eric Knuffke, M.S., science teacher, Mineola High School
Fred Maasch, M.S., science teacher, Islip High School
Paul Paino, M.S., science teacher, The Wheatley High School
Bill Payoski, M.S., science instructor, Nassau Community College
Linda Payoski, B.A., naturalist, Nassau County BOCES
COURSES
Nature Bugs
Nature Detectives
Advanced Nature Study
Introduction to Ecology
Frogs, Flippers, and Fins
Pebble Pups
Bird Study
Fresh Water Life
Seashore Life
They Swim, Walk, and Crawl
Geology of Long Island
Marine Biology
Nature Photography
Adventure Education
Marine Biology Workshop
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Facing page: A replica of an adenovirus particle decorates the gazebo built on top of the
Laboratory's waste water treatment plant.
FINANCIAL
STATEMENT
FINANCIAL STATEMENT
BALANCE SHEET
year ended December 31, 1984
with comparative figures for year ended December 31, 1983
ASSETS
1984 1983
COLD SPRING CURRENT FUNDS
HARBOR Unrestricted
LABORATORY Cash and Short-term investmentsAccounts Receivable
$10,963,401
317,217
$ 4,119,413
375,687
Prepaid expenses and other assets 679,516 289,940
Inventory of books 209,329 194,111
Due from restricted fund 351,938
Due from Banbury Center 115,810
Total unrestricted 12,521,401 5,094,961
Restricted
Marketable securities
(quoted market 1984-287,500) 212,500
Grants and contracts receivable 4,433,529 3,779,375
Due from unrestricted fund 660,906
Total restricted 4,646,029 4,440,281
Total current funds $17,167,430 $ 9,535,242
ENDOWMENT FUNDS
Robertson Research Fund
Cash 3,308,119 3,536,782
Marketable securities
(quoted market 1984-$14,435,055;
1983-13,466,772) 12,772,766 11,446,963
Total Robertson Research Fund 16,080,885 14,983,745
Olney Memorial Fund
Cash 1,693 4,623
Marketable Securities
(quoted market 1984-$33,247;
1983-$23,252) 29,418 27,538
Total Olney Memorial Fund 31,111 32,161
Total endowment funds $16,111,996 $15,015,906
PLANT FUNDS
Investments 759,318 454,212
Due from unrestricted fund 6,608,932 983,773
Land and improvements 1,129,875 1,129,875
Buildings 11,318,113 9,621,165
Furniture, fixtures and equipment 3,490,933 2,485,774
Books and periodicals 365,630 365,630
Construction in progress 1,461,489 960,709
25,134,290 16,001,138
Less allowance for depreciation
and amortization 4,861,975 4,013,770
Total plant funds $20,272,315 $11,987,368
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LIABILITIES AND FUND BALANCES
1984 1983
CURRENT FUNDS
Unrestricted
Accounts payable $ 747,261 $ 835,166
Deferred income 120,000 140,000
Due to Banbury Center 74,580
Due to plant fund 6,608,932 983,773
Due to restricted fund 660,906
Fund balance 4,970,628 2,475,116
Total unrestricted 12,521,401 5,094,961
Restricted
Accounts payable 65,792
Due to Banbury Center 8,952
Due to unrestricted fund 351,938 -
Fund balance 4,250,458 4,440,281
Total restricted 4,646,029 4,440,281
Total current funds $17,167,430 $ 9,535,242
ENDOWMENT FUNDS
Fund balance $16,111,996 $15,015,906
PLANT FUNDS
Accounts payable 121,055
Loan payable 8,000,000
Fund balance 12,151,260 11,987,368
Total Plant Funds $20,272,315 $11,987,368
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ASSETS
BANBURY CENTER
1984 1983
CURRENT FUNDS
Unrestricted
Cash 700 700
Prepaid and deferred expenses 19,184 15,025
Inventory of books 46,763 36,857
Due from Banbury restricted fund 95,505
Due from CSHL unrestricted fund 16,497
Total unrestricted 83,144 148,087
Restricted
Grants and contracts receivable 111,450 142,988
Due from CSHL unrestricted fund 58,083
Due from CSHL restricted fund 8,952
Total restricted 178,485 142,988
Total current funds 261,629 291,075
ENDOWMENT FUNDS
Robertson Maintenance Fund
Cash 597,661 494,054
Marketable securities
(quoted market 1984 -$2,347,644;
1983 -$2,314,259) 2,077,778 1,978,853
Total endowment funds 2,675,439 2,472,907
PLANT FUNDS
Land 772,500 772,500
Buildings 846,028 845,967
Furniture, fixtures and equipment 180,383 176,318
Construction in progress 1,385 1,386
1,800,296 1,796,171
Less allowance for depreciation 357,019 320,450
Total plant funds 1,443,277 1,475,721
Total Banbury Center $ 4,380,345 $ 4,239,703
Total-All funds $57,932,086 $40,778,219
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LIABILITIES AND FUND BALANCES
1984 1983
CURRENT FUNDS
Unrestricted
Accounts payable $ 18,466 $ 32,277
Due to CSHL unrestricted fund 115,810
Fund balance 64,678
Total unrestricted 83,144 148,087
Restricted
Accounts payable 1,394
Due to Banbury unrestricted 95,505
Fund balance 177,091 47,483
Total restricted 178,485 142,988
Total current funds 261,629 291,075
ENDOWMENT FUNDS
Fund balance 2,675,439 2,472,907
PLANT FUNDS
Fund balance 1,443,277 1,475,721
Total Banbury Center $ 4,380,345 $ 4,239,703
Total -All funds $57,932,086 $40,778,219
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CURRENT REVENUES, EXPENSES AND TRANSFERS
year ended December 31, 1984
with comparative figures for year ended December 31, 1983
1984 1983
COLD SPRING REVENUES
HARBOR Grants and contractsIndirect cost allowances on grants
$12,418,740 $11,650,901
LABORATORY and contracts 4,141,453 3,626,022
Contributions
Unrestricted 154,046 27,800
Restricted and capital 421,918 868,528
Long Island Biological Association 515,252 33,300
Robertson Research Fund Distribution 475,000 453,000
Summer programs 487,966 491,049
Laboratory rental 20,732 20,732
Marina rental 58,528 56,170
Investment income 775,231 481,992
Publications sales 1,512,667 1,655,691
Dining Hall 556,931 490,678
Rooms and apartments 309,924 216,179
Other sources 56,998 26,371
Total revenues 21,905,386 20,098,413
EXPENSES
Research* 10,628,482 10,098,170
Summer and training programs* 1,388,942 993,338
Publications sales* 1,276,015 1,306,539
Dining hall* 735,044 671,602
Research support 289,493 256,676
Library 236,255 223,117
Operation and maintenance of plant 2,179,543 1,921,985
General and Administrative 1,805,567 1,632,045
Depreciation 848,205 643,097
Total expenses 19,387,546 17,746,569
TRANSFERS
Capital building projects 2,003,456 1,738,298
Banbury Center to (from) 80,420 (80,420)
Total transfers- net 2,083,876 1,657,878
Total expenses and transfers 21,471,422 19,404,447
Excess of revenues over
expenses and transfers $ 433,964 $ 693,966
'Reported exclusive of an allocation for research support, operation and maintenance of plant, general and
administrative, library, and depreciation expenses.
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1984 1983
BANBURY CENTER REVENUES
Endowment income $106,000 $100,000
Grants & contributions 407,806 261,436
Indirect cost allowances on
grants and contracts 2,060 13,576
Rooms and apartments 65,757 76,522
Publications 102,410 191,993
Conference fees 14,697 54,096
Dining Hall 34,884 4,708
Transfer from (to) Cold
Spring Harbor Laboratory 80,420 (80,420)
Total revenues 814,034 621,911
EXPENSES
Conferences 171,095 206,659
Publications 128,181 126,618
Operation and maintenance
of plant 120,103 93,548
Programiiadministration 196,244 202,651
Depreciation 36,569 45,107
Capital plant 4,125
Total expenses 656,317 674,583
Excess (deficit) of revenues
over expenses $157,717 $(52,672)
NOTE: Copies of our complete, audited financial statements, certified by our independent
auditors, Peat, Marwick, Mitchell & Co., are available upon request from the Comptroller, Cold
Spring Harbor Laboratory.
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COLD SPRING HARBOR LABORATORY
SOURCES OF REVENUE
YEAR ENDED DECEMBER 31, 1984
Federal Grants and Contracts
48.7%
Endowments
3.2%
Foundation Grants
9.3%
Corporate Contributions
and Grants 12.0%
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Auxiliary Activities
17.1%
Private Contributions
5.2%
Interest and
Miscellaneous 4.5%

Recto: Detail of Carnegie Library, built in 1905 by the Carnegie Institution of Washington.
Originally designed as a laboratory, the building was refitted as a library in 1953 and partially
renovated in 1980 to house the Marketing offices.
GRANTS
January 1, 1984-December 31, 1984
COLD SPRING HARBOR LABORATORY
Duration of
Grantor Program/Principal Investigator Grant Total Award
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Projects
Research Support
Cancer Research Center, Dr. Roberts
Gene Organization, Dr. Sambrook
Dr. Beach
Dr. Blose
11/77-12/86
4/81- 3/86
12/84-11/87
12/78-11/87
18,604,426
5,626,997
361,511"
1,094,594
Dr. Feramisco 7/80- 7/86 686,968
Dr. Gething 2/83- 1/87 976,587
Dr. Hicks 7/81- 6/86 1,710,283
Dr. Hockfield 2/82- 1/85 282,400
Dr. Klar 7/81- 6/86 1,572,978
Dr. Klar 12/83-11/84 149,678
Dr. Kurtz 4/80- 3/86 606,389
Dr. Lin 9/82- 2/84 134,049
Dr. Mathews 4/80- 3/86 729,283
Dr. Matsumura 7/83-12/86 469,737
Dr. McKay 7/81- 6/84 288,546
Dr. Silver 2/82- 9/84 587,862
Dr. Stillman 7/83- 6/86 677,384
Dr. Topp 3/82- 2/84 279,134
Dr. Watson 4/84- 3/85 103,479*
Dr. Watson 4/83- 3/84 111,124
Dr. Watts 9/84- 8/87 254,731
Dr. Welch 4/84- 3/86 279,316*
Dr. Zipser 12/81-11/84 299,219
Dr. Zipser 12/83-11/86 358,081
Fellowships Dr. Bautch 9/83- 8/86 57,244
Dr. Flanagan 9/83- 9/85 36,204
Dr. Gerard 5/84- 4/86 38,204*
Dr. Ivy 1/82- 1/84 38,776
Dr. Krangel 10/82- 9/85 54,584
Dr. Livi 10/83-10/86 57,244
Dr. Quinlan 6/84- 5/87 57,244*
Dr. Roth 9/83- 8/85 36,776
Dr. Taparowsky 10/82-10/84 34,116
Dr. Welch 9/82- 3/84 29,332
Training Institutional, Dr. Grodzicker 7/78- 8/89 1,291,646
Course Support Advanced Bacterial Genetics, Dr. Hicks 5/80- 4/88 302,523
Cancer Center, Dr. Grodzicker 6/82-12/86 657,174
Neurobiology, Dr. Hockfield 6/79- 3/86 646,143
Neurobiology, Dr. Hockfield 5/82- 4/85 131,277
*New grants awarded in 1984.
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Grantor Program/Principal Investigator
Duration of
Grant Total Award
Meeting Support Ciliate Molecular Genetics, Dr. Watson 4/84- 3/85 7,000*
Modern Approaches to Vaccines, Dr. Watson 9/84- 8/85 10,000*
RNA Processing, Dr. Mathews 4/82- 4/84 12,500
Symposium: Recombination at the DNA Level, Dr.
Watson 4/84- 3/85 27,000*
Tubulin and Cytoskeletal Proteins, Dr. Watson 4/84- 3/85 10,500*
NATIONAL SCIENCE FOUNDATION
Research Support Dr. Malmberg, Dr. Hicks 3/84- 2/87 121,676*
Dr. Lewis 11/83-12/85 140,000
Dr. Roberts 1/83- 8/86 28,442
Dr. Roberts 1/83-12/86 200,000
Dr. Roberts 7/83-12/86 252,000
Dr. Tamanoi 7/82-12/84 88,000
Course Support Plant Molecular Biology, Dr. Hicks 5/81- 4/84 99,600
Plant Molecular Biology, Dr. Malmberg 5/84- 4/87 121,676*
Meeting Support Photosynthetic Apparatus, Dr. Watson 4/84- 3/85 4,000*
RNA Processing, Dr. Mathews 5/84- 4/85 5,000"
Symposium: Recombination at the DNA Level,
Dr. Watson 5/84- 4/85 6,480*
Tubulin and Cytoskeletal Proteins, Dr. Watson 4/84- 3/85 3,000*
Construction Plant Genetics Facility, Dr. Watson 12/83- 5/85 406,350
DEPARTMENT OF AGRICULTURE
Research Support Dr. Dellaporta 9/84- 8/86 100,000*
Meeting Support Photosynthetic Apparatus 1984 9,280*
DEPARTMENT OF ENERGY
Meeting Support Symposium: Recombination at the DNA Level 1984 9,000*
NORTH ATLANTIC TREATY ORGANIZATION
Meeting Support Photosynthetic Apparatus 1984 4,852*
NONFEDERAL GRANTS
Research Support
A.B.C. Foundation Dr. Wigler 5/82- 4/87 600,000
Rita Allen Foundation Dr. Stillman 1/83-12/87 150,000
American Cancer Society Dr. Chow 1/82- 8/84 85,255
Dr. Rossini 1/82-12/84 110,000
Dr. Stillman-Institutional 7/82- 6/85 80,000
Dr. Wigler 7/84- 6/86 200,000*
Cancer Research Institute Dr. Garrels 7/83- 6/85 72,000
Russell and Janet Doubleday
Fund General Support 1/84-12/84 20,000*
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Grantor Program/Principal Investigator
Duration of
Total Award
Exxon Research and
Engineering Company Cooperative Research 1/82-12/86 7,500,000
Robert G. Hatfield Fund General Support 1/84-12/84 2,000*
International Foundation for
Cancer Research Dr. Hanahan 10/84- 9/85 50,000*
McKnight Foundation Dr. Malmberg 3/83- 2/86 105,000
Monsanto Company Cooperative Research 10/84- 9/89 2,060,252*
Muscular Dystrophy
Association Dr. Garrels 1/80-12/84 100,000
Dr. Lin 1/81- 2/84 105,311
Dr. Mathews 7/83- 6/85 50,000
Dr. Matsumura 1/83-12/84 32,228
New England Biolabs Dr. Roberts 1/82-12/84 30,065
New York State Science and
Technology Foundation Dr. Garrels 10/84- 9/85 25,000*
William and Maude Pritchard
Charitable Trust Plant Molecular Biology 12/84-11/85 60,000*
Marie Robertson Memorial
Fund Neurobiology 1/84-12/84 125,000*
SUNY Stony Brook
(Subcontract) Dr. Topp 8/82- 1/84 9,597
Surdna Foundation Plant Molecular Biology 11/84-10/85 50,000*
Fellowships
American Cancer Society Dr. Young 8/84- 7/85 16,500*
Jane Coffin Childs Memorial
Fund for Medical Research Dr. Sundin 7/82- 6/84 32,000
Leukemia Society of America Dr. Hanahan 7/84- 6/86 44,280*
Dr. Powers 12/83-12/85 34,000
Dr. Sadaie 7/84- 8/85 34,000*
Muscular Dystrophy
Association Dr. Hellman 7/83- 6/85 37,000
Robert P Olney Memorial
Cancer Fund Graduate Research 1984 2,800*
Rockefeller Foundation Dr. Hicks 9/84- 8/85 25,900*
Damon Runyon-Walter
Winchell Cancer Fund Dr. Bhagwat 7/82- 6/84 35,000
Dr. Broek 6/84- 5/86 38,000*
Dr. Gallagher 7/84- 6/86 38,000*
Dr. Gerard 5/83- 4/84 17,000
Dr. Hearing 9/84- 8/86 38,000*
Dr. Hiatt 8/84- 7/86 38,000*
Dr. Mains 4/83-11/84 29,030
Dr. Patterson 4/84-12/84 12,743*
Dr. Sass 9/84- 8/86 38,000*
Dr. White 11/83-10/85 35,000
Helen Hay Whitney Foundation Dr. Herr 1/83- 6/84 39,250
Training
Metropolitan Life Foundation Undergraduate Research Program 1984 5,000"
Grass Foundation Neurobiology Scholarships 1980-1984 63,190
Alfred P Sloan Foundation Undergraduate Research Program 1984 20,000*
Visiting Nurse Service Undergraduate Research Program 1984 150"
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Grantor Program/Principal Investigator
Duration of
Grant Total Award
Course Support
Bayer Company (Glenbrook
Labs) Developmental Neurobiology 1984 3,500*
Charles E. Culpeper
Foundation Developmental Neurobiology 1984 10,000*
Epp ly Foundation for Research Neurobiology of Human Diseases 1984 21,000*
The Esther A. and Joseph
Klingenstein Fund Neurobiology 1982-1985 150,000
Metropolitan Life Foundation Developmental Neurobiology 1984 10,000*
Meeting Support
Advanced Genetic Sciences,
Inc. Photosynthetic Apparatus 1984 1,500*
Amicon Corporation Ciliate Molecular Genetics 1984 100*
Arco Plant Cell Research
Institute Photosynthetic Apparatus 1984 1,500*
J.T. Baker Chemical Company Ciliate Molecular Genetics 1984 100*
Boehringer-Manheim
Biochemicals Ciliate Molecular Genetics 1984 100*
Ciba-Geigy Corporation Photosynthetic Apparatus 1984 1,500*
Dow Chemical Company Photosynthetic Apparatus 1984 1,500*
Exxon Research and
Engineering Company Photosynthetic Apparatus 1984 1,500*
Fotodyne, Inc. Ciliate Molecular Genetics 1984 100*
H.P. Genenchem Ciliate Molecular Genetics 1984 320*
Hans Biologics, Inc. Ciliate Molecular Genetics 1984 250*
Johnson & Johnson
Biotechnology Center Inc. Modern Approaches to Vaccines 1984 5,000*
Kontes Glass Company Ciliate Molecular Genetics 1984 100*
Nikon, Inc. Ciliate Molecular Genetics 1984 200*
Promega Biotec Ciliate Molecular Genetics 1984 50*
Rhone-Poulenc, Inc. Photosynthetic Apparatus 1984 750*
Schleicher & Schuell, Inc. Ciliate Molecular Genetics 1984 100*
Shell Development Company Photosynthetic Apparatus 1984 1,000*
Society for Developmental
Biology, Inc. Ciliate Molecular Genetics 1984 1,500*
Standard Oil Company 1984 500*
(Amoco) Photosynthetic Apparatus 1984 1,500*
Stauffer Chemical Company Photosynthetic Apparatus 1984 500*
Wellcome Biotechnical Ltd. Modern Approaches to Vaccines 1984 5,000*
Construction
Pew Memorial Trust Monoclonal Antibody Facility 1981-1984 400,000
Equipment
Samuel Freeman Charitable
Trust Monoclonal Antibody Facility 1984 15,000*
William Randolf Hearst
Foundation Monoclonal Antibody Facility 1984 30,000*
McKnight Foundation Neurobiology Course 1984-1985 110,000*
Fannie E. Rippel Foundation Monoclonal Antibody Facility 1983-1984 100,000
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BANBURY CENTER
Grantor Program/Principal Investigator
Duration of
Grant Total Award
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Meeting Support Genetic Manipulation of Mammalian Ovum and Early 9/84- 8/85 9,550*
Embryo, M. Shodell
DEPARTMENT OF ENERGY
Meeting Support Risk Quantitation 4/84- 3/85 8,000*
OFFICE OF NAVAL
RESEARCH
Meeting Support Gap Junctions 1984 4,700*
NONFEDERAL GRANTS
Meeting Support
Council for Research Planning
in Biological Sciences, Inc. EPA Workshop 8/84-12/84 4,000*
Diamond Shamrock Biological Mechanisms of Dioxin Action 4/84- 3/85 2,000*
Dow Chemical, U.S.A. Biological Mechanisms of Dioxin Action 4/84- 3/85 2,000*
Hoffmann-La Roche, Inc. Biological Mechanisms of Dioxin Action 4/84- 3/85 5,000*
March of Dimes Genetic Manipulation of Mammalian Ovum and Early
Embryo 10/84- 9/85 7,500*
Monsanto Company Biological Mechanisms of Dioxin Action 4/84- 3/85 5,000*
Risk Quantitation 4/84- 3/85 5,000*
National Distillers & Chemical
Corporation Risk Quantitation 4/84- 3/85 1,000*
Alfred P. Sloan Foundation Journalists' Workshop 1984-1986 162,000*
Computational Neuroscience Workshop 7/84- 6/85 21,000*
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Corporate Sponsor Program
A heritage of pioneering research and prominence as a gathering place for sci-
entists from many disciplines make Cold Spring Harbor Laboratory an ideal win-
dow on the world of molecular biology and its applications to medicine and in-
dustry. The Corporate Sponsor Program was established in 1984 to offer a select
group of companies an opportunity to share that vantage point.
Considering that high-caliber research goes on within industry, as well as
within academia, the future demands that we foster closer ties within the entire
molecular biological community. Thus, a major goal of the Corporate Sponsor
Program is to encourage the flow of biotechnical information between academic
and industrial laboratories. Cold Spring Harbor and Banbury conferences pro-
vide an ideal context for this interaction: 260 scientists from 60 companies partic-
ipated in the 1984 meetings program.
The yearly commitment of $15,000 by each Sponsor ensures a stable base of
support for our meetings program, which had long been at the mercy of fluctua-
tions in government and foundation support. This core support has done much
to abate the insecurity that once shadowed our summer meetings program. Now
we can devote more time to planning timely conferences that meet the informa-
tion needs of the research community and less time scurrying about for funding.
Proceeds from the Corporate Sponsor Program entirely support a series of
Special Banbury conferences that deal with technical aspects of genetic engi-
neering especially relevant to industry. Combining high-level science with a rest-
ful country setting conducive to informal exchange, these meetings are unique in
science. The 1984 meetings were "Site Directed Mutagenic Approaches to Pro-
tein Structure and Function," "Yeast Cloning Vectors," and "Protein Transport and
Secretion."
Benefits to Sponsor companies include gratis attendance for six representa-
tives at Cold Spring Harbor meetings and Special Banbury conferences, gratis
Cold Spring Harbor and Banbury publications, and recognition in meeting ab-
stracts and publications.
1984 Members
Agrigenetics Corporation
Biogen S.A.
CPC International, Inc.
E.I. du Pont de Nemours & Company
Genentech, Inc.
Genetics Institute
Hoffmann-La Roche Inc.
Johnson & Johnson
Eli Lilly and Company
Molecular Genetics, Inc.
Monsanto Company
Pall Corporation
Pfizer Inc.
Schering-Plough Corporation
Upjohn Company
322
Long Island Business Cancer Campaign
For many years, the international scientific community has known what a great
asset Cold Spring Harbor Laboratory is to science. It is a sad irony that the labo-
ratory is not well known to many local people and, thus, remains one of Long
Island's best-kept "secrets." However, just as the world belatedly recognized the
achievements of CSH researcher Dr. Barbara McClintock with the 1983 Nobel
Prize, so, too, are Long Islanders now becoming aware of the great asset that
has quietly been at work in their own backyard since 1890.
The Long Island Association, the official chamber of commerce for Nassau
and Suffolk Counties, voted Cold Spring Harbor Laboratory as recipient of its
1984 Medal of Honor. This award was given "in recognition of the Laboratory's
vital work for the good of Long Islanders and all mankind."
In an era of shrinking government funding the private sector must assume a
larger responsibility for supporting biomedical research. The Long Island Busi-
ness Cancer Campaign offers businesses an opportunity to participate in the
Laboratory's research on the molecular basis of cancer. We hope that this local
cancer initiative will help build a greater sense of community on Long Island.
The 1984 campaign netted $50,000 in cash and donated equipment, which
was used in the development of the new monoclonal antibody laboratory. We
thank the following companies who joined in saying "Long Island is doing some-
thing about cancer."
Benefactor Contributors
Chemap, Inc. Castro Convertibles
Patrons ExecutoneGovernment Employees Insurance
Brinkmann Instruments Company
Entenmann's Bakery Hartman Systems
Grumman Corporation Hazeltine Corporation
Sponsors Jameco IndustriesMichelin Tire Corporation
Fortunoff's NEC America, Inc.
Long Island Savings Bank Olympus Camera Corporation
Long Island Trust Company Travelers Companies Foundation
Lumex
Manufacturers Hanover Trust Other Donations
Newsday Analytab Products, Inc.
Sperry Corporation Fairchild Weston Systems
Tampax, Inc. Health Extension Services
IJT Limited
Lawrence Aviation Industries
Photocircuits
Pinkerton's Inc.
R.J. Rudden Associates, Inc.
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CONTRIBUTORS
Mr. Christopher C. Abbot
ACTION for the Preservation and Conservation
of the North Shore of L.I., Inc.
Rita Allen Foundation
Ms. Judy Altman
Mrs. Charles E. Ames
Ms. Rosamond R. Arthur
Mr. George Avazis
Dr. & Mrs. Alfred Azzoni
Mr. & Mrs. William N. Bannard
Mr. & Mrs. Daniel Barsanti
Mrs. Robert E. Belknap
Mr. & Mrs. Thomas H. Belknap
Dr. Paul Berg
Ms. Barbara Berman
Mr. Bruno Bich
Edith Blum Foundation
Mrs. Shirley F Bowring
Mr. & Mrs. William Bremer
Mrs. Louise McDowell Brighton
Mr. & Mrs. James T Bryan, Jr.
Mr. & Mrs. Sydney G. Butler
Mr. Thorne Butler
Mr. Jeremiah J. Callahan
Mr. & Mrs. Samuel R. Callaway
Miss Patricia Casentini
Mr. & Mrs. Chaikowski
Dr. Lan Bo Chen
Mr. & Mrs. Beverly C. Chew
Citibank, N.A.
Mr. John P. Cleary
Columbia University
Dr. & Mrs. Crispin Cooke
Mr. & Mrs. Robert Cunningham
Mr. Roderick Cushman
Mr. & Mrs. George W. Cutting, Jr.
Mr. Lawrence L. Davis
Mr. & Mrs. John W. Dayton
Mr. Howard W. Dippel, Jr.
Mr. & Mrs. Lawrence Drennan
Mr. & Mrs. Richard T. du Moulin
Dr. & Mrs. Lester Dubnick
Duke University
Mr. & Mrs. Edgar P. Dunlaevy
Mr. William T Dunn, Jr.
Mrs. Emily Earley
Albert Einstein College of Medicine
Mr. & Mrs. Harold L. Fates
Mr. & Mrs. E.E. Fessenden
Folk Music Society of Huntington
Walter N. Frank & Company
Ms. Jamie Gagarin
Mr. Clarence E. Galston
Mr. & Mrs. John W. Galston
Mr. & Mrs. John W. Gates
Mr. & Mrs. Henry A. Gerry
Mr. & Mrs. Bentley Glass
Mr. & Mrs. Lawrence R. Glenn
Mr. & Mrs. Robert G. Goelet
Dr. & Mrs. Richard L. Golden
Ms. Gail W. Goltra
Mr. & Mrs. Oliver R. Grace
Mr. Frank Graven
Mr. Edward R. Greef
Mr. & Mrs. Richard Haar
Ms. Rochelle Habib
Mr. & Mrs. Hamilton Hadden
Harley Avenue P.T.A.
Mr. & Mrs. Henry U. Harris
Ms. Louise Harrison
Ms. Maxine Harrison
Mr. & Mrs. George Hegeman
Dr. William W. Heroy
Dr. Ira Herskowitz
Dr. Bernhard Hirt
Ms. Sandy Hoffman
Dr. Alexander Hollaender
Mr. Charles S. Hoppin
Mr. & Mrs. Abraham Hsie
The Hon. John P Humes
Mrs. David Ingraham
Mr. & Mrs. Richard M. Jackson
I. Janvey & Sons, Inc.
Mr. Abraham A. Janvey
Mr. David J. Kalal
Ms. Tae Kamihara
Mr. & Mrs. John P. Kipp
Mrs. T.W. Lapham
Mr. & Mrs. Ernest V. Lazio, Jr.
Mr. & Mrs. Richard E. Leckerling
Mrs. Louise Woods Levenson
Dr. & Mrs. Monroe Levin
Mr. & Mrs. George N. Lindsay
Mr. & Mrs. Robert V. Lindsay
Ms. Debbie Lipman
Mr. & Mrs. Russell W. London
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Long Island League to Abolish Cancer
Long Island University
Mr. & Mrs. William R. Lucas
Mr. & Mrs. Michael Luckey
Mktg. Inc.
Mr. John B. Marsh
Massachusetts Institute of Technology
Mr. & Mrs. Dick McAdoo
Miss Leila McKnight
Mr. Jo Zach Miller IV
Mr. William H. Miller
Mr. & Mrs. Daniel C. Mil lett
Mrs. Stella Monchick
Mr. & Mrs. F. Franklin Moon
Mr. & Mrs. John P. Morgan
Ms. Alice Morganstern
Mr. George Murnane
Mr. & Mrs. Francis W. Murray III
Mr. F Wisner Murray
Mr. & Mrs. Rem V. Myers
New York University
The Hon. Eugene H. & Marie-Louise Nickerson
Mr. & Mrs. Basil Northern
Mr. Charles Noyes
Mr. & Mrs. George D. O'Neill
Mr. & Mrs. Arthur W. Page
Mr. & Mrs. John Page
Mr. & Mrs. Walter H. Page
Mrs. Marcel Palmaro
Mr. Nicholas R. Parks
Parkway School
Ms. Irene Pelled
Rev. Linda Peyton
Ms. Pamela Peyton Post
Mr. J. Gardiner Pieper
Ms. Claire Platkin
Mr. & Mrs. Graham L. Platt
Mr. & Mrs. Richardson Pratt, Jr.
William and Maude Pritchard Charitable Trust
Ms. Mar len C. Robb
Mrs. Donald W. Rose
Mr. & Mrs. Jack Rosenbaum
Mr. & Mrs. Walter Rothschild
Mr. & Mrs. J.A. Rousmaniere
Ms. Rosina B. Rue
Mr. Quentin B. Sammis
Mrs. John K. Sands
Mrs. Norman Schaff, Jr.
Schiff Foundation
Dr. & Mrs. Carl Schmidlapp
Mrs. Franz Schneider
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Dr. & Mrs. Roland Sebbane
Mr. Willard Sektberg
Dr. & Mrs. W. Shropshire, Jr.
Memorial Sloan-Kettering Cancer Center
Dr. & Mrs. Robert Smirnow
Mr. & Mrs. William Smoot
State University of New York, Stony Brook
Mr. & Mrs. Thomas Steitz
Dr. Gunther Stent
Mr. Norman W. Stewart
Mr. & Mrs. Richard S. Storrs
Mrs. Jeannette Jennings Taylor
Mr. & Mrs. Evan W. Thomas
Ms. Joan P Tilney
Mr. & Mrs. E.T. Turner
Mr. & Mrs. Baxter Venable
Mr. & Mrs. Colton P Wagner
Mr. & Mrs. Sherwood Waldron
Waldron Memorial Fund
Mr. James C. Wang
Mr. & Mrs. Charles W.B. Wardell
Mrs. David E. Warden
Mrs. Ethelbert Warfield
Mr. Samuel Warren
Dr. James D. Watson
Ms. Phyllis Weekes
Mr.
Mr. & Mrs. Edward C.R. Whitcraft
Whitehall Foundation
Mrs. Fred Williams
University of Wisconsin
Yale University
In memory of . .
Mr. Robert Cavanagh
Mr. Aldo Esposito
Mr. Michael Foley
Ms. Mildred Sally Galan
Ms. Phyllis Kilkenny
Mrs. G. Kirstein
Mrs. Beatrice Levin
Mr. Salvatore Mannina
Mrs. Janet Psipsikas
Mrs. Sara Delano Redmond
Mr. Stanley Ross
Mrs. Mildred Smith
Mr. James Stais
Mr. Chester Stiles
Mr. Walter G. Uhl
Mr. Harry D. Williams
FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory is a nonprofit research and educational institu-
tion chartered by the University of the State of New York. Contributions are tax
exempt under the provisions of Section 501(c)(3) of the Internal Revenue Code.
In addition, the Laboratory has been designated a "public charity" and, there-
fore, may receive funds resulting from the termination of "private" foundations.
Because its endowment is limited and the uses of research grants are formally
restricted, the Laboratory depends on generous contributions from private foun-
dations, sponsors, and friends for central institutional needs and capital improve-
ments.
Over the years, the Laboratory has won a reputation for innovative research
and high-level science education. By training young scientists in the latest exper-
imental techniques, it has helped spur the development of many research fields,
including tumor virology, cancer genes, gene regulation, moveable genetic ele-
ments, yeast genetics, and molecular neurobiology. However, the continued de-
velopment of new research programs and training courses requires substantial
support from private sources.
METHODS OF CONTRIBUTING TO COLD SPRING HARBOR LABORATORY
Gifts of money can be made directly to Cold Spring Harbor Laboratory.
Securities You can generally deduct the full amount of the gift on your income tax return,
and, of course, you need pay no capital gains tax on the stock's appreciation.
We recommend any of the following methods:
(1) Have your broker sell the stock and remit the proceeds to Cold Spring Harbor Labo-
ratory.
(2) Deliver the stock certificates to your broker with instructions to him to open an ac-
count for Cold Spring Harbor Laboratory and hold the securities in that account
pending instructions from Cold Spring Harbor Laboratory.
(3) Send the unendorsed stock certificates directly to the Laboratory: Comptroller, Cold
Spring Harbor Laboratory, Cold Spring Harbor, New York 11724. In a separate enve-
lope send an executed stock power.
Bequests Probably most wills need to be updated. Designating Cold Spring Harbor Lab-
oratory as beneficiary ensures that a bequest will be utilized as specified for continuing
good.
Appreciated real estate or personal property Sizable tax benefits can result from such
donations; the Laboratory can use some in its program and can sell others.
Life insurance and charitable remainder trusts can be structured to suit the donor's
specific desires as to extent, timing, and tax needs.
Conversion of privation foundation to "public" status on termination This may be
done by creating a separate fund within Cold Spring Harbor Laboratory whereby the
assets of the private foundation are accounted for as a separate fund and used for the
purposes specified by the donor. Alternatively, the private foundation can be established
as a "supporting organization of Cold Spring Harbor Laboratory."
For additional information, please contact the Director of Information Services, Cold Spring
Harbor Laboratory, Box 100, Cold Spring Harbor, N.Y. 11724, or call 516-367-8397.
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LABORATORY
STAFF
Recto: Demerec laboratory extension, erected in 1983.
Laboratory Staff
Research Staff
David Beach
Stephen Blose
Susan Bonitz
Fevzi Daldal
Steven Dellaporta
James Feramisco
Robert Franza
James Garrels
Mary-Jane Gething
Yakov Gluzman
Terri Grodzicker
Douglas Hanahan
Edward Harlow
Winship Herr
James Hicks
Steven Hinton
Susan Hockfield
Amar Klar
David Kurtz
John Lewis
Daniel Lundell
Russell Malmberg
Michael Mathews
Fumio Matsumura
Richard Roberts
Mara Rossini
Pablo Scolnik
Clive Slaughter
Bruce Stillman
Fuyuhiko Tamanoi
Paul Thomas
William Welch
Michael Wig ler
Douglas Youvan
Mark Zoller
Postdoctoral
Research Fellows
Timothy Adams
William Addison
Dafna Bar-Sagi
Victoria Bautch
Ashok Bhagwat
Carmen Birchmeier
Philip Bird
Daniel Broek
Steven Cheley
Patricia Cotton
Claude Dery
John Diffley
Shimon Efrat
Thomas Flanagan
Gregory Freyer
Beth Friedman
Patricia Gallagher
Robert Gerard
Joan Harper
Janet Hearing
David Helfman
Andrew Hiatt
John Ivy
Tohru Kamata
Yuriko Kataoka
Antal Kiss
Krystyna Slaska-Kiss
Richard Kostriken
Michael Krangel
John Langstaff
Patsy Lin
George Livi
Janet Maclnnes
Kathy Martin
Shigeko Matsumura
Maureen McLeod
Elizabeth Moran
Scott Powers
Margaret Quinlan
Michael Roth
Reza Sadaie
Philip Sass
Petra Schumann
Toda Takashi
Susan Watts
Eileen White
Masao Yamada
Dalian Young
Sam Zaremba
Bradley Zerler
James D. Watson, Director
Joseph Sambrook, Assistant Director for Research
William R. Udry, Administrative Director
John Maroney, Assistant Administrative Director
William Keen, Comptroller
Jack Richards, Director Buildings & Grounds
Michael Shodell, Banbury Center Director
Genetics Research Unit
Carnegie Institution
of Washington
Alfred D. Hershey
Barbara McClintock
Visiting Scientists
Susan Alpert
Daniel Birnbaum
Ottavio Fasano
Asao Fujiyama
Nickolas Gillham
timothy Harrison
Mark Homonoff
Eric Hunter
Tohru Kataoka
Graduate Students
Robert Booher
Edward Bylina
Scott Cameron
Paul Chomet
William Costello
Carolyn Doyle
Margaret Kelly
Lonny Levin
Robert O'Malley
Gregory Prelich
Madan Rao
Nora Sarvetnick
Sreenath Sharma
Carmel la Stephens
Kevin Van Doren
Peter Whyte
Support Staff
Patricia Bird
Louisa Dalessandro
Joanne Dellaporta
Marilyn Goodwin
Christopher Keller
Philip Renna
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Regina Schwarz Rodney Chisum Elizabeth Ritcey
Joseph Suhan Mary Freedman Pauline Tannenholz
Madeline Szadkowski Connie Hallaran Michaela Taylor
Barbara Weinkauff Brian Klee
Eleanor Mathews
Sandra Penzi Library/Marketing
Laboratory Technicians Maureen Rice
Susan Rook Susan Gensel
Barbara Ahrens Douglas Sankar Library
Joy Applebaum Leonard Sansone Genemary Falvey
Carmelita Bautista Suzanne Vavrinec Laura Hyman
Georgia Binns Albert Yan Margaret Main
Gladys Blose Michela McBride
Christopher Bunn
Cecile Chang Medium Makers Marketing
Dolly Chao Ellen DeWeerdt
Jennifer Clarke William Eisner Monica Ewing
Joan Cossetti Margaret Falkowski Elaine Gaveglia
Debra Danna Marie Hallaran Amy Gibson
Kathleen Dinota Monika Stein Maureen Spirn
Louise Edlund Margaret Wallace
Barbara Faha
Linda Finn Accounting
Thomas Fischer Safety and Core
Jane Gould Facilities Services Accounting
Eric Grubman
Guy Cozza
Arthur Brings Fran GerardJean Henneberry Mary Ellen Goldstein
Sajida Ismail Safety Carolyn Kempf
Stephen Johann Marlene Rubino Dorrine Lambert
Karen Johnson
Nancy Kronenberg Computing Center
Fred Lukas
Michael Balamuth Carlos MendezMark Lacey Robert Pace
Alan Louis Harris Animal Facility June Polistina
Robert McGuirk Deborah Lukralle
Jeanne Mclndoo FulfillmentRichard ShubertLisa Miglio Charlaine Apsel
Carolyn Moomaw Connie Parra Ann Felton
Phyllis Myers Art Department Barbara Skelly
Kathy O'Neill Michael Ockler Barbara Terry
Diane Pascucci
Daniel Pollock David Greene Grants
DMichael Riggs ebra Lindner Susan SchultzJean MichaelisLinda Rodgers Patricia Kurfess
Nasrollah Samiy Technical Services Patricia Maroney
Carol Schley Robert Borruso
Patricia Scolnik August Dulis
Scott Silbiger Raymond Mickus Information Services
Susan Smith Clifford Sutkevich
Linda Vanderwal David Mick los
Gayle Waitches Jenny Flanagan
Elizabeth Waldvogel Publications Herb Parsons
Patricia Wendel
Heidi Wenzel Nancy Ford
Jeanne Wiggins Annette Kirk Personnel and MeetingsJonathan Wood Dorothy Brown William PutnamJudith Cuddihy
Laboratory Aides Joan Ebert Personnel
Adrienne Guerra Rita Duffy
Jennifer Brooks Martha O'Gorman Catherine Erb
Angela Ca lasso Douglas Owen Jacqueline Terrence
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Meetings
Maureen Berejka
Chris Bret
Gladys Kist
Merilyn Simkins
Barbara Ward
Purchasing
Peter Rice
Deon Baker
Sandra D'Arcangelo
Bruce Fahlbush
Steven Horly
GraceAnn Lovell
Thomas Maloney
James Sabin
Elissa Troisi
Central Administration
Roberta Salant
Andrea Stephenson
Buildings and Grounds
Administration
Charles Schneider
Barbara Cuff
Carpentry and Painting
Diamond Scarduzio
Joseph Brodawchuk
John Chilcott
Lawrence Daw
John Larsen
Thomas Lyden
John Meyer
Joseph Pirnak
Custodial Banbury Center
Charles Marshall
John Berejka
Joseph Canner
William Gardner
Daniel Jusino
Alfred Nickel
Richard O'Leary
Frank Russell
Steven Tang
Peter Tierney
Electrical and Mechanical
Maintenance
Robert Collins
Frank Messina
Jerry Reichert
Owen Stewart
Grounds
Hans Trede
Vincent Carey
Warren Eddy
Joseph Ellis
John Robert Fuchs
Christopher McEvoy
Anthony Zanoni
Housekeeping
Dorothy Youngs
Rita Abrams
Carol Caldarelli
Turid Faret
Barbara Robinson
Cherie Thurn
Plumbing
Lane Smith
Douglas Haskett
Security
Paul Anzalone
Banbury Grounds and Maintenance
Peter Stahl
Daniel Miller
Judith Blum
Dessie Carter
Katya Davey
Beatrice To liver
Scientific Staff
Departures during 1984
Senior Staff Scientists
Thomas Broker
Louise Chow
Jeffrey Strathern
Senior Staff Investigators
Stephen Hughes
Ronald McKay
Earl Ruley
Lee Silver
William Topp
Staff Investigators
Mitchel Goldfarb
James Lin
Visiting Scientists
Guang-Yun Cai
Kristen Frederiksen
Jin-Zhao Li
Postdoctoral Fellows
Richard Guilfoyle
William Huse
Prasad Koka
Nita Maihle
Paul Mains
Kazuo Maruyama
Olof Sundin
Elizabeth Taparowski
Stuart Weisbrod
Robert Weiss
Graduate Students
Chin Sheng Chou
Michele Manos
Kent Matlack
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Recto: Williams House (ca. 1850), rebuilt in 1977 with funds raised by LISA, provides five
apartments for staff scientists. It is named for Col. Timothy S. Williams, first president of LISA.
Officers Executive Committee
Mr. Edward Pulling, Chairman
Mr. George J. Hossfeld, Jr., Vice-Chairman
Mr. James A. Eisenman, Treasurer
Mrs. James J. Pirtle, Secretary
Mr. William R. Udry, Asst. Secretary-Treasurer
Directors
The Officers, also
Mr. Samuel R. Callaway
Mrs. Henry U. Harris, Jr.
Mrs. Richardson Pratt
Mrs. Donald Arthur
Dr. Alfred A. Azzoni
Mrs. Gilbert A. Ball
Mr. Edmund Bartlett
Mr. Samuel R. Callaway
Mrs. John P Campbell
Mrs. Miner D. Crary, Jr.
Mr. Arthur M. Crocker
Mr. Roderick H. Cushman
Mr. George W. Cutting, Jr.
Mr. Lawrence L. Davis
Mr. Joseph C. Dey, Jr.
Mr. Charles Dolan
Mr. James A. Eisenman
Mrs. R. Duncan Elder
Mrs. Henry U. Harris, Jr.
Mr. George J. Hossfeld, Jr.
Mr. Edward M. Lamont
Mr. Arthur C. Merrill
Mr. Grinnell Morris
335
Mrs. James J. Pirtle, Jr.
Mrs. Richardson Pratt
Mr. Edward Pulling
Mr. John R. Reese
Mr. Harvey E. Sampson
Mr. Stanley S. Trotman, Jr.
Dr. James D. Watson
Mrs. Alex M. White
The LONG ISLAND BIOLOGICAL ASSOCIATION (LIBA)
and Its Relation to the Cold Spring Harbor Laboratory
Biological research at Cold Spring Harbor began in 1890 when the Brooklyn Institute of Arts
and Sciences was looking for a place to set up a summer laboratory as the headquarters of its
Department of Zoology. Representatives of the Institute were invited by Eugene S. Blackford,
at that time the Fish Commissioner of the State of New York, to inspect a site on Bungtown
Road across Northern Boulevard (25A) from the Fish Hatchery. The site was found to be ideal,
and so the original Laboratory was organized with Mr. Blackford as president of the Board of
Trustees. The land was leased from Mr. John D. Jones, whose family since 1819 had operated
various industries including shipbuilding, coopering, and textile manufacture (later whaling,
also) at the head of Cold Spring Harbor. Bungtown Road, which runs through the Lab prop-
erty, got its name from the factory that specialized in making bungs-or stoppers-for barrels.
In 1892 the Laboratory's land was leased for a dollar a year from the Wawepex Society,
which Mr. Jones had organized as a corporation for holding real estate and for investing funds
for the propagation of fishes and for scientific research. In 1904 the Wawepex Society leased
additional land to the Carnegie Institution of Washington, which wanted to locate a Department
of Experimental Evolution in the Cold Spring Harbor area. Charles B. Davenport, who had
been directing the Laboratory since 1896, assumed the additional duties of director of the Car-
negie Institution's experimental station. It is interesting to note that Mr. Davenport lived in what
came to be known later as the Carnegie Dormitory, the Victorian house on 25A built by John
D. Jones before the turn of the century, and recently repainted in its original colors,
The Long Island Biological Association was established in 1924 when the Brooklyn Institute
decided to discontinue its research at Cold Spring Harbor and offered its laboratory to two
universities. Fortunately, a local group of interested neighbors decided to assume responsibility
for the Lab, and thus LIBA came into being. For 38 years LIBA actually operated the Labora-
tory in conjunction with the Carnegie Institution, but in 1962 it seemed advisable for the Labo-
ratory to be reorganized as an independent unit. Therefore, the property on which it now
stands was conveyed to it by LIBA, which, however, still retains reversionary rights. Today
LIBA is one of twelve institutions participating in the support of the Laboratory, each institution
being represented on the Laboratory's Board of Trustees.
What has happened, in effect, is that LIBA has become an expanding group of local
"Friends of the Laboratory" who help support it through annual contributions. Also, from time
to time, the Association undertakes campaigns to finance special important projects for which
the Lab cannot obtain funds from the Federal Government or from other sources. For instance,
in recent years, building the James Laboratory Annex and the renovation of Blackford Hall, the
rebuilding of Williams House, the acquisition of the land formerly belonging to the Carnegie
Institution, and (in part) the construction of the new Grace Auditorium.
The affairs of LIBA are handled by a board of 28 directors who are elected to office by the
membership at an annual meeting, At least twice a year LIBA members are invited to bring
their friends to a lecture or an open house at the Lab.
Membership in LIBA requires a minimum annual contribution (tax deductible) of $25 for
a husband and wife, $15 for a single adult, $5 for a junior member (under 21). Further
information can be obtained from the Long Island Biological Association, Box 100, Cold
Spring Harbor, N.Y. 11724, or by telephoning the Laboratory at (516) 367-8300.
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CHAIRMAN'S REPORT
At the Autumn meeting of the Board of Directors I was pleased to announce a sub-
stantial growth in the number of LIBA members during the year, also that the gener-
ous response to our campaign to raise at least $500,000 towards the cost of the
new auditorium indicated that we would be able to increase our contribution to
$600,000. At the annual meeting of LIBA members in December it was voted to do
this. Approval was given also to the directors' recommendation that our next project
should be the financing of a much needed documentary movie (or tape) depicting
the history and current research of the Laboratory.
As usual, LIBA members and their guests were invited to two lectures during the
year. At the first, the Dorcas Cummings Memorial Lecture, in May, our speaker was
Professor Ian Sussex of the Department of Biology at Yale University. Because of the
recently established Department of Plant Genetics at the Lab, Dr. Sussex appropri-
ately spoke on "The new plant genetics and its implications for biotechnology". He
lucidly explained how independent lines of research had come together in the past
few years to allow us to get a whole new approach to understanding how plants
develop and are regulated.
At the annual meeting in December we were most fortunate to secure as our
speaker Captain Eugene A. Cernan, U.S.N., who made three space flights for
NASA and, as commander of Apollo 17, was the last man to leave his footprints on
the surface of the moon. Captain Cernan described his fascinating experiences as
an astronaut and then went on to explain the advantages of outer space for scien-
tific research. As the overflow audience was leaving the auditorium we could hear
on all sides the comment that Captain Cernan's lecture was exceptionally interesting
and also inspiring.
The custom of giving dinner parties for visiting scientists during the June Sympo-
sium was successfully continued in 1984. It is a custom enjoyed equally by the sci-
entists and by their hosts and hostesses. This year's parties were given by
Mrs. Donald Arthur
Mrs. Gilbert A. Ball
Mr. & Mrs. John P. Campbell
Mr. & Mrs. Miner D. Crary
Mr. & Mrs. James A. Eisenman
Mr. & Mrs. Henry U. Harris, Jr.
Mr. & Mrs. Kennedy B. Middendorf
Mr. & Mrs. Grinnell Morris
Mr. & Mrs. Walter H. Page
Mrs. H. Irving Pratt
Mr. & Mrs. John K. Sands
Mr. & Mrs. Franz Schneider
Mr. & Mrs. Richard S. Storrs
Mr. & Mrs. Martin B. Travis
At the Annual Meeting regret was expressed that the terms of office as directors
for Messrs. Charles S. Gay and William F. Parsons, Jr. had expired. Their places
were filled by the election of Mrs. R. Duncan Elder and Mr. Roderick H. Cushman.
At a subsequent meeting of the Board of Directors the previous officers and
members of the Executive Committee were re-elected.
Edward Pulling, Chairman
Long Island Biological Association
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LIBA audience listens to . .
Capt. Eugene A. Cernan, U.S.N.,
describing life in outer space.
Members
of the Long Island Biological Association
Mr. & Mrs. Thomas Ackerman Mr. & Mrs. T.C. Cattrall, Jr. Mr. & Mrs. James C. Dudley
Mr. & Mrs. Amyas Ames Mr. & Mrs. Lionel Chaikin Dr. & Mrs. John L. Duffy
Mrs. Charles E. Ames Dr. Carton Chen Mr. Anthony Drexel Duke
Mr. & Mrs. Hoyt Ammidon Mrs. Helen Chenery Mr. & Mrs. Edgar P Dunlaevy
Miss Barbara Amott Mr. & Mrs. Beverly C. Chew Mr. & Mrs. William T Dunn, Jr.
Drs. Harold & Shirley Andersen Mr. Jan S. Chock Dr. & Mrs. Gerard L. Eastman
Mr. Robert W. Anthony Mr. & Mrs. Charles M. Clark Dr. & Mrs. James D. Ebert
Mr. & Mrs. J.S. Armentrout Mr. & Mrs. David C. Clark Mr. & Mrs. Paul S. Eckhoff
Mrs. Donald Arthur Dr. & Mrs. Bayard Clarkson Mr. & Mrs. James A. Eisenman
Dr. & Mrs. Joseph T August Mrs. Robert L. Clarkson, Jr. Mrs. Fred J. Eissler
Mr. & Mrs. Henry Austin III Mr. & Mrs. John P. Cleary Mr. & Mrs. Duncan Elder
Mrs. Robert W. Ayer Mr. & Mrs. Thomas N. Cochran Mr. & Mrs. Ashton G. Eldredge
Dr. & Mrs. Alfred Azzoni Dr. & Mrs. Peter Cohn Mr. & Mrs. Martin Elias
Mr. & Mrs. Henry D. Babcock, Jr. Mrs. C. Payson Coleman Mr. & Mrs. John Evans
Mr. & Mrs. Benjamin H. Balkind Mr. & Mrs. Francis X. Coleman, Jr. Mr. Henri Eyl
Mrs. Gilbert Ball Mr. & Mrs. John H. Coleman Mr. & Mrs. Raymond Z. Fahs
Mr. & Mrs. William M. Bannard Mrs. John K. Colgate Mr. & Mrs. Joel M. Fairman
Mrs. George C. Barclay Mr. & Mrs. Emilio G. Collado Mr. & Mrs. Harold L. Fates
Dr. & Mrs. Henry H. Bard Mr. & Mrs. Bradley Collins Mr. John R. Fell, Jr.
Mrs. Lila Barnes Mr. & Mrs. Patrick Collins Mrs. Allston Flagg
Mr. & Mrs. Edmund Bartlett Mr. & Mrs. Kingsley Colton Mr. & Mrs. Mario Fog
Mrs. Robert E. Belknap, Jr. Mrs. Ralph C. Colyer Mr. & Mrs. Joseph G. Fogg Ill
Dr. & Mrs. Stefan Belman Dr. & Mrs. Joseph B. Conolly, Jr. Mr. & Mrs. Henry L. Fox
Miss Linda Bennetta Dr. & Mrs. Crispin Cooke Mr. Walter N. Frank, Jr.
Mr. & Mrs. Loren C. Berry Mrs. Howard Corning, Jr. Mr. & Mrs. George S. Franklin
Mr. & Mrs. Robert P. Beuerlein Mr. Duncan B. Cox Ms. Mary Freedman
Mr. & Mrs. Nicholas Biddle, Jr. Mr. & Mrs. Charles L. Craig Mr. & Mrs. Jack B. Friedman
Mrs. William Binnian Mr. & Mrs. Miner D. Crary, Jr. Mr. Louis M. Fuccio
Mr. F Roberts Blair Mr. & Mrs. Arthur M. Crocker Mr. D. Kent Gale
Mrs. Mary Lenore Blair Mr. & Mrs. Robert Cuddeback Mr. & Mrs. Clarence E. Galston
Mr. & Mrs. Bache Bleecker Mr. Robert L. Cummings Mr. & Mrs. John W. Galston
Mrs. Margery Blumenthal Mr. Robert L. Cummings Ill Mrs. James E. Gardner, Jr.
Mr. & Mrs. Elito Bongarzone Mr. & Mrs. Richard T. Cunniff Mr. & Mrs. Robert Gardner, Jr.
Mr. & Mrs. A.L. Boorstein Dr. & Mrs. Paul Cushman, Jr. Mr. & Mrs. Charles S. Gay
Mr. & Mrs. Murray Borson Mr. & Mrs. Roderick H. Cushman Mr. & Mrs. Robert A. Gay
Dr. & Mrs. George Bower Mr. & Mrs. George W. Cutting, Jr. Mrs. Louis F Geissler, Jr.
Mr. & Mrs. William Braden Miss Lucy Cutting Mr. & Mrs. Harry Giffords
Dr. & Mrs. Arik Brissenden Mrs. Howard Dana Mr. & Mrs. Stephen E. Gilhuley
Mrs. Horace Brock Mr. Theodore H. Danforth Mrs. Ruth Reed Gillespie
Mr. & Mrs. F. Sedgwick Browne Mr. & Mrs. Norris Darrell, Jr. Mr. & Mrs. Robert Gilmore, Jr.
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